<SEC-DOCUMENT>0001396814-22-000050.txt : 20220803
<SEC-HEADER>0001396814-22-000050.hdr.sgml : 20220803
<ACCEPTANCE-DATETIME>20220803154651
ACCESSION NUMBER:		0001396814-22-000050
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220803
DATE AS OF CHANGE:		20220803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pacira BioSciences, Inc.
		CENTRAL INDEX KEY:			0001396814
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				510619477
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35060
		FILM NUMBER:		221132363

	BUSINESS ADDRESS:	
		STREET 1:		5401 WEST KENNEDY BOULEVARD
		STREET 2:		SUITE 890
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609
		BUSINESS PHONE:		813-553-6680

	MAIL ADDRESS:	
		STREET 1:		5 SYLVAN WAY
		STREET 2:		SUITE 300
		CITY:			PARSIPPANY
		STATE:			NJ
		ZIP:			07054

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pacira Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20101029

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIRA INC
		DATE OF NAME CHANGE:	20080318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Acquisition Corp
		DATE OF NAME CHANGE:	20070418
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>pcrx-20220630.htm
<DESCRIPTION>10-Q - PCRX - 6.30.2022
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:1acf2e72-2487-45a7-a11c-6bf309df42b1,g:86a623c9-da96-4e80-aae2-29b4daaaad57,d:5c712f7be21e495eb7af67327cbd7e07--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:pcrx="http://www.pacira.com/20220630" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pcrx-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV8zLTEtMS0xLTg2MTI3_0e0a2a94-9650-4039-829a-8af8960d490a">0001396814</ix:nonNumeric><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV80LTEtMS0xLTg2MTI3_c66d9871-8aa7-445a-acf4-3cdc5ebbc4d6">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV82LTEtMS0xLTg2MTI3_eaff17cf-d9f9-4c11-bebb-a1d341d02c57">2022</ix:nonNumeric><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV83LTEtMS0xLTg2MTI3_309efad3-337b-4678-9bc1-f28ffb83552e">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV84LTEtMS0xLTg2MTI3_553a5951-91be-4530-934b-0f8c374fe1e5">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ib06fd977f58642338910637dc9ee051e_D20210101-20211231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy0wLTEtMS04ODU1Mg_82e450ad-29e0-449d-a33a-5002227870d7">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006RetrospectiveMember</ix:nonNumeric><ix:nonNumeric contextRef="i5dd7ecccda904eaca960004478e3d7cf_D20220101-20220630" name="pcrx:AccountsReceivablePaymentTerms" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfMjk1OA_60482776-f82e-46b2-bdd2-45bb82b080c0">P0D</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i230c25fa74ac476dacc08c72752f5a63_D20170502-20170502" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182NC9mcmFnOmQyZWY2NTljNjg4ZTRiMmY4YWJiNWI5NjY3ZjYxMDQ4L3RleHRyZWdpb246ZDJlZjY1OWM2ODhlNGIyZjhhYmI1Yjk2NjdmNjEwNDhfMjQ0_524c4740-228d-4802-a0fe-2c34b05b4e43">0.0373413</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i292cd08d718c48e594813938f2045cca_I20220630" decimals="INF" name="pcrx:DebtInstrumentMarketPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182NC9mcmFnOmQyZWY2NTljNjg4ZTRiMmY4YWJiNWI5NjY3ZjYxMDQ4L3RleHRyZWdpb246ZDJlZjY1OWM2ODhlNGIyZjhhYmI1Yjk2NjdmNjEwNDhfMjc1_19ee4390-4eb2-476b-87d8-2f468fad0bcc">1.038</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if2e6ec6d226541d0822abc76ae23a4ea_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182NC9mcmFnOmQyZWY2NTljNjg4ZTRiMmY4YWJiNWI5NjY3ZjYxMDQ4L3RleHRyZWdpb246ZDJlZjY1OWM2ODhlNGIyZjhhYmI1Yjk2NjdmNjEwNDhfMzIw_f3f510c5-2e7b-40ca-9f95-aa0c19fbd4b1">.0139324</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pcrx-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i065f6b275a044a978b8835a167a0421e_I20220801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ibfe1468fe7344d909a88362d4b43314a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if1e299ef910a46358668913b0b2f165d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iaf4570f968674f3bbe27c560bfb9be87_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7284aa2c87d44f68ba483dff38427eec_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0df55d4c445d47adb69a0c7a9cd64df5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i872e83e0083747ac98f21041708778df_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeac445eb2804a44bf29e75079f90ec5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id57b66a9719a44e5b652fa1c6eea2346_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1899070b94594becb2264b63d5eea7dd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53613137983c432ca979eea4cef3c97d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic98bf5546d144ab99b2b83c44eb9cc95_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7ee03c49a9340679a4b219e33e24837_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0314b81a8a7c4118becd58eee01d8a94_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e93fd6ed579409bb376796f42c77e60_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccf3379ece1b49aea990c4cbfe1e487c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d0b4678edcd488697408216205ad39b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2c3caff01d94b05951897818e26b19d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5453e5f10bc4d4aa7d46326ba9a6399_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7067da57a3274ecf8bb92bb5fda7ddaf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0438bbb5f15b47bd8ab7763bf832a111_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie08d96e6b19e4981b99d8b86ea0ec01d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i777b16255019457c83b5ff68beb54018_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i185060e0af3c419b9d025a6ac414a2f5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95d1f5844c744661a795601ebc428092_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20af892b1391416d8055702cfd957969_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cecd213310d42d68564b49f725b9213_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i567c41f53acf4b4bae12b345b50893b0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id58a1548551d42eba0f5d2a6190bebda_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia659c853cae9490aae174ba93d4c6a36_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4392427a33b4b249cac4e1f1e0c7826_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7562b9b9bc8848fc8b1a14abdedbaf01_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf4fb171f06b4fec8794e510a10f6378_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d156e98f8514a71bf2585134d6222c5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9755c2106fc64b00958c9861c96d0980_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie21f1393db9f45fa9638f6757ed692e7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbf1abb3d2514d0f971d679c231c0a78_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4d8d5d2b3b942849ad9361740d23cec_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id12c8e6e979d472c83e9f7f03a527326_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e6079e472454d8fb92f206183fe3fe5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8530ce71c50341ceb2fe3a2f7c1ce761_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6ae8fb92c414c1c9c45317f16ffd7cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7debda168a402bbbfc0400a6f7fb72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02ecdd29c7414c46a2309f3f15aa4ef2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06fd977f58642338910637dc9ee051e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d66fc0f21124cb982ea945c36dceeba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0c67d9e97e742bfa7decef41c722bc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71d1eeb1f3f6452887a684bfaeb06c53_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40fceb10d076413aa7ec6129f9f379d7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i496381cd52774acb947c0ce28a210627_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e4e8f15d4b41d3bd530ae73c637d3a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2c30c32c194470fb58444961164cced_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dfdd1ff2fdf4d5ca8edd50b87a21dbe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67ba2e38a38f4c4c81d24bf4be710a79_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12b13809861f4e14b44f538d78e89322_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56eabe321e00448ea73bc225c791a124_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie355b25162354a51a4bc570c648c9f9e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a25b26562da46c48252ec4826cc94cf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b7745796664d7e8311edc369bcf819_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f182ffbc7a04691b94793c0d2ea763b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dc9a2abb73b42f889beb685eb78dd97_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id49160a04d45489ba6dde67831452514_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec41903ab5748ad8e93035d8503fcf3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>pcrx:product</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>pcrx:segment</xbrli:measure></xbrli:unit><xbrli:context id="ied39c8b2a0e847a5aafe78db72f6e93b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03aa3ab5fbee4d6896c79200467028e0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id48c04a202fa42f2867a0499bc23d873_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a665b7edb9415ebeb211b1577d0e34_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcb274e947a44a4e80b58a578e44dac3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a79f2001b894c3ea7b2a9c85bc4315c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d4cf75231141769e7cdbeaae57f7f8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39f4cab5dbc846cf86be5b20cc204e02_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if69a41444b6640d0b674261a2129cd82_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80247e37f19a4037b6459ac43a27bcd0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2059729d521343c3aa297a7c8e0d5961_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i574ac6f9ebfe47ff8dc15c79df815095_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecace58dec9b480d953f4cefa650d762_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie417a4089ec14158a8f46542e241d728_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a0b4f16e3040808a0a4267e092d844_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia484b08689c24460bdf7e5e604ec229e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ff898a5c1f4f7b89f0bc15a892e222_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed27d17e7e04841a903c038b2cd6d5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dcc7f6a743b4e1c826e40098ec5b555_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39f0d77661b4d21bd5c329207058dec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dd7ecccda904eaca960004478e3d7cf_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i137156d0fcb14f6083cfb7e0561f67e9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf70633f4d2743c483f890199a5aad26_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f1153b8275e426baedcb6cb32988ed3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c7a76e695d24007a56305d765b02b64_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74f4f821973e47688841421beb03e3aa_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i093201d8522546898104838bef2c7008_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c42c8c170474d2a954da97bce047946_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6903f565b296494fb0447554914bdfeb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac412655aca24aa0a92d19bfdb08ebfe_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i561be2fe92244f3c871d388185d4dbf7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0762b6431de84121b7b88717e0492b34_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7c1bb2dd8df417db479a9448b35c207_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ea87effbd54309b6396f1449ed1cb1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ccef0cf2b3a4d7aa7364dc01727ff19_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50dda10391554e928f44961a18eb294f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i577bddc29b634b9c8f0d64449773fe54_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e15ee9cbfaa484b99723cebd4de0305_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19c54c90141d46f5b4ed7575ff155dfa_D20211119-20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-11-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia90f47b531e341d18e987adf7e3cab92_D20211119-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pcrx:RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i521f1b4e7f96420b850707ae1c48fed0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6affd4b067a74053a80dafaecc998dce_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d78b23f2b384db1952457d16ecfc25a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3a7bcd6cd0649a3af561d8e804dfa32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0c585d3783403c875879dfaad021a3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee1c1e7325aa446388971997460585da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1509ca5743b4070b16fb4bc87afe9d7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i826ff833dd74486b9ea7e8f9bff4a586_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33dfed9d67c948b4a47a8e552ba5b8b0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b8d87ead91c4e5d9b76bca54c19862f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15e904416e0c433ca74cb7980b2e6633_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4be0edf10e0548a6b2cff393c65da1f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i763696419f734dfaa3b176b7f09e6547_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d0655252144469e8a6289d5d0cea2f3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if281a36c7ccc4a4aae4dad712d455bfc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a7ee7ba6eb240858ec746652a6fdc24_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i391acdd0982f425f84071afc5d969737_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>pcrx:lease</xbrli:measure></xbrli:unit><xbrli:context id="i29a197404c3243d9b8b707eb226c77fd_I20220701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83f2e14bdb904ac69fc8abf1f24b5ab6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="pcrx:MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis">pcrx:UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:SkyePharmaHoldingIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65d966ca6353411282f9165d72de2694_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib460bbff86ec431dbef5039959fb47c2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iede544d07eb8434cbb48cd6e2d2f78cf_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ee767a49874dee966e06f8b34939c7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a8f5d97b3248aeb01adea4b0c7fe72_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1658c43324b5453cb15e998032d6549e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9452190b1e4796b95b0775fa97bde7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i123f4f9994ab4fb68fe6439b61e60b8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76602afa0926462bbcd383a88f3f3ef8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc3334cacbe145ba953c4eed59a7b31b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i125dd11a1f7244a59ed136faf48d4dc0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i292cd08d718c48e594813938f2045cca_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c9dded19a964d11981b36b085b753ff_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4d6abb8ceed479bada14abc5c7d6b1b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7189f61d0f74daea85087e80f151740_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e4c5d796d09442cacf138a186e3cdec_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i356d1afe505c441eb90b0423c3fb17f2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86c516f1d6f04f26b3b01ed70a06cb25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c5268d5a41d453387099bbdce493860_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib78f8ec858814f8b9f80f0d166898244_I20211230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2012b55273641219ce287b6c7a3676c_D20220630-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id396246417f747219b1efc00393a410a_D20251231-20251231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-12-31</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14cfaef699694c8aa95e5b1497db08f8_I20261207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-12-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="payment"><xbrli:measure>pcrx:payment</xbrli:measure></xbrli:unit><xbrli:context id="i9713356e4b794cad87f61cdf66d71cda_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba15de8dac143c1b4bc141eea541035_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f34a25fd03649ce9d8283d456471160_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9511fd772a33485880857ed5ca7d851a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4de17e595d074a81bcbe5f3e180aa7ae_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae7a6225dc9403087ba9ca504bd5fb5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31ba252e9c0a48188e8038d7fcbf3bc2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb0b227a9c66456c9e5719df73099bd6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">pcrx:FederalReserveBankOfNYRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7caa5a1b4a74f499d82959cd49c6133_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3d5f239abc04c23a4020b220c65ce7b_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6590fbf0d3a9462e9127e6b54ee201c6_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd912dc0b8b41f3bd7d557dac967d17_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba8867ac2f1d4283b42fe8008031479f_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c1498310e443e7af3ba4aa7ad28e3a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsPriorToFebruary32023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i8fd9f584f9084e259a06bbfddce30195_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia62779f0fd434d20b021fcde6a57f24a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsOnOrAfterAugust12023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9395aa55649e4194b09292b57bc4118a_I20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e21d63eae54e80a8ef9375cebac9c5_I20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45a17b9799754d8382dc1b30711bd51f_D20211206-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3c970a4569147d397783bc1f4e7311d_I20211206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i991d1519897b4f2ea80c13d8da3de071_I20220107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i015d29a64d0646edbc9915f35b26c446_D20170301-20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-01</xbrli:startDate><xbrli:endDate>2017-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5b5fbc6d47e4f9f9e6d40924ce413db_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idecdb2c3fc1449cfab60ca69c9d1fe48_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37476438df894c20a4bc4a280d425eb6_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i230c25fa74ac476dacc08c72752f5a63_D20170502-20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-02</xbrli:startDate><xbrli:endDate>2017-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e6ec6d226541d0822abc76ae23a4ea_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e4721a6974c47a4b2d7646849bd93fd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c8cd2acac994e3fb138accb3626a770_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id24058253a50408188a9e11bcb502ad1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a50652bf64e4acb8120bf54d9198e87_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8e4e6f04e6b4ff791a9370ec1559121_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b8cad7de1da4c2db70aedc902c27e25_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16c8b9c91dac49cca9cd3167f0c77333_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87be4045b1ee4290b6f4d157746a446a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb17c50c746a4fb99da95cf89348f9ce_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie68e64f1b5724490a26fff0a570e6bba_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i724c52c24b4d431f9f6b2362fdc0f0e1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieede5540398c4dc58694079e2fb20f85_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4904ad55b53844fba2ec392689cda980_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if52a538e2d054df5b39586e4fac623ae_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idea088cac0574f4bb8455403924088b6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2c7ec07806341f485488028d8ebbf96_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2055f75ada8d436fb802dc413014b5c1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5f5585697664021b9b028fc12de735e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba288a5b7ff409c940d4b0449afb0cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e03211b48e14029b06e9f14140d2baa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c295ad4598945c2ba9f47a504b4472c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia819f5487dbc4bb38b0e991835be6ef0_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic59e7ba74b4b45cfab0ae29982cc8e9d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c4255beee6d40db938f1050821cc199_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65bfea142670495289d5c647467570b9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAndMyoScienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1587b3c1d7e7411cbd588e6bc0bfb723_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAndMyoScienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fc8018e6ec54834baf8d0e5d5a8d0db_I20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f0c78a9972546d4a4bf2bfb19a1c536_D20211119-20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-11-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d717792cb904a9c8671026179052f91_D20211119-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6168e02aa26e4349847195bf09c3eacf_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21ca7a53ce30416b93b74cd8a9870e74_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c49317fb1254c648300f85c536d596a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9835d59ac7914259affd398b5712be27_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c963cd0f8b24890b29f01580d4dafa6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e462270f4d749ada2b41a121bfaaf93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59c47ce6aa614060975818db7878464b_D20190401-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic35614cca1f842c6b25edec7754b753e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b2f0c4184a8447cb9800ac82b098ef2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie60dfafd369d49e9a8915074448de244_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f238205c3474a579a6577a0cfb931fc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib55aafc43f234774b601b8faca0c6b5d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15a06e8c3c614623bffeb6e3b147f2bf_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77eaafc589a34116b77b15bbc4fff3e5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2efee5eb27da4de2a1ed8e6d5e6eecd3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebe6ca8b87dc455e8cbf5d62768fb93d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee968166c6e54c399c9428c7ce8b8057_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc02a21d3efb40b2a085eac6cf253ef8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a822b3a761c4bf49157f47c28748111_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55e627016d97492ba0681471fbd8968c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f80639d084b4aa89ec55b9178bb46a1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a5bb2973c6b4c96abe3db554e6d078f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee16b76f339b45f1bc4250ddc76ad052_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd89bb1f4f08443fb61357d5cf825054_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0afc326973624dedabbf6ad485dfc1e5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i710e2f14bbb34bba99311d3b4e837f2f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf3fcd52747443ab910304b3bdf6b6e8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd1f2abc0e78467d927adac6fa878af8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc2e8e031b6c4f349a9a22d1b983860b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93ff7976ca834ff8be1fb773760bf3ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43ff4e22b20243b28a23578412c3b209_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb3acbf69765400b99cbf96568b817cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>pcrx:customer</xbrli:measure></xbrli:unit><xbrli:context id="id7c6f1c8ace3439a97adbf4622bc27e9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf44d8e1eb24bb38df6f546dbde1595_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic92dd8c00b21453d812274cd1558efeb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i364140fb0ecb4c5b90678acdcbc6f1ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6fb800aa91a443a8562539853dbd945_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1df9fb6c8864c09a8ff94e2cb57ad21_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeada0763b1349a6a781e82453974c12_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab2955eb68904b22a10de3106fc90299_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34fc14fcb0fe4ad4984107a1fefc0823_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie211f03ed1a748f1aa10a0c73727da12_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedea906cd76a4d4bba0431551477a909_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31ac85e1887749e4b9a817256cbd8b28_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48031d7bf51f42d489a3a3a50bf8e6af_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6cb2fdecf4b4a0a85c84a8fd76f0bbe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25d448a3f20f451b9239b04a6513c8cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08b536b7990b4e1894b876ae5ada1a24_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1995fc5495b4921bfb8486c9d6f9f19_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83f4b65463347e6a51d901c1e50e22e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e1e3475775b4e76ab6efcb59dd158f6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff0cddc2bc28438a8934112eb263d081_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c88759301c941b096aecd8a4937c534_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55eab178e9a043b1a145b43918fe8858_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a8f20a978a34500a4d487f8a56ade4b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i212b2c71c3a147c7a27ebf79f5a7c12e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20270789c96347f29c7c132e72ddd5c4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50d1f8b7f2c346eeb7844217241e3a36_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b1b5de0b8e42078315f31d7aef6b00_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a4c08595d646a1baa2a16e237083a6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifecfe644d38148929046d13feafd4dab_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf0d15f2737042a888b6d0615dc70cd1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7634d27564544329107cc50cd79208f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85df01f524b547a39620a6cd60ab5eae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ca303801f644e169133ec4d7e0c6998_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5b71027039a48cebc64faf0916105d2_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39a0a2f43861465f96e848700239814f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="offeringperiod"><xbrli:measure>pcrx:offeringPeriod</xbrli:measure></xbrli:unit><xbrli:context id="i43454386d0e64c9aa58f37a86d3898e1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i303f42a872d84848a26c7935521e8d9d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id76d6ea4321e4124937fc7c109c12121_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23b9728da5774e0f8865eb56c0287548_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb138ead7c8749139ab55dab62470f1f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cfbe4103aec4e4dbf93af04eba8abe1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0362692f03ce4f04b845f4ef84d3150e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd17b7148b4b4336ae3a8a8ab12951b8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a329b7adfca4c45be13dd71376e3285_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie39e757d15684b84b80beb859cc71a9a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5e85fea4b1749a0a9ab002bc71033a2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0baf3a23aeb847d8b41472f49c4054e5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i111e70709f1a49f58e7bc236e873db49_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80a72523d0c1401185af1aa98e145d67_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb41bddccc844a8b1608c8a5f1eb2f1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie519317e61de4bd4b61b769f86af2017_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7926f8178c944494b800dc70a8aee09b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b13dbca109f40d59b428f6eb0fcce41_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia852df3ea8e7487d833721f9de1ece5b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23cdbff094c5425f8aa1a90414d51f06_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae72f39fcbeb458cb1ae7c42c5e4d55e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33a60813e9f44095913e43e93a53efc0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i728ca8324e5149769ed4f7f8eb7732dc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ec452862f584d9196d9a07fc8b8ddc6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c65baa223334a0a825004fd918ececa_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21203a7e95a542a1bb5a7bdfa160cd8e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i812548bedd2c4f138ae40720d5ab3452_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d271c16dc5b4e50b5f8b6e36bc439dd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3eff8369f3a447bb8c7f19a5bccdce2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89ca9116e3b44efaa7a91cf17de3ff05_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1626a61d1e96472bb1b34f2c5b6812bb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i990dfdef52e040719fa28dbb661db8d9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib78e38aec2fa45a58c7a556502d296ac_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9662be69372649fdb9f55eaf2dddc1cb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77aff11637744366ad3beae32e8eac9d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie51cc6d770c1439bbf87e1a1246d6e15_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e717cf4ed5406d82a7bcd4eb4a20c9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56aff27448c64dbaacbbf8b0552a16b7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29042b95beda4bcf93f5b0e944d9e035_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8634775cc9bc464884a372b878f6a608_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf3a6876c8774d06bf57b261d16c5eaf_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic60ea8d3b79d48c4b025712186e3026c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe0d71dff18d49c48f2bf3e271341ed5_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:FortisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0b9052c119f49399daa2d218196b388_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifec5c95984324d979dd83044fa9e7ec4_I20200320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-20</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5c712f7be21e495eb7af67327cbd7e07_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDcz_b38602c7-c193-44d0-80c3-80e418688270">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Mark One)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6ZDRiZWJlMTg5YWVmNDk0ZmI1ODM2ZjBmNzI0NjY2ZmUvdGFibGVyYW5nZTpkNGJlYmUxODlhZWY0OTRmYjU4MzZmMGY3MjQ2NjZmZV8xLTAtMS0xLTg2MTI3_8c220ed5-a192-46cb-ad32-5e7e55d1e056">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8xMjg_21dfa1f9-2350-43fc-9018-174d92288f00">June&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6NWQ0NmMxOWJjY2Y4NDc5OWJkOGY5MGRlZjJkZGFlZjAvdGFibGVyYW5nZTo1ZDQ2YzE5YmNjZjg0Nzk5YmQ4ZjkwZGVmMmRkYWVmMF8wLTAtMS0xLTg2MTI3_4a29ae81-ae77-40fd-9d68-7c48acfccd73">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160; to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDgz_d4681c00-3f9d-43d6-93b6-a41bf6a9bcbb">001-35060</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="pcrx-20220630_g1.jpg" alt="pcrx-20220630_g1.jpg" style="height:96px;margin-bottom:5pt;vertical-align:text-bottom;width:246px"/></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc5_d942dc54-c07f-4ea6-a13b-5b4e60d12f38">PACIRA BIOSCIENCES,&#160;INC.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.435%"><tr><td style="width:1.0%"></td><td style="width:48.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6NWZmOWVkODYwZmFhNGE2YjhiYmVmYWRmOWYzMmM1NDUvdGFibGVyYW5nZTo1ZmY5ZWQ4NjBmYWE0YTZiOGJiZWZhZGY5ZjMyYzU0NV8wLTAtMS0xLTg2MTI3_6acf7e9d-ca1d-4a72-84e8-6e81802817b9">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6NWZmOWVkODYwZmFhNGE2YjhiYmVmYWRmOWYzMmM1NDUvdGFibGVyYW5nZTo1ZmY5ZWQ4NjBmYWE0YTZiOGJiZWZhZGY5ZjMyYzU0NV8wLTItMS0xLTg2MTI3_474c1f68-8cb3-4bdc-8969-7cbac9dcb363">51-0619477</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>&#160;Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDg0_68a8676a-f232-45e2-becc-d304ad315e16">5401 West Kennedy Boulevard, Suite 890</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc0_f7f488ff-6408-43e6-8947-74c917b6a0fe">Tampa</ix:nonNumeric>, <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDgw_c24cbd58-96bc-4984-aab1-3324f97503ec">Florida</ix:nonNumeric>, <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc2_fdaeb3c9-10d0-4556-97bd-73203ed4badc">33609</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address and Zip Code of Principal Executive Offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc3_67fc1298-0da9-4317-a22d-309de8ef6782">813</ix:nonNumeric>) <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDgx_a1fa4d45-4e5b-4df9-a2e7-e6833bdbdb7f">553-6680</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.758%"><tr><td style="width:1.0%"></td><td style="width:37.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Yzk4YjgzY2UxNjVjNDQyODkyY2EyYzU5ODc3YTFmNGQvdGFibGVyYW5nZTpjOThiODNjZTE2NWM0NDI4OTJjYTJjNTk4NzdhMWY0ZF8xLTAtMS0xLTg2MTI3_6f678c95-b6d6-497c-bb5d-eb267ba27b42">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Yzk4YjgzY2UxNjVjNDQyODkyY2EyYzU5ODc3YTFmNGQvdGFibGVyYW5nZTpjOThiODNjZTE2NWM0NDI4OTJjYTJjNTk4NzdhMWY0ZF8xLTItMS0xLTg2MTI3_ac695272-5493-4c3b-9f2f-d5446be72125">PCRX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Yzk4YjgzY2UxNjVjNDQyODkyY2EyYzU5ODc3YTFmNGQvdGFibGVyYW5nZTpjOThiODNjZTE2NWM0NDI4OTJjYTJjNTk4NzdhMWY0ZF8xLTQtMS0xLTg2MTI3_6694a5ae-7044-4d9b-afd2-e75bd507bd73">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDg1_426c2f4e-3a7b-4331-ba2f-bf76224c664d">Yes</ix:nonNumeric>   &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files.)&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc4_f5cf3aa9-4d89-4742-8c09-6f006f0e2c57">Yes</ix:nonNumeric>&#160;   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.168%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.168%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Njc5ZWMzOWViMzQ5NDkyNDlkODZhMDY3NDU1MTkyMjkvdGFibGVyYW5nZTo2NzllYzM5ZWIzNDk0OTI0OWQ4NmEwNjc0NTUxOTIyOV8wLTEtMS0xLTg2MTI3_98d3814d-98d2-4a40-aea6-d0e87384d16e">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Njc5ZWMzOWViMzQ5NDkyNDlkODZhMDY3NDU1MTkyMjkvdGFibGVyYW5nZTo2NzllYzM5ZWIzNDk0OTI0OWQ4NmEwNjc0NTUxOTIyOV8xLTUtMS0xLTg2MTI3_bf54ce5f-03b3-41f4-9891-a7ace7eaed3d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Njc5ZWMzOWViMzQ5NDkyNDlkODZhMDY3NDU1MTkyMjkvdGFibGVyYW5nZTo2NzllYzM5ZWIzNDk0OTI0OWQ4NmEwNjc0NTUxOTIyOV8yLTUtMS0xLTg2MTI3_49729089-f1e6-4e2a-9119-6dbcc0b70b78">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDgy_df2aef4f-fad7-4b94-a8b8-5f7a7b6d266e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Yes   &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August&#160;1, 2022, <ix:nonFraction unitRef="shares" contextRef="i065f6b275a044a978b8835a167a0421e_I20220801" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8xOTg1_15259543-28c2-4842-a899-d2e13946da34">45,824,210</ix:nonFraction> shares of the registrant&#8217;s common stock, $0.001 par value per share, were outstanding.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUARTERLY REPORT ON FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR THE QUARTER ENDED JUNE 30, 2022</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page #</span></td></tr><tr><td colspan="9" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_10">PART&#160;I. FINANCIAL INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_13">Item&#160;1.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_19">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_22">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_22">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_25">Condensed Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_25">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_28">9</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_31">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_94">Item&#160;2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_94">32</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_118">Item&#160;3.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_118">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_118">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_121">Item&#160;4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_121">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_121">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_124">PART&#160;II. OTHER INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_127">Item&#160;1.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_127">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_127">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_130">Item&#160;1A.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_130">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_130">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_133">Item&#160;2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_133">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_133">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_136">Item&#160;3.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_136">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_136">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_139">Item&#160;4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_139">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_139">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_142">Item&#160;5.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_142">Other Information</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_142">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_145">Item&#160;6.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_145">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_145">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_148">Signatures</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_148">52</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 3</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_10"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I &#8212; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%"> </span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FINANCIAL STATEMENTS (Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMy0xLTEtMS04NjEyNw_c5eb2787-291d-4c22-877c-076e4e168b7b">122,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMy0zLTEtMS04NjEyNw_daeddc55-3dd5-4165-a93e-b0aa81d6eea9">585,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Short-term available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNC0xLTEtMS04NjEyNw_3425b599-2d68-4e2a-9d40-e1d5ee453ca8">194,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNC0zLTEtMS04NjEyNw_e62b01ff-9a9e-4aea-995d-9114efe3e8c9">70,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNS0xLTEtMS04NjEyNw_8ab548d4-8fb9-42ff-a6ec-78ca86b543d2">91,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNS0zLTEtMS04NjEyNw_6c33fa80-e0aa-48bd-ae32-abcab87f273d">96,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNi0xLTEtMS04NjEyNw_70f14a42-238a-499e-944c-013c5533abbb">100,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNi0zLTEtMS04NjEyNw_53324c14-293a-47b1-b857-97bc0be24afe">98,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNy0xLTEtMS04NjEyNw_4826cb5f-b983-4fd9-b083-5c730e826efd">18,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNy0zLTEtMS04NjEyNw_20388e2d-6e96-4e4c-a502-1c2c67b69e21">14,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfOC0xLTEtMS04NjEyNw_224ff459-5e89-4b59-8842-04cd1896590c">526,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfOC0zLTEtMS04NjEyNw_0fcd2e95-3319-440e-ab80-a9db1f25e92e">866,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTAtMS0xLTEtODYxMjc_557963c9-a637-4d77-b4ff-baccb55c1659">191,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTAtMy0xLTEtODYxMjc_52bcd851-4c73-4d6e-affe-12319e35f909">188,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTEtMS0xLTEtODYxMjc_d596c213-8d6a-48b6-b5dd-07858e3bbbe5">72,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTEtMy0xLTEtODYxMjc_9a3c0113-081c-4dcb-889e-c89fa2577a86">76,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTItMS0xLTEtODYxMjc_6e8ffe54-7279-4f43-87fc-a3d541a478b3">146,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTItMy0xLTEtODYxMjc_0cbf3914-0340-4d3b-8da7-2d0381156a75">145,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTMtMS0xLTEtODYxMjc_881867e2-8185-458f-9ca2-9c6186aedf7f">595,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTMtMy0xLTEtODYxMjc_cd0195dc-9bb5-4a49-8b21-d8e9bc67b5e6">623,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTQtMS0xLTEtODYxMjc_0d319ed4-c48f-459e-9c51-d60a014b4388">167,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTQtMy0xLTEtODYxMjc_4c5ab739-e942-42b1-bddf-ecf3e23d78ec">153,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:EquityMethodInvestmentsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTUtMS0xLTEtODYxMjc_eb622caa-2a7f-487f-a6f6-58ecc232fcc0">35,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="pcrx:EquityMethodInvestmentsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTUtMy0xLTEtODYxMjc_dddb396d-20dc-4622-9f05-b828e87cc233">21,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTYtMS0xLTEtODYxMjc_1f809f81-ae4f-495e-aa2c-a323544fe695">1,733,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTYtMy0xLTEtODYxMjc_0111594e-d18d-4c76-897d-a1586b678a5a">2,075,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjAtMS0xLTEtODYxMjc_9d73120e-5a83-49e6-936d-7de1ba9a97e8">13,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjAtMy0xLTEtODYxMjc_c1607968-fde5-4a48-9483-57128b14006c">10,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjEtMS0xLTEtODYxMjc_74c08d75-e9dd-4bd1-a2f3-c176580739a3">77,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjEtMy0xLTEtODYxMjc_3b403a43-6e32-469d-8620-46e4bcbf99be">127,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjItMS0xLTEtODYxMjc_3cd0c9b3-c2d8-4116-94e8-6791a12994e2">8,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjItMy0xLTEtODYxMjc_8328ef8b-7aaa-48a1-8610-ec3c84455c48">7,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjMtMS0xLTEtODYxMjc_39cdb37a-cbbe-4716-b259-27b9f7e3cc23"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjMtMS0xLTEtODYxMjc_40aaad8e-7be3-4071-b5ae-4840257deeb6">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjMtMy0xLTEtODYxMjc_943ae2fe-967a-4f88-b17a-eaaba1f96f17"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjMtMy0xLTEtODYxMjc_b3da91c2-0c8c-4616-93a5-17f699a62b5a">350,466</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjUtMS0xLTEtODYxMjc_c27f8eda-dfb6-47e5-9b31-14150ffe276c">33,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjUtMy0xLTEtODYxMjc_fe750462-2d05-4322-89e8-ea555a52cffb">24,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjYtMS0xLTEtODYxMjc_c2b46f49-9fc3-403b-a8ab-f474de7b8be6">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjYtMy0xLTEtODYxMjc_ebfc0ec6-b2a2-4e78-b89d-de9d3f12c479">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjctMS0xLTEtODYxMjc_9f272e6d-bc4c-4afc-9d4d-b5f6ece4e57f">133,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjctMy0xLTEtODYxMjc_aa03062f-d0df-40fb-8ba4-8af248850fb7">521,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjgtMS0xLTEtODYxMjc_abbc0bc6-47c7-4480-8038-c2d74b2ebbff">403,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjgtMy0xLTEtODYxMjc_4f224eea-0822-426b-9488-8d6d4c9faf6a">339,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjktMS0xLTEtODYxMjc_f552c09a-66aa-4a66-8e38-aff9e34e5a41">318,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjktMy0xLTEtODYxMjc_cf17b822-6c1a-4929-9fe8-8f724a304369">335,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzAtMS0xLTEtODYxMjc_fef43669-83a3-42e5-8a4b-00ebd347c587">67,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzAtMy0xLTEtODYxMjc_e0377dbd-ffd1-407c-88eb-0127ee10284c">71,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:ContingentConsiderationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzItMS0xLTEtODYxMjc_852f7a16-0ea5-4ecc-8228-c528139e5ff4">35,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="pcrx:ContingentConsiderationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzItMy0xLTEtODYxMjc_98333c5d-23c1-4023-9774-b56e035fb15f">57,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzMtMS0xLTEtODYxMjc_ebfb48bd-4f97-4bed-99eb-4b53942ff544">19,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzMtMy0xLTEtODYxMjc_e8b8e48f-a309-481a-892f-1a1080cff62e">19,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzQtMS0xLTEtODYxMjc_07959387-7a6d-43fa-a2e5-bf043c6b817f">977,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzQtMy0xLTEtODYxMjc_25496763-a5b3-4793-a812-6b71a1cd9e40">1,344,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 16)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzUtMS0xLTEtODYxMjc_3fa6965e-e253-41bc-8079-8a315154afd7"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzUtMy0xLTEtODYxMjc_ae129100-795f-4bcd-8b86-6d34e1e21e1e"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl8zMQ_5e73da2e-2723-4160-962d-3dd186c56e56"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl8zMQ_de7de8f1-2f94-464a-b4f6-bc1e5842e5a5">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl8zNQ_100a265a-e6fe-4f2a-b7c2-88a19691ca84"><ix:nonFraction unitRef="shares" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl8zNQ_f3de7f39-b313-4e1e-aedc-8abd3b4a4480">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl81Nw_48238eaf-a3df-4c13-88ea-dfcc43f39f48"><ix:nonFraction unitRef="shares" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl81Nw_78decc01-afd2-4a88-883b-0682d9218710"><ix:nonFraction unitRef="shares" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl81Nw_e6a75cda-8002-4e21-9c9b-aca682a282bc"><ix:nonFraction unitRef="shares" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl81Nw_f1c88fa2-d074-4cca-9cd2-250ce5d4a3fd">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMS0xLTEtODYxMjc_aca2d0e6-3ecc-488e-ad3d-15efc1a53242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMy0xLTEtODYxMjc_65dbb43d-bc64-4d7c-b1ff-6184b85ccb02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV8yOA_028d7579-813a-40f3-8e40-e1444c0a9817"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV8yOA_76b4baef-7ef3-4e37-aae0-0f978f5dc5b6">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV8zMg_65e16a35-327b-4839-afd4-83055c146110"><ix:nonFraction unitRef="shares" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV8zMg_f16e56eb-b1b1-490f-9b6f-37e31ff7c1a9">250,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV81NA_25470ab4-e0b9-4e24-b6ea-dcb599867278"><ix:nonFraction unitRef="shares" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV81NA_7e6996e4-5cdf-488b-802b-25abf56ea7f8">45,801,578</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV82MQ_2fc204ab-4e21-4dff-ad38-520d7ef4b9bd"><ix:nonFraction unitRef="shares" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV82MQ_e2bc389f-d1c7-4d51-9e06-19edf74ba262">44,734,308</ix:nonFraction></ix:nonFraction> shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMS0xLTEtODYxMjc_e3058df4-a20e-4373-9769-4848d724eb67">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMy0xLTEtODYxMjc_487dfc20-72a5-4c25-9f8a-3f6759a7fa44">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzktMS0xLTEtODYxMjc_0d5e2a70-70d2-4bcc-9a56-ae5508af144a">895,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzktMy0xLTEtODYxMjc_c8ba0392-a559-445c-ae4a-3d35d0ec8beb">942,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDAtMS0xLTEtODYxMjc_19ebe11c-9e14-455f-89d0-cdea63eeb300">137,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDAtMy0xLTEtODYxMjc_9912e4a6-db3b-470f-8fee-5b9ea170a3a3">211,895</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDEtMS0xLTEtODYxMjc_8f9468f5-c753-462c-9e2d-b89f9ef0291e">605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDEtMy0xLTEtODYxMjc_9c1f614a-6a59-495c-85c2-d524d11599e4">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDItMS0xLTEtODYxMjc_48e0c467-7954-45cb-94d5-5a9dd87044d6">756,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDItMy0xLTEtODYxMjc_302fda93-813b-4409-bd5e-f7cd00cd1b01">730,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDMtMS0xLTEtODYxMjc_da6d6bd1-5f60-4dfe-ae6f-c78fbf68af79">1,733,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDMtMy0xLTEtODYxMjc_56fcdd55-5e49-418c-87ff-67a8f3d90116">2,075,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 4</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4570f968674f3bbe27c560bfb9be87_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMy0xLTEtMS04NjEyNw_e52e219b-9cab-4b25-8faa-ce85b426029f">168,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7284aa2c87d44f68ba483dff38427eec_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMy0zLTEtMS04NjEyNw_12c8d27c-27ed-482a-84e2-b0f99463782f">134,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df55d4c445d47adb69a0c7a9cd64df5_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMy01LTEtMS04NjEyNw_a626d10d-3595-482f-b69d-7f15e5593157">326,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872e83e0083747ac98f21041708778df_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMy03LTEtMS04NjEyNw_70c80cc7-d0a5-4e15-80dd-594fe06ab942">253,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeac445eb2804a44bf29e75079f90ec5_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNC0xLTEtMS04NjEyNw_b1216e20-0477-4ede-9116-792270f35eff">830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57b66a9719a44e5b652fa1c6eea2346_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNC0zLTEtMS04NjEyNw_ebfdb45a-f629-4b65-afe7-28c0eeb9db1e">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1899070b94594becb2264b63d5eea7dd_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNC01LTEtMS04NjEyNw_9abc6346-2f22-4a88-97a9-4ba1dcef5171">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53613137983c432ca979eea4cef3c97d_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNC03LTEtMS04NjEyNw_0db560cc-f486-4efa-b934-ebdc5d0ad2a8">891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative licensing and milestone revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98bf5546d144ab99b2b83c44eb9cc95_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNS0xLTEtMS04NjEyNw_463e51b7-58dd-45ee-9f97-a7ad7f782373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ee03c49a9340679a4b219e33e24837_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNS0zLTEtMS04NjEyNw_c2184068-3a28-44d8-b617-4a5a6e7266f8">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0314b81a8a7c4118becd58eee01d8a94_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNS01LTEtMS04NjEyNw_a722f9f0-265e-49ce-8c45-78c823659a30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e93fd6ed579409bb376796f42c77e60_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNS03LTEtMS04NjEyNw_9683ab7f-e9fb-4381-98ba-7e565f072c01">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNi0xLTEtMS04NjEyNw_8b2f6fa0-48ec-4977-b37e-95ae32b9ba35">169,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNi0zLTEtMS04NjEyNw_1b8ff1dd-fec0-48df-ba55-8a14a58ab0f8">135,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNi01LTEtMS04NjEyNw_9f72e920-bbe8-4734-b57f-b1f90c2f2a11">327,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNi03LTEtMS04NjEyNw_dd1def58-9a9b-40ca-9159-dd437b44218c">254,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOC0xLTEtMS04NjEyNw_034f8a77-62ed-4752-843e-3922c9a03300">50,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOC0zLTEtMS04NjEyNw_8736a8d4-7d72-4139-a65f-a68758d1cbd2">35,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOC01LTEtMS04NjEyNw_6ab9b3cd-da25-4e5a-80ff-20b55a588224">86,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOC03LTEtMS04NjEyNw_3b76a3ce-2922-4ba7-bc76-174eaa27da4a">66,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOS0xLTEtMS04NjEyNw_d16819e1-8e15-4702-a422-5864bbed0956">26,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOS0zLTEtMS04NjEyNw_da432cc5-bde7-4472-9961-87c9705da4bd">12,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOS01LTEtMS04NjEyNw_3f5bdaeb-1052-4308-ba43-9391ee9a2f55">47,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOS03LTEtMS04NjEyNw_f6eea932-071e-426b-86dd-55f26bd6dc6f">28,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTAtMS0xLTEtODYxMjc_e2913f15-e099-47d3-9349-9b760a7abf53">65,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTAtMy0xLTEtODYxMjc_9992bd88-f4dc-4baa-b42c-4b45c654c124">50,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTAtNS0xLTEtODYxMjc_baff6aa5-cba7-48be-9679-d87bb89614a6">129,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTAtNy0xLTEtODYxMjc_5ed61ded-5145-4897-8cfb-f09089c3d558">99,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTEtMS0xLTEtODYxMjc_2615610e-c3e1-4194-8a0b-864630420a96">14,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTEtMy0xLTEtODYxMjc_1dda6341-8341-46ab-84c7-639d1e263c7d">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTEtNS0xLTEtODYxMjc_427e0afb-6d36-4dc9-a9b8-8ef08de62259">28,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTEtNy0xLTEtODYxMjc_2f731c57-ec65-4ca3-a3f0-beb2f0ee2c91">3,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related (gains) charges, product discontinuation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTItMS0xLTEtODYxMjc_86ba6025-c93b-4bfd-a372-06bb29a86bd6">18,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTItMy0xLTEtODYxMjc_fd66af17-927f-4791-8000-a6d942f9559d">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTItNS0xLTEtODYxMjc_979773a8-b3ad-48f6-90a9-cffb58bd7d0d">13,721</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTItNy0xLTEtODYxMjc_aca04532-5287-4997-a430-ef35fe5b6308">2,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTMtMS0xLTEtODYxMjc_61b77207-6804-45b1-b25c-9ad9e139d3b7">138,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTMtMy0xLTEtODYxMjc_40fe5132-4697-41d2-ab88-ef4898c99311">100,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTMtNS0xLTEtODYxMjc_ffda57cc-4e06-42fb-ab90-224b620f6a0f">278,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTMtNy0xLTEtODYxMjc_41ffb6f8-0c9e-4bca-a0a8-9d12b93f6b84">200,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTQtMS0xLTEtODYxMjc_7d9baf08-b30c-43e4-a65c-feb6f3d34215">31,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTQtMy0xLTEtODYxMjc_17e039cf-5f11-4366-98b0-75c2aabeb2a6">34,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTQtNS0xLTEtODYxMjc_b8c0699b-d9bc-484e-b6b2-fb43204a3a71">48,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTQtNy0xLTEtODYxMjc_be99974d-256b-407a-b0ba-72983ae7d665">54,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTYtMS0xLTEtODYxMjc_b7503372-4a59-4c5c-8c42-f9c212297968">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTYtMy0xLTEtODYxMjc_563bd809-3148-4932-80c0-e72222bdb6a2">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTYtNS0xLTEtODYxMjc_54e1fb2e-d8fe-4e8d-9cf8-18d5fc07a468">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTYtNy0xLTEtODYxMjc_ffcecd9b-fae2-4680-b487-642b59c17c45">639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTctMS0xLTEtODYxMjc_69b58715-1884-4f3a-8fdc-3470461c1327">8,833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTctMy0xLTEtODYxMjc_b9d0b951-d7ff-42b7-8482-1bdf0b1b31d7">7,023</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTctNS0xLTEtODYxMjc_0cef3dee-00f2-45ff-8185-820091bf8fb1">19,079</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTctNy0xLTEtODYxMjc_2c2a5223-bffb-4009-b976-5d8f219460df">13,994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTktMS0xLTEtODYxMjc_3604fe3c-bd87-42b8-ab5c-bd9d0a5f23a1">647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTktMy0xLTEtODYxMjc_d03c4eb3-4fc2-4c21-a5c3-f9f449a40efe">2,396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTktNS0xLTEtODYxMjc_23e36f21-e8ba-4208-9d4c-c5c76f2fbb53">771</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTktNy0xLTEtODYxMjc_87f1d12d-f7f1-445e-acef-a5959c066ae2">2,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjAtMS0xLTEtODYxMjc_fef5e389-4617-4d92-bdae-1837783960d9">9,228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjAtMy0xLTEtODYxMjc_ba35fb12-a305-47b2-9f54-a8a3915abb92">9,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjAtNS0xLTEtODYxMjc_ce2efb09-4cd6-4e0e-8f30-cca79a8e92b7">19,327</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjAtNy0xLTEtODYxMjc_2d3be483-e4a5-41d2-a5fe-41d69cf32f98">15,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjEtMS0xLTEtODYxMjc_191c8c42-ac57-461e-aae8-73f9a90c7f61">22,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjEtMy0xLTEtODYxMjc_fa000da0-ff72-4d43-986c-dca0823af1a2">25,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjEtNS0xLTEtODYxMjc_10e47049-4c89-4087-930a-6abf702c33b3">29,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjEtNy0xLTEtODYxMjc_ac35f001-f590-41c4-8a6f-f2619dee9403">38,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjItMS0xLTEtODYxMjc_589b3d2d-a751-4f73-9a97-f5bce6fb96fd">2,131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjItMy0xLTEtODYxMjc_ba7b8cd4-f83a-42e3-9a2c-7e671b852d7f">6,567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjItNS0xLTEtODYxMjc_36d7bafa-e02c-4a32-9cfa-6ca0ca99285a">2,597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjItNy0xLTEtODYxMjc_e9c339e0-c027-4455-bfe6-1ea73c364a4b">8,921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjMtMS0xLTEtODYxMjc_a8a6a987-f9dd-47b4-88aa-b71fe5740c77">19,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjMtMy0xLTEtODYxMjc_adf26d4e-6d3f-4eca-9caf-11c19961359c">19,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjMtNS0xLTEtODYxMjc_4faeef17-c885-4e17-8c1f-65f98bf6f29f">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjMtNy0xLTEtODYxMjc_516a95a9-4bcf-4364-bdcd-fd4d28da0cf0">29,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjYtMS0xLTEtODYxMjc_5227a05f-2911-4e11-9d10-5370ef6f361c">0.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjYtMy0xLTEtODYxMjc_5ec63f63-798f-4fe9-8a0f-4524b013119c">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjYtNS0xLTEtODYxMjc_9ab683d7-92a9-4ba9-9c75-5854828df522">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjYtNy0xLTEtODYxMjc_73d96873-4c74-407c-afb9-d67240d464a4">0.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjctMS0xLTEtODYxMjc_2653492b-c7bd-444a-b44b-4c08fde807fa">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjctMy0xLTEtODYxMjc_51d50910-014b-45fc-af71-7d3d822ebbaa">0.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjctNS0xLTEtODYxMjc_4d034885-adc2-42a9-80a9-cf74d7eab821">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjctNy0xLTEtODYxMjc_3e125f79-2cce-47e7-90ce-d609e70d1c8d">0.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjktMS0xLTEtODYxMjc_8e3913bb-8848-4d4d-8803-bd8f3575204e">45,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjktMy0xLTEtODYxMjc_8367c2fd-0a88-4876-8263-d0afb87ce095">44,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjktNS0xLTEtODYxMjc_6cf7260e-5412-4d1c-8216-3d0ad7285658">45,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjktNy0xLTEtODYxMjc_44c5ce6d-ca9f-4047-84df-8fb1ab982410">43,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMzAtMS0xLTEtODYxMjc_18ce1a29-e1c6-4a09-ae08-34f3d440ca1a">52,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMzAtMy0xLTEtODYxMjc_edc03a8b-1bd6-44b1-adcc-fbc350cad5f8">45,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMzAtNS0xLTEtODYxMjc_7a08bb94-04da-4d0f-8e83-6ceeae05aaa6">52,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMzAtNy0xLTEtODYxMjc_04156c5c-b52a-47bc-a559-b5d63a91ed2a">45,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 5</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfMi0xLTEtMS04NjEyNw_a8a6a987-f9dd-47b4-88aa-b71fe5740c77">19,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfMi0zLTEtMS04NjEyNw_52d64a14-a98b-46f9-95ca-e3231c348253">19,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfMi01LTEtMS04NjEyNw_4faeef17-c885-4e17-8c1f-65f98bf6f29f">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfMi03LTEtMS04NjEyNw_b96ecf49-b037-4db4-bfcd-74169a2645db">29,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain on investments, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNC0xLTEtMS04NjEyNw_49c4bc1a-e350-46a4-a34a-9fe066e8d3fc">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNC0zLTEtMS04NjEyNw_6904e4b1-1257-4843-9033-ebaeeed09206">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNC01LTEtMS04NjEyNw_f8d6d456-6222-4d6a-a689-591b686c233f">893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNC03LTEtMS04NjEyNw_5530133a-31f8-4490-879e-267ef97d1725">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNS0xLTEtMS04NjEyNw_5377067b-c642-41ad-9321-a43f768fea46">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNS0zLTEtMS04NjEyNw_7cdae59a-1d7a-4075-af81-9e71841c3bb4">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNS01LTEtMS04NjEyNw_e78caa98-3b0c-4542-b880-bbc84877459a">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNS03LTEtMS04NjEyNw_ef4f4bb9-946d-4d9f-9e50-36af470ef19b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNi0xLTEtMS04NjEyNw_80061f52-bcb2-45bb-bcb4-57a42beaf104">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNi0zLTEtMS04NjEyNw_e4d681e0-8cc6-4c38-a226-57b6f9ce2ca5">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNi01LTEtMS04NjEyNw_392e06dd-7dcc-4be0-bfe1-e857f490f1ba">772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNi03LTEtMS04NjEyNw_d488e633-651d-4ede-8ea7-ead3110c190c">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNy0xLTEtMS04NjEyNw_d27e4a1a-8286-43c6-9d90-94bc11afc761">19,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNy0zLTEtMS04NjEyNw_728905d7-b219-4da0-a020-24a8cda00e95">19,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNy01LTEtMS04NjEyNw_1b06fe82-a9c4-4e52-b63e-446c97e8ce8c">25,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNy03LTEtMS04NjEyNw_7020a80a-302f-4843-808b-2b0f9df72f6d">29,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 6</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED JUNE 30, 2022 AND 2021</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iccf3379ece1b49aea990c4cbfe1e487c_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi0xLTEtMS04NjEyNw_f6ce9479-fdad-4aa0-a729-5058d66e5813">45,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccf3379ece1b49aea990c4cbfe1e487c_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi0zLTEtMS04NjEyNw_373d1a29-b03e-4784-a950-e300fe36efd5">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d0b4678edcd488697408216205ad39b_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi01LTEtMS04NjEyNw_d649c14c-d81b-4e00-9b1d-e2742f516bb2">867,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2c3caff01d94b05951897818e26b19d_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi03LTEtMS04NjEyNw_f72d9a5f-bf87-4714-8be1-b2852b3e55ea">157,832</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5453e5f10bc4d4aa7d46326ba9a6399_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi05LTEtMS04NjEyNw_699c5ad8-b58f-4043-b5fc-7004578bbc4a">527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7067da57a3274ecf8bb92bb5fda7ddaf_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi0xMS0xLTEtODYxMjc_2aa39a72-0224-4cd6-b755-eace8036b64a">709,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNS0xLTEtMS04NjEyNw_cd826559-27b9-493d-af25-cd80bdf70a5f">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNS0zLTEtMS04NjEyNw_ab21882e-9d0f-4a46-99c9-c3023815e500">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNS01LTEtMS04NjEyNw_cd879d84-3234-4b78-af7b-f67318e9a4a3">10,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNS0xMS0xLTEtODYxMjc_02df7dd3-481a-4b2c-96d5-8c899e8bee74">10,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNi0xLTEtMS04NjEyNw_3e595030-f964-4fba-8afb-df4ae14b54ab">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNi0xMS0xLTEtODYxMjc_ee67c4d9-5328-4bf2-a32f-123e4d9f0fca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock<br/>purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNy0xLTEtMS04NjEyNw_51514aed-fbf0-41c9-ae2c-bfd3e6c39f3e">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNy01LTEtMS04NjEyNw_e24d5d7d-da69-41de-93c8-7dc05f5829fd">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNy0xMS0xLTEtODYxMjc_c3ca2a65-09eb-4a81-b2bb-a795f17b2a90">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOC01LTEtMS04NjEyNw_d271c1c6-cd66-446a-95e2-eaf44c38b510">11,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOC0xMS0xLTEtODYxMjc_6500a20f-a4ef-4fa6-a6ca-e823bc9bad01">11,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOS0xLTEtMS04NjEyNw_db5fdfb8-4c5b-4b49-b145-c88df688f44e">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOS01LTEtMS04NjEyNw_82576189-a4b1-4ad1-8d1b-0d7684755066">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOS0xMS0xLTEtODYxMjc_8828c8ec-6b47-4ddc-a087-35a7990abcd0">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0438bbb5f15b47bd8ab7763bf832a111_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTItOS0xLTEtODYxMjc_17b2d6e7-d2cc-420c-8ffb-ad3a1869933a">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTItMTEtMS0xLTg2MTI3_763a10d4-4acc-41bf-adf2-ce598d786eae">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie08d96e6b19e4981b99d8b86ea0ec01d_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTMtNy0xLTEtODYxMjc_3ad8d295-28e4-42a9-a94d-13258fb7bca4">19,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTMtMTEtMS0xLTg2MTI3_e14bbda0-a3f6-4679-996b-2ed88dedb229">19,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i777b16255019457c83b5ff68beb54018_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtMS0xLTEtODYxMjc_4dadcd18-39d8-4a66-856e-3d48ef49c29e">45,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i777b16255019457c83b5ff68beb54018_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtMy0xLTEtODYxMjc_596083ec-133b-41f2-b085-a82b2568d903">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185060e0af3c419b9d025a6ac414a2f5_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtNS0xLTEtODYxMjc_fdea005a-28f8-4a2d-82c0-ef06ede1446e">895,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95d1f5844c744661a795601ebc428092_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtNy0xLTEtODYxMjc_1b55aa9a-69d0-4bdc-9558-ead24a0806c8">137,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20af892b1391416d8055702cfd957969_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtOS0xLTEtODYxMjc_f05519f5-5411-4db4-882b-27a6e6f471c7">605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtMTEtMS0xLTg2MTI3_3a57f87d-ffea-4953-9704-d389ea5178dd">756,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3cecd213310d42d68564b49f725b9213_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi0xLTEtMS04NjEyNw_0318a7e1-196f-4f57-bbf5-4f664d4ce953">43,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cecd213310d42d68564b49f725b9213_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi0zLTEtMS04NjEyNw_ded46d64-b423-4400-9da2-ceffbe913118">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i567c41f53acf4b4bae12b345b50893b0_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi01LTEtMS04NjEyNw_e4e37f3d-025f-4e6f-bbfe-5012d0715497">894,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id58a1548551d42eba0f5d2a6190bebda_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi03LTEtMS04NjEyNw_7ae8431f-21f9-47dd-b01e-1cd1235e92f5">243,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia659c853cae9490aae174ba93d4c6a36_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi05LTEtMS04NjEyNw_c428a63c-e364-4fee-b674-b5d296e18f55">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4392427a33b4b249cac4e1f1e0c7826_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi0xMS0xLTEtODYxMjc_7f22c80c-81ef-477a-85af-d2ab17b64a7f">650,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7562b9b9bc8848fc8b1a14abdedbaf01_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNS0xLTEtMS04NjEyNw_4e7e6eac-d2cc-41d1-8316-16e434b21157">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4fb171f06b4fec8794e510a10f6378_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNS01LTEtMS04NjEyNw_c40f2dba-5c12-4e15-8598-d952ee7aaa4e">5,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNS0xMS0xLTEtODYxMjc_5a34d268-e916-4a31-9b7c-4c0656817e4d">5,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7562b9b9bc8848fc8b1a14abdedbaf01_D20210401-20210630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNi0xLTEtMS04NjEyNw_93b64e39-666d-44ed-963e-9c24b58da2a9">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNi0xMS0xLTEtODYxMjc_90880d94-0d6a-4bc2-a78e-9df9c7b4ff7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock<br/>purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7562b9b9bc8848fc8b1a14abdedbaf01_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNy0xLTEtMS04NjEyNw_dd7e223a-aa15-4c0a-8eaa-2bf1f277ebc2">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4fb171f06b4fec8794e510a10f6378_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNy01LTEtMS04NjEyNw_4450b956-0694-4485-aa41-e9cc30ee4161">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNy0xMS0xLTEtODYxMjc_9ba635dc-adf9-4186-bc8d-90f86b038432">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4fb171f06b4fec8794e510a10f6378_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfOC01LTEtMS04NjEyNw_0971e058-f26c-4111-95cb-aab38cf67031">10,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfOC0xMS0xLTEtODYxMjc_a04de27e-8415-439e-9042-00f12bf15476">10,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d156e98f8514a71bf2585134d6222c5_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTItOS0xLTEtODYxMjc_cd799915-ae74-4bb5-976b-346a049d62c4">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTItMTEtMS0xLTg2MTI3_2db81523-be26-4037-ad2c-b3d1b56f5be9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9755c2106fc64b00958c9861c96d0980_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTMtNy0xLTEtODYxMjc_3533c84c-7928-45d7-bc4e-54426f51f75b">19,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTMtMTEtMS0xLTg2MTI3_3d474f03-a93a-4d1c-adfb-2572c10859d8">19,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie21f1393db9f45fa9638f6757ed692e7_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtMS0xLTEtODYxMjc_6d37296a-29d5-4381-9429-874dda3c84e9">44,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21f1393db9f45fa9638f6757ed692e7_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtMy0xLTEtODYxMjc_082a983a-ea4c-45b3-aced-d93d7aa7dedd">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbf1abb3d2514d0f971d679c231c0a78_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtNS0xLTEtODYxMjc_60921d0e-03d4-4709-94b5-3dee3b06de8e">911,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d8d5d2b3b942849ad9361740d23cec_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtNy0xLTEtODYxMjc_bfda2118-76f3-4ac2-8761-1e464734e667">224,425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12c8e6e979d472c83e9f7f03a527326_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtOS0xLTEtODYxMjc_fd98ad9c-1a3d-48fa-b4a1-ac137b7ccb22">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtMTEtMS0xLTg2MTI3_ab5f2d6a-a34f-4dbd-8856-11734bac9025">687,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8530ce71c50341ceb2fe3a2f7c1ce761_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi0xLTEtMS04ODU1Mg_d3355fa2-4000-4498-9116-dfdb6891ddea">44,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8530ce71c50341ceb2fe3a2f7c1ce761_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi0zLTEtMS04ODU1Mg_c6a629b4-3d38-406e-b849-50e381bee639">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ae8fb92c414c1c9c45317f16ffd7cb_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi01LTEtMS04ODU1Mg_2f6366c1-b571-48c0-b879-c120af2d9805">942,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7debda168a402bbbfc0400a6f7fb72_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi03LTEtMS04ODU1Mg_1a500099-88c5-4290-8061-60348b91ecfd">211,895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02ecdd29c7414c46a2309f3f15aa4ef2_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi05LTEtMS04ODU1Mg_8f0a81a5-d549-4487-ba37-7a4a18e12b0d">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi0xMS0xLTEtODg1NTI_56d915d7-b774-44e1-a0a8-dc415e07ca08">730,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy0wLTEtMS04ODU1Mg_82e450ad-29e0-449d-a33a-5002227870d7">Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d66fc0f21124cb982ea945c36dceeba_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy01LTEtMS04ODU1Mg_f6ff9525-8e87-41d5-9add-6aeab56481ab">96,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c67d9e97e742bfa7decef41c722bc2_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy03LTEtMS04ODU1Mg_7824889b-8a74-46e0-ad9f-499a53d05b09">47,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71d1eeb1f3f6452887a684bfaeb06c53_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy0xMS0xLTEtODg1NTI_bf14d0c8-2f26-4d48-afa8-71c620585a61">49,233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNS0xLTEtMS04ODU1Mg_406059d2-ade1-4fc5-9eea-c05100e94255">630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNS0zLTEtMS04ODU1Mg_7b7ebc81-2d28-4aea-a37b-2996bad8f3d5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNS01LTEtMS04ODU1Mg_cb68c88b-65fb-4411-9127-dbf9f04e8bc4">21,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNS0xMS0xLTEtODg1NTI_b1fed4bb-0aec-4ea3-9bde-7111b277b57e">21,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNi0xLTEtMS04ODU1Mg_baaf37a3-a568-4f89-93fc-7aad81e22867">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNi0xMS0xLTEtODg1NTI_833555b5-02d9-4680-8963-af67d2de2ef2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock<br/>purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNy0xLTEtMS04ODU1Mg_40504fd4-a7f9-4de4-aaae-10e81dea1404">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNy01LTEtMS04ODU1Mg_2dee467e-de34-42a8-9536-55ff23c70ef8">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNy0xMS0xLTEtODg1NTI_ff053c73-ee50-481e-9227-b9919aae23d5">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOC01LTEtMS04ODU1Mg_d9c0f7d1-e57d-4273-8e3e-7ea318b08a3c">22,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOC0xMS0xLTEtODg1NTI_f43113f7-6110-46db-be35-faa9edb304b6">22,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOS0xLTEtMS04ODU1Mg_6067d82a-eea5-44e4-8dc2-c657739a4246">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOS01LTEtMS04ODU1Mg_d60f5026-cf76-4842-8040-265df90dc80d">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOS0xMS0xLTEtODg1NTI_ef43453b-f08f-4145-b2a9-cf765ea52322">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40fceb10d076413aa7ec6129f9f379d7_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTItOS0xLTEtODg1NTI_3732278a-cf65-42e8-b13e-049e1e039cae">772</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTItMTEtMS0xLTg4NTUy_21c4ebd9-ee59-4674-8c50-26da4eef831e">772</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i496381cd52774acb947c0ce28a210627_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTMtNy0xLTEtODg1NTI_cb4bb9cf-fab1-4324-b468-698cd86053d3">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTMtMTEtMS0xLTg4NTUy_11ebe6d0-b74f-4044-935a-da22df4dd5ed">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i777b16255019457c83b5ff68beb54018_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtMS0xLTEtODg1NTI_8b9dee93-713b-494d-b422-4a848eb92b9f">45,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i777b16255019457c83b5ff68beb54018_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtMy0xLTEtODg1NTI_1ad3abb5-73a8-4b61-b6c7-b997d7daa3e8">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185060e0af3c419b9d025a6ac414a2f5_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtNS0xLTEtODg1NTI_d57bf6e7-b4c9-469e-b941-08976eb10cec">895,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95d1f5844c744661a795601ebc428092_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtNy0xLTEtODg1NTI_27db4a01-74a7-4c46-8235-43f72145503b">137,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20af892b1391416d8055702cfd957969_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtOS0xLTEtODg1NTI_ff4a9eb3-2f89-4a7d-8607-11fde8695150">605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtMTEtMS0xLTg4NTUy_c45155c6-0f4f-4c0d-aa80-fb4ef669add7">756,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8e4e8f15d4b41d3bd530ae73c637d3a_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi0xLTEtMS04ODU1Mg_69d8ae79-b131-4b10-b558-843d941ace6a">43,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e4e8f15d4b41d3bd530ae73c637d3a_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi0zLTEtMS04ODU1Mg_0d5dcbc3-ee1c-4577-8b91-a599fcb5249b">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2c30c32c194470fb58444961164cced_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi01LTEtMS04ODU1Mg_af64b51d-4e3d-41a8-bba8-389098aa9cb3">873,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dfdd1ff2fdf4d5ca8edd50b87a21dbe_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi03LTEtMS04ODU1Mg_5bc75c5b-9420-461b-ada0-ee3a6abbf695">253,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ba2e38a38f4c4c81d24bf4be710a79_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi05LTEtMS04ODU1Mg_abaf58d6-73ba-4528-9226-db7921f1f576">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b13809861f4e14b44f538d78e89322_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi0xMS0xLTEtODg1NTI_9dc0ddc2-0a70-4c89-9479-47182e50fecd">619,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNS0xLTEtMS04ODU1Mg_724036cc-1833-49e1-a32a-f64a5fae5d3a">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56eabe321e00448ea73bc225c791a124_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNS01LTEtMS04ODU1Mg_4fcc7c45-0c3d-4592-a286-6322a2625dd3">16,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNS0xMS0xLTEtODg1NTI_6df2b886-46a6-4ca2-af78-0aab9391e3f3">16,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNi0xLTEtMS04ODU1Mg_67cc94f0-01bb-4dae-a432-219f43a648d8">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNi0xMS0xLTEtODg1NTI_b91adbc4-8b2b-44fa-8228-85684b3c563b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock<br/>purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNy0xLTEtMS04ODU1Mg_c5f0c305-45df-4dd4-a414-c30b1474047d">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56eabe321e00448ea73bc225c791a124_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNy01LTEtMS04ODU1Mg_45ced4ae-8acc-46c7-9637-838a3abbc4a8">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNy0xMS0xLTEtODg1NTI_b839a05b-bd4e-4e89-8d21-7b212d60c484">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56eabe321e00448ea73bc225c791a124_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfOC01LTEtMS04ODU1Mg_7a34cb78-351f-44c8-8cda-6c66efcf72d0">20,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfOC0xMS0xLTEtODg1NTI_4cf76b85-6f83-494b-a800-5c485fd3680a">20,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie355b25162354a51a4bc570c648c9f9e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTItOS0xLTEtODg1NTI_c7bb8083-e061-4a31-a2df-499d20b7631e">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTItMTEtMS0xLTg4NTUy_5aad4660-52c0-4c2b-8c16-c1697d5e3961">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a25b26562da46c48252ec4826cc94cf_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTMtNy0xLTEtODg1NTI_dbf02a1a-9e88-4d36-b72b-4a817948ca2e">29,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTMtMTEtMS0xLTg4NTUy_e46040b6-e389-4eb8-8b19-f05534794df0">29,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie21f1393db9f45fa9638f6757ed692e7_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtMS0xLTEtODg1NTI_58d13426-e68a-4f4e-b351-7fe88d7ae0b1">44,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21f1393db9f45fa9638f6757ed692e7_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtMy0xLTEtODg1NTI_76f737f7-50a1-4a7d-a451-09a9cc07380d">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbf1abb3d2514d0f971d679c231c0a78_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtNS0xLTEtODg1NTI_8e4dff99-3fe6-481b-9406-5d5fdbcdf111">911,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d8d5d2b3b942849ad9361740d23cec_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtNy0xLTEtODg1NTI_15aea857-297f-4591-9e15-f50328df2cdf">224,425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12c8e6e979d472c83e9f7f03a527326_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtOS0xLTEtODg1NTI_9addfb65-04ec-40af-84cc-9e148df873c7">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtMTEtMS0xLTg4NTUy_8fc14e33-8414-4d1f-ace6-6308f3c70b81">687,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 8</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMy0xLTEtMS04NjEyNw_4a5efab3-cf26-4a75-8539-018af30781a9">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMy0zLTEtMS04NjEyNw_945138b6-057a-4fad-9056-4534c73eb071">29,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNS0xLTEtMS04NjEyNw_611644e9-6d64-4442-afde-1c779bcb439b">2,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNS0zLTEtMS04NjEyNw_04e45d41-4e4a-444e-b662-f10e93c33bc4">7,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of fixed assets and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNi0xLTEtMS04NjEyNw_7bd1ce34-17bc-41f0-8880-304e73cf5ea4">40,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNi0zLTEtMS04NjEyNw_3bfe0ddd-fb9f-4b9e-b3b9-e936cdddf4df">9,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNy0xLTEtMS04NjEyNw_a612bfec-8fa0-4b1f-8622-9f0c26d35685">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNy0zLTEtMS04NjEyNw_d7417891-838a-4364-a742-bbf8ba846447">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfOC0xLTEtMS04NjEyNw_35c680e9-deb2-429b-813a-67d814859706">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfOC0zLTEtMS04NjEyNw_dbc518c4-3186-44c6-8cd5-06e9905db18f">11,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss (gain) on disposal of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTAtMS0xLTEtODYxMjc_a4fda597-19ad-47a0-a058-7f2ff4a24f1e">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTAtMy0xLTEtODYxMjc_040cceaf-7b76-4b30-9c6f-05aa63f19851">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTEtMS0xLTEtODYxMjc_feaf5e5c-8528-4da7-a974-6c530c047489">22,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTEtMy0xLTEtODYxMjc_379cb85d-36dc-45c7-a3b2-0c6df8bfed5b">20,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Changes in contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTItMS0xLTEtODYxMjc_f1c6654d-2032-418c-82e0-8ecdce932272">22,351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTItMy0xLTEtODYxMjc_bdc8aac6-0103-4827-9765-1a7b85661bdc">988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTMtMS0xLTEtODYxMjc_d0978da9-cdf0-41fb-a8f1-d394e30db815">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTMtMy0xLTEtODYxMjc_9004d2da-3d58-4d72-9d7b-44bdca22e013">2,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTUtMS0xLTEtODYxMjc_ade354fb-cf62-43f0-99ee-e165eccb18b1">5,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTUtMy0xLTEtODYxMjc_d6b6f10b-7a53-41c4-aec3-49041be47b39">15,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTYtMS0xLTEtODYxMjc_c2e5df6d-2ecf-45dd-87b5-6daa79ac1c6a">2,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTYtMy0xLTEtODYxMjc_71290524-e2fd-44d2-b748-369905330ef7">615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTctMS0xLTEtODYxMjc_7ef916a9-ec1d-43a6-b374-d384f309ffbe">3,233</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTctMy0xLTEtODYxMjc_ccd71e51-a253-483f-bc4b-161c3103890e">944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTgtMS0xLTEtODYxMjc_ecb9d259-e24e-4db2-b076-afcfbba8b758">5,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTgtMy0xLTEtODYxMjc_6051af14-c648-444d-9c55-ebb279f467c3">2,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued expenses and income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTktMS0xLTEtODYxMjc_a38de9d0-45eb-4ab8-ab06-a26588528cbe">19,038</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTktMy0xLTEtODYxMjc_4cf94a46-908e-4c98-8451-a2f527d87f69">18,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjAtMS0xLTEtODYxMjc_3191d7ef-bec2-4997-b546-8a866dbc2a7f">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjAtMy0xLTEtODYxMjc_e5876d65-9e21-4f5d-9745-5d8b00b9bf79">964</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjEtMS0xLTEtODYxMjc_19546ebc-91f0-4dba-bc43-c0f4097f214b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjEtMy0xLTEtODYxMjc_9310006d-7a46-465d-9d55-942cd72e8dc4">5,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjItMS0xLTEtODYxMjc_cdc2755b-1910-44de-9a5c-dc3e7f47d225">60,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjItMy0xLTEtODYxMjc_03868a2b-8b17-4b3a-842d-9bb7e990e2f0">42,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjUtMS0xLTEtODYxMjc_27b83433-ec86-4773-99bd-4d5a5990277f">19,403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjUtMy0xLTEtODYxMjc_f4dc5226-a14d-4beb-a3ec-354d9c971548">23,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of available-for-sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjYtMS0xLTEtODYxMjc_696e67a4-3664-4694-bb85-ccdcafa3c550">187,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjYtMy0xLTEtODYxMjc_b1e1b6ec-9482-49ef-accb-cdb8095024e1">318,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Sales of available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjctMS0xLTEtODYxMjc_157c59c6-c535-4abb-ba9d-d59f7ad45c0c">62,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjctMy0xLTEtODYxMjc_6a3a49fe-ede4-423e-b96b-19c25e931dea">294,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="pcrx:PaymentOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjgtMS0xLTEtODYxMjc_b466eaa0-f016-41aa-b010-459d735ae82b">32,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="pcrx:PaymentOfContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjgtMy0xLTEtODYxMjc_fef4b1f3-2a52-44f4-a8ae-c08682db1bd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of equity and debt investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjktMS0xLTEtODYxMjc_4606384b-970c-479a-a9c7-76ce47890363">12,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjktMy0xLTEtODYxMjc_05f0964a-a33a-4003-9c90-7a193c3cdd12">14,220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Sale of equity investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzAtMS0xLTEtODYxMjc_5ff93992-8930-409b-9106-ffa3548a7e87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzAtMy0xLTEtODYxMjc_43d8bda4-6cc4-42b1-b107-9f94fbce66fd">9,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzItMS0xLTEtODYxMjc_873dee1c-15cc-44ac-870f-2315731003b7">188,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzItMy0xLTEtODYxMjc_5cec3d92-fe80-4f7a-978c-fbab491b62d3">52,631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Proceeds from exercises of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzQtMS0xLTEtODYxMjc_19c90110-07ef-4e75-94b1-df640fc0346d">21,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzQtMy0xLTEtODYxMjc_968c63ae-afab-4eb9-91da-5cb5df018e57">15,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Proceeds from shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzUtMS0xLTEtODYxMjc_b49fc723-b87d-494e-9a79-6d8c19af5330">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzUtMy0xLTEtODYxMjc_721dfa21-f503-4db9-85a0-7ae450762b80">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Repayment of 2022 convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1b7745796664d7e8311edc369bcf819_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzgtMS0xLTEtOTYzNTQ_b8d6a2ba-2a81-45a9-a9c8-e8925a4878dd">156,960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f182ffbc7a04691b94793c0d2ea763b_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzgtMy0xLTEtOTYzNTQ_d69e425e-0664-49a3-ad2c-4b4d5192cefd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Repayment of 2024 convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dc9a2abb73b42f889beb685eb78dd97_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzgtMS0xLTEtODYxMjc_62a3f9a3-1d2d-4f17-a80c-1a1e658071eb">192,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id49160a04d45489ba6dde67831452514_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzgtMy0xLTEtODYxMjc_113caaa1-7db7-41cd-991f-6d207e546530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Repayment of Term loan B facility maturing December 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDAtMS0xLTEtOTQ4NzA_227d1fa7-ea45-48f9-83f6-773377816ccd">9,375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDAtMy0xLTEtOTQ4NzA_67636c22-c2c0-48a3-8efa-7ea2dce8f455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of contingent consideration to MyoScience, Inc. securityholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDMtMS0xLTEtODYxMjc_180e4592-4919-4e7c-af88-250b4306a01f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDMtMy0xLTEtODYxMjc_54f2d378-2605-4ff0-8fd7-876ebccc6164">1,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDQtMS0xLTEtODYxMjc_fe9d9398-34ed-497f-8495-8b194887713d">335,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDQtMy0xLTEtODYxMjc_520f344c-c8b3-4b74-9617-409f1bdcc7e2">16,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDUtMS0xLTEtODYxMjc_001268e4-cc7f-4c08-b453-d654b56f90e4">463,517</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDUtMy0xLTEtODYxMjc_77e74e46-d84e-47ce-8338-1737f0d953fa">5,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDYtMS0xLTEtODYxMjc_f5a3a844-e42d-48fe-ab9b-26a38da818cd">585,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b13809861f4e14b44f538d78e89322_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDYtMy0xLTEtODYxMjc_ae51b82a-904d-42a8-821c-e31b3dec1b0a">99,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDctMS0xLTEtODYxMjc_2a6ccd61-b387-48c1-afec-8133bf4d3bf0">122,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDctMy0xLTEtODYxMjc_e72c14e3-db38-46c9-803c-3976d84f4fef">105,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash paid for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTQtMS0xLTEtODYxMjc_9ab4c46c-a6df-4ec4-b14f-a53b42a87e87">14,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTQtMy0xLTEtODYxMjc_37881ead-2999-4889-944e-6960ba286ecb">3,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash paid for income taxes, net of refunds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTUtMS0xLTEtODYxMjc_0a40c887-be5a-4c03-88fb-3c399da119b8">4,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTUtMy0xLTEtODYxMjc_6832917e-c98b-4421-8e44-6e2528292d3c">1,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Issuance of common stock from conversion of 2022 convertible senior notes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTctMS0xLTEtODYxMjc_d6a0099e-b71d-4e88-bf69-96bd0fc5ea6c">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTctMy0xLTEtODYxMjc_62ddbc7c-44ca-4940-83ef-6e75ef4af5c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed assets included in accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNjEtMS0xLTEtODYxMjc_aa1d76ba-163e-4bff-bcca-5eeabe5f9b2b">2,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNjEtMy0xLTEtODYxMjc_a0a6fc48-cfa0-46cd-bcd1-4c7d58934fcc">8,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 9</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNC9mcmFnOjI4MzJmOGZiODY0MTRjMTg4YzdhMTg5OTM1ZjdiNWQwL3RleHRyZWdpb246MjgzMmY4ZmI4NjQxNGMxODhjN2ExODk5MzVmN2I1ZDBfNDQ1MQ_a1144ef6-ab07-46ea-a52e-dda258892fe9" continuedAt="i230264f1ad564a959cd62edadadcc0c7" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i230264f1ad564a959cd62edadadcc0c7"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Pacira&#8221;) is the industry leader in its commitment to non-opioid pain management and providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain and spasticity. The Company&#8217;s long-acting, local analgesic, EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bupivacaine liposome injectable suspension), was commercially launched in the United States, or U.S., in April 2012 and approved in select European countries and the United Kingdom, or U.K. in November 2021. EXPAREL utilizes the Company&#8217;s proprietary multivesicular liposome drug delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In November 2021, the Company acquired Flexion Therapeutics, Inc., or Flexion, and added ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension) to its product portfolio. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of osteoarthritis, or OA, knee pain. For more information, see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In April 2019, the Company added iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience (the &#8220;MyoScience Acquisition&#8221;). The iovera&#176; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to only targeted nerves.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from <ix:nonFraction unitRef="product" contextRef="ieec41903ab5748ad8e93035d8503fcf3_D20220101-20220630" decimals="INF" name="pcrx:ConcentrationRiskNumberOfProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNC9mcmFnOjI4MzJmOGZiODY0MTRjMTg4YzdhMTg5OTM1ZjdiNWQwL3RleHRyZWdpb246MjgzMmY4ZmI4NjQxNGMxODhjN2ExODk5MzVmN2I1ZDBfMTY3Nw_22139b84-afc2-4508-a25a-df6dac985495">three</ix:nonFraction> products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as <ix:nonFraction unitRef="segment" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNC9mcmFnOjI4MzJmOGZiODY0MTRjMTg4YzdhMTg5OTM1ZjdiNWQwL3RleHRyZWdpb246MjgzMmY4ZmI4NjQxNGMxODhjN2ExODk5MzVmN2I1ZDBfMjQ3Mw_18df68f3-0387-4083-8f84-ce81151c65c0">one</ix:nonFraction> reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coronavirus (COVID-19) Pandemic and Global Economic Conditions</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, the Company&#8217;s revenues have been impacted by COVID-19 pandemic-related challenges that included the significant postponement or suspension in the scheduling of elective surgical procedures due to public health guidance and government directives. While the degree of impact has diminished during the course of the pandemic due to the introduction of vaccines and therapeutics, as well as the lessening of elective surgery restrictions, certain pandemic-related operational and staffing challenges persist. It remains unclear how long it will take the elective surgery market to normalize or if restrictions on elective procedures will recur due to future COVID-19 variants or otherwise. Direct effects of the pandemic and global economic conditions may negatively impact the Company&#8217;s business, financial condition and results of operations. Such impacts may include the effect of prolonged periods of inflation on the Company&#8217;s customers and suppliers and longer lead-times or the inability to secure a sufficient supply of materials. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.</span></div></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_37"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc3Ng_8e0ae60d-ec57-4fd5-adde-8a8445e134e4" continuedAt="i028ebdf907734381918af238c065cc1f" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i028ebdf907734381918af238c065cc1f" continuedAt="i86af0617ce474752b88f403710cfd313"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc2Mw_605bf0e3-d6b2-4e1d-90cc-57cb47eeebc9" continuedAt="i630e01509f6540038b8688c4716c966d" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form&#160;10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at June&#160;30, 2022, and for the three and six-month periods ended June&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i86af0617ce474752b88f403710cfd313" continuedAt="i8ab3c772295f4f60b9474e8145bf1c39"><ix:continuation id="i630e01509f6540038b8688c4716c966d"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div></ix:continuation><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc4NA_9ae308ad-d3f0-4625-8b6c-8e04b5747376" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#176; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc2MQ_cdd4eab3-3594-4470-b58e-1d1ae4926927" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes the percentage of revenues comprised by the Company&#8217;s <ix:nonFraction unitRef="segment" contextRef="ied39c8b2a0e847a5aafe78db72f6e93b_D20220101-20220630" decimals="INF" name="pcrx:ConcentrationRiskNumberOfCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfMjk0MQ_50b7fb46-13eb-4206-8ba7-6c026f6efd3c">three</ix:nonFraction> largest wholesalers in each period presented: </span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03aa3ab5fbee4d6896c79200467028e0_D20220401-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMi0xLTEtMS04NjEyNw_295e8148-3b21-4c4d-9513-73af6519aea1">32</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id48c04a202fa42f2867a0499bc23d873_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMi0zLTEtMS04NjEyNw_194e3c13-76f4-4016-ba34-aac51cbc25a3">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia1a665b7edb9415ebeb211b1577d0e34_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMi01LTEtMS04NjEyNw_e4018dd6-7ad9-43e0-ad6f-34e4829df320">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idcb274e947a44a4e80b58a578e44dac3_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMi03LTEtMS04NjEyNw_4857b8c5-af99-477c-9a48-0dbef131fde3">31</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a79f2001b894c3ea7b2a9c85bc4315c_D20220401-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMy0xLTEtMS04NjEyNw_a6963a23-9f5c-4805-ae42-0c8aae83ebb6">23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52d4cf75231141769e7cdbeaae57f7f8_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMy0zLTEtMS04NjEyNw_76f5e854-8d14-411a-91a7-506e3d0f8481">29</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39f4cab5dbc846cf86be5b20cc204e02_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMy01LTEtMS04NjEyNw_45272790-5a61-41b5-8702-0f98495b936a">23</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if69a41444b6640d0b674261a2129cd82_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMy03LTEtMS04NjEyNw_d44e1457-c5ff-463a-ac05-b4efd85bdd0c">29</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80247e37f19a4037b6459ac43a27bcd0_D20220401-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNC0xLTEtMS04NjEyNw_326ead23-10f0-45d6-83e3-032d9369fd6a">22</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2059729d521343c3aa297a7c8e0d5961_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNC0zLTEtMS04NjEyNw_1f05eeff-400b-416d-a674-da9e8c1e3f0b">26</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i574ac6f9ebfe47ff8dc15c79df815095_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNC01LTEtMS04NjEyNw_59b87cdb-49d5-4247-9133-a302bdf7b75a">22</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iecace58dec9b480d953f4cefa650d762_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNC03LTEtMS04NjEyNw_51343182-a9c4-415b-9801-751e88853970">26</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie417a4089ec14158a8f46542e241d728_D20220401-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNS0xLTEtMS04NjEyNw_05f889d8-e510-4140-b6ae-532591c6c295">77</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1a0b4f16e3040808a0a4267e092d844_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNS0zLTEtMS04NjEyNw_121d8f0f-d42d-40a6-b694-3a5a12b88c76">86</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia484b08689c24460bdf7e5e604ec229e_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNS01LTEtMS04NjEyNw_3a0bc81a-b262-4207-bb3e-a364e8b9ee4d">76</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86ff898a5c1f4f7b89f0bc15a892e222_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNS03LTEtMS04NjEyNw_e7d8ae6a-2b15-49c5-b3b7-c1b7063b9cf2">86</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of revenues from the Company&#8217;s <ix:nonFraction unitRef="segment" contextRef="ied39c8b2a0e847a5aafe78db72f6e93b_D20220101-20220630" decimals="INF" name="pcrx:ConcentrationRiskNumberOfCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfMzAzOA_50b7fb46-13eb-4206-8ba7-6c026f6efd3c">three</ix:nonFraction> largest wholesalers have shifted in the current year with the addition of ZILRETTA sales.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc1Ng_a08f6acc-a3f1-4b26-88e1-73bf24c2d8c7" continuedAt="ia9cd0dfc69e34390a7373117669bb859" escape="true">Recently Adopted Accounting Pronouncements</ix:nonNumeric></span></div></ix:continuation><div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"><ix:continuation id="i8ab3c772295f4f60b9474e8145bf1c39" continuedAt="iaee52cf9ea2144a89339fa252733fac1"><ix:continuation id="ia9cd0dfc69e34390a7373117669bb859" continuedAt="ib30be33ea6f24817bfcc883c1d35680a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaee52cf9ea2144a89339fa252733fac1"><ix:continuation id="ib30be33ea6f24817bfcc883c1d35680a">which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $<ix:nonFraction unitRef="usd" contextRef="i7ed27d17e7e04841a903c038b2cd6d5b_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDYyNw_c7a4afe6-46b1-4382-90a0-527f1b767b35">64.9</ix:nonFraction>&#160;million, reduced accumulated deficit by $<ix:nonFraction unitRef="usd" contextRef="i1dcc7f6a743b4e1c826e40098ec5b555_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDY2Mg_bec835c6-472a-4bf1-b794-f4cd5d5c0a43">47.2</ix:nonFraction>&#160;million, reduced additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="id39f0d77661b4d21bd5c329207058dec_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDcwNA_d25bb6a1-e8ba-4a62-b35a-710b61012e87">96.5</ix:nonFraction>&#160;million and decreased deferred tax liabilities by $<ix:nonFraction unitRef="usd" contextRef="i7ed27d17e7e04841a903c038b2cd6d5b_I20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc0OQ_ee565b26-8c8e-4cc7-b1b8-685cf0622700">15.7</ix:nonFraction>&#160;million.</ix:continuation></ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 11</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfNDYzNw_086296e8-65dc-4739-ac2a-3269d74847ec" continuedAt="ia7ba2d8af55449ddaa4e131e3147b64f" escape="true">REVENUE</ix:nonNumeric></span></div><ix:continuation id="ia7ba2d8af55449ddaa4e131e3147b64f" continuedAt="i2040d0da6e6041d3a7ace80f2585f5f8"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net product sales consist of (i) EXPAREL in the U.S., the European Union, or E.U., and the U.K.; (ii) ZILRETTA in the U.S.; (iii) iovera&#176; in the U.S., Canada and the E.U. and (iv) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use. Royalty revenues are from the Company&#8217;s collaborative licensing agreements. The Company does not consider revenue from sources other than sales of EXPAREL and ZILRETTA to be material sources of its consolidated revenue. As such, the following disclosure only relates to revenue associated with net EXPAREL and ZILRETTA product sales. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Product Sales</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. The Company primarily sells ZILRETTA to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as GPOs. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL and ZILRETTA revenue is recorded at the time the product is transferred to the customer.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, service fees, government rebates, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts, statutory requirements and other related information that may become known in the future. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers, specialty distributors, specialty pharmacy, GPOs and doctors. Payment terms generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfMjk1OA_60482776-f82e-46b2-bdd2-45bb82b080c0">zero</span> to <ix:nonNumeric contextRef="i137156d0fcb14f6083cfb7e0561f67e9_D20220101-20220630" name="pcrx:AccountsReceivablePaymentTerms" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfMjk2NA_1471b95c-8ee9-40e4-8126-9e636180e8a1">97</ix:nonNumeric> days from the date of the transaction, and accordingly, there is no significant financing component.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#8217;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#8217;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL and ZILRETTA to its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i2040d0da6e6041d3a7ace80f2585f5f8"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfNDY0MQ_4697f357-e15b-4e53-bf7b-448e3bfa28b2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf70633f4d2743c483f890199a5aad26_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfMy0yLTEtMS04NjEyNw_6b56bc88-fc00-4754-ac68-c09b97419992">137,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1153b8275e426baedcb6cb32988ed3_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfMy00LTEtMS04NjEyNw_d95906fb-d326-4c82-8763-6bdfe71662eb">130,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c7a76e695d24007a56305d765b02b64_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfMy02LTEtMS04NjEyNw_98f15f28-de04-41a0-94c0-1f2b1e6c2637">266,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f4f821973e47688841421beb03e3aa_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfMy04LTEtMS04NjEyNw_85d4cf39-2c8c-43eb-bd13-05bbbb228e8b">244,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;ZILRETTA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093201d8522546898104838bef2c7008_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNC0yLTEtMS04NjEyNw_4b69209e-76e4-41ae-a259-46764b3e27bf">27,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c42c8c170474d2a954da97bce047946_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNC00LTEtMS04NjEyNw_7993b5fe-a728-4917-8c63-e57d29e94e61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6903f565b296494fb0447554914bdfeb_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNC02LTEtMS04NjEyNw_ef8fae07-785c-4288-a7bb-ee78469277f7">51,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac412655aca24aa0a92d19bfdb08ebfe_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNC04LTEtMS04NjEyNw_c249d26d-dce3-4b9d-a733-23b864c19bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561be2fe92244f3c871d388185d4dbf7_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNS0yLTEtMS04NjEyNw_48398c62-5c11-4642-8963-6fbe4ced196e">3,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0762b6431de84121b7b88717e0492b34_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNS00LTEtMS04NjEyNw_bb0fe857-1bad-4378-aeea-56493c7d33a0">3,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7c1bb2dd8df417db479a9448b35c207_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNS02LTEtMS04NjEyNw_1313c2cb-d7a1-45c9-b5d6-033087fff6d8">6,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ea87effbd54309b6396f1449ed1cb1_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNS04LTEtMS04NjEyNw_179a3a35-227d-4f22-9bd2-9658fb51fbc2">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ccef0cf2b3a4d7aa7364dc01727ff19_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNi0yLTEtMS04NjEyNw_56982449-7423-4c9c-9ca5-c99b8ec70c9b">956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50dda10391554e928f44961a18eb294f_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNi00LTEtMS04NjEyNw_d76fa7a8-0b0d-4ba1-97ef-61d9b60584b5">992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577bddc29b634b9c8f0d64449773fe54_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNi02LTEtMS04NjEyNw_dd4249d1-add5-4502-a0d8-9065d551633e">2,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15ee9cbfaa484b99723cebd4de0305_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNi04LTEtMS04NjEyNw_00f4abbd-e5be-44ab-a6a2-ce8c3e8ea1ad">1,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4570f968674f3bbe27c560bfb9be87_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNy0yLTEtMS04NjEyNw_319e1a58-aba1-4667-9344-ed48c5d3c005">168,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7284aa2c87d44f68ba483dff38427eec_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNy00LTEtMS04NjEyNw_e6673d3b-27cb-4dd6-b5a0-905640a766e1">134,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df55d4c445d47adb69a0c7a9cd64df5_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNy02LTEtMS04NjEyNw_965f60cc-7f89-4679-b5f9-c96bfd2c223c">326,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872e83e0083747ac98f21041708778df_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNy04LTEtMS04NjEyNw_ee71fe1e-9824-49a7-ac5b-256a7b12d0f4">253,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_46"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMzQzMg_5183852b-afa6-4e47-a459-8bbab23f09f4" continuedAt="id1c26d41ca8b4de999bd2d93ed17052a" escape="true">FLEXION ACQUISITION</ix:nonNumeric></span></div><ix:continuation id="id1c26d41ca8b4de999bd2d93ed17052a" continuedAt="i5bd64620bbe44293bd64be2172615419"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2021, the Company acquired Flexion (the &#8220;Flexion Acquisition&#8221;), a biopharmaceutical company focused on the discovery, development, and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. Upon consummation of the Flexion Acquisition, Flexion became a wholly-owned subsidiary of the Company and was renamed Pacira Therapeutics, Inc.</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total consideration for the Flexion Acquisition was approximately $<ix:nonFraction unitRef="usd" contextRef="i19c54c90141d46f5b4ed7575ff155dfa_D20211119-20211119" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfNTcz_64f0ae28-edd1-44ef-b149-dc662cd05289">578.8</ix:nonFraction>&#160;million consisting of: (i) $<ix:nonFraction unitRef="usd" contextRef="ia90f47b531e341d18e987adf7e3cab92_D20211119-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfNTk1_e5df499f-7fd9-424a-b7ce-c1d043c1d4c7">448.5</ix:nonFraction>&#160;million of cash paid to former Flexion stockholders and to settle restricted stock units and in-the-money stock options; (ii) an $<ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-5" name="pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfNzE5_1b76bfe6-28fb-40fe-a4c4-2e14cbb0097f">85.1</ix:nonFraction>&#160;million cash payment to repay Flexion debt that was not assumed by the Company and (iii) $<ix:nonFraction unitRef="usd" contextRef="i19c54c90141d46f5b4ed7575ff155dfa_D20211119-20211119" decimals="-5" name="pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfODAz_61aa4b12-c7af-4e6d-aba8-255576540908">45.2</ix:nonFraction>&#160;million of estimated contingent consideration related to contingent value rights, or CVRs, that were issued to Flexion shareholders and certain equity award holders in conjunction with the Flexion Acquisition. The consideration is subject to adjustments based on the achievement of certain potential milestone payments. Up to an additional $<ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMTEzOA_255004d6-ba42-4672-b64b-ae705308fe1c">380.2</ix:nonFraction>&#160;million in the aggregate may be payable to holders of the CVRs if each of the applicable milestones are achieved. No contingent consideration milestones were achieved in the six months ended June&#160;30, 2022. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the methodology and key assumptions used in the fair value measurements of contingent consideration and for more information regarding the changes in fair value.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i5bd64620bbe44293bd64be2172615419" continuedAt="id1ea9213c2724320b1a197801766b655"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is finalizing its valuation of liabilities and tax analyses, and anticipates finalizing the purchase price allocation as the information necessary to complete the analysis is obtained, but no later than one year after the acquisition date. <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMzQyOQ_bf3f3eef-7642-4d5a-b30a-2c7bac78a8c1" continuedAt="i17374109c9e84afc8224d29f210b9bc7" escape="true">The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):</ix:nonNumeric></span><ix:continuation id="i17374109c9e84afc8224d29f210b9bc7" continuedAt="iac88651d164b4e24a65c9eca58bca670"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.348%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(as previously </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">reported) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS ACQUIRED</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMi0yLTEtMS04NjEyNw_05a49719-a71f-42e4-91f6-ce18a4c727bc">113,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMi02LTEtMS04NjEyNw_8ecf11f2-b6ef-4138-98ed-bacb94728674">113,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMy0yLTEtMS04NjEyNw_34b41371-a32a-49fd-924f-688af3539847">11,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMy02LTEtMS04NjEyNw_80cc8e43-eb69-4bd4-920d-6407cc572e18">11,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNC0yLTEtMS04NjEyNw_fc5893e0-5e42-450f-84cf-77eb83c44a7e">32,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNC02LTEtMS04NjEyNw_09bb149d-e55c-4eab-8358-7de50279afa1">32,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNS0yLTEtMS04NjEyNw_111c19c7-bb3c-413c-bc6f-33df8f1b6e1f">29,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNS02LTEtMS04NjEyNw_826ee909-c87a-46de-a144-109e50d7b9cf">29,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNi0yLTEtMS04NjEyNw_8349f923-879c-4e07-953a-1b383dfdf6e4">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNi02LTEtMS04NjEyNw_352613ab-7e3c-4c0d-9ab9-3bc5d0e82658">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNy0yLTEtMS04NjEyNw_12932268-5665-4cac-abb7-ca3351529c43">23,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNy02LTEtMS04NjEyNw_5ca644fa-fd45-4d47-9f2e-0306d62fb7c0">23,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfOC0yLTEtMS04NjEyNw_4da03a23-e58c-4447-bc9e-2916d96545d5">58,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfOC02LTEtMS04NjEyNw_e61a6d94-e2c8-4ca3-92b4-bda9f22ec6cf">58,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfOS0yLTEtMS04NjEyNw_b130db70-b9da-45f9-9b3b-dfca287f9fcf">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfOS02LTEtMS04NjEyNw_1d8634d2-9a76-4321-a138-765a12e0566a">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTAtMi0xLTEtODYxMjc_68645054-94f3-4f37-ad3b-6e056d5f1fdd">480,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTAtNi0xLTEtODYxMjc_0d2a5c4c-ba1d-4912-be9e-ee5918f0ef6a">480,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTEtMi0xLTEtODYxMjc_3ce9fc87-4a49-4ea3-977a-43ac92b524b3">61,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTEtNi0xLTEtODYxMjc_749342ea-f0b2-43be-97c5-e2b776f76670">61,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTItMi0xLTEtODYxMjc_6b3930d0-d147-4cd7-ad24-604bdec7028a">820,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630" decimals="-3" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTItNC0xLTEtODYxMjc_1836e049-2b8b-4868-a73d-1181f7304361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTItNi0xLTEtODYxMjc_e90ffba2-58bf-47b2-ab1d-3510e3ff6bb5">820,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES ASSUMED</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTUtMi0xLTEtODYxMjc_8eb425c9-c95a-494b-809c-3d675faf9905">9,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTUtNi0xLTEtODYxMjc_cb71f1b9-7ac5-46eb-be5d-e4cdd62a8262">9,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTYtMi0xLTEtODYxMjc_78ba6e55-0466-438e-9b95-28ddbfb84bfd">22,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630" decimals="-3" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTYtNC0xLTEtODYxMjc_f5090c99-6fbe-4c0e-82a6-2807967de526">957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTYtNi0xLTEtODYxMjc_86de65a4-97bd-485b-ac58-a5acedb3bd0b">23,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTctMi0xLTEtODYxMjc_1d4cd047-7476-42d5-9b1b-db825972a364">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTctNi0xLTEtODYxMjc_7e532cd5-8ee3-488c-8167-7476034cdb8f">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTgtMi0xLTEtODYxMjc_06e1df4e-40da-43f0-a508-70d0f6bac613">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTgtNi0xLTEtODYxMjc_1ea9b98d-1c7f-4d9a-9b02-8bbd2d3d8332">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTktMi0xLTEtODYxMjc_db4d2db7-f96b-4328-83ff-4c2aee3a7233">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTktNi0xLTEtODYxMjc_13fe7348-a6dd-485a-a862-998f06ed1a6b">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjAtMi0xLTEtODYxMjc_221d5004-824d-4e15-b8c2-dc6f56a5b781">201,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjAtNi0xLTEtODYxMjc_56223dfb-5195-4093-869e-16c72b341200">201,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjEtMi0xLTEtODYxMjc_80afcbde-8ade-4bdb-a1a9-ad2dcb574347">251,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630" decimals="-3" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjEtNC0xLTEtODYxMjc_89ef4c6d-bae3-4ac2-ad82-4bc4940e0b21">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjEtNi0xLTEtODYxMjc_4f421e24-def5-491f-ba1b-0013a6f8220d">252,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjItMi0xLTEtODYxMjc_0ef4a2ae-de26-4e05-be4f-96a998ac4cc5">569,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630" decimals="-3" sign="-" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjItNC0xLTEtODYxMjc_7a46a752-7ccd-4835-a0ef-fd1ecb944eba">957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjItNi0xLTEtODYxMjc_8b50a38e-3cfb-418f-a4b8-51e3c07eaead">568,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjMtMi0xLTEtODYxMjc_6b2c9c6a-40fc-4123-81b7-2c5ae9c278b4">9,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjMtNC0xLTEtODYxMjc_13983e17-cf84-4fbe-be3c-756b4ce3c3df">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjMtNi0xLTEtODYxMjc_7723f69a-f9f7-43a2-b9e0-5ce45f896c73">10,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjQtMi0xLTEtODYxMjc_95d9a5cf-487b-417d-806c-d02b9d344deb">578,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630" decimals="-3" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjQtNC0xLTEtODYxMjc_0109f0fc-e196-4def-926c-da6a7a2a4084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjQtNi0xLTEtODYxMjc_672d65e2-3a7d-45cc-a376-74e3abf8cc39">578,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:continuation id="iac88651d164b4e24a65c9eca58bca670"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)  As previously reported in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b)  Represents pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.</span></div></ix:continuation><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Summary of Operations</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the unaudited pro forma summary of operations for the three and six-month periods ended June&#160;30, 2021, as if the Flexion Acquisition had occurred on January 1, 2020. <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMzQzMA_4bb71814-59be-47bf-817c-1d26f843981d" continuedAt="if237b8f098a5483eb99a618f68218ce6" escape="true">This pro forma information does not purport to represent what the Company&#8217;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):</ix:nonNumeric></span><ix:continuation id="if237b8f098a5483eb99a618f68218ce6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6affd4b067a74053a80dafaecc998dce_D20210401-20210630" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMS0xLTEtMS05MTE3Ng_a9cb4e87-f418-4752-bd74-c0a99c46b05f">163,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMi0yLTEtMS04NjEyNw_97e29921-d23f-4ca3-93ae-541d1c188bf5">307,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6affd4b067a74053a80dafaecc998dce_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMi0xLTEtMS05MTE3Ng_da0ed871-78f1-45da-abec-8a776fa75e94">3,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMy0yLTEtMS04NjEyNw_93097c87-8000-4612-b65d-40ce075c9966">20,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic and diluted net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMy0xLTEtMS05MTE3Ng_abc5f608-8044-49fd-aa79-052014dae28a"><ix:nonFraction unitRef="usdPerShare" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMy0xLTEtMS05MTE3Ng_d5aa51d5-bc14-4d20-b13c-81f9946852b0">0.08</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfNC0yLTEtMS04NjEyNw_a4735145-e2ea-4638-850a-a277e39bc05a"><ix:nonFraction unitRef="usdPerShare" contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfNC0yLTEtMS04NjEyNw_db1e85a8-1622-48cf-9ec5-2214bb12e504">0.47</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information was prepared using the acquisition method of accounting and was based on the historical financial information of the Company and Flexion. The summary pro forma financial information primarily reflects the following pro forma adjustments:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Recognition of the income tax benefit resulting from decreasing Flexion&#8217;s existing valuation allowance on deferred tax assets for the three and six months ended June&#160;30, 2021;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="id1ea9213c2724320b1a197801766b655"><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Removal of Flexion&#8217;s interest expense and associated deferred financing cost amortization related to the $<ix:nonFraction unitRef="usd" contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119" decimals="-5" name="pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMjk1Mg_0e054391-1ffa-4a36-9159-a7469285bcac">85.1</ix:nonFraction>&#160;million of debt not assumed;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Adjustments to the Company&#8217;s interest income for the cash used to acquire Flexion; </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional cost of goods sold related to a step-up value in inventory;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional amortization expense from the acquired developed technology intangible assets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional depreciation of Flexion&#8217;s fixed assets; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional lease expense on Flexion&#8217;s right-of-use, or ROU, assets.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, all of the above adjustments were adjusted for the applicable tax impact.</span></div></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_49"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RleHRyZWdpb246NTg5NDcxNWM0MjFjNDkwY2I4ZWU3YzA5YWU4Yjg1YjBfOTg_7229eea0-1324-4a09-913d-5f13bcde6acd" continuedAt="ia4f026bb3a7a47d6a5de61c60f011edc" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="ia4f026bb3a7a47d6a5de61c60f011edc"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RleHRyZWdpb246NTg5NDcxNWM0MjFjNDkwY2I4ZWU3YzA5YWU4Yjg1YjBfMTA0_7da2fd5a-e4c0-435a-b389-65919efb7792" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfMi0xLTEtMS04NjEyNw_1b312855-dc25-427c-99c3-8d794bfc700d">36,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfMi0zLTEtMS04NjEyNw_72a1bc8a-f38e-4153-81eb-3a53573885ee">36,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfMy0xLTEtMS04NjEyNw_ddbf3b0b-ce1f-47e9-a019-b175c48207cb">39,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfMy0zLTEtMS04NjEyNw_122950df-198a-41c7-8254-cd0b84f6ee5f">35,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfNC0xLTEtMS04NjEyNw_ad96a945-6591-4e5d-820e-6f7468407705">24,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfNC0zLTEtMS04NjEyNw_03f7218f-5753-4612-b1d1-2c6f016f28f1">27,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfNS0xLTEtMS04NjEyNw_e996fd91-04f6-41da-a4fb-c363e8dcd482">100,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfNS0zLTEtMS04NjEyNw_0d4b003d-cc8e-4637-bbc7-43eed16a0493">98,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_52"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfODM5_60460d3e-9b8d-483f-acad-1ba37b96e4c0" continuedAt="ie20669dfe2a340d9af304105f576e433" escape="true">FIXED ASSETS</ix:nonNumeric></span></div><ix:continuation id="ie20669dfe2a340d9af304105f576e433"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfODQx_73dd855e-9ad5-41dd-8da7-9e370362aeda" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d78b23f2b384db1952457d16ecfc25a_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfMi0xLTEtMS04NjEyNw_62b8303a-6673-4dd3-b3ef-857b1e9f3f10">116,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a7bcd6cd0649a3af561d8e804dfa32_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfMi0zLTEtMS04NjEyNw_a576e0aa-6ae3-4b92-a861-1aceb87e48e0">117,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0c585d3783403c875879dfaad021a3_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfMy0xLTEtMS04NjEyNw_ef36a343-c7a7-4746-b60a-87708afe4eea">60,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1c1e7325aa446388971997460585da_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfMy0zLTEtMS04NjEyNw_a9292937-60f7-4da4-aee2-a7bac791c09c">59,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1509ca5743b4070b16fb4bc87afe9d7_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNC0xLTEtMS04NjEyNw_1a0fea11-a7b9-4fa8-8f2c-f3aba769f68e">13,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i826ff833dd74486b9ea7e8f9bff4a586_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNC0zLTEtMS04NjEyNw_9f76f01d-94a5-40c2-a034-e8b86f86c852">13,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33dfed9d67c948b4a47a8e552ba5b8b0_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNS0xLTEtMS04NjEyNw_1c69fffa-6a73-447b-8fbd-f46be7a0bef9">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b8d87ead91c4e5d9b76bca54c19862f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNS0zLTEtMS04NjEyNw_88c30aee-cfe3-41da-b362-b8875c3c9600">2,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e904416e0c433ca74cb7980b2e6633_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNi0xLTEtMS04NjEyNw_ebf5f696-5f0e-439c-9bdd-cdc77faaaab4">94,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4be0edf10e0548a6b2cff393c65da1f4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNi0zLTEtMS04NjEyNw_7ccf59e4-2b7a-468a-b566-a127051b54d9">80,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNy0xLTEtMS04NjEyNw_dbd211d5-cfdf-40b9-8e32-7c5c2a87e2bd">286,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNy0zLTEtMS04NjEyNw_bcab4634-bfc8-4405-8c22-15fa802a0931">273,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfOC0xLTEtMS04NjEyNw_10898b93-0108-4c5b-b968-412e5dda5e53">95,473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfOC0zLTEtMS04NjEyNw_98fbc3b2-a1aa-47f5-87e2-2087e518405d">85,240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfOS0xLTEtMS04NjEyNw_bb95c19d-20ef-4e6f-b676-df3d90ba723d">191,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfOS0zLTEtMS04NjEyNw_346aee29-b0e0-41ff-989f-a2349b3a498c">188,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2022 and 2021, depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfMTgx_5b8f2bee-e1bd-4801-9dad-5b05041b1a53">6.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfMTg4_5c6d53fc-56ce-426f-8246-cc33f1c6156d">2.9</ix:nonFraction> million, respectively. For the three months ended June&#160;30, 2022 and 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i763696419f734dfaa3b176b7f09e6547_D20220401-20220630" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfMjU0_fb93d3aa-eb0c-48e4-8525-3269c3ff989e">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2d0655252144469e8a6289d5d0cea2f3_D20210401-20210630" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfMjYx_06c6b994-c2db-4d41-a7ec-bc0ac413e644">1.1</ix:nonFraction> million of capitalized interest on the construction of manufacturing sites, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2022 and 2021, depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk0NzgwMjMyNjEzMw_be81be52-ea8a-40f8-afa7-017c3ecc87fd">12.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk0NzgwMjMyNjE0MQ_f72a59bd-ca27-47cf-bdb5-596d760661fe">5.8</ix:nonFraction> million, respectively. For the six months ended June&#160;30, 2022 and 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk0NzgwMjMyNjM5Mg_2d2b3398-feaa-45ae-8ea2-e39693f23efc">1.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk0NzgwMjMyNjQwNw_31f457b6-40dd-4fad-8712-181f21b1a96f">2.1</ix:nonFraction>&#160;million of capitalized interest on the construction of manufacturing sites, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and December&#160;31, 2021, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $<ix:nonFraction unitRef="usd" contextRef="if281a36c7ccc4a4aae4dad712d455bfc_I20220630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDg4_6f250a64-c134-415d-9e5e-9546dcc3546c">60.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8a7ee7ba6eb240858ec746652a6fdc24_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk1_470b0248-565f-4bab-91c2-862297039b11">65.4</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the Company had asset retirement obligations of $<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-5" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNTc5_72bf0c44-ca55-4b31-aa61-b0bc2390beb7">3.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-5" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNTg2_5532fafe-69d9-4d66-89e8-8233c5a09118">2.4</ix:nonFraction>&#160;million, respectively, included in accrued expenses and other liabilities on its condensed consolidated balance sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 15</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE1Mg_038f98ac-3c5e-45cc-a58e-1fc881aa2404" continuedAt="i51f453a423a34a24b35251e324fa650e" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i51f453a423a34a24b35251e324fa650e" continuedAt="ie601c099b18c44578b48e5b0aafb23b3"><div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all of its facilities, including its EXPAREL and iovera&#176; manufacturing facility in San Diego, California. These leases have remaining terms up to <ix:nonNumeric contextRef="i391acdd0982f425f84071afc5d969737_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE1Nw_bf21647b-8bf6-4421-9131-375a815cc007">8.2</ix:nonNumeric> years, some of which provide renewal options at the then-current market value. The Company also has <ix:nonFraction unitRef="lease" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="pcrx:NumberOfLeases" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE0OQ_0ba09a6c-5d2f-427c-acad-da54d3b7da22">two</ix:nonFraction> embedded leases with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England for the production of EXPAREL and ZILRETTA. A portion of the associated monthly base fees has been allocated to the lease components based on a relative fair value basis.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE0Ng_9c2758a3-012d-4c11-b42b-6564238bbda5" continuedAt="ie48807b5972945a780f5f3eac49be4d2" escape="true">Total operating lease costs are as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="ie48807b5972945a780f5f3eac49be4d2" continuedAt="i7186a58f48be47e1b3ac91f59dea9184"><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfMy0yLTEtMS04NjEyNw_4e47f738-af2f-4478-bd32-9d2953b28c56">3,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfMy00LTEtMS04NjEyNw_8406db85-f18f-496c-880e-a47a1e24f020">2,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfMy02LTEtMS04NjEyNw_19b154d9-949e-4d00-95ba-ea5315ff26f2">7,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfMy04LTEtMS04NjEyNw_2ef23414-535a-4038-a9b7-4f01f92538fc">5,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNC0yLTEtMS04NjEyNw_974570b8-edb3-45c7-a973-7034e71cd568">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNC00LTEtMS04NjEyNw_aa24d9d9-7c6b-40b9-91e9-0bdea79941d6">424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNC02LTEtMS04NjEyNw_0f41d64c-762a-4cd0-8758-81cdbfc1d7a4">980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNC04LTEtMS04NjEyNw_e502d51a-b319-405c-98aa-eff291ef00f7">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNS0yLTEtMS04NjEyNw_a3d2c51b-d2e0-4a42-b04a-68c704a6335f">4,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNS00LTEtMS04NjEyNw_6f0a8fd3-418f-4948-81ad-54e37c03f774">3,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNS02LTEtMS04NjEyNw_49a4ad72-ee85-48f8-accb-731f86cb47b9">8,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNS04LTEtMS04NjEyNw_1984cd19-167b-432f-96d5-c9c863aa93cf">6,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjZlNGU2NzAxYWJkZTQ4YTNiYzc3YWU4NzNkYWU4NTdhL3RhYmxlcmFuZ2U6NmU0ZTY3MDFhYmRlNDhhM2JjNzdhZTg3M2RhZTg1N2FfMy0yLTEtMS04NjEyNw_904df07e-7532-417d-ac30-6f88425b998b">6,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjZlNGU2NzAxYWJkZTQ4YTNiYzc3YWU4NzNkYWU4NTdhL3RhYmxlcmFuZ2U6NmU0ZTY3MDFhYmRlNDhhM2JjNzdhZTg3M2RhZTg1N2FfMy00LTEtMS04NjEyNw_c1bf3976-bf58-4f94-9a05-1b6f9163f10e">7,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjZlNGU2NzAxYWJkZTQ4YTNiYzc3YWU4NzNkYWU4NTdhL3RhYmxlcmFuZ2U6NmU0ZTY3MDFhYmRlNDhhM2JjNzdhZTg3M2RhZTg1N2FfNC0yLTEtMS04NjEyNw_53d26b96-5f76-4e9f-8419-da079e744065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjZlNGU2NzAxYWJkZTQ4YTNiYzc3YWU4NzNkYWU4NTdhL3RhYmxlcmFuZ2U6NmU0ZTY3MDFhYmRlNDhhM2JjNzdhZTg3M2RhZTg1N2FfNC00LTEtMS04NjEyNw_586c665c-c3eb-4822-af2c-76efe47377e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to net the amortization of the ROU asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. <ix:continuation id="i7186a58f48be47e1b3ac91f59dea9184" continuedAt="icdf51665b6554db4b35769d26f63dac6">The weighted average remaining lease term and the weighted average discount rate are summarized as follows:</ix:continuation></span><ix:continuation id="icdf51665b6554db4b35769d26f63dac6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmYxZjNmMDJhYjM3NjQ0MmNhNzI4MjgzOWY1ZTRkZGQ0L3RhYmxlcmFuZ2U6ZjFmM2YwMmFiMzc2NDQyY2E3MjgyODM5ZjVlNGRkZDRfMi0yLTEtMS04NjEyNw_0d60d228-0ee6-48a3-9541-632c8a400285">7.33</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmYxZjNmMDJhYjM3NjQ0MmNhNzI4MjgzOWY1ZTRkZGQ0L3RhYmxlcmFuZ2U6ZjFmM2YwMmFiMzc2NDQyY2E3MjgyODM5ZjVlNGRkZDRfMi00LTEtMS04NjEyNw_2d615217-6e91-4a48-ba0e-e38ad95e333d">8.71</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmYxZjNmMDJhYjM3NjQ0MmNhNzI4MjgzOWY1ZTRkZGQ0L3RhYmxlcmFuZ2U6ZjFmM2YwMmFiMzc2NDQyY2E3MjgyODM5ZjVlNGRkZDRfMy0yLTEtMS04NjEyNw_c8c8263e-8bbf-49b2-9bf8-c12a709e5331">6.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmYxZjNmMDJhYjM3NjQ0MmNhNzI4MjgzOWY1ZTRkZGQ0L3RhYmxlcmFuZ2U6ZjFmM2YwMmFiMzc2NDQyY2E3MjgyODM5ZjVlNGRkZDRfMy00LTEtMS04NjEyNw_b152b0bb-a194-4aac-a887-87ba2dce8078">6.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE1MA_aa885630-b510-4ba9-8066-97980a0d1f71" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining six months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfMS0yLTEtMS04NjEyNw_2c4d9550-75c0-4747-a91a-15180879769f">6,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfMi0yLTEtMS04NjEyNw_bed921c9-1ec7-42ed-8b2f-a10978390f3a">13,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfMy0yLTEtMS04NjEyNw_6497456a-ecdd-410b-ad95-4aa2209e359f">13,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfNC0yLTEtMS04NjEyNw_d33649a5-9afc-4fd6-a955-01a19e662d6e">12,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfNS0yLTEtMS04NjEyNw_2c7c8596-37eb-42ab-a140-5aaa6b4c0675">12,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfNi0yLTEtMS04NjEyNw_6d0d404f-f228-40e9-9618-76e525a4e1f0">39,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfNy0yLTEtMS04NjEyNw_0da531c9-3a5f-4f60-9a8c-6e574d136a07">97,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfOC0yLTEtMS04NjEyNw_c0f60cc6-3648-49bf-be43-34d3bd94c468">21,846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfOS0yLTEtMS04NjEyNw_ba44c9a0-185b-4749-a760-ebc05ae0a0fa">75,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="ie601c099b18c44578b48e5b0aafb23b3"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE1MQ_39572707-5334-4ef8-a0ae-c309ec0ac1dd" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company has entered into <ix:nonFraction unitRef="segment" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMTYzNA_411805ea-207e-4015-a493-264d396b7e5f">one</ix:nonFraction> lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining six months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfMS0yLTEtMS04NjEyNw_66580feb-0802-4254-b707-4a5500c57900">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfMi0yLTEtMS04NjEyNw_f6d1cd27-0ada-4864-acc1-605985868243">492</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfMy0yLTEtMS04NjEyNw_3317e998-98e1-4608-b8b7-e14e9afc503b">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfNC0yLTEtMS04NjEyNw_32c5e942-6f3a-465f-bb94-fb081b541ab9">503</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfNS0yLTEtMS04NjEyNw_aba221e8-1ee8-45b8-9e0a-7efd16612707">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfNi0yLTEtMS04NjEyNw_f50f5d79-3c27-4b66-b21b-f8d8d931a086">443</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfNy0yLTEtMS04NjEyNw_d704d0e0-2a43-4999-b7cc-65913bbeb30b">2,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to June 30, 2022, the Company entered into a sublease for the former Flexion research and development laboratory in Woburn, Massachusetts in July 2022 which resulted in a $<ix:nonFraction unitRef="usd" contextRef="i29a197404c3243d9b8b707eb226c77fd_I20220701" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMzI5ODUzNDg4NjI5NQ_751e4cfd-8e10-43b0-acd2-d6cee253bfb0">0.4</ix:nonFraction>&#160;million ROU asset to be reclassified to a fixed asset.</span></div></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_58"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTk0NQ_6e5ddccd-215b-4e4b-8afa-d45028efd32d" continuedAt="i2462ac78a4d04f4eb34bdb512ef0b747" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i2462ac78a4d04f4eb34bdb512ef0b747" continuedAt="id66c2428efa940d8b09c270a0fb5264e"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#8217;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#8220;Skyepharma Acquisition&#8221;), MyoScience, Inc., or MyoScience, (the &#8220;MyoScience Acquisition&#8221;) in April 2019 and the Flexion Acquisition in November 2021. The balances at June&#160;30, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjIwMg_ed2ffe1c-f792-4ff5-bc2e-771b66cd36cb">146.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfNDc5_4887dba2-bb7b-4558-9653-05725273fd96">145.2</ix:nonFraction>&#160;million, respectively. The increase was due to measurement period adjustments associated with the Flexion Acquisition. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. The final Skyepharma milestone payment of $<ix:nonFraction unitRef="usd" contextRef="i83f2e14bdb904ac69fc8abf1f24b5ab6_I20220331" decimals="-5" name="pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfOTgx_7cd0e334-6a60-47f4-839f-f90b18d5c295">32.0</ix:nonFraction>&#160;million when annual net sales collected reached $<ix:nonFraction unitRef="usd" contextRef="i83f2e14bdb904ac69fc8abf1f24b5ab6_I20220331" decimals="-5" name="pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTAyNA_b5ebe8f4-b336-400b-9d86-aceae6a2c8f8">500.0</ix:nonFraction>&#160;million was achieved in the fourth quarter of 2021 and paid during the first quarter of 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Intangible Assets</span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTkzNw_3053033f-ebaa-4acd-9e02-17257f6c4315" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net, consist of the in-process research and development, or IPR&amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d966ca6353411282f9165d72de2694_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMS0yLTEtMS04NjEyNw_84cc2a07-373a-4f63-b6ad-420b5bdbdb5c">590,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65d966ca6353411282f9165d72de2694_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMS00LTEtMS04NjEyNw_db583523-8d2f-4c6b-9942-2daa69d59d7c">55,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d966ca6353411282f9165d72de2694_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMS02LTEtMS04NjEyNw_2c765716-18ad-47a0-acc6-24764a94e203">534,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib460bbff86ec431dbef5039959fb47c2_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMS04LTEtMS04NjEyNw_46433248-9824-4b8d-b9f1-0c7140dc9e79">10 years, 5 months</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede544d07eb8434cbb48cd6e2d2f78cf_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMi0yLTEtMS04NjEyNw_5ed0f297-0133-483a-866d-91bfd79c349b">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iede544d07eb8434cbb48cd6e2d2f78cf_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMi00LTEtMS04NjEyNw_be7a1c50-bcac-490f-a580-dce9d5c0ec4b">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede544d07eb8434cbb48cd6e2d2f78cf_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMi02LTEtMS04NjEyNw_4c8f9550-602c-46fe-bbf7-a04fa8520972">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia5ee767a49874dee966e06f8b34939c7_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMi04LTEtMS04NjEyNw_e84d1064-3112-4a94-a1fb-16abe096e0b9">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMy0yLTEtMS04NjEyNw_cd6a9518-e02f-4ade-8920-2c74fc2b5236">590,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMy00LTEtMS04NjEyNw_a803b12c-8598-42e6-bb3e-956ef8a51780">55,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMy02LTEtMS04NjEyNw_777bc90d-3ece-40f7-9ac7-3f5ee9a2755d">534,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a8f5d97b3248aeb01adea4b0c7fe72_I20220630" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNC0yLTEtMS04NjEyNw_ca471f40-e14c-47c3-8897-33ea0f03afce">61,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a8f5d97b3248aeb01adea4b0c7fe72_I20220630" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNC02LTEtMS04NjEyNw_aaf2f9d7-4d0c-46b5-80f3-b171b00a0b3c">61,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNS0yLTEtMS04NjEyNw_fc6c49e2-c75f-4169-8b80-40653b7c9170">651,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNS00LTEtMS04NjEyNw_ad6ab9fa-0a7a-4d96-8c3b-891fa17f956b">55,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNS02LTEtMS04NjEyNw_797d033c-6c68-4d93-9c09-3e1159c1d96b">595,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1658c43324b5453cb15e998032d6549e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOC0yLTEtMS04NjEyNw_bd3fb2b8-9be8-4157-9d58-23077c4ebd4e">590,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1658c43324b5453cb15e998032d6549e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOC00LTEtMS04NjEyNw_3e68e8c1-1936-4ad3-86f2-4be5061bd7c1">27,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1658c43324b5453cb15e998032d6549e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOC02LTEtMS04NjEyNw_ffde7e72-381b-4ce1-a5ed-39c1257b5f4a">562,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7c9452190b1e4796b95b0775fa97bde7_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOC04LTEtMS04NjEyNw_455c6dfb-88f9-4712-877d-1c08a024c4da">10 years, 5 months</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123f4f9994ab4fb68fe6439b61e60b8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOS0yLTEtMS04NjEyNw_ba4361da-2f10-4da1-9cb3-52c976b5f32c">90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i123f4f9994ab4fb68fe6439b61e60b8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOS00LTEtMS04NjEyNw_3231295a-5df3-43d6-abf5-406682d40fbc">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123f4f9994ab4fb68fe6439b61e60b8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOS02LTEtMS04NjEyNw_497d6a24-6bb6-4e6a-999a-15456e3fc7be">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i76602afa0926462bbcd383a88f3f3ef8_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOS04LTEtMS04NjEyNw_ed3019cb-d5a3-4392-8397-650718048bff">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTAtMi0xLTEtODYxMjc_e9b5acc7-cada-49f5-bea4-d37c3267030e">590,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTAtNC0xLTEtODYxMjc_1fb56cb7-1c8f-46c8-97c9-bb1ba058e786">27,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTAtNi0xLTEtODYxMjc_9d61eb07-3a4b-44f2-9274-edcdd12fde25">562,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3334cacbe145ba953c4eed59a7b31b_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTEtMi0xLTEtODYxMjc_f2af82a0-345e-4d78-af09-fdcac1a60215">61,000</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3334cacbe145ba953c4eed59a7b31b_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTEtNi0xLTEtODYxMjc_2caf8fad-fff5-443f-ba1a-6f70449fe862">61,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTItMi0xLTEtODYxMjc_9d0318fc-9123-4864-ac63-f511456acfbc">651,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTItNC0xLTEtODYxMjc_dc43c015-5125-4f1e-baf0-541619949893">27,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTItNi0xLTEtODYxMjc_7e36fe36-c6db-4255-a72a-4d121c8f27f6">623,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense on intangible assets for the three and six months ended June&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjI1Mg_e7d17a13-f15d-4843-95f3-62c03495aeaa">14.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjI4MQ_0b038420-539d-4e0d-8138-8b5fb62bcdd4">28.6</ix:nonFraction>&#160;million, respectively. Amortization expense on intangible assets for the three and six months ended June 30, 2021 was </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="id66c2428efa940d8b09c270a0fb5264e"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjIyNA_07f15077-3d0f-4b10-b06d-6835c2e84fef">2.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjIzOA_4687c035-499f-47d2-a721-c4e2f6663f77">3.9</ix:nonFraction>&#160;million, respectively. The increase in amortization expense in the current year is a result of the amortization of ZILRETTA for osteoarthritis knee pain acquired as part of the Flexion Acquisition in November 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming no changes in the gross carrying amount of these intangible assets, the future estimated amortization expense on the finite-lived intangible assets will be $<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTgzOQ_03eefa4a-cfc8-4a70-8c18-dc82b6f74f0a">28.6</ix:nonFraction>&#160;million for the remaining six months of 2022, $<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-5" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTg3Nw_9f3e6cd5-ef4c-4eda-921e-89cc673cead3">57.3</ix:nonFraction>&#160;million from 2023 to 2030, $<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-5" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTkwMA_0c7ce8d7-3643-44d5-bd46-be11b3621391">37.4</ix:nonFraction>&#160;million in 2031, $<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-5" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTkxMg_52dff262-3d24-4768-90a4-6fe0549ff162">7.9</ix:nonFraction>&#160;million in 2032 and $<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-5" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTkyNw_25ced9d3-b19c-4a88-8705-63efa4b1390b">2.2</ix:nonFraction>&#160;million in 2033.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets for impairment whenever an event or change in circumstances arise that indicate the carrying amount of an asset group is at risk of not being recoverable. A triggering event was identified for the ZILRETTA asset group due to a reduction in the near-term projected cash flows from the ZILRETTA product. The Company completed an impairment assessment through a recoverability test at June 30, 2022 by comparing the net carrying value of ZILRETTA asset group against the undiscounted net cash flows expected to be generated from ZILRETTA. It was determined that the ZILRETTA asset group was recoverable and not impaired.</span></div></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_61"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;9&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NDQ_68b4436b-52f3-4981-a689-a5a322f26c44" continuedAt="ie3285a0d57964de9ba6d810ec20fae62" escape="true">DEBT </ix:nonNumeric></span></div><ix:continuation id="ie3285a0d57964de9ba6d810ec20fae62" continuedAt="i30f6432b61be443ba66f5faee801fe42"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NDk_388ab25e-bf27-4606-bf81-dbc821d9b6db" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s outstanding debt is summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan B facility maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMi0xLTEtMS04NjEyNw_9759b411-6fa8-465d-94f3-6edf04bf282f">352,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMi0zLTEtMS04NjEyNw_d7950c04-300a-49e3-b71c-387f8b096317">359,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i292cd08d718c48e594813938f2045cca_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMy0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOmM0N2VjMWRhMDlkMjQ3OTNhMjZkNWFlNGNkY2ZiZGU0XzQ_08083722-b88d-4d55-9843-1e806a021a79">0.750</ix:nonFraction>% Convertible senior notes due August 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMy0xLTEtMS04NjEyNw_dfb583b4-5e95-4050-8d5b-b178a0f2643b">394,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMy0zLTEtMS04NjEyNw_4b34b8cd-d944-4a4a-975f-abed19f09229">330,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c9dded19a964d11981b36b085b753ff_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNC0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOmViYWMyYWRiMDdhYzQ2NmE5OTdmNzBhODAzZmUzZjIwXzQ_30d44774-68d6-4b77-aca4-65bea7f0f307">3.375</ix:nonFraction>% Convertible senior notes due May 2024 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d6abb8ceed479bada14abc5c7d6b1b_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNC0xLTEtMS04NjEyNw_7c7d3c9f-7622-4439-bddb-9c92af0615ae">8,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7189f61d0f74daea85087e80f151740_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNC0zLTEtMS04NjEyNw_246dea42-f4ad-485a-a8eb-1185ff9e3b33">201,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e4c5d796d09442cacf138a186e3cdec_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNS0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOjg5Yzg4MGJjMTk5YjRjNzhhMGFjMjAyN2U4YjdiMDc0XzQ_dc1c42b4-f9d4-41eb-beec-1b9c9548d7e8">2.375</ix:nonFraction>% Convertible senior notes due April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNS0xLTEtMS04NjEyNw_ae3c1bea-c9f5-4153-8dd8-b2e2e2750823">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNS0zLTEtMS04NjEyNw_356281fc-903b-42b8-803a-9b6e803c3780">157,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356d1afe505c441eb90b0423c3fb17f2_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNi0xLTEtMS04NjEyNw_e33fefd1-321d-4810-aa44-66aaa65a68c6">755,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c516f1d6f04f26b3b01ed70a06cb25_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNi0zLTEtMS04NjEyNw_7daed849-133f-4879-acce-ac4e2b822214">1,049,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The 2022 Notes (as defined below) matured on April 1, 2022.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan B Facility</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a term loan credit agreement (the &#8220;Credit Agreement&#8221;) with JP Morgan Chase Bank, N.A., as administrative agent and the initial lender. The term loan issued under the Credit Agreement (the &#8220;Term Loan&#8221;) was issued at a <ix:nonFraction unitRef="number" contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231" decimals="2" name="pcrx:DebtInstrumentDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDU5_19ee2992-6d52-4bfe-ad01-4d0f7ebf339a">3</ix:nonFraction>% discount and allows for a single-advance term loan B facility in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNTUx_3c04caae-ed0e-44ef-902f-95de375580b6">375.0</ix:nonFraction>&#160;million, which is secured by substantially all of the Company&#8217;s and each subsidiary guarantor&#8217;s assets. Subject to certain conditions, the Company may, at any time, on one or more occasion, add one or more new classes of term facilities and/or increase the principal amount of the loans of any existing class by requesting one or more incremental term facilities. The net proceeds of the Term Loan were approximately $<ix:nonFraction unitRef="usd" contextRef="i7c5268d5a41d453387099bbdce493860_D20211201-20211231" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfOTYz_563ae9dc-677f-4580-b708-c37dee421bd5">363.8</ix:nonFraction>&#160;million after deducting an original issue discount of $<ix:nonFraction unitRef="usd" contextRef="ib78f8ec858814f8b9f80f0d166898244_I20211230" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTAxMg_24fdda1e-b2da-4eb1-86ed-0cd5b170c85a">11.2</ix:nonFraction>&#160;million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NTg_4b10bcd4-eb44-48bd-8c47-545eaf7ae072" continuedAt="i43ba1147df1b45c1ac41f16bcef73554" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the Term Loan is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfMi0xLTEtMS04NjEyNw_3e8738f8-eec2-4fc3-8ade-bee3f0489ec7">365,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfMi0zLTEtMS04NjEyNw_b5fea520-9651-4df3-8923-8b540e23acd8">375,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfMy0xLTEtMS04NjEyNw_6cd76f18-72f9-4280-861a-0c6e240fcb69">3,856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfMy0zLTEtMS04NjEyNw_fe690a8e-8b71-41a5-ad83-afb84ee82539">4,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfNC0xLTEtMS04NjEyNw_7282685b-1c40-4bdf-be49-ced549b507e5">9,649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfNC0zLTEtMS04NjEyNw_b609224d-eb0b-4cc1-8b0d-123af1f28fd3">11,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfNS0xLTEtMS04NjEyNw_1dc13d67-d6bd-4439-bf2a-8fa4613a40c8">352,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfNS0zLTEtMS04NjEyNw_4fbc16ec-9902-4f3c-8860-6871a96af52b">359,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan matures on December 7, 2026 and requires quarterly repayments of principal in the amount of $<ix:nonFraction unitRef="usd" contextRef="ie2012b55273641219ce287b6c7a3676c_D20220630-20220630" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTE5Nw_9bd729ac-bc34-482f-bd1e-cf9984698549">9.4</ix:nonFraction>&#160;million commencing June 30, 2022, increasing to $<ix:nonFraction unitRef="usd" contextRef="id396246417f747219b1efc00393a410a_D20251231-20251231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI0MA_4cac023d-8b22-4563-8b82-2e310d1431e1">14.1</ix:nonFraction>&#160;million commencing December 31, 2025, with a remaining balloon payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i14cfaef699694c8aa95e5b1497db08f8_I20261207" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTMyMw_80431d53-9f56-4135-828f-c4ad2f26a267">188.0</ix:nonFraction>&#160;million due at maturity. During 2022, the Company is required to make <ix:nonFraction unitRef="payment" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="INF" name="pcrx:DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NDc_d23c0392-8133-4dfa-b0e5-0242db0ecd9f">three</ix:nonFraction> quarterly payments totaling $<ix:nonFraction unitRef="usd" contextRef="i9713356e4b794cad87f61cdf66d71cda_D20220101-20221231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQyNw_5b6d2e29-f807-4443-a0ab-f50b76bb7242">28.1</ix:nonFraction>&#160;million. The Company is also required to make mandatory prepayments of principal from (i) the Company&#8217;s excess cash flow (as defined in the Credit Agreement) existing in any fiscal year and if the Senior Secured Leverage Ratio (as defined in the Credit Agreement) for such fiscal year exceeds certain predetermined limits (ii) net proceeds (as defined in the Credit Agreement) of non-ordinary course assets sales and casualty events and (iii) debt issuance proceeds (other than permitted debt under the Credit Agreement). Prepayment penalties for the Term Loan are <ix:nonFraction unitRef="number" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="2" name="pcrx:DebtInstrumentPrepaymentPenaltyPercentYear1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTk4Nw_f0bd64ce-3d85-4233-bed3-d465eca7ae26">2</ix:nonFraction>% in the first loan year plus an interest make-whole payment, <ix:nonFraction unitRef="number" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="2" name="pcrx:DebtInstrumentPrepaymentPenaltyPercentYear2" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMjA1MA_00f47175-6373-4ee2-adc6-83fe342edf3a">2</ix:nonFraction>% in the second loan year, <ix:nonFraction unitRef="number" contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630" decimals="2" name="pcrx:DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMjA3OA_fc1c589a-47fc-437f-bbe6-9742e4f4209d">1</ix:nonFraction>% in the third loan year and nothing thereafter. Prepayment penalties generally do not apply to mandatory prepayment obligations under the Credit Agreement, such as prepayments due in connection with excess cash flow. During the three and six months ended June&#160;30, 2022, the Company made a scheduled principal payment of $<ix:nonFraction unitRef="usd" contextRef="i8ba15de8dac143c1b4bc141eea541035_D20220101-20220630" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzI5ODUzNDg5ODkxNw_7ca5cb1a-1032-454e-b449-faaffeccc2a6"><ix:nonFraction unitRef="usd" contextRef="i7f34a25fd03649ce9d8283d456471160_D20220401-20220630" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzI5ODUzNDg5ODkxNw_f286d363-1699-4a5b-a27d-86cdbcbfd56b">9.4</ix:nonFraction></ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i30f6432b61be443ba66f5faee801fe42" continuedAt="i454ce25f79fc4f01999676a8a6a348b2"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan requires the Company to, among other things, maintain (i) a first lien net leverage ratio, determined as of the last day of any fiscal quarter, of no greater than <ix:nonFraction unitRef="number" contextRef="i9511fd772a33485880857ed5ca7d851a_I20220630" decimals="INF" name="pcrx:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMjQ2OQ_ba4ba165-862f-4cd2-b19b-c6cb15eea883">1.75</ix:nonFraction> to 1.00 and (ii) liquidity, at any time, of at least $<ix:nonFraction unitRef="usd" contextRef="i9511fd772a33485880857ed5ca7d851a_I20220630" decimals="-5" name="pcrx:DebtInstrumentCovenantLeverageRatioMaximumValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMjUyMw_f12f5d74-2790-4ecb-b64e-13ec42e89ce0">150.0</ix:nonFraction>&#160;million. The Term Loan also contains customary affirmative and negative covenants, financial covenants, representations and warranties, events of default and other provisions. As of June&#160;30, 2022, the Company was in compliance with all financial covenants under the Credit Agreement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company may elect to borrow either term benchmark borrowings or alternate base rate borrowings. Term benchmark borrowings bear interest at a variable rate per annum equal to the Adjusted Term SOFR Rate (as defined in the Credit Agreement) (subject to a <ix:nonFraction unitRef="number" contextRef="i4de17e595d074a81bcbe5f3e180aa7ae_D20220101-20220630" decimals="INF" name="pcrx:DebtInstrumentVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzA0OQ_083744c5-03ce-4770-9c25-f28946f76668">75</ix:nonFraction> basis points floor) plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="iaae7a6225dc9403087ba9ca504bd5fb5_D20220101-20220630" decimals="INF" name="pcrx:DebtInstrumentBasisSpreadTwoOnVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzEwMQ_c6ac0bc8-062f-4458-a35e-a9abe8da8c78">700</ix:nonFraction> basis points. Alternate base rate borrowings bear interest at a variable rate per annum determined using a base rate (subject to a <ix:nonFraction unitRef="number" contextRef="i31ba252e9c0a48188e8038d7fcbf3bc2_D20220101-20220630" decimals="INF" name="pcrx:DebtInstrumentVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzIzNQ_79c6e4f1-7fd6-4376-91d7-ee008c97c930">175</ix:nonFraction> basis points floor) equal to the greatest of (i) the Prime Rate (as defined in the Credit Agreement) in effect on such day, (ii) the NYFRB Rate (as defined in the Credit Agreement) plus <ix:nonFraction unitRef="number" contextRef="idb0b227a9c66456c9e5719df73099bd6_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzQyNA_0f59e1c1-49c2-44d4-8aa5-f5b2d144bce2">50</ix:nonFraction> basis points or (iii) the Adjusted Term SOFR Rate (as defined in the Credit Agreement) plus <ix:nonFraction unitRef="number" contextRef="iaae7a6225dc9403087ba9ca504bd5fb5_D20220101-20220630" decimals="INF" name="pcrx:DebtInstrumentBasisSpreadOneOnVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzUxOQ_1c5b8244-4dff-4bad-845d-67dd43aa1fe1">100</ix:nonFraction> basis points, subject to certain exceptions, plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="if7caa5a1b4a74f499d82959cd49c6133_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzU5Ng_d83b267b-d0af-45c7-82df-38a0ea202fec">600</ix:nonFraction> basis points. As of June&#160;30, 2022, borrowings under the Term Loan consisted entirely of term benchmark borrowings at a rate of <ix:nonFraction unitRef="number" contextRef="i9511fd772a33485880857ed5ca7d851a_I20220630" decimals="INF" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzcxNQ_8e584e10-e762-4d4e-b5d7-b6549c405e7a">7.81</ix:nonFraction>%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2025</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="id3d5f239abc04c23a4020b220c65ce7b_I20200731" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzgxMg_7a0f7267-ab1e-4ca7-b90c-b24ca520abb9">402.5</ix:nonFraction>&#160;million in aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="id3d5f239abc04c23a4020b220c65ce7b_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzg1Mg_8f3239fc-2129-4e03-82a8-8747d3bad586">0.750</ix:nonFraction>% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="id3d5f239abc04c23a4020b220c65ce7b_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDAzNw_0d675d7f-0a31-4d94-8a29-af422fdeb4e0">0.750</ix:nonFraction>% per year, payable semiannually in arrears on February 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and August 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. The 2025 Notes mature on August 1, 2025.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><ix:continuation id="i43ba1147df1b45c1ac41f16bcef73554" continuedAt="iee83cdafd8864cfbbeda24034f83a0d9"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMi0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOmI1NmFlNGY5ZDRlNTQ0YjU5OTRhNDExOGJjZWNjZTQ1XzQ_8af9fe3e-3d07-48d3-8f2f-35ec085409bc">0.750</ix:nonFraction>% convertible senior notes due August 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMi0xLTEtMS04NjEyNw_3ea6cb25-c508-4e27-8364-73f556c074d9">402,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMi0zLTEtMS04NjEyNw_652737d2-298a-4cb5-bc4d-d187c5350c81">402,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMy0xLTEtMS04NjEyNw_a98aaa6b-b6bf-4df8-87c4-61085c5b27c2">7,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMy0zLTEtMS04NjEyNw_149bb35d-02b6-42f4-8065-b478b336ab98">7,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfNC0xLTEtMS04NjEyNw_5d9e876a-e100-4c77-951f-977914fa1187">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfNC0zLTEtMS04NjEyNw_b0619132-6c49-4f1f-bed7-869778837c1c">64,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfNS0xLTEtMS04NjEyNw_7636ccef-c056-445a-8ae2-026190ed037d">394,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfNS0zLTEtMS04NjEyNw_10ec0389-2d62-4f52-b6f0-d3447b670d13">330,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the issuance of the 2025 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i6590fbf0d3a9462e9127e6b54ee201c6_D20200701-20200731" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDMxNg_79972d23-0b1d-47b0-be00-796413bbf958">390.0</ix:nonFraction>&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $<ix:nonFraction unitRef="usd" contextRef="iccd912dc0b8b41f3bd7d557dac967d17_I20200731" decimals="-5" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDQ4NA_b87e5702-d57b-4212-ad2c-766827ffa8b4">185.0</ix:nonFraction>&#160;million in aggregate principal amount of its then-outstanding <ix:nonFraction unitRef="number" contextRef="iccd912dc0b8b41f3bd7d557dac967d17_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDU0MQ_516aaca9-4f47-4034-b39a-bb564dc91212">2.375</ix:nonFraction>% convertible senior notes due 2022 in privately-negotiated transactions for a total of $<ix:nonFraction unitRef="usd" contextRef="iba8867ac2f1d4283b42fe8008031479f_D20200701-20200731" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDYzMA_c8cc69c1-83ee-4635-a161-b212bac12404">211.1</ix:nonFraction>&#160;million of cash (including accrued interest).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert the 2025 Notes at any time prior to February 3, 2025, only if certain circumstances are met, including if during the previous calendar quarter, the last reported sales price of the Company&#8217;s common stock was greater than <ix:nonFraction unitRef="number" contextRef="i15c1498310e443e7af3ba4aa7ad28e3a_D20220401-20220630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDkxMg_fe7d0016-c159-441e-91be-f5b2613a6a60">130</ix:nonFraction>% of the conversion price then applicable for at least <ix:nonFraction unitRef="d" contextRef="i15c1498310e443e7af3ba4aa7ad28e3a_D20220401-20220630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDk2OA_4bfad832-8cc5-42a1-a7c4-ef3be804749b">20</ix:nonFraction> out of the last <ix:nonFraction unitRef="d" contextRef="i15c1498310e443e7af3ba4aa7ad28e3a_D20220401-20220630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDk4Nw_bb8ed561-fe75-4db3-98c0-5f3730a477b1">30</ix:nonFraction> consecutive trading days of the quarter. During the quarter ended&#160;June&#160;30, 2022, this condition for conversion was not met.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="pcrx:SettlementPeriodConvertibleDebtConversionRequest" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNTQ3Nw_d4354c0d-8c54-4f7c-b711-f658b2663345">40</ix:nonNumeric> consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8fd9f584f9084e259a06bbfddce30195_I20200731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNTk0Ng_97c67561-b3c0-4257-821a-e97d0bb1181c">71.78</ix:nonFraction> per share of the Company&#8217;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately <ix:nonFraction unitRef="number" contextRef="i8fd9f584f9084e259a06bbfddce30195_I20200731" decimals="3" name="pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNjIwMg_92d91af5-9662-4a0c-8014-c608234ba6d0">32.5</ix:nonFraction>% to the closing sale price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8fd9f584f9084e259a06bbfddce30195_I20200731" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNjIzNA_02216669-d4d8-492b-9e27-1bda6fbe774f">54.17</ix:nonFraction> per share of the Company&#8217;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the 2025 Notes had a market price o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1,038</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i454ce25f79fc4f01999676a8a6a348b2" continuedAt="i6ef3805bff42451693eaa90c4b5ce0ba"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ia62779f0fd434d20b021fcde6a57f24a_D20220101-20220630" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNjg3MA_8e1dfae1-b216-4bc3-ab47-7193e129c450">402.5</ix:nonFraction>&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#8217;s option).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> scheduled trading day immediately before the maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNzQ0Mg_316f8f70-c656-4ddc-9e2a-2d59b3184437">130</ix:nonFraction>% of the conversion price then in effect for (i) each of at least <ix:nonFraction unitRef="segment" contextRef="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNzUwOQ_e56af9eb-f0a3-4cc4-86a5-d857219a679a">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNzU2NQ_1f891dcc-5a0b-466e-b01e-791d9c4846c5">30</ix:nonFraction> consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) <ix:nonFraction unitRef="number" contextRef="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630" decimals="INF" name="pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNzg0NQ_e7426b1f-1ab5-447c-940c-777f2b16fd10">100</ix:nonFraction>% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#8220;make-whole fundamental change&#8221; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the 2025 Notes are currently classified on the Company&#8217;s condensed consolidated balance sheet at June&#160;30, 2022 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#8217;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2024 Assumed from the Flexion Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Flexion Acquisition, on May 2, 2017, Flexion issued an aggregate of $<ix:nonFraction unitRef="usd" contextRef="i9395aa55649e4194b09292b57bc4118a_I20170502" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfOTEyOQ_d8106333-36ed-4f00-89cd-d2a17bb5cee4">201.3</ix:nonFraction>&#160;million principal amount of <ix:nonFraction unitRef="number" contextRef="i9395aa55649e4194b09292b57bc4118a_I20170502" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfOTE1Mg_b424f91d-a778-47cb-9f42-25e425ec34d8">3.375</ix:nonFraction>% convertible senior notes due 2024 (the &#8220;Flexion 2024 Notes&#8221;), pursuant to the indenture, dated as of May 2, 2017 (the &#8220;Original Flexion Indenture&#8221;), between Flexion and Wells Fargo Bank, N.A., as trustee (the &#8220;Flexion Trustee&#8221;), as supplemented by the First Supplemental Indenture, dated as of November 19, 2021, between Flexion and the Flexion Trustee (the &#8220;First Supplemental Flexion Indenture&#8221; and, together with the Original Flexion Indenture, the &#8220;Flexion Indenture&#8221;). The Flexion 2024 Notes have a maturity date of May 1, 2024, are unsecured, and accrue interest at a rate of <ix:nonFraction unitRef="number" contextRef="i9395aa55649e4194b09292b57bc4118a_I20170502" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfOTcyMQ_ec310eb6-f685-41f6-896d-0d4829fadbbd">3.375</ix:nonFraction>% per annum, payable semi-annually on May 1 and November 1 of each year. Upon the Flexion Acquisition, the principal was assumed and recorded at fair value by the Company. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the Flexion 2024 Notes, at the election of each holder thereof, each Flexion 2024 Note was convertible into cash, shares of Flexion&#8217;s common stock, or a combination thereof, at Flexion&#8217;s election, at a conversion rate of approximately 37.3413 shares of Flexion common stock per $1,000 principal amount of the Flexion 2024 Notes, which corresponded to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i48e21d63eae54e80a8ef9375cebac9c5_I20170502" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTAzMDU_122ec762-60cd-4ac2-a1e0-112f8830c083">26.78</ix:nonFraction> per share of Flexion&#8217;s common stock. As a result of the Flexion Acquisition, and in connection with the Notice (as defined below), holders of the Flexion 2024 Notes became entitled to certain Flexion Acquisition-related conversion and repurchase rights, as discussed below. In addition, as a result of the Flexion Acquisition and as discussed in more detail below, any future conversion rights are subject to the occurrence of any future events giving rise to such conversion rights under the Flexion Indenture.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2021, as a result of the Flexion Acquisition and in accordance with the Flexion Indenture, Flexion provided a Fundamental Change Company Notice and Offer to Purchase (the &#8220;Notice&#8221;) to the holders of the Flexion 2024 Notes and offered to repurchase for cash all of the outstanding Flexion 2024 Notes, at a repurchase price in cash equal to <ix:nonFraction unitRef="number" contextRef="i45a17b9799754d8382dc1b30711bd51f_D20211206-20220106" decimals="2" name="pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTExNzQ_b6d5942e-e17c-4841-a769-e55147c347a5">100</ix:nonFraction>% of the principal amount of the Flexion 2024 Notes being repurchased, plus accrued and unpaid interest thereon to, but excluding, January 7, 2022, subject to the terms and conditions set forth therein. The offer to purchase expired at 5:00 p.m., New York City time, on January 6, 2022, as scheduled. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any holder that did not exercise its repurchase right in accordance with the terms of the Notice retained the conversion rights associated with such holder&#8217;s Flexion 2024 Notes under the Flexion Indenture. For conversion of Flexion 2024 Notes in connection with the Fundamental Change and the Make-Whole Fundamental Change (each as defined in the Flexion Indenture) resulting from the Flexion Acquisition, each $1,000 principal amount of the Flexion 2024 Notes was convertible into (i) $<ix:nonFraction unitRef="usdPerShare" contextRef="if3c970a4569147d397783bc1f4e7311d_I20211206" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTE5NjM_0cf40794-4893-484f-903a-850c236a4d6c">317.40</ix:nonFraction> in cash and (ii) <ix:nonFraction unitRef="shares" contextRef="if3c970a4569147d397783bc1f4e7311d_I20211206" decimals="INF" name="pcrx:DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTE5ODM_4ad548cc-0a28-417d-98bd-a9ad9bbc3136">37.3413</ix:nonFraction> CVRs, based on the conversion rate of 37.3413, prior to 5:00 p.m., New York City time, on January 7, 2022. Alternatively, holders could retain their Flexion 2024 Notes and such Flexion 2024 Notes would remain outstanding subject to their existing terms, including with respect to a holder&#8217;s right to receive interest payments on the Flexion 2024 Notes and exercise any future conversion rights that may arise under the Flexion Indenture.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, following the expiration of the offer to purchase, the Company accepted the $<ix:nonFraction unitRef="usd" contextRef="i991d1519897b4f2ea80c13d8da3de071_I20220107" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI1MTU_67594dee-7958-4bf3-8e95-f4a4a72c8452">192.6</ix:nonFraction>&#160;million aggregate principal amount of Flexion 2024 Notes that were validly tendered (and not validly withdrawn). No Flexion 2024 Notes were converted in connection with the Notice. At June&#160;30, 2022, the remaining principal outstanding is $<ix:nonFraction unitRef="usd" contextRef="id4d6abb8ceed479bada14abc5c7d6b1b_I20220630" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI3Mzc_061cce1c-ea8d-4c09-ac9a-4812f5e9ad5c">8.6</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i6ef3805bff42451693eaa90c4b5ce0ba"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2022</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="i015d29a64d0646edbc9915f35b26c446_D20170301-20170331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI4MzU_f9e47d71-9ae3-4029-8d67-b2bdb92c78be">345.0</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ib5b5fbc6d47e4f9f9e6d40924ce413db_I20170331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI4NzE_242199c9-468d-42cb-a286-15d318e6e75f">2.375</ix:nonFraction>% convertible senior notes due 2022, or 2022 Notes. The 2022 Notes accrued interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="ib5b5fbc6d47e4f9f9e6d40924ce413db_I20170331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI5NzU_e27b18c0-a7d4-4774-bce6-14bac6b0f4dd">2.375</ix:nonFraction>% per year, payable semiannually in arrears on April&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and October&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. In July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $<ix:nonFraction unitRef="usd" contextRef="iccd912dc0b8b41f3bd7d557dac967d17_I20200731" decimals="-5" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTMxODk_d5b9e5c3-55f1-4f09-8420-51512088974e">185.0</ix:nonFraction>&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $<ix:nonFraction unitRef="usd" contextRef="iba8867ac2f1d4283b42fe8008031479f_D20200701-20200731" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTMyOTQ_e8284e9c-f75c-461c-84cd-24895adea058">211.1</ix:nonFraction>&#160;million in cash (including accrued interest).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><ix:continuation id="iee83cdafd8864cfbbeda24034f83a0d9"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMi0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOjk2OTExZDUwMzU1MDQ2ZTViMTM5YWY4NjA2MWQxZDZlXzQ_3be6f422-c2f3-43df-b57a-a6986f8ff47c">2.375</ix:nonFraction>% convertible senior notes due April 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMi0xLTEtMS04NjEyNw_d8541d89-3898-478b-95dc-d0f31f6ff2e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMi0zLTEtMS04NjEyNw_6ba2227d-88d3-4e08-b353-24cc175bd3bd">160,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMy0xLTEtMS04NjEyNw_d5e8d298-659e-4fa0-a8e8-4876d917052a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMy0zLTEtMS04NjEyNw_4a326d56-bb5d-4551-8724-e5df4e870f13">223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfNC0xLTEtMS04NjEyNw_381dc0c2-b6f4-4391-9e0b-63caa439d3e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfNC0zLTEtMS04NjEyNw_fd74c709-2fd9-4b3a-bf94-cdd336743c09">1,920</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfNS0xLTEtMS04NjEyNw_62f41748-cf1a-461f-b9bc-1db5dd36b96f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfNS0zLTEtMS04NjEyNw_e1d47c9b-64e8-4abb-b5f7-87ce15d82da6">157,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the 2022 Notes matured and the Company settled the remaining outstanding principal balance of $<ix:nonFraction unitRef="usd" contextRef="idecdb2c3fc1449cfab60ca69c9d1fe48_D20220401-20220401" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTM1Mzg_b3d508b3-bd28-4012-a152-22a6a06555a6">160.0</ix:nonFraction>&#160;million and a conversion premium of $<ix:nonFraction unitRef="usd" contextRef="idecdb2c3fc1449cfab60ca69c9d1fe48_D20220401-20220401" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTM1Njk_cd25b35c-4c65-427f-8e3d-8692cc6b22e9">4.8</ix:nonFraction>&#160;million through a cash payment of $<ix:nonFraction unitRef="usd" contextRef="idecdb2c3fc1449cfab60ca69c9d1fe48_D20220401-20220401" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTM1OTg_22fa83f5-1b34-4904-9aed-d01e247ba085">156.9</ix:nonFraction>&#160;million and the issuance of <ix:nonFraction unitRef="shares" contextRef="i37476438df894c20a4bc4a280d425eb6_D20220401-20220401" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTM2MjE_ec934203-fdaa-4930-b528-e8b2c513962b">101,521</ix:nonFraction> shares of the Company&#8217;s common stock, which increased additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="i37476438df894c20a4bc4a280d425eb6_D20220401-20220401" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzI5ODUzNDg5ODY3Nw_a6287182-b963-4d23-aa22-f0a5d468c1ba">3.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="pcrx:ScheduleOfInterestExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NTM_99e113c2-3b1d-4035-a29f-035c9247bb50" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMi0xLTEtMS04NjEyNw_8db87a00-ef9c-4a9a-853c-73fdc4e114ca">8,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMi0zLTEtMS04NjEyNw_94584ae9-328f-4bfa-ab4b-29d4ed8c9cd9">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMi01LTEtMS04NjEyNw_632c66a5-6ecb-4e2d-9158-630875a1b6c6">17,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMi03LTEtMS04NjEyNw_3eac5ca4-9846-4710-9b84-437f00b46e79">3,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMy0xLTEtMS04NjEyNw_c48c67c2-4578-4b84-9178-b45a450c438d">874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMy0zLTEtMS04NjEyNw_045a0f16-9971-44fd-a441-dd23c17dfaa8">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMy01LTEtMS04NjEyNw_d24ceda7-cd5d-4a6a-8327-d5bac237e504">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMy03LTEtMS04NjEyNw_fbfc63cd-649e-42b5-b7fa-754126c89aeb">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNC0xLTEtMS04NjEyNw_093a81c0-7f33-434a-ae56-3a660d9a446c">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNC0zLTEtMS04NjEyNw_76f08d47-2924-4c5c-b2f3-dd52c88422ef">5,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNC01LTEtMS04NjEyNw_0fe67130-45b8-4c3f-a318-be9bdde233bf">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNC03LTEtMS04NjEyNw_01b6e3ef-54b4-4191-ab35-0dae64b9370f">11,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNS0xLTEtMS04NjEyNw_25bef7c4-1fd6-469d-bfa7-ffc1f982c0de">943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNS0zLTEtMS04NjEyNw_77f2ce50-c0a2-4e51-a509-960fbb97b040">1,093</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNS01LTEtMS04NjEyNw_d9b4b20d-e412-4d50-8b60-36306ced48f4">1,767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNS03LTEtMS04NjEyNw_25337d2f-6653-4e06-ad2f-f0e598f55a7d">2,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNi0xLTEtMS04NjEyNw_57ec4993-5ada-45f1-b74b-d61c7b65766e">8,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNi0zLTEtMS04NjEyNw_563dae65-17ca-426a-b1b4-c8202d584f13">7,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNi01LTEtMS04NjEyNw_c32bfd94-bd1d-40a3-955c-463383f593e1">19,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNi03LTEtMS04NjEyNw_91158b52-d149-4aa4-a601-a91877afc505">13,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfOC0xLTEtMS04NjEyNw_ee03ed62-9f0e-42b4-bf9f-28217d588395">5.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfOC0zLTEtMS04NjEyNw_314dc274-c2f4-41ce-935c-fa7034da6447">6.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfOC01LTEtMS04NjEyNw_e64d4c45-28bb-4dbf-815d-5d98efb44a8a">5.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfOC03LTEtMS04NjEyNw_5536f1cf-1ddd-4f5f-9faf-a3e8ec925ce4">6.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Upon the adoption of ASU 2020-06 effective January 1, 2022, the Company eliminated the convertible debt discounts associated with the 2022 Notes and the 2025 Notes that were originally recorded as offsets to the embedded conversion features recognized in equity. Effective January 1, 2022, the Company will not record interest expense on the previously recorded discounts on convertible debt. The deferred financing costs previously allocated to the conversion features have since been re-allocated to the outstanding debt, slightly increasing the future annual amortization of deferred financing costs. For additional information regarding the adoption of ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_67"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE5MA_743896e6-1393-416b-b07b-16daf913c0a1" continuedAt="ibad2ed0a13764623b266e1657914123a" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="ibad2ed0a13764623b266e1657914123a" continuedAt="i6ccf3c8386e24945b6237882f47ff5e1"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i6ccf3c8386e24945b6237882f47ff5e1" continuedAt="i6efc9f6a1f8a46e191b53bb6be98be75"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#8217;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#8217;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amounts of equity investments and convertible notes receivable without readily determinable fair values have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions.</span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE5MQ_0fdb7988-587e-4455-98f5-f48493ee0834" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e4721a6974c47a4b2d7646849bd93fd_I20220630" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNC0yLTEtMS04NjEyNw_b0501368-a884-44c3-b8c7-b1bea5297833">25,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8cd2acac994e3fb138accb3626a770_I20220630" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNC00LTEtMS04NjEyNw_68a7260d-a43e-4be2-b1ca-dfd943066a8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id24058253a50408188a9e11bcb502ad1_I20220630" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNC02LTEtMS04NjEyNw_cf121e72-17eb-4f99-9840-d368558dad74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a50652bf64e4acb8120bf54d9198e87_I20220630" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNC04LTEtMS04NjEyNw_e72ba06d-b9c2-4e71-929b-c06fb38b9465">25,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e4721a6974c47a4b2d7646849bd93fd_I20220630" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNS0yLTEtMS04NjEyNw_73e6d357-46d5-4ad3-b9d2-b7825604bdbd">5,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8cd2acac994e3fb138accb3626a770_I20220630" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNS00LTEtMS04NjEyNw_53a63687-ca56-471b-abcf-d66517ca8bb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id24058253a50408188a9e11bcb502ad1_I20220630" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNS02LTEtMS04NjEyNw_5cb6d0b9-a2a2-4422-abf5-3bfb0cf66dca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a50652bf64e4acb8120bf54d9198e87_I20220630" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNS04LTEtMS04NjEyNw_3020c442-6a52-4be2-a111-4e4aefa432c8">5,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e4721a6974c47a4b2d7646849bd93fd_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNy0yLTEtMS04NjEyNw_cbddc29d-5e8a-4a91-8aae-8a8bfa32a140">35,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8cd2acac994e3fb138accb3626a770_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNy00LTEtMS04NjEyNw_a67e5289-a884-42be-a662-aa765771da32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id24058253a50408188a9e11bcb502ad1_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNy02LTEtMS04NjEyNw_d103e3d2-ca47-42bb-bb65-1f7f903768e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a50652bf64e4acb8120bf54d9198e87_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNy04LTEtMS04NjEyNw_2611fe26-f46e-488c-a62d-b213eb741543">35,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility due December 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8e4e6f04e6b4ff791a9370ec1559121_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTAtMi0xLTEtODYxMjc_24b7ef9b-5887-466b-8117-e748de552cf4">352,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8cad7de1da4c2db70aedc902c27e25_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTAtNC0xLTEtODYxMjc_0a84f055-2991-4c90-9eb6-d0c52c087dcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16c8b9c91dac49cca9cd3167f0c77333_I20220630" decimals="-2" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTAtNi0xLTEtODYxMjc_30bef4da-a48a-4537-8ecf-45b3e6145a90">366,562.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87be4045b1ee4290b6f4d157746a446a_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTAtOC0xLTEtODYxMjc_83197300-2b2e-4757-9f54-46989d3867e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjplZjc4N2VmMzU0MTg0ODM0YjI4ZDI0NWUwOTY5Zjg3Yl83_a0fc1891-adf4-4462-850b-c01dccdce592">0.750</ix:nonFraction>% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb17c50c746a4fb99da95cf89348f9ce_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtMi0xLTEtODYxMjc_394262a1-5948-4cf9-ae1a-a8617cc37d02">394,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68e64f1b5724490a26fff0a570e6bba_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtNC0xLTEtODYxMjc_2211d889-ef7b-4e7b-89f5-ed86e16885e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i724c52c24b4d431f9f6b2362fdc0f0e1_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtNi0xLTEtODYxMjc_760fc1f9-6631-4059-ab40-e0f8ad433352">417,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieede5540398c4dc58694079e2fb20f85_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtOC0xLTEtODYxMjc_0d4f7a6a-2bd4-4552-a6a7-2ec0dcded990">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i4904ad55b53844fba2ec392689cda980_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjoyYzFmNzAyMDhlOGI0ZGU4OGI1MzY2MzJhYzkzZTMzYl83_e5c62a3d-acba-4867-b3c5-e425e0d17363">3.375</ix:nonFraction>% convertible senior notes due 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52a538e2d054df5b39586e4fac623ae_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItMi0xLTEtODYxMjc_60ea7bc0-57d2-4948-8e60-58e74361e2c7">8,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idea088cac0574f4bb8455403924088b6_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItNC0xLTEtODYxMjc_bf6e361e-5eb3-4477-ba78-cf9f39bef113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c7ec07806341f485488028d8ebbf96_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItNi0xLTEtODYxMjc_68f8a204-ba3b-4059-b42d-4841ba83357f">8,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2055f75ada8d436fb802dc413014b5c1_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItOC0xLTEtODYxMjc_aebf8413-b394-424d-8334-769a41e48bf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was $<ix:nonFraction unitRef="usdPerShare" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzI5ODUzNDg5NDE3OQ_83ea961e-c13f-473a-94e2-ea603ca6617f">58.30</ix:nonFraction> per share at June&#160;30, 2022 compared to a conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i292cd08d718c48e594813938f2045cca_I20220630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzI5ODUzNDg5NDE4OA_51ab3fe4-fbd3-49bc-8e88-787bf8fb366c">71.78</ix:nonFraction> per share. Therefore, at June&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is <ix:nonFraction unitRef="shares" contextRef="ib5f5585697664021b9b028fc12de735e_D20220101-20220630" decimals="-5" name="pcrx:DebtInstrumentConvertibleConversionPremiumShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzI5ODUzNDg5NDMxMw_68b0375f-8759-4ec2-adfc-ec45caa795de">5.6</ix:nonFraction>&#160;million shares of the Company&#8217;s common stock, which assumes no increase in the conversion rate for certain corporate events.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity and Convertible Note Investments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds strategic investments in clinical and preclinical stage privately-held biotechnology companies in the form of equity and convertible note investments. <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE3Mw_84863492-b87e-4899-8b41-39fb2e674da3" continuedAt="i363ccf53760a43afae725362310b38a1" escape="true">The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):</ix:nonNumeric></span></div><div style="margin-top:4pt"><ix:continuation id="i363ccf53760a43afae725362310b38a1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba288a5b7ff409c940d4b0449afb0cc_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMS0xLTEtMS04NjEyNw_bcc106da-3b2b-49a9-8db3-c1972807e393">14,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e03211b48e14029b06e9f14140d2baa_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMS0zLTEtMS04NjEyNw_d0f59ed2-bb62-4e1c-a808-658dda96729a">4,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMS01LTEtMS04NjEyNw_e05ea6e5-6928-4a70-8613-2600b56a3b4c">18,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c295ad4598945c2ba9f47a504b4472c_D20220101-20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMi0xLTEtMS04NjEyNw_7f77b269-959f-4708-99bc-3df18cfcc76d">11,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia819f5487dbc4bb38b0e991835be6ef0_D20220101-20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMi0zLTEtMS04NjEyNw_1df5f88e-b73e-4918-8c77-d95b952e6155">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMi01LTEtMS04NjEyNw_f2520559-5b8e-4541-b607-5f31b74c4415">12,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c295ad4598945c2ba9f47a504b4472c_D20220101-20220630" decimals="-3" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMy0xLTEtMS04NjEyNw_71010232-2c51-4925-a5a3-0ad398982be7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia819f5487dbc4bb38b0e991835be6ef0_D20220101-20220630" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMy0zLTEtMS04NjEyNw_d59f7693-064c-4d18-9cd5-c6cd748fc64b">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMy01LTEtMS04NjEyNw_e85db494-b7e4-4c61-8bd1-d1c10f2cda08">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59e7ba74b4b45cfab0ae29982cc8e9d_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfNC0xLTEtMS04NjEyNw_8b34dde1-e465-4573-899d-9b860f74da5b">25,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c4255beee6d40db938f1050821cc199_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfNC0zLTEtMS04NjEyNw_03262d62-d789-472a-bbb7-e60d15f905e3">5,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfNC01LTEtMS04NjEyNw_98002036-8320-4785-9a6b-0dd6df4bd95d">30,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i6efc9f6a1f8a46e191b53bb6be98be75" continuedAt="ie0696bbe05994e25b6caf7532e905fa0"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Contingent Consideration</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recognized contingent consideration related to the Flexion Acquisition and the MyoScience Acquisition in the amount of $<ix:nonFraction unitRef="usd" contextRef="i65bfea142670495289d5c647467570b9_I20220630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzA1Nw_553da366-94b6-4ab4-af31-a3406220bf8f">35.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1587b3c1d7e7411cbd588e6bc0bfb723_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzA2NA_547aa9ed-6918-4337-a837-2c237534c50c">57.6</ix:nonFraction>&#160;million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. The Company&#8217;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rates used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company completed the Flexion Acquisition, which provided for contingent consideration related to CVRs that were issued to Flexion shareholders and certain equity award holders which could aggregate up to a total of $<ix:nonFraction unitRef="usd" contextRef="i0fc8018e6ec54834baf8d0e5d5a8d0db_I20211119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDM5ODA0NjUyNDE5OQ_5e9dab1f-42e8-4b37-a4e5-7521734ddc11">425.5</ix:nonFraction>&#160;million if certain regulatory and commercial milestones are met. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2030, and are to be paid within <ix:nonNumeric contextRef="i4f0c78a9972546d4a4bf2bfb19a1c536_D20211119-20211119" name="pcrx:ContingentConsiderationPaymentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDM5ODA0NjUyNDYyNA_0cb50947-8813-4679-ba6f-90250cfac2fc">60</ix:nonNumeric> days of the end of the fiscal quarter of achievement. As part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i4f0c78a9972546d4a4bf2bfb19a1c536_D20211119-20211119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDEyNw_e85316bb-0554-4f8b-bc2b-9acc07e078cc">45.2</ix:nonFraction>&#160;million, which represented the Company&#8217;s potential achievement of meeting the regulatory and commercial milestones. For the period from the date of the Flexion Acquisition through December 31, 2021, the Company recorded an additional $<ix:nonFraction unitRef="usd" contextRef="i0d717792cb904a9c8671026179052f91_D20211119-20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDM1Mg_607c3a74-d134-472c-a61e-991a283a150e">1.2</ix:nonFraction>&#160;million liability. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded gains of $<ix:nonFraction unitRef="usd" contextRef="i6168e02aa26e4349847195bf09c3eacf_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzI5ODUzNDg5NDg1NQ_7c1f9b0e-1e78-455c-8c03-c42a2c6aa9e9">12.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i21ca7a53ce30416b93b74cd8a9870e74_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDUwMg_888aabca-5795-49af-a3f0-aac8a1e31b45">13.3</ix:nonFraction>&#160;million, respectively, primarily due to adjustments to near-term forecasts for the earnout period of the contingent consideration. These adjustments were recorded as acquisition-related gains in the condensed consolidated statements of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At June&#160;30, 2022, the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i0c49317fb1254c648300f85c536d596a_I20220630" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDc0Mg_193c0b71-93e9-4d32-9e55-fd38f5d9d82a">13.5</ix:nonFraction>% and the weighted average probability of success for regulatory milestones was <ix:nonFraction unitRef="number" contextRef="i9835d59ac7914259affd398b5712be27_I20220630" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDgyMw_e75b90e2-b146-442d-9cbb-8f495dad5525">11.1</ix:nonFraction>%. As of June&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the Flexion Acquisition was recognized in the amount of $<ix:nonFraction unitRef="usd" contextRef="i4c963cd0f8b24890b29f01580d4dafa6_I20220630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDk0OA_d5ec9855-8fb6-4896-a36a-6e7e09270c29">33.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3e462270f4d749ada2b41a121bfaaf93_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDk1NQ_2ec934e5-2397-4b8c-923e-0cef04663715">46.4</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="i59c47ce6aa614060975818db7878464b_D20190401-20190430" decimals="-5" name="pcrx:ContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTE2OQ_7632f391-0852-4cfe-ac9d-87acb556df34">100.0</ix:nonFraction> million upon the achievement of certain regulatory and commercial milestones. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within <ix:nonNumeric contextRef="i59c47ce6aa614060975818db7878464b_D20190401-20190430" name="pcrx:ContingentConsiderationPaymentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTM4Nw_c4960dcd-2ba1-4b37-8704-eaf9dcc975a2">60</ix:nonNumeric> days of the end of the fiscal quarter of achievement. As of June&#160;30, 2022, the maximum potential remaining milestone payments to be paid are $<ix:nonFraction unitRef="usd" contextRef="ic35614cca1f842c6b25edec7754b753e_I20220630" decimals="-5" name="pcrx:ContingentConsiderationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTUyMA_801f4245-bade-40d5-b926-88eafec97e6a">43.0</ix:nonFraction>&#160;million. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized contingent consideration gains of $<ix:nonFraction unitRef="usd" contextRef="i8b2f0c4184a8447cb9800ac82b098ef2_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzg0ODI5MDcwNjg1NQ_5a7dd1df-55b2-468f-9252-ccaa23ed56e7">8.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie60dfafd369d49e9a8915074448de244_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzg0ODI5MDcwNjg2OQ_5077d286-f5c1-4268-aefe-eda06d4083d7">9.0</ix:nonFraction>&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, due to the reduced probability of meeting the contingent consideration milestones by December 31, 2023, the expiration date for achieving the milestones. The Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i1f238205c3474a579a6577a0cfb931fc_D20210401-20210630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzg0ODI5MDcwNzM2Mw_b46c23de-4d4a-45cd-a9d1-780d9084bcb9">0.1</ix:nonFraction>&#160;million contingent consideration charge and a $<ix:nonFraction unitRef="usd" contextRef="ib55aafc43f234774b601b8faca0c6b5d_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzg0ODI5MDcwNzM3Nw_d787ba3c-47ad-4a77-8da1-c06e8eb2d409">1.0</ix:nonFraction>&#160;million gain during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended June 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i15a06e8c3c614623bffeb6e3b147f2bf_I20220630" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTY5Ng_12d62eab-4fd0-4466-a99e-51784f546729">12.5</ix:nonFraction>% and the probability of success for the regulatory milestone that has not yet been met was reduced to <ix:nonFraction unitRef="number" contextRef="i77eaafc589a34116b77b15bbc4fff3e5_I20220630" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTc4OQ_dc246fa9-5b93-4061-88b0-a9f9f3c75986">zero</ix:nonFraction>. As of June&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $<ix:nonFraction unitRef="usd" contextRef="ic35614cca1f842c6b25edec7754b753e_I20220630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTkyMw_9a115be6-4f4c-4957-9beb-61b335b95b96">2.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2efee5eb27da4de2a1ed8e6d5e6eecd3_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTkzMA_59cabb01-8aca-490a-996f-9ec01e8f07f7">11.2</ix:nonFraction>&#160;million, respectively.</span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE5OA_f4f711dc-1398-4ce5-89a0-e278dc7c84f4" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flexion Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June&#160;30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MyoScience Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebe6ca8b87dc455e8cbf5d62768fb93d_I20220630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMS0yLTEtMS04NjEyNy90ZXh0cmVnaW9uOmNkY2U0YTEwNWRlNTRmYmY4NDk0M2FkNjQ1ZjVjMGJmXzQ_ff25539e-9b92-4842-a8f0-79875a957dfe">12.64</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="iee968166c6e54c399c9428c7ce8b8057_I20220630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMS0yLTEtMS04NjEyNy90ZXh0cmVnaW9uOmNkY2U0YTEwNWRlNTRmYmY4NDk0M2FkNjQ1ZjVjMGJmXzEw_5e97acca-b9ed-47f2-85f5-6e5cb5f2c0a1">14.37</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc02a21d3efb40b2a085eac6cf253ef8_I20220630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMS00LTEtMS04NjEyNy90ZXh0cmVnaW9uOjFkMTQ3ZjE3NmFkYTQ2ZTU5NDVjMmFhMTYxMmMzMjM0XzQ_12e5cb34-2e4e-4f94-ad64-d0b65288b16c">11.69</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i0a822b3a761c4bf49157f47c28748111_I20220630" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMS00LTEtMS04NjEyNy90ZXh0cmVnaW9uOjFkMTQ3ZjE3NmFkYTQ2ZTU5NDVjMmFhMTYxMmMzMjM0XzEw_f8c04ddc-6aff-4f98-a476-6f7e2c1fee08">13.34</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55e627016d97492ba0681471fbd8968c_I20220630" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMi0yLTEtMS04NjEyNy90ZXh0cmVnaW9uOjMwNmFlNzg0NjQwYzQzMTZhN2VlOTJkNDM2NjRiYzVmXzQ_44159c69-6228-4ecb-8c58-6ac03f8a050f">5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i6f80639d084b4aa89ec55b9178bb46a1_I20220630" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMi0yLTEtMS04NjEyNy90ZXh0cmVnaW9uOjMwNmFlNzg0NjQwYzQzMTZhN2VlOTJkNDM2NjRiYzVmXzEw_c2998d16-77e3-4cf3-a0fd-3c222e2aca66">15</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a5bb2973c6b4c96abe3db554e6d078f_I20220630" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMi00LTEtMS04NjEyNy90ZXh0cmVnaW9uOmJkMzMxYzNhNjQ2OTQxYjM5ZGMxYTk1M2VhMjM3N2U5XzQ_d1d84001-28eb-44e0-a655-cb39b66ffcb6">0</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE4Mw_ddb86435-9eff-4c00-a814-8271d3133e34" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee16b76f339b45f1bc4250ddc76ad052_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjAyZDljOWE4ODljNDQ4Yjg5ZTFhZTZiMjg2NDNiMjAzL3RhYmxlcmFuZ2U6MDJkOWM5YTg4OWM0NDhiODllMWFlNmIyODY0M2IyMDNfMS0yLTEtMS04NjEyNw_0d4f6f03-6a23-4074-a546-28709cd6e845">57,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd89bb1f4f08443fb61357d5cf825054_D20220101-20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjAyZDljOWE4ODljNDQ4Yjg5ZTFhZTZiMjg2NDNiMjAzL3RhYmxlcmFuZ2U6MDJkOWM5YTg4OWM0NDhiODllMWFlNmIyODY0M2IyMDNfMy0yLTEtMS04NjEyNw_1c28b134-549d-49eb-8bc2-f080e782c924">22,351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afc326973624dedabbf6ad485dfc1e5_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjAyZDljOWE4ODljNDQ4Yjg5ZTFhZTZiMjg2NDNiMjAzL3RhYmxlcmFuZ2U6MDJkOWM5YTg4OWM0NDhiODllMWFlNmIyODY0M2IyMDNfNi0yLTEtMS04NjEyNw_57c88513-f62d-4fd4-b09d-b4fc595bdd11">35,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="ie0696bbe05994e25b6caf7532e905fa0"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available-for-Sale Investments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate and government bonds with maturities greater than three months, but less than one year. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#8217;s short-term investments are reported in other comprehensive income (loss). At June&#160;30, 2022 and December&#160;31, 2021, all of the Company&#8217;s short-term investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term investments had an &#8220;A&#8221; or better rating by Standard&#160;&amp; Poor&#8217;s.&#160;</span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE3MQ_54e4792d-7858-4c97-b1df-9e5f82071c76" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s short-term available-for-sale investments at June&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June&#160;30, 2022 Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710e2f14bbb34bba99311d3b4e837f2f_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMi0yLTEtMS04NjEyNw_50f7ba4c-9e88-4286-ad19-39dcc2b5eec7">30,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710e2f14bbb34bba99311d3b4e837f2f_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMi00LTEtMS04NjEyNw_fc578883-ab80-4532-b09c-9ab19886e9de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710e2f14bbb34bba99311d3b4e837f2f_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMi02LTEtMS04NjEyNw_c239b135-da2e-4d63-8519-191b88dc877b">239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710e2f14bbb34bba99311d3b4e837f2f_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMi04LTEtMS04NjEyNw_4fc53981-bcde-4387-b699-026d38b60d6d">30,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3fcd52747443ab910304b3bdf6b6e8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMy0yLTEtMS04NjEyNw_fbb0d939-ebfb-48b1-94c6-3bfd1bc4b9cc">138,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3fcd52747443ab910304b3bdf6b6e8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMy00LTEtMS04NjEyNw_f68cf23b-b03b-4983-8358-2b8c72f2cd96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf3fcd52747443ab910304b3bdf6b6e8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMy02LTEtMS04NjEyNw_3a3ad7b4-b433-48e0-9dab-521c93ecb5a3">796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3fcd52747443ab910304b3bdf6b6e8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMy04LTEtMS04NjEyNw_08705f89-ff64-4b3d-a7a6-1e8022be1a4b">137,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1f2abc0e78467d927adac6fa878af8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNC0yLTEtMS04NjEyNw_1cd2d700-10a1-4ed0-8f2c-9a78f5320982">6,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1f2abc0e78467d927adac6fa878af8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNC00LTEtMS04NjEyNw_530eff9a-c979-4666-ad87-483504ddbd74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd1f2abc0e78467d927adac6fa878af8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNC02LTEtMS04NjEyNw_7ce8aa90-9735-4564-ba82-f992e44a1c0a">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1f2abc0e78467d927adac6fa878af8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNC04LTEtMS04NjEyNw_94f64b02-6066-4007-9d5c-4073f2f6648b">6,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc2e8e031b6c4f349a9a22d1b983860b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNS0yLTEtMS04NjEyNw_b2c22152-2360-4c30-a788-8df8f7b9f41d">19,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc2e8e031b6c4f349a9a22d1b983860b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNS00LTEtMS04NjEyNw_dc3e8a04-b561-4ada-a612-6cf86e8cd804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc2e8e031b6c4f349a9a22d1b983860b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNS02LTEtMS04NjEyNw_3a26f712-ae83-45ea-8b1a-90ec7f3b3d88">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc2e8e031b6c4f349a9a22d1b983860b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNS04LTEtMS04NjEyNw_6b10abfa-c8bb-487e-8d22-0bfa05ee2e1f">19,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMTItMi0xLTEtODYxMjc_d61cfb41-fd30-4d70-ae57-9aaac23d1d44">195,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMTItNC0xLTEtODYxMjc_eb97dfb5-308e-4ff1-a393-b91b60987526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMTItNi0xLTEtODYxMjc_c7fb54b0-c465-4fa9-8775-0a05553084b7">1,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMTItOC0xLTEtODYxMjc_01bedff7-27ea-464d-af26-a7f49e0d70b7">194,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2021 Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff7976ca834ff8be1fb773760bf3ba_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMi0yLTEtMS04NjEyNw_a5d2417e-e6a2-4d2e-9209-34c5cb8bd05b">3,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff7976ca834ff8be1fb773760bf3ba_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMi00LTEtMS04NjEyNw_1c7d53e5-4b7b-4cc4-a28e-87591efdcd2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff7976ca834ff8be1fb773760bf3ba_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMi02LTEtMS04NjEyNw_ead44572-10ad-49a0-85e6-03cb4f5f1b00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ff7976ca834ff8be1fb773760bf3ba_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMi04LTEtMS04NjEyNw_8107347e-e2db-448e-ada6-d4cba7d9bc1d">3,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ff4e22b20243b28a23578412c3b209_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMy0yLTEtMS04NjEyNw_62d7e651-f7ab-4f12-a483-4b0528ed9548">57,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ff4e22b20243b28a23578412c3b209_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMy00LTEtMS04NjEyNw_531921db-14e9-4cf1-abcc-3b4c6af55623">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43ff4e22b20243b28a23578412c3b209_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMy02LTEtMS04NjEyNw_26249285-8e8c-41ca-bae3-38dba56c56bf">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ff4e22b20243b28a23578412c3b209_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMy04LTEtMS04NjEyNw_16b4ddfa-d886-4ff3-9903-4f30696b160b">57,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3acbf69765400b99cbf96568b817cc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNC0yLTEtMS04NjEyNw_aa0c496c-c834-413f-afe2-ee01cf25622e">9,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3acbf69765400b99cbf96568b817cc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNC00LTEtMS04NjEyNw_ab8ab4ef-7d9b-43b7-8df5-fc75dd528319">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3acbf69765400b99cbf96568b817cc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNC02LTEtMS04NjEyNw_9e7b04a7-a70e-49db-9b7a-43d939efa322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3acbf69765400b99cbf96568b817cc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNC04LTEtMS04NjEyNw_29d84e05-c4ae-4e52-abe8-bd55c94f8e11">10,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNi0yLTEtMS04NjEyNw_7507a1a2-93ac-4dd8-8aa0-7f8c31dcd87d">70,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNi00LTEtMS04NjEyNw_a221f14c-3b42-4c62-80cb-6e2b395bc069">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNi02LTEtMS04NjEyNw_7cba5dd3-ce10-4e7b-9a78-143f9c525491">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNi04LTEtMS04NjEyNw_08a39282-aff6-434d-9e95-24dc722ce1c8">70,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, there were no investments available for sale that were materially less than their amortized cost.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elects to recognize its interest receivable separate from its available-for-sale investments. At June&#160;30, 2022 and December&#160;31, 2021, the interest receivable recognized in prepaid expenses and other current assets was $<ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="-5" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNzgyNA_86c5a689-e238-4206-a496-49ddd410395d">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="-5" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNzgzMQ_92d3ea2f-b47c-4053-aeea-2e3ec9cba831">0.1</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term available-for-sale investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As of June&#160;30, 2022, <ix:nonFraction unitRef="customer" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="pcrx:NumberOfMajorCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODIzMA_d2740865-5028-48bb-a904-a5077d0b59ab">three</ix:nonFraction> wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at <ix:nonFraction unitRef="number" contextRef="id7c6f1c8ace3439a97adbf4622bc27e9_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODMxNA_de86d933-7d46-4bf8-941f-1549f10dd1da">34</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="iddf44d8e1eb24bb38df6f546dbde1595_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODMxOA_973aa968-ab0c-4766-ad70-35d7e03bdc33">17</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic92dd8c00b21453d812274cd1558efeb_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODMyNQ_9272d75b-67f6-47d0-8788-0d747231fd6a">17</ix:nonFraction>%. At December&#160;31, 2021, <ix:nonFraction unitRef="segment" contextRef="ib06fd977f58642338910637dc9ee051e_D20210101-20211231" decimals="INF" name="pcrx:NumberOfMajorCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODMzNg_200033d4-ed1b-4530-a05a-39356f180bc0">four</ix:nonFraction> wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at <ix:nonFraction unitRef="number" contextRef="i364140fb0ecb4c5b90678acdcbc6f1ab_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODQyMA_5cf19d59-702d-4f7d-8dce-ea1c3ac3c118">30</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="if6fb800aa91a443a8562539853dbd945_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODQyNA_21163b6c-08bf-421d-a4aa-134e8118c086">20</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ia1df9fb6c8864c09a8ff94e2cb57ad21_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODQyOA_cef5c5a0-b974-4a1f-abab-a747bcd4365f">17</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="iaeada0763b1349a6a781e82453974c12_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODQzNQ_eae037d6-4aa8-4b5d-8690-7363ff4da51b">11</ix:nonFraction>%. For additional information regarding the Company&#8217;s wholesalers, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EXPAREL and ZILRETTA revenues are primarily derived from major wholesalers and specialty distributors that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the Company&#8217;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of June&#160;30, 2022 and December&#160;31, 2021, the Company did <ix:nonFraction unitRef="usd" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTA4OA_a24a966c-e331-416e-a7eb-d6c291610a72"><ix:nonFraction unitRef="usd" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTA4OA_bfded682-dbc9-4a7c-985a-52f350a7ffa7">no</ix:nonFraction></ix:nonFraction>t deem any allowances for credit losses on its accounts receivable necessary.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 24</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RleHRyZWdpb246YjVmMTM2MzEzMjc5NGU4ZGFjZWVlNWQ0ZDEzZWM4ZDFfMjUx_d7c36333-9607-44ca-a704-bfe428b78a00" continuedAt="i336ddea6fe074dfd9d3678b653c58a8f" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i336ddea6fe074dfd9d3678b653c58a8f"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income </span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RleHRyZWdpb246YjVmMTM2MzEzMjc5NGU4ZGFjZWVlNWQ0ZDEzZWM4ZDFfMjQx_d4fa53f8-2c48-44e0-9c9f-6c65a95495c7" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables illustrate the changes in the balances of the Company&#8217;s accumulated other comprehensive (loss) income for the periods presented (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab2955eb68904b22a10de3106fc90299_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMS0yLTEtMS04NjEyNw_f4ba0ebf-c63b-442a-8b15-62ef997c7624">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34fc14fcb0fe4ad4984107a1fefc0823_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMS00LTEtMS04NjEyNw_e7f547e8-9d91-453c-a413-6feea4236637">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02ecdd29c7414c46a2309f3f15aa4ef2_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMS02LTEtMS04NjEyNw_f5f6d6c5-7931-4c3e-bb30-2e34fdea8025">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie211f03ed1a748f1aa10a0c73727da12_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMi0yLTEtMS04NjEyNw_9cb3e2a1-97d7-405b-8ea5-9a1c96957991">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40fceb10d076413aa7ec6129f9f379d7_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMi02LTEtMS04NjEyNw_e5224ae6-199a-4d0d-94e2-fd2aeaea8de8">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedea906cd76a4d4bba0431551477a909_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMy00LTEtMS04NjEyNw_2211cddf-c0ac-4c6c-8fc9-a5c2f6399cb3">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40fceb10d076413aa7ec6129f9f379d7_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMy02LTEtMS04NjEyNw_12294013-d2a9-4ee5-882a-af676767686f">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31ac85e1887749e4b9a817256cbd8b28_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfNS0yLTEtMS04NjEyNw_3e702020-c358-4f6a-94c3-826567e36736">754</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48031d7bf51f42d489a3a3a50bf8e6af_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfNS00LTEtMS04NjEyNw_3a042285-f45b-4be1-a080-96cdbd01d655">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20af892b1391416d8055702cfd957969_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfNS02LTEtMS04NjEyNw_d1951c5c-70ec-4db0-9ae7-177ddbcbe7e0">605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb2fdecf4b4a0a85c84a8fd76f0bbe_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMS0yLTEtMS04NjEyNw_812acb80-b8fd-4a24-96e6-0d4414611b71">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25d448a3f20f451b9239b04a6513c8cd_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMS00LTEtMS04NjEyNw_2b29ee60-9898-49bb-9b32-ef4ae4ba6b2a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ba2e38a38f4c4c81d24bf4be710a79_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMS02LTEtMS04NjEyNw_db43c7ae-d896-44c2-a03a-dc0faf2d8be6">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08b536b7990b4e1894b876ae5ada1a24_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMi0yLTEtMS04NjEyNw_ccd7b083-6797-4e19-bc32-5eca6bfb1e71">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie355b25162354a51a4bc570c648c9f9e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMi02LTEtMS04NjEyNw_7d85c157-d8c1-475e-8df5-4bd61131413c">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1995fc5495b4921bfb8486c9d6f9f19_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMy00LTEtMS04NjEyNw_066edac6-eb5e-486a-a017-f8b402f0076b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie355b25162354a51a4bc570c648c9f9e_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMy02LTEtMS04NjEyNw_b128d24b-4207-48b3-b373-300b2405cae7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83f4b65463347e6a51d901c1e50e22e_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfNS0yLTEtMS04NjEyNw_0ef36e63-4a35-48ad-9f71-f00fe0f56de7">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e1e3475775b4e76ab6efcb59dd158f6_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfNS00LTEtMS04NjEyNw_158b0eb3-7a72-4297-9b24-e2bb3d3cbc1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12c8e6e979d472c83e9f7f03a527326_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfNS02LTEtMS04NjEyNw_29694036-3a65-4edf-a549-774b38b5ba9f">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_73"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;12&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTA5NA_fbe37845-5a60-42cb-b7e8-f3005c27a5e8" continuedAt="iec6602dff13c42a39137cb69280f131c" escape="true">STOCK PLANS</ix:nonNumeric></span></div><ix:continuation id="iec6602dff13c42a39137cb69280f131c" continuedAt="i60ba3ef4abe54f0280a28144f95c85b8"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTEwOA_97c0e02b-b52a-42be-964a-574081dd2fa9" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0cddc2bc28438a8934112eb263d081_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMi0yLTEtMS04NjEyNw_656bcc24-1413-4e3a-9437-828ab417cc78">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c88759301c941b096aecd8a4937c534_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMi00LTEtMS04NjEyNw_aadb02c7-7ab9-4506-922a-86fea0bae3f4">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55eab178e9a043b1a145b43918fe8858_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMi02LTEtMS04NjEyNw_a8b3884c-0523-492e-96f6-be95d8888f7f">2,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8f20a978a34500a4d487f8a56ade4b_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMi04LTEtMS04NjEyNw_8b3baafe-ccdd-4d7b-8ec6-36af60d6223c">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i212b2c71c3a147c7a27ebf79f5a7c12e_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMy0yLTEtMS04NjEyNw_0d969976-13d1-4af8-b1b5-09b85481f27f">1,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20270789c96347f29c7c132e72ddd5c4_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMy00LTEtMS04NjEyNw_5f9621fd-185f-46ce-bdcc-3cedc3c116e7">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50d1f8b7f2c346eeb7844217241e3a36_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMy02LTEtMS04NjEyNw_809517a8-79e5-4a87-b5e7-2cf5cdf0b12d">2,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1b5de0b8e42078315f31d7aef6b00_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMy04LTEtMS04NjEyNw_0ac62f3e-b5a5-4136-929f-d86441b87254">2,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a4c08595d646a1baa2a16e237083a6_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNC0yLTEtMS04NjEyNw_b36f2021-2245-4da3-be13-7cad24255bf7">8,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifecfe644d38148929046d13feafd4dab_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNC00LTEtMS04NjEyNw_72ea6c99-74ce-4e7d-b45d-9910bb6955f0">7,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0d15f2737042a888b6d0615dc70cd1_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNC02LTEtMS04NjEyNw_0bdefb71-ef38-4cfe-9d25-ea6ad25abe5d">16,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7634d27564544329107cc50cd79208f_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNC04LTEtMS04NjEyNw_b080699e-5685-428d-a800-090a4f0aee8b">15,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNS0yLTEtMS04NjEyNw_667bd6b2-4c21-45cc-a4dc-5f44e6d412c5">11,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNS00LTEtMS04NjEyNw_fc661b6f-da80-4413-9b9a-860620d13c17">10,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNS02LTEtMS04NjEyNw_c338e7d4-9ac3-434b-9575-4528a914cb24">22,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNS04LTEtMS04NjEyNw_c899d48b-564e-439a-8b45-c921a703d9ee">20,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="pcrx:Compensationexpensefromstockoptionsemployees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOC0yLTEtMS04NjEyNw_ac1ee2fb-218c-41af-bbe4-5ca58c88c9d2">6,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="pcrx:Compensationexpensefromstockoptionsemployees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOC00LTEtMS04NjEyNw_4d9b1848-b998-456a-825c-f59b1809f9c9">6,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="pcrx:Compensationexpensefromstockoptionsemployees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOC02LTEtMS04NjEyNw_c7698bb6-71a7-41fc-a0cd-203adf49b3a7">13,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="pcrx:Compensationexpensefromstockoptionsemployees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOC04LTEtMS04NjEyNw_9f5478b8-4cf9-456b-ad0b-494abf5dfebc">13,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOS0yLTEtMS04NjEyNw_07521642-9f55-4744-88e9-32fc577a0919">4,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOS00LTEtMS04NjEyNw_00a41fd1-578c-4205-a681-097a96ac4753">3,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOS02LTEtMS04NjEyNw_1e998cf4-6c8b-42a9-9b20-427cda385a0f">8,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOS04LTEtMS04NjEyNw_7f69aa3b-8663-4537-a424-da042c61559b">7,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTAtMi0xLTEtODYxMjc_6eed832a-fa94-46bb-9ece-da77e99f89bb">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTAtNC0xLTEtODYxMjc_463281e3-4e09-40ad-a1d3-95e1197887ee">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTAtNi0xLTEtODYxMjc_f89f6e0a-b934-4c75-ab95-e9a2b3990a6d">576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTAtOC0xLTEtODYxMjc_b03a65ce-ba89-462d-85f8-38d9aeeda059">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTEtMi0xLTEtODYxMjc_147e82e7-c2a4-4f6b-a7d7-f75a79796d4d">11,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTEtNC0xLTEtODYxMjc_01717bda-4297-4c41-8fd2-a5e5679f3e5a">10,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTEtNi0xLTEtODYxMjc_d659994d-b1e1-4276-8689-3d0d232f3e3c">22,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTEtOC0xLTEtODYxMjc_29607823-c001-4f58-adf9-947f5f480c85">20,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i60ba3ef4abe54f0280a28144f95c85b8"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards</span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTExMA_c51a7fce-e2b3-4ebc-9a67-8eede5a554a2" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the six months ended June&#160;30, 2022:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMS0yLTEtMS04NjEyNw_1a3f57ee-0b53-4cc7-8b08-e919b0363aea">6,050,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1e299ef910a46358668913b0b2f165d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMS00LTEtMS04NjEyNw_1315471a-7995-4095-b29f-bfc27231111c">49.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMi0yLTEtMS04NjEyNw_3c4baf99-3a47-4869-a753-b1ad9e003dfa">1,010,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMi00LTEtMS04NjEyNw_519ccc63-d001-4a37-a321-fffc4aca9664">60.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMy0yLTEtMS04NjEyNw_c053f6e5-0e28-42bd-a5b6-6ce3d37e39d5">630,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMy00LTEtMS04NjEyNw_a02f7152-c0d0-48c3-9b4f-527e7bd4bf9b">34.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNC0yLTEtMS04NjEyNw_3d9a9e65-72be-432c-88bb-fb23eed45f19">54,215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNC00LTEtMS04NjEyNw_fd1f87f3-cd46-4ae1-a352-3a07ef68e777">52.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNS0yLTEtMS04NjEyNw_0be765fa-9a60-4dd3-8852-57e4c93b9143">13,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNS00LTEtMS04NjEyNw_43df9c7a-76a0-487d-b515-bd92a4e1db75">85.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNi0yLTEtMS04NjEyNw_a023638e-9544-4b1f-b10c-e91e2b0f0a55">6,363,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNi00LTEtMS04NjEyNw_cea9bd27-db65-458e-adc8-13ccd8ec8ac3">52.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85df01f524b547a39620a6cd60ab5eae_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMS0yLTEtMS04NjEyNw_78311ff9-5d3f-4b31-96da-ad5510511ed9">955,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85df01f524b547a39620a6cd60ab5eae_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMS00LTEtMS04NjEyNw_4822b989-d6ee-439b-bf80-55a678bd97c8">52.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMi0yLTEtMS04NjEyNw_2533e5e1-6f2e-42c9-a726-1e5d9e8adf39">568,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMi00LTEtMS04NjEyNw_a2ea4fcd-8f0a-46c6-b52a-d10e1b75fe09">60.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMy0yLTEtMS04NjEyNw_35fef379-0f0b-4f65-9f96-a1298ed45c37">298,607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMy00LTEtMS04NjEyNw_bf5e28c1-e615-46c4-a05e-2d101d503255">49.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfNC0yLTEtMS04NjEyNw_3dbcc440-d6de-404b-9df9-9e6abecbfff3">44,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfNC00LTEtMS04NjEyNw_75a18a57-130c-41df-9390-7617e85f647f">54.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ca303801f644e169133ec4d7e0c6998_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfNS0yLTEtMS04NjEyNw_afc9012d-616f-42ed-9c32-21020ded655d">1,179,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ca303801f644e169133ec4d7e0c6998_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfNS00LTEtMS04NjEyNw_d87f94b8-b879-459c-8f4b-0f11a5ac2fd9">57.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the six months ended June&#160;30, 2022 wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfNDE1_ffa9e01d-4c8e-4ca1-ad23-89f450a6b0cf">25.69</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share. <ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTEwMQ_efc03388-aba4-4cc6-ba38-b1457c9be635" continuedAt="i6ac0a116f472494cbcb64072356db0ff" escape="true">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><ix:continuation id="i6ac0a116f472494cbcb64072356db0ff"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjRlNzZjZDc1ZTVlZTQ3OTk5ZmM1MTlhMmFlMjZmOWU3L3RhYmxlcmFuZ2U6NGU3NmNkNzVlNWVlNDc5OTlmYzUxOWEyYWUyNmY5ZTdfMS0yLTEtMS04NjEyNw_19b97ba4-274e-40c0-80f3-695c1974f692">None</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjRlNzZjZDc1ZTVlZTQ3OTk5ZmM1MTlhMmFlMjZmOWU3L3RhYmxlcmFuZ2U6NGU3NmNkNzVlNWVlNDc5OTlmYzUxOWEyYWUyNmY5ZTdfMi0yLTEtMS04NjEyNw_c1ab9baf-92e9-4b2d-a7cb-c3b311b38cf5">2.83</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjRlNzZjZDc1ZTVlZTQ3OTk5ZmM1MTlhMmFlMjZmOWU3L3RhYmxlcmFuZ2U6NGU3NmNkNzVlNWVlNDc5OTlmYzUxOWEyYWUyNmY5ZTdfMy0yLTEtMS04NjEyNw_6a09f7cd-d09c-4308-af96-17715339ba6d">45.15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjRlNzZjZDc1ZTVlZTQ3OTk5ZmM1MTlhMmFlMjZmOWU3L3RhYmxlcmFuZ2U6NGU3NmNkNzVlNWVlNDc5OTlmYzUxOWEyYWUyNmY5ZTdfNC0yLTEtMS04NjEyNw_dd5ab241-859f-4a3a-b3df-dcee39f9e62c">4.92</ix:nonNumeric> years</span></td></tr></table></ix:continuation></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company&#8217;s stockholders approved the Amended and Restated 2014 Employee Stock Purchase Plan, or ESPP. The ESPP was amended to increase the number of shares of common stock that may be sold under the ESPP by an additional <ix:nonFraction unitRef="shares" contextRef="ie5b71027039a48cebc64faf0916105d2_D20220601-20220630" decimals="INF" name="pcrx:EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTA5OTUxMTYzMDQ5OQ_0ec80bf9-eacd-414a-855a-82b2976fa881">500,000</ix:nonFraction> shares.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP features <ix:nonFraction unitRef="offeringperiod" contextRef="i39a0a2f43861465f96e848700239814f_D20220101-20220630" decimals="INF" name="pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfNjc5_1a241adb-7ee6-43a9-8f64-7668066eaa44">two</ix:nonFraction> <ix:nonNumeric contextRef="i39a0a2f43861465f96e848700239814f_D20220101-20220630" name="pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTA5OA_559ccce6-8107-44a2-bff0-d160e53d6521">six-month</ix:nonNumeric> offering periods per year, running from January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at <ix:nonFraction unitRef="number" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfODcw_53ff5688-33cc-4910-8570-7704985a46fb">85</ix:nonFraction>% of the closing fair market value of the Company&#8217;s common stock on either the offering date or the purchase date, whichever is less. During the six months ended June&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTAzNg_7afcdfa8-c9a5-4937-9444-c202252c4b01">36,729</ix:nonFraction> shares were purchased and issued through the ESPP.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 26</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;13&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RleHRyZWdpb246MWViOWVmMjdhZDJmNGQ5MmE0YmJjOGIwY2EzODMyNmVfMjE4NA_dd8fe6dc-9949-43f1-b605-5da6cdffae1b" continuedAt="idafc622e14364898893c6f2a7249de3f" escape="true">NET INCOME (LOSS) PER SHARE</ix:nonNumeric></span></div><ix:continuation id="idafc622e14364898893c6f2a7249de3f" continuedAt="i75c69f4e444344be9d9f21e273f42310"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-06 was adopted on January 1, 2022 and requires the Company to use the if-converted method to calculate the number of potentially dilutive shares for convertible debt. Under the if-converted method, adjustments are made to the diluted net income (loss) per common share calculation as if the Company had converted the convertible debt on the first day of each period presented. Adjustments to the numerator are made to add back the interest expense associated with the convertible debt on a post-tax basis. Adjustments to the denominator reflect the number of shares assumed to be convertible at the beginning of the period. For additional information regarding ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to January 1, 2022, the Company used the treasury stock method to calculate dilutive shares on its convertible debt.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs and the purchase of shares from the ESPP (using the treasury stock method), if applicable. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive.</span></div><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RleHRyZWdpb246MWViOWVmMjdhZDJmNGQ5MmE0YmJjOGIwY2EzODMyNmVfMjE3Mw_30f389d4-e9fe-43b3-944f-b889d63a6bf9" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per common share for the three and six mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended June&#160;30, 2022 and 2021 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net income&#8212;basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMy0xLTEtMS04NjEyNw_a8a6a987-f9dd-47b4-88aa-b71fe5740c77">19,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMy0zLTEtMS04NjEyNw_b96f8954-4e13-4041-a2d8-2caa3909d3ff">19,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMy01LTEtMS04NjEyNw_4faeef17-c885-4e17-8c1f-65f98bf6f29f">26,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMy03LTEtMS04NjEyNw_0865c80d-ed85-4e1f-8353-903d21380f3c">29,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNC0xLTEtMS05MTQ3MA_3ed9c6db-549d-45df-8402-5dc1d9ecb2f3">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNC0zLTEtMS05MTQ3MA_7d24b80b-c7aa-47ca-91b3-3da2bdb6cad6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNC01LTEtMS04NjEyNw_27ea9404-1b3e-4b10-9dec-08e093cd4a91">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNC03LTEtMS04NjEyNw_146974e6-c243-47db-af58-3b1cacf8151f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Adjusted net income&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLossAttributableToParentDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNi0xLTEtMS04NjEyNw_cd92a547-987d-4fcd-b4ea-5ee99c94e2ab">20,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLossAttributableToParentDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNi0zLTEtMS04NjEyNw_f8ea6dbf-19a4-42cc-9331-5b04a14aed00">19,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLossAttributableToParentDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNi01LTEtMS04NjEyNw_ddbc615b-b675-4564-871e-2959b4bb2f1e">28,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLossAttributableToParentDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNi03LTEtMS04NjEyNw_c75322bb-841e-48d2-9ecd-25d980ae5ef0">29,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTMtMS0xLTEtODYxMjc_f0944291-da58-4494-aa6c-a31bafdc80a8">45,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTMtMy0xLTEtODYxMjc_48455602-aeed-4e5f-8d01-389ba7f63e7b">44,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTMtNS0xLTEtODYxMjc_af84c92f-c9ee-4c92-ac9b-69d5b4488714">45,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTMtNy0xLTEtODYxMjc_eda1be55-7704-4038-a30c-986d19354794">43,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i43454386d0e64c9aa58f37a86d3898e1_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTUtMS0xLTEtODk5ODg_fd2aa14d-f3a7-40b0-947d-91082637d6b2">5,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i303f42a872d84848a26c7935521e8d9d_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTUtMy0xLTEtODk5ODg_b761f32d-0a42-4a6b-b51e-17896b024d87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id76d6ea4321e4124937fc7c109c12121_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTUtNS0xLTEtODYxMjc_fbb0ebf4-0e7c-4b1c-be51-44d1c86e5dee">5,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23b9728da5774e0f8865eb56c0287548_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTUtNy0xLTEtODYxMjc_0489e453-1a42-4c58-a96d-2111364cde6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb138ead7c8749139ab55dab62470f1f_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTYtMS0xLTEtODYxMjc_90a76ff0-6fb4-422b-b296-5514397b84c7">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cfbe4103aec4e4dbf93af04eba8abe1_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTYtMy0xLTEtODYxMjc_23442147-223a-46cd-9ddc-edcd88c45070">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTYtNS0xLTEtODYxMjc_cadaa73c-65e1-4d0a-9cf2-d362d419b43d">1,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0362692f03ce4f04b845f4ef84d3150e_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTYtNy0xLTEtODYxMjc_09ca4bba-1bef-4bc1-b289-be94520c53b4">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd17b7148b4b4336ae3a8a8ab12951b8_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTctMS0xLTEtODYxMjc_cdac0686-f7a9-43ca-98aa-8a60aabb8858">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a329b7adfca4c45be13dd71376e3285_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTctMy0xLTEtODYxMjc_c820fc7c-0076-4095-b859-ae4ebd5b6596">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTctNS0xLTEtODYxMjc_b69d8ac6-8fd2-4324-a8f2-768d6121eed7">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie39e757d15684b84b80beb859cc71a9a_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTctNy0xLTEtODYxMjc_06eb6224-10d3-4a96-abc3-914312ade8f6">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTgtMS0xLTEtODYxMjc_a1fbaaa3-4f25-41b0-b737-821bba9a621c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTgtMy0xLTEtODYxMjc_fcf1a713-9d35-47b3-b993-a4cae7542f27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTgtNS0xLTEtODYxMjc_a4212176-8bb1-4695-871b-565f1691fcd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTgtNy0xLTEtODYxMjc_95c02e04-6212-4b61-9235-cb47ae501c6b">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5e85fea4b1749a0a9ab002bc71033a2_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTktMS0xLTEtODYxMjc_70bcf796-8cba-4847-b105-60223679cd26">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0baf3a23aeb847d8b41472f49c4054e5_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTktMy0xLTEtODYxMjc_b95ef1bf-6833-43a5-aff7-35559310404b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39a0a2f43861465f96e848700239814f_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTktNS0xLTEtODYxMjc_82b64da5-d1ac-47b9-8ae1-e6b95bb3018f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i111e70709f1a49f58e7bc236e873db49_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTktNy0xLTEtODYxMjc_f15463f3-b884-4e18-8c03-bdb138a6b99a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjEtMS0xLTEtODYxMjc_3fc27253-be4e-44e7-a2ac-191abdffb1d9">52,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjEtMy0xLTEtODYxMjc_c99ef07d-7cbf-4b98-9940-ff73c13e3859">45,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjEtNS0xLTEtODYxMjc_a2824037-9be0-4b99-ac1d-1b8d78fa425b">52,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjEtNy0xLTEtODYxMjc_14a02358-0041-484c-872e-c47226d9a4b2">45,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjMtMS0xLTEtODYxMjc_ebdac077-cf17-4761-bc72-34f5d4ea7e31">0.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjMtMy0xLTEtODYxMjc_b47163d0-41db-4f91-8b6e-ae57b26907b3">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjMtNS0xLTEtODYxMjc_e2bd38cb-5437-4b75-9e16-4e8318105553">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjMtNy0xLTEtODYxMjc_94a81177-29f0-42fe-be1d-f909fe6e017e">0.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjQtMS0xLTEtODYxMjc_02239255-d586-423a-a4c3-c13e15c05569">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjQtMy0xLTEtODYxMjc_9c4e63fb-b470-4544-8260-3b78f2a00a7e">0.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjQtNS0xLTEtODYxMjc_4e8bdeea-6056-4a10-bec2-c77951f76c82">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjQtNy0xLTEtODYxMjc_61539f24-dc28-4f9c-9618-cf54fe4e1852">0.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="text-indent:22.5pt"><ix:continuation id="i75c69f4e444344be9d9f21e273f42310"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RleHRyZWdpb246MWViOWVmMjdhZDJmNGQ5MmE0YmJjOGIwY2EzODMyNmVfMjE4OQ_1c1a2753-da83-47a5-906b-fdadc2573d8c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80a72523d0c1401185af1aa98e145d67_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMi0xLTEtMS04NjEyNw_af5ffb71-8936-46f4-ad00-21fc417a7479">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcb41bddccc844a8b1608c8a5f1eb2f1_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMi0zLTEtMS04NjEyNw_7d7f567e-efc6-4048-90cc-9da17c8eba26">2,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie519317e61de4bd4b61b769f86af2017_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMi01LTEtMS04NjEyNw_790338ef-f734-4b69-9903-dff5a9bf118f">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7926f8178c944494b800dc70a8aee09b_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMi03LTEtMS04NjEyNw_c64404a6-46fc-4b39-b6d3-1e245214b65a">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b13dbca109f40d59b428f6eb0fcce41_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMy0xLTEtMS05MDA0NQ_1bc72056-1191-4c4b-b820-c8bd8e3b5d7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia852df3ea8e7487d833721f9de1ece5b_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMy0zLTEtMS05MDA0NQ_e0947592-a0ca-47aa-b68b-8ae343c9c8f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23cdbff094c5425f8aa1a90414d51f06_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMy01LTEtMS04NjEyNw_46198a96-b356-4541-b810-8691f72de868">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae72f39fcbeb458cb1ae7c42c5e4d55e_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMy03LTEtMS04NjEyNw_8e191f81-2418-444e-90b2-326b1d0a53ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33a60813e9f44095913e43e93a53efc0_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNC0xLTEtMS04NjEyNw_367b7d3b-e2f1-4661-8b29-ab6a5a5ef264">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i728ca8324e5149769ed4f7f8eb7732dc_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNC0zLTEtMS04NjEyNw_d2ff4956-2529-4444-b40c-8c4ee34800fd">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ec452862f584d9196d9a07fc8b8ddc6_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNC01LTEtMS04NjEyNw_d6be8685-b35a-474f-9467-f83b73f346dc">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c65baa223334a0a825004fd918ececa_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNC03LTEtMS04NjEyNw_bbdaa1ce-ada4-4d73-aeb6-ee8bcff57b19">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNi0xLTEtMS04NjEyNw_ac840ad5-fa5b-4012-9f47-94d2daf4c288">1,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNi0zLTEtMS04NjEyNw_c6721fb5-fe11-4ef2-b883-c95e24a20e77">2,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNi01LTEtMS04NjEyNw_6fd07376-eeb4-4d9f-b5f1-37057185acbd">3,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNi03LTEtMS04NjEyNw_2b3ad6c3-2c70-43d5-8f21-5b92595bfb3f">1,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_79"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RleHRyZWdpb246OWY4NDMyMDU0MzZlNGNjZGJmNTMxN2ZlZTJkYzRlYzhfMzg1_f4735025-3626-4ef5-8284-b2ec021dd9ba" continuedAt="ibd51c8cbe1444baba99ab74e7d0dd430" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="ibd51c8cbe1444baba99ab74e7d0dd430"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RleHRyZWdpb246OWY4NDMyMDU0MzZlNGNjZGJmNTMxN2ZlZTJkYzRlYzhfMzg0_ae9c4f4f-1733-4caa-9fb6-a9e3f82fc6f9" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes and income tax expense is as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfMy0xLTEtMS04NjEyNw_0140f2bf-55e3-4070-8499-d55d1ed12029">23,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfMy0zLTEtMS04NjEyNw_fb82df71-3026-4082-b1a6-72da8c554f9c">25,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfMy01LTEtMS04NjEyNw_eaa2a069-37cd-4015-bd66-8e3c35eae849">30,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfMy03LTEtMS04NjEyNw_72ca15af-d5dc-49ce-a2aa-fbd25459cc92">41,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNC0xLTEtMS04NjEyNw_7f029c16-d7bf-404b-90c8-628c42c3844d">1,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNC0zLTEtMS04NjEyNw_a4b8a69b-2bc7-467e-a98e-8e10548ac9a1">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNC01LTEtMS04NjEyNw_fb6a7864-96b1-41f8-9279-837bab576bcd">1,079</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNC03LTEtMS04NjEyNw_dd43fb55-addd-4938-bb95-06c6f5bfe31d">3,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNS0xLTEtMS04NjEyNw_36c2edc7-7c86-44b5-855e-4c4d02b3fda6">22,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNS0zLTEtMS04NjEyNw_50045157-5a38-45b7-8460-f06326f380a0">25,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNS01LTEtMS04NjEyNw_65ae801d-9220-43de-87db-675b2891b2cc">29,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNS03LTEtMS04NjEyNw_e2545c4c-c953-4254-9604-6a9ee0ee0f75">38,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNy0xLTEtMS05ODI1Ng_a3114b85-aefe-42bf-a6c8-d92c3fbce8fd">2,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNy0zLTEtMS05ODI1Ng_b2ce288f-cdcc-42ea-947f-483f76ab2892">6,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNy01LTEtMS05ODI1Ng_6428e838-f0b1-4974-9088-03343dfde94a">2,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNy03LTEtMS05ODI1Ng_fa7bd7a4-5a2b-46dd-8a0a-be263d2d3d6d">8,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfOC0xLTEtMS05ODI1Ng_8e8e364b-5be9-43b3-85f4-22aa93fed8fd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfOC0zLTEtMS05ODI1Ng_50288be2-a4a7-43d3-899c-8aa4edcb9e19">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfOC01LTEtMS05ODI1Ng_47985ca7-b279-4e0b-9d0d-7899e4dc100d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfOC03LTEtMS05ODI1Ng_34ea2b58-5595-424f-8d5a-506749076e3b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax expense represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items. The Company&#8217;s effective tax rates for the three and six months ended June&#160;30, 2022 include benefits related to stock-based compensation, a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration, partially offset by non-deductible executive compensation costs and a valuation allowance against non-U.S. results. The Company&#8217;s effective tax rates for the three and six months ended June&#160;30, 2021 include benefits related to stock-based compensation offset by non-deductible executive compensation costs and valuation allowances recorded against deductible capital losses and non-U.S. results.</span></div></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_82"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;15&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMjIwOQ_b5cfc934-403f-4a38-8651-82256c036220" continuedAt="ia6406803b3b14993980018ff3d2b2ed7" escape="true">ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER</ix:nonNumeric></span></div><ix:continuation id="ia6406803b3b14993980018ff3d2b2ed7" continuedAt="icb14dca7df194ec0b4064e031e2b3d61"><ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMjIxMA_9465bdb0-e924-4227-a5ae-4f6a684896c7" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related (gains) charges, product discontinuation and other for the three and six months ended June&#160;30, 2022 and 2021 summarized below (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMi0xLTEtMS05MDE4OQ_49fb2b07-ad7b-47a9-a776-2740f40c607b">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMi0zLTEtMS05MDE4OQ_3057c3e9-600a-4b38-9e81-9c015942608c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMi0xLTEtMS04NjEyNw_3a67fff6-bb60-4adf-a363-eb7418c38ba5">4,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMi0zLTEtMS04NjEyNw_735adb8a-7585-4489-919b-326314a91135">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21203a7e95a542a1bb5a7bdfa160cd8e_D20220401-20220630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMy0xLTEtMS05MDE4OQ_646f3154-492c-4ced-ad8c-a058912c56d8">2,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i812548bedd2c4f138ae40720d5ab3452_D20210401-20210630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMy0zLTEtMS05MDE4OQ_ec38f537-e02a-404d-9e64-33026a537ce2">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d271c16dc5b4e50b5f8b6e36bc439dd_D20220101-20220630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMy0xLTEtMS04NjEyNw_a3bd348d-1448-48f7-bafa-80938a9a8e3f">4,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3eff8369f3a447bb8c7f19a5bccdce2_D20210101-20210630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMy0zLTEtMS04NjEyNw_f6e54f97-08dd-4359-b0af-c53c906f6f7d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ca9116e3b44efaa7a91cf17de3ff05_D20220401-20220630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNC0xLTEtMS05MDE4OQ_1be889ce-7c95-4847-ae54-a74e4894728f">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1626a61d1e96472bb1b34f2c5b6812bb_D20210401-20210630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNC0zLTEtMS05MDE4OQ_cd2bd191-9e8e-46b1-8c7e-074d11a75930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i990dfdef52e040719fa28dbb661db8d9_D20220101-20220630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNC0xLTEtMS04NjEyNw_0051ad8d-e925-4c64-99e8-85b453ff3864">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78e38aec2fa45a58c7a556502d296ac_D20210101-20210630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNC0zLTEtMS04NjEyNw_75493b69-6d6b-401e-83f5-bd5e34bd6936">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" name="pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNS0xLTEtMS05MDE4OQ_e656b7de-f4eb-490c-8953-33068d79835d">3,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNS0zLTEtMS05MDE4OQ_75a8974d-e44e-4107-8b3c-e02d31be951c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" name="pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNS0xLTEtMS04NjEyNw_665b9264-10df-41c8-a8db-65bd03f89449">8,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNS0zLTEtMS04NjEyNw_e006d765-3897-4d3a-a377-e7adf4dc8640">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flexion contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9662be69372649fdb9f55eaf2dddc1cb_D20220401-20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNi0xLTEtMS05MDE4OQ_66cd1232-bbf2-453c-8fa7-a94fbadcde2c">12,523</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6affd4b067a74053a80dafaecc998dce_D20210401-20210630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNi0zLTEtMS05MDE4OQ_e506d6ac-8a46-4979-b1b0-beea6541b5eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77aff11637744366ad3beae32e8eac9d_D20220101-20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNi0xLTEtMS04NjEyNw_e66f950c-c8e4-4dab-aefc-46b50e34745b">13,317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNi0zLTEtMS04NjEyNw_d1995979-f361-4fd3-be01-69bc40d7fcde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoScience contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b2f0c4184a8447cb9800ac82b098ef2_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNy0xLTEtMS05MDE4OQ_790e2b98-9060-4c35-9a90-15eb94bace7e">8,757</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f238205c3474a579a6577a0cfb931fc_D20210401-20210630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNy0zLTEtMS05MDE4OQ_852849dd-fb14-49e3-b31b-ebaf17c19646">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60dfafd369d49e9a8915074448de244_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNy0xLTEtMS04NjEyNw_d230f9cd-8873-4a08-ac65-6dba24617b6d">9,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib55aafc43f234774b601b8faca0c6b5d_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNy0zLTEtMS04NjEyNw_0b93fdfa-536e-4621-94c9-fdc44e73281f">988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuance Biotech Co. Ltd. agreement dissolution costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51cc6d770c1439bbf87e1a1246d6e15_D20220401-20220630" decimals="-3" name="us-gaap:GainLossOnContractTermination" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOC0xLTEtMS05MDE4OQ_3c1c4562-208b-4b8d-a702-4c124cbaaf83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e717cf4ed5406d82a7bcd4eb4a20c9_D20210401-20210630" decimals="-3" name="us-gaap:GainLossOnContractTermination" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOC0zLTEtMS05MDE4OQ_3835dbd6-e351-48c2-851f-67a3199a3e19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56aff27448c64dbaacbbf8b0552a16b7_D20220101-20220630" decimals="-3" name="us-gaap:GainLossOnContractTermination" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOC0xLTEtMS04NjEyNw_a7d0dde4-b112-4e63-a90f-b6ec5dacfbb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29042b95beda4bcf93f5b0e944d9e035_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:GainLossOnContractTermination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOC0zLTEtMS04NjEyNw_35887102-ff70-4e49-a06e-98167f9ae936">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related (gains) charges, product discontinuation and other</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOS0xLTEtMS05MDE4OQ_b9447810-c88f-45a0-bb42-049c8af4516e">18,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630" decimals="-3" name="pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOS0zLTEtMS05MDE4OQ_320a339f-0db4-4cb9-a73a-3d07b5420062">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOS0xLTEtMS04NjEyNw_f86318d2-ed7a-4a00-805e-09bf24a05319">13,721</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630" decimals="-3" name="pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOS0zLTEtMS04NjEyNw_e721f862-0e1a-4f5d-b28c-3b64cdf23140">2,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="icb14dca7df194ec0b4064e031e2b3d61"><div style="margin-top:9pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="i8634775cc9bc464884a372b878f6a608_D20220401-20220630" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDY5OTUyOQ_195a3e14-ec8f-4edd-bb65-5d6de94a885d">3.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="idf3a6876c8774d06bf57b261d16c5eaf_D20220101-20220630" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMjgz_c94f8305-6ad0-4a11-bac0-7ce63271cf41">8.6</ix:nonFraction>&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022, respectively</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily for severance, legal fees, third-party services and other one-time charges related to the Flexion Acquisition. See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2021, as part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i4f0c78a9972546d4a4bf2bfb19a1c536_D20211119-20211119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfNjQ0_cbacadff-8327-4afb-a3ec-b11c21b015ca">45.2</ix:nonFraction>&#160;million, which represents the Company&#8217;s potential achievement of meeting regulatory and sales-based milestones. During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i6168e02aa26e4349847195bf09c3eacf_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDY5OTY1Mg_5ee5aa26-b9c4-445f-8784-3a94ac297905">12.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i21ca7a53ce30416b93b74cd8a9870e74_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfODA4_af7e2e94-4d01-4edf-b796-598d1467711c">13.3</ix:nonFraction>&#160;million gains, respectively, due to a decrease to the fair value of its contingent consideration, which was included in acquisition-related (gains) charges in the condensed consolidated statements of operations. See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i8b2f0c4184a8447cb9800ac82b098ef2_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDcwMDI3Mw_a799548e-9d71-41ee-ac79-bf1da25218ce">8.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie60dfafd369d49e9a8915074448de244_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDcwMDMwNg_a32a2fc2-6e9b-4a39-aec5-e00334595937">9.0</ix:nonFraction>&#160;million contingent consideration gains during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended June&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i1f238205c3474a579a6577a0cfb931fc_D20210401-20210630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDcwMDA4Nw_6af9ae75-d056-49b0-867f-814aba266fae">0.1</ix:nonFraction>&#160;million contingent consideration charge and a $<ix:nonFraction unitRef="usd" contextRef="ib55aafc43f234774b601b8faca0c6b5d_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDcwMDExNA_5c1a8668-1ca3-4264-9ba4-aed4e2436e44">1.0</ix:nonFraction>&#160;million gain during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended June 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nuance Biotech Co. Ltd.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#8217;s intellectual property against the risk of a generic product. Dissolution costs of $<ix:nonFraction unitRef="usd" contextRef="ic60ea8d3b79d48c4b025712186e3026c_D20210101-20210630" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMjA2OA_b31e450b-c991-4c87-8d24-38faeafaebc4">3.0</ix:nonFraction>&#160;million were included in other operating expenses in the condensed consolidated statements of operations for the six months ended June 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021.</span></div></ix:continuation><div id="i5c712f7be21e495eb7af67327cbd7e07_88"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;16&#8212;<ix:nonNumeric contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184OC9mcmFnOjNmYTNiOWExYmY1ODRiMTM5ZjlhZWFkOGM5MDliN2UxL3RleHRyZWdpb246M2ZhM2I5YTFiZjU4NGIxMzlmOWFlYWQ4YzkwOWI3ZTFfNzMxNQ_9b6f760a-d8f5-4d67-adf0-b85fa47b142b" continuedAt="i108d3517b13842cd849567d0e6c37bd1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i108d3517b13842cd849567d0e6c37bd1" continuedAt="i696c165bf4834802b98e1e0cee82d690"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Milestone Litigation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#8220;Pacira CryoTech&#8221;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#8220;Fortis&#8221;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#8220;Merger Agreement&#8221;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $<ix:nonFraction unitRef="usd" contextRef="ibe0d71dff18d49c48f2bf3e271341ed5_D20201001-20201031" decimals="-5" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184OC9mcmFnOjNmYTNiOWExYmY1ODRiMTM5ZjlhZWFkOGM5MDliN2UxL3RleHRyZWdpb246M2ZhM2I5YTFiZjU4NGIxMzlmOWFlYWQ4YzkwOWI3ZTFfMTczNw_8bdea37f-e9db-408e-a2bb-d2f6a599a4de">30.0</ix:nonFraction>&#160;million, plus attorneys&#8217; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">eVenus Pharmaceutical Laboratories Litigations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Company received a Notice Letter advising that eVenus Pharmaceutical Laboratories, Inc., or eVenus, of Princeton, New Jersey, submitted to the FDA an Abbreviated New Drug Application (ANDA) with a Paragraph IV certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,033,495 (the &#8217;495 patent).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i696c165bf4834802b98e1e0cee82d690" continuedAt="i710554b9344f4bc7ad53fbbf4797a5f2"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company filed a patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (21-cv-19829) asserting infringement of the &#8217;495 patent. This triggered an automatic 30-month stay of final approval of the eVenus ANDA. On January 6, 2022, eVenus filed an Answer with counterclaims to the Complaint, alleging the &#8217;495 patent is invalid and/or not infringed through the manufacture, sale, or offer for sale of the product described in product described in eVenus&#8217;s ANDA submission.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a second Notice Letter advising that eVenus submitted to the FDA an amendment to its ANDA with a Paragraph IV Certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (133 mg/10 mL) in the U.S. prior to the expiration of the &#8217;495 patent. In the Notice Letter, eVenus also advised that it submitted a Paragraph IV Certification to the FDA seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL and 133 mg/10 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,179,336 (the &#8217;336 patent). eVenus further alleges in the Notice Letter that both the &#8217;495 patent and the &#8217;366 patent are invalid and/or not infringed.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company filed a second patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (22-cv-00718) asserting that the 133 mg/10 mL ANDA product will infringe the &#8217;495 and &#8217;336 patents and that the 266 mg/20 mL ANDA product will infringe the &#8217;336 patent. This filing triggered a second automatic 30-month stay of final approval for the 133 mg/10 mL ANDA product.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These litigations are in their infancy, and the Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research Development Foundation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an agreement with the Research Development Foundation, or RDF, the Company was required to pay RDF a low single-digit royalty on the collection of revenues from certain products, for as long as certain patents assigned to the Company under the agreement remain valid. RDF has the right to terminate the agreement for an uncured material breach by the Company, in connection with its bankruptcy or insolvency or if it directly or indirectly opposes or disputes the validity of the assigned patent rights. The Company&#8217;s U.S. Patent No. 11,033,495 was issued on June 15, 2021. Thereafter, RDF asserted that the issuance of that patent extends the Company&#8217;s royalty obligations under the agreement until 2041. The Company believes that the royalty period under the agreement was set to end on December 24, 2021 with the expiration of its U.S. Patent No. 9,585,838. Because of the disagreement over the interpretation of the agreement, in December 2021, the Company filed a declaratory judgment lawsuit in the U.S. District Court for the District of Nevada (21-cv-02241). The lawsuit seeks a declaration from the court that the Company owes no royalties to RDF with respect to its EXPAREL product after December 24, 2021. During the pendency of the lawsuit, the Company will continue to pay royalties to RDF under protest, however, the Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments and Contingencies</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Trial Commitments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the U.K.&#8217;s withdrawal from the E.U., the agreed pediatric plan is applicable in the U.K.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#8220;PLAY&#8221;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and U.K. to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency, or MHRA, are still reviewing the Type II variations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hong Kong Pharma Tainuo Ltd.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Flexion Acquisition, in March 2020, Flexion entered into an exclusive license agreement with Hong Kong Tainuo Pharma Ltd., or HK Tainuo, and Jiangsu Tainuo Pharmaceutical Co. Ltd., or Jiangsu Tainuo, a subsidiary of China </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><ix:continuation id="i710554b9344f4bc7ad53fbbf4797a5f2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shijiazhuang Pharmaceutical Co, Ltd., for the development and commercialization of ZILRETTA in Greater China (consisting of mainland China, Hong Kong, Macau and Taiwan). Under the terms of the agreement, HK Tainuo paid Flexion an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ib0b9052c119f49399daa2d218196b388_D20200101-20201231" decimals="-5" name="pcrx:ProceedsFromDevelopmentAndCommercializationOfZILRETTA" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184OC9mcmFnOjNmYTNiOWExYmY1ODRiMTM5ZjlhZWFkOGM5MDliN2UxL3RleHRyZWdpb246M2ZhM2I5YTFiZjU4NGIxMzlmOWFlYWQ4YzkwOWI3ZTFfMzI5ODUzNDg5MjMyMw_b3151e9a-418d-4672-87ed-a1a4c46347ca">10.0</ix:nonFraction>&#160;million during the year ended December 31, 2020 which was recorded in other liabilities as of June&#160;30, 2022 and December 31, 2021. The Company was also eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="ifec5c95984324d979dd83044fa9e7ec4_I20200320" decimals="-5" name="pcrx:CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184OC9mcmFnOjNmYTNiOWExYmY1ODRiMTM5ZjlhZWFkOGM5MDliN2UxL3RleHRyZWdpb246M2ZhM2I5YTFiZjU4NGIxMzlmOWFlYWQ4YzkwOWI3ZTFfMzI5ODUzNDg5MjM1Mg_a96e9ddc-5d10-48ec-84a5-719f12c5b8c3">32.5</ix:nonFraction>&#160;million in aggregate development, regulatory and commercial sales milestone payments under the exclusive license agreement. HK Tainuo was responsible for the clinical development, product registration and commercialization of ZILRETTA in Greater China. The Company was solely responsible for the manufacture and supply of ZILRETTA to HK Tainuo for all clinical and commercial activities. The terms related to product manufacturing and supply, including pricing and minimum purchase requirements agreed to in the license agreement, were to be covered by a separate supply agreement, which had not yet been finalized as of June 30, 2022. Unless terminated earlier in accordance with its terms, the license agreement was scheduled to continue in effect in perpetuity or as long as HK Tainuo or Jiangsu Tainuo continued to sell ZILRETTA in Greater China. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequently, in July 2022, the Company submitted a termination letter to HK Tainuo associated with this license agreement.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 31</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MANAGEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and in accordance with the rules and regulations of the United States Securities and Exchange Commission, or SEC.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form&#160;10-Q and certain other communications made by us contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and the Private Securities Litigation Reform Act of 1995, including, without limitation, statements related to: the Flexion Acquisition (as defined below) and the costs and benefits thereof, our growth and future operating results and trends, our strategy, plans, objectives, expectations (financial or otherwise) and intentions, future financial results and growth potential, anticipated product portfolio, development programs, strategic alliances, patent terms and intellectual property. For this purpose, any statement that is not a statement of historical fact should be considered a forward-looking statement. We often use the words &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;can&#8221; and similar expressions to help identify forward-looking statements. We cannot assure you that our estimates, assumptions and expectations will prove to have been correct. Actual results may differ materially from these indicated by such forward-looking statements as a result of various important factors, including risks relating to, among others: risks associated with acquisitions, such as the risk that the businesses will not be integrated successfully, that such integration may be more difficult, time-consuming or costly than expected or that the expected benefits of the transaction will not occur; the possibility that if we do not achieve the perceived benefits of the Flexion Acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of our shares could decline; the impact of the COVID-19 pandemic on elective surgeries, our manufacturing and supply chain, global and United States, or U.S., economic conditions, and our business, including our revenues, financial condition and results of operations; the success of our sales and manufacturing efforts in support of the commercialization of EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (bupivacaine liposome injectable suspension), ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension) and iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and the rate and degree of market acceptance of EXPAREL, ZILRETTA and iovera&#176;; the size and growth of the potential markets for EXPAREL, ZILRETTA and iovera&#176; and our ability to serve those markets; our plans to expand the use of EXPAREL, ZILRETTA and iovera&#176; to additional indications and opportunities, and the timing and success of any related clinical trials for EXPAREL, ZILRETTA and iovera&#176;; the commercial success of EXPAREL, ZILRETTA and iovera&#176;; the related timing and success of United States Food and Drug Administration, or FDA, supplemental New Drug Applications, or sNDAs, and premarket notification 510(k)s; the related timing and success of European Medicines Agency, or EMA, Marketing Authorization Applications, or MAA; our plans to evaluate, develop and pursue additional product candidates utilizing our proprietary multivesicular liposome, or pMVL, drug delivery technology; the approval of the commercialization of our products in other jurisdictions; clinical trials in support of an existing or potential pMVL-based product; our commercialization and marketing capabilities, our ability to successfully construct an additional EXPAREL manufacturing suite in San Diego, California; our ability to successfully complete a ZILRETTA capacity expansion project in Swindon, England; the outcome of any litigation; the ability to successfully integrate Flexion or any future acquisitions into our existing business; the recoverability of our deferred tax assets; and assumptions associated with contingent consideration payments. Important factors could cause our actual results to differ materially from those indicated or implied by forward-looking statements, and as such we anticipate that subsequent events and developments will cause our views to change. Except as required by applicable law, we undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, and readers should not rely on the forward-looking statements as representing our views as of any date subsequent to the date of the filing of this Quarterly Report on Form&#160;10-Q.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include items mentioned herein and the matters discussed and referenced in Part&#160;I-Item&#160;1A. &#8220;Risk Factors&#8221; included in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and in other reports as filed with the SEC.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references to &#8220;Pacira,&#8221; &#8220;we,&#8221; the &#8220;Company,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this Quarterly Report on Form&#160;10-Q refer to Pacira BioSciences,&#160;Inc. and its subsidiaries.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 32</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is the industry leader in our commitment to non-opioid pain management and providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. We are also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain and spasticity. Our long-acting, local analgesic EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (bupivacaine liposome injectable suspension) was commercially launched in April 2012. EXPAREL utilizes our unique pMVL drug delivery technology that encapsulates drugs without altering their molecular structure and releases them over a desired period of time. In the U.S., EXPAREL is the only opioid-free, long-acting local and regional analgesic approved for infiltration, field blocks and interscalene brachial plexus nerve block to produce local or regional postsurgical analgesia. EXPAREL is also approved for infiltration in pediatric patients aged six years and older in the U.S. In Europe, EXPAREL is approved as a brachial plexus block or femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults. Since its initial approval in 2011, more than 10 million patients have been treated with EXPAREL. We drop-ship EXPAREL directly to end-users based on orders placed to wholesalers or directly to us, and there is no product held by wholesalers. With the acquisition (the &#8220;Flexion Acquisition&#8221;) of Flexion Therapeutics, Inc. (&#8220;Flexion&#8221;) in November 2021, we acquired ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension), the first and only extended-release, intra-articular therapy that can provide major relief for osteoarthritis, or OA, knee pain for three months and has the potential to become an alternative to hyaluronic acid, or HA, and platelet rich plasma, or PRP, injections or other early intervention treatments. With the acquisition of MyoScience, Inc. (the &#8220;MyoScience Acquisition&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in April 2019, we acquired iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature only to targeted nerves, which we sell directly to end users. The iovera&#176; system is highly complementary to EXPAREL as a non-opioid therapy that alleviates pain by disrupting pain signals being transmitted to the brain from the site of injury or surgery. We also believe ZILRETTA is highly complementary to iovera&#176;.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to pursue the expanded use of EXPAREL, ZILRETTA and iovera&#176; in additional procedures; progress our earlier-stage product candidate pipeline; advance regulatory activities for EXPAREL, ZILRETTA, iovera&#176; and other product candidates; invest in sales and marketing resources for EXPAREL, ZILRETTA and iovera&#176;; expand and enhance our manufacturing capacity for EXPAREL, ZILRETTA and iovera&#176;; invest in products, businesses and technologies; and support legal matters.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Flexion Acquisition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we completed the Flexion Acquisition pursuant to an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), under which Flexion became our wholly owned subsidiary and added ZILRETTA, a non-opioid corticosteroid that employs a proprietary microsphere technology to provide extended pain relief, to our commercial offering. The addition of ZILRETTA to our innovative non-opioid product portfolio directly aligns with our mission to provide an opioid alternative to as many patients as possible and address medical needs along the neural pain pathway.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total consideration of $578.8&#160;million included an initial payment of $428.3 million which represented $8.50 in cash per share of Flexion common stock, $20.2 million paid to settle restricted stock units and in-the-money stock options, an $85.1&#160;million cash payment to repay Flexion debt that was not assumed by us and $45.2&#160;million in contingent consideration representing the fair value of contingent value rights, or CVRs, that were issued in conjunction with the Flexion Acquisition. The Merger Agreement provided for one non-tradeable CVR per share of Flexion common stock as well as one CVR per share for certain Flexion equity awards. Each CVR entitles Flexion shareholders to contingent milestone payments of up to an aggregate of $8.00 in cash per share of Flexion common stock if certain milestones are met on or prior to December 31, 2030. Up to an additional $380.2 million in the aggregate may be payable to holders of the CVRs if each of the applicable milestones are achieved. For more information, see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Coronavirus (COVID-19) Pandemic and Global Economic Conditions</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, our revenues have been impacted by COVID-19 pandemic-related challenges that included the significant postponement or suspension in the scheduling of elective surgical procedures due to public health guidance and government directives. While the degree of impact has diminished during the course of the pandemic due to the introduction of vaccines and therapeutics, as well as the lessening of elective surgery restrictions, certain pandemic-related operational and staffing challenges persist. It remains unclear how long it will take the elective surgery market to normalize or if restrictions on elective procedures will recur due to future COVID-19 variants or otherwise. Direct effects of the pandemic and global economic conditions may negatively impact our business, financial condition and results of operations. Such impacts may include the effect of prolonged periods of inflation on our customers and suppliers and longer lead-times or the inability to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">secure a sufficient supply of materials. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise that we are unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to actively monitor the situation and implement measures recommended by federal, state or local authorities, or that we determine are in the best interests of our patients, employees, partners, suppliers, shareholders and stakeholders. For a description of risks facing us that relate to the COVID-19 pandemic or any other future pandemic, epidemic or outbreak of contagious disease, see our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Highlights</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The U.S. Patent and Trademark Office issued Patent Nos. 11,304,904, and 11,311,486 in April 2022, and issued Patent No. 11,357,727 in June 2022. The &#8217;904, &#8217;486, and &#8217;727 patents are listed in the FDA Approved Drug Products with Therapeutic Equivalence Evaluations (the &#8220;Orange Book&#8221;). With these three new patents, there are currently six EXPAREL patents listed in the Orange Book, each with an expiration date of January 22, 2041.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In June 2022, we announced the launch of a partnership with the National Safety Council, or NSC, and the Connect2Prevent program. Connect2Prevent is an innovative employee-family educational program that increases awareness and prevention of opioid addiction. The NSC created a comprehensive curriculum designed to educate employees on the risks associated with opioids and provide them with the tools to have meaningful discussions with adolescent family members. The curriculum includes 10-12 weeks of engaging lessons on opioids, addiction, stigma, risk factors for substance use, refusal skills, harm reduction, how to talk to doctors about opioid alternatives and more. The lessons provide easy-to-understand education, action steps and evidence-based tools to connect and communicate with teens.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In August 2022, we announced the completion of patient enrollment in our two Phase 3 studies of EXPAREL as a nerve block in lower extremity surgeries. The first study is evaluating EXPAREL as an adductor canal block for total knee arthroplasty, or TKA, and the second is evaluating EXPAREL as a popliteal sciatic nerve block for bunionectomy. We believe positive results from these studies will form the basis for an sNDA submission seeking label expansion to include lower extremity nerve blocks.</span></div><div><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPAREL</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., EXPAREL is currently indicated in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia, and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks. In the E.U., EXPAREL is indicated as a brachial plexus block and femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EXPAREL Label and Global Expansion</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Lower extremity nerve block. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have completed enrollment in two Phase 3 registration studies of EXPAREL as a nerve block in lower extremity surgeries. One is a popliteal sciatic nerve block for bunionectomy and the second is an adductor canal block for TKA. We believe positive results from these studies will form the basis for an sNDA submission seeking label expansion to include lower extremity nerve blocks. We believe the addition of this indication is significant as anesthesia-driven regional approaches using nerve and field blocks continue to expand as institutional protocols.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Pediatrics. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are working with the FDA to finalize our studies to support expansion of the EXPAREL single-dose infiltration label to include patients under six years of age. We have met with the FDA to discuss appropriate studies of EXPAREL in pediatric patients aged 0 to less than 6 years of age. We expect that these studies, if successful, will be the basis for an sNDA seeking expansion of the EXPAREL label to include this patient population for single-dose infiltration. We are also discussing our regulatory strategy for EXPAREL administered as a nerve block in the pediatric setting. We are working with both the FDA and the European Medicines Agency, or EMA, with the goal of harmonizing our pediatric clinical studies as much as possible between the two regions.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Stellate ganglion block. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Planning is underway for a multicenter registration study of EXPAREL as a stellate ganglion block for treating refractory cardiac ventricular dysrhythmias and for use to prevent postoperative atrial fibrillation after open heart surgery. We are working with a steering committee of Key Opinion Leaders in regional anesthesia and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stellate ganglion blocks who will convene later this year to help finalize study design. After an FDA meeting to align on our regulatory strategy for expanding the EXPAREL label to include stellate ganglion block, we expect to proceed with a registration trial. We believe a stellate ganglion block utilizing EXPAREL will last for several days and address a significant unmet need in patients with ventricular and atrial dysrhythmias.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Global expansion. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prioritized the European and Latin American markets for global expansion. In Europe, we were granted marketing authorization by the EC in November 2020 for EXPAREL as a brachial plexus block or femoral nerve block for treatment of post-operating pain in adults and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults. We launched EXPAREL in the U.K. and targeted E.U. countries in the fourth quarter of 2021. In Latin America, we have a distribution agreement with Eurofarma Laboratories S.A., or Eurofarma, for the development and commercialization of EXPAREL. Eurofarma has the exclusive right to market and distribute EXPAREL in 19 countries in Latin America, including Argentina, Brazil, Colombia and Mexico. In addition, Eurofarma will be responsible for regulatory filings for EXPAREL in these countries. We will receive royalties and are also eligible to receive regulatory- and commercial-based milestone payments that are triggered by the achievement of certain events.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ZILRETTA</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ZILRETTA was approved by the FDA in October 2017 and launched in the U.S. shortly thereafter. We market ZILRETTA through our ZILRETTA and iovera&#176; sales force of approximately 50 Treatment Solutions Managers who are providing clinicians with two unique OA treatment options to individualize patient care. ZILRETTA is the first and only extended-release, intra-articular therapy for patients confronting OA knee pain. ZILRETTA employs a proprietary microsphere technology combining triamcinolone acetonide, or TA, a commonly administered, immediate-release corticosteroid, with a poly lactic-co-glycolic acid, or PLGA, matrix to provide extended pain relief. PLGA is a proven extended-release delivery vehicle that is metabolized to carbon dioxide and water as it releases drug in the intra-articular space and is used in other approved drug products and surgical devices. The ZILRETTA microspheres slowly and continuously release triamcinolone acetonide into the knee to provide significant pain relief for 12 weeks, with some people experiencing pain relief through 16 weeks.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe ZILRETTA&#8217;s extended-release profile may also provide effective treatment for OA pain of the shoulder, and we intend to initiate a Phase 3 trial investigating ZILRETTA in shoulder OA in 2023 after aligning with the FDA on study design. In addition, we are planning a study comparing ZILRETTA to immediate release triamcinolone acetonide in patients with Type 2 diabetes and are evaluating a repeat dosing study.</span></div><div><span><br/></span></div><div><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ZILRETTA Clinical Benefits</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ZILRETTA combines a commonly administered steroid, TA, with PLGA, delivering a 32 milligram dose of TA to provide extended therapeutic concentrations in the joint and persistent analgesic effect.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the strength of its pivotal and other clinical trials, we believe that ZILRETTA represents an important treatment option for the millions of patients in the U.S. in need of safe and effective extended relief from OA knee pain. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pivotal Phase 3 trial, on which the approval of ZILRETTA was based, showed that ZILRETTA significantly reduced OA knee pain for 12 weeks, with some people experiencing pain relief through Week 16. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the magnitude and duration of pain relief provided by ZILRETTA in clinical trials were clinically meaningful with the magnitude of pain relief amongst the largest seen to date in OA clinical trials. The overall frequency of treatment-related adverse events in these trials was similar to those observed with placebo, and no drug-related serious adverse events were reported. We believe that ZILRETTA holds the potential to become the corticosteroid of choice given its safety and efficacy profile, and the fact that it is the first and only extended-release corticosteroid on the market. In September 2021, the American Association of Orthopaedic Surgeons, or AAOS, updated its evidence-based clinical practice guidelines, finding ZILRETTA can improve patient outcomes over traditional immediate-release corticosteroids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">iovera&#176;</span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The iovera&#176; system is an FDA-approved, non-opioid handheld cryoanalgesia device used to produce precise, controlled doses of cold temperature only to targeted nerves. It has been FDA 510(k) cleared in the U.S., has a CE mark in the E.U. and is cleared for marketing in Canada for the blocking of pain. We believe the iovera&#176; system is highly complementary to EXPAREL and ZILRETTA as a non-opioid therapy that alleviates pain using a non-pharmacological nerve block to disrupt pain signals being transmitted to the brain from the site of injury or surgery. It is also indicated for the relief of pain and symptoms associated with arthritis of the knee for up to 90 days.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iovera&#176; Clinical Benefits</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a growing body of clinical data demonstrating success with iovera&#176; treatment for OA of the knee. Surgical intervention is typically a last resort for patients suffering from OA of the knee. In one study, the majority of the patients suffering from OA of the knee experienced pain relief up to 150 days after being treated with iovera&#176;.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary findings demonstrated reductions in opioids, including:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The daily morphine equivalent consumption in the per protocol group analysis was significantly lower at 72 hours (p&lt;0.05), 6 weeks (p&lt;0.05) and 12 weeks (p&lt;0.05).</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients who were administered iovera&#176; were far less likely to take opioids six weeks after surgery. The number of patients taking opioids six weeks after TKA in the control group was three times the number of patients taking opioids in the cryoanalgesia group (14% vs. 44%, p&lt;0.01).</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients in the iovera&#176; group demonstrated a statistically significant reduction in pain scores from their baseline pain scores at 72 hours (p&lt;0.05) and at 12 weeks (p&lt;0.05).</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe these data validate iovera&#176; as a clinically meaningful non-opioid alternative for patients undergoing TKA, and that iovera&#176; offers the opportunity to provide patients with non-opioid pain control well in advance of any necessary surgical intervention through a number of key product attributes:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is safe and effective with immediate pain relief that can last for months as the nerve regenerates over time;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is repeatable;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The iovera&#176; technology does not risk damage to the surrounding tissue;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is a convenient handheld device with a single-use procedure-specific Smart Tip; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; can be delivered precisely using ultrasound guidance or an anatomical landmark.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the AAOS updated its evidence-based clinical practice guidelines, reporting that denervation therapy&#8212;including cryoneurolysis&#8212;may reduce knee pain and improve function in patients with symptomatic OA of the knee.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also encouraged by usage of iovera&#176; in other areas. Key opinion leaders in orthopedics, spine and anesthesia are interested in replacing heat-based radiofrequency ablation with iovera&#176; cold therapy. There is interest across a wide range of treatment opportunities such as low back pain, spine, spasticity and rib fracture. We intend to use investigator-initiated studies and grants to develop data across these areas.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iovera&#176; Global Expansion</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we entered into a licensing agreement with Verve Medical Products, Inc. for the distribution of iovera&#176; in Canada. We began selling iovera&#176; in Canada in the fourth quarter of 2021. Additionally, we began selling iovera&#176; in the E.U. through a contracted sales force in the first quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Osteoarthritis Market</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OA is the most common form of arthritis. It is also called degenerative joint disease and occurs most frequently in the hands, hips and knees. With OA, the cartilage within a joint begins to break down and the underlying bone begins to change. These changes usually develop slowly and get worse over time. OA can cause pain, stiffness and swelling. In some cases it also causes reduced function and disability; some people are no longer able to do daily tasks or work. According to the CDC, OA affects over 32.5 million adults in the U.S.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lifetime risk of developing symptomatic knee OA is 45 percent. The prevalence of symptomatic knee OA increases with each decade of life, with the annual incidence of knee OA being highest between age 55 and 64 years old. There are 14 million individuals in the U.S. who have symptomatic knee OA, and nearly two million are under the age of 45. Surgical intervention is typically a last resort for patients suffering from OA of the knee.</span></div><div><span><br/></span></div><div style="text-indent:22.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the addition of ZILRETTA to our product offering, we can now offer clinicians the flexibility to individualize OA knee pain treatment with either ZILRETTA or a drug-free nerve block with iovera&#176; based on patient factors and preference, physician training, site of care and reimbursement considerations.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 36</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Development Programs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PCRX-201 and PCRX-301 (Formerly FX-201 and FX-301)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PCRX-201 and PCRX-301 were added to our portfolio as part of the Flexion Acquisition. PCRX-201 is a gene therapy product candidate designed to provide &#8220;on demand&#8221; production of an anti-inflammatory protein, interleukin-1 receptor antagonist (IL-1Ra) whenever inflammation is detected in the joint. PCRX-301, is a locally administered Na</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7 inhibitor, known as funapide, formulated for extended release in a thermosensitive hydrogel. The initial development of PCRX-301 was intended to support administration as a peripheral analgesic lower extremity nerve block for management of post-operative pain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">pMVL-Based Clinical Programs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the proven safety, flexibility and customizability of our pMVL drug delivery technology platform for acute, sub-acute and chronic pain applications, we have several pMVL-based products in clinical development. Following data readouts from preclinical and feasibility studies for these candidates, we have prioritized three programs for clinical development: (i) PCRX-401, a dexamethasone-pMVL for low back pain; (ii) PCRX-501, a high potency bupivacaine-pMVL for longer-lasting pain relief (20.0 mg/mL) and (iii) a bupivacaine-pMVL for intrathecal analgesia (13.3 mg/mL). We are planning to initiate the second half of our Phase 1 study of low-concentration bupivacaine-pMVL for intrathecal analgesia in late 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">External Innovation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In parallel to our internal clinical programs, our business development team continues to pursue innovative acquisition targets that are complementary to EXPAREL, ZILRETTA and iovera&#176; and that we believe are of great interest to the surgical and anesthesia audiences we are already calling on today. We are using a combination of strategic investments, in-licensing and acquisition transactions to build out a pipeline of innovation to improve patients&#8217; journeys along the neural pain pathway. Select strategic investments we have made to support promising early stage platforms are summarized below.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eaeaea;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#eaeaea;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Development Stage</span></td><td colspan="3" style="background-color:#eaeaea;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description of Platform Technology</span></td><td colspan="3" style="background-color:#eaeaea;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Potential Therapeutic Areas</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carthronix, Inc.</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">CX-011, an intra-articular injection designed to slow joint degeneration by mediating IL-6 cytokines</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Knee OA</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Coda Therapeutics, Inc.</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Chemogenetic platform to reverse the aberrant neuronal activity underlying neurological disorders using optimized Adeno-Associated Virus (AAV) vectors</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neuropathic pain</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genascence Corporation</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Phase 1</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">AAV vector-based gene therapy targeting Interleukin 1 Receptor Antagonist (IL-1Ra)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Knee OA</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GeneQuine Biotherapeutics GmbH</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Next-generation gene transfer vehicles that enter joint cells to confer multi-year gene expression</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OA and other musculoskeletal disorders</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spine BioPharma, LLC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Phase 3-ready</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Remedisc 7-amino acid chain peptide that binds to and induces down regulation of transforming growth factor, beta 1 (TGF&#946;1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Degenerative disc disease</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Portfolio and Internal Pipeline</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current product portfolio and internal product candidate pipeline, along with anticipated milestones over the next 12 to 18 months, are summarized in the table below:</span></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><img src="pcrx-20220630_g2.jpg" alt="pcrx-20220630_g2.jpg" style="height:675px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Study designs have not been finalized for infiltration in pediatric patients aged 0 to 6 years old or for nerve block in pediatric patients.</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- NOCITA</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> is a registered trademark of Aratana Therapeutics, Inc., a wholly owned subsidiary of Elanco Animal Health, Inc.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pacira Training Facilities</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we opened the Pacira Innovation and Training center of Tampa (the &#8220;PITT&#8221;). We designed this facility to help advance clinician understanding of the latest local, regional and field block approaches for managing pain. The PITT provides an unparalleled training environment for healthcare providers working to reduce or eliminate patient exposure to opioids. The PITT supports a full range of educational events to advance clinician understanding of the latest local, regional, and field block approaches for managing pain and reducing or eliminating exposure to opioids. Our corporate headquarters are also located at the PITT.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PITT consists of approximately 13,000 square-feet of fully adaptable space and is equipped with state-of-the-art technology and audio/visual capabilities and features several distinct training spaces including a simulation lab equipped with seven ultrasound scanning stations; a lecture hall featuring a 4&#189;-foot tall by 24-foot wide liquid crystal display video wall to support live, virtual and even global presentations; and a green-screen broadcast studio designed to livestream content with single or multiple hosts.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our EXPAREL programs, we are hosting ongoing workshops to train new users on best practice techniques for iovera&#176; administration at the PITT. Led by healthcare professionals, these labs include didactic lectures and hands-on trainings including live model nerve scanning and identification using ultrasound and peripheral nerve stimulation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At no fee to the organization, the PITT also serves as a venue for national anesthesia provider organizations to host their own workshops and training sessions to educate healthcare providers.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have launched development plans for a second training facility in Houston, Texas. This 19,000 square-foot state-of-the-art facility will feature an adaptive lecture hall, broadcast studio and lab space for cadaver and other interactive workshops. These training centers are core to developing both our physician champions and community-based clinicians who want to stay on the forefront of opioid-sparing pain management. We expect to open this facility before the end of 2022 which would immediately double our capacity and ability to host programs for EXPAREL, ZILRETTA and iovera&#176;.</span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_106"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three and Six Months Ended June&#160;30, 2022 and 2021 </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales consist of (i) EXPAREL in the U.S., the European Union, or E.U., and the United Kingdom, or U.K.; (ii) ZILRETTA in the U.S.; (iii) iovera&#176; in the U.S., Canada and the E.U. and (iv) sales of, and royalties on, our bupivacaine liposome injectable suspension for veterinary use.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our revenues during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXPAREL</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZILRETTA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iovera&#176;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bupivacaine liposome injectable suspension</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net product sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,581&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,863&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,601&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative licensing and milestone revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,590&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,617&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXPAREL revenue increased 5% and&#160;9% in the three and six months ended June&#160;30, 2022 versus 2021, respectively, primarily due to increases of 3.6% and 7.2% in gross vial volume and increases of 3.7% and 3.8% in gross selling price per </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unit, partially offset by the sales mix of EXPAREL vial sizes. Although the demand for EXPAREL has continued to increase primarily as a result of Ambulatory Surgical Centers and anesthesiologists broadening the use of long-acting EXPAREL regional approaches as a foundation of multimodal opioid-minimization strategies that enable shifting inpatient procedures to 23-hour sites of care, the elective surgery market has faced additional pandemic-related challenges due to regional surges in COVID-19 variant cases, staffing shortages and fatigue from care teams addressing significant procedure backlogs. EXPAREL utilization remains above the overall sharp decline in elective surgical procedures relative to pre-pandemic baseline levels due to increased utilization in outpatient settings and emergent procedures.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Flexion Acquisition, we acquired ZILRETTA in November 2021, which is an extended-release corticosteroid treatment for OA knee pain. We recognized net product sales of $27.4 million and $51.1 million for the three and six months ended June&#160;30, 2022, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales of iovera&#176; decreased 16% and 12% in the three and six months ended June&#160;30, 2022 versus 2021, respectively, primarily due to a delay in the transition from generation 1 to generation 2 iovera&#176; products and short-term variations in reimbursement policies in certain territories.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bupivacaine liposome injectable suspension net product sales decreased and its related royalties increased nominally in the three months ended June&#160;30, 2022 versus 2021. Bupivacaine liposome injectable suspension net product sales and its related royalties increased in the six months ended June&#160;30, 2022 versus 2021. These changes versus the prior year periods were due to the timing of orders placed by Aratana Therapeutics, Inc. for veterinary use.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any renewed government suspension of or reluctance of patients to have elective procedures would impact our future sales of EXPAREL, ZILRETTA and iovera&#176; during the ongoing COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of activity with respect to our sales related allowances and accruals related to EXPAREL and ZILRETTA for the six months ended June&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.701%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Returns Allowances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prompt Payment Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Service<br/>Fees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume<br/>Rebates and<br/>Chargebacks</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Government Rebates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,540)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,876)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,960)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,166&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Returns Allowances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prompt Payment Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Service<br/>Fees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume<br/>Rebates and<br/>Chargebacks</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Government<br/>Rebates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,846)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,838&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total reductions of gross product sales from sales-related allowances and accruals were $34.4 million and $15.6 million, or 9.6% and 5.8% of gross product sales, for the six months ended June 30, 2022 and 2021, respectively. The overall increase in sales-related allowances and accruals as a percentage of gross product sales was primarily related to the addition of the ZILRETTA-related allowances and accruals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Goods Sold </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold primarily relates to the costs to produce, package and deliver our products to customers. These expenses include labor, raw materials, manufacturing overhead and occupancy costs, depreciation of facilities, royalty payments, quality control and engineering.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our cost of goods sold and gross margin during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,701</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,597</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Gross margin</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin decreased four percentage points in the three months ended June 30, 2022 versus 2021 mainly due to higher EXPAREL inventory reserves due to raw material supply chain delays and the ZILRETTA step-up of fixed assets and inventory to fair value in accordance with purchase accounting. There was no change in gross margin in the six months ended June 30, 2022 versus 2021, when a two percentage point increase due to the prior period&#8217;s unplanned downtime was offset by a two percentage point decrease due to higher EXPAREL inventory reserves attributable to raw material supply chain delays.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses primarily consist of costs related to clinical trials and related outside services, product development and other research and development costs, including trials that we are conducting to generate new data for EXPAREL, ZILRETTA and iovera&#176; and stock-based compensation expense. Clinical and preclinical development expenses include costs for clinical personnel, clinical trials performed by third-parties, toxicology studies, materials and supplies, database management and other third-party fees. Product development and manufacturing capacity expansion expenses include development costs for our products, which include personnel, equipment, materials and contractor costs for process development and product candidates, development costs related to significant scale-ups of our manufacturing capacity and facility costs for our research space. Regulatory and other expenses include regulatory activities related to unapproved products and indications, medical information expenses and related personnel. Stock-based compensation expense relates to the costs of stock option grants, awards of restricted stock units, or RSUs, and our employee stock purchase plan, or ESPP.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a breakout of our research and development expenses during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical and preclinical development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,174</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,131</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product development and manufacturing capacity expansion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,073</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,309</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,662</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,578</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,435</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,887</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,453</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;% of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total research and development expense increased over 100% and 68% in the three and six months ended June&#160;30, 2022 versus 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical and preclinical development expense increased over 100% in each of the three and six months ended June&#160;30, 2022 versus 2021, due to the start-up of and continued enrollment in two EXPAREL lower extremity nerve block trials in bunionectomy and TKA and ongoing trials for the product candidates acquired as part of the Flexion Acquisition.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product development and manufacturing capacity expansion expense increased 10% and 8% in the three and six months ended June&#160;30, 2022 versus 2021, respectively, mainly attributable to the significant scale-up of our EXPAREL manufacturing capacity at our Science Center Campus in San Diego, California.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory and other expense increased 28% and 2% in the three and six months ended June&#160;30, 2022 versus 2021, respectively, due to increased support of E.U. EXPAREL pediatric submissions, partially offset by lower ongoing costs in 2022 related to our iovera&#176; clinical data registry, as compared to start-up expenses incurred in the first half of 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased 14% and 22% in the three and six months ended June&#160;30, 2022 versus 2021, respectively, primarily due to greater equity awards outstanding for research and development personnel.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses primarily consist of compensation and benefits for our sales force and personnel that support our sales, marketing, medical and scientific affairs operations, payments to our marketing partners for the promotion and sale of our products, expenses related to communicating the health outcome benefits of our products, investments in provider-level market access and patient reimbursement support and educational programs for our customers. General and administrative expenses consist of compensation and benefits for legal, finance, regulatory activities related to approved products and indications, compliance, information technology, human resources, business development, executive management and other supporting personnel. It also includes professional fees for legal, audit, tax and consulting services. Stock-based compensation expense relates to the costs of stock option grants, RSU awards and our ESPP.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our selling, general and administrative expenses during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,294</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,361</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,044</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,755</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,925</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,219</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total selling, general and administrative expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,813&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,263</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,335</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;% of total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total selling, general and administrative expenses increased 28% and&#160;30% in the three and six months ended June&#160;30, 2022 versus 2021, respectively</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses increased 30% and 36% in the three and six months ended June&#160;30, 2022 versus 2021, respectively. The increases were driven by a sales force expansion supporting iovera&#176;, the addition of a sales force to support ZILRETTA and fully staffing a contracted sales force in Europe. We are continuing our marketing investment in EXPAREL and iovera&#176;, which includes educational initiatives and programs related to the impact of opioids and postsurgical pain management and our national advocacy campaign designed to educate patients about non-opioid treatment options. Additionally, we continue our investment in clinician training in the use of EXPAREL and iovera&#176; at our PITT training facility in Tampa, Florida. The addition of ZILRETTA to our commercial portfolio has increased our sales and marketing spend in 2022 as we increased the size of our ZILRETTA and iovera&#176; sales force, which is providing clinicians with two unique OA treatment options to individualize patient care and patient reimbursement support for ZILRETTA.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased 32% and 29% in the three and six months ended June&#160;30, 2022 versus 2021, respectively. The increases were driven by administrative support costs as a result of the Flexion Acquisition in November 2021, including transition expenses during integration, and additional support for our expansion into European markets. The increase in the six months ended June 30, 2022 also includes legal costs to support intellectual property protection.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased 11% in both the three and six months ended June&#160;30, 2022 and 2021 primarily due to an increase in the number of equity awards outstanding for selling, general and administrative personnel.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-bottom:10pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the amortization of acquired intangible assets during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of acquired intangible assets increased substantially in the three and six months ended June&#160;30, 2022 versus 2021 due to the Flexion Acquisition. We acquired a developed technology intangible asset for ZILRETTA for OA knee pain, which is being amortized over a useful life of approximately ten years. For more information, see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related (Gains) Charges, Product Discontinuation and Other</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the costs related to the Flexion Acquisition, MyoScience Acquisition, termination costs and other activities during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related (gains) charges, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,058)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,721)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(981)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%+</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related (gains) charges, product discontinuation and other</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,058)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,721)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total acquisition-related (gains) charges, product discontinuation and other increased substantially in the three and six months ended June&#160;30, 2022 versus 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2022, we recognized acquisition-related gains, net of $18.1 million and $13.7 million, respectively. These gains were primarily driven by reductions in acquisition contingent consideration liabilities due to adjustments to near-term forecasts for the applicable period during which the Flexion contingent consideration may be achieved under the Merger Agreement and due to the reduced probability of meeting the MyoScience contingent consideration milestones by December 31, 2023, the expiration date for achieving the milestones</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These gains were partially offset by </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">severance, legal fees, third-party services and other one-time charges related to the Flexion Acquisition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Charges, Product Discontinuation and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three and six months ended June&#160;30, 2021, as part of the MyoScience Acquisition, we recognized acquisition-related charges of $0.1 million and gains of $1.0 million, respectively, primarily related to changes in the fair value of contingent consideration. See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein, for information regarding the methods and key assumptions used in the fair value measurements of contingent consideration.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we entered into an agreement with Nuance Biotech Co. Ltd. to advance the development and commercialization of EXPAREL in China. In April 2021, we agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards our intellectual property against the risk of a generic product. Dissolution costs of $3.0 million were included in other operating expenses in the condensed consolidated statements of operations for the six months ended June&#160;30, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense)</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding other expense, net during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,833)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,023)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,079)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(771)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,554)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,228)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,195)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,327)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,909)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net increased nominally and 21% in&#160;the three and six months ended June&#160;30, 2022 versus 2021, respectively. The 26% and 36% increase in interest expense during the three and six months ended June&#160;30, 2022, respectively, was due to the $375.0 million term loan B credit agreement (the &#8220;Term Loan&#8221;) entered into in December 2021. This increase was partially offset by the absence of debt discount amortization associated with our convertible notes in the current year due to adopting Accounting Standards Update, or ASU, 2020-06 in 2022, and the maturing of our 2.375% convertible senior notes due 2022, or 2022 Notes, on April 1, 2022. For additional information regarding the adoption of ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements herein. </span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net in the prior year periods included a realized loss on the sale of an equity investment in the amounts of $2.5&#160;million and $2.6&#160;million during the three and six months ended June 30, 2021, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our income tax expense during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Income tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Effective tax rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were 10% and 9% for the three and six months ended June&#160;30, 2022, respectively. The effective tax rates were 26% and 23% for the three and six months ended June&#160;30, 2021, respectively. Income tax expense represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items. The effective tax rates for the three and six months ended June&#160;30, 2022 include benefits related to stock-based compensation, a first quarter SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc), milestone payment and a fair value adjustment for Flexion contingent consideration, offset by non-deductible executive compensation costs and a valuation allowance against non-U.S. results. The effective tax rates for the three and six months ended June&#160;30, 2021 include benefits related to stock-based compensation offset by non-deductible executive compensation costs and valuation allowances recorded against deductible capital losses and non-U.S. results.</span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_109"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in 2006, we have devoted most of our cash resources to manufacturing, research and development and selling, general and administrative activities related to the development and commercialization of EXPAREL. In addition, we acquired ZILRETTA as part of the Flexion Acquisition in November 2021 and iovera&#176; as part of the MyoScience Acquisition in April 2019. We are primarily dependent on the commercial success of EXPAREL and ZILRETTA. We have financed our operations primarily with the proceeds from the sale of convertible senior notes and other debt, common stock, product sales and collaborative licensing and milestone revenue. As of June&#160;30, 2022, we had an accumulated deficit of $138.0 million, cash and cash equivalents and short-term available-for-sale investments of $316.4 million and working capital of $393.0 million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our cash and available-for-sale investments on hand will be adequate to cover our short-term liquidity needs, and that we would be able to access other sources of financing should the need arise.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law in response to the COVID-19 pandemic. The CARES Act, among other things, allows for certain measures to increase liquidity for businesses </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such as the deferral of employer payroll taxes, a tax credit for retaining employees and other provisions. We benefited from the provision to defer the payment of certain employer payroll taxes in the amount of $2.8 million for the year ended December 31, 2020 and remitted $1.4 million in December 2021. The remaining $1.4 million is due by December 31, 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Cash Flows</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:73.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Cash Flows Data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Net cash (used in) provided by:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,858)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463,517)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, net cash provided by operating activities was $60.6 million, compared to $42.2 million during the six months ended June&#160;30, 2021. The increase&#160;of $18.4 million was primarily attributable to increased net product sales from both ZILRETTA, acquired as part of the Flexion Acquisition in November 2021, and EXPAREL, coupled with realized efficiencies from the acquisition of Flexion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, net cash used in investing activities was $188.9 million, which reflected $124.7 million of short-term available-for-sale investment purchases (net of maturities), a $32.0 million contingent consideration milestone payment that had been achieved in the fourth quarter of 2021 associated with our 2007 acquisition of Pacira Pharmaceuticals, Inc. from Skyepharma, purchases of fixed assets of $19.4 million for fill lines for our products and equipment for a 200-liter EXPAREL capacity expansion project at our Science Center Campus in San Diego, California and purchases of equity and debt investments of $12.8 million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, net cash used in investing activities was $52.6 million, which reflected $23.8 million of short-term and long-term investment purchases (net of maturities) and purchases of fixed assets of $23.6 million. Major fixed asset purchases included equipment for a new 200-liter EXPAREL capacity expansion project at our Science Center Campus in San Diego, California, and continuing expenditures for our expanding EXPAREL manufacturing capacity in Swindon, England. In addition, we made a $10.0 million equity investment and also purchased a total of $4.2 million in convertible notes. We also sold one of our equity investments for net cash proceeds of $9.1 million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, net cash used in financing activities was $335.2 million, which primarily consisted of a $192.6 million principal repayment of the 3.375% convertible senior notes due 2024 (the &#8220;Flexion 2024 Notes&#8221;) as part of a repurchase offer to the holders of the Flexion 2024 Notes that was triggered by the Flexion Acquisition, $157.0 million to settle the 2022 Notes that matured on April 1, 2022 and a $9.4 million scheduled repayment of Term Loan principal, partially offset by $21.9 million of proceeds from the exercise of stock options and $1.8 million from the issuance of common stock through our ESPP.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, net cash provided by financing activities was $16.2 million, which consisted of proceeds from the exercise of stock options of $16.0 million and $1.6 million from the issuance of common stock through our ESPP, partially offset by the $1.3 million financing component of the $7.0 million contingent consideration payment made to MyoScience securityholders.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2026 Term Loan B Facility</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we entered into the $375.0 million Term Loan which is secured by substantially all of our and any subsidiary guarantor&#8217;s assets and is scheduled to mature on December 7, 2026, subject to certain exceptions set forth in the term loan credit agreement (the &#8220;Credit Agreement&#8221;). We may elect to borrow either alternate base rate borrowings or term benchmark borrowings. Each term loan borrowing which is an alternate base rate borrowing bears interest at a variable rate per annum equal to the Alternate Base Rate (as defined in the Credit Agreement) subject to a 1.75% floor, plus 6.00%. Each term loan borrowing which is a term benchmark borrowing bears interest at a variable rate per annum equal to (i) the Adjusted Term SOFR Rate (as defined in the Credit Agreement) subject to a 0.75% floor plus (ii) 7.00%.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement requires us to, among other things, maintain (i) a first lien net leverage ratio, determined as of the last day of any fiscal quarter, of no greater than 1.75 to 1.00 and (ii) liquidity, at any time, of at least $150.0 million. The Credit Agreement also contains customary affirmative and negative covenants, financial covenants, representations and warranties, events of default and other provisions. As of June&#160;30, 2022, we were in compliance with all financial covenants under the Credit Agreement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, we made a scheduled principal payment of $9.4&#160;million. At June&#160;30, 2022, we had $365.6 million in outstanding borrowings under the Term Loan. As a result of our entry into the Term Loan, we expect our interest expense to increase in 2022. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion.</span></div><div style="margin-bottom:8pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Convertible Senior Notes</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we completed a private placement of $402.5 million in aggregate principal amount of our 0.750% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per annum, payable semiannually in arrears on February&#160;1 and August 1 of each year. The 2025 Notes mature on August 1, 2025. At June&#160;30, 2022, the outstanding principal on the 2025 Notes was $402.5 million. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Convertible Senior Notes</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, as part of the Flexion Acquisition, we assumed $201.3 million in aggregate principal amount of the Flexion 2024 Notes. The Flexion 2024 Notes have a maturity date of May 1, 2024, are unsecured, and accrue interest at a rate of 3.375% per annum, payable semi-annually on May 1 and November 1 of each year. In January 2022, we repurchased $192.6 million aggregate principal amount of the Flexion 2024 Notes. At June&#160;30, 2022, the outstanding principal on the Flexion 2024 Notes was $8.6&#160;million. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Capital Requirements</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents, available-for-sale investments and cash received from product sales will be sufficient to enable us to fund our operating expenses, capital expenditure requirements and payment of the interest and principal on our Term Loan and our convertible notes, and any conversions of our Notes through the next 12 months. Our future use of operating cash and capital requirements will depend on many forward-looking factors, including, but not limited to, the following:</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of successfully integrating Flexion into our existing business and expanding the commercialization of ZILRETTA;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of the potential Flexion milestone payments under the CVR Agreement, which could be up to an aggregate of $425.5&#160;million if certain regulatory and commercial milestones are met. (See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for more information);</span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the impact of the COVID-19 pandemic and global economic conditions, including the amounts and delays of suspended elective surgical procedures, clinical trials, longer lead-times for or the inability to secure a sufficient supply of materials;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of and extent to which the holders of our convertible senior notes elect to convert their notes and the timing of principal and interest payments on our Term Loan;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and impact of increases to the variable interest rate on our Term Loan borrowings in accordance with the terms of the Credit Agreement;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and our ability to successfully continue to expand the commercialization of EXPAREL, ZILRETTA and iovera&#176;, including outside of the U.S.;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of expanding and maintaining our manufacturing facilities, including the current EXPAREL capacity expansion project at our Science Center Campus in San Diego, California and a ZILRETTA capital project at the Thermo Fisher site in Swindon, England;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of potential remaining milestone payments to MyoScience security holders, which could be up to an aggregate of $43.0&#160;million if certain regulatory and commercial milestones are met (See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for more information);</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of additional strategic investments, including additional investments under existing agreements;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs related to legal and regulatory issues;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of inflation on our product costs, operating expenses and business strategy;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of performing additional clinical trials for our products, including the additional pediatric trials required by the FDA and EMA as a condition of approval of EXPAREL;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs for the development and commercialization of other product candidates;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of future payments under our employee benefit plans, including but not limited to our cash long-term incentive plan and non-qualified deferred compensation plan; and</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in products, businesses and technologies.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may require additional debt or equity financing to meet our future operating and capital requirements. We have no committed external sources of funds, and additional equity or debt financing may not be available on acceptable terms, if at all. In particular, capital market disruptions or negative economic conditions, especially in light of the COVID-19 pandemic, may hinder our access to capital.</span></div><div><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_112"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for a discussion of recently issued accounting pronouncements and their impact or future potential impact on our financial results, if determinable. For a description of critical accounting policies that affect our significant judgments and estimates used in the preparation of our consolidated financial statements, refer to our most recent </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_115"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for a new lease described in Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein, there have been no material changes in our contractual obligations relating to our indebtedness, lease obligations and purchase obligations from those reported in our Annual Report on Form 10-K for the year ended December&#160;31, 2021. For more information on our contractual obligations and commercial commitments, see Part II, Item 7 in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 47</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of our cash equivalents and investment activities is to preserve principal while at the same time maximizing the income that we receive from our investments without significantly increasing risk. We invest in corporate bonds, commercial paper, asset-backed securities and U.S. Treasury and other government agency notes, which are reported at fair value. These securities are subject to interest rate risk and credit risk. This means that a change in prevailing interest rates may cause the fair value of the investment to fluctuate. For example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the interest rate later rises, we expect that the fair value of our investment will decline. A hypothetical 100 basis point increase in interest rates would have reduced the fair value of our available-for-sale securities at June&#160;30, 2022 by approximately $0.6&#160;million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our Notes are impacted by both the fair value of our common stock and interest rate fluctuations. As of&#160;June&#160;30, 2022, the estimated fair value of the 2025 Notes was $1,038 per $1,000 principal amount. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion of our Notes, which bear interest at a fixed rate. At June&#160;30, 2022, all $402.5 million of principal remains outstanding on the 2025 Notes and $8.6&#160;million of principal remains outstanding on the Flexion 2024 Notes. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan provided for a single-advance term loan in the principal amount of $375.0&#160;million and is scheduled to mature on December 7, 2026. Each term loan borrowing which is an alternate base rate borrowing bears interest at a variable rate per annum equal to the Alternate Base Rate (as defined in the Credit Agreement) subject to a 1.75% floor, plus 6.00%. Each term loan borrowing which is a term benchmark borrowing bears interest at a variable rate per annum equal to (i) the Adjusted Term SOFR rate (as defined in the Credit Agreement) subject to a 0.75% floor plus (ii) 7.00%. At June&#160;30, 2022, we had $365.6 million in outstanding borrowings under the Term Loan. A hypothetical 100 basis point increase in interest rates would have increased interest expense during the three and six months ended June&#160;30, 2022 by approximately $0.9&#160;million and $1.9&#160;million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Flexion Acquisition and as discussed in more detail in Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements included herein, any future conversion rights for the Flexion 2024 Notes are subject to the occurrence of any future events giving rise to such conversion rights under the indenture governing the Flexion 2024 Notes. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreements with certain vendors and partners that operate in foreign jurisdictions. The more significant transactions are primarily denominated in the U.S. Dollar, subject to an annual adjustment based on changes in currency exchange rates.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our accounts receivable are primarily concentrated with four large wholesalers of pharmaceutical products. In the event of non-performance or non-payment, there may be a material adverse impact on our financial condition, results of operations or net cash flow.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 48</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Rule 13a-15(b) under the Exchange Act, our management, including our Chief Executive Officer and Chairman and our Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. As defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, disclosure controls and procedures are controls and other procedures which are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chairman and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we acquired Flexion (now Pacira Therapeutics, Inc., or Pacira Therapeutics). As such, the scope of our assessment of the effectiveness of our disclosure controls and procedures did not include the internal control over financial reporting of Pacira Therapeutics. These exclusions are consistent with the SEC Staff&#8217;s guidance that an assessment of a recently acquired business may be omitted from the scope of our assessment of the effectiveness of disclosure controls and procedures that are also part of internal control over financial reporting in the 12 months following the acquisition. Assets acquired in the Flexion Acquisition (excluding goodwill, intangible assets, and their related deferred taxes which are included within the scope of the assessment) accounted for a minimal fraction of our total assets and ZILRETTA represented 16% of our total revenue as of and for each of the three and six months ended June&#160;30, 2022.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on that evaluation, our Chief Executive Officer and Chairman and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June&#160;30, 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other changes in our internal control over financial reporting that occurred during the quarter ended June&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Flexion Acquisition, we have commenced an evaluation of the Pacira Therapeutics internal control processes and procedures and have begun incorporating those processes and procedures into our internal control framework.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including the Chief Executive Officer and Chairman and our Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 49</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II &#8212; OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information related to Item 1. Legal Proceedings, refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated financial statements included herein.</span></div><div><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the factors discussed in Part I, Item 1A. &#8220;Risk Factors&#8221; in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which could materially affect our business, financial condition, cash flows or future results. There have been no material changes in our risk factors included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021. The risks described in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.</span></div><div><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFAULTS UPON SENIOR SECURITIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Not applicable.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i5c712f7be21e495eb7af67327cbd7e07_145"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBITS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed below are filed or furnished as part of this report.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1396814/000139681422000038/exhibit1016-7x22.htm">10.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated 2014 Employee Stock Purchase Plan.(1)&#8224;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-6302022xex311.htm">31.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer and Chairman pursuant to Rule&#160;13a-14(a)&#160;and 15d-14(a), as amended.*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-6302022xex312.htm">31.2</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Rule&#160;13a-14(a)&#160;and 15d-14(a), as amended.*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-6302022xex321.htm">32.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer and Chairman and Chief Financial Officer pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc. for the quarter ended June&#160;30, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders&#8217; Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Condensed Notes to Consolidated Financial Statements.*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (Formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denotes management contract or compensatory plan or arrangement.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K, filed on June 10, 2022.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 51</span></div></div></div><div id="i5c712f7be21e495eb7af67327cbd7e07_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5c712f7be21e495eb7af67327cbd7e07_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACIRA BIOSCIENCES,&#160;INC.<br/>(REGISTRANT)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DAVID STACK</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHARLES A. REINHART, III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q2 2022 Form 10-Q  |  Page 52</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>pcrx-6302022xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3fc0920354814304ac9e0cc9284acf05_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David Stack, certify that&#58;</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">I have reviewed this quarterly report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. (the &#8220;Registrant&#8221;)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the Registrant and have&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">disclosed in this report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the Registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DAVID STACK</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>pcrx-6302022xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5b76827ef5bf41ba8917a686ed2236ca_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Charles A. Reinhart, III, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">I have reviewed this quarterly report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. (the &#8220;Registrant&#8221;)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the Registrant and have&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">disclosed in this report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the Registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; CHARLES A. REINHART, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>pcrx-6302022xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1db8936ebe9f4db696aa1ac7efdfd6d3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C.&#160;&#167;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned certifies that this Quarterly Report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. for the quarter ended June&#160;30, 2022, fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Pacira BioSciences,&#160;Inc. at the dates and for the periods indicated.</font></div><div style="text-indent:27pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DAVID STACK</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:4.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.827%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; CHARLES A. REINHART, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>pcrx-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1acf2e72-2487-45a7-a11c-6bf309df42b1,g:86a623c9-da96-4e80-aae2-29b4daaaad57-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pcrx="http://www.pacira.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.pacira.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.pacira.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSDetails" roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails">
        <link:definition>2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails">
        <link:definition>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails">
        <link:definition>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.pacira.com/role/REVENUE">
        <link:definition>2108103 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.pacira.com/role/REVENUETables">
        <link:definition>2309302 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENarrativeDetails" roleURI="http://www.pacira.com/role/REVENUENarrativeDetails">
        <link:definition>2410404 - Disclosure - REVENUE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEScheduleofDisaggregatedRevenueDetails" roleURI="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails">
        <link:definition>2411405 - Disclosure - REVENUE - Schedule of Disaggregated Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITION" roleURI="http://www.pacira.com/role/FLEXIONACQUISITION">
        <link:definition>2112104 - Disclosure - FLEXION ACQUISITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITIONTables" roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONTables">
        <link:definition>2313303 - Disclosure - FLEXION ACQUISITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITIONNarrativeDetails" roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails">
        <link:definition>2414406 - Disclosure - FLEXION ACQUISITION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails">
        <link:definition>2415407 - Disclosure - FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITIONScheduleofProFormaInformationDetails" roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails">
        <link:definition>2416408 - Disclosure - FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.pacira.com/role/INVENTORIES">
        <link:definition>2117105 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.pacira.com/role/INVENTORIESTables">
        <link:definition>2318304 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.pacira.com/role/INVENTORIESDetails">
        <link:definition>2419409 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETS" roleURI="http://www.pacira.com/role/FIXEDASSETS">
        <link:definition>2120106 - Disclosure - FIXED ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETSTables" roleURI="http://www.pacira.com/role/FIXEDASSETSTables">
        <link:definition>2321305 - Disclosure - FIXED ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETSSummaryofMajorCategoriesDetails" roleURI="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails">
        <link:definition>2422410 - Disclosure - FIXED ASSETS - Summary of Major Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETSNarrativeDetails" roleURI="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails">
        <link:definition>2423411 - Disclosure - FIXED ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.pacira.com/role/LEASES">
        <link:definition>2124107 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.pacira.com/role/LEASESTables">
        <link:definition>2325306 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.pacira.com/role/LEASESNarrativeDetails">
        <link:definition>2426412 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails">
        <link:definition>2427413 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails">
        <link:definition>2428414 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1">
        <link:definition>2428414 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails">
        <link:definition>2429415 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2130108 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2331307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSNarrativeDetails" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails">
        <link:definition>2432416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails">
        <link:definition>2433417 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.pacira.com/role/DEBT">
        <link:definition>2134109 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.pacira.com/role/DEBTTables">
        <link:definition>2335308 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCarryingValueofDebtDetails" roleURI="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails">
        <link:definition>2436418 - Disclosure - DEBT - Carrying Value of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://www.pacira.com/role/DEBTNarrativeDetails">
        <link:definition>2437419 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofDebtDetails" roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails">
        <link:definition>2438420 - Disclosure - DEBT - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofInterestExpenseDetails" roleURI="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails">
        <link:definition>2439421 - Disclosure - DEBT - Schedule of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2140110 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2341309 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails">
        <link:definition>2442422 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails">
        <link:definition>2443423 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>2444424 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails">
        <link:definition>2445425 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails">
        <link:definition>2446426 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails">
        <link:definition>2447427 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2148111 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2349310 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDetails" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails">
        <link:definition>2450428 - Disclosure - STOCKHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANS" roleURI="http://www.pacira.com/role/STOCKPLANS">
        <link:definition>2151112 - Disclosure - STOCK PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSTables" roleURI="http://www.pacira.com/role/STOCKPLANSTables">
        <link:definition>2352311 - Disclosure - STOCK PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails">
        <link:definition>2453429 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofStockBasedCompensationActivityDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails">
        <link:definition>2454430 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSNarrativeDetails" roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails">
        <link:definition>2455431 - Disclosure - STOCK PLANS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofValuationAssumptionsDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails">
        <link:definition>2456432 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHARE" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARE">
        <link:definition>2157113 - Disclosure - NET INCOME (LOSS) PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHARETables" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables">
        <link:definition>2358312 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails">
        <link:definition>2459433 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails">
        <link:definition>2460434 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.pacira.com/role/INCOMETAXES">
        <link:definition>2161114 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.pacira.com/role/INCOMETAXESTables">
        <link:definition>2362313 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails">
        <link:definition>2463435 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER" roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER">
        <link:definition>2164115 - Disclosure - ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables" roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables">
        <link:definition>2365314 - Disclosure - ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails" roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails">
        <link:definition>2466436 - Disclosure - ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Product Discontinuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails" roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails">
        <link:definition>2467437 - Disclosure - ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2168116 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2469438 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" abstract="false" name="DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" abstract="true" name="UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentConvertibleConversionPremiumShares" abstract="false" name="DebtInstrumentConvertibleConversionPremiumShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" abstract="false" name="ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pcrx_NuanceBiotechCo.Ltd.Member" abstract="true" name="NuanceBiotechCo.Ltd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" abstract="false" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_FlexionAcquisitionMember" abstract="true" name="FlexionAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" abstract="false" name="AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_NumberOfLeases" abstract="false" name="NumberOfLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_LargestCustomerMember" abstract="true" name="LargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_IoveraMember" abstract="true" name="IoveraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MajorCustomerTwoMember" abstract="true" name="MajorCustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" abstract="false" name="EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" abstract="false" name="AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" abstract="false" name="DebtInstrumentBasisSpreadTwoOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_SkyePharmaHoldingIncMember" abstract="true" name="SkyePharmaHoldingIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ThreeLargestCustomersMember" abstract="true" name="ThreeLargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ConvertibleNotesReceivableMember" abstract="true" name="ConvertibleNotesReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AccountsReceivablePaymentTerms" abstract="false" name="AccountsReceivablePaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" abstract="false" name="COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_MyoscienceAcquisitionMember" abstract="true" name="MyoscienceAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MeasurementInputExpectedMilestonePaymentMember" abstract="true" name="MeasurementInputExpectedMilestonePaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" abstract="false" name="DebtInstrumentPrepaymentPenaltyPercentYear1" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_ConcentrationRiskNumberOfCustomers" abstract="false" name="ConcentrationRiskNumberOfCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDueMay2024Member" abstract="true" name="ConvertibleSeniorNotesDueMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" abstract="false" name="DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pcrx_DebtInstrumentMarketPrice" abstract="false" name="DebtInstrumentMarketPrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" abstract="true" name="DebtRedemptionTermsOnOrAfterAugust12023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDue2022Member" abstract="true" name="ConvertibleSeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_SecondLargestCustomerMember" abstract="true" name="SecondLargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_Compensationexpensefromstockoptionsemployees" abstract="false" name="Compensationexpensefromstockoptionsemployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" abstract="false" name="CompensationExpenseFromEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" abstract="true" name="EXPARELbupivacaineliposomeinjectablesuspensionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtConversionAndRedemptionTermsDomain" abstract="true" name="DebtConversionAndRedemptionTermsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_FlexionTherapeuticsIncMember" abstract="true" name="FlexionTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AcquisitionRelatedFeesMember" abstract="true" name="AcquisitionRelatedFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FederalReserveBankOfNYRateMember" abstract="true" name="FederalReserveBankOfNYRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LegalFeesMember" abstract="true" name="LegalFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MajorCustomerOneMember" abstract="true" name="MajorCustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MajorCustomerThreeMember" abstract="true" name="MajorCustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentVariableRate" abstract="false" name="DebtInstrumentVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtRedemptionTermsPriorToFebruary32023Member" abstract="true" name="DebtRedemptionTermsPriorToFebruary32023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDue2025Member" abstract="true" name="ConvertibleSeniorNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ConcentrationRiskNumberOfProducts" abstract="false" name="ConcentrationRiskNumberOfProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_HongKongPharmaTainuoLtdMember" abstract="true" name="HongKongPharmaTainuoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" abstract="true" name="StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" abstract="false" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ContingentConsiderationPaymentTerm" abstract="false" name="ContingentConsiderationPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_ZILRETTAMember" abstract="true" name="ZILRETTAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" abstract="false" name="AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" abstract="false" name="AcquisitionRelatedChargesProductDiscontinuationAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentDiscountRate" abstract="false" name="DebtInstrumentDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" abstract="true" name="MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ThirdLargestCustomerMember" abstract="true" name="ThirdLargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_SettlementPeriodConvertibleDebtConversionRequest" abstract="false" name="SettlementPeriodConvertibleDebtConversionRequest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_TermLoanBFacilityDue2026Member" abstract="true" name="TermLoanBFacilityDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_FortisMember" abstract="true" name="FortisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_NumberOfMajorCustomers" abstract="false" name="NumberOfMajorCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" abstract="false" name="DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" abstract="false" name="AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BupivacaineLiposomeInjectableSuspensionMember" abstract="true" name="BupivacaineLiposomeInjectableSuspensionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" abstract="false" name="DebtInstrumentBasisSpreadOneOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_MajorCustomerFourMember" abstract="true" name="MajorCustomerFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" abstract="true" name="RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" abstract="true" name="MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" abstract="false" name="ProceedsFromDevelopmentAndCommercializationOfZILRETTA" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" abstract="false" name="BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" abstract="false" name="CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_DebtConversionAndRedemptionTermsAxis" abstract="true" name="DebtConversionAndRedemptionTermsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_FlexionAndMyoScienceAcquisitionMember" abstract="true" name="FlexionAndMyoScienceAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ScheduleOfInterestExpenseTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDue2024Member" abstract="true" name="ConvertibleSeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" abstract="false" name="BusinessCombinationAcquisitionAndIntegrationRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_CollaborativeLicensingAndMilestoneRevenueMember" abstract="true" name="CollaborativeLicensingAndMilestoneRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" abstract="false" name="DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" abstract="false" name="DebtInstrumentPrepaymentPenaltyPercentYear2" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_ContingentConsiderationNoncurrent" abstract="false" name="ContingentConsiderationNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ContingentConsiderationCurrent" abstract="false" name="ContingentConsiderationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" abstract="false" name="ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_EquityMethodInvestmentsAndOtherAssets" abstract="false" name="EquityMethodInvestmentsAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ContingentConsideration" abstract="false" name="ContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximumValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" abstract="false" name="DebtInstrumentConversionObligationPremiumOnCommonStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>pcrx-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1acf2e72-2487-45a7-a11c-6bf309df42b1,g:86a623c9-da96-4e80-aae2-29b4daaaad57-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_eeef5b1b-80fb-49b3-81d8-9dbd0bdf1597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c47d69f4-03f7-41bd-9daf-9a57a9cd324a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eeef5b1b-80fb-49b3-81d8-9dbd0bdf1597" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c47d69f4-03f7-41bd-9daf-9a57a9cd324a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3cfb7405-ea48-4bea-8ac0-d949c5b3423c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eeef5b1b-80fb-49b3-81d8-9dbd0bdf1597" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3cfb7405-ea48-4bea-8ac0-d949c5b3423c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_3ac5fc38-f665-4cb8-8aab-7c7bb7e40b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eeef5b1b-80fb-49b3-81d8-9dbd0bdf1597" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_3ac5fc38-f665-4cb8-8aab-7c7bb7e40b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8d5fc361-cd33-49e8-8c80-0e1c902934d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eeef5b1b-80fb-49b3-81d8-9dbd0bdf1597" xlink:to="loc_us-gaap_LiabilitiesCurrent_8d5fc361-cd33-49e8-8c80-0e1c902934d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent_a35ce4ab-4a82-4013-b9ec-28d693bb4295" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eeef5b1b-80fb-49b3-81d8-9dbd0bdf1597" xlink:to="loc_pcrx_ContingentConsiderationNoncurrent_a35ce4ab-4a82-4013-b9ec-28d693bb4295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_edc45ef4-9a93-4fb6-9433-bdb0cea5eba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eeef5b1b-80fb-49b3-81d8-9dbd0bdf1597" xlink:to="loc_us-gaap_SecuredLongTermDebt_edc45ef4-9a93-4fb6-9433-bdb0cea5eba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_aafd125d-56c0-4974-a2cb-67713691c496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ba958c9f-f5c8-4abc-a118-c44927e9406c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aafd125d-56c0-4974-a2cb-67713691c496" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ba958c9f-f5c8-4abc-a118-c44927e9406c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_56184300-6bf4-45a3-8ade-6743c1bacb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aafd125d-56c0-4974-a2cb-67713691c496" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_56184300-6bf4-45a3-8ade-6743c1bacb11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c0bf013c-46f7-4590-8cdd-deec6be5dfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aafd125d-56c0-4974-a2cb-67713691c496" xlink:to="loc_us-gaap_Goodwill_c0bf013c-46f7-4590-8cdd-deec6be5dfb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_c70b0322-b4e6-4bd7-a1d6-510e9b1b592a" xlink:href="pcrx-20220630.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aafd125d-56c0-4974-a2cb-67713691c496" xlink:to="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_c70b0322-b4e6-4bd7-a1d6-510e9b1b592a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_33394603-74b1-4cdf-b204-b0e0db855800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aafd125d-56c0-4974-a2cb-67713691c496" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_33394603-74b1-4cdf-b204-b0e0db855800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a97d237d-e66b-4536-be4d-b0c7f06f3ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aafd125d-56c0-4974-a2cb-67713691c496" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a97d237d-e66b-4536-be4d-b0c7f06f3ad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b90adc0b-1d24-4cac-9b9f-577bf46806fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aafd125d-56c0-4974-a2cb-67713691c496" xlink:to="loc_us-gaap_AssetsCurrent_b90adc0b-1d24-4cac-9b9f-577bf46806fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8ffae41b-6102-4c08-aa26-6ed0015525f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_b1908087-3286-470e-8a2c-f6cd10474454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ffae41b-6102-4c08-aa26-6ed0015525f7" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_b1908087-3286-470e-8a2c-f6cd10474454" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_d1b9ec68-1e44-4d91-ae74-3c0a35481288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ffae41b-6102-4c08-aa26-6ed0015525f7" xlink:to="loc_us-gaap_TaxesPayableCurrent_d1b9ec68-1e44-4d91-ae74-3c0a35481288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c6a162c7-0ba2-4749-94e7-923dcbca84eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ffae41b-6102-4c08-aa26-6ed0015525f7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c6a162c7-0ba2-4749-94e7-923dcbca84eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_91127f2d-af65-44fa-8ac1-6857b65866b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ffae41b-6102-4c08-aa26-6ed0015525f7" xlink:to="loc_us-gaap_AccountsPayableCurrent_91127f2d-af65-44fa-8ac1-6857b65866b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_40401297-3a1b-46c0-acf2-9c94956f6ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ffae41b-6102-4c08-aa26-6ed0015525f7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_40401297-3a1b-46c0-acf2-9c94956f6ec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_ddfd5238-4fbd-4a48-959d-03c8431c2446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ffae41b-6102-4c08-aa26-6ed0015525f7" xlink:to="loc_us-gaap_SecuredDebtCurrent_ddfd5238-4fbd-4a48-959d-03c8431c2446" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b448d927-6aa7-408f-88e3-c2b8c49f88ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_920173ab-8a10-4131-9fae-a953e1a47867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b448d927-6aa7-408f-88e3-c2b8c49f88ee" xlink:to="loc_us-gaap_Liabilities_920173ab-8a10-4131-9fae-a953e1a47867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e05759b7-7c15-4205-a156-4936b6ebe562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b448d927-6aa7-408f-88e3-c2b8c49f88ee" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e05759b7-7c15-4205-a156-4936b6ebe562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_480f9613-2e27-4fe2-9237-e0f3965b73b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b448d927-6aa7-408f-88e3-c2b8c49f88ee" xlink:to="loc_us-gaap_StockholdersEquity_480f9613-2e27-4fe2-9237-e0f3965b73b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a2a6177c-e782-4c2b-bc9e-45fb04245e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_cb81a6f3-f5b9-4e18-9c96-5372b409f5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a2a6177c-e782-4c2b-bc9e-45fb04245e31" xlink:to="loc_us-gaap_PreferredStockValue_cb81a6f3-f5b9-4e18-9c96-5372b409f5bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8d3d03c0-acf2-4ec7-8ce8-765b8aafdb16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a2a6177c-e782-4c2b-bc9e-45fb04245e31" xlink:to="loc_us-gaap_CommonStockValue_8d3d03c0-acf2-4ec7-8ce8-765b8aafdb16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4dee6b89-3a63-4da4-b670-8f84983d0a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a2a6177c-e782-4c2b-bc9e-45fb04245e31" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4dee6b89-3a63-4da4-b670-8f84983d0a0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_92829f30-33bc-4bd8-b540-0127a91515ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a2a6177c-e782-4c2b-bc9e-45fb04245e31" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_92829f30-33bc-4bd8-b540-0127a91515ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fd1dd536-2904-4001-99cc-ea8029386c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a2a6177c-e782-4c2b-bc9e-45fb04245e31" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fd1dd536-2904-4001-99cc-ea8029386c8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_be9707bb-6cca-4c75-8bd6-d5159afe0faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b5ef22c8-fd14-4552-9353-a40ab34b5965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_be9707bb-6cca-4c75-8bd6-d5159afe0faa" xlink:to="loc_us-gaap_InventoryNet_b5ef22c8-fd14-4552-9353-a40ab34b5965" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_55897b3c-be30-4f44-9dce-a4e6f5f7cd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_be9707bb-6cca-4c75-8bd6-d5159afe0faa" xlink:to="loc_us-gaap_ShortTermInvestments_55897b3c-be30-4f44-9dce-a4e6f5f7cd69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_498a04c8-ea15-4de4-801c-f9a02206dda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_be9707bb-6cca-4c75-8bd6-d5159afe0faa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_498a04c8-ea15-4de4-801c-f9a02206dda8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9510ce50-b95b-4f68-a30c-d369a0afc213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_be9707bb-6cca-4c75-8bd6-d5159afe0faa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9510ce50-b95b-4f68-a30c-d369a0afc213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_160a3d09-1525-4568-aa51-9464189460b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_be9707bb-6cca-4c75-8bd6-d5159afe0faa" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_160a3d09-1525-4568-aa51-9464189460b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4765c90-ca56-4e9d-93ab-087486b012c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aa591383-7e4c-4528-8d00-33a746a9c678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e4765c90-ca56-4e9d-93ab-087486b012c8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aa591383-7e4c-4528-8d00-33a746a9c678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a3298250-a0dc-4f6f-a8bc-c9dd00f9809b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e4765c90-ca56-4e9d-93ab-087486b012c8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a3298250-a0dc-4f6f-a8bc-c9dd00f9809b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_98fa98c3-5a1a-4129-8b14-3f743dcf9a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1a1644e5-5c3f-458c-81b4-6618846b7cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_98fa98c3-5a1a-4129-8b14-3f743dcf9a45" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1a1644e5-5c3f-458c-81b4-6618846b7cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_a8b347de-1fa8-4ba3-9474-8756f67d95f3" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_98fa98c3-5a1a-4129-8b14-3f743dcf9a45" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_a8b347de-1fa8-4ba3-9474-8756f67d95f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e77549cd-c097-4f6a-8a13-d32eb5616d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_98fa98c3-5a1a-4129-8b14-3f743dcf9a45" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e77549cd-c097-4f6a-8a13-d32eb5616d05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_52cfddcf-99c9-4381-9d87-53aef8af5e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_98fa98c3-5a1a-4129-8b14-3f743dcf9a45" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_52cfddcf-99c9-4381-9d87-53aef8af5e66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_e5b708d4-70db-4eec-a33e-d833b6b9b2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_98fa98c3-5a1a-4129-8b14-3f743dcf9a45" xlink:to="loc_us-gaap_CostOfRevenue_e5b708d4-70db-4eec-a33e-d833b6b9b2c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dac44c72-a1bd-4629-b9c1-4c2fca1f813d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0e074a27-0716-4e56-ac2a-102e7c70ad7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dac44c72-a1bd-4629-b9c1-4c2fca1f813d" xlink:to="loc_us-gaap_OperatingIncomeLoss_0e074a27-0716-4e56-ac2a-102e7c70ad7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7b6316da-052a-4795-b1e8-b787e94ef422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dac44c72-a1bd-4629-b9c1-4c2fca1f813d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7b6316da-052a-4795-b1e8-b787e94ef422" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_104536bf-2800-463a-97f1-8596f34c13ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_be364f7b-f474-4e56-9d02-d2057a3a30c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_104536bf-2800-463a-97f1-8596f34c13ed" xlink:to="loc_us-gaap_CostsAndExpenses_be364f7b-f474-4e56-9d02-d2057a3a30c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ef0ff138-2f16-4ce4-8f3a-bb08e29a6ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_104536bf-2800-463a-97f1-8596f34c13ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ef0ff138-2f16-4ce4-8f3a-bb08e29a6ff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c4a4be65-f17c-4f7d-bcd4-47ae95493cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8bd17625-b069-45e9-9d61-992061522186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4a4be65-f17c-4f7d-bcd4-47ae95493cdc" xlink:to="loc_us-gaap_InterestExpense_8bd17625-b069-45e9-9d61-992061522186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6ebb36ce-5334-4131-acc3-65672d5b5005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4a4be65-f17c-4f7d-bcd4-47ae95493cdc" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6ebb36ce-5334-4131-acc3-65672d5b5005" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d6162a78-1ae4-4d1f-9e48-9cbcdbdc6860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4a4be65-f17c-4f7d-bcd4-47ae95493cdc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d6162a78-1ae4-4d1f-9e48-9cbcdbdc6860" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_544f8912-dc3c-43e4-9f4e-e356fc84429f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_61fd836d-a9e9-40b8-8928-da1d9ee03ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_544f8912-dc3c-43e4-9f4e-e356fc84429f" xlink:to="loc_us-gaap_NetIncomeLoss_61fd836d-a9e9-40b8-8928-da1d9ee03ce7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8cbfd4b1-0ae1-4c9c-a510-499287b5bc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_544f8912-dc3c-43e4-9f4e-e356fc84429f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8cbfd4b1-0ae1-4c9c-a510-499287b5bc6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_da45cd0c-7655-4072-818c-04e3063d020c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3c6a3bd4-a156-4059-8afc-baaa2ce76c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_da45cd0c-7655-4072-818c-04e3063d020c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3c6a3bd4-a156-4059-8afc-baaa2ce76c52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9e4bd895-4c71-47f3-b084-3db58c56fa27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_da45cd0c-7655-4072-818c-04e3063d020c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9e4bd895-4c71-47f3-b084-3db58c56fa27" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c0a5186e-d549-4f78-a9bf-9edc0a1aa2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c0a5186e-d549-4f78-a9bf-9edc0a1aa2c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_08f2a0bd-e070-4254-bffc-66e94d04d608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_NetIncomeLoss_08f2a0bd-e070-4254-bffc-66e94d04d608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d4614391-0d5f-4331-89e9-a361a7b48391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d4614391-0d5f-4331-89e9-a361a7b48391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d8af4235-eae6-424a-9a14-f6ce990478f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d8af4235-eae6-424a-9a14-f6ce990478f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6ed57ec0-666f-4274-b2f5-62d102d2088c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6ed57ec0-666f-4274-b2f5-62d102d2088c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_472b1dc3-7174-444a-a8a3-babb31db91b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_472b1dc3-7174-444a-a8a3-babb31db91b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_2505c404-4aed-4672-8c3c-3c9ebd9f2fa7" xlink:href="pcrx-20220630.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_2505c404-4aed-4672-8c3c-3c9ebd9f2fa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_d16764d4-79c0-481c-9bd9-0678339e23a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_d16764d4-79c0-481c-9bd9-0678339e23a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_fb13b696-761c-49d8-a549-9ae091fdff54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_GainLossOnInvestments_fb13b696-761c-49d8-a549-9ae091fdff54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_d684b91c-af25-429a-8918-8f294a874416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_d684b91c-af25-429a-8918-8f294a874416" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_2653a418-ab17-426a-8c82-00fb50d5224c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_2653a418-ab17-426a-8c82-00fb50d5224c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5418e2d7-e0d9-4c3f-b282-4b38499182c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5418e2d7-e0d9-4c3f-b282-4b38499182c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_32a61c89-a3f0-4a5f-b342-bb80bcfd23f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_32a61c89-a3f0-4a5f-b342-bb80bcfd23f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a49b9221-3951-465f-beb8-9966c475325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_ShareBasedCompensation_a49b9221-3951-465f-beb8-9966c475325e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a8a085a5-4eb7-4eb2-ab54-0dc8651db24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a8a085a5-4eb7-4eb2-ab54-0dc8651db24b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_90b0d88a-bc0a-450c-a210-3294945309c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dec00035-2482-4947-8ad4-107e68d645cc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_90b0d88a-bc0a-450c-a210-3294945309c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_78e23185-e7a8-44da-8255-69cc5dbc6976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13f452b8-d1c4-4cbf-8489-a31e8e7ce328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_78e23185-e7a8-44da-8255-69cc5dbc6976" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13f452b8-d1c4-4cbf-8489-a31e8e7ce328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75eddc41-7dbc-46b3-a36d-55909a93827c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_78e23185-e7a8-44da-8255-69cc5dbc6976" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75eddc41-7dbc-46b3-a36d-55909a93827c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_77522583-23b0-42b5-937d-c1d20fb2cdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_78e23185-e7a8-44da-8255-69cc5dbc6976" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_77522583-23b0-42b5-937d-c1d20fb2cdf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce21fc8b-e835-4b20-9fc4-ac0f7ce3a730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_4795401d-4821-4012-ae99-f13a0109c14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce21fc8b-e835-4b20-9fc4-ac0f7ce3a730" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_4795401d-4821-4012-ae99-f13a0109c14f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_f0408588-396f-4a52-9348-136eb5b24312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce21fc8b-e835-4b20-9fc4-ac0f7ce3a730" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_f0408588-396f-4a52-9348-136eb5b24312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_a0c5040c-13b7-46de-b35f-68bf99f39295" xlink:href="pcrx-20220630.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce21fc8b-e835-4b20-9fc4-ac0f7ce3a730" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_a0c5040c-13b7-46de-b35f-68bf99f39295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_80851b8e-aace-4bbe-93b0-8d927898802e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce21fc8b-e835-4b20-9fc4-ac0f7ce3a730" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_80851b8e-aace-4bbe-93b0-8d927898802e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_d3607f53-a60c-4668-bf31-3a34aa36b7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce21fc8b-e835-4b20-9fc4-ac0f7ce3a730" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_d3607f53-a60c-4668-bf31-3a34aa36b7f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d4ae6292-ca7c-4a1d-ae52-7eda3f04b782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_19bbbef1-7bba-4c0c-8232-663fa3e064a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d4ae6292-ca7c-4a1d-ae52-7eda3f04b782" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_19bbbef1-7bba-4c0c-8232-663fa3e064a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_c0d009fe-8b66-44d9-b925-b4292e77d82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d4ae6292-ca7c-4a1d-ae52-7eda3f04b782" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_c0d009fe-8b66-44d9-b925-b4292e77d82f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1f48056d-c6e1-4333-bace-17396582b244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d4ae6292-ca7c-4a1d-ae52-7eda3f04b782" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1f48056d-c6e1-4333-bace-17396582b244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_3cab35fd-d003-4d53-9aab-39403f703a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d4ae6292-ca7c-4a1d-ae52-7eda3f04b782" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_3cab35fd-d003-4d53-9aab-39403f703a33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_716f0031-275a-4531-ab38-48618ab1c962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d4ae6292-ca7c-4a1d-ae52-7eda3f04b782" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_716f0031-275a-4531-ab38-48618ab1c962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PaymentOfContingentConsideration_e33a3fe4-c9fe-408a-a910-7651ab64aca7" xlink:href="pcrx-20220630.xsd#pcrx_PaymentOfContingentConsideration"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d4ae6292-ca7c-4a1d-ae52-7eda3f04b782" xlink:to="loc_pcrx_PaymentOfContingentConsideration_e33a3fe4-c9fe-408a-a910-7651ab64aca7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_e6d61aeb-f3eb-4790-a9b5-813e7a05c803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_0d2fae03-d2b3-454b-9731-74920e790772" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_e6d61aeb-f3eb-4790-a9b5-813e7a05c803" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_0d2fae03-d2b3-454b-9731-74920e790772" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_2b120be4-8f9b-4736-ac1a-21d00b189ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_e6d61aeb-f3eb-4790-a9b5-813e7a05c803" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_2b120be4-8f9b-4736-ac1a-21d00b189ea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_06577e99-82fe-48bb-9f93-bf8cce2f4eae" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_3f1a792b-06b9-4d7e-af33-49108a7cae65" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_06577e99-82fe-48bb-9f93-bf8cce2f4eae" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_3f1a792b-06b9-4d7e-af33-49108a7cae65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_26ad8ee6-6f43-4e29-b70d-2ff1e44c3bd7" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_06577e99-82fe-48bb-9f93-bf8cce2f4eae" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_26ad8ee6-6f43-4e29-b70d-2ff1e44c3bd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4137cc36-3840-46ed-a757-ed336e66890c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_71cc0ea4-7127-41c9-837e-6d98c2169a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4137cc36-3840-46ed-a757-ed336e66890c" xlink:to="loc_us-gaap_Goodwill_71cc0ea4-7127-41c9-837e-6d98c2169a55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_367169e1-b6a3-4f2e-b987-fd86371ed0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4137cc36-3840-46ed-a757-ed336e66890c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_367169e1-b6a3-4f2e-b987-fd86371ed0d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_1937f930-0ff9-4ae0-a421-bd85c00c0721" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_080477ec-0644-4e2c-8b3e-c8c3d89894bc" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_1937f930-0ff9-4ae0-a421-bd85c00c0721" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_080477ec-0644-4e2c-8b3e-c8c3d89894bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_19356f91-1f0d-4e59-b83b-8dede4740d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_19356f91-1f0d-4e59-b83b-8dede4740d59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_9b9ab2e1-067b-43f3-857e-e1bf245631fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_9b9ab2e1-067b-43f3-857e-e1bf245631fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f3b9472e-7abe-43c3-8856-a3cad54decc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f3b9472e-7abe-43c3-8856-a3cad54decc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_794f18a7-8c8a-4063-8e94-ee4d8f4fcc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_794f18a7-8c8a-4063-8e94-ee4d8f4fcc60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_61850c43-9b53-4687-9a44-baabaaf61fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_61850c43-9b53-4687-9a44-baabaaf61fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_45be3d32-c699-4bcd-aac7-1f18d679775d" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_45be3d32-c699-4bcd-aac7-1f18d679775d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_f757191b-8fb0-4fd2-a8a8-84b4ee60b54c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_f757191b-8fb0-4fd2-a8a8-84b4ee60b54c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4db8bc12-212f-4fef-a356-a5bc6e472d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4db8bc12-212f-4fef-a356-a5bc6e472d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_cb347e99-c2ca-4e08-8499-abe090c7d5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_cb347e99-c2ca-4e08-8499-abe090c7d5fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d6e2207f-92d0-4aa6-a2e5-78a1f2904d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7d4c64f1-6520-4fbf-81f1-0d6457912f50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d6e2207f-92d0-4aa6-a2e5-78a1f2904d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2f8c64e9-a75c-4d73-910d-ad0a015f3c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_fae216be-bc60-4a36-b3a5-0703aba15466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2f8c64e9-a75c-4d73-910d-ad0a015f3c3d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_fae216be-bc60-4a36-b3a5-0703aba15466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7b04f329-25ab-4dfd-929d-4d391c5f0570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2f8c64e9-a75c-4d73-910d-ad0a015f3c3d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7b04f329-25ab-4dfd-929d-4d391c5f0570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3e1d889-78aa-4054-a791-5c08235c92ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0c43432b-de0c-4e83-a10b-aed6b137f009" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3e1d889-78aa-4054-a791-5c08235c92ce" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0c43432b-de0c-4e83-a10b-aed6b137f009" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3a19add0-32f4-420c-a8d3-c381a9a451c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3e1d889-78aa-4054-a791-5c08235c92ce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3a19add0-32f4-420c-a8d3-c381a9a451c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_54eb7873-2de2-48af-b0aa-ab21601764d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3e1d889-78aa-4054-a791-5c08235c92ce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_54eb7873-2de2-48af-b0aa-ab21601764d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_cad85e68-f2f7-4243-939b-d570e9ddd40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3e1d889-78aa-4054-a791-5c08235c92ce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_cad85e68-f2f7-4243-939b-d570e9ddd40b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2c87ec6b-7641-4d23-a498-3ece2152cd43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3e1d889-78aa-4054-a791-5c08235c92ce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2c87ec6b-7641-4d23-a498-3ece2152cd43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_9ba76142-1957-4866-806d-ba16adb43c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3e1d889-78aa-4054-a791-5c08235c92ce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_9ba76142-1957-4866-806d-ba16adb43c79" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bd982478-b341-42ea-84c3-8f839ef96a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1c3b0a42-8167-40c1-9baf-29506cc83137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bd982478-b341-42ea-84c3-8f839ef96a0d" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1c3b0a42-8167-40c1-9baf-29506cc83137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_47d73d60-7eda-413e-a518-1e66f7511b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bd982478-b341-42ea-84c3-8f839ef96a0d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_47d73d60-7eda-413e-a518-1e66f7511b75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_7ba8c3e2-dd53-4738-ace7-9c15a39eaf79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bd982478-b341-42ea-84c3-8f839ef96a0d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_7ba8c3e2-dd53-4738-ace7-9c15a39eaf79" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FIXEDASSETSSummaryofMajorCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_04ecdeae-f3ea-4c28-ad37-9addb38a27b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9e53bf7d-6998-45c6-85b4-6f85ebdaa9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_04ecdeae-f3ea-4c28-ad37-9addb38a27b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9e53bf7d-6998-45c6-85b4-6f85ebdaa9db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d3cbad42-5b28-4340-9381-039b57324045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_04ecdeae-f3ea-4c28-ad37-9addb38a27b4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d3cbad42-5b28-4340-9381-039b57324045" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_431ddcb9-2535-4536-91d4-b56ecde3380e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_119c9a3e-f639-4908-a31b-cb53deed2549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_431ddcb9-2535-4536-91d4-b56ecde3380e" xlink:to="loc_us-gaap_OperatingLeaseCost_119c9a3e-f639-4908-a31b-cb53deed2549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_7d7ab1e7-02b7-4614-a9b4-be2ad1d2e05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_431ddcb9-2535-4536-91d4-b56ecde3380e" xlink:to="loc_us-gaap_VariableLeaseCost_7d7ab1e7-02b7-4614-a9b4-be2ad1d2e05b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_116a3f38-e4e6-49c4-9169-49e3aaf8850b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1f0d622c-a7a6-4f7c-b55d-4f212c46750c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_116a3f38-e4e6-49c4-9169-49e3aaf8850b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1f0d622c-a7a6-4f7c-b55d-4f212c46750c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_98e6804a-0346-4659-ae8e-fd2192a0b39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_116a3f38-e4e6-49c4-9169-49e3aaf8850b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_98e6804a-0346-4659-ae8e-fd2192a0b39d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_24074e61-cfd1-44e1-a1f4-25e887c2718f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_116a3f38-e4e6-49c4-9169-49e3aaf8850b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_24074e61-cfd1-44e1-a1f4-25e887c2718f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_dcc94a2a-60b6-4e79-bc96-e73ebf02cd06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_116a3f38-e4e6-49c4-9169-49e3aaf8850b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_dcc94a2a-60b6-4e79-bc96-e73ebf02cd06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_702b3c8d-953c-4b39-88ad-ad8d895f2eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_116a3f38-e4e6-49c4-9169-49e3aaf8850b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_702b3c8d-953c-4b39-88ad-ad8d895f2eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_0a01bd0d-9409-44ca-bf9a-2dc394f17661" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_116a3f38-e4e6-49c4-9169-49e3aaf8850b" xlink:to="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_0a01bd0d-9409-44ca-bf9a-2dc394f17661" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c5b4004-07bc-4d94-b194-f3e8e52268a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9b4ae13a-835a-4b21-8451-328a12bc57d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c5b4004-07bc-4d94-b194-f3e8e52268a4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9b4ae13a-835a-4b21-8451-328a12bc57d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4b10bede-af9d-4a93-a167-66c34743d9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c5b4004-07bc-4d94-b194-f3e8e52268a4" xlink:to="loc_us-gaap_OperatingLeaseLiability_4b10bede-af9d-4a93-a167-66c34743d9a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_52e55954-898b-4168-95c9-b8cd703aa674" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_7a73a0ac-a045-444e-a1cb-4048f5ae9684" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_52e55954-898b-4168-95c9-b8cd703aa674" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_7a73a0ac-a045-444e-a1cb-4048f5ae9684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_57046f5a-d899-44ae-a44f-b0e2eaa6b87e" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_52e55954-898b-4168-95c9-b8cd703aa674" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_57046f5a-d899-44ae-a44f-b0e2eaa6b87e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_97f99480-a846-4b53-8baf-0ffcbc3f47e0" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_52e55954-898b-4168-95c9-b8cd703aa674" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_97f99480-a846-4b53-8baf-0ffcbc3f47e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_d51079d5-c388-4c83-ae0d-14aa124058ed" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_52e55954-898b-4168-95c9-b8cd703aa674" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_d51079d5-c388-4c83-ae0d-14aa124058ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_fb649073-6f0e-44a7-90c8-2a4af34150ed" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_52e55954-898b-4168-95c9-b8cd703aa674" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_fb649073-6f0e-44a7-90c8-2a4af34150ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_3c342123-e3ba-4025-b246-e21bac343b44" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_52e55954-898b-4168-95c9-b8cd703aa674" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_3c342123-e3ba-4025-b246-e21bac343b44" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1edcef6b-e7ea-49f8-add1-637f7f23ac0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_894c5075-57f4-43d4-a4d5-aa5b0fc18166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1edcef6b-e7ea-49f8-add1-637f7f23ac0c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_894c5075-57f4-43d4-a4d5-aa5b0fc18166" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_5304c43d-b0b1-4ffb-ae06-8d3c2af23bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1edcef6b-e7ea-49f8-add1-637f7f23ac0c" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_5304c43d-b0b1-4ffb-ae06-8d3c2af23bcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e01b9dd2-d8b3-41db-b516-fa3ff4de0027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1edcef6b-e7ea-49f8-add1-637f7f23ac0c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e01b9dd2-d8b3-41db-b516-fa3ff4de0027" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_65c2f073-7674-49c7-b84f-a897d5bd73f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ebb778c8-89b9-4c09-8f9d-bea0dfdbce11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_65c2f073-7674-49c7-b84f-a897d5bd73f1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ebb778c8-89b9-4c09-8f9d-bea0dfdbce11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ea56aad7-33de-494f-9e78-e9041be6492e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_65c2f073-7674-49c7-b84f-a897d5bd73f1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ea56aad7-33de-494f-9e78-e9041be6492e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8baea103-ba3a-4c1f-9078-8f4c99c6547d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_65c2f073-7674-49c7-b84f-a897d5bd73f1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8baea103-ba3a-4c1f-9078-8f4c99c6547d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_82437e81-e419-492f-865a-19fa99984c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_87513898-fd1b-426f-a2bf-bfe2c3c143da" xlink:href="pcrx-20220630.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_82437e81-e419-492f-865a-19fa99984c99" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_87513898-fd1b-426f-a2bf-bfe2c3c143da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_f2cfc2e9-311f-4e9f-a32a-8f905fa226a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_82437e81-e419-492f-865a-19fa99984c99" xlink:to="loc_us-gaap_RestrictedStockExpense_f2cfc2e9-311f-4e9f-a32a-8f905fa226a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_672a32ad-a5e0-45cb-849a-6a9b54554a9b" xlink:href="pcrx-20220630.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_82437e81-e419-492f-865a-19fa99984c99" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_672a32ad-a5e0-45cb-849a-6a9b54554a9b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b0b34979-97b5-4aa8-b0b4-0fc8550a8d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9799c8a6-dffc-45d3-a436-743a2eb5cffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b0b34979-97b5-4aa8-b0b4-0fc8550a8d1b" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9799c8a6-dffc-45d3-a436-743a2eb5cffa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_3f204226-e1c8-4a44-89d8-c609cadc1673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b0b34979-97b5-4aa8-b0b4-0fc8550a8d1b" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_3f204226-e1c8-4a44-89d8-c609cadc1673" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9da2a0f5-4bf9-4de5-aabd-cbd6f9267607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b0b34979-97b5-4aa8-b0b4-0fc8550a8d1b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9da2a0f5-4bf9-4de5-aabd-cbd6f9267607" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_838a5b96-49b3-4ec2-a797-375ceaf2e565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_7293d98c-fddd-4d64-be25-3c6795db4bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_838a5b96-49b3-4ec2-a797-375ceaf2e565" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_7293d98c-fddd-4d64-be25-3c6795db4bb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a79ccd5b-a796-4ce3-a6fd-786bc9fcfc88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_838a5b96-49b3-4ec2-a797-375ceaf2e565" xlink:to="loc_us-gaap_NetIncomeLoss_a79ccd5b-a796-4ce3-a6fd-786bc9fcfc88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f776ab8-189f-4b1e-9e1f-60735f4fc4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_46defcd9-3064-4892-b4c8-179c002dd611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f776ab8-189f-4b1e-9e1f-60735f4fc4bb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_46defcd9-3064-4892-b4c8-179c002dd611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_825657a6-7916-4e7e-a21b-1767e16094ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f776ab8-189f-4b1e-9e1f-60735f4fc4bb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_825657a6-7916-4e7e-a21b-1767e16094ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_8564f386-f2d1-4ce7-94ee-0244bb62d2e6" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c119d8d9-a97f-4da7-88b3-496f97a62782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_8564f386-f2d1-4ce7-94ee-0244bb62d2e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c119d8d9-a97f-4da7-88b3-496f97a62782" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_bdd13d5b-3ff4-4679-a9ce-9184ce578690" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_8564f386-f2d1-4ce7-94ee-0244bb62d2e6" xlink:to="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_bdd13d5b-3ff4-4679-a9ce-9184ce578690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_388bf296-0682-4972-9bc4-7e1debd98818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_8564f386-f2d1-4ce7-94ee-0244bb62d2e6" xlink:to="loc_us-gaap_GainLossOnContractTermination_388bf296-0682-4972-9bc4-7e1debd98818" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>pcrx-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1acf2e72-2487-45a7-a11c-6bf309df42b1,g:86a623c9-da96-4e80-aae2-29b4daaaad57-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i4c1aea5e3fc347779c1bd683aef0256e_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_e2bfd1eb-c591-407a-81de-70e9e84a0d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_RevenuesAbstract_e2bfd1eb-c591-407a-81de-70e9e84a0d5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b00efd33-a42b-4a5c-a14a-20014cd19472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_e2bfd1eb-c591-407a-81de-70e9e84a0d5d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b00efd33-a42b-4a5c-a14a-20014cd19472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_88f39f13-0069-45cc-9a86-0f7d89a15d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_CostOfRevenue_88f39f13-0069-45cc-9a86-0f7d89a15d21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e794603e-e67f-4f8e-ab46-0de72c8e199b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e794603e-e67f-4f8e-ab46-0de72c8e199b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05c254ba-b42f-4c23-b672-9defec080d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05c254ba-b42f-4c23-b672-9defec080d32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_01a979c5-888f-45a2-aaae-484fa01232a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_01a979c5-888f-45a2-aaae-484fa01232a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_49c668eb-4a10-4556-a9a9-8c46dbdc7ae0" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_49c668eb-4a10-4556-a9a9-8c46dbdc7ae0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_07f503ee-d2d3-49a9-bab9-ed5a42e03b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_CostsAndExpenses_07f503ee-d2d3-49a9-bab9-ed5a42e03b35" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fcc4780b-8995-49fd-9497-860c0f36ea67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_OperatingIncomeLoss_fcc4780b-8995-49fd-9497-860c0f36ea67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c1cb5394-851c-451e-822f-be1a03d80f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c1cb5394-851c-451e-822f-be1a03d80f78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_eca9a000-e2b3-48ff-b270-014708cc2e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:to="loc_us-gaap_InterestExpense_eca9a000-e2b3-48ff-b270-014708cc2e22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5df20a40-3237-4d08-827b-606be7de3a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5df20a40-3237-4d08-827b-606be7de3a13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6ba7dc63-1daa-403a-b4e0-08ad93ac8767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_6ba7dc63-1daa-403a-b4e0-08ad93ac8767" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c4ace8a1-5842-4ef5-86ab-8d903127078c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c4ace8a1-5842-4ef5-86ab-8d903127078c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7c82dc2f-7ba5-4fe0-a18c-998c7a6b5d58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7c82dc2f-7ba5-4fe0-a18c-998c7a6b5d58" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d9ea350a-dfb1-44bd-b346-781e12b115b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_NetIncomeLoss_d9ea350a-dfb1-44bd-b346-781e12b115b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_89feec1e-819c-4468-ac0e-3a93fd14106d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_89feec1e-819c-4468-ac0e-3a93fd14106d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_698c411c-a895-40f1-889f-0d70849d6e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89feec1e-819c-4468-ac0e-3a93fd14106d" xlink:to="loc_us-gaap_EarningsPerShareBasic_698c411c-a895-40f1-889f-0d70849d6e73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a512bffc-3a11-4a31-8f3f-2e4509a88ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89feec1e-819c-4468-ac0e-3a93fd14106d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a512bffc-3a11-4a31-8f3f-2e4509a88ea4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0fdb2182-12a6-4649-859b-911cb0521677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0fdb2182-12a6-4649-859b-911cb0521677" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88eea4bc-062e-4523-b79a-7ee63adaa07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0fdb2182-12a6-4649-859b-911cb0521677" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88eea4bc-062e-4523-b79a-7ee63adaa07a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba8edfae-0513-47c6-9929-383244a06163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0fdb2182-12a6-4649-859b-911cb0521677" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba8edfae-0513-47c6-9929-383244a06163" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c0f98c67-b2cf-47a7-8942-a12e07f5191f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_StatementTable_c0f98c67-b2cf-47a7-8942-a12e07f5191f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_89679b26-9e11-4540-a367-0386ef1c1c6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c0f98c67-b2cf-47a7-8942-a12e07f5191f" xlink:to="loc_srt_ProductOrServiceAxis_89679b26-9e11-4540-a367-0386ef1c1c6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_89679b26-9e11-4540-a367-0386ef1c1c6f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_89679b26-9e11-4540-a367-0386ef1c1c6f" xlink:to="loc_srt_ProductsAndServicesDomain_89679b26-9e11-4540-a367-0386ef1c1c6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_89679b26-9e11-4540-a367-0386ef1c1c6f" xlink:to="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_55ee828c-57e3-4e8f-aab5-a0f5851497ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:to="loc_us-gaap_ProductMember_55ee828c-57e3-4e8f-aab5-a0f5851497ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_913c422f-3433-44be-831d-9e405d451a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:to="loc_us-gaap_RoyaltyMember_913c422f-3433-44be-831d-9e405d451a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_b602e4f9-12b6-4383-9c4c-721c7ebcca24" xlink:href="pcrx-20220630.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:to="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_b602e4f9-12b6-4383-9c4c-721c7ebcca24" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="ie49ebd0356f1434186bee52906d3a91f_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e7ca383d-bef2-4189-b81d-8ca0fd0098f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e7ca383d-bef2-4189-b81d-8ca0fd0098f2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_20d37e06-650e-4d29-8f9f-68367b3cb4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_SharesOutstanding_20d37e06-650e-4d29-8f9f-68367b3cb4f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6fa6670-e1bd-48f5-879b-f427eaf9dd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockholdersEquity_e6fa6670-e1bd-48f5-879b-f427eaf9dd2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1d21f327-f103-4fa6-a62a-1c6994e62ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1d21f327-f103-4fa6-a62a-1c6994e62ee3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_094a17a8-dc5f-43a1-8d07-fe42cef413df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_094a17a8-dc5f-43a1-8d07-fe42cef413df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_91414fd3-3d59-4565-921f-1b303152678e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_91414fd3-3d59-4565-921f-1b303152678e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6c4d828d-187c-44d0-8424-757466a2cca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6c4d828d-187c-44d0-8424-757466a2cca5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_93f383aa-1bf3-4305-88c6-3011c9d6087f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_93f383aa-1bf3-4305-88c6-3011c9d6087f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_55ce7389-0dd9-4997-a471-91481f0ffc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_55ce7389-0dd9-4997-a471-91481f0ffc9b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fe5e3221-f5f3-4e3a-82b9-399342878b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fe5e3221-f5f3-4e3a-82b9-399342878b0e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c53c51f5-8127-4363-b8d7-a33bcddd6071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c53c51f5-8127-4363-b8d7-a33bcddd6071" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_512db1e7-1745-4a17-9cd1-0f66af4e6e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_512db1e7-1745-4a17-9cd1-0f66af4e6e88" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60d8eb1a-49ac-4501-bf4c-8c5bfecd672a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60d8eb1a-49ac-4501-bf4c-8c5bfecd672a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d2d4ece0-86f4-4217-81ef-28fbd9b17b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_NetIncomeLoss_d2d4ece0-86f4-4217-81ef-28fbd9b17b99" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_fa4ba368-0ab6-433a-9b31-56e60fae1577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_65741789-1534-497a-9402-2f4db212f5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_74d29738-6e34-4c9f-9149-2c6a82a9d368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_74d29738-6e34-4c9f-9149-2c6a82a9d368" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e7ca383d-bef2-4189-b81d-8ca0fd0098f2" xlink:to="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5e232f0c-d74d-4805-959a-2ca6858b4254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5e232f0c-d74d-4805-959a-2ca6858b4254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5e232f0c-d74d-4805-959a-2ca6858b4254_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5e232f0c-d74d-4805-959a-2ca6858b4254" xlink:to="loc_us-gaap_EquityComponentDomain_5e232f0c-d74d-4805-959a-2ca6858b4254_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5e232f0c-d74d-4805-959a-2ca6858b4254" xlink:to="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d883e228-61d5-4556-a29e-e54d4e3d2237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:to="loc_us-gaap_CommonStockMember_d883e228-61d5-4556-a29e-e54d4e3d2237" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_eb19c34b-9e9e-4638-8301-7317f7c346d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_eb19c34b-9e9e-4638-8301-7317f7c346d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9dbca338-2dbe-44bc-bb7d-111958328eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:to="loc_us-gaap_RetainedEarningsMember_9dbca338-2dbe-44bc-bb7d-111958328eb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_891f9f39-8c7b-47f7-a4ea-9e57ac143d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_891f9f39-8c7b-47f7-a4ea-9e57ac143d5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d088d5cc-af3e-4a40-af23-0efe977509ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d088d5cc-af3e-4a40-af23-0efe977509ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d088d5cc-af3e-4a40-af23-0efe977509ec_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d088d5cc-af3e-4a40-af23-0efe977509ec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d088d5cc-af3e-4a40-af23-0efe977509ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e61effc1-43c4-4ce3-b3ec-3745615fe0d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d088d5cc-af3e-4a40-af23-0efe977509ec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e61effc1-43c4-4ce3-b3ec-3745615fe0d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b1f8cba1-6609-47d1-beb3-8e8dd2733cab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e61effc1-43c4-4ce3-b3ec-3745615fe0d7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b1f8cba1-6609-47d1-beb3-8e8dd2733cab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="ia1f46a00c9414d5ea97d9942a4fda6d7_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_90def873-9b2c-4076-83a2-880d4b39325f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:to="loc_us-gaap_NetIncomeLoss_90def873-9b2c-4076-83a2-880d4b39325f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e75899e0-4887-4027-9daa-510cfc075505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e75899e0-4887-4027-9daa-510cfc075505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b82b17d6-62c2-4de6-b633-3c8c72530075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b82b17d6-62c2-4de6-b633-3c8c72530075" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_7cc21b91-1aa8-412c-9368-b51afc308227" xlink:href="pcrx-20220630.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_7cc21b91-1aa8-412c-9368-b51afc308227" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_748b89cc-fe10-4b5f-be73-6ab86f4f1e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_748b89cc-fe10-4b5f-be73-6ab86f4f1e98" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6b244aa9-91d1-43f8-8349-d2fdc093643d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6b244aa9-91d1-43f8-8349-d2fdc093643d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c700b1fa-43a6-49f2-adfd-cd852a7b0d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_ShareBasedCompensation_c700b1fa-43a6-49f2-adfd-cd852a7b0d54" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fb7296c6-efec-4b6c-a908-5ffce96a9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fb7296c6-efec-4b6c-a908-5ffce96a9cbc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_516ad705-53cf-4716-9ffc-b06a0d3222e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_516ad705-53cf-4716-9ffc-b06a0d3222e6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5d082034-9cf8-4294-b9d3-aa090367c575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5d082034-9cf8-4294-b9d3-aa090367c575" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1d3d2f39-a042-4bfd-a43f-1b34b77f7e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1d3d2f39-a042-4bfd-a43f-1b34b77f7e9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8fbdb09f-83ac-4de6-ba52-166286723f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8fbdb09f-83ac-4de6-ba52-166286723f1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0bac8e80-2a0c-4c26-b667-4b4c0638cebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0bac8e80-2a0c-4c26-b667-4b4c0638cebd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ccc83bca-12fe-4f2a-8c8f-41363112e759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ccc83bca-12fe-4f2a-8c8f-41363112e759" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_699a435a-9a5a-4b47-b258-7dac1f55f7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_GainLossOnInvestments_699a435a-9a5a-4b47-b258-7dac1f55f7ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_0110c7cf-cfce-4310-a127-c307256c0d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_0110c7cf-cfce-4310-a127-c307256c0d35" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34081fff-19d1-4c78-a2c3-1b218e57a2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34081fff-19d1-4c78-a2c3-1b218e57a2b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e3cd374-979c-4819-901e-d2de6d14c04b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e3cd374-979c-4819-901e-d2de6d14c04b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_0c8edb8d-3877-4958-9eeb-fba65051e935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_0c8edb8d-3877-4958-9eeb-fba65051e935" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_6c68e532-b020-4571-ab56-72ecb15f2478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_6c68e532-b020-4571-ab56-72ecb15f2478" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PaymentOfContingentConsideration_bb9e2cff-a07b-4b7d-8092-dbc59baa42a0" xlink:href="pcrx-20220630.xsd#pcrx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_pcrx_PaymentOfContingentConsideration_bb9e2cff-a07b-4b7d-8092-dbc59baa42a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_21799821-cdab-4079-aa26-952091764b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_21799821-cdab-4079-aa26-952091764b87" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_6c66fabb-05d3-44be-b45e-49e9e9372e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_6c66fabb-05d3-44be-b45e-49e9e9372e6a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f4e381b2-4877-4ce4-a1c8-ada74adb1788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f4e381b2-4877-4ce4-a1c8-ada74adb1788" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_000bf698-47e2-4f94-9070-be5146378971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_000bf698-47e2-4f94-9070-be5146378971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_b33a32db-6bcc-4ad8-8c39-724fe0e4d303" xlink:href="pcrx-20220630.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_b33a32db-6bcc-4ad8-8c39-724fe0e4d303" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_4c2b615d-fc83-4efa-bf33-676925fa2563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_4c2b615d-fc83-4efa-bf33-676925fa2563" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_e97a2cae-5a26-47ef-900d-a82df455193a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_e97a2cae-5a26-47ef-900d-a82df455193a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9efcfbac-6246-4f6c-bb93-635717b1e78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9efcfbac-6246-4f6c-bb93-635717b1e78d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8a4cebf0-7449-489e-a1ab-5ad780313e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8a4cebf0-7449-489e-a1ab-5ad780313e67" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6cfd2a1e-6800-48c3-8830-706a442c386d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6cfd2a1e-6800-48c3-8830-706a442c386d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cca80697-bf22-4548-9000-bbc5ccc725e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cca80697-bf22-4548-9000-bbc5ccc725e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_35879fbc-72d3-46b4-86f6-29efed48d634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_8f5acfeb-d20d-48c2-851d-ff5c5e58bcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_8f5acfeb-d20d-48c2-851d-ff5c5e58bcf1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_d8ef3347-48ba-4132-b268-7de8707414aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8f5acfeb-d20d-48c2-851d-ff5c5e58bcf1" xlink:to="loc_us-gaap_InterestPaidNet_d8ef3347-48ba-4132-b268-7de8707414aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_f89b01cf-b476-4094-94ca-e40d4f78fc10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8f5acfeb-d20d-48c2-851d-ff5c5e58bcf1" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_f89b01cf-b476-4094-94ca-e40d4f78fc10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ff23e66-4aa2-439b-af86-5bce652f5b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ff23e66-4aa2-439b-af86-5bce652f5b5a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_e0bb0828-86e4-4be8-825a-3ba1f52d2668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ff23e66-4aa2-439b-af86-5bce652f5b5a" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_e0bb0828-86e4-4be8-825a-3ba1f52d2668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_72c196c7-d05f-4bcd-ab35-7e54303900e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ff23e66-4aa2-439b-af86-5bce652f5b5a" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_72c196c7-d05f-4bcd-ab35-7e54303900e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3cf246e-c7e0-4806-8897-4e7718de56f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_StatementTable_e3cf246e-c7e0-4806-8897-4e7718de56f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cb003cc2-0022-4608-8bc1-b68067393328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e3cf246e-c7e0-4806-8897-4e7718de56f8" xlink:to="loc_us-gaap_DebtInstrumentAxis_cb003cc2-0022-4608-8bc1-b68067393328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cb003cc2-0022-4608-8bc1-b68067393328_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cb003cc2-0022-4608-8bc1-b68067393328" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cb003cc2-0022-4608-8bc1-b68067393328_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6ca41d7e-b71b-4cd4-b2bd-fb2f9b6592f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cb003cc2-0022-4608-8bc1-b68067393328" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6ca41d7e-b71b-4cd4-b2bd-fb2f9b6592f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_f27f5c61-1615-43ff-9853-7b33a48e9838" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6ca41d7e-b71b-4cd4-b2bd-fb2f9b6592f3" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_f27f5c61-1615-43ff-9853-7b33a48e9838" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_8fd77cca-2e03-4ab4-94a4-1a7ce3231394" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6ca41d7e-b71b-4cd4-b2bd-fb2f9b6592f3" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_8fd77cca-2e03-4ab4-94a4-1a7ce3231394" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended" id="i7c8e2b618eb74667a1ed852377c7fe07_DESCRIPTIONOFBUSINESSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_a75b8c37-b46a-4fc0-8ff6-92975e1f6e01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts_9744eea4-d953-48e9-815c-f4e5d9624a1d" xlink:href="pcrx-20220630.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_a75b8c37-b46a-4fc0-8ff6-92975e1f6e01" xlink:to="loc_pcrx_ConcentrationRiskNumberOfProducts_9744eea4-d953-48e9-815c-f4e5d9624a1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_aca825cf-5c6b-4e26-b342-1e75c3c515d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_a75b8c37-b46a-4fc0-8ff6-92975e1f6e01" xlink:to="loc_us-gaap_NumberOfReportableSegments_aca825cf-5c6b-4e26-b342-1e75c3c515d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_a75b8c37-b46a-4fc0-8ff6-92975e1f6e01" xlink:to="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a1beb388-eece-46b8-b5f6-ea69d58fb28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a1beb388-eece-46b8-b5f6-ea69d58fb28e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a1beb388-eece-46b8-b5f6-ea69d58fb28e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a1beb388-eece-46b8-b5f6-ea69d58fb28e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a1beb388-eece-46b8-b5f6-ea69d58fb28e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_332515a5-394e-4267-9b49-6d1f7734bbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a1beb388-eece-46b8-b5f6-ea69d58fb28e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_332515a5-394e-4267-9b49-6d1f7734bbda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_f72c6629-7cb8-4e36-a1c7-f0683313b1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_332515a5-394e-4267-9b49-6d1f7734bbda" xlink:to="loc_us-gaap_SalesRevenueNetMember_f72c6629-7cb8-4e36-a1c7-f0683313b1a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_83b2299f-0fb9-467f-98bc-400c540bd077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_83b2299f-0fb9-467f-98bc-400c540bd077" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_83b2299f-0fb9-467f-98bc-400c540bd077_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_83b2299f-0fb9-467f-98bc-400c540bd077" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_83b2299f-0fb9-467f-98bc-400c540bd077_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b917d23f-7fd7-4cd4-8133-04b633add097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_83b2299f-0fb9-467f-98bc-400c540bd077" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b917d23f-7fd7-4cd4-8133-04b633add097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_04977600-98ed-42bc-8069-6ea3ff52e5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b917d23f-7fd7-4cd4-8133-04b633add097" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_04977600-98ed-42bc-8069-6ea3ff52e5c0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="extended" id="i482af26dde3647358aba90c86a4f924b_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_3d4ab0e0-bd6b-4899-813e-34459eac87dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfCustomers_c2448448-7c5a-458d-8e0f-665ba4475616" xlink:href="pcrx-20220630.xsd#pcrx_ConcentrationRiskNumberOfCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_3d4ab0e0-bd6b-4899-813e-34459eac87dd" xlink:to="loc_pcrx_ConcentrationRiskNumberOfCustomers_c2448448-7c5a-458d-8e0f-665ba4475616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f60a457b-684e-4218-a347-34462fcbaa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_3d4ab0e0-bd6b-4899-813e-34459eac87dd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f60a457b-684e-4218-a347-34462fcbaa4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_3d4ab0e0-bd6b-4899-813e-34459eac87dd" xlink:to="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_77bcb992-0601-4c37-bfa3-99e927362694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_77bcb992-0601-4c37-bfa3-99e927362694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_77bcb992-0601-4c37-bfa3-99e927362694_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_77bcb992-0601-4c37-bfa3-99e927362694" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_77bcb992-0601-4c37-bfa3-99e927362694_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_735879b6-85fa-49fc-b424-ca3cab0b8bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_77bcb992-0601-4c37-bfa3-99e927362694" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_735879b6-85fa-49fc-b424-ca3cab0b8bd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_889a6879-4c06-4877-a4f6-b912d4eaaa5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_735879b6-85fa-49fc-b424-ca3cab0b8bd4" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_889a6879-4c06-4877-a4f6-b912d4eaaa5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5c83580f-e210-42de-8fde-be04ef515b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5c83580f-e210-42de-8fde-be04ef515b18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5c83580f-e210-42de-8fde-be04ef515b18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5c83580f-e210-42de-8fde-be04ef515b18" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5c83580f-e210-42de-8fde-be04ef515b18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8d335b28-a966-457b-95c9-4e98e0f87e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5c83580f-e210-42de-8fde-be04ef515b18" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8d335b28-a966-457b-95c9-4e98e0f87e86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d551d4c3-d2ec-434e-b6a6-54007daabd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8d335b28-a966-457b-95c9-4e98e0f87e86" xlink:to="loc_us-gaap_SalesRevenueNetMember_d551d4c3-d2ec-434e-b6a6-54007daabd80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:to="loc_srt_MajorCustomersAxis_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3" xlink:to="loc_srt_NameOfMajorCustomerDomain_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3" xlink:to="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember_e33ef4af-8cf9-4559-a333-7b0e43379679" xlink:href="pcrx-20220630.xsd#pcrx_LargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:to="loc_pcrx_LargestCustomerMember_e33ef4af-8cf9-4559-a333-7b0e43379679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember_0b596cac-101b-43d5-9f35-047f042c22de" xlink:href="pcrx-20220630.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:to="loc_pcrx_SecondLargestCustomerMember_0b596cac-101b-43d5-9f35-047f042c22de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember_1dc03df6-d8d1-41db-9e06-22d0ad18223f" xlink:href="pcrx-20220630.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:to="loc_pcrx_ThirdLargestCustomerMember_1dc03df6-d8d1-41db-9e06-22d0ad18223f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember_914cdd0c-7f8f-4b81-8a82-c403b7f91a69" xlink:href="pcrx-20220630.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:to="loc_pcrx_ThreeLargestCustomersMember_914cdd0c-7f8f-4b81-8a82-c403b7f91a69" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="extended" id="i34956551a1f44412abac32f4c31feebc_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_61144773-4c43-4aad-8344-8cc03f6f7f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:to="loc_us-gaap_LongTermDebt_61144773-4c43-4aad-8344-8cc03f6f7f89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c8de50d-0446-4f48-a546-d88373cd58b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:to="loc_us-gaap_StockholdersEquity_1c8de50d-0446-4f48-a546-d88373cd58b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e8de47b2-b037-464d-9757-337b04510767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e8de47b2-b037-464d-9757-337b04510767" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22dff4a9-3b8d-4e31-b353-54f69432a2a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22dff4a9-3b8d-4e31-b353-54f69432a2a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_22dff4a9-3b8d-4e31-b353-54f69432a2a1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22dff4a9-3b8d-4e31-b353-54f69432a2a1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_22dff4a9-3b8d-4e31-b353-54f69432a2a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3c5eacfd-e10c-441a-a266-4ec367fa017f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22dff4a9-3b8d-4e31-b353-54f69432a2a1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3c5eacfd-e10c-441a-a266-4ec367fa017f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_69c7abb0-5e32-44eb-a0dd-3f682d332df2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3c5eacfd-e10c-441a-a266-4ec367fa017f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_69c7abb0-5e32-44eb-a0dd-3f682d332df2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a9845952-ea0f-4dc4-800e-5347b2d487c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a9845952-ea0f-4dc4-800e-5347b2d487c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a9845952-ea0f-4dc4-800e-5347b2d487c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a9845952-ea0f-4dc4-800e-5347b2d487c8" xlink:to="loc_us-gaap_EquityComponentDomain_a9845952-ea0f-4dc4-800e-5347b2d487c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3b0b6180-907e-4786-85c1-e405436da49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a9845952-ea0f-4dc4-800e-5347b2d487c8" xlink:to="loc_us-gaap_EquityComponentDomain_3b0b6180-907e-4786-85c1-e405436da49f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_085e1151-b578-4f8c-916c-f3f4073df869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3b0b6180-907e-4786-85c1-e405436da49f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_085e1151-b578-4f8c-916c-f3f4073df869" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_656f0ff3-4a12-4902-a5eb-a8d50c27a6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3b0b6180-907e-4786-85c1-e405436da49f" xlink:to="loc_us-gaap_RetainedEarningsMember_656f0ff3-4a12-4902-a5eb-a8d50c27a6c6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUENarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#REVENUENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/REVENUENarrativeDetails" xlink:type="extended" id="iaf7121bdc31f41d0b66a22403f133bee_REVENUENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e1b21262-07cf-4e16-9cc4-e4d13a0d6f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms_ad07a656-581e-4bc5-b84c-c31ed3eac852" xlink:href="pcrx-20220630.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e1b21262-07cf-4e16-9cc4-e4d13a0d6f46" xlink:to="loc_pcrx_AccountsReceivablePaymentTerms_ad07a656-581e-4bc5-b84c-c31ed3eac852" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_13d03285-783c-4bd5-bce4-e58431c50c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e1b21262-07cf-4e16-9cc4-e4d13a0d6f46" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_13d03285-783c-4bd5-bce4-e58431c50c57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_96c55189-f6a9-4d50-95f7-8fed66247ec8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_13d03285-783c-4bd5-bce4-e58431c50c57" xlink:to="loc_srt_RangeAxis_96c55189-f6a9-4d50-95f7-8fed66247ec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_96c55189-f6a9-4d50-95f7-8fed66247ec8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_96c55189-f6a9-4d50-95f7-8fed66247ec8" xlink:to="loc_srt_RangeMember_96c55189-f6a9-4d50-95f7-8fed66247ec8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_972da45b-842e-4bc6-8fcb-261d53b6e50e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_96c55189-f6a9-4d50-95f7-8fed66247ec8" xlink:to="loc_srt_RangeMember_972da45b-842e-4bc6-8fcb-261d53b6e50e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff888041-250c-4616-ad4b-e906008cf8c9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_972da45b-842e-4bc6-8fcb-261d53b6e50e" xlink:to="loc_srt_MinimumMember_ff888041-250c-4616-ad4b-e906008cf8c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_14f73478-ad76-409f-9d7c-105bad80eaf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_972da45b-842e-4bc6-8fcb-261d53b6e50e" xlink:to="loc_srt_MaximumMember_14f73478-ad76-409f-9d7c-105bad80eaf7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#REVENUEScheduleofDisaggregatedRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails" xlink:type="extended" id="ie323e3350eb74fc89cfd7e14871274b7_REVENUEScheduleofDisaggregatedRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_acb6a6be-3d62-470f-9467-bcb98d3e593d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c95d65cf-cf72-4fef-8b11-a6134724b29e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_acb6a6be-3d62-470f-9467-bcb98d3e593d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c95d65cf-cf72-4fef-8b11-a6134724b29e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bf10e2ed-a4a5-498c-852c-dd1fd1f2424a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_acb6a6be-3d62-470f-9467-bcb98d3e593d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bf10e2ed-a4a5-498c-852c-dd1fd1f2424a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f5438111-eecc-4a3d-99d2-b1baaef3b5ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf10e2ed-a4a5-498c-852c-dd1fd1f2424a" xlink:to="loc_srt_ProductOrServiceAxis_f5438111-eecc-4a3d-99d2-b1baaef3b5ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f5438111-eecc-4a3d-99d2-b1baaef3b5ba_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f5438111-eecc-4a3d-99d2-b1baaef3b5ba" xlink:to="loc_srt_ProductsAndServicesDomain_f5438111-eecc-4a3d-99d2-b1baaef3b5ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f5438111-eecc-4a3d-99d2-b1baaef3b5ba" xlink:to="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_2076ba62-b9d0-42ef-b981-7a60cc277e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_us-gaap_ProductMember_2076ba62-b9d0-42ef-b981-7a60cc277e4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_e250c4d5-af5f-4bf6-adad-84d6ed7e3f26" xlink:href="pcrx-20220630.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_e250c4d5-af5f-4bf6-adad-84d6ed7e3f26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ZILRETTAMember_d9082d06-9f79-424b-b56f-44dfa09413ac" xlink:href="pcrx-20220630.xsd#pcrx_ZILRETTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_pcrx_ZILRETTAMember_d9082d06-9f79-424b-b56f-44dfa09413ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember_f5bb465f-1df9-4c5f-a425-7b002d2414f5" xlink:href="pcrx-20220630.xsd#pcrx_IoveraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_pcrx_IoveraMember_f5bb465f-1df9-4c5f-a425-7b002d2414f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember_a362bdb1-7760-4086-8a09-32adc5567945" xlink:href="pcrx-20220630.xsd#pcrx_BupivacaineLiposomeInjectableSuspensionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember_a362bdb1-7760-4086-8a09-32adc5567945" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_b3726e2d-ac0c-461b-8a74-9c8f1b9c5d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails" xlink:type="extended" id="i6ab1b102700544d1a109ff77fcd79f09_FLEXIONACQUISITIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fefab745-e7f5-4325-8adf-0834d095cb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fefab745-e7f5-4325-8adf-0834d095cb2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_bd775067-0d40-4a86-be3f-f7428d799a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_bd775067-0d40-4a86-be3f-f7428d799a2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_5377051f-28a1-4cf8-976c-55f71ff791a1" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_5377051f-28a1-4cf8-976c-55f71ff791a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_ad882b38-7ab0-4e23-8d18-d1cee148f291" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_ad882b38-7ab0-4e23-8d18-d1cee148f291" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6129ffdf-9945-4a20-ba47-c636d4cf4ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6129ffdf-9945-4a20-ba47-c636d4cf4ea0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1088a724-d23d-4248-a0b7-f6786bab27e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1088a724-d23d-4248-a0b7-f6786bab27e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1088a724-d23d-4248-a0b7-f6786bab27e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1088a724-d23d-4248-a0b7-f6786bab27e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1088a724-d23d-4248-a0b7-f6786bab27e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d5569278-c783-4283-bc67-140474119221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1088a724-d23d-4248-a0b7-f6786bab27e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d5569278-c783-4283-bc67-140474119221" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_ba47960c-24ae-4e58-9e1b-e09f7497dac3" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d5569278-c783-4283-bc67-140474119221" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_ba47960c-24ae-4e58-9e1b-e09f7497dac3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d" xlink:to="loc_us-gaap_ClassOfStockDomain_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4cbe6de0-8c5e-4bee-b5c2-e3aca7f91e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d" xlink:to="loc_us-gaap_ClassOfStockDomain_4cbe6de0-8c5e-4bee-b5c2-e3aca7f91e77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_26a4d755-3b6f-45a4-b898-1148d6f6379c" xlink:href="pcrx-20220630.xsd#pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4cbe6de0-8c5e-4bee-b5c2-e3aca7f91e77" xlink:to="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_26a4d755-3b6f-45a4-b898-1148d6f6379c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="extended" id="ic5e4b2927473412aa57c64a3a363032e_FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_21c2c05c-c19f-4e30-8925-e3079afacf80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_21c2c05c-c19f-4e30-8925-e3079afacf80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_acc96b61-c90c-4b6d-9929-26a0a1428045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_acc96b61-c90c-4b6d-9929-26a0a1428045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_47c13009-0e8b-4b82-9e98-ff378e1239d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_47c13009-0e8b-4b82-9e98-ff378e1239d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4b7ea6e0-e702-4005-ab9e-2360be9cfb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4b7ea6e0-e702-4005-ab9e-2360be9cfb74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f947ee43-f50a-42f1-b2b2-862523ec3bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f947ee43-f50a-42f1-b2b2-862523ec3bda" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b1052e53-aa6c-4a83-a03f-03843a9aa6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b1052e53-aa6c-4a83-a03f-03843a9aa6ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d32b6362-2d4c-4342-944c-c8eb5bfe35c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d32b6362-2d4c-4342-944c-c8eb5bfe35c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_0be5a76f-68ac-4cde-8732-c23a7ca602f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_0be5a76f-68ac-4cde-8732-c23a7ca602f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_5d8019ca-d8d9-4e95-b453-418bd535dc68" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_5d8019ca-d8d9-4e95-b453-418bd535dc68" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_000c5a47-49f8-4783-8a72-43bb71526021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_000c5a47-49f8-4783-8a72-43bb71526021" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_2423752c-f41e-4f4e-b529-c139bb320389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_2423752c-f41e-4f4e-b529-c139bb320389" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5143b8b0-9030-4e39-9963-801e5a31f800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5143b8b0-9030-4e39-9963-801e5a31f800" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_5613f95b-041a-4e12-a360-f9b0b9bd53c2" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_5613f95b-041a-4e12-a360-f9b0b9bd53c2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_21c2c05c-c19f-4e30-8925-e3079afacf80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b9063965-f1cc-4015-a786-632da0008dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b9063965-f1cc-4015-a786-632da0008dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2a57a865-894d-4a74-96fa-30698f78fcb9" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2a57a865-894d-4a74-96fa-30698f78fcb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_7ba1859d-d218-4cc9-9d78-46aa2c6a3f06" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_7ba1859d-d218-4cc9-9d78-46aa2c6a3f06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ace9c29b-67a1-4abd-94be-5a04060abb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ace9c29b-67a1-4abd-94be-5a04060abb5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_0ae0f998-0b80-4f8c-89a7-af65b5f76634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_0ae0f998-0b80-4f8c-89a7-af65b5f76634" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_431ecd21-dded-4bff-86b2-5cbf80202224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_431ecd21-dded-4bff-86b2-5cbf80202224" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_cd6eab04-484d-4996-9281-b48e5d8a388c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_cd6eab04-484d-4996-9281-b48e5d8a388c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0abf0c63-c92c-435f-b1ca-5827dc2c30c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0abf0c63-c92c-435f-b1ca-5827dc2c30c4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_27c6ff7b-bedc-4657-ba56-7020412dea2e" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_27c6ff7b-bedc-4657-ba56-7020412dea2e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_27a23853-bae1-422c-8b35-5e41000d2a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_27a23853-bae1-422c-8b35-5e41000d2a73" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_22bfbdd1-b974-452b-a450-0807b2296bf4" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_22bfbdd1-b974-452b-a450-0807b2296bf4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f0b8f644-0292-47c6-a244-f2f15feeb7da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_Goodwill_f0b8f644-0292-47c6-a244-f2f15feeb7da" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_44a464b1-60f2-4288-9fe2-f92993ec65c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_44a464b1-60f2-4288-9fe2-f92993ec65c4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e1ee9b5b-9989-4d56-a18b-25f39ad73f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e1ee9b5b-9989-4d56-a18b-25f39ad73f30" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_756c3b40-f6ef-4767-8dc5-8dfe8636cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_756c3b40-f6ef-4767-8dc5-8dfe8636cb31" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1f15052e-b7bb-4fc1-b1a7-65aca2efc968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_21c2c05c-c19f-4e30-8925-e3079afacf80" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1f15052e-b7bb-4fc1-b1a7-65aca2efc968" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7a07d19-69d1-4d11-9f0e-4fd93788dacb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1f15052e-b7bb-4fc1-b1a7-65aca2efc968" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7a07d19-69d1-4d11-9f0e-4fd93788dacb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7a07d19-69d1-4d11-9f0e-4fd93788dacb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7a07d19-69d1-4d11-9f0e-4fd93788dacb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7a07d19-69d1-4d11-9f0e-4fd93788dacb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d43c0a9-1748-4d52-a78c-0ba6eb2cc9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7a07d19-69d1-4d11-9f0e-4fd93788dacb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d43c0a9-1748-4d52-a78c-0ba6eb2cc9f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_87006139-709b-4f70-b06a-927642475032" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d43c0a9-1748-4d52-a78c-0ba6eb2cc9f3" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_87006139-709b-4f70-b06a-927642475032" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITIONScheduleofProFormaInformationDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails" xlink:type="extended" id="i4626f8190f7b40cf8074a967d60b8702_FLEXIONACQUISITIONScheduleofProFormaInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_973de2ff-aac2-478e-8cc2-0e32e3debbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_973de2ff-aac2-478e-8cc2-0e32e3debbab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_751e51d5-1ed5-42d0-89b3-fba54879098f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_751e51d5-1ed5-42d0-89b3-fba54879098f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_ca00d886-e76a-4b8c-9c04-3494f06765a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_ca00d886-e76a-4b8c-9c04-3494f06765a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f2abb97c-073d-44fc-86e6-7319e1507361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f2abb97c-073d-44fc-86e6-7319e1507361" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db4b63f3-72a8-44e4-a8f6-cc0fdac977f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db4b63f3-72a8-44e4-a8f6-cc0fdac977f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_481cc57d-d8f4-4702-9e8d-ac37db42f317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db4b63f3-72a8-44e4-a8f6-cc0fdac977f1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_481cc57d-d8f4-4702-9e8d-ac37db42f317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_481cc57d-d8f4-4702-9e8d-ac37db42f317_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_481cc57d-d8f4-4702-9e8d-ac37db42f317" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_481cc57d-d8f4-4702-9e8d-ac37db42f317_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65c73636-e151-4dd9-97a4-2179d95fbbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_481cc57d-d8f4-4702-9e8d-ac37db42f317" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65c73636-e151-4dd9-97a4-2179d95fbbb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_cdbd50c1-d2b4-411f-ba1c-66b26ed0f054" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65c73636-e151-4dd9-97a4-2179d95fbbb1" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_cdbd50c1-d2b4-411f-ba1c-66b26ed0f054" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FIXEDASSETSSummaryofMajorCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="extended" id="i4945822d35b14114ba04624db04e5262_FIXEDASSETSSummaryofMajorCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_37ed3106-3dcb-4432-9d6d-2a06e2a70f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_37ed3106-3dcb-4432-9d6d-2a06e2a70f46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_79e1bcb3-c25c-4f5b-8470-95afd35369e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_79e1bcb3-c25c-4f5b-8470-95afd35369e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a905a843-db33-43d0-8aca-b08f61650e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a905a843-db33-43d0-8aca-b08f61650e89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e7f44fc3-772f-4b6a-bfdc-ef6ad02c707d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e7f44fc3-772f-4b6a-bfdc-ef6ad02c707d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49e34019-8ddd-4c70-99a8-3c4b738731b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e7f44fc3-772f-4b6a-bfdc-ef6ad02c707d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49e34019-8ddd-4c70-99a8-3c4b738731b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49e34019-8ddd-4c70-99a8-3c4b738731b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49e34019-8ddd-4c70-99a8-3c4b738731b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49e34019-8ddd-4c70-99a8-3c4b738731b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49e34019-8ddd-4c70-99a8-3c4b738731b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_70ef3f14-28b4-420b-aeea-b56e63e40a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_70ef3f14-28b4-420b-aeea-b56e63e40a7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5207cbee-7d1d-49b0-9aa8-13b230b018f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5207cbee-7d1d-49b0-9aa8-13b230b018f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember_ba126ee2-a864-418f-b5a6-c360b1d6c326" xlink:href="pcrx-20220630.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_pcrx_ComputerEquipmentAndSoftwareMember_ba126ee2-a864-418f-b5a6-c360b1d6c326" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_705205be-b202-4390-9cda-4832d6bc46d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_705205be-b202-4390-9cda-4832d6bc46d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_8f684858-e01b-4d7c-8a34-e97b45298a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_us-gaap_ConstructionInProgressMember_8f684858-e01b-4d7c-8a34-e97b45298a99" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FIXEDASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails" xlink:type="extended" id="ic9b8d2e13381406fbb7837b4ea438a42_FIXEDASSETSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_af59e994-2699-4923-8ef5-1e34784b1fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_Depreciation_af59e994-2699-4923-8ef5-1e34784b1fef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_4a5c285c-01fa-4ac6-9779-45d88a8f5ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_InterestCostsCapitalized_4a5c285c-01fa-4ac6-9779-45d88a8f5ad2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_739c22da-4928-4cae-b316-70660dedaa63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_739c22da-4928-4cae-b316-70660dedaa63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_6c3dfa60-ecf5-4bda-8211-9ca0c835106d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_AssetRetirementObligation_6c3dfa60-ecf5-4bda-8211-9ca0c835106d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_df899d02-6ce6-412b-b2a3-5326ceddd1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_df899d02-6ce6-412b-b2a3-5326ceddd1df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_df899d02-6ce6-412b-b2a3-5326ceddd1df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_df899d02-6ce6-412b-b2a3-5326ceddd1df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_df899d02-6ce6-412b-b2a3-5326ceddd1df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_853128b9-2bf1-4882-aa63-3765c3b2e65a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_df899d02-6ce6-412b-b2a3-5326ceddd1df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_853128b9-2bf1-4882-aa63-3765c3b2e65a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_cfbaf0e9-9d53-4815-8404-633335467e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_853128b9-2bf1-4882-aa63-3765c3b2e65a" xlink:to="loc_us-gaap_ConstructionInProgressMember_cfbaf0e9-9d53-4815-8404-633335467e5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_94bb6967-49e9-4a04-adb8-f143acfd56fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_853128b9-2bf1-4882-aa63-3765c3b2e65a" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_94bb6967-49e9-4a04-adb8-f143acfd56fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8142a895-4aee-4e97-a0b3-9cb8d08c1164" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:to="loc_srt_StatementGeographicalAxis_8142a895-4aee-4e97-a0b3-9cb8d08c1164" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8142a895-4aee-4e97-a0b3-9cb8d08c1164_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8142a895-4aee-4e97-a0b3-9cb8d08c1164" xlink:to="loc_srt_SegmentGeographicalDomain_8142a895-4aee-4e97-a0b3-9cb8d08c1164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_eb24f8cf-18cc-4dee-a3ea-0b872f905948" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8142a895-4aee-4e97-a0b3-9cb8d08c1164" xlink:to="loc_srt_SegmentGeographicalDomain_eb24f8cf-18cc-4dee-a3ea-0b872f905948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0a45bf50-64f8-4d7a-a0f7-26ad735d3be1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_eb24f8cf-18cc-4dee-a3ea-0b872f905948" xlink:to="loc_srt_EuropeMember_0a45bf50-64f8-4d7a-a0f7-26ad735d3be1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="extended" id="i33a51963857b48d59c3aba0c294639df_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7111e6db-45e4-4196-aeed-369d2cdf790c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7111e6db-45e4-4196-aeed-369d2cdf790c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfLeases_97b6aaf8-bfca-4647-b56a-498837d162fb" xlink:href="pcrx-20220630.xsd#pcrx_NumberOfLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_pcrx_NumberOfLeases_97b6aaf8-bfca-4647-b56a-498837d162fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_bf4d3836-93c4-428d-848b-d9a18d69b45d" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_bf4d3836-93c4-428d-848b-d9a18d69b45d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d3354a30-3cf5-44d8-920c-d5bfafdfd01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d3354a30-3cf5-44d8-920c-d5bfafdfd01d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:to="loc_srt_RangeAxis_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4" xlink:to="loc_srt_RangeMember_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cccf6688-a042-46ea-8a8e-53a0378087e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4" xlink:to="loc_srt_RangeMember_cccf6688-a042-46ea-8a8e-53a0378087e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d7e44381-21ec-4830-b292-1afedff935ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cccf6688-a042-46ea-8a8e-53a0378087e9" xlink:to="loc_srt_MaximumMember_d7e44381-21ec-4830-b292-1afedff935ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_30b5bc41-7002-4bdd-ae4c-23abcabf8f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_30b5bc41-7002-4bdd-ae4c-23abcabf8f63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_30b5bc41-7002-4bdd-ae4c-23abcabf8f63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_30b5bc41-7002-4bdd-ae4c-23abcabf8f63" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_30b5bc41-7002-4bdd-ae4c-23abcabf8f63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3176019e-f401-4f9a-aaba-f12fe941cdea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_30b5bc41-7002-4bdd-ae4c-23abcabf8f63" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3176019e-f401-4f9a-aaba-f12fe941cdea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d5ebd81f-eed0-49ed-acb1-553d8ea5b412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3176019e-f401-4f9a-aaba-f12fe941cdea" xlink:to="loc_us-gaap_SubsequentEventMember_d5ebd81f-eed0-49ed-acb1-553d8ea5b412" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#GOODWILLANDINTANGIBLEASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="extended" id="i3049bd948107403faa7a5de9898e27c3_GOODWILLANDINTANGIBLEASSETSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_15c31754-7b64-4cc8-9bf3-a79eea1b8543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_us-gaap_Goodwill_15c31754-7b64-4cc8-9bf3-a79eea1b8543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_ef660f46-5b36-4992-92ee-92f4e001c4cf" xlink:href="pcrx-20220630.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_ef660f46-5b36-4992-92ee-92f4e001c4cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_13d7291c-7681-414c-ad55-437623a32926" xlink:href="pcrx-20220630.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_13d7291c-7681-414c-ad55-437623a32926" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d5ded490-7925-4691-ba48-325376fe4695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d5ded490-7925-4691-ba48-325376fe4695" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_61fc78a2-c405-4504-9396-33d07d7621bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_61fc78a2-c405-4504-9396-33d07d7621bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_d4ab5561-3903-480f-8c22-01964047b1d7" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_d4ab5561-3903-480f-8c22-01964047b1d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_d9c87bec-463c-4214-84c3-a6fe0c19faeb" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_d9c87bec-463c-4214-84c3-a6fe0c19faeb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_3d0794bc-6cec-45f2-8fc9-9dd52a66514f" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_3d0794bc-6cec-45f2-8fc9-9dd52a66514f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_6f4a33fc-983c-4672-b721-4c7555fa65fb" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_6f4a33fc-983c-4672-b721-4c7555fa65fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_7e7680e2-bea5-484d-be20-215941ba5beb" xlink:href="pcrx-20220630.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:to="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_7e7680e2-bea5-484d-be20-215941ba5beb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_7e7680e2-bea5-484d-be20-215941ba5beb_default" xlink:href="pcrx-20220630.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_7e7680e2-bea5-484d-be20-215941ba5beb" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_7e7680e2-bea5-484d-be20-215941ba5beb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_4ca4f09f-5ea6-404a-b9ed-1f7ddf00fe0f" xlink:href="pcrx-20220630.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_7e7680e2-bea5-484d-be20-215941ba5beb" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_4ca4f09f-5ea6-404a-b9ed-1f7ddf00fe0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_fef99876-0a87-4f8e-a440-785c6d1c54ce" xlink:href="pcrx-20220630.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_4ca4f09f-5ea6-404a-b9ed-1f7ddf00fe0f" xlink:to="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_fef99876-0a87-4f8e-a440-785c6d1c54ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_421dd2d2-e12a-41b9-b26e-c4645d2cce33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_421dd2d2-e12a-41b9-b26e-c4645d2cce33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_421dd2d2-e12a-41b9-b26e-c4645d2cce33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_421dd2d2-e12a-41b9-b26e-c4645d2cce33" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_421dd2d2-e12a-41b9-b26e-c4645d2cce33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e09a116-d51e-4e1f-8f41-bd93549d349b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_421dd2d2-e12a-41b9-b26e-c4645d2cce33" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e09a116-d51e-4e1f-8f41-bd93549d349b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember_43923671-a82f-420b-a335-18124207fdc4" xlink:href="pcrx-20220630.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e09a116-d51e-4e1f-8f41-bd93549d349b" xlink:to="loc_pcrx_SkyePharmaHoldingIncMember_43923671-a82f-420b-a335-18124207fdc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9dcfed0-7eec-4ecc-b14c-24f8235441ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9dcfed0-7eec-4ecc-b14c-24f8235441ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9dcfed0-7eec-4ecc-b14c-24f8235441ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9dcfed0-7eec-4ecc-b14c-24f8235441ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9dcfed0-7eec-4ecc-b14c-24f8235441ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb1983f-21b4-4a82-a3e6-9f46d6cc4eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9dcfed0-7eec-4ecc-b14c-24f8235441ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb1983f-21b4-4a82-a3e6-9f46d6cc4eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_06ef0d5f-2291-4678-8f75-d6c46092626a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb1983f-21b4-4a82-a3e6-9f46d6cc4eb4" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_06ef0d5f-2291-4678-8f75-d6c46092626a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_07d0d722-2e1c-4114-8a22-67f53df4b04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb1983f-21b4-4a82-a3e6-9f46d6cc4eb4" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_07d0d722-2e1c-4114-8a22-67f53df4b04f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended" id="ibf2b1baffab649b6b3f339206f7c3b39_GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2940a155-4f59-4e63-9ec9-ceaecc75d3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2940a155-4f59-4e63-9ec9-ceaecc75d3dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_507471a1-cb33-434d-9603-8b678c5fa2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_507471a1-cb33-434d-9603-8b678c5fa2ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e1f8b818-a2a4-497c-8946-e0f1adf813f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e1f8b818-a2a4-497c-8946-e0f1adf813f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d4bdf606-4e2f-44f5-a698-7e859d3056ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d4bdf606-4e2f-44f5-a698-7e859d3056ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_211f43d2-982e-4c6c-94c7-77b9944d62ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_123b11bc-994f-450f-910f-38395ee5d642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_123b11bc-994f-450f-910f-38395ee5d642" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0be60502-b2bd-4824-aaf1-e87aa1a83e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0be60502-b2bd-4824-aaf1-e87aa1a83e79" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aeb2d055-dd46-47ce-afe0-23dd8e8a86fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aeb2d055-dd46-47ce-afe0-23dd8e8a86fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b550e6a8-d484-4d01-827a-db4e6127d071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b550e6a8-d484-4d01-827a-db4e6127d071" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b550e6a8-d484-4d01-827a-db4e6127d071" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3a2d159f-22d6-45c7-98d6-ceb011065238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3a2d159f-22d6-45c7-98d6-ceb011065238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_48a00876-d488-4e6d-b349-c71cc5e07dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:to="loc_us-gaap_CustomerRelationshipsMember_48a00876-d488-4e6d-b349-c71cc5e07dec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_9a160d51-a9ab-4f3c-8b16-2985e8117ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_9a160d51-a9ab-4f3c-8b16-2985e8117ea4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTCarryingValueofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails" xlink:type="extended" id="i53836cfebd8f41fca322d4c5462a64ca_DEBTCarryingValueofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_439f9c35-a90b-468f-b6db-d9680f3be784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_82a463e1-615a-4911-8101-8552878321b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_439f9c35-a90b-468f-b6db-d9680f3be784" xlink:to="loc_us-gaap_LongTermDebt_82a463e1-615a-4911-8101-8552878321b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f243d19c-f033-4427-9eb5-b7e4daefe03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_439f9c35-a90b-468f-b6db-d9680f3be784" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f243d19c-f033-4427-9eb5-b7e4daefe03e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_439f9c35-a90b-468f-b6db-d9680f3be784" xlink:to="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_16b2fc9c-37fa-4cb7-b939-039b85082f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:to="loc_us-gaap_DebtInstrumentAxis_16b2fc9c-37fa-4cb7-b939-039b85082f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_16b2fc9c-37fa-4cb7-b939-039b85082f94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_16b2fc9c-37fa-4cb7-b939-039b85082f94" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_16b2fc9c-37fa-4cb7-b939-039b85082f94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_16b2fc9c-37fa-4cb7-b939-039b85082f94" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_07e65b10-6d24-4026-b67d-fa2a85a1b447" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_07e65b10-6d24-4026-b67d-fa2a85a1b447" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_124ad6c8-1667-410f-85d8-88bc1ac7eb48" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_124ad6c8-1667-410f-85d8-88bc1ac7eb48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_1824e6ad-3cea-4026-9c18-3cabef15f2db" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:to="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_1824e6ad-3cea-4026-9c18-3cabef15f2db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_c75d9680-7a74-4780-82be-dc595b99ee96" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_c75d9680-7a74-4780-82be-dc595b99ee96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_575c08f7-623b-4380-9a43-0d21d872ec77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_575c08f7-623b-4380-9a43-0d21d872ec77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_d5ec93a3-0eff-4cde-ba30-da1d49ad1d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_575c08f7-623b-4380-9a43-0d21d872ec77" xlink:to="loc_us-gaap_SecuredDebtMember_d5ec93a3-0eff-4cde-ba30-da1d49ad1d11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_ab1b88bb-a51c-4184-8fd7-69f98c1e4244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_575c08f7-623b-4380-9a43-0d21d872ec77" xlink:to="loc_us-gaap_UnsecuredDebtMember_ab1b88bb-a51c-4184-8fd7-69f98c1e4244" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="extended" id="i73d62c1d38d2487e8cd6acf04c5b4ff0_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentDiscountRate_ff496677-ffdd-4382-8d6c-4f87cc9f124e" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentDiscountRate_ff496677-ffdd-4382-8d6c-4f87cc9f124e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7985a862-0f04-48ee-9341-8f64ac6303ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7985a862-0f04-48ee-9341-8f64ac6303ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_fa451410-f00f-44e8-b577-1ae789d16fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_fa451410-f00f-44e8-b577-1ae789d16fe9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_9f863bc3-9f3f-4ee4-b3bd-45f159efee73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_9f863bc3-9f3f-4ee4-b3bd-45f159efee73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_297450d6-da29-4821-a29d-686bde10a0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_297450d6-da29-4821-a29d-686bde10a0a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_412fcfd3-598e-43a7-b48d-3388a2cf3abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_412fcfd3-598e-43a7-b48d-3388a2cf3abb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_55859065-e8ad-4986-9eaa-1b567033faa0" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_55859065-e8ad-4986-9eaa-1b567033faa0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_a0611842-1392-4d92-8118-4541bfc8acf4" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_a0611842-1392-4d92-8118-4541bfc8acf4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_da1cd334-9db8-482c-9923-9ef7fb23ee39" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_da1cd334-9db8-482c-9923-9ef7fb23ee39" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_c5664ab4-9569-4886-9557-f4dbfbac0887" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_c5664ab4-9569-4886-9557-f4dbfbac0887" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_e5a032e7-0387-4744-b651-56dd6eb9322c" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_e5a032e7-0387-4744-b651-56dd6eb9322c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_11b418ff-0af1-4f60-bcf8-24508553b3ac" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_11b418ff-0af1-4f60-bcf8-24508553b3ac" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentVariableRate_d40efd55-511d-4079-88c2-815120beab6d" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentVariableRate_d40efd55-511d-4079-88c2-815120beab6d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_5ca1b6e6-1e2f-4ec0-b6a3-4c0acc6c40b5" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_5ca1b6e6-1e2f-4ec0-b6a3-4c0acc6c40b5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_dad29422-f87c-49eb-887c-b6f7c05d5971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_dad29422-f87c-49eb-887c-b6f7c05d5971" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_86b2caec-8880-4298-8cce-560c24220349" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentBasisSpreadOneOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_86b2caec-8880-4298-8cce-560c24220349" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_b2d4b6ee-d83b-4c2c-9d0c-6c262c08f214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_b2d4b6ee-d83b-4c2c-9d0c-6c262c08f214" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ee07ce77-dffe-4626-85e5-44d7b3c1b4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ee07ce77-dffe-4626-85e5-44d7b3c1b4af" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_72196650-0fd1-4a33-82e5-7fb2369063de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_72196650-0fd1-4a33-82e5-7fb2369063de" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_c4fde825-ab0c-4181-a34d-8ecdba4ff3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_c4fde825-ab0c-4181-a34d-8ecdba4ff3e2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_d7a14578-0213-457a-96e8-58525c2be805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_RepaymentsOfDebt_d7a14578-0213-457a-96e8-58525c2be805" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5e64bbc3-4134-438c-a955-e0e4e57a97dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5e64bbc3-4134-438c-a955-e0e4e57a97dd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_8449b228-8abb-4dbc-ae6e-cee7a6fd7826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_8449b228-8abb-4dbc-ae6e-cee7a6fd7826" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2254f4c9-5471-44c7-8c7f-abc1ca2bf89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2254f4c9-5471-44c7-8c7f-abc1ca2bf89d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_f6051052-9d08-40eb-b54f-ccccb78b2a2d" xlink:href="pcrx-20220630.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_f6051052-9d08-40eb-b54f-ccccb78b2a2d" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_49e8fb89-64d7-48c9-8a1d-4d175000bac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_49e8fb89-64d7-48c9-8a1d-4d175000bac3" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_2b624620-02a1-4767-9823-f66a1ee3c5e9" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_2b624620-02a1-4767-9823-f66a1ee3c5e9" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c4f5c280-5604-4954-902f-ee86bc859d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_SharePrice_c4f5c280-5604-4954-902f-ee86bc859d36" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice_db229954-d81b-470f-975b-c8f971e3d068" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentMarketPrice_db229954-d81b-470f-975b-c8f971e3d068" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_395a94ce-6833-4f94-853b-81c99c7c11b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_395a94ce-6833-4f94-853b-81c99c7c11b3" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_364a6ec6-0d0a-430a-9904-1298c9df3621" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_364a6ec6-0d0a-430a-9904-1298c9df3621" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_22ced8bb-fd9a-4a83-a929-6efef8204c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_22ced8bb-fd9a-4a83-a929-6efef8204c52" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_418c4e86-2ff6-4911-a689-ff73459b384b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_LongTermDebt_418c4e86-2ff6-4911-a689-ff73459b384b" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_e0a9568e-2b32-41c8-8fd1-51521377b0dd" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_e0a9568e-2b32-41c8-8fd1-51521377b0dd" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_63b31f4c-8b53-4843-b7b6-9e5d1568a4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_63b31f4c-8b53-4843-b7b6-9e5d1568a4e0" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_7e10bdbe-97c7-4422-96cf-57328aa3ecde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_7e10bdbe-97c7-4422-96cf-57328aa3ecde" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1d3ae902-102a-40d6-b1bb-ba08829887aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1d3ae902-102a-40d6-b1bb-ba08829887aa" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1ffd18a6-2bb3-447b-94f5-180d266f81b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1ffd18a6-2bb3-447b-94f5-180d266f81b4" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4aee1b71-e817-434e-8573-34cfc7c4379a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4aee1b71-e817-434e-8573-34cfc7c4379a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4aee1b71-e817-434e-8573-34cfc7c4379a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4aee1b71-e817-434e-8573-34cfc7c4379a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4aee1b71-e817-434e-8573-34cfc7c4379a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6f15e3e7-589e-4658-8d69-ec430211ba22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4aee1b71-e817-434e-8573-34cfc7c4379a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6f15e3e7-589e-4658-8d69-ec430211ba22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_57676f79-4019-4c43-be5a-3ab23e2c62e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6f15e3e7-589e-4658-8d69-ec430211ba22" xlink:to="loc_us-gaap_UnsecuredDebtMember_57676f79-4019-4c43-be5a-3ab23e2c62e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4e2027c1-12e1-42ae-b467-9b49c0aedd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6f15e3e7-589e-4658-8d69-ec430211ba22" xlink:to="loc_us-gaap_SecuredDebtMember_4e2027c1-12e1-42ae-b467-9b49c0aedd5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c26be990-5252-46ee-811f-14de3ecba6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_DebtInstrumentAxis_c26be990-5252-46ee-811f-14de3ecba6bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c26be990-5252-46ee-811f-14de3ecba6bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c26be990-5252-46ee-811f-14de3ecba6bb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c26be990-5252-46ee-811f-14de3ecba6bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c26be990-5252-46ee-811f-14de3ecba6bb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_d8e59fe1-2c63-4fe0-bd25-69a970b59e1e" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_d8e59fe1-2c63-4fe0-bd25-69a970b59e1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_3c462fc1-2acd-4ab8-b7cf-284dddfdb379" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_3c462fc1-2acd-4ab8-b7cf-284dddfdb379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_6b5a60a7-23c4-4601-94fc-3c84f893e5b6" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_6b5a60a7-23c4-4601-94fc-3c84f893e5b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_b3091e7b-a007-4460-9218-93a622efb30d" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_b3091e7b-a007-4460-9218-93a622efb30d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_9eef5a00-ef68-457e-98f0-cc4db1242a3c" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_9eef5a00-ef68-457e-98f0-cc4db1242a3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis_f5375314-91a6-4ef3-9c3a-29abc01865eb" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsAxis_f5375314-91a6-4ef3-9c3a-29abc01865eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_f5375314-91a6-4ef3-9c3a-29abc01865eb_default" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_f5375314-91a6-4ef3-9c3a-29abc01865eb" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_f5375314-91a6-4ef3-9c3a-29abc01865eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_811b051d-1037-4720-96f1-4fcb623f7cea" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_f5375314-91a6-4ef3-9c3a-29abc01865eb" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_811b051d-1037-4720-96f1-4fcb623f7cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_056b1136-816f-4ed4-9713-3113a2644200" xlink:href="pcrx-20220630.xsd#pcrx_DebtRedemptionTermsPriorToFebruary32023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_811b051d-1037-4720-96f1-4fcb623f7cea" xlink:to="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_056b1136-816f-4ed4-9713-3113a2644200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_d1041cf1-6a66-44a5-81d8-9fc2363157fd" xlink:href="pcrx-20220630.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_811b051d-1037-4720-96f1-4fcb623f7cea" xlink:to="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_d1041cf1-6a66-44a5-81d8-9fc2363157fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_fe20277e-ed00-4e68-a33b-5a644852c821" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_srt_StatementScenarioAxis_fe20277e-ed00-4e68-a33b-5a644852c821" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fe20277e-ed00-4e68-a33b-5a644852c821_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_fe20277e-ed00-4e68-a33b-5a644852c821" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fe20277e-ed00-4e68-a33b-5a644852c821_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1959fe1f-6850-4677-aa12-b34cf0aa99b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_fe20277e-ed00-4e68-a33b-5a644852c821" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1959fe1f-6850-4677-aa12-b34cf0aa99b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_6b29c330-3325-474b-b393-6b4ce4541a51" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1959fe1f-6850-4677-aa12-b34cf0aa99b2" xlink:to="loc_srt_ScenarioForecastMember_6b29c330-3325-474b-b393-6b4ce4541a51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f682b36f-52cb-4052-bb33-6d99188dd03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f682b36f-52cb-4052-bb33-6d99188dd03b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f682b36f-52cb-4052-bb33-6d99188dd03b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f682b36f-52cb-4052-bb33-6d99188dd03b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f682b36f-52cb-4052-bb33-6d99188dd03b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b53d5bbf-ab38-4a2c-877f-526386892bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f682b36f-52cb-4052-bb33-6d99188dd03b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b53d5bbf-ab38-4a2c-877f-526386892bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c7f7b66a-178e-4171-9eb6-f6961270b42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b53d5bbf-ab38-4a2c-877f-526386892bcc" xlink:to="loc_us-gaap_SubsequentEventMember_c7f7b66a-178e-4171-9eb6-f6961270b42b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a65b98bd-58fd-4902-a295-02b85583a730" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_dei_LegalEntityAxis_a65b98bd-58fd-4902-a295-02b85583a730" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a65b98bd-58fd-4902-a295-02b85583a730_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a65b98bd-58fd-4902-a295-02b85583a730" xlink:to="loc_dei_EntityDomain_a65b98bd-58fd-4902-a295-02b85583a730_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_48dd0a02-8dea-4d6a-a5e8-a84cbe7d282f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a65b98bd-58fd-4902-a295-02b85583a730" xlink:to="loc_dei_EntityDomain_48dd0a02-8dea-4d6a-a5e8-a84cbe7d282f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_8746fff1-abd9-4b3c-83e3-6fa091f2ce7a" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_48dd0a02-8dea-4d6a-a5e8-a84cbe7d282f" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_8746fff1-abd9-4b3c-83e3-6fa091f2ce7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c4d37409-c31c-4d33-b79a-505a0149b608" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_srt_RangeAxis_c4d37409-c31c-4d33-b79a-505a0149b608" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c4d37409-c31c-4d33-b79a-505a0149b608_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c4d37409-c31c-4d33-b79a-505a0149b608" xlink:to="loc_srt_RangeMember_c4d37409-c31c-4d33-b79a-505a0149b608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f7139b7d-041d-42f3-991b-5c635b1d4768" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c4d37409-c31c-4d33-b79a-505a0149b608" xlink:to="loc_srt_RangeMember_f7139b7d-041d-42f3-991b-5c635b1d4768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_af39f1ce-039d-438d-9061-049d764e2c60" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f7139b7d-041d-42f3-991b-5c635b1d4768" xlink:to="loc_srt_MinimumMember_af39f1ce-039d-438d-9061-049d764e2c60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_231cbe8f-d78c-4029-970e-b0b139241524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_VariableRateAxis_231cbe8f-d78c-4029-970e-b0b139241524" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_231cbe8f-d78c-4029-970e-b0b139241524_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_231cbe8f-d78c-4029-970e-b0b139241524" xlink:to="loc_us-gaap_VariableRateDomain_231cbe8f-d78c-4029-970e-b0b139241524_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_231cbe8f-d78c-4029-970e-b0b139241524" xlink:to="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_819576f7-19cc-4378-9f57-2cd0cc5083b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_819576f7-19cc-4378-9f57-2cd0cc5083b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_b4d001a7-40b1-42ac-9539-c722e6073452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:to="loc_us-gaap_BaseRateMember_b4d001a7-40b1-42ac-9539-c722e6073452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FederalReserveBankOfNYRateMember_663e4641-488c-43d9-b5d0-fc7b633fb6c0" xlink:href="pcrx-20220630.xsd#pcrx_FederalReserveBankOfNYRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:to="loc_pcrx_FederalReserveBankOfNYRateMember_663e4641-488c-43d9-b5d0-fc7b633fb6c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_38700614-b987-4fe4-8c80-cd5d10bd4802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_38700614-b987-4fe4-8c80-cd5d10bd4802" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_38700614-b987-4fe4-8c80-cd5d10bd4802_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_38700614-b987-4fe4-8c80-cd5d10bd4802" xlink:to="loc_us-gaap_EquityComponentDomain_38700614-b987-4fe4-8c80-cd5d10bd4802_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0331cde4-fbef-4637-a6d3-15fef5141f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_38700614-b987-4fe4-8c80-cd5d10bd4802" xlink:to="loc_us-gaap_EquityComponentDomain_0331cde4-fbef-4637-a6d3-15fef5141f1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_969c7a53-f961-48bf-8da3-583b49509afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0331cde4-fbef-4637-a6d3-15fef5141f1d" xlink:to="loc_us-gaap_CommonStockMember_969c7a53-f961-48bf-8da3-583b49509afd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended" id="i2dc01f42339c4b38ad5a8f691b26fcbd_DEBTScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ee5b1a1c-bc40-4f68-a309-c590a6fd5037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ee5b1a1c-bc40-4f68-a309-c590a6fd5037" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_962c6276-08c4-41b4-ade2-bf289810a6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_962c6276-08c4-41b4-ade2-bf289810a6f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_de4211ef-b6e6-4676-bccd-96d872207f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_de4211ef-b6e6-4676-bccd-96d872207f44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7f7b5f70-fceb-4a24-bd22-bbea90ced7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7f7b5f70-fceb-4a24-bd22-bbea90ced7d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d1d757b0-2217-43d5-af57-83e2613967bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_LongTermDebt_d1d757b0-2217-43d5-af57-83e2613967bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_016bfc5f-8962-4422-91f1-75f4adf06c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_016bfc5f-8962-4422-91f1-75f4adf06c8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_016bfc5f-8962-4422-91f1-75f4adf06c8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_016bfc5f-8962-4422-91f1-75f4adf06c8b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_016bfc5f-8962-4422-91f1-75f4adf06c8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c701313-19c7-4d2a-aa69-073effe330f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_016bfc5f-8962-4422-91f1-75f4adf06c8b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c701313-19c7-4d2a-aa69-073effe330f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_05a3ac5f-ea5b-4634-b9e0-9bfee0951212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c701313-19c7-4d2a-aa69-073effe330f8" xlink:to="loc_us-gaap_UnsecuredDebtMember_05a3ac5f-ea5b-4634-b9e0-9bfee0951212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5d1eac7e-26a6-41c8-99e6-05a71f7b0bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c701313-19c7-4d2a-aa69-073effe330f8" xlink:to="loc_us-gaap_SecuredDebtMember_5d1eac7e-26a6-41c8-99e6-05a71f7b0bc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b9197e6a-498e-470d-b0f4-935ecc296312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:to="loc_us-gaap_DebtInstrumentAxis_b9197e6a-498e-470d-b0f4-935ecc296312" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b9197e6a-498e-470d-b0f4-935ecc296312_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9197e6a-498e-470d-b0f4-935ecc296312" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b9197e6a-498e-470d-b0f4-935ecc296312_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9197e6a-498e-470d-b0f4-935ecc296312" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_f8f7baa0-475b-4dca-8a74-4e66b2ef8e4e" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_f8f7baa0-475b-4dca-8a74-4e66b2ef8e4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_2ea7715e-ccb2-4032-9077-a7f9ccce7a30" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_2ea7715e-ccb2-4032-9077-a7f9ccce7a30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_b3abe425-82fd-440e-b020-33be53b8aa2d" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_b3abe425-82fd-440e-b020-33be53b8aa2d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended" id="ib1fade40fe28454c9e4e045db9582fa8_FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_db395496-e01a-4c62-8558-308ec80eecc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_db395496-e01a-4c62-8558-308ec80eecc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e76caf7a-1784-434c-b3cb-1d330b0b065f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_db395496-e01a-4c62-8558-308ec80eecc3" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e76caf7a-1784-434c-b3cb-1d330b0b065f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_99fd3508-4471-41d9-8753-27f37c330902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_db395496-e01a-4c62-8558-308ec80eecc3" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_99fd3508-4471-41d9-8753-27f37c330902" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_7f43d830-ffe5-4c1b-aebd-d8262f7b0ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_7f43d830-ffe5-4c1b-aebd-d8262f7b0ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a4752873-2a9b-4b4c-b8be-be5a81a1accc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_7f43d830-ffe5-4c1b-aebd-d8262f7b0ff1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a4752873-2a9b-4b4c-b8be-be5a81a1accc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_6e669c1e-4460-4264-9562-79a7d2f95832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_6e669c1e-4460-4264-9562-79a7d2f95832" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8e5f10b8-11aa-4a7d-b29a-a83b8c434f84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8e5f10b8-11aa-4a7d-b29a-a83b8c434f84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_2e3a422e-9a9c-4c7b-934e-0d80cab72f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_SharePrice_2e3a422e-9a9c-4c7b-934e-0d80cab72f5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1fc236f3-5462-45df-87b5-3e84c368a24d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1fc236f3-5462-45df-87b5-3e84c368a24d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_8d336d25-fea2-44f6-964b-ec145e97f426" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_8d336d25-fea2-44f6-964b-ec145e97f426" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_3bff0ee9-2332-4365-8b68-2415772a7495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_3bff0ee9-2332-4365-8b68-2415772a7495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3bff0ee9-2332-4365-8b68-2415772a7495_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_3bff0ee9-2332-4365-8b68-2415772a7495" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3bff0ee9-2332-4365-8b68-2415772a7495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_3bff0ee9-2332-4365-8b68-2415772a7495" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d277eddd-2463-4dff-aed3-a958c74365b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d277eddd-2463-4dff-aed3-a958c74365b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b01b429d-a116-41a1-932d-85b5ca82facf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b01b429d-a116-41a1-932d-85b5ca82facf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6c4f1789-1d3b-431a-8884-908af4f059bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6c4f1789-1d3b-431a-8884-908af4f059bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f054d963-d359-4da8-b956-26388a421630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f054d963-d359-4da8-b956-26388a421630" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f054d963-d359-4da8-b956-26388a421630_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f054d963-d359-4da8-b956-26388a421630" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f054d963-d359-4da8-b956-26388a421630_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f054d963-d359-4da8-b956-26388a421630" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_93e681f8-acc1-4e2b-b9f5-febb3237a002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_93e681f8-acc1-4e2b-b9f5-febb3237a002" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b83fd04e-fecc-4231-88b4-91a041059cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b83fd04e-fecc-4231-88b4-91a041059cb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_863a6573-e350-42c1-b7be-57393f835807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_863a6573-e350-42c1-b7be-57393f835807" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d6174461-e4e4-4062-af32-fc7b20da9c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_DebtInstrumentAxis_d6174461-e4e4-4062-af32-fc7b20da9c7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d6174461-e4e4-4062-af32-fc7b20da9c7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d6174461-e4e4-4062-af32-fc7b20da9c7a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d6174461-e4e4-4062-af32-fc7b20da9c7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d6174461-e4e4-4062-af32-fc7b20da9c7a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_e9ea8e2f-dbb4-42f3-ad14-e8c0d19cc1ae" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_e9ea8e2f-dbb4-42f3-ad14-e8c0d19cc1ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_5e7515f4-c5f9-464c-a2f5-0c25e5180fed" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_5e7515f4-c5f9-464c-a2f5-0c25e5180fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_041559fa-a499-4960-8fc4-f74bc190c424" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_041559fa-a499-4960-8fc4-f74bc190c424" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d55601da-6f11-4206-919c-7889286d2f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d55601da-6f11-4206-919c-7889286d2f03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d55601da-6f11-4206-919c-7889286d2f03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d55601da-6f11-4206-919c-7889286d2f03" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d55601da-6f11-4206-919c-7889286d2f03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_df1719cb-69c2-4372-b807-9f6bb45185c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d55601da-6f11-4206-919c-7889286d2f03" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_df1719cb-69c2-4372-b807-9f6bb45185c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_bdfd0185-eda4-495c-9f1c-a8a0b3f20340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df1719cb-69c2-4372-b807-9f6bb45185c3" xlink:to="loc_us-gaap_SecuredDebtMember_bdfd0185-eda4-495c-9f1c-a8a0b3f20340" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_7bdf8555-7836-4180-ae55-6ae73f42f43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df1719cb-69c2-4372-b807-9f6bb45185c3" xlink:to="loc_us-gaap_UnsecuredDebtMember_7bdf8555-7836-4180-ae55-6ae73f42f43e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_03710226-f5b5-4290-97cc-b60efe8ab244" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_srt_RangeAxis_03710226-f5b5-4290-97cc-b60efe8ab244" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_03710226-f5b5-4290-97cc-b60efe8ab244_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_03710226-f5b5-4290-97cc-b60efe8ab244" xlink:to="loc_srt_RangeMember_03710226-f5b5-4290-97cc-b60efe8ab244_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99e53137-b282-4939-a594-f3b87618ee77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_03710226-f5b5-4290-97cc-b60efe8ab244" xlink:to="loc_srt_RangeMember_99e53137-b282-4939-a594-f3b87618ee77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_84dc6b99-63c6-48bb-9051-987331a349a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_99e53137-b282-4939-a594-f3b87618ee77" xlink:to="loc_srt_MaximumMember_84dc6b99-63c6-48bb-9051-987331a349a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" xlink:type="extended" id="iebba0567898c43748df2dec2ae9a0a66_FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_671be3e1-72d5-45cb-8adf-bfad38087c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_671be3e1-72d5-45cb-8adf-bfad38087c42" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_21b7f870-d5f1-41db-8f5c-58a704c591d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_21b7f870-d5f1-41db-8f5c-58a704c591d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_dcb0c713-c0f8-41fe-9248-706705c9399c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_dcb0c713-c0f8-41fe-9248-706705c9399c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_c83fdd59-615b-4105-8ef2-44a50b93da74" xlink:href="pcrx-20220630.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_c83fdd59-615b-4105-8ef2-44a50b93da74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6b34cc17-5383-41b7-b41b-b75b9a46c716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e30dcb4e-4e88-4852-abf5-0b790db601bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_671be3e1-72d5-45cb-8adf-bfad38087c42" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e30dcb4e-4e88-4852-abf5-0b790db601bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3981b7a0-00f6-47b6-b0c1-9dcc692bb989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e30dcb4e-4e88-4852-abf5-0b790db601bb" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3981b7a0-00f6-47b6-b0c1-9dcc692bb989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3981b7a0-00f6-47b6-b0c1-9dcc692bb989_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3981b7a0-00f6-47b6-b0c1-9dcc692bb989" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3981b7a0-00f6-47b6-b0c1-9dcc692bb989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e03849e6-74ff-423f-870c-40d6a731da46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3981b7a0-00f6-47b6-b0c1-9dcc692bb989" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e03849e6-74ff-423f-870c-40d6a731da46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_cc4bd615-f7f3-4673-bede-ace551053ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e03849e6-74ff-423f-870c-40d6a731da46" xlink:to="loc_us-gaap_EquitySecuritiesMember_cc4bd615-f7f3-4673-bede-ace551053ab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleNotesReceivableMember_60ab5bdd-e05e-4a1e-a340-1115134d52b7" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleNotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e03849e6-74ff-423f-870c-40d6a731da46" xlink:to="loc_pcrx_ConvertibleNotesReceivableMember_60ab5bdd-e05e-4a1e-a340-1115134d52b7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended" id="ia10e47317cf24dfd92aa2cf379a9c0f6_FINANCIALINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_164b490f-c7b9-47ec-a270-83617d1368e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_164b490f-c7b9-47ec-a270-83617d1368e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_cbea6c95-994d-4362-8076-f0c999e01280" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_cbea6c95-994d-4362-8076-f0c999e01280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_27619b64-b133-4a58-9e46-07400f56bc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_27619b64-b133-4a58-9e46-07400f56bc79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_de6be309-6923-4c8c-b3ae-d5b1b79552b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_de6be309-6923-4c8c-b3ae-d5b1b79552b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_e201086c-092c-48ea-9517-af941fec542d" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_pcrx_ContingentConsideration_e201086c-092c-48ea-9517-af941fec542d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent_144d9715-0854-409e-9090-e1ea3690a7df" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_pcrx_ContingentConsiderationCurrent_144d9715-0854-409e-9090-e1ea3690a7df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_37e10765-b245-4467-a80a-f05388098b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_InterestReceivable_37e10765-b245-4467-a80a-f05388098b56" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfMajorCustomers_9679e3af-d0cc-4fb5-a03c-9e28d7ddb184" xlink:href="pcrx-20220630.xsd#pcrx_NumberOfMajorCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_pcrx_NumberOfMajorCustomers_9679e3af-d0cc-4fb5-a03c-9e28d7ddb184" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ae965a38-c846-4e66-9c28-640734e79f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ae965a38-c846-4e66-9c28-640734e79f89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6075ee45-b2da-4948-8924-1724fded04fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6075ee45-b2da-4948-8924-1724fded04fe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_078fa16d-51a6-439c-93df-83d3b5d512d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_078fa16d-51a6-439c-93df-83d3b5d512d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_078fa16d-51a6-439c-93df-83d3b5d512d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_078fa16d-51a6-439c-93df-83d3b5d512d8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_078fa16d-51a6-439c-93df-83d3b5d512d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_078fa16d-51a6-439c-93df-83d3b5d512d8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_9dcb8918-bc13-46d6-9b0d-60ed6cffa033" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_9dcb8918-bc13-46d6-9b0d-60ed6cffa033" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_9e250328-0459-4735-a960-ef9a347c76cb" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:to="loc_pcrx_FlexionAcquisitionMember_9e250328-0459-4735-a960-ef9a347c76cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_adf00834-b9bd-4e56-b467-6449b5e142b1" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAndMyoScienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:to="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_adf00834-b9bd-4e56-b467-6449b5e142b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_c07921d6-f6eb-46d4-b901-8b201f54fe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_c07921d6-f6eb-46d4-b901-8b201f54fe6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c07921d6-f6eb-46d4-b901-8b201f54fe6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c07921d6-f6eb-46d4-b901-8b201f54fe6a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c07921d6-f6eb-46d4-b901-8b201f54fe6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c7eca5f0-57ef-4ce7-931e-dfe3abd361ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c07921d6-f6eb-46d4-b901-8b201f54fe6a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c7eca5f0-57ef-4ce7-931e-dfe3abd361ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_f90fe133-2f7c-4718-9c2b-949b464dfaee" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c7eca5f0-57ef-4ce7-931e-dfe3abd361ee" xlink:to="loc_pcrx_ContingentConsiderationMember_f90fe133-2f7c-4718-9c2b-949b464dfaee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4f52d58f-8742-45fa-886a-24464154f334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4f52d58f-8742-45fa-886a-24464154f334" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f52d58f-8742-45fa-886a-24464154f334_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4f52d58f-8742-45fa-886a-24464154f334" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f52d58f-8742-45fa-886a-24464154f334_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a2313032-632d-4741-83d0-45b45314016f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4f52d58f-8742-45fa-886a-24464154f334" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a2313032-632d-4741-83d0-45b45314016f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_4ff0e378-41f1-4706-ac8d-e195f0143b14" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a2313032-632d-4741-83d0-45b45314016f" xlink:to="loc_pcrx_ContingentConsiderationMember_4ff0e378-41f1-4706-ac8d-e195f0143b14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7495cc83-f1e7-4755-b883-2b11510a7fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7495cc83-f1e7-4755-b883-2b11510a7fc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7495cc83-f1e7-4755-b883-2b11510a7fc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7495cc83-f1e7-4755-b883-2b11510a7fc2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7495cc83-f1e7-4755-b883-2b11510a7fc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7495cc83-f1e7-4755-b883-2b11510a7fc2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_27a07ed1-f097-471a-99a8-c723e39e90c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_27a07ed1-f097-471a-99a8-c723e39e90c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_cc17a63e-e4ca-4359-aea3-98fe07ab7d70" xlink:href="pcrx-20220630.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_cc17a63e-e4ca-4359-aea3-98fe07ab7d70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_1d501cf2-1b78-4598-bf19-1d3733642a7d" xlink:href="pcrx-20220630.xsd#pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:to="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_1d501cf2-1b78-4598-bf19-1d3733642a7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dfded32-7905-4191-9423-117c88dfc22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dfded32-7905-4191-9423-117c88dfc22f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5dfded32-7905-4191-9423-117c88dfc22f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dfded32-7905-4191-9423-117c88dfc22f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5dfded32-7905-4191-9423-117c88dfc22f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37510366-f462-4c9e-b52b-264a922e296f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dfded32-7905-4191-9423-117c88dfc22f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37510366-f462-4c9e-b52b-264a922e296f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ecc47778-b3f7-416f-869c-fbf5c1f4bbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37510366-f462-4c9e-b52b-264a922e296f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ecc47778-b3f7-416f-869c-fbf5c1f4bbcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3241ae77-25fb-43a7-bf99-4c5d4c3a288f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3241ae77-25fb-43a7-bf99-4c5d4c3a288f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3241ae77-25fb-43a7-bf99-4c5d4c3a288f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3241ae77-25fb-43a7-bf99-4c5d4c3a288f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3241ae77-25fb-43a7-bf99-4c5d4c3a288f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_115e5c0f-2293-429c-9aa7-8d13bc775ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3241ae77-25fb-43a7-bf99-4c5d4c3a288f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_115e5c0f-2293-429c-9aa7-8d13bc775ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_baf136c1-5168-4393-8e12-c92ce2ae9b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_115e5c0f-2293-429c-9aa7-8d13bc775ffa" xlink:to="loc_us-gaap_AccountsReceivableMember_baf136c1-5168-4393-8e12-c92ce2ae9b8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e6cb2df7-103f-4aaa-9e29-bd45754692a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e6cb2df7-103f-4aaa-9e29-bd45754692a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e6cb2df7-103f-4aaa-9e29-bd45754692a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e6cb2df7-103f-4aaa-9e29-bd45754692a4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e6cb2df7-103f-4aaa-9e29-bd45754692a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b7f5b9f4-6afc-406c-9c13-56d88b936deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e6cb2df7-103f-4aaa-9e29-bd45754692a4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b7f5b9f4-6afc-406c-9c13-56d88b936deb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_9a858c3a-8f69-4a27-96df-aae07ee15ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b7f5b9f4-6afc-406c-9c13-56d88b936deb" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_9a858c3a-8f69-4a27-96df-aae07ee15ee6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_0237988a-bda7-4ea2-8665-a31739eb667a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_srt_MajorCustomersAxis_0237988a-bda7-4ea2-8665-a31739eb667a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0237988a-bda7-4ea2-8665-a31739eb667a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_0237988a-bda7-4ea2-8665-a31739eb667a" xlink:to="loc_srt_NameOfMajorCustomerDomain_0237988a-bda7-4ea2-8665-a31739eb667a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_0237988a-bda7-4ea2-8665-a31739eb667a" xlink:to="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember_e4f9a523-a10f-4900-be70-3dee0176b4d8" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:to="loc_pcrx_MajorCustomerOneMember_e4f9a523-a10f-4900-be70-3dee0176b4d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember_665cacd2-32ec-4a33-ad87-1b65fd7453dc" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:to="loc_pcrx_MajorCustomerTwoMember_665cacd2-32ec-4a33-ad87-1b65fd7453dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember_7abdd8fa-fc05-4664-b211-92ad82729ed7" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:to="loc_pcrx_MajorCustomerThreeMember_7abdd8fa-fc05-4664-b211-92ad82729ed7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerFourMember_a2a2171e-642a-4af4-9051-afd8fa4897f0" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:to="loc_pcrx_MajorCustomerFourMember_a2a2171e-642a-4af4-9051-afd8fa4897f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_srt_RangeAxis_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e" xlink:to="loc_srt_RangeMember_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_65adc98e-18c9-417f-92b9-c72dd7d9a6f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e" xlink:to="loc_srt_RangeMember_65adc98e-18c9-417f-92b9-c72dd7d9a6f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_cbd12058-e20d-4f47-9363-42ab2bbb6008" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_65adc98e-18c9-417f-92b9-c72dd7d9a6f8" xlink:to="loc_srt_WeightedAverageMember_cbd12058-e20d-4f47-9363-42ab2bbb6008" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="extended" id="ifb694d81aab64d4c89556c98a0d6bf18_FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_863912f6-a86f-403b-9efb-3957feb3c33b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9e66c3b0-b0c9-4908-aa19-2dfc26f3ce85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_863912f6-a86f-403b-9efb-3957feb3c33b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9e66c3b0-b0c9-4908-aa19-2dfc26f3ce85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_863912f6-a86f-403b-9efb-3957feb3c33b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9fd686bd-f611-490d-b636-bf8fece95d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9fd686bd-f611-490d-b636-bf8fece95d99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9fd686bd-f611-490d-b636-bf8fece95d99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9fd686bd-f611-490d-b636-bf8fece95d99" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9fd686bd-f611-490d-b636-bf8fece95d99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2cc4d07-c527-4079-83cc-8d1b331b5729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9fd686bd-f611-490d-b636-bf8fece95d99" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2cc4d07-c527-4079-83cc-8d1b331b5729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5775ba91-3ce2-4be1-901a-09c34bf83082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2cc4d07-c527-4079-83cc-8d1b331b5729" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5775ba91-3ce2-4be1-901a-09c34bf83082" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_srt_RangeAxis_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176" xlink:to="loc_srt_RangeMember_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4fe9931e-d4f2-4e18-9678-2a15e9595f6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176" xlink:to="loc_srt_RangeMember_4fe9931e-d4f2-4e18-9678-2a15e9595f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_84024345-6952-4a4f-af8e-dec0282baa5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4fe9931e-d4f2-4e18-9678-2a15e9595f6d" xlink:to="loc_srt_MinimumMember_84024345-6952-4a4f-af8e-dec0282baa5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2f22990e-85c7-412b-8212-3837aa09f3b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4fe9931e-d4f2-4e18-9678-2a15e9595f6d" xlink:to="loc_srt_MaximumMember_2f22990e-85c7-412b-8212-3837aa09f3b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2755e119-0f7c-461b-b1ff-b432aa9bd869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2755e119-0f7c-461b-b1ff-b432aa9bd869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_be885bef-a607-4c09-9332-02d0d896cc19" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2755e119-0f7c-461b-b1ff-b432aa9bd869" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_be885bef-a607-4c09-9332-02d0d896cc19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_e123f770-9371-45f5-a0d0-4aaff598b047" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2755e119-0f7c-461b-b1ff-b432aa9bd869" xlink:to="loc_pcrx_FlexionAcquisitionMember_e123f770-9371-45f5-a0d0-4aaff598b047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_FinancialInstrumentAxis_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9214b7b6-ce4a-4d0f-bdb6-44e1e949971c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9214b7b6-ce4a-4d0f-bdb6-44e1e949971c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_da3411b2-f8b7-4f54-ba8f-59f8cda2d356" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9214b7b6-ce4a-4d0f-bdb6-44e1e949971c" xlink:to="loc_pcrx_ContingentConsiderationMember_da3411b2-f8b7-4f54-ba8f-59f8cda2d356" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_87f8d2a9-98d6-4199-866c-fa2867832dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_87f8d2a9-98d6-4199-866c-fa2867832dc6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_87f8d2a9-98d6-4199-866c-fa2867832dc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_87f8d2a9-98d6-4199-866c-fa2867832dc6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_87f8d2a9-98d6-4199-866c-fa2867832dc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_2676198a-fdf8-4781-9bc7-568c2338da4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_87f8d2a9-98d6-4199-866c-fa2867832dc6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_2676198a-fdf8-4781-9bc7-568c2338da4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_21c2d7a2-a1d8-4126-aea0-dd6c41eac595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2676198a-fdf8-4781-9bc7-568c2338da4d" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_21c2d7a2-a1d8-4126-aea0-dd6c41eac595" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_8c0a8b15-9b03-40f4-82fb-626deed7ec13" xlink:href="pcrx-20220630.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2676198a-fdf8-4781-9bc7-568c2338da4d" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_8c0a8b15-9b03-40f4-82fb-626deed7ec13" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="extended" id="i1cad27edaade48d7a2dd866300821c6e_FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1018bb86-dd94-4e8c-becb-a1b3f2a73637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1018bb86-dd94-4e8c-becb-a1b3f2a73637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ba1a4dee-ca38-496c-9c6f-530476b6fdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ba1a4dee-ca38-496c-9c6f-530476b6fdf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_75921562-ea33-449d-b62a-b3380be5617e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_2703e4f4-8d2f-4eee-89e8-5dab1f9bd174" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:to="loc_pcrx_ContingentConsideration_2703e4f4-8d2f-4eee-89e8-5dab1f9bd174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_84838b23-04ac-474b-8f46-c096332c970f" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_84838b23-04ac-474b-8f46-c096332c970f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_92c8bd7e-b159-408d-acd8-4ddbf7946cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_92c8bd7e-b159-408d-acd8-4ddbf7946cfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_92c8bd7e-b159-408d-acd8-4ddbf7946cfa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92c8bd7e-b159-408d-acd8-4ddbf7946cfa" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_92c8bd7e-b159-408d-acd8-4ddbf7946cfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c88686f-e768-4352-bf32-9ecb114cfde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92c8bd7e-b159-408d-acd8-4ddbf7946cfa" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c88686f-e768-4352-bf32-9ecb114cfde6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_70b56976-42bd-4bab-8ec0-c787d80f6091" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c88686f-e768-4352-bf32-9ecb114cfde6" xlink:to="loc_pcrx_ContingentConsiderationMember_70b56976-42bd-4bab-8ec0-c787d80f6091" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72ce94b3-de89-4770-8f4b-3d1a04c38eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72ce94b3-de89-4770-8f4b-3d1a04c38eef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_bbfaf879-4125-479f-bcf7-cefb0d502213" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72ce94b3-de89-4770-8f4b-3d1a04c38eef" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_bbfaf879-4125-479f-bcf7-cefb0d502213" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_1272f16d-9c64-4855-bff5-85787991f4d4" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72ce94b3-de89-4770-8f4b-3d1a04c38eef" xlink:to="loc_pcrx_FlexionAcquisitionMember_1272f16d-9c64-4855-bff5-85787991f4d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended" id="ia3f85b63bf8046c196c7dd9c93fdb227_FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0981ccd0-6cc4-4854-a414-cb52eb1947f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0981ccd0-6cc4-4854-a414-cb52eb1947f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_94ccaaf8-8f0e-4448-bab2-a2135181e6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_94ccaaf8-8f0e-4448-bab2-a2135181e6f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2a5d388a-a650-4a05-bea2-51863d7acede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2a5d388a-a650-4a05-bea2-51863d7acede" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_64db4c76-8a18-4724-ab4c-60326c66015d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_64db4c76-8a18-4724-ab4c-60326c66015d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cf169d65-5cbb-4704-ae53-a9aaf449d8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cf169d65-5cbb-4704-ae53-a9aaf449d8e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf169d65-5cbb-4704-ae53-a9aaf449d8e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cf169d65-5cbb-4704-ae53-a9aaf449d8e0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf169d65-5cbb-4704-ae53-a9aaf449d8e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cf169d65-5cbb-4704-ae53-a9aaf449d8e0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_18211cee-7425-41aa-8146-44c06aed7fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_18211cee-7425-41aa-8146-44c06aed7fc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_66f59739-7a02-4aa5-b1a0-052a5c3e9847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:to="loc_us-gaap_CommercialPaperMember_66f59739-7a02-4aa5-b1a0-052a5c3e9847" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_cddcc4d6-1903-44da-85b7-4d6f4b9b9800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_cddcc4d6-1903-44da-85b7-4d6f4b9b9800" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember_9f4e8c73-29fd-40ea-bb49-a0a64e8d7943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:to="loc_us-gaap_USTreasuryBondSecuritiesMember_9f4e8c73-29fd-40ea-bb49-a0a64e8d7943" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ad69d497-e88c-41ba-99d5-e54e869276b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:to="loc_us-gaap_InvestmentTypeAxis_ad69d497-e88c-41ba-99d5-e54e869276b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ad69d497-e88c-41ba-99d5-e54e869276b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ad69d497-e88c-41ba-99d5-e54e869276b4" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ad69d497-e88c-41ba-99d5-e54e869276b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c8da82d7-a562-432d-b75c-07ba47973155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ad69d497-e88c-41ba-99d5-e54e869276b4" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c8da82d7-a562-432d-b75c-07ba47973155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_197cc740-e53c-443c-89c7-5b27a3565a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c8da82d7-a562-432d-b75c-07ba47973155" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_197cc740-e53c-443c-89c7-5b27a3565a9a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKHOLDERSEQUITYDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="extended" id="id3da2ef16d1b4a5b911295ec5203a18e_STOCKHOLDERSEQUITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f96e3971-81dd-4c0f-a563-5842de3b2080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f96e3971-81dd-4c0f-a563-5842de3b2080" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_10ead7af-af63-437d-bc14-a031eb4b5914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:to="loc_us-gaap_StockholdersEquity_10ead7af-af63-437d-bc14-a031eb4b5914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_19d64a5c-75c7-43e6-926e-224567abd16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_19d64a5c-75c7-43e6-926e-224567abd16f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a7fae308-9c23-4e06-97c3-e82cdc946484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a7fae308-9c23-4e06-97c3-e82cdc946484" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_19df1b9a-06af-40ae-a89d-aee7414ad513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f6ac83cf-84fd-4405-805d-96a46f21ef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f96e3971-81dd-4c0f-a563-5842de3b2080" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f6ac83cf-84fd-4405-805d-96a46f21ef1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_23f4d144-39f9-4bca-8e88-fbf21e031367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f6ac83cf-84fd-4405-805d-96a46f21ef1e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_23f4d144-39f9-4bca-8e88-fbf21e031367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_23f4d144-39f9-4bca-8e88-fbf21e031367_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_23f4d144-39f9-4bca-8e88-fbf21e031367" xlink:to="loc_us-gaap_EquityComponentDomain_23f4d144-39f9-4bca-8e88-fbf21e031367_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_23f4d144-39f9-4bca-8e88-fbf21e031367" xlink:to="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9d3117a2-a722-4f2a-bca8-302f2f407364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9d3117a2-a722-4f2a-bca8-302f2f407364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e38b69c5-bcf3-471d-9f05-e999aed8eec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e38b69c5-bcf3-471d-9f05-e999aed8eec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b290d2ae-0d70-434e-8ae1-68b19f9332ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b290d2ae-0d70-434e-8ae1-68b19f9332ed" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended" id="i3c85b85307884107b1c4e6b542c04791_STOCKPLANSScheduleofStockBasedCompensationExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_300b62c8-16fb-4491-a824-0de35ea5a613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_01cf10cf-9925-44f4-89cd-e8a1df229151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_300b62c8-16fb-4491-a824-0de35ea5a613" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_01cf10cf-9925-44f4-89cd-e8a1df229151" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_300b62c8-16fb-4491-a824-0de35ea5a613" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_70b0b358-3100-4f38-a436-e7a7a4e984b8" xlink:href="pcrx-20220630.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_70b0b358-3100-4f38-a436-e7a7a4e984b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_08e902b7-68b1-4baf-99d9-82650681058f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:to="loc_us-gaap_RestrictedStockExpense_08e902b7-68b1-4baf-99d9-82650681058f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_e372817f-4cbc-4780-a219-f981bd95663e" xlink:href="pcrx-20220630.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_e372817f-4cbc-4780-a219-f981bd95663e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_292d667a-1b9d-4095-a575-6cd88e6b0d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:to="loc_us-gaap_ShareBasedCompensation_292d667a-1b9d-4095-a575-6cd88e6b0d53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d05b61d-9408-4c8c-ae72-333fd7a2d420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_300b62c8-16fb-4491-a824-0de35ea5a613" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d05b61d-9408-4c8c-ae72-333fd7a2d420" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6c52b427-0d9f-4c61-8fc7-7c04946af0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d05b61d-9408-4c8c-ae72-333fd7a2d420" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6c52b427-0d9f-4c61-8fc7-7c04946af0f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6c52b427-0d9f-4c61-8fc7-7c04946af0f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c52b427-0d9f-4c61-8fc7-7c04946af0f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6c52b427-0d9f-4c61-8fc7-7c04946af0f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c52b427-0d9f-4c61-8fc7-7c04946af0f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_8a15d321-b03d-433a-8cdb-2f03508a793a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:to="loc_us-gaap_CostOfSalesMember_8a15d321-b03d-433a-8cdb-2f03508a793a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ad69a6ed-0892-4a61-88e0-284eea3a3b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ad69a6ed-0892-4a61-88e0-284eea3a3b45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9bef50f5-1c15-41b9-9d4f-84a82c63987d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9bef50f5-1c15-41b9-9d4f-84a82c63987d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSScheduleofStockBasedCompensationActivityDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="extended" id="i51f041fdbd1b49d5a379cbb0a6293fc0_STOCKPLANSScheduleofStockBasedCompensationActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c962d6f-9972-4f98-b591-2355de6bd835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c962d6f-9972-4f98-b591-2355de6bd835" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5c80529-a495-4f52-9758-42ac100ebb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5c80529-a495-4f52-9758-42ac100ebb11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_65d3c976-07b1-44dd-8316-d8d426dd3a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_65d3c976-07b1-44dd-8316-d8d426dd3a97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea3709ca-501d-427f-bc2d-3d838ad02563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea3709ca-501d-427f-bc2d-3d838ad02563" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ff29c6c2-20f8-4475-a38b-a42d71ad20d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ff29c6c2-20f8-4475-a38b-a42d71ad20d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_97b66389-3285-4efa-9cc8-6d1be0dfda16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_97b66389-3285-4efa-9cc8-6d1be0dfda16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98dee2ff-5a30-4b74-9f60-ed3601a9f993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c962d6f-9972-4f98-b591-2355de6bd835" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1878556-7efb-432f-838b-a081f48155b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1878556-7efb-432f-838b-a081f48155b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_53903f84-f27a-4ff3-a928-26e3a1e4f4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_53903f84-f27a-4ff3-a928-26e3a1e4f4de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_88dd9b73-7a60-43d0-9f2c-86a8d33e7af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_88dd9b73-7a60-43d0-9f2c-86a8d33e7af1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5e231ed2-675c-4b2f-9d8e-b5bda7152f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5e231ed2-675c-4b2f-9d8e-b5bda7152f62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_11f8bc28-0694-42be-97b9-930b679ffe96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_11f8bc28-0694-42be-97b9-930b679ffe96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2463eadc-3f68-40d1-8351-aeeda1a1f6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_862aa616-3b07-4b18-b066-839629e006b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_862aa616-3b07-4b18-b066-839629e006b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ab5a166c-4fdd-46ba-8978-0260b9a7bf16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ab5a166c-4fdd-46ba-8978-0260b9a7bf16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_04c9d912-d24f-486c-bb3a-d09f6ad10b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_04c9d912-d24f-486c-bb3a-d09f6ad10b1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_711897d0-0dcb-49e5-ae36-76aee52524f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_711897d0-0dcb-49e5-ae36-76aee52524f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5300f8d2-4224-49c9-afb8-27794c2c8602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5dfc0b47-17c4-43f0-a678-69e3dfbd68b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5dfc0b47-17c4-43f0-a678-69e3dfbd68b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dd636900-4dba-4ca2-b175-449d4a6cb328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dd636900-4dba-4ca2-b175-449d4a6cb328" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9340774c-8da0-4ea4-b528-097435da5a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9340774c-8da0-4ea4-b528-097435da5a7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_488898d4-a115-4c93-a9e7-d4ca7cd8680b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_488898d4-a115-4c93-a9e7-d4ca7cd8680b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eea90e18-2688-4ca4-a39f-1cf1049e8768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68941cf7-87aa-4e65-bec1-958ec4e8f135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c962d6f-9972-4f98-b591-2355de6bd835" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68941cf7-87aa-4e65-bec1-958ec4e8f135" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b39aee96-2d9b-4ab3-a9d9-4d822ee48911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68941cf7-87aa-4e65-bec1-958ec4e8f135" xlink:to="loc_us-gaap_AwardTypeAxis_b39aee96-2d9b-4ab3-a9d9-4d822ee48911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b39aee96-2d9b-4ab3-a9d9-4d822ee48911_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b39aee96-2d9b-4ab3-a9d9-4d822ee48911" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b39aee96-2d9b-4ab3-a9d9-4d822ee48911_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07abf7af-5616-4b50-9781-0ae10738a3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b39aee96-2d9b-4ab3-a9d9-4d822ee48911" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07abf7af-5616-4b50-9781-0ae10738a3b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0bfe6013-7ce2-4225-8d4b-0ca7802411eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07abf7af-5616-4b50-9781-0ae10738a3b2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0bfe6013-7ce2-4225-8d4b-0ca7802411eb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="extended" id="iddda1ad0fb4449b9a2926b83d0de871a_STOCKPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b23e0e42-3913-4ed5-b73a-1bc857d502fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b23e0e42-3913-4ed5-b73a-1bc857d502fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_1e60f90c-6de1-4037-b293-a8d59ca360c6" xlink:href="pcrx-20220630.xsd#pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_1e60f90c-6de1-4037-b293-a8d59ca360c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_d3245c60-d539-414e-aa05-99af0ef45804" xlink:href="pcrx-20220630.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_d3245c60-d539-414e-aa05-99af0ef45804" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_1c51b112-c277-4d59-acf2-1ffbd2cb9e07" xlink:href="pcrx-20220630.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_1c51b112-c277-4d59-acf2-1ffbd2cb9e07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_18150f64-59df-41bf-b80e-e29fc242d209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_18150f64-59df-41bf-b80e-e29fc242d209" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_40ea3595-b5e8-45ad-92a2-fc3ea8d6cbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_40ea3595-b5e8-45ad-92a2-fc3ea8d6cbd0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ca14761-e5f7-447f-9f7a-fb98985af580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ca14761-e5f7-447f-9f7a-fb98985af580" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_046426fa-8ea5-4f39-8850-411e0a8247ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ca14761-e5f7-447f-9f7a-fb98985af580" xlink:to="loc_us-gaap_AwardTypeAxis_046426fa-8ea5-4f39-8850-411e0a8247ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_046426fa-8ea5-4f39-8850-411e0a8247ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_046426fa-8ea5-4f39-8850-411e0a8247ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_046426fa-8ea5-4f39-8850-411e0a8247ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7062b139-797d-4a85-84e1-ac4b0bddd726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_046426fa-8ea5-4f39-8850-411e0a8247ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7062b139-797d-4a85-84e1-ac4b0bddd726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_91d6c1e1-f1d0-4249-a410-52c6fed68e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7062b139-797d-4a85-84e1-ac4b0bddd726" xlink:to="loc_us-gaap_EmployeeStockMember_91d6c1e1-f1d0-4249-a410-52c6fed68e4a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSScheduleofValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="extended" id="ib2df7dc3cf5f4554a0fbbb30a80a5206_STOCKPLANSScheduleofValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9a4b0e68-5751-4678-b1a0-5081521f1e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9a4b0e68-5751-4678-b1a0-5081521f1e39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_19cfefda-8445-49b1-b914-2b0431700117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_19cfefda-8445-49b1-b914-2b0431700117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_894b2919-11cb-487f-9562-93fa71fe754c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_894b2919-11cb-487f-9562-93fa71fe754c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4e816821-1850-4714-91d8-a6b3c9e355f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4e816821-1850-4714-91d8-a6b3c9e355f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839a078c-1157-4802-b66d-31890c1af462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839a078c-1157-4802-b66d-31890c1af462" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dd132b0b-bf20-47e1-8fbf-381807e48cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839a078c-1157-4802-b66d-31890c1af462" xlink:to="loc_us-gaap_AwardTypeAxis_dd132b0b-bf20-47e1-8fbf-381807e48cf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd132b0b-bf20-47e1-8fbf-381807e48cf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_dd132b0b-bf20-47e1-8fbf-381807e48cf7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd132b0b-bf20-47e1-8fbf-381807e48cf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_992b04b7-0887-4639-81ad-f24d3b0a462e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_dd132b0b-bf20-47e1-8fbf-381807e48cf7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_992b04b7-0887-4639-81ad-f24d3b0a462e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e657a955-6449-4680-a818-c59974de4caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_992b04b7-0887-4639-81ad-f24d3b0a462e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e657a955-6449-4680-a818-c59974de4caf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended" id="i3a80166b020c454e9e30cf4926d382cd_NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ee4403e9-6e92-4a42-9400-89b2cbbad31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:to="loc_us-gaap_NetIncomeLoss_ee4403e9-6e92-4a42-9400-89b2cbbad31a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_ba2397d9-c04e-4c0c-8aef-d1e00d938cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_ba2397d9-c04e-4c0c-8aef-d1e00d938cf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_40806075-7845-4bcf-8259-ba43e31fd3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_40806075-7845-4bcf-8259-ba43e31fd3ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_adf4c288-a925-471c-b705-b6f05a926acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_adf4c288-a925-471c-b705-b6f05a926acc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8fea8211-242b-4d0b-8e02-053584cc3439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_adf4c288-a925-471c-b705-b6f05a926acc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8fea8211-242b-4d0b-8e02-053584cc3439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_9b7a02bd-ce76-49bd-9e5a-e91e96d311f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_9b7a02bd-ce76-49bd-9e5a-e91e96d311f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_69963f46-b4b8-440e-90e7-0619adaebeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_69963f46-b4b8-440e-90e7-0619adaebeca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_41f35bfd-db9b-4194-a981-2ebd8d34b4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_41f35bfd-db9b-4194-a981-2ebd8d34b4bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_bc679bc7-15a4-4757-b62e-5dcfbac62e97" xlink:href="pcrx-20220630.xsd#pcrx_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_bc679bc7-15a4-4757-b62e-5dcfbac62e97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e3ad6bfe-1963-4f8b-a95f-0723c5566323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_bc679bc7-15a4-4757-b62e-5dcfbac62e97" xlink:to="loc_us-gaap_EarningsPerShareBasic_e3ad6bfe-1963-4f8b-a95f-0723c5566323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6377e6b6-74ee-4248-95e5-521982c9fbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_bc679bc7-15a4-4757-b62e-5dcfbac62e97" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6377e6b6-74ee-4248-95e5-521982c9fbc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5a172d09-f037-4655-99bc-eeb2a625d086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:to="loc_us-gaap_AwardTypeAxis_5a172d09-f037-4655-99bc-eeb2a625d086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5a172d09-f037-4655-99bc-eeb2a625d086_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5a172d09-f037-4655-99bc-eeb2a625d086" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5a172d09-f037-4655-99bc-eeb2a625d086_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5a172d09-f037-4655-99bc-eeb2a625d086" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_82d98f46-2f0d-4322-b514-8ff592b0cfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:to="loc_us-gaap_EmployeeStockOptionMember_82d98f46-2f0d-4322-b514-8ff592b0cfe0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b55c5d71-066f-43f9-a30a-2371108e11f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b55c5d71-066f-43f9-a30a-2371108e11f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_fb901334-0373-4802-8e67-33d4d28e4ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:to="loc_us-gaap_EmployeeStockMember_fb901334-0373-4802-8e67-33d4d28e4ea0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5be4b12c-228d-4438-a79b-b98dd7b9c3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5be4b12c-228d-4438-a79b-b98dd7b9c3fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5be4b12c-228d-4438-a79b-b98dd7b9c3fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5be4b12c-228d-4438-a79b-b98dd7b9c3fa" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5be4b12c-228d-4438-a79b-b98dd7b9c3fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0ac464ab-2db9-4680-9499-6bcfffc264d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5be4b12c-228d-4438-a79b-b98dd7b9c3fa" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0ac464ab-2db9-4680-9499-6bcfffc264d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_a7f8423c-ffeb-4502-9707-1b5e6eb2136f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_0ac464ab-2db9-4680-9499-6bcfffc264d4" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_a7f8423c-ffeb-4502-9707-1b5e6eb2136f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="extended" id="i5a84bb36b99643ddae46f5b431124838_NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_83ed3edf-f6de-44d4-8664-1adeefb5cb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_20a30bde-60db-4143-89f0-8a9243199633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_83ed3edf-f6de-44d4-8664-1adeefb5cb7e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_20a30bde-60db-4143-89f0-8a9243199633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_53ef8218-24f2-403c-a5f8-1a4700e8a5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_83ed3edf-f6de-44d4-8664-1adeefb5cb7e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_53ef8218-24f2-403c-a5f8-1a4700e8a5ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4fc8a177-2588-46f7-b9f1-4585b16e1db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_53ef8218-24f2-403c-a5f8-1a4700e8a5ae" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4fc8a177-2588-46f7-b9f1-4585b16e1db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4fc8a177-2588-46f7-b9f1-4585b16e1db3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4fc8a177-2588-46f7-b9f1-4585b16e1db3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4fc8a177-2588-46f7-b9f1-4585b16e1db3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4fc8a177-2588-46f7-b9f1-4585b16e1db3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_25e1eff7-85d2-42d2-9a82-c17ac486afd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:to="loc_us-gaap_EmployeeStockOptionMember_25e1eff7-85d2-42d2-9a82-c17ac486afd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7ed17c45-0ed7-4257-9d55-6344ef9c7391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:to="loc_us-gaap_SeniorNotesMember_7ed17c45-0ed7-4257-9d55-6344ef9c7391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_458c9d4e-9cf9-4ca2-9411-043970ea5f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_458c9d4e-9cf9-4ca2-9411-043970ea5f8c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails" xlink:type="extended" id="id257bb1a39e545e98e87818104d605f0_ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d3ae347c-525a-4116-a5b9-0221e91769b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d3ae347c-525a-4116-a5b9-0221e91769b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_8abb1b8a-76ee-4459-a26c-29eef8c57c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_8abb1b8a-76ee-4459-a26c-29eef8c57c5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_957f3968-8860-473c-bb12-d9c3b2279e35" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_957f3968-8860-473c-bb12-d9c3b2279e35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cf9935aa-09f3-4b1c-967e-76d1ae8dad04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cf9935aa-09f3-4b1c-967e-76d1ae8dad04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_d99590b8-374a-4b62-bdc4-075a8700efcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_GainLossOnContractTermination_d99590b8-374a-4b62-bdc4-075a8700efcf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_c8ebf499-9988-49f3-acc4-e66efc5d9a39" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_c8ebf499-9988-49f3-acc4-e66efc5d9a39" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_b5b509fe-0b36-47fe-8106-54e8eedd5917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_b5b509fe-0b36-47fe-8106-54e8eedd5917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_b5b509fe-0b36-47fe-8106-54e8eedd5917_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_b5b509fe-0b36-47fe-8106-54e8eedd5917" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_b5b509fe-0b36-47fe-8106-54e8eedd5917_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_144c47c5-986e-4be5-bd1d-ddfb052a2afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_b5b509fe-0b36-47fe-8106-54e8eedd5917" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_144c47c5-986e-4be5-bd1d-ddfb052a2afe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedFeesMember_d6340c76-bd86-419b-ab93-7f1868ca82ba" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_144c47c5-986e-4be5-bd1d-ddfb052a2afe" xlink:to="loc_pcrx_AcquisitionRelatedFeesMember_d6340c76-bd86-419b-ab93-7f1868ca82ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_85afd774-caea-4158-9578-b1fbd13eeb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_144c47c5-986e-4be5-bd1d-ddfb052a2afe" xlink:to="loc_us-gaap_OtherRestructuringMember_85afd774-caea-4158-9578-b1fbd13eeb35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_024460fc-f66d-41f5-ab5c-b7c3f74377fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_024460fc-f66d-41f5-ab5c-b7c3f74377fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_024460fc-f66d-41f5-ab5c-b7c3f74377fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_024460fc-f66d-41f5-ab5c-b7c3f74377fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_024460fc-f66d-41f5-ab5c-b7c3f74377fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42bd0adb-2072-463f-b28e-6adc80302271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_024460fc-f66d-41f5-ab5c-b7c3f74377fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42bd0adb-2072-463f-b28e-6adc80302271" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_05da7362-b279-4beb-8ff0-399838c35e35" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42bd0adb-2072-463f-b28e-6adc80302271" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_05da7362-b279-4beb-8ff0-399838c35e35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_1d116fe0-6254-4944-b800-db0c2cd4cb57" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42bd0adb-2072-463f-b28e-6adc80302271" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_1d116fe0-6254-4944-b800-db0c2cd4cb57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_368d32f2-7dbd-4cd1-acf6-dd00173b4564" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:to="loc_srt_CounterpartyNameAxis_368d32f2-7dbd-4cd1-acf6-dd00173b4564" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_368d32f2-7dbd-4cd1-acf6-dd00173b4564_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_368d32f2-7dbd-4cd1-acf6-dd00173b4564" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_368d32f2-7dbd-4cd1-acf6-dd00173b4564_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc7bbc1a-adeb-4022-b510-d5f3eb7bbf34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_368d32f2-7dbd-4cd1-acf6-dd00173b4564" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc7bbc1a-adeb-4022-b510-d5f3eb7bbf34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_ae635364-19b0-4c20-a2d2-0b1141372e1a" xlink:href="pcrx-20220630.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc7bbc1a-adeb-4022-b510-d5f3eb7bbf34" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_ae635364-19b0-4c20-a2d2-0b1141372e1a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails" xlink:type="extended" id="ie40927463c034680b152a5e3ee402f8b_ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a58e1bef-6504-417d-a8ff-2ca9405f9e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a58e1bef-6504-417d-a8ff-2ca9405f9e5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_26b1953a-506a-430d-a3df-ebe5e48e379f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_26b1953a-506a-430d-a3df-ebe5e48e379f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_95a11679-1f90-4301-9888-589f88da4fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:to="loc_us-gaap_LitigationSettlementExpense_95a11679-1f90-4301-9888-589f88da4fc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_25de6923-c0bb-4e77-9a71-4307ae7e7691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_25de6923-c0bb-4e77-9a71-4307ae7e7691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25de6923-c0bb-4e77-9a71-4307ae7e7691_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_25de6923-c0bb-4e77-9a71-4307ae7e7691" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25de6923-c0bb-4e77-9a71-4307ae7e7691_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65cdffb9-4d32-4232-b979-8ac32c4ab83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_25de6923-c0bb-4e77-9a71-4307ae7e7691" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65cdffb9-4d32-4232-b979-8ac32c4ab83f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_633dd900-80a8-4a00-abc4-5fe58477720b" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65cdffb9-4d32-4232-b979-8ac32c4ab83f" xlink:to="loc_pcrx_FlexionAcquisitionMember_633dd900-80a8-4a00-abc4-5fe58477720b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_4c9d0612-0c35-4b7f-8b6f-682dee1974f1" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65cdffb9-4d32-4232-b979-8ac32c4ab83f" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_4c9d0612-0c35-4b7f-8b6f-682dee1974f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a9e31827-2ecd-44b1-9640-2afe157a644b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a9e31827-2ecd-44b1-9640-2afe157a644b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a9e31827-2ecd-44b1-9640-2afe157a644b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a9e31827-2ecd-44b1-9640-2afe157a644b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a9e31827-2ecd-44b1-9640-2afe157a644b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e502ff85-7670-4b2e-b6ac-5261885ff965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a9e31827-2ecd-44b1-9640-2afe157a644b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e502ff85-7670-4b2e-b6ac-5261885ff965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LegalFeesMember_d9153ff5-e736-4ec0-88be-01d2b7bdbd7d" xlink:href="pcrx-20220630.xsd#pcrx_LegalFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e502ff85-7670-4b2e-b6ac-5261885ff965" xlink:to="loc_pcrx_LegalFeesMember_d9153ff5-e736-4ec0-88be-01d2b7bdbd7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_79cc40d6-d789-4c0a-9e02-4d702f70f8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:to="loc_us-gaap_TypeOfArrangementAxis_79cc40d6-d789-4c0a-9e02-4d702f70f8a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_79cc40d6-d789-4c0a-9e02-4d702f70f8a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_79cc40d6-d789-4c0a-9e02-4d702f70f8a9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_79cc40d6-d789-4c0a-9e02-4d702f70f8a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3a81ac62-cc3d-452f-b2af-3160f95fb30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_79cc40d6-d789-4c0a-9e02-4d702f70f8a9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3a81ac62-cc3d-452f-b2af-3160f95fb30e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_0ae2341c-bc2e-4eb6-be73-55a3458d9df0" xlink:href="pcrx-20220630.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3a81ac62-cc3d-452f-b2af-3160f95fb30e" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_0ae2341c-bc2e-4eb6-be73-55a3458d9df0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="i9acd83a4c4f44738abb6e0e40a858d58_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_48619d28-2ff9-4159-94f3-1c4e409492da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_48619d28-2ff9-4159-94f3-1c4e409492da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_5fbeb66d-2bf8-410a-97b2-d700a21eaaea" xlink:href="pcrx-20220630.xsd#pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:to="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_5fbeb66d-2bf8-410a-97b2-d700a21eaaea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_57e1b419-1c43-4c7f-9056-c0bb6bd6f46c" xlink:href="pcrx-20220630.xsd#pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:to="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_57e1b419-1c43-4c7f-9056-c0bb6bd6f46c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:to="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d19522db-f796-4ad5-8bdf-2a2b4c7171e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:to="loc_srt_CounterpartyNameAxis_d19522db-f796-4ad5-8bdf-2a2b4c7171e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d19522db-f796-4ad5-8bdf-2a2b4c7171e7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d19522db-f796-4ad5-8bdf-2a2b4c7171e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d19522db-f796-4ad5-8bdf-2a2b4c7171e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05cc3d77-cf67-4efb-8aec-aa0ed5852452" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d19522db-f796-4ad5-8bdf-2a2b4c7171e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05cc3d77-cf67-4efb-8aec-aa0ed5852452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember_b946aaff-9fe3-41bd-83a9-b440e01060f8" xlink:href="pcrx-20220630.xsd#pcrx_FortisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05cc3d77-cf67-4efb-8aec-aa0ed5852452" xlink:to="loc_pcrx_FortisMember_b946aaff-9fe3-41bd-83a9-b440e01060f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_HongKongPharmaTainuoLtdMember_92af0be2-0f83-49f9-917f-bac266f70f55" xlink:href="pcrx-20220630.xsd#pcrx_HongKongPharmaTainuoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05cc3d77-cf67-4efb-8aec-aa0ed5852452" xlink:to="loc_pcrx_HongKongPharmaTainuoLtdMember_92af0be2-0f83-49f9-917f-bac266f70f55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_488a5532-5b77-4543-bf4f-4cb730f833a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:to="loc_dei_LegalEntityAxis_488a5532-5b77-4543-bf4f-4cb730f833a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_488a5532-5b77-4543-bf4f-4cb730f833a7_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_488a5532-5b77-4543-bf4f-4cb730f833a7" xlink:to="loc_dei_EntityDomain_488a5532-5b77-4543-bf4f-4cb730f833a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a055ce83-5829-427a-88a2-6ed83ba59f7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_488a5532-5b77-4543-bf4f-4cb730f833a7" xlink:to="loc_dei_EntityDomain_a055ce83-5829-427a-88a2-6ed83ba59f7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_44e0b680-19db-47b4-b6c1-39f695411f9c" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a055ce83-5829-427a-88a2-6ed83ba59f7e" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_44e0b680-19db-47b4-b6c1-39f695411f9c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>pcrx-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1acf2e72-2487-45a7-a11c-6bf309df42b1,g:86a623c9-da96-4e80-aae2-29b4daaaad57-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_a4013da3-156e-4cc2-8f2b-bf6de0ce47b3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_192ae7aa-26fa-44a4-9366-dff5a7658ad1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_f5a3cc4f-a7e1-4ae9-b9c7-99cfd25e55e8_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK PLANS</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4876229f-9359-4f41-ade5-6c5a387a2efc_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_b6710a70-5819-41c2-afda-7fd6842f3b90_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_391ee2ac-636d-4acc-ab87-8b5a9f58dd31_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_479eecd0-9bdb-4ded-989e-e7880c693833_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer two</link:label>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Two [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerTwoMember" xlink:to="lab_pcrx_MajorCustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ebfa593e-188f-48c8-a2af-28812ee5dfb1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_c5a37d25-25da-4581-9134-a19b19e9412c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_695f6460-4294-4d40-bd52-bece170a63c1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_2055baca-7fa4-4da5-8895-cb5bf5c5f071_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2d21b98b-aeff-4f46-ac7a-d1fdf767239a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_59daaea4-becf-4bb0-92df-52d8bf120228_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_e20a1f8d-7e7d-4b7f-b4f7-b56f947d25ca_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsideration_9cb0b79f-b4e5-4513-9529-f8618bf61d68_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsideration_label_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsideration_documentation_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the maximum amount of Contingent Consideration related to the acquisition of a business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsideration" xlink:to="lab_pcrx_ContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_7c8aa338-76ff-4863-8c6b-68875f068cfc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_8b093ba7-409d-4ea9-9690-103d1d2409f4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_9a441140-b2db-44ac-bdf2-00a74281a1e3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_8c10dccc-343a-4952-ad5c-7a2f5f9b403a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_f7edcbfa-954f-4d4d-9c2b-f510da2519f8_terseLabel_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment</link:label>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_label_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment [Member]</link:label>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_documentation_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:href="pcrx-20220630.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:to="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_d8dc530a-1e65-4af6-b131-196936480a67_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_cd94998c-068b-49b6-aa34-b1ba7ddbde02_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460ad1ff-5362-4a43-9fb2-d93ae0fd776f_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_43a1a0ed-a971-4966-a23c-1cbb809abc7f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5e4d079c-cd4e-4a46-92c8-d614af0e1499_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_fed3ac82-c639-49f6-a09b-46968b1e9f79_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_label_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:to="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ac738c45-8beb-42cd-a4be-65c97dcb4038_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_96f14322-68e2-4995-982e-7567208c8147_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_640b3b06-01a9-42a6-831e-5107025e38d0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issued in private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_577b8601-93e1-428a-af56-d889af14bef2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_65047565-354f-41c7-a2a6-5977f3f2cca0_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_f0fcc2c6-5843-4087-b658-2a2266a3ee92_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_adcbbdd7-f03c-4fb2-8aab-ecb9772e8fe6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_dd5c1dec-72fe-4189-b3b7-991357898fe5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (in percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_NumberOfLeases_670c6896-77be-4f10-b6f7-88001172c8c2_terseLabel_en-US" xlink:label="lab_pcrx_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of embedded leases</link:label>
    <link:label id="lab_pcrx_NumberOfLeases_label_en-US" xlink:label="lab_pcrx_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Leases</link:label>
    <link:label id="lab_pcrx_NumberOfLeases_documentation_en-US" xlink:label="lab_pcrx_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfLeases" xlink:href="pcrx-20220630.xsd#pcrx_NumberOfLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_NumberOfLeases" xlink:to="lab_pcrx_NumberOfLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_69a772f3-2bc8-4ec2-ba82-d8634d510a79_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_0d270832-03fc-4c0c-bd16-672779b19682_terseLabel_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_label_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense from stock options, employees</link:label>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_documentation_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense from stock options (employee and board of director awards)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees" xlink:href="pcrx-20220630.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_Compensationexpensefromstockoptionsemployees" xlink:to="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_59bbc123-215d-427d-8357-952fe7c06656_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_4d49f21b-aeef-4bdd-97eb-10934439fbc2_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_45170576-6719-49f9-9d17-360a818fb62e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_90fabcb7-ea83-49e6-9bd2-22106cc11cb5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f41d02db-f13b-4b95-88ae-20c432717887_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income&#8212;basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_88cf3ec2-82d1-4414-ad3c-e4895d157328_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_41d936b2-4963-4f7e-bdd3-3ed3e2a84c00_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_62b6c5b4-5e18-4410-9af6-407048e8d926_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b298bdbd-4da4-47bd-b33d-deed2655ff2a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_33315f34-6cbe-4a57-ad3d-a10c71a56d83_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2a210d7d-ae87-4d87-ac19-7389624b9f82_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_58014fe7-bf1f-498e-97d1-989a37112c5d_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_70d4c663-918d-4bb4-9214-8b7382bdda0c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma basic net loss per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_25feefb6-f0ef-40d9-b969-21652e8ee80d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4a4d6ce2-f7a6-460a-978a-ddc971160ddf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_2d218e68-b5e3-44be-a227-d432024055e0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_c436b2be-b12f-4386-90a8-91994c879c3a_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_14a91a66-98e5-4703-bf46-28ab2ccca26f_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e6f6be70-0f2d-4850-93ef-476179f3f48e_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ea6870a0-e470-4719-afff-7affa16e99af_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_4b307c6f-1636-4de9-bd00-67a6933c96f3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d53aa7cd-e8fc-4b80-877b-b34ecee5e43c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value (Level 2)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentDiscountRate_b62883b3-1e1a-4314-a329-56f83add2621_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentDiscountRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentDiscountRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentDiscountRate" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentDiscountRate" xlink:to="lab_pcrx_DebtInstrumentDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_27b9be92-c4a8-409b-a747-30ea22ccdbb5_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_160c8228-4d57-4439-8c33-91a616a8d390_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationMember_9f245877-d23a-46bc-a7e5-eeaad31f2d82_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationMember_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationMember" xlink:to="lab_pcrx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_cbce5a8a-b24a-4fce-aee5-f85a20e4c2ea_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to APIC, convertible debt</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_46f01306-8f07-42b4-8fc9-dd4322a3dc2d_totalLabel_en-US" xlink:label="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisition-related (gains) charges, product discontinuation and other</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_label_en-US" xlink:label="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-Related Charges, Product Discontinuation, And Other</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_documentation_en-US" xlink:label="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-Related Charges, Product Discontinuation, And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:to="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_79e32472-f0a0-4ce2-80a7-330bfdf45ba2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 (remaining six months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_cfd993b1-718d-49a0-af70-fb322ac4476c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_84fca83f-997f-4dfb-ab87-1d6b0047c864_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_b9826a94-0036-487d-b17e-02d2c210e862_terseLabel_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative licensing and milestone revenue</link:label>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_label_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Licensing and Milestone Revenue [Member]</link:label>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_documentation_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Licensing and Milestone Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:href="pcrx-20220630.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:to="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9ec82600-19ae-416b-be17-2445204744a2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_212a8dd1-1cd2-4c08-852b-5f50d95d48ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_11709249-9bfc-407a-97af-455269a9655b_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of convertible debt securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_64567c9a-9995-43ae-bf55-7e0c7261ea46_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_7a042e66-3df3-46bf-a845-adc5c0b5735f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_6304c8ca-f2ea-44c1-a545-8ea8f31f89d9_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2020-06 convertible notes if-converted method adjustment</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:to="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_49773c03-98d9-4ca6-8ee0-abdf58963e7a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c0a48bc4-1691-406e-8338-8ce0374a99bc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_5329644d-32c0-4579-bd6d-ecc6ba44ed6a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_034a63f3-674c-45cf-a6ba-fc7b8a438eb7_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_79a00eb4-dc6c-444b-bcc7-9f2b5b0d01cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_71d7895e-0dde-4282-93d3-b1ee67466319_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_fa1bfd86-93f4-4150-a3b1-f775525dcc6c_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_966c3acc-9832-405e-b96c-8c246a894621_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9430074a-663a-4233-bc44-f73db0df94a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_2c50a231-6724-4f5b-a594-62e4a062a999_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment penalty, percent, year 3 and thereafter</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:to="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_38bc4caf-9065-423e-af4d-bcc4514be50f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_845f4f39-9863-4495-837a-62195ea00193_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_3e64b289-560c-4ffd-8d03-74cd2ac830bf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5fef0c0b-c389-4c52-8647-f59ee67a06e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_e180227a-9b86-4e93-936a-e99ca7d34489_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_5e99a6a5-5a23-4c86-b093-2fe98e9a218b_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a6f745d5-d02f-4f09-9549-7500b3cc4af6_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5c32f5ae-2182-4524-ab8d-f9dc823986c5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cede1cc2-7562-46b4-a1cc-f89304758bfd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_ab6a35d9-cc5c-4ebc-8c31-b5a06430440a_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_b3d3edb8-c20a-48f0-802f-d10cc11792f4_terseLabel_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP purchasing period</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_label_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_documentation_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:href="pcrx-20220630.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:to="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_d1ac15e0-13ec-412e-bbf4-b1c07c9d227a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f0f7c410-6025-4af3-bf47-b741d4179458_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_6e4ad855-47e5-4032-ac07-cbd38de86ee8_verboseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, current</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Current</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationCurrent" xlink:to="lab_pcrx_ContingentConsiderationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_dfee1fa6-6df0-4c79-9281-4928f8e84d2f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member_af54ee64-abb0-4a35-a6cd-df01b18392ae_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due May 2024</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due May 2024 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due May 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_e731ac9a-f83a-4b46-bbd4-76154af63caa_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b76ae22a-6f54-4484-b525-119957ac1da9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_44371439-5114-4e57-823d-9e02dc09bf69_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_NumberOfMajorCustomers_01955994-f849-4660-a718-7874b3cd7186_terseLabel_en-US" xlink:label="lab_pcrx_NumberOfMajorCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of major customers</link:label>
    <link:label id="lab_pcrx_NumberOfMajorCustomers_label_en-US" xlink:label="lab_pcrx_NumberOfMajorCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Major Customers</link:label>
    <link:label id="lab_pcrx_NumberOfMajorCustomers_documentation_en-US" xlink:label="lab_pcrx_NumberOfMajorCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of major customers of the reporting entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfMajorCustomers" xlink:href="pcrx-20220630.xsd#pcrx_NumberOfMajorCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_NumberOfMajorCustomers" xlink:to="lab_pcrx_NumberOfMajorCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9255b59d-48e4-4f23-b7b3-e5845d51ebf3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of fixed assets summarized by major category</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_7ad73484-fc22-47b8-82ee-1dc8551e1dad_terseLabel_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Shares Issued Under Employee Stock Purchase Plans</link:label>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_documentation_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from shares issued under Employee Stock Purchase Plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:href="pcrx-20220630.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:to="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a05fdf26-171c-4dcc-aeac-7c4028edf645_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Unrealized (Loss) Gain From Available For Sale Investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6fd50df8-8221-427a-bee4-0d93f7f75d21_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e60d4a5a-181c-4e8b-a895-be36d6a1143d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56b571a4-fb6c-4c15-8660-0e41dcbcc570_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_38eff336-310f-4fc3-a5db-01c13808b9d0_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8aa7d983-9457-4de3-ae56-7b46af5e06b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_97bc7bb6-a4a3-497d-bd89-a9d3c537cbc4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_5cde835d-a3c8-4228-b3cb-7d2c41b3c01d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_978f5a94-9cf4-4444-b242-7e3da9d62469_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1b9bc1bd-47ac-45d4-b9ee-feb91e32aca7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1a09d78a-0784-4689-8029-bb3da1569bbc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_bec7f9de-cf84-4ef9-b7fe-f3905b025308_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_eed128e2-3374-44d3-95ce-60815be50cf7_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_57a6f95c-96fa-4bde-a5e3-1b314c2d020c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ffef8b31-7e82-4c61-b40b-90a61f5ff0e8_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ed8b0658-a67e-4688-86bd-e5513521f025_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_4896db91-3d31-40b7-a53b-1149ff30ffbd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_34f80ded-8bb1-4329-8ba5-dc4d9682e781_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b3554ef9-15cf-4908-a83e-410aae3503d6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_8ebebec8-d6d8-4b36-b537-be2dcc964926_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_5f0bd7fc-856c-4a68-ba6f-f0f8a52e5174_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technologies</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_b00a26e9-2592-4ad4-b3aa-3084f051f543_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_54957559-0cac-4de5-b9fc-3d9552f3c2db_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_e3f80c92-fa99-449e-8a36-2436937d936e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_dddcd55c-7b3a-4840-bdc5-d9fb2f025f1c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_8433c392-40b9-4f11-b664-a90363ca271b_terseLabel_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of offering periods for ESPP</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_label_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_documentation_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:href="pcrx-20220630.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:to="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FortisMember_b7d1189d-a106-4978-a881-36e6d7790bb9_terseLabel_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis</link:label>
    <link:label id="lab_pcrx_FortisMember_label_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis [Member]</link:label>
    <link:label id="lab_pcrx_FortisMember_documentation_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember" xlink:href="pcrx-20220630.xsd#pcrx_FortisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FortisMember" xlink:to="lab_pcrx_FortisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_c5b7dca8-d21a-47f3-a845-164eead4acd2_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8be9068c-7659-4b57-bd13-2aec9611429d_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_b0afb16b-d97c-4b65-ac82-2de15ced30c1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_21642883-7764-4f79-89a3-3c497bd83daa_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, maximum, value</link:label>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_label_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum, Value</link:label>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:to="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_8c59ed66-3c63-4506-9330-dd9312842383_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt, net</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtCurrent" xlink:to="lab_us-gaap_SecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_99ee9784-b308-470f-8072-561f49203414_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b29d46df-5398-4c1a-aea4-38fa9bab5420_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_5c7e0134-a95b-4909-9433-50c31d867de5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_fdb241a0-334a-4422-be56-1686c9f06464_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_089cefb1-971d-46c7-86d4-6f009a93fd58_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_9feecd39-3201-427d-a0f4-8b7e30f20355_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma diluted net loss per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6ab4951a-aca7-4f0e-85fe-356d1d2714e7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_cd650598-2d48-4bfc-9d29-324eff28e60d_terseLabel_en-US" xlink:label="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS [Abstract]</link:label>
    <link:label id="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="pcrx-20220630.xsd#pcrx_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_06155962-3acb-4153-9554-83a2985fddce_terseLabel_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments for EXPAREL agreed in connection with acquisition</link:label>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_label_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreed Milestone Payments for Sale of Product in Connection with Acquisition</link:label>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_documentation_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:href="pcrx-20220630.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:to="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_1009775b-a59e-41d4-ac92-277829fc02d2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_a760bdd5-383b-4ca1-8ed3-e671316471c0_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4ee5a991-7c36-4892-a93a-ac97cbf264e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f686e9ea-9c2b-4f76-a152-335ac6c13485_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_271fc2c7-0180-4863-a7af-1c85b8ca5722_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_75ce6022-589d-4d99-a5e2-34e84facd577_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c17719e4-f6f1-4cfe-8faa-c85721a1e704_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_7f72e5f0-40b4-4ccf-b73f-69d73f19f435_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_057c64c3-939f-4a67-97a0-80e4d6f020db_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_d4734994-6b8a-4b08-94df-850d696f7061_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_b301ed4f-be60-41c0-a6e1-7fda3d6ddfae_terseLabel_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]</link:label>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_label_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]</link:label>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_documentation_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stages at which milestone payments for products are payable, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:href="pcrx-20220630.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:to="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_c08c06eb-cfda-4c0e-bcbe-d052794d6bef_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cef0b34-e216-4f74-8728-e04e6f6f8cad_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_d9c5ab2a-6e2a-45a7-87b5-c67328009b6a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6cd733ab-cd4e-49c2-a0bc-153ed61f93ea_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_f53d0598-4bd4-47cc-b3ee-9b755e26ad48_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_b2e60c99-ecff-4ad0-aa70-4ce928f048b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_db35cc9b-d461-4fc3-aecc-58ca05e9a004_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_be1f5318-547c-4fc9-b65a-94c05b39281d_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0c7692d7-8d94-4718-ac4b-50a46a99dc24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based payment award, stock options, valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_b6c754cd-d8d0-4786-b1f8-85be44cf9c83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES ASSUMED</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_4b9a94be-5519-4fd4-8afe-6c709c4ccadf_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term:</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab0c748b-fe6a-43e8-a80a-96e50b5e4739_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_1ee12004-cec0-4479-982c-ef636cc41504_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment term</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Payment Term</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationPaymentTerm" xlink:to="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesFairValueDisclosureAbstract_3c803205-1809-4a71-a3d0-6c330303a6dc_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets:</link:label>
    <link:label id="lab_us-gaap_ReceivablesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_2358d309-9123-44e2-9b78-def80abb8eb5_terseLabel_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">When annual net sales collected reach $500.0 million</link:label>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_label_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upon Annual Net Sales Reaching Dollar 500.0 Million Threshold [Member]</link:label>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_documentation_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the stage for milestone payments when the annual net sales reach 500.0 million dollars.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:href="pcrx-20220630.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:to="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_fc488f60-cac7-41da-b082-d22a13255027_terseLabel_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of operating lease not yet commenced, payments due</link:label>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_label_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Not Yet Commenced, Payments Due [Table Text Block]</link:label>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_documentation_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Not Yet Commenced, Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:href="pcrx-20220630.xsd#pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:to="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_7a43435e-6281-4767-830b-0bf2eec99e78_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c10fd9fd-5754-493b-a522-674f2f9208c3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_33052cf3-0a26-4ba4-ac31-490f41c7bb2e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_b4ca7549-aa9a-439c-8a2a-2e7c409e9c1c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0d561a76-1872-4019-8dc5-8fc915f057ba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bce50b5d-d38b-412a-968f-02c7e8d515f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_814561c8-7ab5-4324-b97f-d4ad134a56a4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3296d8ca-ea31-47bf-83b1-376838c7c824_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_aadac172-185f-4821-9571-3dadc9878234_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 (remaining six months)</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_84e4d353-8adf-4389-af59-06b8d2fa595d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_9914a5e5-7c6b-45bf-b863-32c0c34c27ef_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_f114a0f6-176c-486f-b79b-579b5c0347ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_94ea6ecb-e32b-4c2b-8d17-3ee7ba198dc3_terseLabel_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL</link:label>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_label_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL/bupivacaine liposome injectable suspension [Member]</link:label>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_documentation_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL/bupivacaine liposome injectable suspension [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:href="pcrx-20220630.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:to="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LargestCustomerMember_6dd9beb5-0b79-4770-bba0-f3bcb7924195_terseLabel_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest wholesaler</link:label>
    <link:label id="lab_pcrx_LargestCustomerMember_label_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_LargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember" xlink:href="pcrx-20220630.xsd#pcrx_LargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LargestCustomerMember" xlink:to="lab_pcrx_LargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_837e0a1b-a2d8-4fe2-975f-aaa36404c3cc_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_0b10c212-a1b1-4f10-9ee3-535326653724_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate of common stock per $1,000 of principal amount of Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_f11245fb-337b-48db-8322-5407044559f7_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of payments in next fiscal year</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:to="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d51bf20e-78b0-4e3f-97b0-309cac212632_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ba0753a1-c36a-4689-ace7-8338a57b4b05_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_db43231a-b4a8-4927-a1dd-028a11473045_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty revenue</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_cb70f1bb-cbad-4c3c-86fa-02cf350c83c4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_f443dd25-cc57-46dd-ab55-5cadf4bc7a5a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_0d4135ce-42ea-4373-a41e-713c9d5935a7_terseLabel_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of products (in products)</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_label_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number Of Products</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_documentation_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number Of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts" xlink:href="pcrx-20220630.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConcentrationRiskNumberOfProducts" xlink:to="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df0cea08-d53f-42d5-9162-48efddeeb998_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_4088a59a-9650-4bd9-aa24-82b9f07d14b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7a5bbd7e-fcab-4a53-a3e5-7dafda3ee80f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_2706e027-c176-435a-8b10-71da46c8bade_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_5e32ac41-3b82-43eb-a118-9c4883e86690_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing sale price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_1cd02799-03e9-4765-8885-fd9473668d3d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_58954bd5-3118-4c09-b487-0610e7a1d1bc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3f773fa1-938e-44d4-bcf8-a9c14b711c6f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_864d9d12-babe-45b8-8d4f-41336b3615de_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_3ebd0bf5-f9b1-4551-89a0-f6a29be56f11_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_24652321-b99d-41cb-8db1-f291a8eb836e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_a061742e-bbee-40f7-9c28-a8a5c9b0920d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleNotesReceivableMember_4dce8e38-ffe5-4492-a318-170cdd9441d2_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable</link:label>
    <link:label id="lab_pcrx_ConvertibleNotesReceivableMember_label_en-US" xlink:label="lab_pcrx_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleNotesReceivableMember_documentation_en-US" xlink:label="lab_pcrx_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleNotesReceivableMember" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleNotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleNotesReceivableMember" xlink:to="lab_pcrx_ConvertibleNotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3a20646f-fa5b-488b-87eb-927ceb2dd336_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_78c1352e-365b-4f10-a654-e5af4e73eda2_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of term loan</link:label>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_label_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Debt</link:label>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:to="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cb9c2b3f-a837-4027-9c49-cdc6a973f9f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_5478a03d-1a76-49c2-8d72-2524db249285_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_238141e4-b1df-4c6e-bca0-ab8ced448545_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_46f90bc5-c2cd-449e-8a41-2d91bd7c965e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rates (in percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_fd74d396-faab-4e96-b5b3-2d7a59dfbeb2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from lines of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_a633278b-ed2c-47a9-8819-514e1622f1b8_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent value rights (CVRs)</link:label>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_label_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration</link:label>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:to="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_68c4cb1e-0eaf-417a-8a50-150d2d65d04b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_c97a1816-25d3-4de1-8357-471881337039_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLEXION ACQUISITION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_4af5b556-015a-4afd-bf0c-583a2106548e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balloon payment to be paid</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_c3ef66d4-0d5a-416e-8aa7-aed38478e09b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_644d9117-3d53-4f72-8696-d9cc03c74221_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d2be4fb7-50f9-4e0c-826d-4050d3402188_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_be124350-b610-4100-a755-3196995e7f7c_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b861d791-0f17-4991-9a8a-c5298491c2fb_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at June&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_c4e823aa-c5a5-42e0-b4d2-611d6d2ae77d_totalLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_f2c6ddea-49f8-47f0-833f-9bec6020c9a7_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue from customers to total revenue</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_ad62634c-33fa-42a5-9604-ab07a16d4e50_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_2f8151b9-ac43-4558-8e83-650923a2acd9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_33e51087-2925-40bf-bf24-8d22ffd1b555_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_73235095-fcc1-44ee-8d0b-e3fff0bedf1b_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongTermDebt" xlink:to="lab_us-gaap_SecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_cc8dccce-dfcd-49e9-bb34-403e6598969b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_8a5a5ba4-976a-498a-b46c-be953d16d3a9_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisition-related charges</link:label>
    <link:label id="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_label_en-US" xlink:label="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition And Integration Related Costs</link:label>
    <link:label id="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition And Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:to="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5dd7917c-bc54-4016-b352-0eed3ed5af4d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f4fff11f-1e08-4287-aa22-2bbedb647b1f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_eb3ef469-3c84-4529-95f6-c407b44d8519_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_224b12f8-f4eb-4c45-b6c6-62950ab2f404_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per common share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_bf0ac619-d7b4-43ce-a46a-905cad62a181_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9cfaafb2-ed51-4134-aed1-88629ce900c0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a8ecb1e4-26ff-4017-924c-fc898bd78147_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested restricted stock units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbfa9b8-9e19-4299-84c1-e50fb4d52fc4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_4b8ea99d-878f-4e05-ba73-870be463b243_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_b663e182-c598-4a48-b298-80e244cf012a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_7793dfc8-addb-4f21-96c8-38d0f324c30b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_31cd810a-b5b0-45da-99da-1bf8f20749c2_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_56092b49-4a13-4ef4-9f98-a271abc853de_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_99a66a6a-c1af-4036-8865-72b3cb532816_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c7f98a72-3a87-4e4b-9141-9dcfdfe68049_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c2456780-afdc-4953-a16c-7826f079a00e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_44daa4a1-69c9-4054-a7b4-56c09f5ed1ea_negatedLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity attributable to parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_52be3283-73db-4ceb-a1b6-0d030dc78d5a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_14b6b882-d8b2-4f0b-b6aa-850adafed28c_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread one on variable rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread One On Variable Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread One On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentBasisSpreadOneOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:to="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_99bf6222-3465-4d32-85af-24661d851e12_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_3dbce6db-a8b6-4c40-a12a-8cabd4dae2a4_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, maximum</link:label>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_38228a7e-c85b-43e3-a857-5797faf7131d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5d9f8a91-bd7a-421d-8be3-c6f9efb12ac1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f0163501-b4ae-48a3-ad01-fcea605abb44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8c1c84b2-3868-43c2-8afe-71752f82f087_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a0a6ac47-6cf1-465b-9fca-20da4033cbcf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of change in contingent consideration recorded at fair value using Level 3 measurements</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_e26f8531-b718-40ea-9444-95d8bd286bcf_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, percentage of principal amount for computation of redemption price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percentage of Principal Amount for Computation of Redemption Price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:to="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_0205c898-8546-4e74-962a-9555a91a2625_totalLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_e6ac6f99-cc31-4da4-83e2-eb5a4354a1e1_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_bf2fac8d-76a9-4a8f-ba0d-bdd375eb4095_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_be5a3d4d-77b8-4742-8019-fcc4f36b8b3a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_99f6a191-63a7-4f7f-8783-44d9c2980519_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_0967f20b-e768-4724-b5e0-0e2db8160f69_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_326a4e37-08f8-4b8e-b0b9-fc04bf635d3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of recognized stock-based compensation in consolidated statements of operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4d0739ff-6257-4ff1-b5dd-5b64b1bf1f6b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_20b5255e-5f74-4588-a2bf-3b8bc5ac8f87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_65ecbba2-5ac5-4cec-bde8-a43600c9c632_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of operating lease cost and other operating lease information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e4eb803d-c394-4d1c-9770-80bbaf15d67e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_847ee6b3-c1d5-4bac-b1a5-55a31e6999fc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_2d9c9a6d-6098-4595-bdac-c8b162aaa795_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_62861a84-e6c2-48f0-99a0-fbc970fc997b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6d16b3b5-4b17-4f4e-814c-21491b5b14ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_f3d666b8-1190-40ff-8c06-993f62df08c0_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_a813310e-32a3-40cd-8527-69356d3bb1a8_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LegalFeesMember_1f397114-627a-46f2-bf9a-1098fae4ac20_terseLabel_en-US" xlink:label="lab_pcrx_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:label id="lab_pcrx_LegalFeesMember_label_en-US" xlink:label="lab_pcrx_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees [Member]</link:label>
    <link:label id="lab_pcrx_LegalFeesMember_documentation_en-US" xlink:label="lab_pcrx_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LegalFeesMember" xlink:href="pcrx-20220630.xsd#pcrx_LegalFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LegalFeesMember" xlink:to="lab_pcrx_LegalFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_d0d1827d-3e91-4141-8b5e-61771073cf5d_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_5669f37d-6e25-4ffe-b728-15eac95c9212_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_355afb95-6fb8-451b-8ca3-58adc6af65d5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_61329243-b7f2-49d9-b0c0-94700b2a0454_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of key assumptions used in the valuation of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d4af90c7-e78f-415e-8ce0-3bdfdb0c708d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_6fd67874-e6f1-4319-acb4-1e9c117dd57e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of equity investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_50ff0dde-3087-41b2-ba66-f4fd58a0b679_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration to MyoScience, Inc. securityholders</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_44468af3-4085-41ae-9e8a-bba0b842d22f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2b858262-8195-4054-b814-d7a8b2a0b5ad_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_e69df931-bd14-4041-bac8-0e81bc000810_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_efba8fba-3137-4fd1-a57b-be17d0dc82f0_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_4797af20-6c62-44ad-adfd-9f3893837fda_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on investment</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_c33455dc-8e45-4fe2-b694-d647de983bbe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d42c6155-e9b7-445e-b1ed-47cde9f0286b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_652aa42b-156a-43dc-9956-c18e24733594_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_64e3ea08-c22f-4b2b-8773-9a50a1866ae3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_570874ae-3441-44d1-930b-8c61d7df6755_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited pro forma summary of operations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_7b08e5fe-3cb9-412c-b331-229ce775a92a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1bbbe350-df95-456c-9f91-d1c401ca4ef2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_9b8463f5-10d6-4d98-b0f4-9403e9b82166_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_bc1b6c31-6cfd-4b73-a2ef-e82b93ebdbec_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_76f5f44c-ea4a-4614-a62f-f084b34d0ba3_terseLabel_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum milestone payment to be received</link:label>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_label_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments to be Received, Maximum</link:label>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_documentation_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments to be Received, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:href="pcrx-20220630.xsd#pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:to="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88d72e7a-c382-47a6-8461-75bfd80c7a03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8d756524-220c-45d0-8d4a-ebd6587145f0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_96e1463d-f9fe-492d-9bdf-b7b8d744a03b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_4e202656-3f54-420c-b4ce-c5d711103641_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_24faac53-6045-44ba-a0c1-5be13d7742a2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_52f69086-5c95-4be8-a7af-43109fa0e490_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5077b6fe-9bfc-43b9-86e3-31ab60673350_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_de864a04-b549-4e20-b951-bad9c916f049_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_8741290b-69d7-4ef8-9a54-4d0f433984df_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_70bb57dc-ae2a-404b-bd27-342c8a380e95_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f01f0825-f6cd-4bb7-aa3b-3fc8ccaf7e90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_938cb8a4-c060-48aa-931b-b36f69fb99a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_c504cd83-d410-447f-a448-93b634d1acf2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_b01cf02c-b21c-41b1-be90-a9d73ab134eb_netLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales:</link:label>
    <link:label id="lab_us-gaap_ProductMember_f5022be9-ce11-4685-953e-8bb52ad85ee0_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net product sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_fbe2725b-e498-4e4d-88a3-5cc368ef897d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fcdefcd-82fd-45b5-a121-bcdff55f204b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dcc98964-66a1-4600-aca8-a33173efeeb0_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockExpense_5c79655b-4f83-4bb2-aa8c-a2ddf1a129ed_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockExpense_label_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock or Unit Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockExpense" xlink:to="lab_us-gaap_RestrictedStockExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_34cb5479-6698-4f50-a378-c4aad2a5b479_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_37d8f952-736b-4e15-a34d-b3b94d5f042c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b7d91abf-4d41-4908-a3ea-b6e566b1830a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_654a1573-0a9f-4924-b167-242eed5be159_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the company's stock option activity and restricted stock unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_25e41541-bb0a-48eb-97bc-72f2c206f05a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from conversion of 2022 convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d74a8eb3-a5b6-4f07-a568-718d334631b0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_fd92dbc8-b8a2-40ec-8968-de5148515103_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_3baf57e1-8063-4e21-867f-94e596d83cc4_terseLabel_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skye Pharma Holding Inc.</link:label>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_label_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skye Pharma Holding Inc. [Member]</link:label>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_documentation_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to SkyePharma Holding, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember" xlink:href="pcrx-20220630.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SkyePharmaHoldingIncMember" xlink:to="lab_pcrx_SkyePharmaHoldingIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c53b796c-ccc4-4a01-800c-698c05623d12_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_0fb08b60-4ce4-4400-bd2e-1f99c1424fa1_terseLabel_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]</link:label>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_label_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]</link:label>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_documentation_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to milestone payments for products by the stage at which they are payable, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:href="pcrx-20220630.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:to="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_eaedb7dd-e4f7-4dff-967f-b7aed2e6389f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_7e380fb9-e4f6-4b69-bef3-53767dbdd9ed_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of diluted securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bc61e971-e5be-44ab-84c2-0ebf199cb464_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_8583f846-b86b-4996-95aa-e61f3902efac_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_7b8d45af-6342-4661-81a3-3e2f028a8e6e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d2da0af4-56ab-4cec-b294-430290047cf5_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill recorded in connection with the acquisition</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_79a8880a-c3fd-435a-83e3-09954b7e6226_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leases not yet commenced</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_3623395d-8db4-402e-b853-18a921ec149c_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment penalty, percent, year 1</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 1</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:to="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_93818da2-c7f4-4d82-afed-de957f48a721_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_1360898a-e047-450d-a85c-0abcfd3fa749_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment penalty, percent, year 2</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 2</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:to="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_e9b3c381-a270-4611-9c60-656ec5b52fea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d290fe9d-6f41-4d90-823c-acb7085011cb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7e1b1409-b8dd-4e6a-9c53-282ae079da54_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryBondSecuritiesMember_46e148b7-de23-4f47-831a-991f9d057869_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Government bonds</link:label>
    <link:label id="lab_us-gaap_USTreasuryBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryBondSecuritiesMember" xlink:to="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_bd8db094-9319-48ee-b8ae-cd748a15546e_terseLabel_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation [Policy Text Block]</link:label>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_documentation_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for basis of presentation and principles of consolidation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:href="pcrx-20220630.xsd#pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:to="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b8a1c26b-2919-4449-b1ae-66de799f45ce_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1c39ed31-33e0-44e2-afe0-860e9767a95a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_2772161c-7db0-4c0b-bdd2-2dc26d010a5d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_4f2ccb1b-5f18-4db1-9611-f352bea50b08_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_11ce1761-3250-4e1b-b00f-014797108052_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b03b8d8b-7747-4e55-9edc-a881b1108c7a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1a3e3470-83d3-4a28-8315-c4522ce1d05f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_67f58fc8-6abe-4f5f-91a4-87d7e6b063d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2091acdc-6e21-4582-af22-f98953659756_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_579091f9-73b1-4332-b0e0-f5d0c9fc416e_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_af302b93-8de7-44ba-963c-932fc5e442c3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_9fd568d2-8d7d-43fb-8d64-3ceedd7f585b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligation_94844280-838d-4c46-aa49-01f26880a084_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement obligation</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligation" xlink:to="lab_us-gaap_AssetRetirementObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d8abbf06-77b4-44ac-8856-1e0f446984ed_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_72e938f0-5a59-47d2-ac43-36cbf2400ca5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_94b73fd3-6eae-470c-a352-833d4e190c4a_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_957da6ca-5ad2-4348-a0b0-499e4632e4bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd585257-aa2b-40a2-b98c-2453c125e354_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term of options (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_c1a2d793-c539-4693-af38-4bc940342461_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_87dfd458-1896-4859-a74f-56fc90c012f4_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FederalReserveBankOfNYRateMember_8ab7cd2a-9d91-4035-bd19-78c936ec989a_terseLabel_en-US" xlink:label="lab_pcrx_FederalReserveBankOfNYRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of NY, Rate</link:label>
    <link:label id="lab_pcrx_FederalReserveBankOfNYRateMember_label_en-US" xlink:label="lab_pcrx_FederalReserveBankOfNYRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of NY, Rate [Member]</link:label>
    <link:label id="lab_pcrx_FederalReserveBankOfNYRateMember_documentation_en-US" xlink:label="lab_pcrx_FederalReserveBankOfNYRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of NY, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FederalReserveBankOfNYRateMember" xlink:href="pcrx-20220630.xsd#pcrx_FederalReserveBankOfNYRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FederalReserveBankOfNYRateMember" xlink:to="lab_pcrx_FederalReserveBankOfNYRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_b15c6618-2713-434f-a11e-580791dccbfd_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b30b25a9-8197-463c-9f7b-750f006733f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_cd6a0c65-4077-45d2-bcb5-429f13d09cb9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of short-term investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_5b9f08f9-b37d-401c-86e7-5bbbc7d59aa8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_3c3ae9e8-0bdc-494a-80e3-dcc6f407ea13_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ee8d85b8-8911-4f6f-9a32-70465054f5f6_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.001; 250,000,000 shares authorized; 45,801,578 and 44,734,308 shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1a1028e4-1509-45b9-9814-49a2dc2e125f_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AcquisitionRelatedFeesMember_e1e5ee3d-1b01-47cd-9f6a-3e708931b286_terseLabel_en-US" xlink:label="lab_pcrx_AcquisitionRelatedFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Fees</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedFeesMember_label_en-US" xlink:label="lab_pcrx_AcquisitionRelatedFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Fees [Member]</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedFeesMember_documentation_en-US" xlink:label="lab_pcrx_AcquisitionRelatedFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedFeesMember" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AcquisitionRelatedFeesMember" xlink:to="lab_pcrx_AcquisitionRelatedFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_029a5912-b1f9-4dcd-989b-8e90e2a31e4d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_88b8dfcd-e176-45e0-80fa-2233e99e0bd4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_4bf56771-db63-4d50-ad1a-40dd76eeb3d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance-related expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_734df277-36e0-444b-a16e-3709c8b3e0f8_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_ac38c5ea-b161-4ce8-a910-97848a4cd893_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1a3cb087-ea29-490d-9198-934db2235835_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_ac1e38f9-85f0-44c8-887c-ee968d5fc9c5_terseLabel_en-US" xlink:label="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquisition-related Restructuring and Discontinuation Costs</link:label>
    <link:label id="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_label_en-US" xlink:label="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]</link:label>
    <link:label id="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_documentation_en-US" xlink:label="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:href="pcrx-20220630.xsd#pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:to="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4edff9f2-d102-4fc4-8d72-0800c0a9ef76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_d7ae9921-52bc-42b1-a25b-6e781cefad4d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price of notes into common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_4bf91f0d-5b2d-484f-a07b-5fe70ad5704c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS ACQUIRED</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_0f801aa1-40ca-4bd4-bf01-e47d5f106f14_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationNoncurrent" xlink:to="lab_pcrx_ContingentConsiderationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_404642d8-910b-407c-8bbd-03b7bdf86d53_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_11af6337-ac88-4e67-a18d-fac9b524fab1_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d5d49912-07e3-40de-854e-0e92ab0410fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_15ef1ffe-4a37-41fd-9946-a19b29f9c67c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_e6fb15fa-43df-4290-b119-f8a675a33b2b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_2a758136-f2d9-4e21-8b95-99fff23b2b41_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b944a4c6-72c9-42ee-88d9-fe821310e554_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4aef23a1-cdcd-46b9-990b-e6f2f1c70253_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b06f4575-fde6-49df-9d67-bbddfcb87768_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_93fe75d4-4a3a-4083-b485-1918147c3a03_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember_00e89216-1063-495e-a26f-b9acf085e542_terseLabel_en-US" xlink:label="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bupivacaine liposome injectable suspension</link:label>
    <link:label id="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember_label_en-US" xlink:label="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bupivacaine Liposome Injectable Suspension [Member]</link:label>
    <link:label id="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember_documentation_en-US" xlink:label="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bupivacaine Liposome Injectable Suspension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:href="pcrx-20220630.xsd#pcrx_BupivacaineLiposomeInjectableSuspensionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:to="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f7e8d07e-ff45-42b7-bb6c-7fdb9c705584_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d15e4b11-30ac-470f-8743-e05566cdb780_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_2cdea5b0-e7c5-48d2-b396-f0f3d0b9e506_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercises of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5a08cdd5-f12f-4978-8694-3f329aab3b52_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_e99b5f21-7ccc-4c31-82b5-b9be758147fd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_690ff80f-e789-4318-ada7-12dbcad1442b_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Major Customers</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_410144e3-a893-4226-98d3-1fc5d3f46f78_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, warrants or rights issued, per principal amount (in shares)</link:label>
    <link:label id="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_label_en-US" xlink:label="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount</link:label>
    <link:label id="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_documentation_en-US" xlink:label="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:to="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_21398718-960f-4432-aba9-8bdbcf3446d0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_23aa0667-6da1-4649-a16d-11662fa8ed50_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_85c1e514-5762-4c4d-ac30-781aa7f2f4c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_07754ca1-f1af-4efb-bf8d-79dfa1834f59_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ba07a63b-1551-4b65-9f19-61f6d8d01893_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_46b43a2a-8f78-487a-9062-c93abbea122d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_02544b86-fe3a-4dba-8493-0f7dff2d117a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_52d6f65f-56fc-464f-b38c-41b5fb3918c6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_4637608b-659f-4252-bb3a-6a44ebccba58_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_29ae8e2a-3361-4492-8bc7-3fb5c8862ac2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_b4d77e07-920d-4738-85e0-a5988fa4ff16_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_3c62a71f-43fc-4300-aff8-c7756de84ae5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of carrying amount and fair value of the long-term debt</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_b6a64717-26cd-4ad6-bcb6-3603b70722fb_terseLabel_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition</link:label>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_label_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition [Member]</link:label>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_documentation_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MyoscienceAcquisitionMember" xlink:to="lab_pcrx_MyoscienceAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_52237db9-089b-4425-9a6a-671dd6f86521_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_dc4e8171-cfaa-4345-8ba9-2949795e0b88_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_92399bf2-bf2b-4634-bfa0-2cb6541d99cc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_9897f7f6-8988-4fd4-8b4c-3217f2521d7f_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_75e3040c-4b9b-438e-a00d-6300bc97d30f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_4e240e6c-7257-4cec-8dc1-7b666f98c952_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b1dba560-24f1-4b27-b11a-308a09913cf1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_b5de8f4c-7ce2-4ad0-b278-a20cd81fb65f_terseLabel_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and other assets</link:label>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_label_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Other Assets</link:label>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_documentation_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:href="pcrx-20220630.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:to="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2024Member_7fcf24b1-ebc2-4449-b9cd-499a8b9db546_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2024</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2024Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2024 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2024Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a57aaa50-d56f-4175-8ae3-8295304e5675_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of fixed assets and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_64338541-e2ef-4ac9-9cd6-d98387e968ce_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, ESPP (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_7e84ce30-016f-4344-bd33-73ef256eae50_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_e96b3b8e-5351-40c9-b056-2cf580826806_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Major Customers</link:label>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:to="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_385158dc-ffa0-4c47-b81d-c65e3d51671c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_88120773-a028-47e1-a532-3848f2646d36_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_11379a67-21cb-48be-8eef-4dd363b9d71c_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_cf393475-e43f-497c-9369-78fbc320eb37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of recognized identified assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f7cef61e-f950-4e05-973e-2e182b1120f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fada74d2-bac4-4f63-8d05-4c995f3da909_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b611b850-543d-4030-a537-f499de311753_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_10f53a6d-686b-4205-943e-dcfa8014f0a3_terseLabel_en-US" xlink:label="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP increase to shares allowed to be sold</link:label>
    <link:label id="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_label_en-US" xlink:label="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase</link:label>
    <link:label id="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_documentation_en-US" xlink:label="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:href="pcrx-20220630.xsd#pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:to="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_656a48f7-8942-4c48-9cc1-724a96e4326d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1f09beba-4b25-458a-9409-e26267b1faf2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_cacd6d24-8d13-427d-8752-5edf9bdf95a8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_44be52a4-07bc-46f7-ba9c-8bbb856d3f7d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_1b16a821-072f-4c6b-bb4a-29c074b57b4f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for operating lease liabilities, net of lease incentive</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_48129469-f88c-413e-9242-6317ccb6c34d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite-lived intangible assets acquired as part of business combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_05233621-686d-4c75-bfea-d2c049c69f83_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments and accretion</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e0721e3d-f6b6-4296-a661-5d372f66a082_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_97af9097-4565-43a9-98a9-90f660aabcd3_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ca6ca32d-a64e-47c6-aac1-49ace4a9234e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount payable to holders of the CVRs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_330f3f21-dba3-4238-a4c2-161bf6e564a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a8f67895-8400-4f3f-a636-43f481fb8011_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_55ae7789-355e-4c1b-bdb3-5fef652dd141_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_5c7fde17-73e9-4a2e-a252-f7082b122a46_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted net income&#8212;diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:to="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_09b220a0-b375-4107-b308-9e3f35cab65a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_5f979037-8355-4c43-92bb-a233fee57077_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_06acc8f2-a739-4d86-9449-d0dcee70ca51_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt, net of debt discount and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e6aaaf0c-e50d-4121-8dd1-4639146dbaf7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_41ec3779-2d23-48ee-96ec-4ecc395620e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_974da468-3881-4cdd-baf1-9546b3f23f29_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_948b6b48-3f28-4239-92db-fb14d31b4d39_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_a0429add-82c5-4e7c-9db0-4ccafa57c0bd_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_252051ba-2ee6-48e8-ae16-676ae5cdaa19_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_0f944310-03d4-45ee-b0b1-b2ac436b977e_terseLabel_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third largest wholesaler</link:label>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_label_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the third largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember" xlink:href="pcrx-20220630.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ThirdLargestCustomerMember" xlink:to="lab_pcrx_ThirdLargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_f411a806-58f0-4c48-bed1-4099adb72a10_terseLabel_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms Prior to February 3, 2023</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_label_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms Prior to February 3, 2023 [Member]</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_documentation_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms Prior to February 3, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:href="pcrx-20220630.xsd#pcrx_DebtRedemptionTermsPriorToFebruary32023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:to="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_a61966e4-7ec9-4e8f-b06f-38d8148fb623_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_f41a1529-e3cb-4166-bd7d-6246b0eef3b1_terseLabel_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three largest customers</link:label>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_label_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers [Member]</link:label>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_documentation_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember" xlink:href="pcrx-20220630.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ThreeLargestCustomersMember" xlink:to="lab_pcrx_ThreeLargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ce583f5-4461-4df4-a263-6433956f9720_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_afb5e84a-8938-4887-9ff8-1345fd7f5319_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_47c49120-b880-4c1b-8298-652483b1f791_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_2f03db41-12d4-4adf-b092-0a98b7985ee8_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_b4780e01-274b-420c-837f-529796fa72a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_PaymentOfContingentConsideration_66a7e0bf-f363-46b9-93d2-105e6586495f_negatedTerseLabel_en-US" xlink:label="lab_pcrx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_pcrx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_pcrx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Contingent Consideration</link:label>
    <link:label id="lab_pcrx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_pcrx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents earnout and milestone payment made which is associated with the acquisition of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PaymentOfContingentConsideration" xlink:href="pcrx-20220630.xsd#pcrx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_PaymentOfContingentConsideration" xlink:to="lab_pcrx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_ccaadf04-95fb-4884-b92e-f3d136f37f9c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_20ba2589-dd5d-4eca-a25b-04693557b898_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_3c5a803e-c6af-47f3-8e94-83072fb671bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_4d0d3935-81ef-467f-bc0a-21f1304ce429_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_fb75f6ad-268a-4dad-9b37-7a59ba908322_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4ceb11ce-8609-4788-8fb6-92b393771eac_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_4c828545-0dbf-40ee-9d9d-e89d28cc8950_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ba076754-c4f8-4ef0-9747-03fbf2cfcd47_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_763f84f8-5240-4b82-8db2-a60cbbe669c5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_65d843c9-9ff8-4898-888d-505f7d9e60fb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development (IPR&amp;D)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_1254c01e-7d1a-494a-b8f1-8ffd4cb798f7_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3a34ad09-6df1-44b1-93dc-693b4206d943_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_c0f018b3-6888-4fcd-bc17-ae207a31eb00_terseLabel_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_label_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023 [Member]</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_documentation_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:href="pcrx-20220630.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:to="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bca463f2-23d5-47cc-9abd-ae4fd2da5bf5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_51a13076-4659-4dc2-aeaf-015b465f810e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FIXED ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_7f073c16-28e9-4d8b-bd62-cef51b78eaf3_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of percentage of revenue comprised by the three largest customers</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_bee60b70-d714-4a9a-bd41-a57a05ba9e8f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_127a2714-19ba-4ecc-a469-b3174fddc0a1_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount (premium)</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FlexionAndMyoScienceAcquisitionMember_f07dbea5-31cc-4c98-8b3c-cacfa5cc7dfd_terseLabel_en-US" xlink:label="lab_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion And MyoScience Acquisition</link:label>
    <link:label id="lab_pcrx_FlexionAndMyoScienceAcquisitionMember_label_en-US" xlink:label="lab_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion And MyoScience Acquisition [Member]</link:label>
    <link:label id="lab_pcrx_FlexionAndMyoScienceAcquisitionMember_documentation_en-US" xlink:label="lab_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion And MyoScience Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAndMyoScienceAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:to="lab_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_0c62abfa-76b2-4100-91b0-6e3eaf48d84c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dbb3063-cbec-4697-afcb-71917296255f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_026c0783-9fa8-4f29-a9d7-9ce2fa5a0c25_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b47c906c-3e3d-4fff-bef5-ba1dcc04d418_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_82ab79e0-af16-4b4f-9003-2de78b97827a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_e96d5a63-ee20-4a57-810f-495e75cf8116_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, convertible, conversion premium (in shares)</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Premium, Shares</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Premium, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:to="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_84f56fe5-ac68-4929-9d2e-d4c6a7f86815_terseLabel_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual net sales threshold</link:label>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_label_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Net Sales Threshold for Determining Milestone Payments for Product in Connection with Acquisition</link:label>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_documentation_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:href="pcrx-20220630.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:to="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_0cff9a16-fc6a-415e-8abe-354d5a0c9cb3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_d89089d3-1db0-4562-a03e-facdd73d6f89_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_5380997f-cebd-42f4-ae5b-f2ffb2dcd2b2_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_9300fd65-9086-4ceb-9f56-d4039f5a196d_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerFourMember_37ec2855-7297-4bd0-b4db-7582287ecfcf_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer four</link:label>
    <link:label id="lab_pcrx_MajorCustomerFourMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Four [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerFourMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerFourMember" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerFourMember" xlink:to="lab_pcrx_MajorCustomerFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_a3be6c69-eb81-4fff-81a1-eb942fe48485_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f4387e8d-2248-4aed-83f4-ef655ec05b90_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_3750056b-c5e7-42fc-953b-34d70d70285b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT AND FINANCING OBLIGATIONS</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_54f4d4ff-e208-4e19-91a1-1850d213be65_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2fb0d7e0-1fba-4114-b449-e4da9aa90251_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_e3dfa154-9db5-40cb-bda8-fe91cebe04a5_terseLabel_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_label_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Assets and Unfavorable Lease Obligation</link:label>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_documentation_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:href="pcrx-20220630.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:to="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_90e989d6-4e9b-44ea-8f99-73e17b86157f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_98a49826-4c04-4970-adb2-9c26bc9715a3_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_label_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_f45ad454-de91-4c41-a736-b09a1859c7f5_totalLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable net assets acquired</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5e9891ad-83c2-4881-bb22-a8e4c3b3ff2f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_00b88bb7-4e79-4140-a339-9dacc546f248_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_83d187d6-6efc-4a03-9874-e0117b57ee94_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d1f3df02-7329-4ae3-91af-9de491a3ffae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e8df262e-bfc7-4efc-a72d-3d6294c27485_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_aee598a0-93f2-40a5-825f-b26bb37a6c30_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d5c7fa0-562c-42db-bd1b-8e6b7a78e9d1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FlexionAcquisitionMember_cfd69f4e-b73f-43c5-b4e2-209b8aa36ce5_terseLabel_en-US" xlink:label="lab_pcrx_FlexionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Acquisition</link:label>
    <link:label id="lab_pcrx_FlexionAcquisitionMember_label_en-US" xlink:label="lab_pcrx_FlexionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Acquisition [Member]</link:label>
    <link:label id="lab_pcrx_FlexionAcquisitionMember_documentation_en-US" xlink:label="lab_pcrx_FlexionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FlexionAcquisitionMember" xlink:to="lab_pcrx_FlexionAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_2edcb44c-2157-43eb-ab26-394df0e4cab1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_5d9a0444-64e5-4e72-a76e-eb98c82ee6a9_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_7844c305-c5f7-4276-ac17-4ebdf1bc4a17_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_bb2b6ce0-5009-4542-8d6e-637cf5760774_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_c957e5bf-bd62-4ca8-9cae-962f9b658d76_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_d56ada6a-d12c-4125-bc37-76a086617c75_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_a0aa1d00-0d18-4cd6-9c85-684e2dec2d2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ZILRETTAMember_538584cd-8100-4c53-9a67-8502258e40d7_terseLabel_en-US" xlink:label="lab_pcrx_ZILRETTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZILRETTA</link:label>
    <link:label id="lab_pcrx_ZILRETTAMember_label_en-US" xlink:label="lab_pcrx_ZILRETTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZILRETTA [Member]</link:label>
    <link:label id="lab_pcrx_ZILRETTAMember_documentation_en-US" xlink:label="lab_pcrx_ZILRETTAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZILRETTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ZILRETTAMember" xlink:href="pcrx-20220630.xsd#pcrx_ZILRETTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ZILRETTAMember" xlink:to="lab_pcrx_ZILRETTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ff52b8f9-15eb-4ead-8462-4e6357f382d8_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentVariableRate_3b7b2680-8792-493f-8e86-f08c5b8cd5dd_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentVariableRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentVariableRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentVariableRate" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentVariableRate" xlink:to="lab_pcrx_DebtInstrumentVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f8112bd7-ca48-4ab1-bb34-19e57c0b0825_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_83af91f2-df88-4744-b743-e9403c7e8bdb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_90e541b7-2a08-4c57-aedd-b0d7c81f01b0_terseLabel_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd.</link:label>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_label_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd. [Member]</link:label>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_documentation_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member" xlink:href="pcrx-20220630.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_NuanceBiotechCo.Ltd.Member" xlink:to="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_64b0d653-e7ee-47c3-85b3-5087edee3911_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f9ab413a-d9a7-4ce0-b5f3-fcf88efb8ef0_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_723b2f6a-34b2-4f0a-b03c-b05355b9e831_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_fa28ac86-0755-440e-93d5-9e0aee348c38_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7877453a-5ac1-4b3a-9bb8-16b9b3c1ed81_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_17bfd5d9-3828-4143-a3b0-6d509d8524f4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ee8fcc80-8f69-4da7-9558-079b7a9795fb_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Useful Lives</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_376b7b8d-56eb-4287-8f45-b8426e798999_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_cb38ef54-5d3d-42e0-9d32-dc67a3a8b3e2_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_5d50a3a2-5f9d-45fe-bbd1-a28151c5ae51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of composition of the Company's debt and financing obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_ca2d25d7-2484-4cdc-bb41-7924c3df8a45_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FIXED ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_e75a9542-d46b-47bb-b27a-9b45e632c2f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation from:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d189884-f7a9-41ff-8925-11e525a2fbed_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net product sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_a9266753-817b-4c21-ad74-2489dcbbbd97_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_cba0e989-160b-4442-896b-64983c81b71b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_676b1a26-01f6-49b5-8d75-ebf4f277406a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible securities (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_fced0fdf-227c-4df4-8aab-507a82b6c178_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_996fcf86-f8e2-4a89-9850-15ae0066ed40_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of investments without readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_ec39d01d-3193-4c1f-8d57-8377d51c0753_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price of principal amount of notes</link:label>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_label_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Market Price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt market price, per $1,000 principal amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentMarketPrice" xlink:to="lab_pcrx_DebtInstrumentMarketPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_51e320b3-3d5a-4a45-9e06-92b1341c7e95_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_4c26c43f-17d5-47bc-87b0-dfb18457943e_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread two on variable rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread Two On Variable Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread Two On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:to="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_08baac6c-d20a-4c60-90ee-5a2d9e167a7b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_7e001c1a-04cc-4ea9-b4cf-cc35bb79edcc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest and other (Note 6)</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_bd0d10d5-7fac-4cbc-b336-690f5f34e3dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest and other (Note 6)</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_6961ccf4-4f0d-46bc-9571-d73eb6632783_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_3a171372-71b1-4c1a-9610-029147bf14a1_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_7f07c704-3c57-4675-8f35-d0774cd396df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equity and debt investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_2536bc56-1efd-471e-a163-dc81c808ff02_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_1337aabc-ecc8-4f17-99bf-a0100b1d9e2c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_25e98c5f-5bdc-40b6-bca6-3627b7e6a665_terseLabel_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, payment terms</link:label>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_label_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Payment Terms</link:label>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_documentation_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms" xlink:href="pcrx-20220630.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AccountsReceivablePaymentTerms" xlink:to="lab_pcrx_AccountsReceivablePaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_e0590d29-0bf6-4b4d-89d2-1d9bde957e45_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:to="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_3a28f89a-3442-44fb-8a8e-b6c5888df792_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Axis]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_label_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Axis]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_documentation_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information regarding the conversion and redemption terms of the debt instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:to="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_a88dd018-baa3-4c83-80b9-820411021dd8_terseLabel_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement period - convertible debt conversion request</link:label>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_label_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Period - Convertible Debt Conversion Request</link:label>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_documentation_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of trading days in a settlement period for convertible debt conversion requests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:href="pcrx-20220630.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:to="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_5dcc3a05-32f3-494a-9c1f-ed88c0ee7160_terseLabel_en-US" xlink:label="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from development and commercialization of ZILRETTA</link:label>
    <link:label id="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_label_en-US" xlink:label="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Development And Commercialization Of ZILRETTA</link:label>
    <link:label id="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_documentation_en-US" xlink:label="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Development And Commercialization Of ZILRETTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:href="pcrx-20220630.xsd#pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:to="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_68c2e4a4-1c46-4d82-b566-a47bb4bff5f4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_0f3acf9b-c3b9-4985-a080-29e551ad2d78_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_474c575a-69a6-4ed2-afd8-3feb9d4103d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_545f8960-7aa1-47a4-b5ab-29e0735cca98_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_304aa662-b13c-4ef7-a8e3-7e176f8b5c63_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_e340add1-46ed-4dd4-ae78-6cc9fae37cc9_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_IoveraMember_0d2ce21b-a04f-4015-be46-b85a134289f0_terseLabel_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176;</link:label>
    <link:label id="lab_pcrx_IoveraMember_label_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176; [Member]</link:label>
    <link:label id="lab_pcrx_IoveraMember_documentation_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176; [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember" xlink:href="pcrx-20220630.xsd#pcrx_IoveraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_IoveraMember" xlink:to="lab_pcrx_IoveraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_f1a8a40e-395b-42f9-a2c4-1eb3c308094b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_dee1e71c-cf7f-4105-b04a-b4e17a078b6d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_1724c532-dce9-423b-8bc3-d4240039f081_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt, amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21dacd1d-2725-4e59-b5bd-a472cd9d96b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share based compensation arrangements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_731ff9cd-9686-432a-99c5-14119ee6ba39_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b54c33ab-cd79-40b3-925b-b88a97350548_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income before income tax, domestic and foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f7e2c29e-8289-4609-816c-261681197f8b_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8c45bc05-bec0-4582-a514-dc022854dcf3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_27d31973-c22f-49aa-ba55-5a790a51b079_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_50cd179f-3067-4fd2-b5e1-f21a75f15212_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_9fedbae2-fb11-43e9-888c-a6410dbc1ec5_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Domain]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_label_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Domain]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_documentation_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identification of the conversion and redemption terms of the debt instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:to="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_a710d17c-d193-4620-a1bd-e9ce364fe4af_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_567d7cd0-0f94-410b-8505-31867e79cd43_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_970b6057-412e-4aac-9e96-e758dbed9b8b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per common share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3342d608-aff6-4c16-a861-a072dd4fc12f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_66d4c393-e399-4c0a-90e2-6f640e7d0113_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ee8ea318-9149-41a5-b39b-e18f86b3057c_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on disposal of fixed assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f49fb31d-4f1e-4c9b-8403-113428943ff9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Without Readily Determinable Fair Value Roll Forward [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fb3b2246-b23c-4a2a-b914-7cb5466bdcef_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_b77d577e-eceb-4dfb-b087-1641230b9957_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1fb2134f-e3be-4a07-9f28-60e5886924ee_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_bb076380-ab8f-458b-a229-a28a145d4e2b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_6d69162e-0917-4a70-9466-259685c55f20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd. agreement dissolution costs</link:label>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_label_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnContractTermination" xlink:to="lab_us-gaap_GainLossOnContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_287a72af-88f8-4a7d-a1a3-1d218bdd9f43_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_d93def17-55c2-48e6-95e6-da481d2a3b78_terseLabel_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second largest wholesaler</link:label>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_label_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the second largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember" xlink:href="pcrx-20220630.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SecondLargestCustomerMember" xlink:to="lab_pcrx_SecondLargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_15edc326-db0c-441a-9469-06c3a8882437_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk by major customer</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3cc1dea6-b1e9-4fac-9ed3-5d59b0ca1ad8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_a09f7bc6-9a44-4676-bffa-d4f9ef8b475e_terseLabel_en-US" xlink:label="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Success of Regulatory Milestones</link:label>
    <link:label id="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_label_en-US" xlink:label="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Success Of Regulatory Milestones [Member]</link:label>
    <link:label id="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_documentation_en-US" xlink:label="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Success Of Regulatory Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:href="pcrx-20220630.xsd#pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:to="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_95c582dd-73f2-4bc8-b6e0-2c5d4e55276c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_61b7fd1b-6780-41a9-8cc0-7022d58acc24_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_34109608-3f9d-4a9c-a479-0fe74e3d4a1e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f60ebb5b-8ac0-4966-91bb-ff5b656f7a30_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_67fd3f83-c389-4cdd-a296-cc60c5ee24fa_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5957f52e-08d5-42d6-a1a2-9bc9c2f5624c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_78cb7dde-bcb0-43d9-9b02-19e1fcacae18_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_d02da2b6-7d74-459e-a735-93a7487af463_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d5d0ef5d-46e2-42f3-a668-e43275d9b0e4_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_fd65535b-0a91-445e-b188-1692510df570_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_eb0c8407-bde4-4041-8451-93dfe51bf11b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_439601f1-0f49-4855-acf9-1769e2277e75_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer three</link:label>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Three [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerThreeMember" xlink:to="lab_pcrx_MajorCustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0193a84c-8ca1-46ee-9e2f-5c1ba8efee53_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a3ca95bc-0443-4562-896b-f6aec9c9591c_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_dd5f8974-182c-4ebc-acd1-38042909a532_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized (loss) gain on investments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3786b733-ee96-4440-a5f2-49710f926276_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss on investments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_84485e6a-a0ec-48c4-8393-ee0d281219b4_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_34d61c4b-635b-4b88-83af-164c78890f1e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_731f563c-d812-495c-bbcc-98d94d47c79f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of long-term debt instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_4ef345da-2c87-4597-aa8d-88a8bac7c5f4_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_f246acd9-9358-418e-b693-92e22b734157_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, third period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_TermLoanBFacilityDue2026Member_11f5f446-30f9-45ad-a22d-d63c42152e70_terseLabel_en-US" xlink:label="lab_pcrx_TermLoanBFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Facility Due 2026</link:label>
    <link:label id="lab_pcrx_TermLoanBFacilityDue2026Member_label_en-US" xlink:label="lab_pcrx_TermLoanBFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Facility Due 2026 [Member]</link:label>
    <link:label id="lab_pcrx_TermLoanBFacilityDue2026Member_documentation_en-US" xlink:label="lab_pcrx_TermLoanBFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Facility Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_TermLoanBFacilityDue2026Member" xlink:to="lab_pcrx_TermLoanBFacilityDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_78d154bb-7fa1-4b08-8af4-38cb0ad37b6c_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, second period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9cec53cf-c73b-45e1-9b45-257071fe95af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_984fda02-846c-4448-96d8-7d9923850f46_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_972e982d-6433-4dbd-aba8-90aa6c21c26e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_ec32d74d-6dd1-413e-9dca-4726a5260e88_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, fourth period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4be9b372-2254-4550-9e69-91b5107fc5e3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_fb607136-bc48-4f5e-9f51-803565565abf_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, first period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_fedab4b5-574a-4f86-b722-686b2f374222_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfCustomers_60cad51a-90a1-4826-a948-8c54af445900_terseLabel_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfCustomers_label_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfCustomers_documentation_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfCustomers" xlink:href="pcrx-20220630.xsd#pcrx_ConcentrationRiskNumberOfCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConcentrationRiskNumberOfCustomers" xlink:to="lab_pcrx_ConcentrationRiskNumberOfCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_a9cb6581-60bf-45c9-a289-d8e6ded18617_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_41c2ef58-c197-4b1d-b08b-deda8266e67a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, remainder of fiscal year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_0a7031df-57ab-429d-b583-69635957f39d_terseLabel_en-US" xlink:label="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs, In-The-Money Stock Options, and Common Stock</link:label>
    <link:label id="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_label_en-US" xlink:label="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Money Stock Options, And Common Stock [Member]</link:label>
    <link:label id="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_documentation_en-US" xlink:label="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Money Stock Options, And Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:href="pcrx-20220630.xsd#pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:to="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_f50bd191-fdd1-4724-b263-dccf763034da_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_HongKongPharmaTainuoLtdMember_0de8ae67-097f-409b-a72b-f893da7b970c_terseLabel_en-US" xlink:label="lab_pcrx_HongKongPharmaTainuoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong Pharma Tainuo Ltd.</link:label>
    <link:label id="lab_pcrx_HongKongPharmaTainuoLtdMember_label_en-US" xlink:label="lab_pcrx_HongKongPharmaTainuoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong Pharma Tainuo Ltd. [Member]</link:label>
    <link:label id="lab_pcrx_HongKongPharmaTainuoLtdMember_documentation_en-US" xlink:label="lab_pcrx_HongKongPharmaTainuoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong Pharma Tainuo Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_HongKongPharmaTainuoLtdMember" xlink:href="pcrx-20220630.xsd#pcrx_HongKongPharmaTainuoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_HongKongPharmaTainuoLtdMember" xlink:to="lab_pcrx_HongKongPharmaTainuoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_5bd9ec2f-1c21-4156-a19d-a47925e9133d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated settlement fees</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c90d9d3f-9a36-4503-90d9-75df1860756b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_ad8cb4c5-9a3f-4149-ba20-bf23951450f9_terseLabel_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of total interest expense recognized related to the Notes</link:label>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_label_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense [Table Text Block]</link:label>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_documentation_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the amount of interest rate expenses related to convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:href="pcrx-20220630.xsd#pcrx_ScheduleOfInterestExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:to="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_361d1242-f359-4ec3-b8ef-65b70f541356_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_4f72f2e3-081b-4373-93a7-94055394564a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input, contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_10ad4524-0ef4-456a-aa1b-67e3e3fcc85f_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d4163c4e-a192-4ccd-a64b-8567a2111374_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_bd1b132b-15b0-45b1-a386-950402bfeaba_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_75386c38-5551-4b06-88bc-c6de57719650_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Term loan B facility maturing December 2026</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_e8511d2f-0e43-41c0-9720-922627277814_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a75c937e-9f52-4727-adb1-d227906c3123_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value (Per Share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_3b8d8203-81f7-4921-b99f-bd980f0d1666_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, premium on common stock</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion Obligation Premium on Common Stock</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:to="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4342757e-75f8-4dc3-9c0e-1a10aff3c5cc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81cd6504-1434-4a08-a0c6-6deae05928e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_cdcf74a7-dd14-4b7d-92ac-f850f9bfeead_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_6850f49a-7c23-4cee-adbd-39d6e629d5c0_terseLabel_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency adjustments</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_label_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_documentation_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:href="pcrx-20220630.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:to="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_319a3f51-04b9-4459-93c8-a4e2b203e02c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_c6f1f855-324f-4ad3-9e57-ad8acfca15e7_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_5c5cccc3-e112-456e-8623-6641a2e7ef3c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a1bcfd0a-86a5-4db2-a319-814fb3769eaf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_903b4259-1ae8-4874-960f-b13dd2764765_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerOneMember_495c3fbf-dc13-49ae-9ace-295e9fa2e2d5_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer one</link:label>
    <link:label id="lab_pcrx_MajorCustomerOneMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer One [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerOneMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerOneMember" xlink:to="lab_pcrx_MajorCustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a3ff253d-89c2-4c91-ae87-a51eefdc3ff2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_a05d7902-a1fc-493d-91ff-273c26ddbf29_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7cbcdd4a-94e1-4b65-985b-1c74093fb905_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_6461506c-d4b6-49bb-8ad8-053b908efad4_negatedLabel_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related (gains) charges, product discontinuation and other</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_label_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_documentation_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:to="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_edd6a2f9-7f01-4e77-aab3-2e12d66cdbf9_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_fa1713fd-9208-4046-b423-908758ca8393_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at June&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_671e7948-77b9-4902-9002-861dd77cf719_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate, at point in time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FlexionTherapeuticsIncMember_d75cf611-f767-4e33-af8d-b35696dd0dd2_terseLabel_en-US" xlink:label="lab_pcrx_FlexionTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion</link:label>
    <link:label id="lab_pcrx_FlexionTherapeuticsIncMember_label_en-US" xlink:label="lab_pcrx_FlexionTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_pcrx_FlexionTherapeuticsIncMember_documentation_en-US" xlink:label="lab_pcrx_FlexionTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FlexionTherapeuticsIncMember" xlink:to="lab_pcrx_FlexionTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_675672b0-037d-43a4-84b0-32cb5554e6ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ff904bb6-3e9f-4c7b-abaf-905aa1e1160f_totalLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bd40b60c-f1cd-438d-b6b3-2d73e553e297_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4a3127a9-e07d-4ba9-b424-b2f33387c842_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_8aa63c48-37a0-43e8-896b-3119a66ab6c2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_92cf5b87-b03b-496b-b46e-366ff839f311_terseLabel_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense From Employee Stock Purchase Plan</link:label>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense From Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:href="pcrx-20220630.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:to="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fe8f1baf-6f5a-4b9a-b6ee-c87fa1aeb5e3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of fixed assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_ac3fa438-6b18-4fd8-a309-e87d2fe39ec7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d356ecb6-e5c1-490b-9cbb-dbca0c554abb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_0269665c-2426-49f1-9392-78bfd4f3699c_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_f2fde1af-6d0a-4a64-b0c7-ddcc0a86ebfb_terseLabel_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember" xlink:href="pcrx-20220630.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ComputerEquipmentAndSoftwareMember" xlink:to="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f0394cc0-bc07-4ad9-a6a6-b6efcac711f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computation of basic and diluted loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1ddf3a86-d275-467b-b2ca-301e924876ea_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets recorded in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_98187959-0b9c-42d0-a2bc-5df23a3f6ffc_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_48f678a1-db07-4c58-b348-6c9a7be5f5c6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Integration, Restructuring and Other Related Costs [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_4d369711-953e-4f00-9ee2-3d992f40479d_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Major Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_4e01988b-801b-44d3-b191-7dd853449791_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2)</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 Retrospective [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>pcrx-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1acf2e72-2487-45a7-a11c-6bf309df42b1,g:86a623c9-da96-4e80-aae2-29b4daaaad57-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pacira.com/role/CoverPage" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3d24aee5-5c79-4bb2-84c1-ca2ad879af3e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_DocumentType_3d24aee5-5c79-4bb2-84c1-ca2ad879af3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_b4388d80-0f44-4064-a0f8-0c1b5431fa2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_DocumentQuarterlyReport_b4388d80-0f44-4064-a0f8-0c1b5431fa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_55deb005-7743-4092-8681-7eecdde2b90d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_DocumentPeriodEndDate_55deb005-7743-4092-8681-7eecdde2b90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_799db6b8-fc10-411b-bdad-f49496156160" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_DocumentTransitionReport_799db6b8-fc10-411b-bdad-f49496156160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e1eddf28-7cd9-4b5f-9aee-cbc6045a65dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityFileNumber_e1eddf28-7cd9-4b5f-9aee-cbc6045a65dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_dc6b186d-1885-49ef-8e86-b10c70ae56b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityRegistrantName_dc6b186d-1885-49ef-8e86-b10c70ae56b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_634bd452-1b10-47d2-92ef-324c76a8672e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_634bd452-1b10-47d2-92ef-324c76a8672e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_062d1df1-278e-40d1-b91c-ea496c5fe375" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityTaxIdentificationNumber_062d1df1-278e-40d1-b91c-ea496c5fe375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ce086eff-3c77-4afd-a437-e075f51c3539" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityAddressAddressLine1_ce086eff-3c77-4afd-a437-e075f51c3539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_454e2fc7-74d8-4777-ae6f-c07b69189bb8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityAddressCityOrTown_454e2fc7-74d8-4777-ae6f-c07b69189bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f47557de-ac8c-43fc-a075-7bbef83ecf37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityAddressStateOrProvince_f47557de-ac8c-43fc-a075-7bbef83ecf37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7af48579-f2e0-433c-b0d3-ed5ab645751e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityAddressPostalZipCode_7af48579-f2e0-433c-b0d3-ed5ab645751e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0a03af8b-6e81-4a48-b8e0-36a5a5ca6115" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_CityAreaCode_0a03af8b-6e81-4a48-b8e0-36a5a5ca6115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5bb38a63-fb91-4def-a9a4-7879fe4a1bf0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_LocalPhoneNumber_5bb38a63-fb91-4def-a9a4-7879fe4a1bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d9bed73a-ab29-4328-b2d8-56dbe8e235b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_Security12bTitle_d9bed73a-ab29-4328-b2d8-56dbe8e235b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0a63260f-d739-4050-aa58-b7637ef6a21d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_TradingSymbol_0a63260f-d739-4050-aa58-b7637ef6a21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_190fedb6-a40e-43aa-9622-50096c9b06f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_SecurityExchangeName_190fedb6-a40e-43aa-9622-50096c9b06f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_3ef9ae0c-a2dc-4a60-9939-23cee760b748" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityCurrentReportingStatus_3ef9ae0c-a2dc-4a60-9939-23cee760b748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9c04fbe9-f82e-43e8-9f11-2eeb5709a8d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityInteractiveDataCurrent_9c04fbe9-f82e-43e8-9f11-2eeb5709a8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_888ebf92-7bb8-497b-be20-d0854f849655" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityFilerCategory_888ebf92-7bb8-497b-be20-d0854f849655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_071ec956-3af4-41ff-895e-cab8619644b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntitySmallBusiness_071ec956-3af4-41ff-895e-cab8619644b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_22b43208-b8e3-478c-a852-d0f6bf0417fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityEmergingGrowthCompany_22b43208-b8e3-478c-a852-d0f6bf0417fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6984c03c-9695-4fbc-b4cf-d919fbb0e3cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityShellCompany_6984c03c-9695-4fbc-b4cf-d919fbb0e3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0257c5ba-143d-4a1b-9353-b03c492a35fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0257c5ba-143d-4a1b-9353-b03c492a35fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_47ec7438-487c-4a95-bbd3-b47ef4eaa361" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_EntityCentralIndexKey_47ec7438-487c-4a95-bbd3-b47ef4eaa361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c88d621c-9afe-4ade-9a19-f7b61083ff99" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_CurrentFiscalYearEndDate_c88d621c-9afe-4ade-9a19-f7b61083ff99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5a622e66-ff75-45b6-93a8-fc09fae5aa49" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_DocumentFiscalYearFocus_5a622e66-ff75-45b6-93a8-fc09fae5aa49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_bbf5d668-7a46-411d-82c3-e6c6bb935464" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_bbf5d668-7a46-411d-82c3-e6c6bb935464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b87ae64f-6f26-42fb-8cc3-bc9590f4bec4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dd23da40-f4a8-4ce9-b1ee-27d32f042fb4" xlink:to="loc_dei_AmendmentFlag_b87ae64f-6f26-42fb-8cc3-bc9590f4bec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2e87ca94-85a3-4ac4-8030-d549f4c460ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2e87ca94-85a3-4ac4-8030-d549f4c460ba" xlink:to="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_bf0b0bfc-7b5c-427d-b585-87254850f742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:to="loc_us-gaap_AssetsCurrentAbstract_bf0b0bfc-7b5c-427d-b585-87254850f742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b04981d-8123-4864-8e31-2ef607ff80e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bf0b0bfc-7b5c-427d-b585-87254850f742" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b04981d-8123-4864-8e31-2ef607ff80e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_8fcca726-9e58-42f8-ad73-6bdadc8230e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bf0b0bfc-7b5c-427d-b585-87254850f742" xlink:to="loc_us-gaap_ShortTermInvestments_8fcca726-9e58-42f8-ad73-6bdadc8230e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_61c27ee4-d3cc-4ed6-b890-9793e8180eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bf0b0bfc-7b5c-427d-b585-87254850f742" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_61c27ee4-d3cc-4ed6-b890-9793e8180eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7c654d9e-2deb-46a9-aec4-38d77edb9c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bf0b0bfc-7b5c-427d-b585-87254850f742" xlink:to="loc_us-gaap_InventoryNet_7c654d9e-2deb-46a9-aec4-38d77edb9c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_09e5e7e3-9f65-4d77-8a7f-b58cd1e66e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bf0b0bfc-7b5c-427d-b585-87254850f742" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_09e5e7e3-9f65-4d77-8a7f-b58cd1e66e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fb4270e7-760d-46fc-ad08-85a9b1ef8189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bf0b0bfc-7b5c-427d-b585-87254850f742" xlink:to="loc_us-gaap_AssetsCurrent_fb4270e7-760d-46fc-ad08-85a9b1ef8189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6ea82e68-4f81-4ee6-b3c6-a2895522776b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6ea82e68-4f81-4ee6-b3c6-a2895522776b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f089b02f-57cd-4f3b-bbcc-52f4419d2b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f089b02f-57cd-4f3b-bbcc-52f4419d2b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7d265f78-654a-4827-b41e-c2f58b0decbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:to="loc_us-gaap_Goodwill_7d265f78-654a-4827-b41e-c2f58b0decbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a8937ea3-caf9-4cbb-ad0c-5e4c227825e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a8937ea3-caf9-4cbb-ad0c-5e4c227825e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_285842d9-fbcb-43e3-a023-480644a88a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_285842d9-fbcb-43e3-a023-480644a88a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_803bd9e3-38c9-4b43-9b5d-76e053d02747" xlink:href="pcrx-20220630.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:to="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_803bd9e3-38c9-4b43-9b5d-76e053d02747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_243c2a4d-beb1-4746-9c21-e1bb49500cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05974c64-496a-49c8-be83-d8df2e36f3fb" xlink:to="loc_us-gaap_Assets_243c2a4d-beb1-4746-9c21-e1bb49500cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2e87ca94-85a3-4ac4-8030-d549f4c460ba" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a6c79170-be98-4146-8c5f-fd163f25089f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:to="loc_us-gaap_AccountsPayableCurrent_a6c79170-be98-4146-8c5f-fd163f25089f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3ad84217-8717-40d3-8284-1fe5d12741c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3ad84217-8717-40d3-8284-1fe5d12741c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1b9e7bda-d694-4a8e-8cea-c4272725921a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1b9e7bda-d694-4a8e-8cea-c4272725921a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_ad0f4021-b497-4a70-839d-68047c617579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_ad0f4021-b497-4a70-839d-68047c617579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_a8f3ca41-4014-4bb0-bfd8-6c563f275420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:to="loc_us-gaap_SecuredDebtCurrent_a8f3ca41-4014-4bb0-bfd8-6c563f275420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_23d3fc4c-9e97-4706-91cf-e9f1f5b7e3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:to="loc_us-gaap_TaxesPayableCurrent_23d3fc4c-9e97-4706-91cf-e9f1f5b7e3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f88f9664-e339-4c71-8610-c11e16d3bd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa088fe0-63b7-4d6a-99e3-d13b36391c45" xlink:to="loc_us-gaap_LiabilitiesCurrent_f88f9664-e339-4c71-8610-c11e16d3bd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_90302c99-6544-421d-8848-83c572200f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_90302c99-6544-421d-8848-83c572200f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_87931128-a00d-4646-b54f-37287b6ec7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_SecuredLongTermDebt_87931128-a00d-4646-b54f-37287b6ec7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b70a780b-15b6-4b4d-814e-46383159a602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b70a780b-15b6-4b4d-814e-46383159a602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent_f3488598-ff2a-4b4d-9f5d-07877eebd122" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_pcrx_ContingentConsiderationNoncurrent_f3488598-ff2a-4b4d-9f5d-07877eebd122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_40646e24-eeb8-4ef1-a9ce-53529821c39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_40646e24-eeb8-4ef1-a9ce-53529821c39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7c715554-2c67-475d-b1cf-d154a1c9933e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_Liabilities_7c715554-2c67-475d-b1cf-d154a1c9933e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f9010456-07b3-45f0-80fb-ccd4dfee3cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f9010456-07b3-45f0-80fb-ccd4dfee3cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_d92e4174-cf93-45e5-8acb-c9213d60e335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_StockholdersEquityAbstract_d92e4174-cf93-45e5-8acb-c9213d60e335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_dc9fc5ff-6831-4cf8-bc54-2b0e15503dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d92e4174-cf93-45e5-8acb-c9213d60e335" xlink:to="loc_us-gaap_PreferredStockValue_dc9fc5ff-6831-4cf8-bc54-2b0e15503dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_af0d2576-c3ec-49fb-abe2-44608859863e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d92e4174-cf93-45e5-8acb-c9213d60e335" xlink:to="loc_us-gaap_CommonStockValue_af0d2576-c3ec-49fb-abe2-44608859863e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cb7b5fde-0e4a-441a-abdc-a7b38d85a70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d92e4174-cf93-45e5-8acb-c9213d60e335" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cb7b5fde-0e4a-441a-abdc-a7b38d85a70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_87783ec7-71dd-459c-b1fc-0fedde25b747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d92e4174-cf93-45e5-8acb-c9213d60e335" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_87783ec7-71dd-459c-b1fc-0fedde25b747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5bae575-3ccc-4134-a037-4c4f1607fb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d92e4174-cf93-45e5-8acb-c9213d60e335" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5bae575-3ccc-4134-a037-4c4f1607fb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6441bf65-f707-49c0-8e78-f959f647b5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d92e4174-cf93-45e5-8acb-c9213d60e335" xlink:to="loc_us-gaap_StockholdersEquity_6441bf65-f707-49c0-8e78-f959f647b5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_84a33e6c-d771-4f2f-aff1-8a6305a18709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f77b9ab-2f91-466b-9d34-6a4b888d03a1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_84a33e6c-d771-4f2f-aff1-8a6305a18709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7b334dc5-57a6-4862-9049-10ce1e51c939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7b334dc5-57a6-4862-9049-10ce1e51c939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d233ab00-2951-4d61-bf0f-50b0b6d7456b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d233ab00-2951-4d61-bf0f-50b0b6d7456b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3da64f9b-4002-4de7-b6f9-cd4a8a99c316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3da64f9b-4002-4de7-b6f9-cd4a8a99c316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_a3d218f3-b6ca-48d9-8f42-6acb27162374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_a3d218f3-b6ca-48d9-8f42-6acb27162374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e72efdf1-6d3c-41de-b949-becc5d3b4085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e72efdf1-6d3c-41de-b949-becc5d3b4085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_fd6b06c3-d8c6-446e-965d-6616e473683f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_fd6b06c3-d8c6-446e-965d-6616e473683f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1a8191e4-2e14-4e1c-aa7d-aa19234fc717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:to="loc_us-gaap_CommonStockSharesIssued_1a8191e4-2e14-4e1c-aa7d-aa19234fc717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_49bc8677-a091-4b8d-870d-0f10e4cc4527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7ba8ce94-c567-43c9-889f-13266725181e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_49bc8677-a091-4b8d-870d-0f10e4cc4527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_04b75b23-c210-4841-8d02-e3ec5cae82ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c0f98c67-b2cf-47a7-8942-a12e07f5191f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_04b75b23-c210-4841-8d02-e3ec5cae82ee" xlink:to="loc_us-gaap_StatementTable_c0f98c67-b2cf-47a7-8942-a12e07f5191f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_89679b26-9e11-4540-a367-0386ef1c1c6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0f98c67-b2cf-47a7-8942-a12e07f5191f" xlink:to="loc_srt_ProductOrServiceAxis_89679b26-9e11-4540-a367-0386ef1c1c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_89679b26-9e11-4540-a367-0386ef1c1c6f" xlink:to="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_55ee828c-57e3-4e8f-aab5-a0f5851497ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:to="loc_us-gaap_ProductMember_55ee828c-57e3-4e8f-aab5-a0f5851497ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_913c422f-3433-44be-831d-9e405d451a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:to="loc_us-gaap_RoyaltyMember_913c422f-3433-44be-831d-9e405d451a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_b602e4f9-12b6-4383-9c4c-721c7ebcca24" xlink:href="pcrx-20220630.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f054eba-b70e-42b9-8b98-76b99f00cc91" xlink:to="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_b602e4f9-12b6-4383-9c4c-721c7ebcca24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0f98c67-b2cf-47a7-8942-a12e07f5191f" xlink:to="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_e2bfd1eb-c591-407a-81de-70e9e84a0d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_RevenuesAbstract_e2bfd1eb-c591-407a-81de-70e9e84a0d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b00efd33-a42b-4a5c-a14a-20014cd19472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_e2bfd1eb-c591-407a-81de-70e9e84a0d5d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b00efd33-a42b-4a5c-a14a-20014cd19472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_88f39f13-0069-45cc-9a86-0f7d89a15d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_CostOfRevenue_88f39f13-0069-45cc-9a86-0f7d89a15d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e794603e-e67f-4f8e-ab46-0de72c8e199b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e794603e-e67f-4f8e-ab46-0de72c8e199b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05c254ba-b42f-4c23-b672-9defec080d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05c254ba-b42f-4c23-b672-9defec080d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_01a979c5-888f-45a2-aaae-484fa01232a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_01a979c5-888f-45a2-aaae-484fa01232a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_49c668eb-4a10-4556-a9a9-8c46dbdc7ae0" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_49c668eb-4a10-4556-a9a9-8c46dbdc7ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_07f503ee-d2d3-49a9-bab9-ed5a42e03b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ea80c72-4066-4e13-8bde-0f48e451a2b7" xlink:to="loc_us-gaap_CostsAndExpenses_07f503ee-d2d3-49a9-bab9-ed5a42e03b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fcc4780b-8995-49fd-9497-860c0f36ea67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_OperatingIncomeLoss_fcc4780b-8995-49fd-9497-860c0f36ea67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c1cb5394-851c-451e-822f-be1a03d80f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c1cb5394-851c-451e-822f-be1a03d80f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_eca9a000-e2b3-48ff-b270-014708cc2e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:to="loc_us-gaap_InterestExpense_eca9a000-e2b3-48ff-b270-014708cc2e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5df20a40-3237-4d08-827b-606be7de3a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5df20a40-3237-4d08-827b-606be7de3a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6ba7dc63-1daa-403a-b4e0-08ad93ac8767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2ac590ce-d54b-4bc1-ade8-4554e114f808" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_6ba7dc63-1daa-403a-b4e0-08ad93ac8767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c4ace8a1-5842-4ef5-86ab-8d903127078c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c4ace8a1-5842-4ef5-86ab-8d903127078c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7c82dc2f-7ba5-4fe0-a18c-998c7a6b5d58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7c82dc2f-7ba5-4fe0-a18c-998c7a6b5d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d9ea350a-dfb1-44bd-b346-781e12b115b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_NetIncomeLoss_d9ea350a-dfb1-44bd-b346-781e12b115b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_89feec1e-819c-4468-ac0e-3a93fd14106d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_89feec1e-819c-4468-ac0e-3a93fd14106d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_698c411c-a895-40f1-889f-0d70849d6e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89feec1e-819c-4468-ac0e-3a93fd14106d" xlink:to="loc_us-gaap_EarningsPerShareBasic_698c411c-a895-40f1-889f-0d70849d6e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a512bffc-3a11-4a31-8f3f-2e4509a88ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89feec1e-819c-4468-ac0e-3a93fd14106d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a512bffc-3a11-4a31-8f3f-2e4509a88ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0fdb2182-12a6-4649-859b-911cb0521677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b96dadc-71a5-44e9-a2e5-e9783f6743b4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0fdb2182-12a6-4649-859b-911cb0521677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88eea4bc-062e-4523-b79a-7ee63adaa07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0fdb2182-12a6-4649-859b-911cb0521677" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88eea4bc-062e-4523-b79a-7ee63adaa07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba8edfae-0513-47c6-9929-383244a06163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0fdb2182-12a6-4649-859b-911cb0521677" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba8edfae-0513-47c6-9929-383244a06163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b446ad78-f6a7-4e88-b399-460fb2dd6b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d43ff79e-824b-40b9-b386-aa3bd20e05dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b446ad78-f6a7-4e88-b399-460fb2dd6b7e" xlink:to="loc_us-gaap_NetIncomeLoss_d43ff79e-824b-40b9-b386-aa3bd20e05dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8e915aa8-364b-4ad7-9ea7-0a9743959299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b446ad78-f6a7-4e88-b399-460fb2dd6b7e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8e915aa8-364b-4ad7-9ea7-0a9743959299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c7ec9202-2496-480a-a300-1fbaf367a07e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8e915aa8-364b-4ad7-9ea7-0a9743959299" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c7ec9202-2496-480a-a300-1fbaf367a07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_101e1bba-b459-48e5-9c3a-cd4e7fa14056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8e915aa8-364b-4ad7-9ea7-0a9743959299" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_101e1bba-b459-48e5-9c3a-cd4e7fa14056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d5ffbb80-e358-464f-ab9b-7192d64ac7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8e915aa8-364b-4ad7-9ea7-0a9743959299" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d5ffbb80-e358-464f-ab9b-7192d64ac7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_14c85b3f-bd16-4950-9a30-faefcbc93765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b446ad78-f6a7-4e88-b399-460fb2dd6b7e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_14c85b3f-bd16-4950-9a30-faefcbc93765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_45372f35-bccb-40a0-99b6-a02386648ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_45372f35-bccb-40a0-99b6-a02386648ede" xlink:to="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5e232f0c-d74d-4805-959a-2ca6858b4254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5e232f0c-d74d-4805-959a-2ca6858b4254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5e232f0c-d74d-4805-959a-2ca6858b4254" xlink:to="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d883e228-61d5-4556-a29e-e54d4e3d2237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:to="loc_us-gaap_CommonStockMember_d883e228-61d5-4556-a29e-e54d4e3d2237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_eb19c34b-9e9e-4638-8301-7317f7c346d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_eb19c34b-9e9e-4638-8301-7317f7c346d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9dbca338-2dbe-44bc-bb7d-111958328eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:to="loc_us-gaap_RetainedEarningsMember_9dbca338-2dbe-44bc-bb7d-111958328eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_891f9f39-8c7b-47f7-a4ea-9e57ac143d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11423a20-88a3-42fd-b0ce-a664caf873b6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_891f9f39-8c7b-47f7-a4ea-9e57ac143d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d088d5cc-af3e-4a40-af23-0efe977509ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d088d5cc-af3e-4a40-af23-0efe977509ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e61effc1-43c4-4ce3-b3ec-3745615fe0d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d088d5cc-af3e-4a40-af23-0efe977509ec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e61effc1-43c4-4ce3-b3ec-3745615fe0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b1f8cba1-6609-47d1-beb3-8e8dd2733cab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e61effc1-43c4-4ce3-b3ec-3745615fe0d7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b1f8cba1-6609-47d1-beb3-8e8dd2733cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e7ca383d-bef2-4189-b81d-8ca0fd0098f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_544b7f40-53f0-47c7-b63a-b5e89ea8034f" xlink:to="loc_us-gaap_StatementLineItems_e7ca383d-bef2-4189-b81d-8ca0fd0098f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e7ca383d-bef2-4189-b81d-8ca0fd0098f2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_20d37e06-650e-4d29-8f9f-68367b3cb4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_SharesOutstanding_20d37e06-650e-4d29-8f9f-68367b3cb4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6fa6670-e1bd-48f5-879b-f427eaf9dd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockholdersEquity_e6fa6670-e1bd-48f5-879b-f427eaf9dd2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1d21f327-f103-4fa6-a62a-1c6994e62ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1d21f327-f103-4fa6-a62a-1c6994e62ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_094a17a8-dc5f-43a1-8d07-fe42cef413df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_094a17a8-dc5f-43a1-8d07-fe42cef413df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_91414fd3-3d59-4565-921f-1b303152678e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_91414fd3-3d59-4565-921f-1b303152678e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6c4d828d-187c-44d0-8424-757466a2cca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6c4d828d-187c-44d0-8424-757466a2cca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_93f383aa-1bf3-4305-88c6-3011c9d6087f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_93f383aa-1bf3-4305-88c6-3011c9d6087f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_55ce7389-0dd9-4997-a471-91481f0ffc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_55ce7389-0dd9-4997-a471-91481f0ffc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fe5e3221-f5f3-4e3a-82b9-399342878b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fe5e3221-f5f3-4e3a-82b9-399342878b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c53c51f5-8127-4363-b8d7-a33bcddd6071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c53c51f5-8127-4363-b8d7-a33bcddd6071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_512db1e7-1745-4a17-9cd1-0f66af4e6e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_512db1e7-1745-4a17-9cd1-0f66af4e6e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60d8eb1a-49ac-4501-bf4c-8c5bfecd672a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60d8eb1a-49ac-4501-bf4c-8c5bfecd672a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d2d4ece0-86f4-4217-81ef-28fbd9b17b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_NetIncomeLoss_d2d4ece0-86f4-4217-81ef-28fbd9b17b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_fa4ba368-0ab6-433a-9b31-56e60fae1577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_SharesOutstanding_fa4ba368-0ab6-433a-9b31-56e60fae1577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_65741789-1534-497a-9402-2f4db212f5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_StockholdersEquity_65741789-1534-497a-9402-2f4db212f5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_74d29738-6e34-4c9f-9149-2c6a82a9d368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e928e8b-4bbf-4fd2-8c27-e96a7d60d1e5" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_74d29738-6e34-4c9f-9149-2c6a82a9d368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_725a8025-2a80-4b25-ba94-f9f4c9ed8561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3cf246e-c7e0-4806-8897-4e7718de56f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_725a8025-2a80-4b25-ba94-f9f4c9ed8561" xlink:to="loc_us-gaap_StatementTable_e3cf246e-c7e0-4806-8897-4e7718de56f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cb003cc2-0022-4608-8bc1-b68067393328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3cf246e-c7e0-4806-8897-4e7718de56f8" xlink:to="loc_us-gaap_DebtInstrumentAxis_cb003cc2-0022-4608-8bc1-b68067393328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6ca41d7e-b71b-4cd4-b2bd-fb2f9b6592f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cb003cc2-0022-4608-8bc1-b68067393328" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6ca41d7e-b71b-4cd4-b2bd-fb2f9b6592f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_f27f5c61-1615-43ff-9853-7b33a48e9838" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6ca41d7e-b71b-4cd4-b2bd-fb2f9b6592f3" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_f27f5c61-1615-43ff-9853-7b33a48e9838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_8fd77cca-2e03-4ab4-94a4-1a7ce3231394" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6ca41d7e-b71b-4cd4-b2bd-fb2f9b6592f3" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_8fd77cca-2e03-4ab4-94a4-1a7ce3231394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3cf246e-c7e0-4806-8897-4e7718de56f8" xlink:to="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_90def873-9b2c-4076-83a2-880d4b39325f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:to="loc_us-gaap_NetIncomeLoss_90def873-9b2c-4076-83a2-880d4b39325f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e75899e0-4887-4027-9daa-510cfc075505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e75899e0-4887-4027-9daa-510cfc075505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b82b17d6-62c2-4de6-b633-3c8c72530075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b82b17d6-62c2-4de6-b633-3c8c72530075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_7cc21b91-1aa8-412c-9368-b51afc308227" xlink:href="pcrx-20220630.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_7cc21b91-1aa8-412c-9368-b51afc308227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_748b89cc-fe10-4b5f-be73-6ab86f4f1e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_748b89cc-fe10-4b5f-be73-6ab86f4f1e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6b244aa9-91d1-43f8-8349-d2fdc093643d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6b244aa9-91d1-43f8-8349-d2fdc093643d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c700b1fa-43a6-49f2-adfd-cd852a7b0d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_ShareBasedCompensation_c700b1fa-43a6-49f2-adfd-cd852a7b0d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fb7296c6-efec-4b6c-a908-5ffce96a9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fb7296c6-efec-4b6c-a908-5ffce96a9cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_516ad705-53cf-4716-9ffc-b06a0d3222e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_27cbf819-044c-4ec3-bc00-48cb44b59393" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_516ad705-53cf-4716-9ffc-b06a0d3222e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5d082034-9cf8-4294-b9d3-aa090367c575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5d082034-9cf8-4294-b9d3-aa090367c575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1d3d2f39-a042-4bfd-a43f-1b34b77f7e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1d3d2f39-a042-4bfd-a43f-1b34b77f7e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8fbdb09f-83ac-4de6-ba52-166286723f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8fbdb09f-83ac-4de6-ba52-166286723f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0bac8e80-2a0c-4c26-b667-4b4c0638cebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0bac8e80-2a0c-4c26-b667-4b4c0638cebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ccc83bca-12fe-4f2a-8c8f-41363112e759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ccc83bca-12fe-4f2a-8c8f-41363112e759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_699a435a-9a5a-4b47-b258-7dac1f55f7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_GainLossOnInvestments_699a435a-9a5a-4b47-b258-7dac1f55f7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_0110c7cf-cfce-4310-a127-c307256c0d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e6b87a-9160-453c-ae78-a2ad0b9dc9f9" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_0110c7cf-cfce-4310-a127-c307256c0d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34081fff-19d1-4c78-a2c3-1b218e57a2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_af56de0b-c8d3-47fc-a65f-2ebb900afc17" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34081fff-19d1-4c78-a2c3-1b218e57a2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e3cd374-979c-4819-901e-d2de6d14c04b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e3cd374-979c-4819-901e-d2de6d14c04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_0c8edb8d-3877-4958-9eeb-fba65051e935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_0c8edb8d-3877-4958-9eeb-fba65051e935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_6c68e532-b020-4571-ab56-72ecb15f2478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_6c68e532-b020-4571-ab56-72ecb15f2478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PaymentOfContingentConsideration_bb9e2cff-a07b-4b7d-8092-dbc59baa42a0" xlink:href="pcrx-20220630.xsd#pcrx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_pcrx_PaymentOfContingentConsideration_bb9e2cff-a07b-4b7d-8092-dbc59baa42a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_21799821-cdab-4079-aa26-952091764b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_21799821-cdab-4079-aa26-952091764b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_6c66fabb-05d3-44be-b45e-49e9e9372e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_6c66fabb-05d3-44be-b45e-49e9e9372e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f4e381b2-4877-4ce4-a1c8-ada74adb1788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_85cb1f78-db0d-4cf9-97a7-8c6e467625dd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f4e381b2-4877-4ce4-a1c8-ada74adb1788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_000bf698-47e2-4f94-9070-be5146378971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_000bf698-47e2-4f94-9070-be5146378971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_b33a32db-6bcc-4ad8-8c39-724fe0e4d303" xlink:href="pcrx-20220630.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_b33a32db-6bcc-4ad8-8c39-724fe0e4d303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_4c2b615d-fc83-4efa-bf33-676925fa2563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_4c2b615d-fc83-4efa-bf33-676925fa2563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_e97a2cae-5a26-47ef-900d-a82df455193a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_e97a2cae-5a26-47ef-900d-a82df455193a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9efcfbac-6246-4f6c-bb93-635717b1e78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9efcfbac-6246-4f6c-bb93-635717b1e78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8a4cebf0-7449-489e-a1ab-5ad780313e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_cd96cc3d-635f-4d33-8ae2-14ba2f822c70" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8a4cebf0-7449-489e-a1ab-5ad780313e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6cfd2a1e-6800-48c3-8830-706a442c386d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6cfd2a1e-6800-48c3-8830-706a442c386d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cca80697-bf22-4548-9000-bbc5ccc725e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cca80697-bf22-4548-9000-bbc5ccc725e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_35879fbc-72d3-46b4-86f6-29efed48d634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_35879fbc-72d3-46b4-86f6-29efed48d634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_8f5acfeb-d20d-48c2-851d-ff5c5e58bcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_8f5acfeb-d20d-48c2-851d-ff5c5e58bcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_d8ef3347-48ba-4132-b268-7de8707414aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8f5acfeb-d20d-48c2-851d-ff5c5e58bcf1" xlink:to="loc_us-gaap_InterestPaidNet_d8ef3347-48ba-4132-b268-7de8707414aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_f89b01cf-b476-4094-94ca-e40d4f78fc10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8f5acfeb-d20d-48c2-851d-ff5c5e58bcf1" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_f89b01cf-b476-4094-94ca-e40d4f78fc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ff23e66-4aa2-439b-af86-5bce652f5b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_63232441-7ce9-4a06-83bd-50bf5abe9d05" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ff23e66-4aa2-439b-af86-5bce652f5b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_e0bb0828-86e4-4be8-825a-3ba1f52d2668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ff23e66-4aa2-439b-af86-5bce652f5b5a" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_e0bb0828-86e4-4be8-825a-3ba1f52d2668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_72c196c7-d05f-4bcd-ab35-7e54303900e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ff23e66-4aa2-439b-af86-5bce652f5b5a" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_72c196c7-d05f-4bcd-ab35-7e54303900e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c4975bf9-12b0-4a7e-acdf-99f1a8377047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b88fd3f4-6151-4eea-9109-4e7c1a0dfc56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c4975bf9-12b0-4a7e-acdf-99f1a8377047" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b88fd3f4-6151-4eea-9109-4e7c1a0dfc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_603f5e6a-3036-47a5-b154-bd25e8e679cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_603f5e6a-3036-47a5-b154-bd25e8e679cd" xlink:to="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a1beb388-eece-46b8-b5f6-ea69d58fb28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a1beb388-eece-46b8-b5f6-ea69d58fb28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_332515a5-394e-4267-9b49-6d1f7734bbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a1beb388-eece-46b8-b5f6-ea69d58fb28e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_332515a5-394e-4267-9b49-6d1f7734bbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_f72c6629-7cb8-4e36-a1c7-f0683313b1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_332515a5-394e-4267-9b49-6d1f7734bbda" xlink:to="loc_us-gaap_SalesRevenueNetMember_f72c6629-7cb8-4e36-a1c7-f0683313b1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_83b2299f-0fb9-467f-98bc-400c540bd077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_83b2299f-0fb9-467f-98bc-400c540bd077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b917d23f-7fd7-4cd4-8133-04b633add097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_83b2299f-0fb9-467f-98bc-400c540bd077" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b917d23f-7fd7-4cd4-8133-04b633add097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_04977600-98ed-42bc-8069-6ea3ff52e5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b917d23f-7fd7-4cd4-8133-04b633add097" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_04977600-98ed-42bc-8069-6ea3ff52e5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_a75b8c37-b46a-4fc0-8ff6-92975e1f6e01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_81ddd162-b5a1-4bcc-a7ba-d82caeb7f8fa" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_a75b8c37-b46a-4fc0-8ff6-92975e1f6e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts_9744eea4-d953-48e9-815c-f4e5d9624a1d" xlink:href="pcrx-20220630.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_a75b8c37-b46a-4fc0-8ff6-92975e1f6e01" xlink:to="loc_pcrx_ConcentrationRiskNumberOfProducts_9744eea4-d953-48e9-815c-f4e5d9624a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_aca825cf-5c6b-4e26-b342-1e75c3c515d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_a75b8c37-b46a-4fc0-8ff6-92975e1f6e01" xlink:to="loc_us-gaap_NumberOfReportableSegments_aca825cf-5c6b-4e26-b342-1e75c3c515d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="pcrx-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1daea39c-6066-40ea-9e86-53003b56a950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_730e4063-0a2b-4d5c-bfee-d6bb5bb46875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1daea39c-6066-40ea-9e86-53003b56a950" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_730e4063-0a2b-4d5c-bfee-d6bb5bb46875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="pcrx-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d74ecf8a-6345-4a28-803a-8912b55d1e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_ef41a8e2-8d34-4385-94a3-a72424789e17" xlink:href="pcrx-20220630.xsd#pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d74ecf8a-6345-4a28-803a-8912b55d1e1d" xlink:to="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_ef41a8e2-8d34-4385-94a3-a72424789e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_462c2e57-5cf0-4c37-b0da-e7fcb1c97ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d74ecf8a-6345-4a28-803a-8912b55d1e1d" xlink:to="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_462c2e57-5cf0-4c37-b0da-e7fcb1c97ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b027abd3-5743-4583-9121-5014eb20aaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d74ecf8a-6345-4a28-803a-8912b55d1e1d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b027abd3-5743-4583-9121-5014eb20aaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9650ce97-da90-44b0-86c0-20dfad69de20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_9a9381b8-c410-414e-a9db-b533738847e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9650ce97-da90-44b0-86c0-20dfad69de20" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_9a9381b8-c410-414e-a9db-b533738847e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c72733f6-dad3-4b6f-ba69-638651b4867d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c72733f6-dad3-4b6f-ba69-638651b4867d" xlink:to="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_77bcb992-0601-4c37-bfa3-99e927362694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_77bcb992-0601-4c37-bfa3-99e927362694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_735879b6-85fa-49fc-b424-ca3cab0b8bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_77bcb992-0601-4c37-bfa3-99e927362694" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_735879b6-85fa-49fc-b424-ca3cab0b8bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_889a6879-4c06-4877-a4f6-b912d4eaaa5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_735879b6-85fa-49fc-b424-ca3cab0b8bd4" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_889a6879-4c06-4877-a4f6-b912d4eaaa5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5c83580f-e210-42de-8fde-be04ef515b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5c83580f-e210-42de-8fde-be04ef515b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8d335b28-a966-457b-95c9-4e98e0f87e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5c83580f-e210-42de-8fde-be04ef515b18" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8d335b28-a966-457b-95c9-4e98e0f87e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d551d4c3-d2ec-434e-b6a6-54007daabd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8d335b28-a966-457b-95c9-4e98e0f87e86" xlink:to="loc_us-gaap_SalesRevenueNetMember_d551d4c3-d2ec-434e-b6a6-54007daabd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:to="loc_srt_MajorCustomersAxis_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_9f8f6d3b-a717-4bd1-90c2-e952a69dedf3" xlink:to="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember_e33ef4af-8cf9-4559-a333-7b0e43379679" xlink:href="pcrx-20220630.xsd#pcrx_LargestCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:to="loc_pcrx_LargestCustomerMember_e33ef4af-8cf9-4559-a333-7b0e43379679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember_0b596cac-101b-43d5-9f35-047f042c22de" xlink:href="pcrx-20220630.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:to="loc_pcrx_SecondLargestCustomerMember_0b596cac-101b-43d5-9f35-047f042c22de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember_1dc03df6-d8d1-41db-9e06-22d0ad18223f" xlink:href="pcrx-20220630.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:to="loc_pcrx_ThirdLargestCustomerMember_1dc03df6-d8d1-41db-9e06-22d0ad18223f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember_914cdd0c-7f8f-4b81-8a82-c403b7f91a69" xlink:href="pcrx-20220630.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f32159eb-3785-43fa-ad8b-41575b426d98" xlink:to="loc_pcrx_ThreeLargestCustomersMember_914cdd0c-7f8f-4b81-8a82-c403b7f91a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_3d4ab0e0-bd6b-4899-813e-34459eac87dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3e542b5f-dece-4d33-b738-2b5755937857" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_3d4ab0e0-bd6b-4899-813e-34459eac87dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfCustomers_c2448448-7c5a-458d-8e0f-665ba4475616" xlink:href="pcrx-20220630.xsd#pcrx_ConcentrationRiskNumberOfCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_3d4ab0e0-bd6b-4899-813e-34459eac87dd" xlink:to="loc_pcrx_ConcentrationRiskNumberOfCustomers_c2448448-7c5a-458d-8e0f-665ba4475616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f60a457b-684e-4218-a347-34462fcbaa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_3d4ab0e0-bd6b-4899-813e-34459eac87dd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f60a457b-684e-4218-a347-34462fcbaa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_665c383d-ece3-40e5-869d-b577f4d37069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_665c383d-ece3-40e5-869d-b577f4d37069" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22dff4a9-3b8d-4e31-b353-54f69432a2a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22dff4a9-3b8d-4e31-b353-54f69432a2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3c5eacfd-e10c-441a-a266-4ec367fa017f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22dff4a9-3b8d-4e31-b353-54f69432a2a1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3c5eacfd-e10c-441a-a266-4ec367fa017f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_69c7abb0-5e32-44eb-a0dd-3f682d332df2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3c5eacfd-e10c-441a-a266-4ec367fa017f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_69c7abb0-5e32-44eb-a0dd-3f682d332df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a9845952-ea0f-4dc4-800e-5347b2d487c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a9845952-ea0f-4dc4-800e-5347b2d487c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3b0b6180-907e-4786-85c1-e405436da49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a9845952-ea0f-4dc4-800e-5347b2d487c8" xlink:to="loc_us-gaap_EquityComponentDomain_3b0b6180-907e-4786-85c1-e405436da49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_085e1151-b578-4f8c-916c-f3f4073df869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3b0b6180-907e-4786-85c1-e405436da49f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_085e1151-b578-4f8c-916c-f3f4073df869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_656f0ff3-4a12-4902-a5eb-a8d50c27a6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3b0b6180-907e-4786-85c1-e405436da49f" xlink:to="loc_us-gaap_RetainedEarningsMember_656f0ff3-4a12-4902-a5eb-a8d50c27a6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dbdb7dde-7492-42fb-8961-587f1f6557a0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_61144773-4c43-4aad-8344-8cc03f6f7f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:to="loc_us-gaap_LongTermDebt_61144773-4c43-4aad-8344-8cc03f6f7f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c8de50d-0446-4f48-a546-d88373cd58b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:to="loc_us-gaap_StockholdersEquity_1c8de50d-0446-4f48-a546-d88373cd58b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e8de47b2-b037-464d-9757-337b04510767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b2b6a147-db08-452d-902b-a415c7dbe3c0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e8de47b2-b037-464d-9757-337b04510767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUE" xlink:type="simple" xlink:href="pcrx-20220630.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8c26a1eb-73d8-4523-a969-dbed52e17f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_05fd7841-fc84-494c-86f0-31f36b3171b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8c26a1eb-73d8-4523-a969-dbed52e17f2a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_05fd7841-fc84-494c-86f0-31f36b3171b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUETables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_effce5e7-85dd-4d56-96e6-ca975cc5fefd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_73bef5c8-ae93-4c6e-91ac-09f72e7f8ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_effce5e7-85dd-4d56-96e6-ca975cc5fefd" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_73bef5c8-ae93-4c6e-91ac-09f72e7f8ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUENarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#REVENUENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c14c3426-5d18-4f63-8e58-87091d992d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_13d03285-783c-4bd5-bce4-e58431c50c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c14c3426-5d18-4f63-8e58-87091d992d65" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_13d03285-783c-4bd5-bce4-e58431c50c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_96c55189-f6a9-4d50-95f7-8fed66247ec8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_13d03285-783c-4bd5-bce4-e58431c50c57" xlink:to="loc_srt_RangeAxis_96c55189-f6a9-4d50-95f7-8fed66247ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_972da45b-842e-4bc6-8fcb-261d53b6e50e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_96c55189-f6a9-4d50-95f7-8fed66247ec8" xlink:to="loc_srt_RangeMember_972da45b-842e-4bc6-8fcb-261d53b6e50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff888041-250c-4616-ad4b-e906008cf8c9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_972da45b-842e-4bc6-8fcb-261d53b6e50e" xlink:to="loc_srt_MinimumMember_ff888041-250c-4616-ad4b-e906008cf8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_14f73478-ad76-409f-9d7c-105bad80eaf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_972da45b-842e-4bc6-8fcb-261d53b6e50e" xlink:to="loc_srt_MaximumMember_14f73478-ad76-409f-9d7c-105bad80eaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e1b21262-07cf-4e16-9cc4-e4d13a0d6f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_13d03285-783c-4bd5-bce4-e58431c50c57" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e1b21262-07cf-4e16-9cc4-e4d13a0d6f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms_ad07a656-581e-4bc5-b84c-c31ed3eac852" xlink:href="pcrx-20220630.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e1b21262-07cf-4e16-9cc4-e4d13a0d6f46" xlink:to="loc_pcrx_AccountsReceivablePaymentTerms_ad07a656-581e-4bc5-b84c-c31ed3eac852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#REVENUEScheduleofDisaggregatedRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_19ab207d-e9b8-4ac7-83d0-0fd3e37f98df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bf10e2ed-a4a5-498c-852c-dd1fd1f2424a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_19ab207d-e9b8-4ac7-83d0-0fd3e37f98df" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bf10e2ed-a4a5-498c-852c-dd1fd1f2424a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f5438111-eecc-4a3d-99d2-b1baaef3b5ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf10e2ed-a4a5-498c-852c-dd1fd1f2424a" xlink:to="loc_srt_ProductOrServiceAxis_f5438111-eecc-4a3d-99d2-b1baaef3b5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f5438111-eecc-4a3d-99d2-b1baaef3b5ba" xlink:to="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_2076ba62-b9d0-42ef-b981-7a60cc277e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_us-gaap_ProductMember_2076ba62-b9d0-42ef-b981-7a60cc277e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_e250c4d5-af5f-4bf6-adad-84d6ed7e3f26" xlink:href="pcrx-20220630.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_e250c4d5-af5f-4bf6-adad-84d6ed7e3f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ZILRETTAMember_d9082d06-9f79-424b-b56f-44dfa09413ac" xlink:href="pcrx-20220630.xsd#pcrx_ZILRETTAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_pcrx_ZILRETTAMember_d9082d06-9f79-424b-b56f-44dfa09413ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember_f5bb465f-1df9-4c5f-a425-7b002d2414f5" xlink:href="pcrx-20220630.xsd#pcrx_IoveraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_pcrx_IoveraMember_f5bb465f-1df9-4c5f-a425-7b002d2414f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember_a362bdb1-7760-4086-8a09-32adc5567945" xlink:href="pcrx-20220630.xsd#pcrx_BupivacaineLiposomeInjectableSuspensionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember_a362bdb1-7760-4086-8a09-32adc5567945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_b3726e2d-ac0c-461b-8a74-9c8f1b9c5d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f9657ca9-cf1d-4341-98a3-b29ae44d4485" xlink:to="loc_us-gaap_ProductMember_b3726e2d-ac0c-461b-8a74-9c8f1b9c5d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_acb6a6be-3d62-470f-9467-bcb98d3e593d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf10e2ed-a4a5-498c-852c-dd1fd1f2424a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_acb6a6be-3d62-470f-9467-bcb98d3e593d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c95d65cf-cf72-4fef-8b11-a6134724b29e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_acb6a6be-3d62-470f-9467-bcb98d3e593d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c95d65cf-cf72-4fef-8b11-a6134724b29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITION" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITION"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5c58517b-73bf-42e6-bc2a-4a304a0761ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8a769c2c-d282-4f97-a267-9f054035a03a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5c58517b-73bf-42e6-bc2a-4a304a0761ef" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8a769c2c-d282-4f97-a267-9f054035a03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITIONTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2baf6421-efd8-4cc8-9e64-05eaa5e0e95d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_18313ad2-dcf3-4e84-b3fd-d81e84cf9602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2baf6421-efd8-4cc8-9e64-05eaa5e0e95d" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_18313ad2-dcf3-4e84-b3fd-d81e84cf9602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9a72bdce-6bba-4086-9b58-163773cf9348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2baf6421-efd8-4cc8-9e64-05eaa5e0e95d" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9a72bdce-6bba-4086-9b58-163773cf9348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7cd9d58e-a261-4632-9886-996b9be14e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7cd9d58e-a261-4632-9886-996b9be14e73" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1088a724-d23d-4248-a0b7-f6786bab27e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1088a724-d23d-4248-a0b7-f6786bab27e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d5569278-c783-4283-bc67-140474119221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1088a724-d23d-4248-a0b7-f6786bab27e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d5569278-c783-4283-bc67-140474119221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_ba47960c-24ae-4e58-9e1b-e09f7497dac3" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d5569278-c783-4283-bc67-140474119221" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_ba47960c-24ae-4e58-9e1b-e09f7497dac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4cbe6de0-8c5e-4bee-b5c2-e3aca7f91e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2a94be8a-7862-4e6c-a11a-1cb16dc0a06d" xlink:to="loc_us-gaap_ClassOfStockDomain_4cbe6de0-8c5e-4bee-b5c2-e3aca7f91e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_26a4d755-3b6f-45a4-b898-1148d6f6379c" xlink:href="pcrx-20220630.xsd#pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4cbe6de0-8c5e-4bee-b5c2-e3aca7f91e77" xlink:to="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_26a4d755-3b6f-45a4-b898-1148d6f6379c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a670315b-ebb0-48dd-b96f-86c1bc3ff39d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fefab745-e7f5-4325-8adf-0834d095cb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fefab745-e7f5-4325-8adf-0834d095cb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_bd775067-0d40-4a86-be3f-f7428d799a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_bd775067-0d40-4a86-be3f-f7428d799a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_5377051f-28a1-4cf8-976c-55f71ff791a1" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_5377051f-28a1-4cf8-976c-55f71ff791a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_ad882b38-7ab0-4e23-8d18-d1cee148f291" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_ad882b38-7ab0-4e23-8d18-d1cee148f291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6129ffdf-9945-4a20-ba47-c636d4cf4ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2a7ea02c-86fd-4789-bf74-8858f1be9d5a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6129ffdf-9945-4a20-ba47-c636d4cf4ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0779705e-065f-4d7d-a60d-1ee2e33b9e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1f15052e-b7bb-4fc1-b1a7-65aca2efc968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0779705e-065f-4d7d-a60d-1ee2e33b9e43" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1f15052e-b7bb-4fc1-b1a7-65aca2efc968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7a07d19-69d1-4d11-9f0e-4fd93788dacb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1f15052e-b7bb-4fc1-b1a7-65aca2efc968" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7a07d19-69d1-4d11-9f0e-4fd93788dacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d43c0a9-1748-4d52-a78c-0ba6eb2cc9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7a07d19-69d1-4d11-9f0e-4fd93788dacb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d43c0a9-1748-4d52-a78c-0ba6eb2cc9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_87006139-709b-4f70-b06a-927642475032" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d43c0a9-1748-4d52-a78c-0ba6eb2cc9f3" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_87006139-709b-4f70-b06a-927642475032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_21c2c05c-c19f-4e30-8925-e3079afacf80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1f15052e-b7bb-4fc1-b1a7-65aca2efc968" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_21c2c05c-c19f-4e30-8925-e3079afacf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_21c2c05c-c19f-4e30-8925-e3079afacf80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_acc96b61-c90c-4b6d-9929-26a0a1428045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_acc96b61-c90c-4b6d-9929-26a0a1428045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_47c13009-0e8b-4b82-9e98-ff378e1239d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_47c13009-0e8b-4b82-9e98-ff378e1239d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4b7ea6e0-e702-4005-ab9e-2360be9cfb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4b7ea6e0-e702-4005-ab9e-2360be9cfb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f947ee43-f50a-42f1-b2b2-862523ec3bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f947ee43-f50a-42f1-b2b2-862523ec3bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b1052e53-aa6c-4a83-a03f-03843a9aa6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b1052e53-aa6c-4a83-a03f-03843a9aa6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d32b6362-2d4c-4342-944c-c8eb5bfe35c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d32b6362-2d4c-4342-944c-c8eb5bfe35c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_0be5a76f-68ac-4cde-8732-c23a7ca602f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_0be5a76f-68ac-4cde-8732-c23a7ca602f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_5d8019ca-d8d9-4e95-b453-418bd535dc68" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_5d8019ca-d8d9-4e95-b453-418bd535dc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_000c5a47-49f8-4783-8a72-43bb71526021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_000c5a47-49f8-4783-8a72-43bb71526021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_2423752c-f41e-4f4e-b529-c139bb320389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_2423752c-f41e-4f4e-b529-c139bb320389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5143b8b0-9030-4e39-9963-801e5a31f800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5143b8b0-9030-4e39-9963-801e5a31f800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_5613f95b-041a-4e12-a360-f9b0b9bd53c2" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ef2b48dc-80b0-4de1-b0ba-07a6dd0147a1" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_5613f95b-041a-4e12-a360-f9b0b9bd53c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_21c2c05c-c19f-4e30-8925-e3079afacf80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b9063965-f1cc-4015-a786-632da0008dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b9063965-f1cc-4015-a786-632da0008dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2a57a865-894d-4a74-96fa-30698f78fcb9" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2a57a865-894d-4a74-96fa-30698f78fcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_7ba1859d-d218-4cc9-9d78-46aa2c6a3f06" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_7ba1859d-d218-4cc9-9d78-46aa2c6a3f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ace9c29b-67a1-4abd-94be-5a04060abb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ace9c29b-67a1-4abd-94be-5a04060abb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_0ae0f998-0b80-4f8c-89a7-af65b5f76634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_0ae0f998-0b80-4f8c-89a7-af65b5f76634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_431ecd21-dded-4bff-86b2-5cbf80202224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_431ecd21-dded-4bff-86b2-5cbf80202224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_cd6eab04-484d-4996-9281-b48e5d8a388c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_cd6eab04-484d-4996-9281-b48e5d8a388c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0abf0c63-c92c-435f-b1ca-5827dc2c30c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0abf0c63-c92c-435f-b1ca-5827dc2c30c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_27c6ff7b-bedc-4657-ba56-7020412dea2e" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_27c6ff7b-bedc-4657-ba56-7020412dea2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_27a23853-bae1-422c-8b35-5e41000d2a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_27a23853-bae1-422c-8b35-5e41000d2a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_22bfbdd1-b974-452b-a450-0807b2296bf4" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_22bfbdd1-b974-452b-a450-0807b2296bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f0b8f644-0292-47c6-a244-f2f15feeb7da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_Goodwill_f0b8f644-0292-47c6-a244-f2f15feeb7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_44a464b1-60f2-4288-9fe2-f92993ec65c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_44a464b1-60f2-4288-9fe2-f92993ec65c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e1ee9b5b-9989-4d56-a18b-25f39ad73f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e1ee9b5b-9989-4d56-a18b-25f39ad73f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_756c3b40-f6ef-4767-8dc5-8dfe8636cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_e0159e9b-aba9-4892-b245-c790d7949489" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_756c3b40-f6ef-4767-8dc5-8dfe8636cb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FLEXIONACQUISITIONScheduleofProFormaInformationDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c93b81eb-cfb7-42ed-8413-6d71c2e7e14e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db4b63f3-72a8-44e4-a8f6-cc0fdac977f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c93b81eb-cfb7-42ed-8413-6d71c2e7e14e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db4b63f3-72a8-44e4-a8f6-cc0fdac977f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_481cc57d-d8f4-4702-9e8d-ac37db42f317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db4b63f3-72a8-44e4-a8f6-cc0fdac977f1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_481cc57d-d8f4-4702-9e8d-ac37db42f317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65c73636-e151-4dd9-97a4-2179d95fbbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_481cc57d-d8f4-4702-9e8d-ac37db42f317" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65c73636-e151-4dd9-97a4-2179d95fbbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_cdbd50c1-d2b4-411f-ba1c-66b26ed0f054" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65c73636-e151-4dd9-97a4-2179d95fbbb1" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_cdbd50c1-d2b4-411f-ba1c-66b26ed0f054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db4b63f3-72a8-44e4-a8f6-cc0fdac977f1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_973de2ff-aac2-478e-8cc2-0e32e3debbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_973de2ff-aac2-478e-8cc2-0e32e3debbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_751e51d5-1ed5-42d0-89b3-fba54879098f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_751e51d5-1ed5-42d0-89b3-fba54879098f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_ca00d886-e76a-4b8c-9c04-3494f06765a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_ca00d886-e76a-4b8c-9c04-3494f06765a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f2abb97c-073d-44fc-86e6-7319e1507361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_060a0e41-5ee7-4236-a293-0922726fa32e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f2abb97c-073d-44fc-86e6-7319e1507361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIES" xlink:type="simple" xlink:href="pcrx-20220630.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_397ff7a6-7c3f-4d20-b3ec-a3676017dd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_22245d25-d23c-4838-8e01-e0634a93f0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_397ff7a6-7c3f-4d20-b3ec-a3676017dd75" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_22245d25-d23c-4838-8e01-e0634a93f0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2d5c428b-5d41-4e5a-a404-d4619c5f25c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0bc647f7-74c8-4ac9-a070-551ac6edf975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2d5c428b-5d41-4e5a-a404-d4619c5f25c8" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0bc647f7-74c8-4ac9-a070-551ac6edf975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_7e99452c-7a19-4c0f-a4b7-deff87ea4d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9d325ac1-c955-413d-ac2b-ab5248f1dd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7e99452c-7a19-4c0f-a4b7-deff87ea4d08" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9d325ac1-c955-413d-ac2b-ab5248f1dd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2ef67700-15dd-4d87-a3cb-0875c8d9e979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7e99452c-7a19-4c0f-a4b7-deff87ea4d08" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2ef67700-15dd-4d87-a3cb-0875c8d9e979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_360d60c4-0824-4f7a-aa48-9206e0c40d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7e99452c-7a19-4c0f-a4b7-deff87ea4d08" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_360d60c4-0824-4f7a-aa48-9206e0c40d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1e0f13cb-bc47-4dad-993f-e6c944b325e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7e99452c-7a19-4c0f-a4b7-deff87ea4d08" xlink:to="loc_us-gaap_InventoryNet_1e0f13cb-bc47-4dad-993f-e6c944b325e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FIXEDASSETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_403385fb-c179-4ea7-99cc-fb554f9e6df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_41f65323-3510-485c-8d1f-930efdc44bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_403385fb-c179-4ea7-99cc-fb554f9e6df4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_41f65323-3510-485c-8d1f-930efdc44bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FIXEDASSETSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4ce93b9f-cbd5-4b73-bf9a-c877c8bc3893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f2da4758-373f-40a9-8d99-11a6cf8c1706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4ce93b9f-cbd5-4b73-bf9a-c877c8bc3893" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f2da4758-373f-40a9-8d99-11a6cf8c1706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FIXEDASSETSSummaryofMajorCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fa5a8e4e-691c-40ff-b1d1-8b667e269205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e7f44fc3-772f-4b6a-bfdc-ef6ad02c707d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fa5a8e4e-691c-40ff-b1d1-8b667e269205" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e7f44fc3-772f-4b6a-bfdc-ef6ad02c707d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49e34019-8ddd-4c70-99a8-3c4b738731b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e7f44fc3-772f-4b6a-bfdc-ef6ad02c707d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49e34019-8ddd-4c70-99a8-3c4b738731b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49e34019-8ddd-4c70-99a8-3c4b738731b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_70ef3f14-28b4-420b-aeea-b56e63e40a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_70ef3f14-28b4-420b-aeea-b56e63e40a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5207cbee-7d1d-49b0-9aa8-13b230b018f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5207cbee-7d1d-49b0-9aa8-13b230b018f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember_ba126ee2-a864-418f-b5a6-c360b1d6c326" xlink:href="pcrx-20220630.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_pcrx_ComputerEquipmentAndSoftwareMember_ba126ee2-a864-418f-b5a6-c360b1d6c326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_705205be-b202-4390-9cda-4832d6bc46d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_705205be-b202-4390-9cda-4832d6bc46d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_8f684858-e01b-4d7c-8a34-e97b45298a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f03b71ed-b0a9-47d1-9dcf-772276dfc22c" xlink:to="loc_us-gaap_ConstructionInProgressMember_8f684858-e01b-4d7c-8a34-e97b45298a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e7f44fc3-772f-4b6a-bfdc-ef6ad02c707d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_37ed3106-3dcb-4432-9d6d-2a06e2a70f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_37ed3106-3dcb-4432-9d6d-2a06e2a70f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_79e1bcb3-c25c-4f5b-8470-95afd35369e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_79e1bcb3-c25c-4f5b-8470-95afd35369e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a905a843-db33-43d0-8aca-b08f61650e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_667b5fa7-74c8-44e6-a0e3-2633a0f40d03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a905a843-db33-43d0-8aca-b08f61650e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FIXEDASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2e032957-2930-4ff7-a7ab-4b71304c188d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2e032957-2930-4ff7-a7ab-4b71304c188d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_df899d02-6ce6-412b-b2a3-5326ceddd1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_df899d02-6ce6-412b-b2a3-5326ceddd1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_853128b9-2bf1-4882-aa63-3765c3b2e65a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_df899d02-6ce6-412b-b2a3-5326ceddd1df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_853128b9-2bf1-4882-aa63-3765c3b2e65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_cfbaf0e9-9d53-4815-8404-633335467e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_853128b9-2bf1-4882-aa63-3765c3b2e65a" xlink:to="loc_us-gaap_ConstructionInProgressMember_cfbaf0e9-9d53-4815-8404-633335467e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_94bb6967-49e9-4a04-adb8-f143acfd56fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_853128b9-2bf1-4882-aa63-3765c3b2e65a" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_94bb6967-49e9-4a04-adb8-f143acfd56fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8142a895-4aee-4e97-a0b3-9cb8d08c1164" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:to="loc_srt_StatementGeographicalAxis_8142a895-4aee-4e97-a0b3-9cb8d08c1164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_eb24f8cf-18cc-4dee-a3ea-0b872f905948" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8142a895-4aee-4e97-a0b3-9cb8d08c1164" xlink:to="loc_srt_SegmentGeographicalDomain_eb24f8cf-18cc-4dee-a3ea-0b872f905948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0a45bf50-64f8-4d7a-a0f7-26ad735d3be1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_eb24f8cf-18cc-4dee-a3ea-0b872f905948" xlink:to="loc_srt_EuropeMember_0a45bf50-64f8-4d7a-a0f7-26ad735d3be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ced7a3ea-92e1-4697-838e-9f042621a27c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_af59e994-2699-4923-8ef5-1e34784b1fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_Depreciation_af59e994-2699-4923-8ef5-1e34784b1fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_4a5c285c-01fa-4ac6-9779-45d88a8f5ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_InterestCostsCapitalized_4a5c285c-01fa-4ac6-9779-45d88a8f5ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_739c22da-4928-4cae-b316-70660dedaa63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_739c22da-4928-4cae-b316-70660dedaa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_6c3dfa60-ecf5-4bda-8211-9ca0c835106d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_558e2ed9-6175-483c-8334-527080878da4" xlink:to="loc_us-gaap_AssetRetirementObligation_6c3dfa60-ecf5-4bda-8211-9ca0c835106d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASES" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_69a48b96-2a49-4750-8fd1-8d654e79a955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_f2a313b0-8d62-4f19-9e2a-278ea2c0b0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69a48b96-2a49-4750-8fd1-8d654e79a955" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_f2a313b0-8d62-4f19-9e2a-278ea2c0b0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d5a5b7a8-f364-4f63-a81d-d8cfdf360068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_f6d3fd24-821b-44f4-a6b0-f4a6d9caaa47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d5a5b7a8-f364-4f63-a81d-d8cfdf360068" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_f6d3fd24-821b-44f4-a6b0-f4a6d9caaa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_56f44753-87a6-4a52-9d99-f5a873052efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d5a5b7a8-f364-4f63-a81d-d8cfdf360068" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_56f44753-87a6-4a52-9d99-f5a873052efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_6aacd42c-1500-481f-be79-eeefe1f26f30" xlink:href="pcrx-20220630.xsd#pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d5a5b7a8-f364-4f63-a81d-d8cfdf360068" xlink:to="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_6aacd42c-1500-481f-be79-eeefe1f26f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5a65e575-9483-46aa-b1f7-46b6ab9ea7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a65e575-9483-46aa-b1f7-46b6ab9ea7cf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:to="loc_srt_RangeAxis_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cccf6688-a042-46ea-8a8e-53a0378087e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2452bf06-bd39-46ea-9cb9-1fd5cb0272d4" xlink:to="loc_srt_RangeMember_cccf6688-a042-46ea-8a8e-53a0378087e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d7e44381-21ec-4830-b292-1afedff935ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cccf6688-a042-46ea-8a8e-53a0378087e9" xlink:to="loc_srt_MaximumMember_d7e44381-21ec-4830-b292-1afedff935ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_30b5bc41-7002-4bdd-ae4c-23abcabf8f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_30b5bc41-7002-4bdd-ae4c-23abcabf8f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3176019e-f401-4f9a-aaba-f12fe941cdea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_30b5bc41-7002-4bdd-ae4c-23abcabf8f63" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3176019e-f401-4f9a-aaba-f12fe941cdea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d5ebd81f-eed0-49ed-acb1-553d8ea5b412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3176019e-f401-4f9a-aaba-f12fe941cdea" xlink:to="loc_us-gaap_SubsequentEventMember_d5ebd81f-eed0-49ed-acb1-553d8ea5b412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b85ffbfe-e761-4402-abca-e8994b230093" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7111e6db-45e4-4196-aeed-369d2cdf790c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7111e6db-45e4-4196-aeed-369d2cdf790c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfLeases_97b6aaf8-bfca-4647-b56a-498837d162fb" xlink:href="pcrx-20220630.xsd#pcrx_NumberOfLeases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_pcrx_NumberOfLeases_97b6aaf8-bfca-4647-b56a-498837d162fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_bf4d3836-93c4-428d-848b-d9a18d69b45d" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_bf4d3836-93c4-428d-848b-d9a18d69b45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d3354a30-3cf5-44d8-920c-d5bfafdfd01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_58c11514-77db-48bb-a1ec-02ff63f44ac5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d3354a30-3cf5-44d8-920c-d5bfafdfd01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d8222348-ecbd-4515-8f3e-c64f84e62252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_8d84114a-d826-4f27-8655-95822ba60703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8222348-ecbd-4515-8f3e-c64f84e62252" xlink:to="loc_us-gaap_LeaseCostAbstract_8d84114a-d826-4f27-8655-95822ba60703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_25a927e7-97fa-4c17-85e0-95d513741a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8d84114a-d826-4f27-8655-95822ba60703" xlink:to="loc_us-gaap_OperatingLeaseCost_25a927e7-97fa-4c17-85e0-95d513741a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_01318178-3b64-421b-a582-b9c070f706d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8d84114a-d826-4f27-8655-95822ba60703" xlink:to="loc_us-gaap_VariableLeaseCost_01318178-3b64-421b-a582-b9c070f706d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_b9838c2f-3e26-483e-9a5c-154863d3a5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8d84114a-d826-4f27-8655-95822ba60703" xlink:to="loc_us-gaap_LeaseCost_b9838c2f-3e26-483e-9a5c-154863d3a5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_df000dec-3722-48e1-b634-c67e1dca00a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8222348-ecbd-4515-8f3e-c64f84e62252" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_df000dec-3722-48e1-b634-c67e1dca00a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_7e351860-37c4-4588-8950-19ed5ee46623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_df000dec-3722-48e1-b634-c67e1dca00a8" xlink:to="loc_us-gaap_OperatingLeasePayments_7e351860-37c4-4588-8950-19ed5ee46623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_661de6af-731a-4bbc-9095-d91117e9b0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_df000dec-3722-48e1-b634-c67e1dca00a8" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_661de6af-731a-4bbc-9095-d91117e9b0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0cb3092c-1d83-46ec-987f-1839163cbde1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8222348-ecbd-4515-8f3e-c64f84e62252" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0cb3092c-1d83-46ec-987f-1839163cbde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2a51ca6b-987b-44a0-a867-d7acffa00b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8222348-ecbd-4515-8f3e-c64f84e62252" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2a51ca6b-987b-44a0-a867-d7acffa00b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_21d82004-c065-4b50-9536-87e1bbd0f62d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_21d82004-c065-4b50-9536-87e1bbd0f62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e45dba24-477f-41bc-a56b-a58a808241d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e45dba24-477f-41bc-a56b-a58a808241d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cace262a-7168-43f7-b690-14a8cd27e1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cace262a-7168-43f7-b690-14a8cd27e1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cb018c35-fdca-4f5e-8a26-525980d0210f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cb018c35-fdca-4f5e-8a26-525980d0210f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_179e53a4-a10f-4be4-864a-d8df3950f2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_179e53a4-a10f-4be4-864a-d8df3950f2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_8a2ff081-e84d-42b6-86b7-2a7d18157436" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_8a2ff081-e84d-42b6-86b7-2a7d18157436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ca70c08-fa54-423a-a25d-697834c4154a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ca70c08-fa54-423a-a25d-697834c4154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_756860f0-46c0-43bc-9b48-f7b70d8918f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_756860f0-46c0-43bc-9b48-f7b70d8918f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5f3fcb3c-228b-411c-8b54-71e089fe5f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c070b2ab-e9f0-4088-98b6-d90f78aa4b31" xlink:to="loc_us-gaap_OperatingLeaseLiability_5f3fcb3c-228b-411c-8b54-71e089fe5f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f71386ec-d47b-402d-8290-50e2092dc5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_95a2898d-2870-4ff2-8da8-940622a23878" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f71386ec-d47b-402d-8290-50e2092dc5de" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_95a2898d-2870-4ff2-8da8-940622a23878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_8638e6d4-c719-41ae-b571-d7fc1301ea3f" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f71386ec-d47b-402d-8290-50e2092dc5de" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_8638e6d4-c719-41ae-b571-d7fc1301ea3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_abb44abd-837f-4044-80bf-6ee002e6ecc3" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f71386ec-d47b-402d-8290-50e2092dc5de" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_abb44abd-837f-4044-80bf-6ee002e6ecc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_f2741471-ddbe-44b3-afed-bb47440e2f4b" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f71386ec-d47b-402d-8290-50e2092dc5de" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_f2741471-ddbe-44b3-afed-bb47440e2f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_5334ebe5-b039-427e-b11f-809f4fbfa099" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f71386ec-d47b-402d-8290-50e2092dc5de" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_5334ebe5-b039-427e-b11f-809f4fbfa099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_56c6c7a0-dded-4254-8837-99ca6e8a78e6" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f71386ec-d47b-402d-8290-50e2092dc5de" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_56c6c7a0-dded-4254-8837-99ca6e8a78e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_9e23f72c-7649-45b0-9c1e-d38f55fa0467" xlink:href="pcrx-20220630.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f71386ec-d47b-402d-8290-50e2092dc5de" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_9e23f72c-7649-45b0-9c1e-d38f55fa0467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_57d42126-305a-487f-806a-2fe3814a8c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_fd24493d-af5c-4726-bd65-909a52416c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_57d42126-305a-487f-806a-2fe3814a8c2c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_fd24493d-af5c-4726-bd65-909a52416c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_021309f4-c2f0-42df-8f5b-1f2ce5b06229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_cbc5440a-073a-449e-9982-365998d9a0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_021309f4-c2f0-42df-8f5b-1f2ce5b06229" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_cbc5440a-073a-449e-9982-365998d9a0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#GOODWILLANDINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0d92bb02-d0a6-42af-a117-e0ea7a775757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0d92bb02-d0a6-42af-a117-e0ea7a775757" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_7e7680e2-bea5-484d-be20-215941ba5beb" xlink:href="pcrx-20220630.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:to="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_7e7680e2-bea5-484d-be20-215941ba5beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_4ca4f09f-5ea6-404a-b9ed-1f7ddf00fe0f" xlink:href="pcrx-20220630.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_7e7680e2-bea5-484d-be20-215941ba5beb" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_4ca4f09f-5ea6-404a-b9ed-1f7ddf00fe0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_fef99876-0a87-4f8e-a440-785c6d1c54ce" xlink:href="pcrx-20220630.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_4ca4f09f-5ea6-404a-b9ed-1f7ddf00fe0f" xlink:to="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_fef99876-0a87-4f8e-a440-785c6d1c54ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_421dd2d2-e12a-41b9-b26e-c4645d2cce33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_421dd2d2-e12a-41b9-b26e-c4645d2cce33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e09a116-d51e-4e1f-8f41-bd93549d349b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_421dd2d2-e12a-41b9-b26e-c4645d2cce33" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e09a116-d51e-4e1f-8f41-bd93549d349b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember_43923671-a82f-420b-a335-18124207fdc4" xlink:href="pcrx-20220630.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e09a116-d51e-4e1f-8f41-bd93549d349b" xlink:to="loc_pcrx_SkyePharmaHoldingIncMember_43923671-a82f-420b-a335-18124207fdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9dcfed0-7eec-4ecc-b14c-24f8235441ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9dcfed0-7eec-4ecc-b14c-24f8235441ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb1983f-21b4-4a82-a3e6-9f46d6cc4eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9dcfed0-7eec-4ecc-b14c-24f8235441ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb1983f-21b4-4a82-a3e6-9f46d6cc4eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_06ef0d5f-2291-4678-8f75-d6c46092626a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb1983f-21b4-4a82-a3e6-9f46d6cc4eb4" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_06ef0d5f-2291-4678-8f75-d6c46092626a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_07d0d722-2e1c-4114-8a22-67f53df4b04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb1983f-21b4-4a82-a3e6-9f46d6cc4eb4" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_07d0d722-2e1c-4114-8a22-67f53df4b04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ff648018-412d-40fa-b259-e4af1a047204" xlink:to="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_15c31754-7b64-4cc8-9bf3-a79eea1b8543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_us-gaap_Goodwill_15c31754-7b64-4cc8-9bf3-a79eea1b8543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_ef660f46-5b36-4992-92ee-92f4e001c4cf" xlink:href="pcrx-20220630.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_ef660f46-5b36-4992-92ee-92f4e001c4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_13d7291c-7681-414c-ad55-437623a32926" xlink:href="pcrx-20220630.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_13d7291c-7681-414c-ad55-437623a32926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d5ded490-7925-4691-ba48-325376fe4695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d5ded490-7925-4691-ba48-325376fe4695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_61fc78a2-c405-4504-9396-33d07d7621bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_61fc78a2-c405-4504-9396-33d07d7621bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_d4ab5561-3903-480f-8c22-01964047b1d7" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_d4ab5561-3903-480f-8c22-01964047b1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_d9c87bec-463c-4214-84c3-a6fe0c19faeb" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_d9c87bec-463c-4214-84c3-a6fe0c19faeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_3d0794bc-6cec-45f2-8fc9-9dd52a66514f" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_3d0794bc-6cec-45f2-8fc9-9dd52a66514f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_6f4a33fc-983c-4672-b721-4c7555fa65fb" xlink:href="pcrx-20220630.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfa64529-bc53-4888-9a27-111483b6c215" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_6f4a33fc-983c-4672-b721-4c7555fa65fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f3af9b5b-06db-45dd-8aac-ec971893e526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b550e6a8-d484-4d01-827a-db4e6127d071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f3af9b5b-06db-45dd-8aac-ec971893e526" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b550e6a8-d484-4d01-827a-db4e6127d071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b550e6a8-d484-4d01-827a-db4e6127d071" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0c0b1f7-64ce-4c65-bd36-d12361bf0fc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3a2d159f-22d6-45c7-98d6-ceb011065238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3a2d159f-22d6-45c7-98d6-ceb011065238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_48a00876-d488-4e6d-b349-c71cc5e07dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:to="loc_us-gaap_CustomerRelationshipsMember_48a00876-d488-4e6d-b349-c71cc5e07dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_9a160d51-a9ab-4f3c-8b16-2985e8117ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_65970290-ae2d-4a07-9d20-ae8577a36594" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_9a160d51-a9ab-4f3c-8b16-2985e8117ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b550e6a8-d484-4d01-827a-db4e6127d071" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2940a155-4f59-4e63-9ec9-ceaecc75d3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2940a155-4f59-4e63-9ec9-ceaecc75d3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_507471a1-cb33-434d-9603-8b678c5fa2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_507471a1-cb33-434d-9603-8b678c5fa2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e1f8b818-a2a4-497c-8946-e0f1adf813f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e1f8b818-a2a4-497c-8946-e0f1adf813f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d4bdf606-4e2f-44f5-a698-7e859d3056ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d4bdf606-4e2f-44f5-a698-7e859d3056ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_211f43d2-982e-4c6c-94c7-77b9944d62ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_211f43d2-982e-4c6c-94c7-77b9944d62ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_123b11bc-994f-450f-910f-38395ee5d642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_123b11bc-994f-450f-910f-38395ee5d642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0be60502-b2bd-4824-aaf1-e87aa1a83e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0be60502-b2bd-4824-aaf1-e87aa1a83e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aeb2d055-dd46-47ce-afe0-23dd8e8a86fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_1e02838a-7db1-4265-bf98-d2c2b78801fd" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aeb2d055-dd46-47ce-afe0-23dd8e8a86fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBT" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5b499ca8-0f85-4463-8da6-fcd80244bb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_6b3d707b-0b01-4e89-ac0f-c4105d23ae69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5b499ca8-0f85-4463-8da6-fcd80244bb46" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_6b3d707b-0b01-4e89-ac0f-c4105d23ae69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_22807e9f-ed50-4903-853b-d3598c934b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bb6bd7d8-b9b5-4dbf-8262-5237d394a1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_22807e9f-ed50-4903-853b-d3598c934b7f" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bb6bd7d8-b9b5-4dbf-8262-5237d394a1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_e19461b0-55a4-4c77-93af-cc0da0854a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_22807e9f-ed50-4903-853b-d3598c934b7f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_e19461b0-55a4-4c77-93af-cc0da0854a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock_62bfbeb3-1661-4f80-b737-4d87d4cac7f4" xlink:href="pcrx-20220630.xsd#pcrx_ScheduleOfInterestExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_22807e9f-ed50-4903-853b-d3598c934b7f" xlink:to="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock_62bfbeb3-1661-4f80-b737-4d87d4cac7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTCarryingValueofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b191d8bd-dd45-4625-b4fc-cbf9976bb78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b191d8bd-dd45-4625-b4fc-cbf9976bb78c" xlink:to="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_16b2fc9c-37fa-4cb7-b939-039b85082f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:to="loc_us-gaap_DebtInstrumentAxis_16b2fc9c-37fa-4cb7-b939-039b85082f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_16b2fc9c-37fa-4cb7-b939-039b85082f94" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_07e65b10-6d24-4026-b67d-fa2a85a1b447" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_07e65b10-6d24-4026-b67d-fa2a85a1b447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_124ad6c8-1667-410f-85d8-88bc1ac7eb48" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_124ad6c8-1667-410f-85d8-88bc1ac7eb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_1824e6ad-3cea-4026-9c18-3cabef15f2db" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:to="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_1824e6ad-3cea-4026-9c18-3cabef15f2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_c75d9680-7a74-4780-82be-dc595b99ee96" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62b8844a-75b7-45cc-abfc-e75bdec44227" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_c75d9680-7a74-4780-82be-dc595b99ee96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_575c08f7-623b-4380-9a43-0d21d872ec77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f4001bf0-cfa7-48df-97cd-58b3c9be9ff7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_575c08f7-623b-4380-9a43-0d21d872ec77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_d5ec93a3-0eff-4cde-ba30-da1d49ad1d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_575c08f7-623b-4380-9a43-0d21d872ec77" xlink:to="loc_us-gaap_SecuredDebtMember_d5ec93a3-0eff-4cde-ba30-da1d49ad1d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_ab1b88bb-a51c-4184-8fd7-69f98c1e4244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_575c08f7-623b-4380-9a43-0d21d872ec77" xlink:to="loc_us-gaap_UnsecuredDebtMember_ab1b88bb-a51c-4184-8fd7-69f98c1e4244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_439f9c35-a90b-468f-b6db-d9680f3be784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d2530140-0a29-4b3a-9456-4dcba9ee01ea" xlink:to="loc_us-gaap_DebtInstrumentLineItems_439f9c35-a90b-468f-b6db-d9680f3be784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_82a463e1-615a-4911-8101-8552878321b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_439f9c35-a90b-468f-b6db-d9680f3be784" xlink:to="loc_us-gaap_LongTermDebt_82a463e1-615a-4911-8101-8552878321b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f243d19c-f033-4427-9eb5-b7e4daefe03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_439f9c35-a90b-468f-b6db-d9680f3be784" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f243d19c-f033-4427-9eb5-b7e4daefe03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_057da1e3-6c79-4296-bc0c-03a077057d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_057da1e3-6c79-4296-bc0c-03a077057d25" xlink:to="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4aee1b71-e817-434e-8573-34cfc7c4379a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4aee1b71-e817-434e-8573-34cfc7c4379a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6f15e3e7-589e-4658-8d69-ec430211ba22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4aee1b71-e817-434e-8573-34cfc7c4379a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6f15e3e7-589e-4658-8d69-ec430211ba22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_57676f79-4019-4c43-be5a-3ab23e2c62e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6f15e3e7-589e-4658-8d69-ec430211ba22" xlink:to="loc_us-gaap_UnsecuredDebtMember_57676f79-4019-4c43-be5a-3ab23e2c62e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4e2027c1-12e1-42ae-b467-9b49c0aedd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6f15e3e7-589e-4658-8d69-ec430211ba22" xlink:to="loc_us-gaap_SecuredDebtMember_4e2027c1-12e1-42ae-b467-9b49c0aedd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c26be990-5252-46ee-811f-14de3ecba6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_DebtInstrumentAxis_c26be990-5252-46ee-811f-14de3ecba6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c26be990-5252-46ee-811f-14de3ecba6bb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_d8e59fe1-2c63-4fe0-bd25-69a970b59e1e" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_d8e59fe1-2c63-4fe0-bd25-69a970b59e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_3c462fc1-2acd-4ab8-b7cf-284dddfdb379" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_3c462fc1-2acd-4ab8-b7cf-284dddfdb379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_6b5a60a7-23c4-4601-94fc-3c84f893e5b6" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_6b5a60a7-23c4-4601-94fc-3c84f893e5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_b3091e7b-a007-4460-9218-93a622efb30d" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_b3091e7b-a007-4460-9218-93a622efb30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_9eef5a00-ef68-457e-98f0-cc4db1242a3c" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebb72529-18b1-4560-a296-fd2ef0b1923f" xlink:to="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_9eef5a00-ef68-457e-98f0-cc4db1242a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis_f5375314-91a6-4ef3-9c3a-29abc01865eb" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsAxis_f5375314-91a6-4ef3-9c3a-29abc01865eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_811b051d-1037-4720-96f1-4fcb623f7cea" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_f5375314-91a6-4ef3-9c3a-29abc01865eb" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_811b051d-1037-4720-96f1-4fcb623f7cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_056b1136-816f-4ed4-9713-3113a2644200" xlink:href="pcrx-20220630.xsd#pcrx_DebtRedemptionTermsPriorToFebruary32023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_811b051d-1037-4720-96f1-4fcb623f7cea" xlink:to="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_056b1136-816f-4ed4-9713-3113a2644200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_d1041cf1-6a66-44a5-81d8-9fc2363157fd" xlink:href="pcrx-20220630.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_811b051d-1037-4720-96f1-4fcb623f7cea" xlink:to="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_d1041cf1-6a66-44a5-81d8-9fc2363157fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_fe20277e-ed00-4e68-a33b-5a644852c821" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_srt_StatementScenarioAxis_fe20277e-ed00-4e68-a33b-5a644852c821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1959fe1f-6850-4677-aa12-b34cf0aa99b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_fe20277e-ed00-4e68-a33b-5a644852c821" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1959fe1f-6850-4677-aa12-b34cf0aa99b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_6b29c330-3325-474b-b393-6b4ce4541a51" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1959fe1f-6850-4677-aa12-b34cf0aa99b2" xlink:to="loc_srt_ScenarioForecastMember_6b29c330-3325-474b-b393-6b4ce4541a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f682b36f-52cb-4052-bb33-6d99188dd03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f682b36f-52cb-4052-bb33-6d99188dd03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b53d5bbf-ab38-4a2c-877f-526386892bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f682b36f-52cb-4052-bb33-6d99188dd03b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b53d5bbf-ab38-4a2c-877f-526386892bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c7f7b66a-178e-4171-9eb6-f6961270b42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b53d5bbf-ab38-4a2c-877f-526386892bcc" xlink:to="loc_us-gaap_SubsequentEventMember_c7f7b66a-178e-4171-9eb6-f6961270b42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a65b98bd-58fd-4902-a295-02b85583a730" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_dei_LegalEntityAxis_a65b98bd-58fd-4902-a295-02b85583a730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_48dd0a02-8dea-4d6a-a5e8-a84cbe7d282f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a65b98bd-58fd-4902-a295-02b85583a730" xlink:to="loc_dei_EntityDomain_48dd0a02-8dea-4d6a-a5e8-a84cbe7d282f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_8746fff1-abd9-4b3c-83e3-6fa091f2ce7a" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_48dd0a02-8dea-4d6a-a5e8-a84cbe7d282f" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_8746fff1-abd9-4b3c-83e3-6fa091f2ce7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c4d37409-c31c-4d33-b79a-505a0149b608" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_srt_RangeAxis_c4d37409-c31c-4d33-b79a-505a0149b608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f7139b7d-041d-42f3-991b-5c635b1d4768" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c4d37409-c31c-4d33-b79a-505a0149b608" xlink:to="loc_srt_RangeMember_f7139b7d-041d-42f3-991b-5c635b1d4768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_af39f1ce-039d-438d-9061-049d764e2c60" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f7139b7d-041d-42f3-991b-5c635b1d4768" xlink:to="loc_srt_MinimumMember_af39f1ce-039d-438d-9061-049d764e2c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_231cbe8f-d78c-4029-970e-b0b139241524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_VariableRateAxis_231cbe8f-d78c-4029-970e-b0b139241524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_231cbe8f-d78c-4029-970e-b0b139241524" xlink:to="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_819576f7-19cc-4378-9f57-2cd0cc5083b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_819576f7-19cc-4378-9f57-2cd0cc5083b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_b4d001a7-40b1-42ac-9539-c722e6073452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:to="loc_us-gaap_BaseRateMember_b4d001a7-40b1-42ac-9539-c722e6073452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FederalReserveBankOfNYRateMember_663e4641-488c-43d9-b5d0-fc7b633fb6c0" xlink:href="pcrx-20220630.xsd#pcrx_FederalReserveBankOfNYRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_bfdc0b8b-b507-4f21-82a5-dcb6fd6d444b" xlink:to="loc_pcrx_FederalReserveBankOfNYRateMember_663e4641-488c-43d9-b5d0-fc7b633fb6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_38700614-b987-4fe4-8c80-cd5d10bd4802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_38700614-b987-4fe4-8c80-cd5d10bd4802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0331cde4-fbef-4637-a6d3-15fef5141f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_38700614-b987-4fe4-8c80-cd5d10bd4802" xlink:to="loc_us-gaap_EquityComponentDomain_0331cde4-fbef-4637-a6d3-15fef5141f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_969c7a53-f961-48bf-8da3-583b49509afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0331cde4-fbef-4637-a6d3-15fef5141f1d" xlink:to="loc_us-gaap_CommonStockMember_969c7a53-f961-48bf-8da3-583b49509afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236fc800-2fdd-4760-ae66-edbdc324356b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentDiscountRate_ff496677-ffdd-4382-8d6c-4f87cc9f124e" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentDiscountRate_ff496677-ffdd-4382-8d6c-4f87cc9f124e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7985a862-0f04-48ee-9341-8f64ac6303ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7985a862-0f04-48ee-9341-8f64ac6303ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_fa451410-f00f-44e8-b577-1ae789d16fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_fa451410-f00f-44e8-b577-1ae789d16fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_9f863bc3-9f3f-4ee4-b3bd-45f159efee73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_9f863bc3-9f3f-4ee4-b3bd-45f159efee73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_297450d6-da29-4821-a29d-686bde10a0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_297450d6-da29-4821-a29d-686bde10a0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_412fcfd3-598e-43a7-b48d-3388a2cf3abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_412fcfd3-598e-43a7-b48d-3388a2cf3abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_55859065-e8ad-4986-9eaa-1b567033faa0" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_55859065-e8ad-4986-9eaa-1b567033faa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_a0611842-1392-4d92-8118-4541bfc8acf4" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_a0611842-1392-4d92-8118-4541bfc8acf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_da1cd334-9db8-482c-9923-9ef7fb23ee39" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_da1cd334-9db8-482c-9923-9ef7fb23ee39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_c5664ab4-9569-4886-9557-f4dbfbac0887" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_c5664ab4-9569-4886-9557-f4dbfbac0887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_e5a032e7-0387-4744-b651-56dd6eb9322c" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_e5a032e7-0387-4744-b651-56dd6eb9322c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_11b418ff-0af1-4f60-bcf8-24508553b3ac" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_11b418ff-0af1-4f60-bcf8-24508553b3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentVariableRate_d40efd55-511d-4079-88c2-815120beab6d" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentVariableRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentVariableRate_d40efd55-511d-4079-88c2-815120beab6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_5ca1b6e6-1e2f-4ec0-b6a3-4c0acc6c40b5" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_5ca1b6e6-1e2f-4ec0-b6a3-4c0acc6c40b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_dad29422-f87c-49eb-887c-b6f7c05d5971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_dad29422-f87c-49eb-887c-b6f7c05d5971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_86b2caec-8880-4298-8cce-560c24220349" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentBasisSpreadOneOnVariableRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_86b2caec-8880-4298-8cce-560c24220349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_b2d4b6ee-d83b-4c2c-9d0c-6c262c08f214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_b2d4b6ee-d83b-4c2c-9d0c-6c262c08f214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ee07ce77-dffe-4626-85e5-44d7b3c1b4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ee07ce77-dffe-4626-85e5-44d7b3c1b4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_72196650-0fd1-4a33-82e5-7fb2369063de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_72196650-0fd1-4a33-82e5-7fb2369063de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_c4fde825-ab0c-4181-a34d-8ecdba4ff3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_c4fde825-ab0c-4181-a34d-8ecdba4ff3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_d7a14578-0213-457a-96e8-58525c2be805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_RepaymentsOfDebt_d7a14578-0213-457a-96e8-58525c2be805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5e64bbc3-4134-438c-a955-e0e4e57a97dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5e64bbc3-4134-438c-a955-e0e4e57a97dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_8449b228-8abb-4dbc-ae6e-cee7a6fd7826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_8449b228-8abb-4dbc-ae6e-cee7a6fd7826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2254f4c9-5471-44c7-8c7f-abc1ca2bf89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2254f4c9-5471-44c7-8c7f-abc1ca2bf89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_f6051052-9d08-40eb-b54f-ccccb78b2a2d" xlink:href="pcrx-20220630.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_f6051052-9d08-40eb-b54f-ccccb78b2a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_49e8fb89-64d7-48c9-8a1d-4d175000bac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_49e8fb89-64d7-48c9-8a1d-4d175000bac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_2b624620-02a1-4767-9823-f66a1ee3c5e9" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_2b624620-02a1-4767-9823-f66a1ee3c5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c4f5c280-5604-4954-902f-ee86bc859d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_SharePrice_c4f5c280-5604-4954-902f-ee86bc859d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice_db229954-d81b-470f-975b-c8f971e3d068" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentMarketPrice_db229954-d81b-470f-975b-c8f971e3d068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_395a94ce-6833-4f94-853b-81c99c7c11b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_395a94ce-6833-4f94-853b-81c99c7c11b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_364a6ec6-0d0a-430a-9904-1298c9df3621" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_364a6ec6-0d0a-430a-9904-1298c9df3621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_22ced8bb-fd9a-4a83-a929-6efef8204c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_22ced8bb-fd9a-4a83-a929-6efef8204c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_418c4e86-2ff6-4911-a689-ff73459b384b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_LongTermDebt_418c4e86-2ff6-4911-a689-ff73459b384b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_e0a9568e-2b32-41c8-8fd1-51521377b0dd" xlink:href="pcrx-20220630.xsd#pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_e0a9568e-2b32-41c8-8fd1-51521377b0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_63b31f4c-8b53-4843-b7b6-9e5d1568a4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_63b31f4c-8b53-4843-b7b6-9e5d1568a4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_7e10bdbe-97c7-4422-96cf-57328aa3ecde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_7e10bdbe-97c7-4422-96cf-57328aa3ecde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1d3ae902-102a-40d6-b1bb-ba08829887aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1d3ae902-102a-40d6-b1bb-ba08829887aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1ffd18a6-2bb3-447b-94f5-180d266f81b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8278b6bf-799f-4a0e-8bff-a01f19e2a37a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1ffd18a6-2bb3-447b-94f5-180d266f81b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_99ecf2c5-224c-4903-84c0-392e287763cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_99ecf2c5-224c-4903-84c0-392e287763cc" xlink:to="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_016bfc5f-8962-4422-91f1-75f4adf06c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_016bfc5f-8962-4422-91f1-75f4adf06c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c701313-19c7-4d2a-aa69-073effe330f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_016bfc5f-8962-4422-91f1-75f4adf06c8b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c701313-19c7-4d2a-aa69-073effe330f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_05a3ac5f-ea5b-4634-b9e0-9bfee0951212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c701313-19c7-4d2a-aa69-073effe330f8" xlink:to="loc_us-gaap_UnsecuredDebtMember_05a3ac5f-ea5b-4634-b9e0-9bfee0951212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5d1eac7e-26a6-41c8-99e6-05a71f7b0bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c701313-19c7-4d2a-aa69-073effe330f8" xlink:to="loc_us-gaap_SecuredDebtMember_5d1eac7e-26a6-41c8-99e6-05a71f7b0bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b9197e6a-498e-470d-b0f4-935ecc296312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:to="loc_us-gaap_DebtInstrumentAxis_b9197e6a-498e-470d-b0f4-935ecc296312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9197e6a-498e-470d-b0f4-935ecc296312" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_f8f7baa0-475b-4dca-8a74-4e66b2ef8e4e" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_f8f7baa0-475b-4dca-8a74-4e66b2ef8e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_2ea7715e-ccb2-4032-9077-a7f9ccce7a30" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_2ea7715e-ccb2-4032-9077-a7f9ccce7a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_b3abe425-82fd-440e-b020-33be53b8aa2d" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d2e1ba4-71a2-4e9c-9d6e-0d9696decd3b" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_b3abe425-82fd-440e-b020-33be53b8aa2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cc8c6b3d-fd19-46d8-87ee-3d04b9f761c2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ee5b1a1c-bc40-4f68-a309-c590a6fd5037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ee5b1a1c-bc40-4f68-a309-c590a6fd5037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_962c6276-08c4-41b4-ade2-bf289810a6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_962c6276-08c4-41b4-ade2-bf289810a6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_de4211ef-b6e6-4676-bccd-96d872207f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_de4211ef-b6e6-4676-bccd-96d872207f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7f7b5f70-fceb-4a24-bd22-bbea90ced7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7f7b5f70-fceb-4a24-bd22-bbea90ced7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d1d757b0-2217-43d5-af57-83e2613967bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9cbc7707-90d5-49e3-9b30-12931d171ed6" xlink:to="loc_us-gaap_LongTermDebt_d1d757b0-2217-43d5-af57-83e2613967bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#DEBTScheduleofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6401126c-e916-40ff-a4f3-a2582d60ee98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_90e94328-1da1-4a66-80ab-06b683ad0161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6401126c-e916-40ff-a4f3-a2582d60ee98" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_90e94328-1da1-4a66-80ab-06b683ad0161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_bc838021-3f3d-4009-8b0a-9fd744700ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6401126c-e916-40ff-a4f3-a2582d60ee98" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_bc838021-3f3d-4009-8b0a-9fd744700ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_f63c9966-3931-487d-9308-3df6d1999a43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6401126c-e916-40ff-a4f3-a2582d60ee98" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_f63c9966-3931-487d-9308-3df6d1999a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_1a0eea0f-f351-423b-8a6f-248b2c42e9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6401126c-e916-40ff-a4f3-a2582d60ee98" xlink:to="loc_us-gaap_InterestCostsCapitalized_1a0eea0f-f351-423b-8a6f-248b2c42e9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_a30eb18c-3b5b-4608-96ec-0c7029a38fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6401126c-e916-40ff-a4f3-a2582d60ee98" xlink:to="loc_us-gaap_InterestExpenseDebt_a30eb18c-3b5b-4608-96ec-0c7029a38fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_ae330b9a-9ba9-4f1d-8ac9-8dc94f832c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6401126c-e916-40ff-a4f3-a2582d60ee98" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_ae330b9a-9ba9-4f1d-8ac9-8dc94f832c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_83904957-455d-4034-9387-17e9cbdbba58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_e90fb7ad-a352-4226-ab20-2f7739a46e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_83904957-455d-4034-9387-17e9cbdbba58" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_e90fb7ad-a352-4226-ab20-2f7739a46e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9e57704d-9b00-467f-b9aa-43f8dd755f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_9fe6de31-c5c4-4c96-8969-ff47387d9a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9e57704d-9b00-467f-b9aa-43f8dd755f45" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_9fe6de31-c5c4-4c96-8969-ff47387d9a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a1606fb9-3fb4-47d9-ae98-96cc24c9c4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9e57704d-9b00-467f-b9aa-43f8dd755f45" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a1606fb9-3fb4-47d9-ae98-96cc24c9c4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_93cdaa88-3cad-4e1e-b273-6d0b71ab5409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9e57704d-9b00-467f-b9aa-43f8dd755f45" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_93cdaa88-3cad-4e1e-b273-6d0b71ab5409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4aab77fe-2287-4636-8d04-f9d457254eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9e57704d-9b00-467f-b9aa-43f8dd755f45" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4aab77fe-2287-4636-8d04-f9d457254eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_c01c98ed-5b70-4676-921a-8d471f650cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9e57704d-9b00-467f-b9aa-43f8dd755f45" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_c01c98ed-5b70-4676-921a-8d471f650cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bb4a5781-0c4e-42f4-af1c-de3585e80f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bb4a5781-0c4e-42f4-af1c-de3585e80f55" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_3bff0ee9-2332-4365-8b68-2415772a7495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_3bff0ee9-2332-4365-8b68-2415772a7495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_3bff0ee9-2332-4365-8b68-2415772a7495" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d277eddd-2463-4dff-aed3-a958c74365b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d277eddd-2463-4dff-aed3-a958c74365b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b01b429d-a116-41a1-932d-85b5ca82facf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b01b429d-a116-41a1-932d-85b5ca82facf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6c4f1789-1d3b-431a-8884-908af4f059bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_49b0efc6-012e-4d99-8d78-b88db799a00b" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6c4f1789-1d3b-431a-8884-908af4f059bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f054d963-d359-4da8-b956-26388a421630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f054d963-d359-4da8-b956-26388a421630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f054d963-d359-4da8-b956-26388a421630" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_93e681f8-acc1-4e2b-b9f5-febb3237a002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_93e681f8-acc1-4e2b-b9f5-febb3237a002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b83fd04e-fecc-4231-88b4-91a041059cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b83fd04e-fecc-4231-88b4-91a041059cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_863a6573-e350-42c1-b7be-57393f835807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61ca57cd-74e4-4a8b-9966-59e328909860" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_863a6573-e350-42c1-b7be-57393f835807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d6174461-e4e4-4062-af32-fc7b20da9c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_DebtInstrumentAxis_d6174461-e4e4-4062-af32-fc7b20da9c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d6174461-e4e4-4062-af32-fc7b20da9c7a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_e9ea8e2f-dbb4-42f3-ad14-e8c0d19cc1ae" xlink:href="pcrx-20220630.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_e9ea8e2f-dbb4-42f3-ad14-e8c0d19cc1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_5e7515f4-c5f9-464c-a2f5-0c25e5180fed" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_5e7515f4-c5f9-464c-a2f5-0c25e5180fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_041559fa-a499-4960-8fc4-f74bc190c424" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_24cc75fe-4b0e-4372-a597-cf78b4214750" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_041559fa-a499-4960-8fc4-f74bc190c424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d55601da-6f11-4206-919c-7889286d2f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d55601da-6f11-4206-919c-7889286d2f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_df1719cb-69c2-4372-b807-9f6bb45185c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d55601da-6f11-4206-919c-7889286d2f03" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_df1719cb-69c2-4372-b807-9f6bb45185c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_bdfd0185-eda4-495c-9f1c-a8a0b3f20340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df1719cb-69c2-4372-b807-9f6bb45185c3" xlink:to="loc_us-gaap_SecuredDebtMember_bdfd0185-eda4-495c-9f1c-a8a0b3f20340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_7bdf8555-7836-4180-ae55-6ae73f42f43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df1719cb-69c2-4372-b807-9f6bb45185c3" xlink:to="loc_us-gaap_UnsecuredDebtMember_7bdf8555-7836-4180-ae55-6ae73f42f43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_03710226-f5b5-4290-97cc-b60efe8ab244" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_srt_RangeAxis_03710226-f5b5-4290-97cc-b60efe8ab244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99e53137-b282-4939-a594-f3b87618ee77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_03710226-f5b5-4290-97cc-b60efe8ab244" xlink:to="loc_srt_RangeMember_99e53137-b282-4939-a594-f3b87618ee77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_84dc6b99-63c6-48bb-9051-987331a349a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_99e53137-b282-4939-a594-f3b87618ee77" xlink:to="loc_srt_MaximumMember_84dc6b99-63c6-48bb-9051-987331a349a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_81c13c36-6e02-4fc5-865d-e922f0b7b167" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_db395496-e01a-4c62-8558-308ec80eecc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_db395496-e01a-4c62-8558-308ec80eecc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e76caf7a-1784-434c-b3cb-1d330b0b065f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_db395496-e01a-4c62-8558-308ec80eecc3" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e76caf7a-1784-434c-b3cb-1d330b0b065f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_99fd3508-4471-41d9-8753-27f37c330902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_db395496-e01a-4c62-8558-308ec80eecc3" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_99fd3508-4471-41d9-8753-27f37c330902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_7f43d830-ffe5-4c1b-aebd-d8262f7b0ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_7f43d830-ffe5-4c1b-aebd-d8262f7b0ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a4752873-2a9b-4b4c-b8be-be5a81a1accc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_7f43d830-ffe5-4c1b-aebd-d8262f7b0ff1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a4752873-2a9b-4b4c-b8be-be5a81a1accc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_6e669c1e-4460-4264-9562-79a7d2f95832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_6e669c1e-4460-4264-9562-79a7d2f95832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8e5f10b8-11aa-4a7d-b29a-a83b8c434f84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8e5f10b8-11aa-4a7d-b29a-a83b8c434f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_2e3a422e-9a9c-4c7b-934e-0d80cab72f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_SharePrice_2e3a422e-9a9c-4c7b-934e-0d80cab72f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1fc236f3-5462-45df-87b5-3e84c368a24d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1fc236f3-5462-45df-87b5-3e84c368a24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_8d336d25-fea2-44f6-964b-ec145e97f426" xlink:href="pcrx-20220630.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6ec1cdd9-89d5-47fd-a34c-5dcee1ad415d" xlink:to="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_8d336d25-fea2-44f6-964b-ec145e97f426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e520315b-3051-4f07-b46a-d3761add4b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e30dcb4e-4e88-4852-abf5-0b790db601bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e520315b-3051-4f07-b46a-d3761add4b28" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e30dcb4e-4e88-4852-abf5-0b790db601bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3981b7a0-00f6-47b6-b0c1-9dcc692bb989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e30dcb4e-4e88-4852-abf5-0b790db601bb" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3981b7a0-00f6-47b6-b0c1-9dcc692bb989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e03849e6-74ff-423f-870c-40d6a731da46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3981b7a0-00f6-47b6-b0c1-9dcc692bb989" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e03849e6-74ff-423f-870c-40d6a731da46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_cc4bd615-f7f3-4673-bede-ace551053ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e03849e6-74ff-423f-870c-40d6a731da46" xlink:to="loc_us-gaap_EquitySecuritiesMember_cc4bd615-f7f3-4673-bede-ace551053ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleNotesReceivableMember_60ab5bdd-e05e-4a1e-a340-1115134d52b7" xlink:href="pcrx-20220630.xsd#pcrx_ConvertibleNotesReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e03849e6-74ff-423f-870c-40d6a731da46" xlink:to="loc_pcrx_ConvertibleNotesReceivableMember_60ab5bdd-e05e-4a1e-a340-1115134d52b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_671be3e1-72d5-45cb-8adf-bfad38087c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e30dcb4e-4e88-4852-abf5-0b790db601bb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_671be3e1-72d5-45cb-8adf-bfad38087c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_671be3e1-72d5-45cb-8adf-bfad38087c42" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_21b7f870-d5f1-41db-8f5c-58a704c591d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_21b7f870-d5f1-41db-8f5c-58a704c591d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_dcb0c713-c0f8-41fe-9248-706705c9399c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_dcb0c713-c0f8-41fe-9248-706705c9399c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_c83fdd59-615b-4105-8ef2-44a50b93da74" xlink:href="pcrx-20220630.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_c83fdd59-615b-4105-8ef2-44a50b93da74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6b34cc17-5383-41b7-b41b-b75b9a46c716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ff8cdde5-c185-4b39-9a1e-d2a9240f4f8e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6b34cc17-5383-41b7-b41b-b75b9a46c716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_605b0db2-64e7-4b44-ab1b-219f7859cf08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_605b0db2-64e7-4b44-ab1b-219f7859cf08" xlink:to="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_078fa16d-51a6-439c-93df-83d3b5d512d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_078fa16d-51a6-439c-93df-83d3b5d512d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_078fa16d-51a6-439c-93df-83d3b5d512d8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_9dcb8918-bc13-46d6-9b0d-60ed6cffa033" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_9dcb8918-bc13-46d6-9b0d-60ed6cffa033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_9e250328-0459-4735-a960-ef9a347c76cb" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:to="loc_pcrx_FlexionAcquisitionMember_9e250328-0459-4735-a960-ef9a347c76cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_adf00834-b9bd-4e56-b467-6449b5e142b1" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAndMyoScienceAcquisitionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412fde1b-8ae6-4775-9da3-cbeaf618a38c" xlink:to="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_adf00834-b9bd-4e56-b467-6449b5e142b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_c07921d6-f6eb-46d4-b901-8b201f54fe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_c07921d6-f6eb-46d4-b901-8b201f54fe6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c7eca5f0-57ef-4ce7-931e-dfe3abd361ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c07921d6-f6eb-46d4-b901-8b201f54fe6a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c7eca5f0-57ef-4ce7-931e-dfe3abd361ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_f90fe133-2f7c-4718-9c2b-949b464dfaee" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c7eca5f0-57ef-4ce7-931e-dfe3abd361ee" xlink:to="loc_pcrx_ContingentConsiderationMember_f90fe133-2f7c-4718-9c2b-949b464dfaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4f52d58f-8742-45fa-886a-24464154f334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4f52d58f-8742-45fa-886a-24464154f334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a2313032-632d-4741-83d0-45b45314016f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4f52d58f-8742-45fa-886a-24464154f334" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a2313032-632d-4741-83d0-45b45314016f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_4ff0e378-41f1-4706-ac8d-e195f0143b14" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a2313032-632d-4741-83d0-45b45314016f" xlink:to="loc_pcrx_ContingentConsiderationMember_4ff0e378-41f1-4706-ac8d-e195f0143b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7495cc83-f1e7-4755-b883-2b11510a7fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7495cc83-f1e7-4755-b883-2b11510a7fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7495cc83-f1e7-4755-b883-2b11510a7fc2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_27a07ed1-f097-471a-99a8-c723e39e90c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_27a07ed1-f097-471a-99a8-c723e39e90c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_cc17a63e-e4ca-4359-aea3-98fe07ab7d70" xlink:href="pcrx-20220630.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_cc17a63e-e4ca-4359-aea3-98fe07ab7d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_1d501cf2-1b78-4598-bf19-1d3733642a7d" xlink:href="pcrx-20220630.xsd#pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_bd01072e-292d-4abc-83af-9c6c57e0b1f9" xlink:to="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_1d501cf2-1b78-4598-bf19-1d3733642a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dfded32-7905-4191-9423-117c88dfc22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dfded32-7905-4191-9423-117c88dfc22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37510366-f462-4c9e-b52b-264a922e296f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dfded32-7905-4191-9423-117c88dfc22f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37510366-f462-4c9e-b52b-264a922e296f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ecc47778-b3f7-416f-869c-fbf5c1f4bbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37510366-f462-4c9e-b52b-264a922e296f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ecc47778-b3f7-416f-869c-fbf5c1f4bbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3241ae77-25fb-43a7-bf99-4c5d4c3a288f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3241ae77-25fb-43a7-bf99-4c5d4c3a288f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_115e5c0f-2293-429c-9aa7-8d13bc775ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3241ae77-25fb-43a7-bf99-4c5d4c3a288f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_115e5c0f-2293-429c-9aa7-8d13bc775ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_baf136c1-5168-4393-8e12-c92ce2ae9b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_115e5c0f-2293-429c-9aa7-8d13bc775ffa" xlink:to="loc_us-gaap_AccountsReceivableMember_baf136c1-5168-4393-8e12-c92ce2ae9b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e6cb2df7-103f-4aaa-9e29-bd45754692a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e6cb2df7-103f-4aaa-9e29-bd45754692a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b7f5b9f4-6afc-406c-9c13-56d88b936deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e6cb2df7-103f-4aaa-9e29-bd45754692a4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b7f5b9f4-6afc-406c-9c13-56d88b936deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_9a858c3a-8f69-4a27-96df-aae07ee15ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b7f5b9f4-6afc-406c-9c13-56d88b936deb" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_9a858c3a-8f69-4a27-96df-aae07ee15ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_0237988a-bda7-4ea2-8665-a31739eb667a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_srt_MajorCustomersAxis_0237988a-bda7-4ea2-8665-a31739eb667a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_0237988a-bda7-4ea2-8665-a31739eb667a" xlink:to="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember_e4f9a523-a10f-4900-be70-3dee0176b4d8" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:to="loc_pcrx_MajorCustomerOneMember_e4f9a523-a10f-4900-be70-3dee0176b4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember_665cacd2-32ec-4a33-ad87-1b65fd7453dc" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:to="loc_pcrx_MajorCustomerTwoMember_665cacd2-32ec-4a33-ad87-1b65fd7453dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember_7abdd8fa-fc05-4664-b211-92ad82729ed7" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:to="loc_pcrx_MajorCustomerThreeMember_7abdd8fa-fc05-4664-b211-92ad82729ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerFourMember_a2a2171e-642a-4af4-9051-afd8fa4897f0" xlink:href="pcrx-20220630.xsd#pcrx_MajorCustomerFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0425a69f-99e2-4164-b48a-37bc8e38fb1e" xlink:to="loc_pcrx_MajorCustomerFourMember_a2a2171e-642a-4af4-9051-afd8fa4897f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_srt_RangeAxis_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_65adc98e-18c9-417f-92b9-c72dd7d9a6f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_26aa01fa-67d7-4e19-8ccc-1dfb50c5f66e" xlink:to="loc_srt_RangeMember_65adc98e-18c9-417f-92b9-c72dd7d9a6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_cbd12058-e20d-4f47-9363-42ab2bbb6008" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_65adc98e-18c9-417f-92b9-c72dd7d9a6f8" xlink:to="loc_srt_WeightedAverageMember_cbd12058-e20d-4f47-9363-42ab2bbb6008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_31eb40be-4981-4008-8478-6cefa457997d" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_164b490f-c7b9-47ec-a270-83617d1368e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_164b490f-c7b9-47ec-a270-83617d1368e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_cbea6c95-994d-4362-8076-f0c999e01280" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_cbea6c95-994d-4362-8076-f0c999e01280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_27619b64-b133-4a58-9e46-07400f56bc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_27619b64-b133-4a58-9e46-07400f56bc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_de6be309-6923-4c8c-b3ae-d5b1b79552b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_de6be309-6923-4c8c-b3ae-d5b1b79552b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_e201086c-092c-48ea-9517-af941fec542d" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsideration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_pcrx_ContingentConsideration_e201086c-092c-48ea-9517-af941fec542d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent_144d9715-0854-409e-9090-e1ea3690a7df" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_pcrx_ContingentConsiderationCurrent_144d9715-0854-409e-9090-e1ea3690a7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_37e10765-b245-4467-a80a-f05388098b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_InterestReceivable_37e10765-b245-4467-a80a-f05388098b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfMajorCustomers_9679e3af-d0cc-4fb5-a03c-9e28d7ddb184" xlink:href="pcrx-20220630.xsd#pcrx_NumberOfMajorCustomers"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_pcrx_NumberOfMajorCustomers_9679e3af-d0cc-4fb5-a03c-9e28d7ddb184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ae965a38-c846-4e66-9c28-640734e79f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ae965a38-c846-4e66-9c28-640734e79f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6075ee45-b2da-4948-8924-1724fded04fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48d06ee7-373f-45bf-87c3-21dc1bb40f3c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6075ee45-b2da-4948-8924-1724fded04fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6f79af2c-4a74-46f6-8f2a-d0b4b2d6275e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6f79af2c-4a74-46f6-8f2a-d0b4b2d6275e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9fd686bd-f611-490d-b636-bf8fece95d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9fd686bd-f611-490d-b636-bf8fece95d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2cc4d07-c527-4079-83cc-8d1b331b5729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9fd686bd-f611-490d-b636-bf8fece95d99" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2cc4d07-c527-4079-83cc-8d1b331b5729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5775ba91-3ce2-4be1-901a-09c34bf83082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2cc4d07-c527-4079-83cc-8d1b331b5729" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5775ba91-3ce2-4be1-901a-09c34bf83082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_srt_RangeAxis_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4fe9931e-d4f2-4e18-9678-2a15e9595f6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7f2f391d-b5b3-4cc8-8ce0-5b40b3b8a176" xlink:to="loc_srt_RangeMember_4fe9931e-d4f2-4e18-9678-2a15e9595f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_84024345-6952-4a4f-af8e-dec0282baa5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4fe9931e-d4f2-4e18-9678-2a15e9595f6d" xlink:to="loc_srt_MinimumMember_84024345-6952-4a4f-af8e-dec0282baa5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2f22990e-85c7-412b-8212-3837aa09f3b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4fe9931e-d4f2-4e18-9678-2a15e9595f6d" xlink:to="loc_srt_MaximumMember_2f22990e-85c7-412b-8212-3837aa09f3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2755e119-0f7c-461b-b1ff-b432aa9bd869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5e4eb1e5-44ef-4901-9f24-2f65d6f2a2c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2755e119-0f7c-461b-b1ff-b432aa9bd869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_be885bef-a607-4c09-9332-02d0d896cc19" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2755e119-0f7c-461b-b1ff-b432aa9bd869" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_be885bef-a607-4c09-9332-02d0d896cc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_e123f770-9371-45f5-a0d0-4aaff598b047" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2755e119-0f7c-461b-b1ff-b432aa9bd869" xlink:to="loc_pcrx_FlexionAcquisitionMember_e123f770-9371-45f5-a0d0-4aaff598b047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_FinancialInstrumentAxis_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9214b7b6-ce4a-4d0f-bdb6-44e1e949971c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dc9b46fb-1a1e-420b-ae14-0a6c4bd47b1b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9214b7b6-ce4a-4d0f-bdb6-44e1e949971c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_da3411b2-f8b7-4f54-ba8f-59f8cda2d356" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9214b7b6-ce4a-4d0f-bdb6-44e1e949971c" xlink:to="loc_pcrx_ContingentConsiderationMember_da3411b2-f8b7-4f54-ba8f-59f8cda2d356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_87f8d2a9-98d6-4199-866c-fa2867832dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_87f8d2a9-98d6-4199-866c-fa2867832dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_2676198a-fdf8-4781-9bc7-568c2338da4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_87f8d2a9-98d6-4199-866c-fa2867832dc6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_2676198a-fdf8-4781-9bc7-568c2338da4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_21c2d7a2-a1d8-4126-aea0-dd6c41eac595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2676198a-fdf8-4781-9bc7-568c2338da4d" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_21c2d7a2-a1d8-4126-aea0-dd6c41eac595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_8c0a8b15-9b03-40f4-82fb-626deed7ec13" xlink:href="pcrx-20220630.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2676198a-fdf8-4781-9bc7-568c2338da4d" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_8c0a8b15-9b03-40f4-82fb-626deed7ec13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_863912f6-a86f-403b-9efb-3957feb3c33b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_616f91cd-9ee0-4bbf-a0a7-5af86c38bb78" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_863912f6-a86f-403b-9efb-3957feb3c33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9e66c3b0-b0c9-4908-aa19-2dfc26f3ce85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_863912f6-a86f-403b-9efb-3957feb3c33b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9e66c3b0-b0c9-4908-aa19-2dfc26f3ce85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_aed84544-92be-48c7-9fbd-8479a9c1f5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aed84544-92be-48c7-9fbd-8479a9c1f5f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_92c8bd7e-b159-408d-acd8-4ddbf7946cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_92c8bd7e-b159-408d-acd8-4ddbf7946cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c88686f-e768-4352-bf32-9ecb114cfde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92c8bd7e-b159-408d-acd8-4ddbf7946cfa" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c88686f-e768-4352-bf32-9ecb114cfde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_70b56976-42bd-4bab-8ec0-c787d80f6091" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c88686f-e768-4352-bf32-9ecb114cfde6" xlink:to="loc_pcrx_ContingentConsiderationMember_70b56976-42bd-4bab-8ec0-c787d80f6091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72ce94b3-de89-4770-8f4b-3d1a04c38eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eeeb83ed-2bf3-41aa-9ee8-91fc5838b2e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72ce94b3-de89-4770-8f4b-3d1a04c38eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_bbfaf879-4125-479f-bcf7-cefb0d502213" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72ce94b3-de89-4770-8f4b-3d1a04c38eef" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_bbfaf879-4125-479f-bcf7-cefb0d502213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_1272f16d-9c64-4855-bff5-85787991f4d4" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72ce94b3-de89-4770-8f4b-3d1a04c38eef" xlink:to="loc_pcrx_FlexionAcquisitionMember_1272f16d-9c64-4855-bff5-85787991f4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_af349cb2-9c89-43ab-97db-c3129fc64f00" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1018bb86-dd94-4e8c-becb-a1b3f2a73637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1018bb86-dd94-4e8c-becb-a1b3f2a73637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ba1a4dee-ca38-496c-9c6f-530476b6fdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ba1a4dee-ca38-496c-9c6f-530476b6fdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_75921562-ea33-449d-b62a-b3380be5617e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_550a6efc-f39e-430a-b087-6e519ca1a8ec" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_75921562-ea33-449d-b62a-b3380be5617e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_2703e4f4-8d2f-4eee-89e8-5dab1f9bd174" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:to="loc_pcrx_ContingentConsideration_2703e4f4-8d2f-4eee-89e8-5dab1f9bd174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_84838b23-04ac-474b-8f46-c096332c970f" xlink:href="pcrx-20220630.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f1df2d77-ffa8-4bad-9967-5febf512deca" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_84838b23-04ac-474b-8f46-c096332c970f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cbf375dd-1d1c-440a-8b3d-063320f92f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cbf375dd-1d1c-440a-8b3d-063320f92f05" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cf169d65-5cbb-4704-ae53-a9aaf449d8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cf169d65-5cbb-4704-ae53-a9aaf449d8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cf169d65-5cbb-4704-ae53-a9aaf449d8e0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_18211cee-7425-41aa-8146-44c06aed7fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_18211cee-7425-41aa-8146-44c06aed7fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_66f59739-7a02-4aa5-b1a0-052a5c3e9847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:to="loc_us-gaap_CommercialPaperMember_66f59739-7a02-4aa5-b1a0-052a5c3e9847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_cddcc4d6-1903-44da-85b7-4d6f4b9b9800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_cddcc4d6-1903-44da-85b7-4d6f4b9b9800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember_9f4e8c73-29fd-40ea-bb49-a0a64e8d7943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aa9f3a8f-b322-424d-9c57-350d0f626de2" xlink:to="loc_us-gaap_USTreasuryBondSecuritiesMember_9f4e8c73-29fd-40ea-bb49-a0a64e8d7943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ad69d497-e88c-41ba-99d5-e54e869276b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:to="loc_us-gaap_InvestmentTypeAxis_ad69d497-e88c-41ba-99d5-e54e869276b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c8da82d7-a562-432d-b75c-07ba47973155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ad69d497-e88c-41ba-99d5-e54e869276b4" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c8da82d7-a562-432d-b75c-07ba47973155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_197cc740-e53c-443c-89c7-5b27a3565a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c8da82d7-a562-432d-b75c-07ba47973155" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_197cc740-e53c-443c-89c7-5b27a3565a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_e0d4b5ec-30e7-4d6a-893e-f2fec1d51db6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0981ccd0-6cc4-4854-a414-cb52eb1947f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0981ccd0-6cc4-4854-a414-cb52eb1947f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_94ccaaf8-8f0e-4448-bab2-a2135181e6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_94ccaaf8-8f0e-4448-bab2-a2135181e6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2a5d388a-a650-4a05-bea2-51863d7acede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2a5d388a-a650-4a05-bea2-51863d7acede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_64db4c76-8a18-4724-ab4c-60326c66015d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed6a113e-7177-4aa4-894f-22f6981fcb2b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_64db4c76-8a18-4724-ab4c-60326c66015d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_09dadeea-be27-4926-afba-778b3bd8c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0bfb9e96-9bec-4550-8881-b016894ffbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_09dadeea-be27-4926-afba-778b3bd8c14a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0bfb9e96-9bec-4550-8881-b016894ffbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_739b6e46-7bfb-4d36-943b-c9232353c549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1d946cbe-32e0-42eb-a591-a86bd057b009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_739b6e46-7bfb-4d36-943b-c9232353c549" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1d946cbe-32e0-42eb-a591-a86bd057b009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKHOLDERSEQUITYDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5fc93f15-5208-45f4-b0ed-5c25ad23b64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f6ac83cf-84fd-4405-805d-96a46f21ef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5fc93f15-5208-45f4-b0ed-5c25ad23b64e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f6ac83cf-84fd-4405-805d-96a46f21ef1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_23f4d144-39f9-4bca-8e88-fbf21e031367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f6ac83cf-84fd-4405-805d-96a46f21ef1e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_23f4d144-39f9-4bca-8e88-fbf21e031367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_23f4d144-39f9-4bca-8e88-fbf21e031367" xlink:to="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9d3117a2-a722-4f2a-bca8-302f2f407364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9d3117a2-a722-4f2a-bca8-302f2f407364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e38b69c5-bcf3-471d-9f05-e999aed8eec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e38b69c5-bcf3-471d-9f05-e999aed8eec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b290d2ae-0d70-434e-8ae1-68b19f9332ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0c575222-4c70-48ea-b1bc-10c9f6b35ad5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b290d2ae-0d70-434e-8ae1-68b19f9332ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f96e3971-81dd-4c0f-a563-5842de3b2080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f6ac83cf-84fd-4405-805d-96a46f21ef1e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f96e3971-81dd-4c0f-a563-5842de3b2080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f96e3971-81dd-4c0f-a563-5842de3b2080" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_10ead7af-af63-437d-bc14-a031eb4b5914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:to="loc_us-gaap_StockholdersEquity_10ead7af-af63-437d-bc14-a031eb4b5914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_19d64a5c-75c7-43e6-926e-224567abd16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_19d64a5c-75c7-43e6-926e-224567abd16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a7fae308-9c23-4e06-97c3-e82cdc946484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a7fae308-9c23-4e06-97c3-e82cdc946484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_19df1b9a-06af-40ae-a89d-aee7414ad513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7ca196ad-304f-43f0-ab94-8b70bc1c41a0" xlink:to="loc_us-gaap_StockholdersEquity_19df1b9a-06af-40ae-a89d-aee7414ad513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANS" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_84279b96-3877-4761-bfcb-31916a97a161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_3f98decb-1198-49e5-9d8e-753a82aeb606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_84279b96-3877-4761-bfcb-31916a97a161" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_3f98decb-1198-49e5-9d8e-753a82aeb606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_744f549b-17e4-445a-8314-71862b2ce2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_8a4e33d5-ff06-4660-aee8-c99a8651caad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_744f549b-17e4-445a-8314-71862b2ce2c3" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_8a4e33d5-ff06-4660-aee8-c99a8651caad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_abc69684-b84e-48c4-8d61-51e27acc1ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_744f549b-17e4-445a-8314-71862b2ce2c3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_abc69684-b84e-48c4-8d61-51e27acc1ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_505a3d7d-6f41-469a-9b07-31b8a89a3984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_744f549b-17e4-445a-8314-71862b2ce2c3" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_505a3d7d-6f41-469a-9b07-31b8a89a3984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_60b3b330-3e86-40e0-9636-2f0488d05168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d05b61d-9408-4c8c-ae72-333fd7a2d420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_60b3b330-3e86-40e0-9636-2f0488d05168" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d05b61d-9408-4c8c-ae72-333fd7a2d420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6c52b427-0d9f-4c61-8fc7-7c04946af0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d05b61d-9408-4c8c-ae72-333fd7a2d420" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6c52b427-0d9f-4c61-8fc7-7c04946af0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c52b427-0d9f-4c61-8fc7-7c04946af0f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_8a15d321-b03d-433a-8cdb-2f03508a793a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:to="loc_us-gaap_CostOfSalesMember_8a15d321-b03d-433a-8cdb-2f03508a793a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ad69a6ed-0892-4a61-88e0-284eea3a3b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ad69a6ed-0892-4a61-88e0-284eea3a3b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9bef50f5-1c15-41b9-9d4f-84a82c63987d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ebb0d89-ef7e-4642-9902-d5303e613b1f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9bef50f5-1c15-41b9-9d4f-84a82c63987d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_300b62c8-16fb-4491-a824-0de35ea5a613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d05b61d-9408-4c8c-ae72-333fd7a2d420" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_300b62c8-16fb-4491-a824-0de35ea5a613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_01cf10cf-9925-44f4-89cd-e8a1df229151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_300b62c8-16fb-4491-a824-0de35ea5a613" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_01cf10cf-9925-44f4-89cd-e8a1df229151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_300b62c8-16fb-4491-a824-0de35ea5a613" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_70b0b358-3100-4f38-a436-e7a7a4e984b8" xlink:href="pcrx-20220630.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_70b0b358-3100-4f38-a436-e7a7a4e984b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_08e902b7-68b1-4baf-99d9-82650681058f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:to="loc_us-gaap_RestrictedStockExpense_08e902b7-68b1-4baf-99d9-82650681058f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_e372817f-4cbc-4780-a219-f981bd95663e" xlink:href="pcrx-20220630.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_e372817f-4cbc-4780-a219-f981bd95663e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_292d667a-1b9d-4095-a575-6cd88e6b0d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6767e230-3aa9-4f3c-840a-3f5dd37758b5" xlink:to="loc_us-gaap_ShareBasedCompensation_292d667a-1b9d-4095-a575-6cd88e6b0d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSScheduleofStockBasedCompensationActivityDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_ec14a20a-145a-4c20-b023-3254324547fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68941cf7-87aa-4e65-bec1-958ec4e8f135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_ec14a20a-145a-4c20-b023-3254324547fc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68941cf7-87aa-4e65-bec1-958ec4e8f135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b39aee96-2d9b-4ab3-a9d9-4d822ee48911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68941cf7-87aa-4e65-bec1-958ec4e8f135" xlink:to="loc_us-gaap_AwardTypeAxis_b39aee96-2d9b-4ab3-a9d9-4d822ee48911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07abf7af-5616-4b50-9781-0ae10738a3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b39aee96-2d9b-4ab3-a9d9-4d822ee48911" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07abf7af-5616-4b50-9781-0ae10738a3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0bfe6013-7ce2-4225-8d4b-0ca7802411eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07abf7af-5616-4b50-9781-0ae10738a3b2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0bfe6013-7ce2-4225-8d4b-0ca7802411eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c962d6f-9972-4f98-b591-2355de6bd835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68941cf7-87aa-4e65-bec1-958ec4e8f135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c962d6f-9972-4f98-b591-2355de6bd835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c962d6f-9972-4f98-b591-2355de6bd835" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5c80529-a495-4f52-9758-42ac100ebb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5c80529-a495-4f52-9758-42ac100ebb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_65d3c976-07b1-44dd-8316-d8d426dd3a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_65d3c976-07b1-44dd-8316-d8d426dd3a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea3709ca-501d-427f-bc2d-3d838ad02563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea3709ca-501d-427f-bc2d-3d838ad02563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ff29c6c2-20f8-4475-a38b-a42d71ad20d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ff29c6c2-20f8-4475-a38b-a42d71ad20d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_97b66389-3285-4efa-9cc8-6d1be0dfda16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_97b66389-3285-4efa-9cc8-6d1be0dfda16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98dee2ff-5a30-4b74-9f60-ed3601a9f993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d9bb0ede-e05f-4d09-aafb-632dba197fd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98dee2ff-5a30-4b74-9f60-ed3601a9f993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c962d6f-9972-4f98-b591-2355de6bd835" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1878556-7efb-432f-838b-a081f48155b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1878556-7efb-432f-838b-a081f48155b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_53903f84-f27a-4ff3-a928-26e3a1e4f4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_53903f84-f27a-4ff3-a928-26e3a1e4f4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_88dd9b73-7a60-43d0-9f2c-86a8d33e7af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_88dd9b73-7a60-43d0-9f2c-86a8d33e7af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5e231ed2-675c-4b2f-9d8e-b5bda7152f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5e231ed2-675c-4b2f-9d8e-b5bda7152f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_11f8bc28-0694-42be-97b9-930b679ffe96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_11f8bc28-0694-42be-97b9-930b679ffe96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2463eadc-3f68-40d1-8351-aeeda1a1f6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2463eadc-3f68-40d1-8351-aeeda1a1f6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_862aa616-3b07-4b18-b066-839629e006b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_862aa616-3b07-4b18-b066-839629e006b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ab5a166c-4fdd-46ba-8978-0260b9a7bf16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ab5a166c-4fdd-46ba-8978-0260b9a7bf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_04c9d912-d24f-486c-bb3a-d09f6ad10b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_04c9d912-d24f-486c-bb3a-d09f6ad10b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_711897d0-0dcb-49e5-ae36-76aee52524f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_711897d0-0dcb-49e5-ae36-76aee52524f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5300f8d2-4224-49c9-afb8-27794c2c8602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec0e9805-0ef8-4ad3-8cb1-0e810031b248" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5300f8d2-4224-49c9-afb8-27794c2c8602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e71d2740-294a-470c-a6ae-da84ab5b0347" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5dfc0b47-17c4-43f0-a678-69e3dfbd68b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5dfc0b47-17c4-43f0-a678-69e3dfbd68b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dd636900-4dba-4ca2-b175-449d4a6cb328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dd636900-4dba-4ca2-b175-449d4a6cb328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9340774c-8da0-4ea4-b528-097435da5a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9340774c-8da0-4ea4-b528-097435da5a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_488898d4-a115-4c93-a9e7-d4ca7cd8680b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_488898d4-a115-4c93-a9e7-d4ca7cd8680b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eea90e18-2688-4ca4-a39f-1cf1049e8768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_de0b72c9-cc79-4f87-82af-326d1ffbd2b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eea90e18-2688-4ca4-a39f-1cf1049e8768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3b6eda4d-254c-4c3e-ac9c-2e058865435e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ca14761-e5f7-447f-9f7a-fb98985af580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3b6eda4d-254c-4c3e-ac9c-2e058865435e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ca14761-e5f7-447f-9f7a-fb98985af580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_046426fa-8ea5-4f39-8850-411e0a8247ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ca14761-e5f7-447f-9f7a-fb98985af580" xlink:to="loc_us-gaap_AwardTypeAxis_046426fa-8ea5-4f39-8850-411e0a8247ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7062b139-797d-4a85-84e1-ac4b0bddd726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_046426fa-8ea5-4f39-8850-411e0a8247ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7062b139-797d-4a85-84e1-ac4b0bddd726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_91d6c1e1-f1d0-4249-a410-52c6fed68e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7062b139-797d-4a85-84e1-ac4b0bddd726" xlink:to="loc_us-gaap_EmployeeStockMember_91d6c1e1-f1d0-4249-a410-52c6fed68e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ca14761-e5f7-447f-9f7a-fb98985af580" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b23e0e42-3913-4ed5-b73a-1bc857d502fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b23e0e42-3913-4ed5-b73a-1bc857d502fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_1e60f90c-6de1-4037-b293-a8d59ca360c6" xlink:href="pcrx-20220630.xsd#pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_1e60f90c-6de1-4037-b293-a8d59ca360c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_d3245c60-d539-414e-aa05-99af0ef45804" xlink:href="pcrx-20220630.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_d3245c60-d539-414e-aa05-99af0ef45804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_1c51b112-c277-4d59-acf2-1ffbd2cb9e07" xlink:href="pcrx-20220630.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_1c51b112-c277-4d59-acf2-1ffbd2cb9e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_18150f64-59df-41bf-b80e-e29fc242d209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_18150f64-59df-41bf-b80e-e29fc242d209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_40ea3595-b5e8-45ad-92a2-fc3ea8d6cbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b75513d4-342b-4dff-8e07-d6c31feda50b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_40ea3595-b5e8-45ad-92a2-fc3ea8d6cbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#STOCKPLANSScheduleofValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_184a6faf-6925-4233-9acf-47a235b3b9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839a078c-1157-4802-b66d-31890c1af462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_184a6faf-6925-4233-9acf-47a235b3b9ad" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839a078c-1157-4802-b66d-31890c1af462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dd132b0b-bf20-47e1-8fbf-381807e48cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839a078c-1157-4802-b66d-31890c1af462" xlink:to="loc_us-gaap_AwardTypeAxis_dd132b0b-bf20-47e1-8fbf-381807e48cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_992b04b7-0887-4639-81ad-f24d3b0a462e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_dd132b0b-bf20-47e1-8fbf-381807e48cf7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_992b04b7-0887-4639-81ad-f24d3b0a462e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e657a955-6449-4680-a818-c59974de4caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_992b04b7-0887-4639-81ad-f24d3b0a462e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e657a955-6449-4680-a818-c59974de4caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839a078c-1157-4802-b66d-31890c1af462" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9a4b0e68-5751-4678-b1a0-5081521f1e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9a4b0e68-5751-4678-b1a0-5081521f1e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_19cfefda-8445-49b1-b914-2b0431700117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_19cfefda-8445-49b1-b914-2b0431700117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_894b2919-11cb-487f-9562-93fa71fe754c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_894b2919-11cb-487f-9562-93fa71fe754c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4e816821-1850-4714-91d8-a6b3c9e355f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f00a6b54-0f25-40fe-94b3-c0a92968d8bb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4e816821-1850-4714-91d8-a6b3c9e355f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARE" xlink:type="simple" xlink:href="pcrx-20220630.xsd#NETINCOMELOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dca7b2a1-4ead-46b2-a344-d9ab38a62c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d65d9cfa-02c1-47ce-8042-1ccab5eae416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dca7b2a1-4ead-46b2-a344-d9ab38a62c06" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d65d9cfa-02c1-47ce-8042-1ccab5eae416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#NETINCOMELOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_70602d13-8779-40f9-b71d-89383b32f4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c9ea94bd-6756-46d7-9425-deff88eeb619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70602d13-8779-40f9-b71d-89383b32f4b2" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c9ea94bd-6756-46d7-9425-deff88eeb619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2ed2c4b8-df05-4f3d-9ae2-cace2d1519df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70602d13-8779-40f9-b71d-89383b32f4b2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2ed2c4b8-df05-4f3d-9ae2-cace2d1519df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6a726f34-0ce1-4666-8ce3-c395decd22a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6a726f34-0ce1-4666-8ce3-c395decd22a5" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5a172d09-f037-4655-99bc-eeb2a625d086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:to="loc_us-gaap_AwardTypeAxis_5a172d09-f037-4655-99bc-eeb2a625d086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5a172d09-f037-4655-99bc-eeb2a625d086" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_82d98f46-2f0d-4322-b514-8ff592b0cfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:to="loc_us-gaap_EmployeeStockOptionMember_82d98f46-2f0d-4322-b514-8ff592b0cfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b55c5d71-066f-43f9-a30a-2371108e11f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b55c5d71-066f-43f9-a30a-2371108e11f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_fb901334-0373-4802-8e67-33d4d28e4ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21dcde9f-3505-42a8-a606-6c512dca9328" xlink:to="loc_us-gaap_EmployeeStockMember_fb901334-0373-4802-8e67-33d4d28e4ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5be4b12c-228d-4438-a79b-b98dd7b9c3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5be4b12c-228d-4438-a79b-b98dd7b9c3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0ac464ab-2db9-4680-9499-6bcfffc264d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5be4b12c-228d-4438-a79b-b98dd7b9c3fa" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0ac464ab-2db9-4680-9499-6bcfffc264d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_a7f8423c-ffeb-4502-9707-1b5e6eb2136f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_0ac464ab-2db9-4680-9499-6bcfffc264d4" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_a7f8423c-ffeb-4502-9707-1b5e6eb2136f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c890d508-53d7-438c-97f4-0cb3c5f5d5e8" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ee4403e9-6e92-4a42-9400-89b2cbbad31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:to="loc_us-gaap_NetIncomeLoss_ee4403e9-6e92-4a42-9400-89b2cbbad31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_ba2397d9-c04e-4c0c-8aef-d1e00d938cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_ba2397d9-c04e-4c0c-8aef-d1e00d938cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_40806075-7845-4bcf-8259-ba43e31fd3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_75cbc695-fd37-4f53-90cc-cd03203b43b0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_40806075-7845-4bcf-8259-ba43e31fd3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_adf4c288-a925-471c-b705-b6f05a926acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_adf4c288-a925-471c-b705-b6f05a926acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8fea8211-242b-4d0b-8e02-053584cc3439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_adf4c288-a925-471c-b705-b6f05a926acc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8fea8211-242b-4d0b-8e02-053584cc3439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_9b7a02bd-ce76-49bd-9e5a-e91e96d311f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_9b7a02bd-ce76-49bd-9e5a-e91e96d311f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_69963f46-b4b8-440e-90e7-0619adaebeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_69963f46-b4b8-440e-90e7-0619adaebeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_41f35bfd-db9b-4194-a981-2ebd8d34b4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_76d7d3e6-8895-45a6-9779-149ddc870d5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_41f35bfd-db9b-4194-a981-2ebd8d34b4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_bc679bc7-15a4-4757-b62e-5dcfbac62e97" xlink:href="pcrx-20220630.xsd#pcrx_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e0f5890a-6d59-4688-8f6e-0d93d9036381" xlink:to="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_bc679bc7-15a4-4757-b62e-5dcfbac62e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e3ad6bfe-1963-4f8b-a95f-0723c5566323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_bc679bc7-15a4-4757-b62e-5dcfbac62e97" xlink:to="loc_us-gaap_EarningsPerShareBasic_e3ad6bfe-1963-4f8b-a95f-0723c5566323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6377e6b6-74ee-4248-95e5-521982c9fbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_bc679bc7-15a4-4757-b62e-5dcfbac62e97" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6377e6b6-74ee-4248-95e5-521982c9fbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4d5aabcf-5622-457c-8cee-3f3e773586b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_53ef8218-24f2-403c-a5f8-1a4700e8a5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4d5aabcf-5622-457c-8cee-3f3e773586b4" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_53ef8218-24f2-403c-a5f8-1a4700e8a5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4fc8a177-2588-46f7-b9f1-4585b16e1db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_53ef8218-24f2-403c-a5f8-1a4700e8a5ae" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4fc8a177-2588-46f7-b9f1-4585b16e1db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4fc8a177-2588-46f7-b9f1-4585b16e1db3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_25e1eff7-85d2-42d2-9a82-c17ac486afd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:to="loc_us-gaap_EmployeeStockOptionMember_25e1eff7-85d2-42d2-9a82-c17ac486afd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7ed17c45-0ed7-4257-9d55-6344ef9c7391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:to="loc_us-gaap_SeniorNotesMember_7ed17c45-0ed7-4257-9d55-6344ef9c7391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_458c9d4e-9cf9-4ca2-9411-043970ea5f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4b2fbd60-ecc7-46f0-b69a-121923872e26" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_458c9d4e-9cf9-4ca2-9411-043970ea5f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_83ed3edf-f6de-44d4-8664-1adeefb5cb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_53ef8218-24f2-403c-a5f8-1a4700e8a5ae" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_83ed3edf-f6de-44d4-8664-1adeefb5cb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_20a30bde-60db-4143-89f0-8a9243199633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_83ed3edf-f6de-44d4-8664-1adeefb5cb7e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_20a30bde-60db-4143-89f0-8a9243199633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXES" xlink:type="simple" xlink:href="pcrx-20220630.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4138bcba-e451-4c07-a398-11dc7b5c350f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_a978b054-46e9-401a-95fb-4bca71e2ee25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4138bcba-e451-4c07-a398-11dc7b5c350f" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_a978b054-46e9-401a-95fb-4bca71e2ee25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3906438e-740d-4901-97d0-509f9ed0893f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_750ae631-0302-4d9c-98ff-8ef2d021db0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3906438e-740d-4901-97d0-509f9ed0893f" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_750ae631-0302-4d9c-98ff-8ef2d021db0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_730f674d-26a4-474f-8b32-d401535b9192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e1f8db9d-7960-4c23-84d0-d41f770dd506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_730f674d-26a4-474f-8b32-d401535b9192" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e1f8db9d-7960-4c23-84d0-d41f770dd506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3084ca16-6d9e-46ea-8b1f-e3e1b4405453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e1f8db9d-7960-4c23-84d0-d41f770dd506" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3084ca16-6d9e-46ea-8b1f-e3e1b4405453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7912c08d-447d-4e58-b886-a3dd375f3eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e1f8db9d-7960-4c23-84d0-d41f770dd506" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7912c08d-447d-4e58-b886-a3dd375f3eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82f0ebeb-793f-42b9-bf32-dae4d5ec222b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e1f8db9d-7960-4c23-84d0-d41f770dd506" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82f0ebeb-793f-42b9-bf32-dae4d5ec222b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_eadbc826-9f8e-4932-8c1f-3fda89adeac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e1f8db9d-7960-4c23-84d0-d41f770dd506" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_eadbc826-9f8e-4932-8c1f-3fda89adeac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3917c9f0-a06d-4ddb-a543-9074506574c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e1f8db9d-7960-4c23-84d0-d41f770dd506" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3917c9f0-a06d-4ddb-a543-9074506574c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER" xlink:type="simple" xlink:href="pcrx-20220630.xsd#ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ad9a9bc4-35b7-4b74-b53f-0df15a50f70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_3aedd430-0956-4db8-af30-5e0d65e1b684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ad9a9bc4-35b7-4b74-b53f-0df15a50f70b" xlink:to="loc_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_3aedd430-0956-4db8-af30-5e0d65e1b684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables" xlink:type="simple" xlink:href="pcrx-20220630.xsd#ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d6c655d6-d0b2-42d8-b6fa-99f44444b487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_de42f3e0-50df-4232-b771-58592aa152d9" xlink:href="pcrx-20220630.xsd#pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d6c655d6-d0b2-42d8-b6fa-99f44444b487" xlink:to="loc_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_de42f3e0-50df-4232-b771-58592aa152d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6ec1713-9282-4693-af13-4ce017ec2b94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6ec1713-9282-4693-af13-4ce017ec2b94" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_b5b509fe-0b36-47fe-8106-54e8eedd5917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_b5b509fe-0b36-47fe-8106-54e8eedd5917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_144c47c5-986e-4be5-bd1d-ddfb052a2afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_b5b509fe-0b36-47fe-8106-54e8eedd5917" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_144c47c5-986e-4be5-bd1d-ddfb052a2afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedFeesMember_d6340c76-bd86-419b-ab93-7f1868ca82ba" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_144c47c5-986e-4be5-bd1d-ddfb052a2afe" xlink:to="loc_pcrx_AcquisitionRelatedFeesMember_d6340c76-bd86-419b-ab93-7f1868ca82ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_85afd774-caea-4158-9578-b1fbd13eeb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_144c47c5-986e-4be5-bd1d-ddfb052a2afe" xlink:to="loc_us-gaap_OtherRestructuringMember_85afd774-caea-4158-9578-b1fbd13eeb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_024460fc-f66d-41f5-ab5c-b7c3f74377fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_024460fc-f66d-41f5-ab5c-b7c3f74377fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42bd0adb-2072-463f-b28e-6adc80302271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_024460fc-f66d-41f5-ab5c-b7c3f74377fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42bd0adb-2072-463f-b28e-6adc80302271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_05da7362-b279-4beb-8ff0-399838c35e35" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42bd0adb-2072-463f-b28e-6adc80302271" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_05da7362-b279-4beb-8ff0-399838c35e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_1d116fe0-6254-4944-b800-db0c2cd4cb57" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42bd0adb-2072-463f-b28e-6adc80302271" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_1d116fe0-6254-4944-b800-db0c2cd4cb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_368d32f2-7dbd-4cd1-acf6-dd00173b4564" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:to="loc_srt_CounterpartyNameAxis_368d32f2-7dbd-4cd1-acf6-dd00173b4564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc7bbc1a-adeb-4022-b510-d5f3eb7bbf34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_368d32f2-7dbd-4cd1-acf6-dd00173b4564" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc7bbc1a-adeb-4022-b510-d5f3eb7bbf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_ae635364-19b0-4c20-a2d2-0b1141372e1a" xlink:href="pcrx-20220630.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc7bbc1a-adeb-4022-b510-d5f3eb7bbf34" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_ae635364-19b0-4c20-a2d2-0b1141372e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e1513b6-e3f8-421c-a74c-8df3e91868a4" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d3ae347c-525a-4116-a5b9-0221e91769b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d3ae347c-525a-4116-a5b9-0221e91769b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_8abb1b8a-76ee-4459-a26c-29eef8c57c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_8abb1b8a-76ee-4459-a26c-29eef8c57c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_957f3968-8860-473c-bb12-d9c3b2279e35" xlink:href="pcrx-20220630.xsd#pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_957f3968-8860-473c-bb12-d9c3b2279e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cf9935aa-09f3-4b1c-967e-76d1ae8dad04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cf9935aa-09f3-4b1c-967e-76d1ae8dad04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_d99590b8-374a-4b62-bdc4-075a8700efcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_us-gaap_GainLossOnContractTermination_d99590b8-374a-4b62-bdc4-075a8700efcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_c8ebf499-9988-49f3-acc4-e66efc5d9a39" xlink:href="pcrx-20220630.xsd#pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_71fb9520-e3d8-4ed0-8339-735af7f4c361" xlink:to="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_c8ebf499-9988-49f3-acc4-e66efc5d9a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9838e3ac-c525-4198-9503-1af8109d949c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9838e3ac-c525-4198-9503-1af8109d949c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_25de6923-c0bb-4e77-9a71-4307ae7e7691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_25de6923-c0bb-4e77-9a71-4307ae7e7691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65cdffb9-4d32-4232-b979-8ac32c4ab83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_25de6923-c0bb-4e77-9a71-4307ae7e7691" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65cdffb9-4d32-4232-b979-8ac32c4ab83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_633dd900-80a8-4a00-abc4-5fe58477720b" xlink:href="pcrx-20220630.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65cdffb9-4d32-4232-b979-8ac32c4ab83f" xlink:to="loc_pcrx_FlexionAcquisitionMember_633dd900-80a8-4a00-abc4-5fe58477720b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_4c9d0612-0c35-4b7f-8b6f-682dee1974f1" xlink:href="pcrx-20220630.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65cdffb9-4d32-4232-b979-8ac32c4ab83f" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_4c9d0612-0c35-4b7f-8b6f-682dee1974f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a9e31827-2ecd-44b1-9640-2afe157a644b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a9e31827-2ecd-44b1-9640-2afe157a644b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e502ff85-7670-4b2e-b6ac-5261885ff965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a9e31827-2ecd-44b1-9640-2afe157a644b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e502ff85-7670-4b2e-b6ac-5261885ff965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LegalFeesMember_d9153ff5-e736-4ec0-88be-01d2b7bdbd7d" xlink:href="pcrx-20220630.xsd#pcrx_LegalFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e502ff85-7670-4b2e-b6ac-5261885ff965" xlink:to="loc_pcrx_LegalFeesMember_d9153ff5-e736-4ec0-88be-01d2b7bdbd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_79cc40d6-d789-4c0a-9e02-4d702f70f8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:to="loc_us-gaap_TypeOfArrangementAxis_79cc40d6-d789-4c0a-9e02-4d702f70f8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3a81ac62-cc3d-452f-b2af-3160f95fb30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_79cc40d6-d789-4c0a-9e02-4d702f70f8a9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3a81ac62-cc3d-452f-b2af-3160f95fb30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_0ae2341c-bc2e-4eb6-be73-55a3458d9df0" xlink:href="pcrx-20220630.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3a81ac62-cc3d-452f-b2af-3160f95fb30e" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_0ae2341c-bc2e-4eb6-be73-55a3458d9df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8727ab86-3158-4b85-b02c-6c98e859ccfd" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a58e1bef-6504-417d-a8ff-2ca9405f9e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a58e1bef-6504-417d-a8ff-2ca9405f9e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_26b1953a-506a-430d-a3df-ebe5e48e379f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_26b1953a-506a-430d-a3df-ebe5e48e379f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_95a11679-1f90-4301-9888-589f88da4fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b4463d91-03a8-40aa-b64e-e58e23f50076" xlink:to="loc_us-gaap_LitigationSettlementExpense_95a11679-1f90-4301-9888-589f88da4fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="pcrx-20220630.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_90cc5732-06af-40c2-a238-314d30769068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f5c42e12-8046-4f45-8f94-81f6583aa282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_90cc5732-06af-40c2-a238-314d30769068" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f5c42e12-8046-4f45-8f94-81f6583aa282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="pcrx-20220630.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_06547461-d90a-480c-a110-5afdb9df5879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_06547461-d90a-480c-a110-5afdb9df5879" xlink:to="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d19522db-f796-4ad5-8bdf-2a2b4c7171e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:to="loc_srt_CounterpartyNameAxis_d19522db-f796-4ad5-8bdf-2a2b4c7171e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05cc3d77-cf67-4efb-8aec-aa0ed5852452" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d19522db-f796-4ad5-8bdf-2a2b4c7171e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05cc3d77-cf67-4efb-8aec-aa0ed5852452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember_b946aaff-9fe3-41bd-83a9-b440e01060f8" xlink:href="pcrx-20220630.xsd#pcrx_FortisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05cc3d77-cf67-4efb-8aec-aa0ed5852452" xlink:to="loc_pcrx_FortisMember_b946aaff-9fe3-41bd-83a9-b440e01060f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_HongKongPharmaTainuoLtdMember_92af0be2-0f83-49f9-917f-bac266f70f55" xlink:href="pcrx-20220630.xsd#pcrx_HongKongPharmaTainuoLtdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05cc3d77-cf67-4efb-8aec-aa0ed5852452" xlink:to="loc_pcrx_HongKongPharmaTainuoLtdMember_92af0be2-0f83-49f9-917f-bac266f70f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_488a5532-5b77-4543-bf4f-4cb730f833a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:to="loc_dei_LegalEntityAxis_488a5532-5b77-4543-bf4f-4cb730f833a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a055ce83-5829-427a-88a2-6ed83ba59f7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_488a5532-5b77-4543-bf4f-4cb730f833a7" xlink:to="loc_dei_EntityDomain_a055ce83-5829-427a-88a2-6ed83ba59f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_44e0b680-19db-47b4-b6c1-39f695411f9c" xlink:href="pcrx-20220630.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a055ce83-5829-427a-88a2-6ed83ba59f7e" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_44e0b680-19db-47b4-b6c1-39f695411f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e49bf6fc-d47c-4a95-9bc3-2aa313b06a71" xlink:to="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_48619d28-2ff9-4159-94f3-1c4e409492da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_48619d28-2ff9-4159-94f3-1c4e409492da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_5fbeb66d-2bf8-410a-97b2-d700a21eaaea" xlink:href="pcrx-20220630.xsd#pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:to="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_5fbeb66d-2bf8-410a-97b2-d700a21eaaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_57e1b419-1c43-4c7f-9056-c0bb6bd6f46c" xlink:href="pcrx-20220630.xsd#pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_311e2d41-4b93-42ee-bd6b-0440379af6ef" xlink:to="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_57e1b419-1c43-4c7f-9056-c0bb6bd6f46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>pcrx-20220630_g1.jpg
<DESCRIPTION>PACIRA BIOSCIENCES LOGO
<TEXT>
begin 644 pcrx-20220630_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !     %$2  0    !
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" #% ?0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ^P^&.GV8_>-/.?]IMH_2M6U\-V-G_J[6'\5W?SHYBCD;,9-:UG;R''[M_\
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MN7^1\RLXHK;#P^[_ (!_,GXJ_P""DW[<_@<-<ZWXR^+NCHO+->Z,UO&OUWP
M55\$_P#!?[]K+P3>+(/BI-JT0ZP:EH]A<(_U)A#C\&%?T[$9%> _M7?\$O\
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MMX=OI'@666TEMI(Y4P)(V210=RDX)&5ST)KT:O&O^">/P.A_9N_8;^%?@N*
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MH'_]EK^6FOZL/^"P%I]M_P""8?QO3^[X5NI/^^0&_I7\I]?LGAO+_8:J_O\
MZ(^VX7?^SS7G^B/V\_X-'-/\OX;_ !NNL?Z[4M)BS_N171_]GK]A*_)3_@TJ
MM-G[.OQ;N/\ GIXCM(\_[MMG_P!FK]:Z^!XQE?.*[\U_Z2CY[.W?&U/E^2"O
MB/\ X.)=*;4_^"2/Q*91DVEQI,_T U.U!_\ 0J^W*^0_^"\MI]M_X)*_&-/[
MMC8R?]\ZC:-_2O.R.5LRP[_OP_\ 2D<V7NV*IO\ O+\S^7NOWB_X-,=/\O\
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M,-T/<H>#['FG:^Q.VY]]33);0M)(RQQQ@LS,<*H'4DU_+G^W[\==8_X*M?\
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M5C1%R=N:]HK\BXBS)8_,*F)A\+=EZ)67W[_,^,S/%+$8F56.W3T6@445YO\
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M%OO^44_QH_[ T?\ Z505YV3_ ._T/\<?_2D<N!_WBG_B7YG\M5?T*?\ !JW
M(_\ @G+XB?O)X\OB?PLK 5_/77]#'_!K!_RC=US_ +'J_P#_ $DL:_8./_\
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M@XK[4_X+^_\ !$B$V.L?'CX/:*L+P*UYXQ\/6,.U'4<OJ-O&HX(&3,BC!&9
M 1(6_%JN3(\/DN/H+$X:A"_5.*;3[?Y/J8Y?3P.(IJK2IQ\U9:,^VO!/_!)[
M]L3_ (*":Q8^*M:T/Q+JT&L0)=P>(O&&N!8Y()0'1T,TC2M&RL&'EHPQTK[L
M_9 _X-3_  SX5O;35OC7XVF\4RQ,'?0?#P>TL7_V9+IL3.I_V%B/ ^:O+?\
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M?B)X-TVW6W\/B_\ [4T,1_ZK[!=J+B%8S_$L8D\K/K$:V?\ @CK^V5_PP_\
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M?$\:Y7]3S*4XKW:GO+U>Z^_7T:/"SW">PQ3:VEJOU_$*_EY_X+L?!Z;X,_\
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MJRODW_@NA<?9O^"3_P 9F]=+MD_[ZOK8?UKS<G_Y&%#_ !Q_]*1RX'_>*?\
MB7YG\N-?T,?\&L!S_P $WM<_['N__P#2.QK^>>OZ#O\ @U4O/._X)W>*(O\
MGCX\O0?QL; U^P<?_P#(I?\ BC^I]IQ%_N?S1^F3#<,'D'@@]Z_GQ_X. /\
M@C\/V0?'$WQ<^'6F;/ACXHO,:E86T?[OPO?2'A0H^[:RL3L_AC<^7\H,0/\
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M30+ZS6\\.^'[C_A)=;1TW1FULV60(X[K).8(C[2U_4J!@5^3_P#P:I?LJ_\
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MV2_C?X@^'_C73SI_B'PY<F"=02T4ZD;HYHF(&Z*1"KJV!E6' .0/[!J^!/\
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M_/!I5NX;![CSIPB@]"L$RGK7ZB7]_!I5C-=74T5O;6T;2S2RN$2)%&69B>
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M^33?Z?J?KYKG[;_P7\,V+7.H?%SX96=N@R7F\3V2#]9*^;_VA_\ @X:_9C^
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MJ\%\UOZ;UC8E<^X&:[JG4ISA+EFFGV>A4HN+M)6"BBFRRK#&SNRJB@LS,<
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M[V>[  &Z::5&DE<X&7=BWO7MFG:?;Z1I\%I:PQ6]K:QK##%$H5(D4855 X
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>pcrx-20220630_g2.jpg
<DESCRIPTION>PRODUCT PIPELINE
<TEXT>
begin 644 pcrx-20220630_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%D86T@1V]L
M9&)E<F<   60 P "    %   $*:0!  "    %   $+J2D0 "     S S  "2
MD@ "     S S  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** *%S_P ?#?A_*HJEN?\ CX;\/Y5%5E!1110 4444
M %%%% !1110 4444 %%%% %?6/\ D"I_UU'\C7/UT&L?\@5/^NH_D:Y^MJ>Q
MI'8****T*"BBB@ HHHH **** "L'QLTJ^!]7,!8/]F;[O7'?],UO4UT62-DD
M4.C AE89!'H:3U0'-?#H0#P#IGV;;C8V_;_>W'.??-9$7_)=)_\ L&C_ -EJ
M^/AOI44DHLK_ %6RMIFW26EM=E(F]B,9_6M2U\*Z?9^(EUBW:99TM5M5C+@H
M$  ';.< =ZBSLD39GG<6N:JWPGUB\.I79NDU7RTG\]MZK^[^4-G(')X'K6E=
M/J^@:UX6NSKU]>-JTZ1W4,[_ +K#%/NH.!PWZ5TB^ -*7PS=Z&)KO[-=7/VE
MWWKO#?+P#MQCY1VJ_J'A:QU*32'GDG4Z3(LD&Q@-Q7;C=D<CY1TQ2Y6*S.5B
MU^_LO%_C&1IYIXK"T\V"W9R40A0>%Z#WQ5GP9I>IZCIVG^(+KQ)?RS3L9);<
MON@9<D; G8\=>WI70VWA>PMM<U+4P99)-201SQ2$&/;C& ,9Y]R:HZ7X!TW2
M;V*:UO-2,$,GFQ6;W),"-Z[<?S-.SN.S.%\0:[*ZZE>Z5K?B.ZFMYR%FMXME
ME%\WW&P?3C/?\:UM3NY;_P 4> ;RX(,MQ LKD# +,JD_J:VYOAGHTOVI%N]2
MAM;ER[VD5SB$.?X@N.H[9STK2?P?I[W.BSF6XW:+&([<!UPX  &_CGIVQ2Y6
M*S-^BBBM2PHHHH **** "BBB@ HHHH *9XV_X_+'_KV'\S3Z9XV_X_+'_KV'
M\S1'XT"^)',4445T&H4444 %%%% !1110 4444 0_%#_ ))IX?\ ^OI_Y-7D
M->O?%#_DFGA__KZ?^35Y#77A?X?S?YF]'X HHHKI-@HHHH **** "BBB@ KW
M7X(?\B/J7_7^?_0$KPJO=?@A_P B/J7_ %_G_P! 2N/&_P %G/B/X9Z#1117
MA'FA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 :E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "33P_\ ]?3_ ,FKR[1K)-2UZPL9F98[FYCA=DZ@,P!(]^:]1^*'_)-/#_\
MU]/_ ":O-O"O_(XZ-_U_P?\ HQ:Z</I1?S-J7\/[SM/B-\-M/\*Z1'J&AW5U
M<)'<""Z6=E8QEE#*<JHQVZ_WA5SPI\*=,U?P?%J6KW=Y!>W,,MQ!%$RA1&O
M)!4DYR#U'!%=5,(O$/C;QMX.O'"I>0P7,#%<['6&,%OS\LX]C5C2]2BN/'^N
MZ79?+9:/I"VD**?E4CEL#\E_X#7+[:I[/EOKO?RT_P S'VD^6U]=SP6PT75-
M55CI>FWEZ$.&-O TFWZ[0:;'I.HS:B=/AT^ZDO1G-LL+&08&3\N,].:]7\%Z
M9>1_#G3KTZIXA>&:[80V6A)&&C.\C+L1RN5R=QP 17172JO[0UD5 !;2220.
MIRX_I71+$M2:MM?\#5UK-KU/,OA]X/&I>,K*T\3:5<K97,,LD:S*\0EVKU#<
M$XR.A]*Y_4M"NUU#59-.TZZ?3[.ZEC::.)G2(*QP&;H.,=37H_@W7-2UCXW3
M)J5Y+/';O=K!&Q^6(?=PH[#"K^6>M3?$5)+_ .'Z2^%GVZ7;7DJZI;(/F\W?
MR[GN-W/_  )3T'"]K-54GUMZ=1<\E.SZGE=MH&L7MG]KL])OKBVY_?16SLG'
M7Y@,5N>%/ 5YXIT75M1B:>);&$O JVID^U. Q\M3D<\ <9/S#BO9]1N(K#5-
M$FTJV\2W-E';*+:'1UB:S=>PD!([8Y) QC'>N<\-7UU>ZA\1;;2%N[601N;6
MS\S#Q3E9 Q4*Q 8N!RI].:EXF<HMI6_X<7MI.+:/%+FUN+*Y>WO()+>>,X>*
M5"K*?<'D5[A\$/\ D1]2_P"O\_\ H"5XMJJZBFJ3C6OM'V[(\[[429,X'WL\
MYQCK7M/P0_Y$?4O^O\_^@)5XS6A]Q6(_AGH-%%%>&>:%%%% 'B_QD\0ZW%XJ
ML])\/ZA>6IALGNIA:S-'D ,QSM(SA4)_&MZU\:W%U\!KC7&N&^WPVK6SS!L,
M)<^6&R/XOF5OJ:S="@C\3?'GQ)<7"B2ULK9K7!Z X6,C\?WE>9W]U=>']*US
MP2X9V;4XS&/4+N!/_ L1&@#W;P%?/8?"_3]2\1ZF[%XVGFNKV<G 9B5^9CZ8
M%6]+^(_A+6=233].UF*2Y=MJ(T;IO/H"R@$^P->9_%E;T:AX8\&Z>BRQPVL;
M+ 7"),_^K4%B1V0]Q]ZDL? 6N:UXJTH:UI^A>&TLV$@M[$HLTRJ03PK,6/'4
MGC)/M0!ZY#XKT6?Q-+X>CO<ZK$NY[<Q.., \,1M/!!X-4W^('AA)M1B.J*3I
MB[KMEAD98OF"_>"X)R0, D_D:\C^*^J"/XC-?^%I9A?Z?9E+Z> 9$6<IG/KA
MPI/;CO77^'=/T/1O@3<W\4,=XEU9-<W!GC5_,F .%(.1\KC ^F>M #O!WQ?M
M]>\27EAJTEM:Q27"PZ6L4$I>?<Q W'D#C;UV]?R]-D=8HVDD.U5!9B>P%>6_
M!3P[I@\&PZI<V5I-?37,DD,\D2M)&JX3"L1D8()X]:[+Q]J/]E?#_6KH-M86
MK1J?1G^0?JPH \H\&Z?XI^(T^K:C'XRU32H([C]VD<LCJ=V3M $BA0!C\Z]$
ML)[7X9Z"%\8^*+O46NKD^7=7,<KD?*/D !<@<$]>YK@? 7P?T?Q+X-M-7U:Z
MU"*>Y+D);R(JA0Q4<%">V>M=1\7_ .R--^&<6CS,QGS%'I\8^9RR8&?IMR"?
M?WH ['5_%^A:%+9Q:G?K')?8^S1I&\K29QC 0$\Y'UJ*]\<>'-.U:[TV^U6*
MWN[.(2SI(K (IVX^;&"3N7@'//2O+O@]9C5O%]]<^)))9=7T>&.WMX+A?]2J
MY0\>JXQ]6SU-1^$-)TGQM\6/$FIZUY4]M:S,\5O*PQ(-Q56([A57GMR,^X!Z
MSX?\8:#XI\X:#J*7;0X,B;&1E![X8 X]ZKZWX_\ "_AV[-KJ^KQ0W ^]$B/(
MR_4(#C\:\I\+W4%CXZ\;>(O#D21Z9I]C/Y(A3$9;(V  <;249OH*PO"FC>)=
M2TB\U&ST#1]2BO782ZEJ;QN\1[X#/\ISSG;GF@#Z'L-;TS5-*_M.POH)K+!)
MG#X5<=<YZ8]ZQ+;XE^#[O5$T^WUR%[EW"(-CA68G  <KM/YUY%XFTRZ\$?"6
MSTI+^.Y.M7AN)Y+5]T1147"!NX)VDGOBO5]+\"^#M.M]*M5L;&2[@VSP3DCS
MIF7G?D'+#/..1[4 <YK'QFLK/QU::=93VKZ,H*WUY)!*71P6!"@=>B\X(.:[
MNZ\6:'8Z';ZQ>:C%!8W2!X99 5,@(R,*1N/';%>5>#](T;7OC+XEFN-/L7T^
MS#1QV[0)Y6[>J!MN,?PL<XZG-97BP:IXC^+\VG:-I5KJ*:/&([;3KEA'"$51
MGC<F?F;. >@'4"@#V/0?&_ASQ/</!H>J1W,R+N,11HVQZ@, 2/I3=:\>>&?#
MU\++5]7A@N3C,05G*YZ;MH.W\<5YWX1\):I9^+[SQ3J\>DZ?/IML[?V7II0;
M28V4;E0D*" W<DD>U4?AG8^'K[P[KWBSQJ+:\E-RRR-=@/M&T,2 ?XF+8'?Y
M>* -/P[=1>*?V@[[5+25)[/3[0^1(C94C8J<'W+L:](\6:HVB^#]5U"-BLEO
M:R-&1V?&%_4BO-O@)81F#7=5CA\N.:=8(AG.P %BN>_WE_*M[XVZC]B^'$L
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M=P$);<P&3G;W_O'UK,U70/".@_ ^.YDMK.;4+RTC>*Y(#2O,V"=K=0!D\#C
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MG\///=<&]NY)E)')4 (/U0_G0!Z/1110 4444 :E%%% !1110 4444 %%%%
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MIC(?BA_R33P__P!?3_R:O(XI9()DE@=HY(V#(Z'#*1R"".AKUSXH?\DT\/\
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M<:HL\5S$FP3VSA6*YS@Y!!ZGMWIOA;X;:!X2-RVG+<32W,1ADEN)<L4/51M
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M'_"8>&?^ABTG_P #H_\ XJOCBBCZLNX?VE+^4^Q_^$P\,_\ 0Q:3_P"!T?\
M\51_PF'AG_H8M)_\#H__ (JOCBBCZLNX?VE+^4^Q_P#A,/#/_0Q:3_X'1_\
MQ5'_  F'AG_H8M)_\#H__BJ^.**/JR[A_:4OY3['_P"$P\,_]#%I/_@='_\
M%4?\)AX9_P"ABTG_ ,#H_P#XJOCBBCZLNX?VE+^4^Q_^$P\,_P#0Q:3_ .!T
M?_Q5+_PF'AK_ *&+2?\ P.C_ /BJ^-Z<*/JR[C_M*7\I]C?\)?X:_P"AATK_
M ,#8_P#XJC_A+O#?_0PZ5_X&Q_\ Q5?'8ZU(*7U==P_M*7\I]@_\)=X;_P"A
M@TK_ ,#8_P#&C_A+?#G_ $,&E_\ @;'_ (U\@"GBCZNNX_[1E_*?7G_"6^'/
M^@_I?_@;'_C1_P )9X<_Z#^E_P#@;'_C7R,*<*7U==Q_VC+^4^N/^$K\._\
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M$_Z#%A_X%)_C7S>*<.U+V*[C^N2['T=_PD.B_P#08L/_  *3_&C_ (2'1?\
MH+V'_@2G^-?.@IPH]BNX_KDNQ]!3:MH[RECK-@N>QN$_QIG]IZ/_ -!JP_\
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M_P">R4?9U_Y[)4%% $_V=?\ GLE'V=?^>R5!10!/]G7_ )[)1]G7_GLE044
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M"@8M HH%(!PI12"E% Q>]+2=Z6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH \C_ &CO^9;_ .WK_P!I5>TC_DU>3_KUN/\ TH>F?M :3J.J?\(_
M_9EA=7GE_:=_V>%I-N?*QG .,X/Y5>TG2M0'[-+Z<;"Y%\;:<"U\EO-),[D#
M9C/3FNI->SCZGE-/ZS4?]W]$?.U%;?\ PA?BG_H6M8_\ )?_ (FC_A"_%/\
MT+6L?^ $O_Q-=G,NYX_LY]CUO3O&O@/5OA+9>%_$6M7%DWV:**X6&WD+J48,
M,,$9>2H]>#7&:_HWPMM]!NY?#WB35+K4E3-O#-$P5VR.#^Y7MGN*Y?\ X0OQ
M3_T+6L?^ $O_ ,31_P (7XI_Z%K6/_ "7_XFLE"*>C.J56I-6E!;6V9Z7JWC
M[PSX<^$Z>&_!5^;J]FC\F:4021D;AF23+ <GD  \9'I5;X3_ !'TC1O#][X>
M\7S[+ [F@9XFD4J_WXR%!.#G/XM7GO\ PA?BG_H6M8_\ )?_ (FC_A"_%/\
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M+FK?^ ,O_P 33QX.\3_]"YJW_@#+_P#$T<R*Y)]C(%.%:X\'^)O^A=U;_P
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MIP\+Z_\ ] /4O_ 23_"E=#Y9=C-%/%:(\,:]_P! 34O_  $D_P *</#.O?\
M0$U'_P !)/\ "BZ'RR[&<*<.U:(\,Z]_T!-1_P# 23_"G#PUKO\ T!=1_P#
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M . [_P"%*-#U;/\ R#+S_P !W_PHNA\K[%0=*<*N#1-5_P"@9>?^ [_X4O\
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MYL?]]?SH\V/^^OYUFTAHY0L:7G1_\]%_[Z%'G1_\]$_[Z%9E-I\H6-7SHO\
MGHG_ 'T*/.B_YZ)_WT*R:0T<@<IK^?%_SU3_ +Z%)]HB_P">J?\ ?0K'IAI\
MB'RFU]HA_P">J?\ ?0H^T0_\]H_^^A6)24<B#E-S[3#_ ,]H_P#OH4?:8?\
MGM'_ -]BL$TTT>S0<IT'VJ#_ )[Q_P#?8I/M4'_/>/\ [[%<\:0T_9H.4Z+[
M5!_SWC_[[%'VNW_Y[Q?]]BN<--H]F@Y3I?M=O_S\1?\ ?8I/M=O_ ,_$7_?8
MKF32&G[-#Y3I_MEM_P _$7_?8H^V6W_/S%_WV*Y:FGK1[)!R'5_;;;_GYA_[
M^"C[;:_\_,/_ '\%<D:::/9(.0Z[[=:_\_,/_?P4?;K7_GZA_P"_@KD#3*?L
MEW'R'8_;[7_GZA_[^"C[?:?\_4/_ '\%<::::/8KN'(CM/[0M/\ G[@_[^"C
M^T+3_G[@_P"_@KB#24_8KN'LT=O_ &C9_P#/W!_W\6C^T;/_ )_(/^_J_P"-
M<,:;1[%=P]FCN_[2LO\ G\M_^_J_XT?VE9?\_EO_ -_5_P :X$TAI^Q7<?LT
M=]_:=E_S^V__ ']7_&C^T['_ )_;?_OZO^->?&FFCV"[A[-'H7]J6/\ S_6_
M_?U?\:/[4L?^?ZW_ ._J_P"->=FFFCV"[A[-'HO]JV'_ #_6W_?Y?\:/[6L/
M^?\ MO\ O\O^->;FFFG[!=P]FCTK^UK#_G_MO^_R_P"-']KZ?_T$+7_O\O\
MC7F9IAI_5UW'[)'IW]KZ?_T$+7_O\O\ C1_;&G?]!"U_[_+_ (UY<:0T?5UW
M#V2/4?[9T[_H(VO_ '_7_&D_MK3?^@C:?]_U_P :\K-,-/ZNNX_9+N>K_P!M
M:;_T$K3_ +_K_C1_;>F_]!*T_P"_Z_XUY,:::/JR[A[)=SUK^V],_P"@G:?]
M_P!?\:/[<TS_ *"=G_W_ $_QKR(TVCZLNX>Q7<]>_MW3/^@G9_\ ?]/\:/[>
MTO\ Z"EG_P"!"?XUX\U,-/ZLNX_8KN>Q_P!O:7_T%+/_ ,"$_P :/[?TK_H*
MV7_@0G^->-&FFCZK'N'L5W/9_P"W]*_Z"ME_X$)_C2?\)!I7_06LO_ A/\:\
M6-,-/ZK'N'L5W/:_^$ATG_H+67_@0G^-'_"1:3_T%['_ ,"4_P :\1-,:G]4
MCW'[%=SW'_A(M(_Z"]C_ .!*?XTA\1Z1_P!!BQ_\"4_QKPRFFCZI'N'L%W/=
M/^$DT?\ Z#%C_P"!*?XT?\)+H_\ T&;#_P "4_QKP<TVG]4CW#V"[GO/_"2Z
M-_T&;#_P)3_&C_A)M&_Z#6G_ /@4G^->!FF&CZI'N/V"[GOW_"3Z-_T&M/\
M_ I/\:/^$GT7_H-Z?_X%1_XU\_&F&G]3CW#ZNNY]!_\ "4:+_P!!O3__  *C
M_P :/^$IT3_H.:=_X%1_XU\]&HVH^IQ[C^KKN?1!\5:)_P!!S3O_  +C_P :
M3_A*]#_Z#NG?^!<?^-?.C5&U/ZE'N'U==SZ/_P"$LT+_ *#VF_\ @7'_ (TG
M_"6Z#_T'M-_\"X_\:^;6J-J?U&/<?U9=SZ5_X2[0?^@_IG_@9'_C2?\ "8:!
M_P!#!IG_ (&1_P"-?,S5&U/ZC'N/ZLNY]._\)CH'_0PZ7_X&1_XTG_"9>'_^
MAATO_P #(_\ &OE]OO5&:?U"/</JJ[GU'_PF?A__ *&+2_\ P,B_QH_X3/P]
M_P!#%I?_ (&Q?XU\L&FT_P"SX_S#^JQ[GU1_PF?A[_H8M+_\#8O\:/\ A,_#
M_P#T,6E_^!L7^-?*]%']GQ_F#ZK'N?5'_"9^'_\ H8M+_P# V+_&C_A,_#__
M $,6E_\ @;%_C7RO11_9\?Y@^JQ[GU/_ ,)IX?\ ^ABTO_P,B_QH_P"$S\/_
M /0Q:7_X&Q?XU\L44?V?'^8/JL>Y]3_\)IH'_0Q:7_X&1?XT?\)IH'_0Q:7_
M .!D7^-?+%%']GQ_F#ZK'N?4_P#PFF@?]#%I?_@9%_C2?\)IH'_0Q:7_ .!D
M7^-?+-%']GQ_F#ZK'N?6=CK5IJ<;/INH6]XB'#-;RK(%/H2*LF>3^]^E?+?A
MGQ-?^%M62^TY^.DL+'Y95]#_ $/:OHKPYXDL/%&DI?:<_'22)C\T3?W3_CWK
MCQ&&E1U6J.>K1=/7H;7GR_WOTH\^7^]^E1T5R& _[1+_ '_TH^T2_P!_]*CH
MH D-Q+_?_2I5F<VKL6^8'@U5-3I_QY2?[W^% #/M$O\ ?_2C[1+_ '_TJ.B@
M"3[1+_?_ $H^T2_W_P!*YZ7QEHL9FV3W-Q' 2)9[6RGGB0@9(,D:%>._/'>M
MJ*6.>%)8762.10R.AR&!Y!![B@"?[1+_ '_TH^T2_P!_]*CHH D^T2_W_P!*
M/M$O]_\ 2HZ* )/M$O\ ?_2C[1+_ '_TJ.B@"3[1+_?_ $H^T2_W_P!*RO[:
MMQXF&A[)?M)LS>;\#9LW[,9SG.3Z?C4FIZO8Z/'!)J4_DK<3I;1'8S;I'^ZO
M .,^IXH T?M$O]_]*/M$O]_]*CHH D^T2_W_ -*/M$O]_P#2HZ* )/M$O]_]
M*/M$O]_]*CHH D^T2_W_ -*/M$O]_P#2HZ* )/M$O]_]*/M$O]_]*SM7U:RT
M+2IM2U6;R+2  R2;&;;D@#A03U([5=H D^T2_P!_]*/M$O\ ?_2HZ* )/M$O
M]_\ 2C[1+_?_ $J.B@"3[1+_ '_TH^T2_P!_]*CHH D^T2_W_P!*/M$O]_\
M2HZ* )/M$O\ ?_2C[1+_ '_TJ.B@"3[1+_?_ $H^T2_W_P!*CHH D^T2_P!_
M]*/M$O\ ?_2HZ* )/M$O]_\ 2C[1+_?_ $J.B@"3[1+_ '_TH^T2_P!_]*CH
MH D^T2_W_P!*/M$O]_\ 2HZ* )/M$O\ ?_2C[1+_ '_TJ.B@"3[1+_?_ $H^
MT2_W_P!*CHH D^T2_P!_]*/M$O\ ?_2HZ* -2BBB@ JKJ8NSI%X--P+PP/\
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M6E>5=%9E813$2$IURV"X&0,5AZ;H7C/PEI.J^'](T:VU*SNY)&M[TW:Q^4'
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M\17&FW%Z^JQ2:7-?6[W*1HZ21X!0E%52ISG.,BMB\\+6M_IL-M>7=[+/!/\
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M:2:24%N3(K *%&, 9))YXQ3Y_ UC>6&J07][>W4VJ^6+B[D:,2[8R"BJ%0(
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M "BBB@ HHHH *SM;T#2_$FFFPURSCO+8L'V/D88="",$'D\CUK1HH YOP_\
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M1/\ H%67_@,G^%/ZW'L/VR['A5-->[?\(_H?_0*LO_ 9/\*/^$>T/_H$V/\
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MSF]!2>>WH*8:::=D!+Y[>@I/M#^BU'6?KU_)I7AS4M0@57DM+26=%?[I*H6
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MO!?B"Y\2:"U]>QQ1R"=HPL0(&  >Y//-)XAU^YTG7-#LK>.)H]1G:.5G!)4
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M=#\13<\):W;GKZ(Y_D?P-<6)PEEST_N.>M0M[T#UNBBBO+.(2BBB@!#4Z?\
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M?_T$U9ILD:RQM'(,HX*L/4&@#YID=H_V:;5HV*L-;R"#[-78:EX>M?!'Q?\
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M:!F%\53CX9ZMC_IC_P"CDK@M6L+/0]'\*^(-$OYYM9NYHQ)(9RYF!7YEQG
M.%QCH<&O2?'^DWFN>!M0T[3(O.NIA'Y<>X+NQ(K'DD#H#5?0? 6A:<MC?R:3
M#'JD4,?F/N)"R!1DA<[<Y[@4P.8T^YFLOB%XZNK1=T\%EYD2XSE@@('YBN0L
M;#5M0\-QZU8Z9)_:(E,C:[)K**<ACD&-B-OX_7I7MUMH6FV>KW>J6UL$O+P
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M=Y4BNY(W#!SD_-P3USBHK7P-X:L=2%_:Z3"EPK;U;<Q"GU"DX'X"F,9X\./
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MG9L+M+*"$QQDO@8(P3@X]-K.TC1;?1A>BU>5_MMY)>2>80<.Y&0, <<<?SH
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MC_WJ/,?^]3^N51_6)GAI^"7B4G_C[TS_ +^R?_&Z:?@AXF/_ "]Z9_W]D_\
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M1#]I64,;F0DKM5<#'(]3U!IFG_$:[.KZ79^(?#5QH\.KG;8W#7*RB0G& R@
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M!<CID <8H ]3HKA=1\17=UXNU72TU#4M-@TU(T5M.TMKMII)$#[G/E2!54$
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MNM$U82R1+UFMFB43)]< ,,]"M 'HMQXJT:TM-1NKB\V0Z7*(KMO*<^6YQ@8
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MI'F[;BZ7Y.J(?XO<^U=!117/*3;,6[B4445(@HHHH 0T4&B@ HHHH 2BBB@
MI*6DH **** $-)2FDH **** $HHHH 2BBB@ H-%!H 2D-+2&@ HHHH 2BBB@
M!#4Z?\>4G^]_A4!J=/\ CRD_WO\ "@""F21I-$\<J*\;J59&&0P/4$=Q3Z*
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M8K;HH Q9/"]K-J%W>S7%S)/>:>+"5B4&4&?FP%X8[C[>U-E\*6,VC:-IC2W
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MI)B"S.V.. .   !VIND:!::)<:A)8M*%U"Y-U)$Q&Q'( 8J .,XR<YYK4HH
M**** "BBB@ HHHH U**** "BBB@ HHHH **** "BC-&: "BC-)F@!:*3-&:
M%HI-U&Z@!:*3<*3>* '44W>/>CS![T .HIOF#WI/,'O0 ^BF>:/>CS1Z&@!]
M%,\U?0T>:OH: 'T4SSE]#2><OH:=@)**C\]?0T>>OH:+,"2BHOM"^C4?:$]&
MHLP):*B^T)Z-1]I3T:BS EHJ'[2GHU)]J3T;\J+,":BH/M2>C?E1]K3T;\J+
M,">BH/M<?HWY4GVR/T;\J+,=BQ15?[;'Z-^5'VV/T;\J+,+,LTE5OMT?]UOR
M%'VZ/^ZWY"BS"S+-%5OMT7]U_P A2?;XO[K_ )"BS"S+5%5?[0B_NO\ D/\
M&C^T(O[K_D/\:+,+,M\4E5/[1B_NO^0_QH_M*'^Z_P"0_P :.5A9ENBJG]I0
M_P!U_P A_C2?VE#_ '7_ "'^-'*PLRYQ1Q5(ZG#_ '9/R'^-)_:D/]V3\A_C
M1RL+,O<4<51_M6#^[)^0_P :3^U8/[DGY#_&GRL+,O\ %'%4/[6@_N2?D/\
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M=K!)<,8QC+XC5B%Y'S'CFLT>)+/5[K0[G2=:DM[6[GD187L'_P!.PF<!G4%
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M-O)DL[6QC,#X?<&6<P[=O1LF0'J.O% '=:KXOT719KB*_N90UJBO<&&UEF6
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MH"N:2K'V.?\ YY_J*3[%<?\ //\ 44[H+D%-JS]BN/\ GG_X\*3[#<?\\_\
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MVT^E)M/I0 E)3MI]*-I]* &T4NT^E+M/I0 V@TNT^E!5O2@!M%.V-Z4;&]*
M&T4[8WI1L;TH 913MC>E&QO0T -HIVQO2C8WH: &&BG;&]#1L;T- #:*=L;T
M-&QO0T ,HIWEM_=-'EO_ '30 VDI_EM_=-)Y;_W30 VBG>6_]TT>6_\ =- #
M#24\QO\ W31Y3_W30 RBG^4_]TT>4_\ =- $=%/\I_[IH\I_[IH CHI_E/\
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MZ3^^WYT>=)_?;\Z910 _SI/[[?G1YTG]]OSIE% #_.D_OM^='G2?WV_.F44
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M D#(]_KBG>(O#WB_Q1X/\.P7/A]+.\TW48O,@6]C?,*1@>;G(')S\H)(XZT
M=5XA\?2Z=XG7PYX=T2;7=7\GSY84G6!(4XY9V!&>1^8]:SH/BS#)X5U[49]&
MFMM2T)E6ZTV:8 Y9MHP^.F<\X[>XJ'6- \3:!\4+GQ=X8TN'6H=0M5@N;1KI
M8'4J% (9N,?(OZ\=ZQF^'WB6[\*^,K_4+6 :WXA:,Q6$,RE8E60-@N3MSCWQ
MQ[T :R?%VXC?1[K4_"EW8Z/JTB107TEPI.YL<^6!G;SD$D9'(':O3*\L\5>#
M-=U+P%X*TZRLA)=Z6]J;N/SD'EA(@K').#@CL3[5ZG0 4444 %%%% !1110
M4E+24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%%% !1110
M4444 %%%% !1110 E%%% !1110 4444 %%%% "4444 %%%% !24M)0 E%%%
M!1110 4E+24 %%%% !0:*#0 E%%% !1110 E%%% !1110 AHH-% !1110 E%
M%% !24M)0 4444 (:2E-)0 4444 )1110 E%%% !0:*#0 E(:6D- !1110 E
M%%% "&IT_P"/*3_>_P *@-3I_P >4G^]_A0!!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &I1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFS!Z-1^X]&H AH-39@]&I,P>C4 0TAJ?-OZ-03;^C4 045-FW]&H_P!']&H
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M5:S_ ,_G_D)/\*8?%>M?\_O_ )"3_"LHTPT^2'8?+'L:Q\6:U_S^_P#D)/\
M"FGQ;K?_ #^_^0D_PK(---/V<.P<L>QKGQ=KG_/[_P"0D_\ B::?&&N?\_W_
M )!3_P")K':F&G[.'8?+'L;)\8Z[_P _W_D%/_B:8?&6O?\ /_\ ^08__B:Q
MVJ,T_9P[(.6/8VCXSU[_ )__ /R#'_\ $TT^--?_ .?_ /\ (,?_ ,36*:8:
M?LX=D/ECV-L^-?$'_00_\@Q__$TP^-_$/_00_P#(,?\ \36(:8:/9P[(?+'L
M;A\<>(?^@A_Y C_^)IA\=>(_^@C_ .0(_P#XFL,U&:KV<.R#DCV-X^._$?\
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MOQ:.FK?^2T7_ ,37,FHVJO94_P"5?</DAV.F;XG>+QTU?_R6A_\ B*C/Q/\
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M_P#$5R-%'L:7\J^X/9P[(Z[_ (6IXR_Z#'_DK#_\11_PM/QE_P!!C_R5A_\
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M?4)I]1MM1M\-<VK#+9E()RISM5@>:])L-$TK2X)(=,TRSLXI?]9';VZQJ_U
M SU/YT:?HFE:0TATK3+.Q,G+FVMTCW_7:!F@#E_BZ[+\-;]-Q2&66".>0 G9
M&95W'\OYUSMWI'ANR\;>%X? S(VI&Z\Z\FM;II<VBJ=_FMDYR=H&>M>JRQ1S
MPO%/&LD;J59'7(8'L0>M4]/T72]'5ETG3;.Q#_>%M L>[Z[0,T >?^*-,\2W
MWC?0=+/B.W97N)M0A TP?Z*(EPA;]Y\_,@';GGVKT'3(+VVTZ.+5+U;ZZ7.^
M=(1$&Y.,)DXP,#J>E7*2F!Y%?7MS8>(?%OA'2RWV_7+V)[7'\"31?OI?HH4\
M^I%.URQ:/QWIVA6EQH]O9:-I4;6D&L*S12,6*F0*&4,X"@<YZD]Z[7PYX;NK
M36M0U_7VMYM7O3Y:FWR4MX ?EC4D GU)P,FM?4=%TK5PG]K:99WWE_<^TVZR
M;?IN!Q0,\UUC35\.?#O4;BSUB"=M=U")+J]LE6*&%&<(^P*2   5)SW.>:DO
M[?PU=_$/PGHGAVVLRVGR/<336J*?+6-,HA8=26P2.O0]Z]);3K%M/-@UG;FS
M*[3;&)?+QZ;<8Q45IHVF6#1M8Z=:6QB5EC,,"IL!QD# X!P,_04P.-T+1['Q
M#\0_$^M:C;)<I:SII]NDRAD4I&-YP>"<M^ )]:R)3IMKXOBNK=](\1:?XDOH
MP$&&N;8XX93SF-=N3T(KU"WM+:T$@M+>* 2R-+)Y:!=[MU8XZD]SU-5;;1-*
MLKM[NRTRSM[F3[\T5NJ.WU8#)I@7324II*8"4TTZFF@8E,-/IAI@(:;3C3:8
MQ#3:<:;0 AI#2FD-,8TTUJ<::U,!II#2FD-,8TTTTXTTT -I#2TAIC&FFFG&
MFFF TTTTXTTTQC3333C333 ::::<:::8QM--.III@,---.--- QC4TTYJ::8
MQAIIIQIII@,--IQIM,!#333C333&1&FFG&FFF,8:8:>:8:8QIIAIYIAIC&&F
MFG&FFF QJ8:>U,-,8UJC-2-49I@--,-/-,-,8PTPT\TPTQC#49J0U&:8#349
MJ0U&:8QAJ,U(:C-,8PTPT\TPTP&&F-3S3&IE$1J-JD-1M5 1&HVJ0U&U,HB:
MHFJ5JB:K&1&HVJ0U&U4,C-%!HIC"BBB@ HHHH **** "BBB@ I\,,MQ.D-O&
MTDLC!41!DL3T %$,,MQ.D-O&TDLC!41!DL3T %>\?#SX>1^&H%U'556359%X
M'46X/8?[7J?P'OA7KQHQN]S.I45-79I?#SP[J'AOPREKJMTTLLC>8+?(*V^?
MX0?U/;/3N3U=%%?/SDYR<GU/+E)R=V)1114DB&IT_P"/*3_>_P *@-3I_P >
M4G^]_A0!!5#6]*CUS0;[2YV*)=P/$7 R4R,!L>QY_"K]% '+Z3>^(K+2[;3K
MSP^\UW JPFZCNHA;2 8&_);S ".<>63GCWJKI]OKGAF?6X+;1Y-42]O9;ZTG
MAGB15:3GRY0[*PVD=5#?*1W&*[*B@#A=*\(ZAH]WX-B 6XCTJ&[%W.C *KR*
M", \D;L@<=N<5=L]$U"*_P#&,DEOA-293:'>O[S$ 3UX^;CG%=;10!P7AWPW
MJUCJ'A.2ZM?+33M)EMKH^8A\N0[,+P>>AY&15F#0-332/&T+6V)-4FN&LU\Q
M?WH: *O?C)&.<5VE% 'G?_"*ZA:7>AZA-8WMV(M%ATZZMM/U VTT3I\P;<)$
M5UR2I&[T(S5JX\,3'3=,_LO29;1O[?AU"YCGO?/EVKPTCLS'YL ?*K-^/-=U
M10!S&O:;J$7BS2=?TZT:_2UBEMI[6-T63:^"'0N0N05Y!(X-1:I9:KK.K>&[
MXZ8ULEG?22S1O,C-'&8V52V#C))'"EL9ZUUE% 'EGB+PWXFU?1=5L[FQU"]U
M&>Z+PW U,1V8A#J4581(!G:H&&3KDELUN:O)=^&M=\2^)IH/]%.FP1VS;@?,
MF!8!-N<_>91T[UV]0W-I;7D:QWEO%<(KAU65 P# Y!P>X/0T <+K>CMH7P8D
MTN1XS=21HDI<_P"MGDD4N <'YBS$ ] <$\"F06%S:^)(;'Q,LL][K%A-8VE]
M]M6X\E%4LRE1#%C(.=V&)( )%=QJ6F6>L:=-8ZG;I<VTR[7C<=?<'J".H(Y!
MY%5;'PWIFGW_ -MBCGEN@FQ9KNZEN'13U"F1FVY[XQF@#D-&\*RIINFZ3K.@
MZE/):-&DEPVM.;,B,\2*GFENB@A/+ !P.!R-+3[?7/#,^MP6VCR:HE[>RWUI
M/#/$BJTG/ERAV5AM(ZJ&^4CN,5V5% 'EB>'-6TO5_#FC:7>Q&_TW2YY)7BG$
M)'F2#.2\,@9,Y &W.1GBK-C827UAI^F:;I\D=UHGB*.74B]RLN\X9FF$A"[\
M[U)&T$$XVX%=OJ7A[3=5O(KN[BE6ZA0HEQ;W$D$@4\E=\;*2,\X)Q4^F:59:
M/:M;Z= (D>1I7)8LTCL<EV9B2S'N22: ,/Q1::O<:OIS6\5]=:2BR&YMM.NQ
M;3-)C",7+H2HR> PYP2#BN+O]'U31? UTMW:?9[BY\317-O%-=&;*L\>W=)R
M3R,$G)X)YKURJ>I:59ZO;I!J,/G1QRI,J[BN'0Y4\$="* .:GT_5O$'B:SU&
M[TM]-@TVRN$1)IHW>::8!2%V,0$ 7J2"21QZ9\OAG6#\+-"TA+3_ $^TFMGF
MB\U/D"2 L=V<' ]#7H-% 'GVJ>$=6U >+/)C2-[R]MKJQ,CC;-Y2H2#C) )4
MCG'KTKK],U#4+Z1OMFC3Z:BH"3<3Q.6<]E$;-P/4D'IQUQI44 <5KOAZY_X3
M4ZU%9W]_:W%FMO+%I^H&UEC=6)#?ZR,,I!Q@MD$5%>^&;B[\-KH5AI#6%IJU
MVTNHR7%W]HDACR&+$LS$ROM X+!3DY[UW5% 'EFIV&KZ)X3T?1Y[:)GT_P 0
M6D6GSLX5+J/?F,MMR5/9N.V1G-;\^GZ]K?B(:O'8_P!C266FS06?VN2.1FN)
M,88B,L-B[1UY.>E=3J&EV>J+;K?0^:+:X2YB^8KMD0Y5N",X/8\5;H \TL_#
MNM3ZYX9NY],U2-["3??SZAJ@GW.T1!9$$C*!N] IY&!C.-)?#NJ#P/XNT\VO
M^E:C>7TMK'YB_O%D)V'.<#/OC'>NYHH \_UK0=0GTRU6VT.\76K;3HX+75;*
M_2(Q-M&4E^=25##.,.""<8)-2:AX2U;5M3UQ;IE5=0T2*S6[!&UI@6+?*.0,
MD=NAKO** .&O;'7?$.CZ9HMWH[Z<()H9+N[DGB:,B)@<1!6+$L0,;E7 ZU>T
MS1;^WO?%TDT&U=1FW6IWJ?,'DA?7CD8YQ75T4 8?@O3[O2?!6E6&HQ^5=6]N
MJ2)N#;2.V02#^%;E%% !1110 4444 %%%% !1110 4444 :E%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1BBB@!,4;:6B@!-HI-@
MIU% #?+'O2>6/>GT4 ,\H>]'E+ZFGT4 1^2OJ:/(7U-244[L"+R%]31]G3U:
MI:*+L"'[,GJU(;1/5OSJ>DHNP(/LB>K?G1]C3U;\ZGHHNQW*_P!BC]6_,4?8
M8_5OS%6**+L+LK?8(_5_S%'V"/\ O/\ F*LT4<S"[*O]G1'^)_S%(=.B/\3_
M )C_  JW13YF%V5/[-B_O/\ F/\ "D_LR'^])^8_PJY11S,+LIG2X?[TGYC_
M  I/[*A_O2?F/\*NT4<S"[*/]D0?WI/S'^%']D0?WI/S'^%7J*.9A=E#^QH/
M[\GYC_"D_L6W_OR_F/\ "M"BCFD%V9W]BV_]^7\Q_A2?V);_ -^7\Q_A6CFC
M-'-+N',S-_L*W/\ '+_WT/\ "C^P;;^_-^8_PK2S1FCGEW#F9F?V!;?WYO\
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M]K_\3719/K1D^M'M)]PYY=SG?^$'T[_GM=?]]K_\33?^$%T[_GM=_P#?:_\
MQ-=)D^M&3ZT>UGW'SR[G-?\ "!Z=_P ]KO\ [[7_ .)I/^$"TW_GM=_]]K_\
M372Y/J:,GU-'M9]PYY=SF3X TT_\MKS_ +[7_P")I/\ A7^F?\][S_OM?_B:
MZ?<?6C<?6CVL^X<\NYRY^'NF'_EO>?\ ?:?_ !--_P"%=Z8?^6]Y_P!]I_\
M$UU6X^M)N/J:?M9]PYY=SE?^%=:7_P ][W_OM/\ XFD/PXTL_P#+>]_[[3_X
MFNKW'U-&X^IH]M4[A[27<Y/_ (5OI1_Y;WO_ '\3_P")I#\-=*_Y^+[_ +^)
M_P#$UUNX^IH+'U-'MJG</:2[G(?\*STG_GXOO^_B?_$TG_"L=)_Y^+[_ +^)
M_P#$UU^YO4T;F]31[:IW#VDNYQ__  J_2/\ GXOO^_B?_$TT_"W1S_R\7_\
MW\3_ .(KLMS>IHW-ZFCVU3N'M)]SC/\ A5FC_P#/Q?\ _?Q/_B*3_A56CG_E
MYU#_ +^)_P#$5V>YO4_G1N;U/YT_;5.X_:3[G%?\*HT;_GYU#_OXG_Q%)_PJ
M;1C_ ,O.H?\ ?Q/_ (BNVW-ZG\Z-S>I_.CV]3N'M)]SB#\)-%_Y^=0_[^)_\
M133\(]%/_+SJ/_?R/_XBNYWM_>/YTF]O[Q_.CV]3N'M)]SAC\(-$/_+SJ/\
MW]C_ /B*:?@]H9_Y>M2_[^Q__$5W>]O[Q_.C>W]X_G1[>KW#VL^YP1^#>AG_
M )>M2_[^Q_\ Q%-/P8T(_P#+UJ?_ ']C_P#B*[[>W]X_G1O;^\?SI_6*O\P>
MUGW//S\%=!/_ "]ZG_W]C_\ B*:?@GH!_P"7O5/^_L?_ ,17H6]O[Q_.C>W]
MX_G1]8J_S#]K/N>=_P#"D- /_+WJG_?V/_XBFGX&^'S_ ,O>J_\ ?V/_ .-U
MZ+YC_P!X_G1YC_WC^='UFM_,'MJG<\Y_X47X>_Y^]5_[_1__ !NC_A1?A_\
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M!D,I!(XR=O/H*Y6RO]3OO"O@M6U:^BDO=3GBN)TG/F2)F;Y23G/  &>F!C!
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M<-G!))QWK>LD?Q1XJ\017][?00:;*EM;V]I=R6^T&,,9&\L@L23QG( '3KD
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MI:[MY0@5HU0<%L@ 9/!/0U;L/ ]_<_"?PQ8VIMHM0T^:+4?*OHRT<DAWLR2
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M_;_]IL9_MAQ<[\C;LQ\WWLYV]\YH ]TN+B&TMI+B[FC@@B4O)+*P544=22>
M*H1^)-#ENH+:+6M/>>X4-#$MTA:4$9!49R0>V*S/B/\ \DT\0?\ 7C)_*O%_
M$.@:5IO[/^@:Q8V,,.IR7,;O>*O[TDA_XNN/E''08H ^@M1UC3-'C635M1M+
M%'.%:ZG6,,?8L11+K&F6^EC4I]1M(K @$73SJ(CDX'SDXZ\=:\2\<-=M\<;M
M;_\ X1_R!8H++_A)-_V79A=VW'&[=OZ\=>^*S;O3Y-/^!OB1!JFG:A;'5HS&
M-->1H86)0LBEU''S+TR/?.: /=W\4:!'(\<FN::KI(L3*UW&"KMG:I&>"<'
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MF,AC&_,)D(R"3QMX]L5)I/BS3-)\)Z-(K:SJ$>H7$L%N]R!-<NX9SAR#TRI
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MNTB-1,^XG)&2%XYZ\5F2^%]9/P4N=!2T_P")H[2E(/-3G-R7'S9V_=(/7]:
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M@T %%+M-&TT -HI=IHVGTH 2BEVGTHVGTH 2DIVT^E)M/I0 VBG;3Z4;3Z4
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MCPFPMO(O)I0$'FLQ*@?-P2>.GYBL/:1YE%QW/4>#K^QE6C634=[-_P"1Q_\
M;^L?]!:^_P# E_\ &C^W]8_Z"U]_X$O_ (UUGC7PSI.C^%[.[T^V,4\DR([F
M1FW HQ/!..H%%]X9TJ#X9)JT=L1?&&)S+YC=6=0>,XZ$]J%4IM)VW=@E@L7"
M<X.?PQYGJ]O\SD_[?UC_ *"U]_X$O_C1_;^L?]!:^_\  E_\:IVT8FNHHF)
M=PI(]S7IOB#1?!OAN"&2^TF>03,57R9G)R!WRXJIRA!I6W,<-0Q&(A*HJEE&
MU[M]?2YY]_;^L?\ 06OO_ E_\:/[?UC_ *"U]_X$O_C78:UX2T6]\+-K?AHO
M$D:&38S,0R@_,/FR01@_E^-.\&^&=$O_  K+J.JVC7$B.Y)$C+A5 X ! ]:G
MVM/EYK&ZP&,=94N?=73N[-'&_P!OZQ_T%K[_ ,"7_P :/[?UC_H+7W_@2_\
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M2:VL6 ,R2DDX&2QSN.,C Z]:(U(25^70*^#Q-&:INJG)M*R;OK\C(_M_6/\
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MH#7-6_Z"E[_X$/\ XTO]N:M_T$[S_P "'_QK/%.I<J[%^VJ?S/[R^-;U7/\
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M^_S?XT[^U+__ )_KG_O\W^-4Z<*5D/VD^Y;_ +3O\_\ ']<_]_F_QI?[3O\
M_G]N?^_K?XU4[TM%D5SS[EL:G?\ _/[<_P#?UO\ &E&IW_\ S^W'_?UO\:J"
ME%*R*YY=RW_:5]_S^W'_ '];_&E_M*^_Y_+C_OZW^-5:44K(I3EW+7]I7V?^
M/RX_[^M_C2_VC>_\_EQ_W];_ !JKWIU%D4IR[EG^T;W_ )_+C_OZW^-*-1O?
M^?RX_P"_K?XU5%.%*R*YY=RS_:-[_P _EQ_W];_&E&H7O_/W/_W];_&JU**+
M(?/+N6?[0O?^?N?_ +^M_C2_VA>?\_<__?T_XU6I12LA\\NY9_M"\_Y^Y_\
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M8=J*.U% Q:44E**0Q:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=J]/^P6/_/C;?]^E_P */L-C_P ^-M_WZ7_"E[==A_V5/^8\Q%**]-^PV/\
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M ^N!7$O'YGP)TE&4LK:]@CVV/7T4:::!'FWQHMHK;X=0Q6L*11I>1*J1K@*
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MX2\D4Q#/N5!?ZUZ-4,5G;07,]Q#;Q1SW!4S2H@#2[1@;CU.!P,]*FH ****
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M_95E_P ^EM_WZ7_"C^R;'_GTMO\ OTO^%5O[3_Z9?^/?_6H_M/\ Z8_^/?\
MUJ/>#4L?V18_\^EM_P!^E_PH_LBQ_P"?2U_[]+_A5;^T_P#IC_X]_P#6I/[4
M_P"F/_CW_P!:BT@U+/\ 8]A_SYVO_?I?\*3^QK#_ )\[7_OTO^%5CJO_ $Q_
M\>_^M2?VK_TQ_P#'_P#ZU%I!J6O[&L/^?.U_[]+_ (4?V+I__/E:_P#?E?\
M"JO]K?\ 3'_Q_P#^M1_:W_3'_P ?_P#K46F'O%G^Q=/_ .?*T_[\K_A1_8FG
M?\^5I_WY7_"JO]K_ /3#_P ?_P#K4G]K_P#3#_Q__P"M1:8>\6_[$T[_ )\;
M/_ORO^%)_8>G?\^-G_WY7_"JAUC_ *8?^/\ _P!:D_MG_IA_X_\ _6IVF'O%
MS^PM-_Y\;/\ [\K_ (4G]A:;_P ^%G_WY7_"JG]M?],/_'__ *U)_;7_ $[_
M /C_ /\ 6HM,+2+G]@Z9_P ^%G_WX7_"C^P-,_Y\++_OPO\ A5/^V_\ IW_\
M?_\ K4G]M_\ 3O\ ^/\ _P!:BTPM(N?V!IG_ #X67_?A?\*3_A']+_Z!]C_W
MX7_"J?\ ;?\ T[_^/_\ UJ3^W/\ IW_\?_\ K46F.TB[_P (]I?_ $#['_OP
MO^%'_"/:5_T#K'_OPO\ A5+^W?\ IW_\?_\ K4G]O?\ 3M_Y$_\ K46F%I%[
M_A'=)_Z!UC_X#I_A2?\ ".:3_P! ZP_\!T_PJD=>_P"G;_R)_P#6IO\ ;_\
MT[?^1/\ ZU%IA:1>_P"$<TG_ *!MA_X#I_A1_P (WI'_ $#;#_P'3_"J'_"0
M?].W_D3_ .M1_P )!_T[?^1/_K4[3"TB_P#\(UI'_0,T_P#\!T_PI#X:TC_H
M&:?_ . Z?X50_P"$A_Z=?_(G_P!:@^(?^G7_ ,B?_6HM4#WB_P#\(SH__0+T
M_P#\!D_PH_X1C1O^@7I__@,G^%9__"1?].O_ )$_^M6G9WL=[!OCX(^\IZJ:
M3YUN)\R(_P#A%]&_Z!>G?^ R?X4G_"+Z+_T"M._\!D_PJY14\TNXN9E/_A%M
M%_Z!6G?^ R?X4?\ "*Z)_P! G3?_  &3_"KE%'-+N',RE_PBFB?] G3?_ 9/
M\*3_ (1/1/\ H$Z;_P" J?X5=HHYI=PYF4O^$2T/_H$:9_X"I_A2?\(EH7_0
M(TS_ ,!4_P *O44<\NX<S[E ^$-!_P"@/I?_ ("Q_P"%'_"'Z!_T!M+_ / 2
M/_"KQI:.>7<.9]S//@[0/^@-I?\ X"1_X4?\(;X?_P"@+I7_ ("1_P"%:!I*
M.>7<?,^YG_\ "&>'O^@)I/\ X!Q_X4?\(7X>_P"@)I/_ (!Q_P"%:%%'/+N'
M-+N9W_"%>'?^@'I/_@''_P#$T?\ "%>'?^@'I'_@''_\36C13YY=PYI=S._X
M0KP[_P! /2?_  #C_P#B:3_A"O#O_0#TG_P#C_\ B:T311SR[AS2[F=_PA7A
MW_H!Z1_X!Q__ !-'_"%>'?\ H!Z3_P" <?\ \36C11SR[AS2[F=_PA7AW_H!
MZ3_X!Q__ !-'_"%>'?\ H!Z3_P" <?\ \36C11SR[AS2[F=_PA/AW_H!Z1_X
M!Q__ !-'_"$^'?\ H!Z3_P" <?\ \36A1VHYY=PYI=S/_P"$)\._] 32/_ .
M/_XFC_A"?#O_ $ ])_\  ./_ .)K0HHYY=PYI=R*QT#3M+W_ -F6=E9^9C?]
MGA6/=CIG &:N?9C_ ,]%_.H**EMO5D[D_P!F/_/1?SI/LI_YZ)^=0TE("?[*
M?^>B?G1]E/\ ST3\Z@[44 3_ &4_\]$_.I8X=L#+N4Y.<U3JQ%_QZ/\ [U #
M_(/]]:/(/]]:AHH F\@_WUH\@_WUJ&B@";R#_?6CR#_?6H:* )O(/]]:/(/]
M]:AHH F\@_WUH\@_WUJ&B@";R#_?6CR#_?6H:* )O(/]]:/(/]]:AHH F\@_
MWUH\@_WUJ&B@";R#_?6CR#_?6H:* )O(/]]:/(/]]:AHH F\@_WUH\@_WUJ&
MB@";R#_?6CR#_?6H:* )O(/]]:/(/]]:AHH F\@_WUH\@_WUJ&B@";R#_?6C
MR#_?6H:* )O(/]]:/(/]]:AHH F\@_WUH\@_WUJ&B@";R#_?6CR#_?6H:* )
MO(/]]:/(/]]:AHH F\@_WUH\@_WUJ&B@";R#_?6CR#_?6H:* )O(/]]:/(/]
M]:AHH F\@_WUH\@_WUJ&B@";R#_?6CR#_?6H:* +]%%% !03@9/ HJMJ=G_:
M.DW=EYAB^TP/#YBC)3<I&?PS0!SD'Q0\&76L)I=OKUO)=O((T 1]C,3@ /MV
MGGWJ_9^+M/OO&NH>%X8[@7VGPI-,[(!&0P4@ YR3AQV%>5:3J>J?"FUL_#_C
MGP]:W>@_:LP:G H<*Y;<&((Y(ZC.U@!QG JU]DUV^_:$\50>&]2@TN9K.'S;
MJ6W$Q1/*AX5#P23CKVS0![117C-E\6-:L?A;JVI:FL%WJUAJ']GQ3;-J2,1D
M.RC X&[IC.!TJYJNN>.? E[H5[XAUNVU>SU*Y2WN;06:0F!FZ[67EL<\GTZ4
M >M5B>+?%5CX-T%]6U2.XE@618]MNH9R6Z<$@?K7.^&/$NK:C\6_%&BWEUYF
MGV$<9MH?+4>62%S\P&3U/4FO-]>\2:KXH^!>JW>N77VF>'7A!&WEJF$"H0,*
M .K'GK0!] PRK/!'*F=LBAAGT/-8>C^+]/UOQ+JVB6D5RESI+*L[2*H1LY^Z
M023T[@5Q^K>(O$6I>.-+\'>%]1BTD)IZW5U>/;+,WW>%"MQCIZ=>O%<[X/U>
M]\,^*/B)JFMF*ZO;&)7E,"E4E<%L8'8$X^F30![@:0U\^Q?&'6+2WLM5E\46
MNHS2S#[5H2:88Q#&2<[9L<D#W[]ZZ^]UKQGK/Q<UOPQH6M0:=96D$4RRR6B2
MM$#&A(4$?,69^YX'2F!ZG165X@UC_A'/"E[JMPOGM9VQD*CCS& X'MDUY?=^
M(?B!8^ 8?'4FN6<EN^R5]*^PJ$6-W"KB3[Q/(XSWZT >R&JUYJ5CIYA6_O;>
MU-PXCA$\JIYC?W5R>3["O+_&?CO6[;6M)$.I'PYHE]8QW*Z@; 70,C#/EMGI
MVZ<]^]97Q,&JZC!X*O/[=MIA<311H]K K1"?(S.I/)!R/D/'R^] 'MM':O*_
M'/C35O"#Z)X>FU^**[N8VDO=;EL0VQ,D K"N1G@C'/0>I-4O#OQ7NHK3Q*MY
M?1:_'I5L+BTOTMC;>?DA=K)@8^9E'3L>O% SV"@5X[J'B'Q]HO@JR\:76MVE
MS;7'EROI1LE55CDQMQ(/F/!'TSWK7\9^,)[2]M?*\96/ARUFM$G6/[";NX9F
MR?F7!"KC&#UZTP/2J@NKNVL+5[F^N(K:",9>69PBJ.G)/ KR*+XC^(+OX)W^
MNI=1QZG:7XM1<QPKAURAW;6&,D/CI4OB^S\6W/PGU#4M<\0PNEQ%!<-9062!
M40GF,/UZLAW=<J1T.: /0?$GB[3?#/AP:Y=^9=6;% C6FURX?[I!) (QSG-;
M$4JS0I*F=KJ&&?0BO$_%%GJ5I^S_ &+ZEJOV^.9;-[:/[,L7V:,QC$>1]_']
MX\\5N?VWXN\,^*O"UMJ^J6M]9ZX?*:TBM0BV^-@^5_O-C>.3Z'B@#U,UDVGB
M;1[W5[_3;:]5KO3AFZ0JRB(>NX@ _@3BN$L]8\9>(?B)XAT;3=;@L;+3I597
M>T21E'9!QR&YR3DC'%5X+K4-3\2?$.RM;BVL9((E\NXCL8B^T9W!C@%\J",L
M3C.10!Z2^NZ6NBRZNM_!+I\*,[W,#^:@"]>5SG&.U/TS5+/6M+@U'3)O/M9U
MW1R!2NX9(Z$ CD=Z\A\$)JEA\%=4U/\ M..:R^R7 @T^2SC98G#'+%CG>#S\
MI&.:MWOBK7=*^''A2XTYTT^UNT87U_;V".+8 C&(@ H!RQZ=J!GKIH-8'@S4
M9=4\.1W$^L6NLGS&5;RWC\O>.VY/X6]1]*WS0 AI*4TE,0&D-*:0T#$HHHH
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M% SF]BC C&/]I6 ]RM 'J=%9'A71O^$?\+V&FL=TL40,[YSOE;YG;\6)K7H
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M@)M#<_4FMC7?!8UK6/#=_P#;C!_84ID">3N\_.SC.1M^Y[]:ZSRS[4GE'VH
MY?0O!XT3Q=KFN"^\_P#M9E;R?*V^5C/\63NZ^@J+2?!$>F^)O$.J2WIN(];
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MB@!*.U%':@ HHHH **** "DI:2@ [44=J* "K$7_ !Z/_O57JQ%_QZ/_ +U
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M/POH&G7:76GZ'IMK<1YV306D:.N1@X8#(X)'XU>CL[:&ZFN8K>)+BX"B:54
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M+1O_ /H'VW_?34?\+1O_ /H'VW_?35PU%'U'#?R!_:N-_P"?C_ [G_A:-_\
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M;#_\\(ZS>]+2Y(C]I/N:7]L/_P \(Z/[7?\ YX1UFBG#I2Y8C]I+N:/]KO\
M\\8Z/[6?_GC'6?11RQ#VDNYH?VL__/&.E_M5_P#GC'6>*44N5%<\NYH?VHW_
M #QCH_M1O^>,=4.]%+E0<\NY?_M1O^>,=*-4;_GC'5 4"CE0^>1?_M-O^>,=
M+_:3?\\8ZHTM+E0^:1=_M)O^>,=+_:3?\\4JB*6CE0^9EW^T3_SQ2E_M _\
M/%*I"EI60^9ES^T#_P \4H^WG_GBGY53I:+(?,RW]O/_ #R2E^W'_GDGY53%
M**5D.[+?VX_\\D_*G?;R!CREJGWI:+(+LM_;C_SR2C[<?^>254%+2L.[+7VT
M_P#/-*7[:?\ GFE5>U H"[+7VP_\\TH^V'_GFM5N]':D.Y:^V'_GFM+]K/\
MSS6JHI:!EG[6?^>:T?:S_P \UJN*!2&6/M1_YYK1]J/_ #S6H** )_M1_P">
M:T?:C_SS6H** )_M1_YYK1]J/_/-:@HH G^U'_GFM'VH_P#/-:@HH G^U'_G
MFM'VH_\ /-:@HH G^U'_ )YK1]J/_/-:@HH G^U'_GFM'VH_\\UJ"B@"?[4?
M^>:T?:C_ ,\UJ"B@"?[4?^>:T?:C_P \UJ"B@"?[4?\ GFM'VH_\\UJ"B@"?
M[4?^>:T?:C_SS6H** )_M1_YYK1]J/\ SS6H** )_M1_YYK1]J/_ #S6H**
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M,L,E9/\  3R7'-W:_$\PHKT__A5^G?\ /]=?DO\ A1_PJ_3O^?ZZ_)?\*?\
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MR;?_ )ZM^5(+%<4M6/*M_P#GJWY4>7;_ //4_E0,@% J?R[?_GJ?RI?+M_\
MGJ?RI#(**G\NW_YZG\J/+M_^>I_*@""BI_+M_P#GJ?RH\NW_ .>I_*@""BI_
M+M_^>I_*CR[?_GJ?RH @HJ?R[?\ YZG\J/+M_P#GJ?RH @HJ?R[?_GJ?RH\N
MW_YZG\J (**G\NW_ .>I_*CR[?\ YZG\J (**G\NW_YZG\J/+M_^>I_*@""B
MI_+M_P#GJ?RH\NW_ .>I_*@""BI_+M_^>I_*CR[?_GJ?RH @HJ?R[?\ YZG\
MJ/+M_P#GJ?RH @HJ?R[?_GJ?RH\NW_YZG\J (**G\NW_ .>I_*CR[?\ YZG\
MJ (**G\NW_YZG\J/+M_^>I_*@""BI_+M_P#GJ?RH\NW_ .>I_*@""BI_+M_^
M>I_*CR[?_GJ?RH @HJ?R[?\ YZG\J/+M_P#GJ?RH @HJ?R[?_GJ?RH\NW_YZ
MG\J (**G\NW_ .>I_*CR[?\ YZG\J (**G\NW_YZG\J/+M_^>I_*@"[1110
M4454U2XO+32[B?3+'^T+N-<Q6OG"+S3Z;SP/J: +=%>7Q_%/Q/+XIE\.)X!S
MJL47G/;_ -LQ<)@'.[9M_B'>O2;&6XN-.MIKVV^R7,D2M-;^8'\IR 63<.&P
M<C(ZXH GHJIJNHPZ1H][J5RKM#9V[W$BQ@%BJ*6.,XYP*K^'->M?$_AZTUBP
M2:.WNE+(LR@.,,1R 2.H]: -.BBN-\'^+[[Q%XM\5Z7>0V\<&C720V[1*P9P
M3("6))!/R#H!UH [+-)FN-\4>,+[1/'OAG0[6&W>WU9W6=Y%8NH&,;<$ =>X
M-=C0 NZDW>U%)VI@+O\ :D\SVI#24#'>9[?K2>;[?K3#13L _P WV_6CSO\
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MIII^SB/E1M'Q%_TZ_P#D3_ZU)_PDG_3K_P"1/_K5BFF4>SCV#E1M_P#"2?\
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M_P"I<_\ )[_[71_PO?\ ZES_ ,GO_M=>0T4?4Z'\OXL/84^QZ[_PO;_J7/\
MR>_^UT?\+V_ZES_R>_\ M=>144?4Z'\OXL/84^QZ[_PO;_J7/_)[_P"UT?\
M"]O^I=_\GO\ [77D5%'U.A_+^+#V%/L>]>$_BO8>(]5&GWMI_9DTF! 6G\Q9
M&_NYVC!]/7ZXSWQKY'!P<C@U[3\-_B3_ &B(M$\038O!A;:Y<_Z[T5C_ 'O0
M]_KUXL3A.5<]/8YZU"RYH'I]%%%>:<8E%%% "&IT_P"/*3_>_P *@-3I_P >
M4G^]_A0!!115+6;R33]"O[V$*TEM;22H'&02JDC/MQ0!=HKBK+Q-K<3^&I-1
M;3[N+7E&(+6W>*6 F+S-V3(^]5&0>!U!]JW+CQ;HMK>R6L]VP:&18II%@D:&
M%V( 5Y0NQ#DCAB.H]: -FBL>\\5:/8ZG)IT]S(U]&JN;:&WDED*MG!"HI+#Y
M3DC..,XR,J_BC1DTBUU,7JR6MX0+8PHTCS$]E106)ZY &1@YQ@T :]%8O_"7
M:(-)NM2DO3%;6<@CN3+"Z/"Q( #(RAEY8=1WSTK.U7Q]8:?%ITMO:WUU'>WB
M6P<64Z *P)WJ?+_>=L!?O<XS@T =7155M0MTTMM1E,D5LD1F<R1.C*H&22A&
MX'';&:S[?Q=HEUIDVI17A%A!&)'NY()$B*_[+LH#'/&%)(/'7B@#:HK+LO$>
MEW[7*Q7#PO:IYDT=W ]N\:?WRLBJ=O!^;IP:;8>)M+U*_%E;33)<-&94CN+6
M6 R(.K)YBC<.>HS0!K45SW@75+S6?!]K?:E-YUQ)+.K/M"Y"S.J\  =% K0.
MO::%U(M<8_LO_C\!C8&+Y=_3'S94@C&<]J -&BLX:]IK?V9LN=W]JKNL]J,?
M-&S?GIP-O.3BJL7C#0YKR*WCNW/G3FWBG^SR""27GY%FV^63D$ !N3P.>* -
MNBL<>*=(;6I-)BN));Z&18Y88K:5S&2 06*J0J_,/F)Q[\&L?PUXL4>$(M1\
M17A::6]FMX]D)9Y")6545(URQP.P)XR: .PHKE?#/B-]<\6>(8(KDS6-G]F$
M$;1;&B9D;S%8$!@=PY#<C':M74?$NE:5>"UO;AQ/Y1F=(H))?*CSC>Y13L7_
M &FP.#Z&@#5HKD/"GBL3>!]-U'6[F2XNKMI@OD6[2/+MD89$<2DD!0,D#'KU
MJ;6O'FG:;X;CUBQCEU"*2X6 *D4B[6WA6#_(2C#/W6 )/ Y- '4T5DR^)=.A
M@@D?[9NG#,D"V$[3;5."QB";U7..2 .1ZBKFGZE::KIL.H:=.MQ:S)OCD0'D
M?3J".A!Y!&#S0!:HK@]&\9)=ZEKNI:IJ%_:Z=IMP\:VYTYTB$2HGS.QBW;\L
M3LW ]/EQ71CQ7HQTR74#=.MG&P43/;R*LI)P/+)7][GMLW9[=: -FBL>'Q5I
M$UM?3?:)(AI\1FNHY[:6*2) I;<8W4,1@'D#G%5E\=^'&:,?VB5$T;20,]O(
MJW(& 1$Q7$K98#:F6R<8H Z&BJ.EZQ8ZU!)+ITQD$4ABE1XVC>-QU5D8!E/L
M16/_ ,)5]EUSQ+%J7EQV&BVT%P'13O8.CLP.3@_=&  .O>@#IJ*YJSG\6:CI
MZZA&=+L1,GF16$]O)(X!&0KRB0 $]\(=N?XL<OO-;O[GQ&-"T06L=S#;BXO+
MFY5I$A#<(BH"I=B03G*@ 9Y)Q0!T5%<S:Z_J%MK5[HNM);-=QVAO+6YMT9(Y
MXP<,"A8E65L<;CD'/%8^F^+M=.D^'-5U!M-GAUJXB@-K;V[Q21[\_,K&1@P7
M&2-HXSR* .^HJEJVL6&AV/VS5KE;:V#JAE<$@%C@9QT&3UZ#O51_%.E1Z='>
MRRW$<4T@BA5[.999F/0)&5WOQSE01C)[&@#8HK)7Q-I!T:;5#>!+6!S'*7C9
M71P<;#&1O#Y(PN,G(P.167J'C#3+S2]6BT_5+G3+FQ@\R>YFTN;_ $4'!!*.
M@!)!R%ZD<@<4 =516-)XFTNSGCM+F[>281QM(\=M(RQA^%:1E4K&#@GYB. >
MPJI:>,K>Z\87V@FRNU:U$86<6TQ#LQ8'/R811MX<G:V>#0!TE%<ZOCSPZ]E-
M>1WLKVL!Q-<+:3&.,[@I5F"84Y(X)S@@].:UI]4L[;4[33IIMMW>!V@B"D[@
M@RQR!@ 9'7'6@"Y1110 4444 %%%% &I1110 4444 >36'_)T>I?]@Q?_0(Z
MCU>SM_&7QTN_#OBJ61]*LK!9+.R$S1I.Y"$M\I!)^9O?Y?05Z1'X8TB+Q1+X
MBCLP-5FB$+W'F,<I@#&W.T?='.,U5\1>!_#GBR2.37]+CNY(AM23>T;@>FY2
M"1[4 >1:5I]O<Z#\2/#XDEU#0](C>XT\O,S"&54D*[6!YP5''3Y>>IJ_X7MO
M#?AKX#RZ[*MU!<:A ([R6PN66:4B9E4#)(3T) '&:]9TGPUHVA:2^F:3IT%M
M9R ^9$JY\S(P=Q.2W''.>*S-/^&_A+2[._M++1HDM]14+=1M([B0 Y'WF.,'
MD8Q0!X]HBOHWQ2\*/IN@3^&X=1Y=&U3[4;R-AP[C^'.>A_#I7<?##_DI'Q%_
M["$7_H4U=)IGPP\':->VUWINBI#<6LGFQ2^?*S*V,=2QR/8\5L:9X<TK1M2U
M&_TVT\BZU.027<GF,WFL,X."2!]X],=: /,_BW+?P?$;PC+H\*3WZ+.UO&YP
M&<8P/S_R*R-%CT^X^"/BK5UFEGUV[5QJDD_$B/NX7'9<'/OSZ8'L6H>'-*U3
M6;#5+^T\V]TXL;67S&7RR>O (!Z=P:I/X$\-O/JDITT!M739?!9I%689S]T-
M@'/.1@]?6F!XSK&A6^@?#CPAXKT^XNQK4US;HUT]PS$(8V(0#. HV   =.#F
MM;QJ]_X@^,%UHMUHLFNV=G:*UMIW]I"S5BRJ3)D_>(+$8'/ ["O5+SP;H-_H
M-EHMW8"33[%T>WA\UQY94$*=P;)X)ZD]:;XA\%>'?%+QR:]I<=U)&-JR;F1P
M/3<I!Q[4 >.7][XJ\-_"/4K.X=[=#JJVT82^2=[:!D+&,R(3CD*.<'#],&M/
MPQHFLZ/X[T6YTK0/[!L;@%+J-]<BNA>+M)WA=V20 3\H/3/ %>IVOA'0+'0)
M=$MM*MTTV4EI+<KN#GCDD\D\#G.>!Z52T7X>^%O#NHB_T?2([>Z7.V4R.Y7(
MP<;F.."1QZTQE7XFZI8:5X'N)-5-[Y$LB1A;*7RY)#G.W=V4@'/MFO.?"<4V
MB_&71[.VT67P]!>VLAFLSJ/VKSAY;L';^Z<J.#Z5[/J^D6&NZ;)8:M:I=6LF
M-T;Y[="".0?<5C:3\//"VA:A;7VDZ2EO=6I<Q2B61F&Y=K9RQSP2.<XSQB@#
MS[X=>%M/\0>(O$-[JWGSFQU=GMXA,RHDF\DO@'D_*!SVI?ASX7T*/XC>)@UJ
MJOI%Z@T\&9\Q F0'^+YNB]<UZEI/A[2]"DO'TJU^SM>S&>X.]FWN>_)..O08
M%4Y/!?AZ7Q(NOMIJ?VFK!Q.KN/F QDJ#M)]R*8SQ_0/"^GZQX.\9ZC?F=Y;&
M:YDMD69E2-U0L'VC@G@#G/%3:Y/=:M\._ )N;N83S7GEFX#?.N&VA@?4#'->
MO6?A31=/T_4+&SLA';:D7:ZC\QSYA<8;DG(R/3%0MX+T!M.TZQ;3P;;3)/-M
M$\Y_W39SG.[)Y]<T".$\<:7;>&;;P]X<TN::PT?4]1_T^03,2?N @L3D9R3Z
M9%)%IEIX0^,.CZ;X5>2*UO;=S>68F:10-K$,022.@//I[UZ5J^BZ=KU@UGJ]
MI'=6Y.=CCH?4$<@^XJAH?@SP_P"&I7ET33([:5UVM(69VQZ;F)('TIC/'?#F
MA:1K'@/Q)?:M>R_:M/EF>WC\\A8#M!#A0>2S?+SZ<<UHS7MWJ&D_#*YU!V>X
M;4<%W.2P69%4D]_E K>\'?"ZR.DW*^,M&C:[%_))"WG<F,JN,E&Y&0W!_+FN
MXN_#6D7S:<;BR0_V6XDLPC,@A(QC 4@$?*.#QQ3 \K\8-8:WKWB+[+HE[JL^
MGH?.NI]3$$=D0N,QIW *DXYR<U:CM=5\3_!W0(K>^62[:9]UM/<>6;Q$=U\O
M=G)P ./\*[O4? ?AG5=5;4M0TF*:Z8@LY9@&/J5!P?Q%.F\$^'9]!M]&FTU'
ML+9F:&(R/E"222&SNY)/>@9YP8M&U+X8^(K6'3+FQETN82M9RW32I;S %<HV
M>1C=P<_RJ=O!]C-\&HKS1XO+U!88M0=TD9B[H#DX).."W QR*](T_P ,:+I6
MDS:;8:=#%:3@B6/EO,!&#N)R3QZFHM+\-:5X9L;M-!TX1^<-SQ>8S>:P!P,N
M3CKCTYI@<'H6J'Q]\0-)O3_Q[Z18+-*O;[0W!'YX/_ :T_C$?^*2L5/W&U*(
M/Z;=C]?TJ[\,_"UUX:T.Y;4[9;>]O)R[QJP;8@X5<@D=V/7O6AX[T"3Q)X0N
M[&V4-<C$L ) RZG.,G@9&1^-,"3QO_R(NL_]>C_RK'\'?\D?M_\ KSF_F]=#
M:6<FI^%H;/Q!;8DFMA'=PF3.3C#?,I_D:FM-)LK#2%TNT@$=FJ&,1;B<*<Y&
M2<]SWH&>)^&BVA)X=\1:DANM*$DL&".+5RY^<#]?P/H*['XF:FMS-HVBP0S7
MD=U,+J>*T3S'DB7LH'7/S'_@-=A'X6T:+P^VAI9+_9S9S 78]3G.XG/7WJ.R
M\+:/IU]!>6EH4N+>#[/$[3.^R/\ NC<2.],9PFC:R+;XLO+_ &??:;:ZS%L\
MJ^@,1,BC@@9YY&/JQK3^[\<OW7\6G?O<?U_):ZW4]"TW6+BTGU&V\Z6R?S+=
M][*8VR#G@C/W1U]*P]"T2_'CC6M>U6#R1+BWM%+JQ,8Q\W!.,[1QUY-,#JC3
M33C330 TTAI32&F,0TVG&FTP&FD-*:0TP&TT]:=33UIC&FFFG&FF@8AIE/-,
MI@(:::<:::8##24II*!C33:<:;3 8:0TII#3&,---.---,!IIIIQIIH&,---
M.---,!IIAIYIAJAC#2&E-(:!D9IAIYIAIC&FFFG&FFF PTVG&FTQC&IAI[4P
MTP&FFFG&FFF,8:8:>:8:!C#3&IYIC50#*::=330,C--IQIM4,8:8:>:8: &&
MF&GFF&F,::C:I#4;4QD;5&U2-4;50(C:HVJ1JC:FBB)JC:I&J-JH:(V^]49J
M1OO5&:I#(S3:<:;5#"BBB@ HHHH **** "BBB@ HHHH * <'(X-%>H_#;X;&
M_,6M^((<6O#6ULX_UOHS#^[Z#O\ 3KG5JQI1YI$3FH*[.Z^&]_KFH>$XI?$,
M>#TMYG/[R:/'#,/Y'N.?<];0!@8' HKYV<N:3DE8\J3N[B4445!(AJ=/^/*3
M_>_PJ U.G_'E)_O?X4 05F^(HI)_"^JQ0HTDDEG,J(@R6)0@ #N:TJ* /.K#
M07\.1>$=8TC2F@F:&*SU:"VMRK.DD8_>2*!G*.,DGGDYJI#HEQ'I^KZ%K5SX
MA'VN\G;R+&RCDANDE<L&$QB8*3GG>ZX(["O4** //XK^/1?BIJWFVEY<1?V;
M;1^;;6[3LA&_ *H"W..H&,CG&15'2-(U'0Y?#^LWVGW1MTFOGFMH8FEDM!<-
MN0[$R3@#! !QFO0HM*LX=6N-3BAVWEQ&D4LFX_,JYVC&<#&3T%7* /+_ !%I
ME_K.F^+=3M=.NQ!J LH;>W>W=99_*E&]S$1N YP,@' STKJ/&]K,]GHUQ;V\
MTT=AJUO<3);Q&1UC!*DA%R3C<#@ G&>*ZBB@#)UMCJ'@[43:Q3.UQ8R^7&8F
M60DQG V$!@?8C-<QJ>BW\WPLT*WL[>>.>Q6RN)K:*-1*1'M+JJN,%QR=K Y(
MQ@]*[VB@#AX(;@75_K>DR:UJNJ6^FR06XU2S6UB8E@P3;Y43,<J.>F,C()JC
MI8U*_P#&GAR\N'UN\6"VG^TRW^G+;QP2/&N57$:'J.^X=,$G->C44 <5X,T7
M4?\ A";"&34-1T>6.6Y+PQPQ MNN)""1+&Q'!!&,<&J_B#2;Z+QE$EG;W$]I
MK<=O%>S(F0A@E#%G(&%W1EES[5WM% 'GNAZ)?W.KW5I=6\]O#HUK<6=C/,A5
M9#-(Q5T/?;&J*2/4U6,%Y??#C3_",6DWD&JH8+>4R6LBPP>5("TWG$;",)N&
MUB3N''6O2Z* .6\,V4]OXP\67$UM)$ES=0&*5XRHE40@?*>X!ST[YKE]%T[4
M-+M?#>I7>G7AAL+_ %#[3$EL[2QK,SA)!&!N(^@/#9Z5ZC10!Q_A07%QXV\4
MZC)IUU9VUW]D^SO<PF,S!8V4M@].W!Y QD \4B2SZ!XYUV[NM/OKF'4XK=K1
M[2V:7<T:E3&Q PAR<@N57YCR,&NQHH \QT%M=T;P=X:L7M]0TNU9KK[=):61
MGN(#O<QILV/A6R?FV'H.F<F(:1J<_P .M=!LM0>X;6_MB1W$ 6>:,2Q.6VJ
M"2 3A1U&,5ZG10!QVM:UJ,FIV36IU:RT>6VDD-Q9:6TEPTP; C:-XV*#&2"4
M&?7%3_#FSNK'P='!?V\]O.+JX8I<(%?!F<@D#CD'/''IQ7544 >;W>EW[>"/
M'L"V-R9KO4;A[>,0MNF4I$ 4&,L#@\CT-;/B2PN5T[PW>6]I+/%I5W%-/:PQ
MEG">6R;E0<DJ6!P!GKBNOHH \\UNVN]?O/$&JZ?87BVR^';C3X_.MGBDN9F^
M<!(V 8@=,XY+$#.#5]M.N3?^ S]CEVV:.)SY1Q!_HI W<?+\V!SWKM** .7\
M,VES;^+?%<LUO+%#/=PO"[H560>2H)4]#SQQ67?>'+K6];\<6;));QZC96D5
MO<2(0C,J2=#WP<9QTS7>44 >:^)=GB#P7+8ZCX7NO^$D6W%O$&TUI0DAP,I<
M!2@7OG<,=\5KQP7/AOQ>^J7-G=3V.H6,$$DEK T[6\T0; *("Q4@_> (!ZXS
M79T4 <;';7.M^*KO75L[BWLK?3)+*V%Q$T<D[LVYF$; ,H&T ;@"<Y QS7/Z
M3X=E\/\ A7PMKVG:/+!JEHT<>HPP6Q6::"0[9-Z 99E.UN>F#7J5% '*_$.R
MGU#PND%M;273&^MF:..,N2HE4L2!V ZU!XRL;T^(M"U6"6_BM+,3QS/I\"S2
MQ&0*%8(4?</E(.%)&?K78T4 >7ZY8^1H[7FG2:I/?:AK=F\4NH6R1R2RIC#)
M#B+H%P0X3(5CG&&+=32ZNM+\6VE[;7A\1:CI\<PMA;*JO"F47RUCDER0Q;.6
MS\PXQ7HNIZ39:Q:K;ZC#YJ)(LJ%79'C=3D,KJ0RL/4$'KZU%IN@:?I5Q+<6D
M4K7$RA7GN+B2>0J.B[Y&9L>V<4 <?K<=[I]U]L\.1:O!KK0V\?D+:&2TO@"O
M$C8*I@;E+%D8 'MC.K;)+IWQ/U.>XMKHP:E:6RP3QV[R1[D+A@S*"$Z@_-BN
MMHH XWP9H7F_#,Z3JMH]N;HW231RQE&P\TF"0>?ND$'TQ6=\.EO]4U&XU'5T
M*R:1 NBQY_B>,_O7_$A/R->AU3TO2K/1K!;/38?)@5F?:79B69BQ)9B2223U
M- %RBBB@ HHHH **** -2BBB@ HHHH **** "BBB@ HHHH 3%&*6B@!,4FTT
MZB@!FTT;#[4^BG<"/RS[4>6?:I**+@1>4?:D\IO45-11<"'R6]12>0WJ*GHH
MNP(/(;U%)]G?U6K%%%V.Y6^S/ZK2?9G]5_.K5%',PN5/LK^J_G2?9)/5?SJY
M13YF%RG]CD]5_.D^QR>J_G5VBCF87*/V*3^\OYFD^PR_WD_,U?HHYF%V4/L$
MO]Y/S-)_9\O]Y/S/^%:%%',PNS._L^7^\GYG_"F?V;-_>3\S_A6I24^=AS,S
M/[,F_O)^9_PI/[,F_O)^9_PK4HHYV',S*.ESG^*/\S_A2'2I_P"]'^9_PK6H
MHYV/F9D?V3/_ 'X_S/\ A2?V1<?WH_S/^%;%%'.PYF8QT>X_OQ_F?\*3^QKC
M^_'^9_PK:HH]I(.9F)_8MS_?B_,_X4AT2Y_OQ?F?\*W**?M)!S,PO[#N?[\7
MYG_"F_V%=?WXOS/^%;]%'M)!S,Y_^P;K^_#^9_PI#H%U_?A_,_X5T-%'M)!S
M,YT^'[K_ )Z0_P#?1_PI/^$>N_\ GI#_ -]'_"NCHH]I(?.SFO\ A';O_GI#
M_P!]'_"D/AR\_P">D/\ WT?\*Z;)I,FG[60<[.9_X1J\_P">D/\ WT?\*3_A
M&KS_ )Z0?]]'_"NGR:,FCVL@YV<L?#%Z?^6D'_?1_P *3_A%[W_GI!_WTW^%
M=5DT9-'M9!SLY0^%K[_GI!_WTW^%(?"M]_SUM_\ OIO\*ZS)HR:/;2#G9R)\
M)WW_ #UM_P#OIO\ "D_X1*__ .>MO_WTW^%=?DT9-/VTPYV<<?"-_P#\];?_
M +Z;_P")I/\ A$-0_P">MO\ ]]-_\3799-&XT>VF/VDCBSX/U _\M;?_ +Z;
M_P")II\&ZA_SUMO^^F_^)KMMQHW&CVTP]I(X@^#-1_Y[6W_?3?\ Q-(?!>H_
M\]K;_OIO_B:[C<:-QH]O,/:2.%/@G4C_ ,MK7_OIO_B:3_A"-2_Y[6O_ 'TW
M_P 37=[C1N-/V\P]I(X$^!M3_P">UK_WVW_Q-(? NI_\]K7_ +[;_P")KOMQ
MHW'UH]O,/:2//_\ A ]4_P">UI_WVW_Q-(? 6J?\][3_ +[;_P")KT'<?6C<
M?6CV\P]I(\\/@#5?^>]I_P!]M_\ $TG_  K_ %7_ )[VG_?;_P#Q->B;CZT;
MCZT?6)C]K(\Y/P^U8_\ +>T_[[?_ .)II^'FK?\ />S_ .^W_P#B:]'WGUHW
MGUI_6)A[61YN?AWJ_P#SWL_^^W_^)II^'.KG_EO9_P#?;_\ Q->E;SZT;SZT
M?6*@>UD>9GX<:Q_SWL_^^W_^)II^&^L'_EXLO^^W_P#B:].WMZTF]O6CZQ4#
MVLCS$_#763_R\67_ 'V__P 33#\,]9/_ "\67_?;_P#Q%>H[V]:-[>M/ZS4#
MVTCRW_A6.M?\_%C_ -]O_P#$4T_##6O^?BQ_[[?_ .(KU3>WK07;UH^LU!^V
MF>4GX7:W_P _-C_WV_\ \13?^%6ZW_S\V/\ W\?_ .(KU?S&]:/,;UH^M5 ]
MM,\F/PKUS_GYL/\ OX__ ,133\*==/\ R\V'_?Q__B*];\QO6CS&]:/K50/;
M3/(S\*-=_P"?FP_[^/\ _$4T_"?7?^?FP_[^/_\ $5Z[YC>OZ4>8WK^E/ZU4
M#VTSR _"77O^?G3_ /OY)_\ $4T_"/7S_P O6G_]_)/_ (BO8?,;U_2CS&]?
MTH^M50]O,\;/PAU\_P#+UI__ '\D_P#B*:?@_P"(#_R]:?\ ]_)/_B*]F\Q_
M7]*3S7]?TI_6ZH_;S/%S\'?$)_Y>M._[^2?_ !%,;X->(C_R]Z;_ -_)/_B*
M]K\U_7]*/-?U_2CZY5#V\SQ$_!CQ&?\ E[TW_OY)_P#$4P_!7Q&?^7O3?^_D
MG_Q%>X^:_K^E'FOZ_I3^N51_6)GAA^"?B0G_ (^],_[^R?\ QNF'X(^)?^?O
M3/\ O[)_\;KW;S7]?TI/.?\ O?I1]=JA]8J'@Y^!WB8_\OFE_P#?V3_XW2?\
M*-\3?\_FE_\ ?V7_ .-U[SYS_P![]*/.?^]^E/Z[6#ZQ4/!O^%'>)O\ G[TO
M_O[+_P#&Z/\ A1WB;_G[TS_O[+_\;KW@S/\ WOTH\Z3^]^E'UVL'UBH>#_\
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MO]_]!1]IE_O_ *"@!GEO_<;\J/+?^XWY4_[3+_?_ $%'VF7^_P#H* &>6_\
M<;\J/+?^XWY4_P"TR_W_ -!1]IE_O_H* &>6_P#<;\J/+?\ N-^5/^TR_P!_
M]!1]IE_O_H* &>6_]QORH\M_[C?E3_M,O]_]!1]IE_O_ *"@!GEO_<;\J/+?
M^XWY4_[3+_?_ $%'VF7^_P#H* &>6_\ <;\J/+?^XWY4_P"TR_W_ -!1]IE_
MO_H* &>6_P#<;\J/+?\ N-^5/^TR_P!_]!1]IE_O_H* &>6_]QORH\M_[C?E
M3_M,O]_]!1]IE_O_ *"@!GEO_<;\J/+?^XWY4_[3+_?_ $%'VF7^_P#H* &>
M6_\ <;\J/+?^XWY4_P"TR_W_ -!1]IE_O_H* &>6_P#<;\J/+?\ N-^5/^TR
M_P!_]!1]IE_O_H* &>6_]QORH\M_[C?E3_M,O]_]!1]IE_O_ *"@!GEO_<;\
MJ/+?^XWY4_[3+_?_ $%'VF7^_P#H* &>6_\ <;\J/+?^XWY4_P"TR_W_ -!1
M]IE_O_H* &>6_P#<;\J/+?\ N-^5/^TR_P!_]!1]IE_O_H* &>6_]QORH\M_
M[C?E3_M,O]_]!1]IE_O_ *"@!GEO_<;\J/+?^XWY4_[3+_?_ $%'VF7^_P#H
M* &>6_\ <;\J/+?^XWY4_P"TR_W_ -!1]IE_O_H* &>6_P#<;\J/+?\ N-^5
M/^TR_P!_]!1]IE_O_H* &>6_]QORH\M_[C?E3_M,O]_]!1]IE_O_ *"@!GEO
M_<;\J/+?^XWY4_[3+_?_ $%'VF7^_P#H* &>6_\ <;\J/+?^XWY4_P"TR_W_
M -!1]IE_O_H* +]%%% !11574Q=G2+P:;@7A@?[/G&/,VG;UXZXH M45\]^
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M **** "BBB@ HHHH **** $HHHH **** "BBB@ HHHH **** $HHHH ****
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MGWS[F&%.P)\O'' [YJ?1=)@T+1+32[1Y'@M8Q&C2D%B!ZD #]*OT4 :E%%%
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MT;\O_K4;+;_GHWY?_6J"B@"?9;?\]&_+_P"M1LMO^>C?E_\ 6J"B@"?9;?\
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M2EI* "BBB@!#24II* "BBB@!**** $HHHH *#10: $I#2TAH **** $HHHH
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M3O*D_N-^5'E2?W&_*@!M%.\J3^XWY4>5)_<;\J &T4[RI/[C?E1Y4G]QORH
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M/M$O]_\ 2HZ* )/M$O\ ?_2C[1+_ '_TJ.B@"3[1+_?_ $H^T2_W_P!*CHH
MD^T2_P!_]*/M$O\ ?_2HZ* )/M$O]_\ 2C[1+_?_ $J.B@"3[1+_ '_TH^T2
M_P!_]*CHH D^T2_W_P!*/M$O]_\ 2LZRU>QU&\O;6SG\R:QD$5PNQAL8C(&2
M,'CTS5BXG6VM99Y 2L2%V"]2 ,T 6?M$O]_]*/M$O]_]*SM'U2'6]%M-3M%D
M2&[B65%D # 'UP2,_C5V@"3[1+_?_2C[1+_?_2HZ* )/M$O]_P#2C[1+_?\
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M>I8?[Y /L*K>#O ,MKXJT^\G^']GH26C%Y+LZQ)<LS!3M\M Y ^;'WL\9[T
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M9R-(K!P'WJ3M)(!('7GVH O-\7;VSL[+5M9\(7=CH%\ZK#J'VI)#AN0S1@9
MQSR>>V:UM<^(=Q:^*V\.^&= EU_4(8!<7"I<K"D2$ CYF!R<%3V^\*Y+4/#G
MCWQ3X3TSP?JFAVFFV=JT23ZG]L23S$C& 5C7D''KU/I6K<^'/$_A+XD7OB#P
MKI,6M6.I6R12VSW:P/$RA1G<W4?+GC/4], T 9?C+5Q<?$+X?ZKJ-O)I8Q++
M/%=?*T&,;MWTQU]*Z_0]?;XD:'K,3:.UKHTRR6UM=32Y-V""I8)M&T#UR>?H
M:P/%O@S7/&'B#PE<ZSI<#V\22KJB0S+MA#8X&3EN.XSR*T? MGK_ ('TO5M+
M\01>=HNF*\]AJ'G*2T0RQ0KG<,#GIZCIB@!OP0U*:^^&L5O<G,FGW,EISV P
MP'X!\?A7HE>;? FSEM_AR;J=2IO[Z6Y'&,CY4_FAKTF@ HHHH 2BBB@ HHHH
M **** "BBB@ HHHH 2BBB@ HHHH **** "BBB@!**** "BBB@ I*6DH 2BBB
M@ HHHH *2EI* "BBB@ H-%!H 2BBB@ HHHH 2BBB@ HHHH 0T4&B@ HHHH 2
MBBB@ I*6DH **** $-)2FDH **** $HHHH 2BBB@ H-%!H 2D-+2&@ HHHH
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M3@B31?"DU[=>)VN;O5-,6\U6966$A%N82B8(WJ<#EQO3!.3R<#$E]X9+>/\
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M(YK?U?2;37-)N--U%#);W"X8 X(P<@@]B" 1[BJ"^&(9[&YL]9U"^UBWN(1
MT=XZ !?81JG/3YCEN.".: ,N_GUGPS=:)-=:S+JD=[>1V-U!/!$BAI!Q)&45
M2,,.C%L@GN,UER:IXBN=&\6ZI%K;0#1;RY6U@2VB*NL2A]LA922,<#;M(Y))
MR,=):^$H8[NQGU#4]0U3^SN;2.\:,K$V-N_Y$4NP' +EL9)Z\U*GA:R32=:T
M\2W'E:S+/+<,67<AE7:VSC@8'&<_C0!@KK&LV.I>%[F[U+[3#KC%+BT$")'"
M6CWJ8R!O&",'<S9R>G&,Q]<\1GPCKVOC6F5M+OIT@MEMHMDD<<N-LA*DGY>
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MB@#G/$_BK6M UY;".>)QKL4:Z:9]B_8)BP5MXX)0!MP)!.X;:T//URY\=2:
MNMR0VMOI<,\DZ6\7G/)N92PRI5=V 3\I'& !G-:=[X,TO4I-7?4/.N7U6-(9
M&D89A1.56/ ^4!OF[_-R<UB+X;O)/B1)*+W5(%@T>&&/4DVYE8.VY6+(8W)&
M"05XX(Q0 67B2Z;1;N#6-9-I<6>K2:=]JM[023W87!7RXP&&\[AG",,!N!U&
M?+XOU6'PWXQ$%]<2S:/Y;6EW=68AFQ(@;#QLBC(.1G8,C!KIO^$'TY+&SAMK
MF\M[FTN7NDODD5IFF<$.[;E*L6R<Y7'IBF'P'8266M6]Q?:A<-K:H+N>21"Y
M*C *X7 X[8P,   4 5CJ&KZ3XI\/P7VJ&]AUGSDFA:!$2%UCWJ8]HW <;<,S
M<'K47AS6[^77H[/Q#J5U9ZG(\X_LR>S58)44Y#6\H7+84J3EV/WN!P1T-]X?
MM-0U'2KR:299-+9VA", &W)L.[C/3T(JM;>%8HM4L[V\U/4-1:P5A:1W;QE8
M2PVELJ@9VV\9<L>2>O- '-:3XGUC5-#\,6?VWR[[69[GSKT1)NCBA9B0BXV[
MB J@D$#DX-7;K5]6T74]9TF747OO+T:34K2ZFBC66)ERA1MBA6&0&!VYY(.>
M*TH_ ^FPZ)I^GP3W<3Z;,TUI>(Z^=$[,6;G;M(.X@@J01U'>IH?"=HJZD]U=
M75[=ZE!]FGO)V3S!%M("*%4*H&2>%Y)R<T <]#J^NV&F>%-6O=7:[_MB>WM[
MFU-O&D2^<A(9"%WA@0,Y8@G/"C '?UB3^%K*XTO1K!Y;@1:/-!-;D,NYFB7"
M[N.0>^,?A6W0!J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?K
MFA:;XDTF33=:MOM-I*07CWLN2#D<J01R/6M"B@"."".VMXX(%VQ1($1<YP ,
M 5)110 4444 %9FM>'=*\0K:C5[07'V.<7$!\QD,<@Z$%2#^'2M.B@ HHHH
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M324 %%%% "4444 )1110 4&B@T )2&EI#0 4444 )1110 AJ=/\ CRD_WO\
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MI((=@NU>5.,D9QQF@#8HK$A\7Z)<7D=O%>,?-F,$4Q@D$$D@S\BS%?+9L@C
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MQCYA'3@G Z]@* /#M2BU/QA\1/%4-[X>EU][&8P6D?\ ;"V8LD4L%=5/WL@
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M>IH \C\,75S)\%_'=G,TBPVDI6&!YO-$ )Y4-T(XZC@]>]>O?#C_ ))IX?\
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M* "BBB@ H-%!H 2BBB@ HHHH 2BBB@ HHHH 0T4&B@ HHHH 2BBB@ I*6DH
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MV4%M:K<6S(\[*Q,D@B;#$JK?*"!N(P,TRQ@O[KXAP7@?6KZT32YX3=:A8"W
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MXAU;_G^E_,4O_"0:K_S_ $OYB@#TC%&*\X_X2#5?^?Z7\Q2_V_JO_/[+^8H
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M_P">K4"]N/\ GJU &AY3_P!T_E1Y3_W3^54!>7'_ #U:C[9<?\]6H O^4_\
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MPIPIHIPH 44HI!2B@!PI12"E% "BG4T4Z@!:<*;3A0 HI12"E% #A2BD%**
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M &-_PB&@?] JW_[YH_X1#0/^@5;_ /?-;-% &-_PB&@?] JW_P"^:/\ A$-
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M-$_Z!L'_ 'S6M24 97_",:)_T#8/^^:7_A&=%_Z!L'_?-:E% &7_ ,(SHO\
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MY]4J:B@"'[%9?\^R4?8K/_GU2IJ* (?L=G_S[)2_8[/_ )]DJ2B@"/['9_\
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MO+8+@EOM"?O/<G!R?4'MB@#U)?'&BZ)I>CQ>)M;MTO;RP6?SO+=4FP@+./E
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MTXKSKQ+XFU35-)\1:;?7L>DRK=.?^$?MM&!,JA@QE:;'RXY);.3@GH: /?\
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MY7 C(('(W!?Y<"CX=:C'I?BGQ;X:N7EM-8O[^9[1#$W("N=^X# ' .2><C%
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MY(EU"5XI&,4+;2CH5X.06/&[H.*[W3]0MM5TVWO["3S;:YC$D4FTKN4C(."
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M0_:_CUXPNHO]5';PPL?]H+&/_9&JA\7-3;1O&WA;4(9+>VEMEG=+B]C>2WZ
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M <EKGQ9U&#P/X5GCN+?3;[6@QN;UH#*ELB-M9P@!R2><<]"/0T_P;\2=0O\
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MY7E;_.R4.,Y&W[G7!ZT <MHVN>+;?XA:MX-U36H;^5].:XM+\6B1&"0@;?E
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MGW?@077BGP[K/]HE?[$@\GR?)SYWRXSG=\O7T-:WBS0/^$H\*WVC?:?LOVM
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MG\-Z'<W4MU<Z-I\UQ,"))I+5&=P1C!)&3QQ5U;2V2\>[6WB6YD0(\P0;V4=
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M9^)8X+=463C'S #!XXYH Y7P9"FB:])H%WHUE8ZC'I\<S76G2'RKI Y7<ZD
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MYJ?\\A^='FI_SR'YT 145+YJ?\\A^='FI_SR% $-%3>:G_/(4GFI_P \A^=
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MY\?_ #P7\Z (**G\^/\ YX+^='GQ_P#/!?SH @HJ?SX_^>"_G1Y\?_/!?SH
M@HJ?SX_^>"_G1Y\?_/!?SH @HJ?SX_\ G@OYT>?'_P \%_.@""BI_/C_ .>"
M_G1Y\?\ SP7\Z (**G\^/_G@OYT>?'_SP7\Z (**G\^/_G@OYT>?'_SP7\Z
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M9+&C,91USP/E'/\ %COZ&@#:W-GJ?SI-S>I_.N5NOB;X.L]4:PN-=@6X5MC
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M[7KCXAVT6G7:QZ(^K1Z<(_)1O-P5$AW$9_B['N/QZ/1/$.J)\3M9\/:Q<B6
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MVNX_Y^)?^^S49ZTVG9 2F[N?^?B7_OLTGVNY_P"?B7_OLU&:::+(9+]LN?\
MGXE_[[---Y<_\_$W_?9J,TTT[("4WEU_S\S?]_#2&]NO^?F;_OX:B---.R E
M-[=?\_,W_?PT"_NT8,+F7(.>7)%0FFFBR&=5INI)?Q=EE7[R?U'M5VN'BF>"
M59(F*NIR"*ZK3=22_B[+*H^9/ZCVK"<+:HSE&Q>HHHK,@**** "BBB@!****
M "BBB@ I*6DH 2BBB@ HHHH *2EI* "BBB@ H-%!H 2BBB@ HHHH 2BBB@ H
MHHH 0T4&B@ HHHH 2BBB@ I*6DH **** $-)2FDH **** $HHHH 2BBB@ H-
M%!H 2D-+2&@ HHHH 2BBB@!#4Z?\>4G^]_A4!J=/^/*3_>_PH @HHK*\3_\
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MEY8:3(T5S-)=>4[NG,@B380VT=V9<G('3-=#87L.I:;;7UJ2T%S$LT9(P2K
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M4444 %)2TE !1110 AI*4TE !1110 E%%% "4444 %!HH- "4AI:0T %%%%
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M>#&YVY4[2>0&P?6M/6M&UOQ!IMM'=C3[:6#4K>Y$<4SR*(XV!;YR@RQYP-H
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M'_&D_LJS_P">/_CY_P :F^U6_P#SWB_[[%)]KM_^?B+_ +[%%Y!J1?V59_\
M/'_Q\_XT?V39_P#/'_Q]O\:E^UV__/Q%_P!]BC[7;?\ /Q%_WV*+R#4B_LBS
M_P">/_C[?XTG]CV7_/'_ ,?;_&IOMEM_S\1?]]BC[9;?\_$7_?8HO(-2'^Q[
M+_GC_P"/M_C1_8UC_P \/_'V_P :E^V6O_/S#_W\%'VVU_Y^8?\ OX*+R#4A
M_L6Q_P">'_C[?XTJZ-8JP80#(.1EB?ZU+]MM?^?F'_OX*5;RV9@JW$18G  <
M<T7D&I-MHVTE%2(7;1MI** %VFC::2B@!=IHVFDHH -AHV&DHH 7::-II**
M%VFC::2DH 78?:EV'VIE% #]A]J-A]J910 [8?:CRS[4VDH ?Y9]J/+/M3**
M '^6?:D\L^U-H- #O+/M1Y9]J910 _RS[4>4?:F44 /\IO44GE-ZBF44 /\
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MBB@ IKNL4;/(=JJ"6/H!3JK:C_R"[K_KB_\ Z": .2@^,/@.XN%AC\01AF.
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M<>C?!R[TV 96VM8TR.Y#KD_B<FN5\5V-NOP]\#A+:,;WMPP"#YM\8+9^IY-
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MP,XZ=*X3Q?HZWWQ*T:UMI0J:I%_Q,X.TD,#K(A/U/R?0_EZ+0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &I112.ZQH6=@
MJCJ2< 4 +14'V^S_ .?J#_OX*/M]I_S]0_\ ?P4[,GFCW)Z*@^W6G_/U#_W\
M%'VZT_Y^H?\ OX*+,.9=R:BH/MUI_P _4/\ W\%+]MM/^?J'_OX*+,.9=R44
M"H?MEI_S]0_]_!1]LM/^?J'_ +^"BS'S+N3"BH?MEI_S]0_]_!1]LM?^?J'_
M +^"BS#F7<FI*B^V6O\ S]0_]_!1]KM?^?J'_OL4PYEW):3M4?VNU_Y^H?\
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M^= 'F/QS_P"8%_V\?^TZMZ;_ ,F[O_U[S?\ H]JJ?'/_ )@7_;Q_[3JWIO\
MR;N__7O-_P"CVKTE_ I^OZL^;E_O^(_P?I$\;%.'2FBG#I7J'RZ'"G"O<_\
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M 4X4T4X4ABBB@44 +2BDI12&+0**!0,6E%)2BD,6E%)2B@ I124HH&%+24M
M"BEI!2T# 4M(*6D,*6DI: %H%% H&+1112 444"B@8HHH%% #J***  4M(*6
MD,*6DI: "@44"@8M%%% "T444#%%**04HI %%%% Q12T@I: "BBB@ I:2EH
M**** %HHHH&%%%%(!110**8!2BDI12 ****!A2TE+0(****!A1110 4M)2TP
M"BBBD 4444 **6D%+0 4444 %%%% 'G'QS_Y@7_;Q_[3J[I*/+^STR1JSLT$
MP"J,D_OVKTQXTDQYB*V.FX9Q2JJHH5%"@= !BNGV_P"[C"VSN>:\#?$5*W-\
M2M:VVW^1\JC3;[_GRN/^_3?X4X:;??\ /E<?]^F_PKZIHKI^OO\ E/-_L&/_
M #\_#_@GRP--OO\ GSN/^_3?X4X:;??\^=Q_WZ;_  KZEHH^O/\ E'_84?\
MGY^'_!/EP:=>_P#/G<?]^F_PIPTZ]_Y\[C_OTW^%?4-%+Z\_Y1_V''^?\/\
M@GS -.O?^?.X_P"_3?X4[^SKW_GSN/\ OTW^%?3M%+Z\_P"4?]AQ_G_#_@GS
M&-.O?^?.X_[]-_A3QI][_P ^=Q_WZ;_"OIFBCZZ_Y1_V)'^?\/\ @GS.-/O?
M^?2?_OTW^%.&GWO_ #Z3_P#?IO\ "OI;-&11]=?\H_[%C_/^'_!/FL:?>?\
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M\^TW_?LTHLKK_GVF_P"_9KWGS8_[Z_G1YL?]]?SI?6GV'_9:_F_ \(%E=?\
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MC1_:-G_S^0?]_5H]J^P?4O,\V^S3_P#/&3_O@TOV:?\ YXR?]\&O2/[2LO\
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M=&VFM+%B9K1B"1EMYW@$;22B9X.!TJ]H6LZYK>N:K&18V^GZ;J#VN[RG>2<
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MA31=>T[69+K#30X:RN4W<.Q/ SP<'@9.:VUT[5A\8;F_6SDV'2=BW!C/DF7
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M@!,48HHH ,48HHH ,48HHH ,48HHH ,48HHH -M&VBB@ VT;:** #;1MHHH
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*8E_OG\J** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087388912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Aug. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PACIRA BIOSCIENCES,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0619477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5401 West Kennedy Boulevard, Suite 890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tampa<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">553-6680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PCRX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,824,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001396814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090084423472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 122,061<span></span>
</td>
<td class="nump">$ 585,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term available-for-sale investments</a></td>
<td class="nump">194,332<span></span>
</td>
<td class="nump">70,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">91,105<span></span>
</td>
<td class="nump">96,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">100,588<span></span>
</td>
<td class="nump">98,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">18,124<span></span>
</td>
<td class="nump">14,771<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">526,210<span></span>
</td>
<td class="nump">866,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">191,279<span></span>
</td>
<td class="nump">188,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">72,082<span></span>
</td>
<td class="nump">76,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">146,132<span></span>
</td>
<td class="nump">145,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">595,324<span></span>
</td>
<td class="nump">623,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">167,149<span></span>
</td>
<td class="nump">153,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_EquityMethodInvestmentsAndOtherAssets', window );">Investments and other assets</a></td>
<td class="nump">35,812<span></span>
</td>
<td class="nump">21,987<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,733,988<span></span>
</td>
<td class="nump">2,075,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">13,983<span></span>
</td>
<td class="nump">10,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">77,275<span></span>
</td>
<td class="nump">127,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">8,134<span></span>
</td>
<td class="nump">7,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible senior notes, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">350,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Current portion of long-term debt, net</a></td>
<td class="nump">33,776<span></span>
</td>
<td class="nump">24,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">429<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">133,179<span></span>
</td>
<td class="nump">521,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible senior notes, net</a></td>
<td class="nump">403,534<span></span>
</td>
<td class="nump">339,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredLongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">318,344<span></span>
</td>
<td class="nump">335,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="nump">67,575<span></span>
</td>
<td class="nump">71,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">35,247<span></span>
</td>
<td class="nump">57,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">19,473<span></span>
</td>
<td class="nump">19,972<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">977,352<span></span>
</td>
<td class="nump">1,344,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001; 250,000,000 shares authorized; 45,801,578 and 44,734,308 shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">895,151<span></span>
</td>
<td class="nump">942,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(137,956)<span></span>
</td>
<td class="num">(211,895)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(605)<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">756,636<span></span>
</td>
<td class="nump">730,408<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,733,988<span></span>
</td>
<td class="nump">$ 2,075,353<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_EquityMethodInvestmentsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments and Other Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_EquityMethodInvestmentsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087318464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">45,801,578<span></span>
</td>
<td class="nump">44,734,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">45,801,578<span></span>
</td>
<td class="nump">44,734,308<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085594576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 169,411<span></span>
</td>
<td class="nump">$ 135,590<span></span>
</td>
<td class="nump">$ 327,402<span></span>
</td>
<td class="nump">$ 254,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of goods sold</a></td>
<td class="nump">50,627<span></span>
</td>
<td class="nump">35,248<span></span>
</td>
<td class="nump">86,701<span></span>
</td>
<td class="nump">66,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">26,282<span></span>
</td>
<td class="nump">12,573<span></span>
</td>
<td class="nump">47,887<span></span>
</td>
<td class="nump">28,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">65,003<span></span>
</td>
<td class="nump">50,813<span></span>
</td>
<td class="nump">129,263<span></span>
</td>
<td class="nump">99,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">14,322<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
<td class="nump">28,644<span></span>
</td>
<td class="nump">3,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet', window );">Acquisition-related (gains) charges, product discontinuation and other</a></td>
<td class="num">(18,058)<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="num">(13,721)<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">138,176<span></span>
</td>
<td class="nump">100,747<span></span>
</td>
<td class="nump">278,774<span></span>
</td>
<td class="nump">200,337<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">31,235<span></span>
</td>
<td class="nump">34,843<span></span>
</td>
<td class="nump">48,628<span></span>
</td>
<td class="nump">54,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(8,833)<span></span>
</td>
<td class="num">(7,023)<span></span>
</td>
<td class="num">(19,079)<span></span>
</td>
<td class="num">(13,994)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(647)<span></span>
</td>
<td class="num">(2,396)<span></span>
</td>
<td class="num">(771)<span></span>
</td>
<td class="num">(2,554)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(9,228)<span></span>
</td>
<td class="num">(9,195)<span></span>
</td>
<td class="num">(19,327)<span></span>
</td>
<td class="num">(15,909)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">22,007<span></span>
</td>
<td class="nump">25,648<span></span>
</td>
<td class="nump">29,301<span></span>
</td>
<td class="nump">38,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(2,131)<span></span>
</td>
<td class="num">(6,567)<span></span>
</td>
<td class="num">(2,597)<span></span>
</td>
<td class="num">(8,921)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 19,876<span></span>
</td>
<td class="nump">$ 19,081<span></span>
</td>
<td class="nump">$ 26,704<span></span>
</td>
<td class="nump">$ 29,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in USD per share)</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in USD per share)</a></td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">45,501<span></span>
</td>
<td class="nump">44,145<span></span>
</td>
<td class="nump">45,185<span></span>
</td>
<td class="nump">43,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">52,478<span></span>
</td>
<td class="nump">45,592<span></span>
</td>
<td class="nump">52,262<span></span>
</td>
<td class="nump">45,779<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 168,581<span></span>
</td>
<td class="nump">$ 134,863<span></span>
</td>
<td class="nump">$ 326,003<span></span>
</td>
<td class="nump">$ 253,601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">830<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember', window );">Collaborative licensing and milestone revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090084404784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 19,876<span></span>
</td>
<td class="nump">$ 19,081<span></span>
</td>
<td class="nump">$ 26,704<span></span>
</td>
<td class="nump">$ 29,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized (loss) gain on investments, net of tax</a></td>
<td class="num">(160)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">82<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive (loss) income</a></td>
<td class="num">(78)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(772)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 19,798<span></span>
</td>
<td class="nump">$ 19,090<span></span>
</td>
<td class="nump">$ 25,932<span></span>
</td>
<td class="nump">$ 29,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090081314544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive (loss) income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,637,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 619,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 873,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (253,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">479,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">16,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested restricted stock units</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">20,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">29,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">687,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">911,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(224,425)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,637,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">619,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">873,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(253,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,734,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2021</a></td>
<td class="nump">$ 730,408<span></span>
</td>
<td class="num">$ (49,233)<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">942,091<span></span>
</td>
<td class="num">$ (96,468)<span></span>
</td>
<td class="num">(211,895)<span></span>
</td>
<td class="nump">$ 47,235<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2)</a></td>
<td class="text">Accounting Standards Update 2020-06 Retrospective [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,958,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="nump">$ 650,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">894,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(243,506)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">5,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested restricted stock units</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">10,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">19,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">687,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">911,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(224,425)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,734,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 730,408<span></span>
</td>
<td class="num">$ (49,233)<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">942,091<span></span>
</td>
<td class="num">$ (96,468)<span></span>
</td>
<td class="num">(211,895)<span></span>
</td>
<td class="nump">$ 47,235<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">630,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 21,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">21,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested restricted stock units</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">36,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">$ 1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">22,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)</a></td>
<td class="nump">3,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(772)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">26,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,802,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">756,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">895,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(137,956)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(605)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,064,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2022</a></td>
<td class="nump">709,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">867,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(157,832)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(527)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">10,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">10,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested restricted stock units</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">11,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)</a></td>
<td class="nump">3,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">19,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,802,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">$ 756,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 895,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (137,956)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (605)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090084471616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 26,704<span></span>
</td>
<td class="nump">$ 29,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="nump">2,193<span></span>
</td>
<td class="nump">7,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation of fixed assets and amortization of intangible assets</a></td>
<td class="nump">40,897<span></span>
</td>
<td class="nump">9,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation', window );">Amortization of debt issuance costs</a></td>
<td class="nump">2,053<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">11,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss (gain) on disposal of fixed assets</a></td>
<td class="nump">193<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">22,733<span></span>
</td>
<td class="nump">20,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="num">(22,351)<span></span>
</td>
<td class="num">(988)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Loss on investment</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">2,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">5,213<span></span>
</td>
<td class="num">(15,312)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(2,038)<span></span>
</td>
<td class="num">(615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(3,233)<span></span>
</td>
<td class="num">(944)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">5,258<span></span>
</td>
<td class="nump">2,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and income taxes payable</a></td>
<td class="num">(19,038)<span></span>
</td>
<td class="num">(18,140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Other liabilities</a></td>
<td class="nump">479<span></span>
</td>
<td class="num">(964)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,662)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">60,583<span></span>
</td>
<td class="nump">42,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of fixed assets</a></td>
<td class="num">(19,403)<span></span>
</td>
<td class="num">(23,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of available-for-sale investments</a></td>
<td class="num">(187,641)<span></span>
</td>
<td class="num">(318,132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Sales of available-for-sale investments</a></td>
<td class="nump">62,936<span></span>
</td>
<td class="nump">294,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="num">(32,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchases of equity and debt investments</a></td>
<td class="num">(12,750)<span></span>
</td>
<td class="num">(14,220)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLongtermInvestments', window );">Sale of equity investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,057<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(188,858)<span></span>
</td>
<td class="num">(52,631)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercises of stock options</a></td>
<td class="nump">21,881<span></span>
</td>
<td class="nump">15,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans', window );">Proceeds from shares issued under employee stock purchase plan</a></td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of Term loan B facility maturing December 2026</a></td>
<td class="num">(9,375)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration to MyoScience, Inc. securityholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,338)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(335,242)<span></span>
</td>
<td class="nump">16,233<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(463,517)<span></span>
</td>
<td class="nump">5,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">585,578<span></span>
</td>
<td class="nump">99,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">122,061<span></span>
</td>
<td class="nump">105,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">14,686<span></span>
</td>
<td class="nump">3,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">4,104<span></span>
</td>
<td class="nump">1,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Issuance of common stock from conversion of 2022 convertible senior notes</a></td>
<td class="nump">3,040<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Fixed assets included in accounts payable and accrued liabilities</a></td>
<td class="nump">2,454<span></span>
</td>
<td class="nump">8,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of convertible senior notes</a></td>
<td class="num">(156,960)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member', window );">Convertible Senior Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of convertible senior notes</a></td>
<td class="num">$ (192,609)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents earnout and milestone payment made which is associated with the acquisition of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from shares issued under Employee Stock Purchase Plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090882592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Pacira&#8221;) is the industry leader in its commitment to non-opioid pain management and providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain and spasticity. The Company&#8217;s long-acting, local analgesic, EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bupivacaine liposome injectable suspension), was commercially launched in the United States, or U.S., in April 2012 and approved in select European countries and the United Kingdom, or U.K. in November 2021. EXPAREL utilizes the Company&#8217;s proprietary multivesicular liposome drug delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In November 2021, the Company acquired Flexion Therapeutics, Inc., or Flexion, and added ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension) to its product portfolio. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of osteoarthritis, or OA, knee pain. For more information, see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In April 2019, the Company added iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience (the &#8220;MyoScience Acquisition&#8221;). The iovera&#176; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to only targeted nerves.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from three products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as one reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coronavirus (COVID-19) Pandemic and Global Economic Conditions</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, the Company&#8217;s revenues have been impacted by COVID-19 pandemic-related challenges that included the significant postponement or suspension in the scheduling of elective surgical procedures due to public health guidance and government directives. While the degree of impact has diminished during the course of the pandemic due to the introduction of vaccines and therapeutics, as well as the lessening of elective surgery restrictions, certain pandemic-related operational and staffing challenges persist. It remains unclear how long it will take the elective surgery market to normalize or if restrictions on elective procedures will recur due to future COVID-19 variants or otherwise. Direct effects of the pandemic and global economic conditions may negatively impact the Company&#8217;s business, financial condition and results of operations. Such impacts may include the effect of prolonged periods of inflation on the Company&#8217;s customers and suppliers and longer lead-times or the inability to secure a sufficient supply of materials. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090195778336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Report on Form&#160;10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at June&#160;30, 2022, and for the three and six-month periods ended June&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#176; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes the percentage of revenues comprised by the Company&#8217;s three largest wholesalers in each period presented: </span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of revenues from the Company&#8217;s three largest wholesalers have shifted in the current year with the addition of ZILRETTA sales.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span>which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $64.9&#160;million, reduced accumulated deficit by $47.2&#160;million, reduced additional paid-in capital by $96.5&#160;million and decreased deferred tax liabilities by $15.7&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090720928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text">REVENUE<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net product sales consist of (i) EXPAREL in the U.S., the European Union, or E.U., and the U.K.; (ii) ZILRETTA in the U.S.; (iii) iovera&#176; in the U.S., Canada and the E.U. and (iv) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use. Royalty revenues are from the Company&#8217;s collaborative licensing agreements. The Company does not consider revenue from sources other than sales of EXPAREL and ZILRETTA to be material sources of its consolidated revenue. As such, the following disclosure only relates to revenue associated with net EXPAREL and ZILRETTA product sales. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Product Sales</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. The Company primarily sells ZILRETTA to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as GPOs. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL and ZILRETTA revenue is recorded at the time the product is transferred to the customer.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, service fees, government rebates, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts, statutory requirements and other related information that may become known in the future. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers, specialty distributors, specialty pharmacy, GPOs and doctors. Payment terms generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfMjk1OA_60482776-f82e-46b2-bdd2-45bb82b080c0">zero</span> to 97 days from the date of the transaction, and accordingly, there is no significant financing component.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#8217;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#8217;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL and ZILRETTA to its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;ZILRETTA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,003&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,601&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090736320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">FLEXION ACQUISITION</a></td>
<td class="text">FLEXION ACQUISITION<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2021, the Company acquired Flexion (the &#8220;Flexion Acquisition&#8221;), a biopharmaceutical company focused on the discovery, development, and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. Upon consummation of the Flexion Acquisition, Flexion became a wholly-owned subsidiary of the Company and was renamed Pacira Therapeutics, Inc.</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total consideration for the Flexion Acquisition was approximately $578.8&#160;million consisting of: (i) $448.5&#160;million of cash paid to former Flexion stockholders and to settle restricted stock units and in-the-money stock options; (ii) an $85.1&#160;million cash payment to repay Flexion debt that was not assumed by the Company and (iii) $45.2&#160;million of estimated contingent consideration related to contingent value rights, or CVRs, that were issued to Flexion shareholders and certain equity award holders in conjunction with the Flexion Acquisition. The consideration is subject to adjustments based on the achievement of certain potential milestone payments. Up to an additional $380.2&#160;million in the aggregate may be payable to holders of the CVRs if each of the applicable milestones are achieved. No contingent consideration milestones were achieved in the six months ended June&#160;30, 2022. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the methodology and key assumptions used in the fair value measurements of contingent consideration and for more information regarding the changes in fair value.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is finalizing its valuation of liabilities and tax analyses, and anticipates finalizing the purchase price allocation as the information necessary to complete the analysis is obtained, but no later than one year after the acquisition date. The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(as previously </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">reported) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS ACQUIRED</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES ASSUMED</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(957)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,260&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)  As previously reported in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b)  Represents pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Summary of Operations</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the unaudited pro forma summary of operations for the three and six-month periods ended June&#160;30, 2021, as if the Flexion Acquisition had occurred on January 1, 2020. This pro forma information does not purport to represent what the Company&#8217;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic and diluted net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information was prepared using the acquisition method of accounting and was based on the historical financial information of the Company and Flexion. The summary pro forma financial information primarily reflects the following pro forma adjustments:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Recognition of the income tax benefit resulting from decreasing Flexion&#8217;s existing valuation allowance on deferred tax assets for the three and six months ended June&#160;30, 2021;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Removal of Flexion&#8217;s interest expense and associated deferred financing cost amortization related to the $85.1&#160;million of debt not assumed;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Adjustments to the Company&#8217;s interest income for the cash used to acquire Flexion; </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional cost of goods sold related to a step-up value in inventory;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional amortization expense from the acquired developed technology intangible assets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional depreciation of Flexion&#8217;s fixed assets; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional lease expense on Flexion&#8217;s right-of-use, or ROU, assets.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, all of the above adjustments were adjusted for the applicable tax impact.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090637088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIES<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,588&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090679232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">FIXED ASSETS</a></td>
<td class="text">FIXED ASSETS<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,473)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,279&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,401&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2022 and 2021, depreciation expense was $6.5 million and $2.9 million, respectively. For the three months ended June&#160;30, 2022 and 2021, there was $1.0 million and $1.1 million of capitalized interest on the construction of manufacturing sites, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2022 and 2021, depreciation expense was $12.2 million and $5.8 million, respectively. For the six months ended June&#160;30, 2022 and 2021, there was $1.8&#160;million and $2.1&#160;million of capitalized interest on the construction of manufacturing sites, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and December&#160;31, 2021, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $60.0 million and $65.4&#160;million, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the Company had asset retirement obligations of $3.1&#160;million and $2.4&#160;million, respectively, included in accrued expenses and other liabilities on its condensed consolidated balance sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090642944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all of its facilities, including its EXPAREL and iovera&#176; manufacturing facility in San Diego, California. These leases have remaining terms up to 8.2 years, some of which provide renewal options at the then-current market value. The Company also has two embedded leases with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England for the production of EXPAREL and ZILRETTA. A portion of the associated monthly base fees has been allocated to the lease components based on a relative fair value basis.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. Total operating lease costs are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to net the amortization of the ROU asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. The weighted average remaining lease term and the weighted average discount rate are summarized as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.33 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.71 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining six months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company has entered into one lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining six months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to June 30, 2022, the Company entered into a sublease for the former Flexion research and development laboratory in Woburn, Massachusetts in July 2022 which resulted in a $0.4&#160;million ROU asset to be reclassified to a fixed asset.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090637088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#8217;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#8220;Skyepharma Acquisition&#8221;), MyoScience, Inc., or MyoScience, (the &#8220;MyoScience Acquisition&#8221;) in April 2019 and the Flexion Acquisition in November 2021. The balances at June&#160;30, 2022 and December&#160;31, 2021 were $146.1&#160;million and $145.2&#160;million, respectively. The increase was due to measurement period adjustments associated with the Flexion Acquisition. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. The final Skyepharma milestone payment of $32.0&#160;million when annual net sales collected reached $500.0&#160;million was achieved in the fourth quarter of 2021 and paid during the first quarter of 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Intangible Assets</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net, consist of the in-process research and development, or IPR&amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,737)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years, 5 months</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,766)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,766)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,097)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years, 5 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,090&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,122)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense on intangible assets for the three and six months ended June&#160;30, 2022 was $14.3&#160;million and $28.6&#160;million, respectively. Amortization expense on intangible assets for the three and six months ended June 30, 2021 was </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.0&#160;million and $3.9&#160;million, respectively. The increase in amortization expense in the current year is a result of the amortization of ZILRETTA for osteoarthritis knee pain acquired as part of the Flexion Acquisition in November 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming no changes in the gross carrying amount of these intangible assets, the future estimated amortization expense on the finite-lived intangible assets will be $28.6&#160;million for the remaining six months of 2022, $57.3&#160;million from 2023 to 2030, $37.4&#160;million in 2031, $7.9&#160;million in 2032 and $2.2&#160;million in 2033.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets for impairment whenever an event or change in circumstances arise that indicate the carrying amount of an asset group is at risk of not being recoverable. A triggering event was identified for the ZILRETTA asset group due to a reduction in the near-term projected cash flows from the ZILRETTA product. The Company completed an impairment assessment through a recoverability test at June 30, 2022 by comparing the net carrying value of ZILRETTA asset group against the undiscounted net cash flows expected to be generated from ZILRETTA. It was determined that the ZILRETTA asset group was recoverable and not impaired.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090782368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s outstanding debt is summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan B facility maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% Convertible senior notes due August 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375% Convertible senior notes due May 2024 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Convertible senior notes due April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755,654&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The 2022 Notes (as defined below) matured on April 1, 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan B Facility</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a term loan credit agreement (the &#8220;Credit Agreement&#8221;) with JP Morgan Chase Bank, N.A., as administrative agent and the initial lender. The term loan issued under the Credit Agreement (the &#8220;Term Loan&#8221;) was issued at a 3% discount and allows for a single-advance term loan B facility in the principal amount of $375.0&#160;million, which is secured by substantially all of the Company&#8217;s and each subsidiary guarantor&#8217;s assets. Subject to certain conditions, the Company may, at any time, on one or more occasion, add one or more new classes of term facilities and/or increase the principal amount of the loans of any existing class by requesting one or more incremental term facilities. The net proceeds of the Term Loan were approximately $363.8&#160;million after deducting an original issue discount of $11.2&#160;million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the Term Loan is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,497&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan matures on December 7, 2026 and requires quarterly repayments of principal in the amount of $9.4&#160;million commencing June 30, 2022, increasing to $14.1&#160;million commencing December 31, 2025, with a remaining balloon payment of approximately $188.0&#160;million due at maturity. During 2022, the Company is required to make three quarterly payments totaling $28.1&#160;million. The Company is also required to make mandatory prepayments of principal from (i) the Company&#8217;s excess cash flow (as defined in the Credit Agreement) existing in any fiscal year and if the Senior Secured Leverage Ratio (as defined in the Credit Agreement) for such fiscal year exceeds certain predetermined limits (ii) net proceeds (as defined in the Credit Agreement) of non-ordinary course assets sales and casualty events and (iii) debt issuance proceeds (other than permitted debt under the Credit Agreement). Prepayment penalties for the Term Loan are 2% in the first loan year plus an interest make-whole payment, 2% in the second loan year, 1% in the third loan year and nothing thereafter. Prepayment penalties generally do not apply to mandatory prepayment obligations under the Credit Agreement, such as prepayments due in connection with excess cash flow. During the three and six months ended June&#160;30, 2022, the Company made a scheduled principal payment of $9.4&#160;million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan requires the Company to, among other things, maintain (i) a first lien net leverage ratio, determined as of the last day of any fiscal quarter, of no greater than 1.75 to 1.00 and (ii) liquidity, at any time, of at least $150.0&#160;million. The Term Loan also contains customary affirmative and negative covenants, financial covenants, representations and warranties, events of default and other provisions. As of June&#160;30, 2022, the Company was in compliance with all financial covenants under the Credit Agreement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company may elect to borrow either term benchmark borrowings or alternate base rate borrowings. Term benchmark borrowings bear interest at a variable rate per annum equal to the Adjusted Term SOFR Rate (as defined in the Credit Agreement) (subject to a 75 basis points floor) plus an applicable margin of 700 basis points. Alternate base rate borrowings bear interest at a variable rate per annum determined using a base rate (subject to a 175 basis points floor) equal to the greatest of (i) the Prime Rate (as defined in the Credit Agreement) in effect on such day, (ii) the NYFRB Rate (as defined in the Credit Agreement) plus 50 basis points or (iii) the Adjusted Term SOFR Rate (as defined in the Credit Agreement) plus 100 basis points, subject to certain exceptions, plus an applicable margin of 600 basis points. As of June&#160;30, 2022, borrowings under the Term Loan consisted entirely of term benchmark borrowings at a rate of 7.81%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2025</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company completed a private placement of $402.5&#160;million in aggregate principal amount of its 0.750% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per year, payable semiannually in arrears on February 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and August 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. The 2025 Notes mature on August 1, 2025.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% convertible senior notes due August 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,894&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,627&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the issuance of the 2025 Notes were approximately $390.0&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $185.0&#160;million in aggregate principal amount of its then-outstanding 2.375% convertible senior notes due 2022 in privately-negotiated transactions for a total of $211.1&#160;million of cash (including accrued interest).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert the 2025 Notes at any time prior to February 3, 2025, only if certain circumstances are met, including if during the previous calendar quarter, the last reported sales price of the Company&#8217;s common stock was greater than 130% of the conversion price then applicable for at least 20 out of the last 30 consecutive trading days of the quarter. During the quarter ended&#160;June&#160;30, 2022, this condition for conversion was not met.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the 40 consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $71.78 per share of the Company&#8217;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately 32.5% to the closing sale price of $54.17 per share of the Company&#8217;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the 2025 Notes had a market price o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1,038</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$402.5&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#8217;s option).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> scheduled trading day immediately before the maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for (i) each of at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) 100% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#8220;make-whole fundamental change&#8221; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the 2025 Notes are currently classified on the Company&#8217;s condensed consolidated balance sheet at June&#160;30, 2022 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#8217;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2024 Assumed from the Flexion Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Flexion Acquisition, on May 2, 2017, Flexion issued an aggregate of $201.3&#160;million principal amount of 3.375% convertible senior notes due 2024 (the &#8220;Flexion 2024 Notes&#8221;), pursuant to the indenture, dated as of May 2, 2017 (the &#8220;Original Flexion Indenture&#8221;), between Flexion and Wells Fargo Bank, N.A., as trustee (the &#8220;Flexion Trustee&#8221;), as supplemented by the First Supplemental Indenture, dated as of November 19, 2021, between Flexion and the Flexion Trustee (the &#8220;First Supplemental Flexion Indenture&#8221; and, together with the Original Flexion Indenture, the &#8220;Flexion Indenture&#8221;). The Flexion 2024 Notes have a maturity date of May 1, 2024, are unsecured, and accrue interest at a rate of 3.375% per annum, payable semi-annually on May 1 and November 1 of each year. Upon the Flexion Acquisition, the principal was assumed and recorded at fair value by the Company. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the Flexion 2024 Notes, at the election of each holder thereof, each Flexion 2024 Note was convertible into cash, shares of Flexion&#8217;s common stock, or a combination thereof, at Flexion&#8217;s election, at a conversion rate of approximately 37.3413 shares of Flexion common stock per $1,000 principal amount of the Flexion 2024 Notes, which corresponded to an initial conversion price of approximately $26.78 per share of Flexion&#8217;s common stock. As a result of the Flexion Acquisition, and in connection with the Notice (as defined below), holders of the Flexion 2024 Notes became entitled to certain Flexion Acquisition-related conversion and repurchase rights, as discussed below. In addition, as a result of the Flexion Acquisition and as discussed in more detail below, any future conversion rights are subject to the occurrence of any future events giving rise to such conversion rights under the Flexion Indenture.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2021, as a result of the Flexion Acquisition and in accordance with the Flexion Indenture, Flexion provided a Fundamental Change Company Notice and Offer to Purchase (the &#8220;Notice&#8221;) to the holders of the Flexion 2024 Notes and offered to repurchase for cash all of the outstanding Flexion 2024 Notes, at a repurchase price in cash equal to 100% of the principal amount of the Flexion 2024 Notes being repurchased, plus accrued and unpaid interest thereon to, but excluding, January 7, 2022, subject to the terms and conditions set forth therein. The offer to purchase expired at 5:00 p.m., New York City time, on January 6, 2022, as scheduled. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any holder that did not exercise its repurchase right in accordance with the terms of the Notice retained the conversion rights associated with such holder&#8217;s Flexion 2024 Notes under the Flexion Indenture. For conversion of Flexion 2024 Notes in connection with the Fundamental Change and the Make-Whole Fundamental Change (each as defined in the Flexion Indenture) resulting from the Flexion Acquisition, each $1,000 principal amount of the Flexion 2024 Notes was convertible into (i) $317.40 in cash and (ii) 37.3413 CVRs, based on the conversion rate of 37.3413, prior to 5:00 p.m., New York City time, on January 7, 2022. Alternatively, holders could retain their Flexion 2024 Notes and such Flexion 2024 Notes would remain outstanding subject to their existing terms, including with respect to a holder&#8217;s right to receive interest payments on the Flexion 2024 Notes and exercise any future conversion rights that may arise under the Flexion Indenture.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, following the expiration of the offer to purchase, the Company accepted the $192.6&#160;million aggregate principal amount of Flexion 2024 Notes that were validly tendered (and not validly withdrawn). No Flexion 2024 Notes were converted in connection with the Notice. At June&#160;30, 2022, the remaining principal outstanding is $8.6&#160;million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2022</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company completed a private placement of $345.0 million in aggregate principal amount of 2.375% convertible senior notes due 2022, or 2022 Notes. The 2022 Notes accrued interest at a fixed rate of 2.375% per year, payable semiannually in arrears on April&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and October&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. In July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $185.0&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $211.1&#160;million in cash (including accrued interest).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% convertible senior notes due April 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the 2022 Notes matured and the Company settled the remaining outstanding principal balance of $160.0&#160;million and a conversion premium of $4.8&#160;million through a cash payment of $156.9&#160;million and the issuance of 101,521 shares of the Company&#8217;s common stock, which increased additional paid-in capital by $3.0&#160;million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,767)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Upon the adoption of ASU 2020-06 effective January 1, 2022, the Company eliminated the convertible debt discounts associated with the 2022 Notes and the 2025 Notes that were originally recorded as offsets to the embedded conversion features recognized in equity. Effective January 1, 2022, the Company will not record interest expense on the previously recorded discounts on convertible debt. The deferred financing costs previously allocated to the conversion features have since been re-allocated to the outstanding debt, slightly increasing the future annual amortization of deferred financing costs. For additional information regarding the adoption of ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090642944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#8217;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#8217;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amounts of equity investments and convertible notes receivable without readily determinable fair values have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility due December 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,562.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;0.750% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;3.375% convertible senior notes due 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was $58.30 per share at June&#160;30, 2022 compared to a conversion price of $71.78 per share. Therefore, at June&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is 5.6&#160;million shares of the Company&#8217;s common stock, which assumes no increase in the conversion rate for certain corporate events.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity and Convertible Note Investments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds strategic investments in clinical and preclinical stage privately-held biotechnology companies in the form of equity and convertible note investments. The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,627&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,926&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Contingent Consideration</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recognized contingent consideration related to the Flexion Acquisition and the MyoScience Acquisition in the amount of $35.2&#160;million and $57.6&#160;million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. The Company&#8217;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rates used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company completed the Flexion Acquisition, which provided for contingent consideration related to CVRs that were issued to Flexion shareholders and certain equity award holders which could aggregate up to a total of $425.5&#160;million if certain regulatory and commercial milestones are met. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2030, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $45.2&#160;million, which represented the Company&#8217;s potential achievement of meeting the regulatory and commercial milestones. For the period from the date of the Flexion Acquisition through December 31, 2021, the Company recorded an additional $1.2&#160;million liability. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded gains of $12.5&#160;million and $13.3&#160;million, respectively, primarily due to adjustments to near-term forecasts for the earnout period of the contingent consideration. These adjustments were recorded as acquisition-related gains in the condensed consolidated statements of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At June&#160;30, 2022, the weighted average discount rate was 13.5% and the weighted average probability of success for regulatory milestones was 11.1%. As of June&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the Flexion Acquisition was recognized in the amount of $33.1&#160;million and $46.4&#160;million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $100.0 million upon the achievement of certain regulatory and commercial milestones. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As of June&#160;30, 2022, the maximum potential remaining milestone payments to be paid are $43.0&#160;million. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized contingent consideration gains of $8.8&#160;million and $9.0&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, due to the reduced probability of meeting the contingent consideration milestones by December 31, 2023, the expiration date for achieving the milestones. The Company recognized a $0.1&#160;million contingent consideration charge and a $1.0&#160;million gain during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended June 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the weighted average discount rate was 12.5% and the probability of success for the regulatory milestone that has not yet been met was reduced to zero. As of June&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $2.1&#160;million and $11.2&#160;million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flexion Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June&#160;30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MyoScience Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.64% to 14.37%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.69% to 13.34%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5% to 15%</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available-for-Sale Investments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate and government bonds with maturities greater than three months, but less than one year. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#8217;s short-term investments are reported in other comprehensive income (loss). At June&#160;30, 2022 and December&#160;31, 2021, all of the Company&#8217;s short-term investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term investments had an &#8220;A&#8221; or better rating by Standard&#160;&amp; Poor&#8217;s.&#160;</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s short-term available-for-sale investments at June&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June&#160;30, 2022 Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,332&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2021 Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,651&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,831&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, there were no investments available for sale that were materially less than their amortized cost.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elects to recognize its interest receivable separate from its available-for-sale investments. At June&#160;30, 2022 and December&#160;31, 2021, the interest receivable recognized in prepaid expenses and other current assets was $0.2&#160;million and $0.1&#160;million, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term available-for-sale investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As of June&#160;30, 2022, three wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at 34%, 17% and 17%. At December&#160;31, 2021, four wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at 30%, 20%, 17% and 11%. For additional information regarding the Company&#8217;s wholesalers, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EXPAREL and ZILRETTA revenues are primarily derived from major wholesalers and specialty distributors that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the Company&#8217;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of June&#160;30, 2022 and December&#160;31, 2021, the Company did not deem any allowances for credit losses on its accounts receivable necessary.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090580704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables illustrate the changes in the balances of the Company&#8217;s accumulated other comprehensive (loss) income for the periods presented (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.131%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.131%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090642944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock', window );">STOCK PLANS</a></td>
<td class="text">STOCK PLANS<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,733&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,544&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,733&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,571&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the six months ended June&#160;30, 2022:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,363,638&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179,790&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the six months ended June&#160;30, 2022 wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$25.69</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share. The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:80.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.15%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92 years</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company&#8217;s stockholders approved the Amended and Restated 2014 Employee Stock Purchase Plan, or ESPP. The ESPP was amended to increase the number of shares of common stock that may be sold under the ESPP by an additional 500,000 shares.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP features two six-month offering periods per year, running from January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at 85% of the closing fair market value of the Company&#8217;s common stock on either the offering date or the purchase date, whichever is less. During the six months ended June&#160;30, 2022, 36,729 shares were purchased and issued through the ESPP.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090574896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME (LOSS) PER SHARE</a></td>
<td class="text">NET INCOME (LOSS) PER SHARE<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-06 was adopted on January 1, 2022 and requires the Company to use the if-converted method to calculate the number of potentially dilutive shares for convertible debt. Under the if-converted method, adjustments are made to the diluted net income (loss) per common share calculation as if the Company had converted the convertible debt on the first day of each period presented. Adjustments to the numerator are made to add back the interest expense associated with the convertible debt on a post-tax basis. Adjustments to the denominator reflect the number of shares assumed to be convertible at the beginning of the period. For additional information regarding ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to January 1, 2022, the Company used the treasury stock method to calculate dilutive shares on its convertible debt.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs and the purchase of shares from the ESPP (using the treasury stock method), if applicable. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per common share for the three and six mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended June&#160;30, 2022 and 2021 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net income&#8212;basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Adjusted net income&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,915&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,782&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090633360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes and income tax expense is as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,371&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax expense represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items. The Company&#8217;s effective tax rates for the three and six months ended June&#160;30, 2022 include benefits related to stock-based compensation, a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration, partially offset by non-deductible executive compensation costs and a valuation allowance against non-U.S. results. The Company&#8217;s effective tax rates for the three and six months ended June&#160;30, 2021 include benefits related to stock-based compensation offset by non-deductible executive compensation costs and valuation allowances recorded against deductible capital losses and non-U.S. results.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090789488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock', window );">ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER</a></td>
<td class="text">ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related (gains) charges, product discontinuation and other for the three and six months ended June&#160;30, 2022 and 2021 summarized below (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,630&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flexion contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoScience contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,757)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,034)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuance Biotech Co. Ltd. agreement dissolution costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related (gains) charges, product discontinuation and other</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,058)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,721)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized acquisition-related costs of $3.2&#160;million and $8.6&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022, respectively</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily for severance, legal fees, third-party services and other one-time charges related to the Flexion Acquisition. See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2021, as part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $45.2&#160;million, which represents the Company&#8217;s potential achievement of meeting regulatory and sales-based milestones. During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded $12.5&#160;million and $13.3&#160;million gains, respectively, due to a decrease to the fair value of its contingent consideration, which was included in acquisition-related (gains) charges in the condensed consolidated statements of operations. See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $8.8&#160;million and $9.0&#160;million contingent consideration gains during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended June&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a $0.1&#160;million contingent consideration charge and a $1.0&#160;million gain during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended June 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nuance Biotech Co. Ltd.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#8217;s intellectual property against the risk of a generic product. Dissolution costs of $3.0&#160;million were included in other operating expenses in the condensed consolidated statements of operations for the six months ended June 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090782368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Milestone Litigation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#8220;Pacira CryoTech&#8221;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#8220;Fortis&#8221;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#8220;Merger Agreement&#8221;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $30.0&#160;million, plus attorneys&#8217; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">eVenus Pharmaceutical Laboratories Litigations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Company received a Notice Letter advising that eVenus Pharmaceutical Laboratories, Inc., or eVenus, of Princeton, New Jersey, submitted to the FDA an Abbreviated New Drug Application (ANDA) with a Paragraph IV certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,033,495 (the &#8217;495 patent).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company filed a patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (21-cv-19829) asserting infringement of the &#8217;495 patent. This triggered an automatic 30-month stay of final approval of the eVenus ANDA. On January 6, 2022, eVenus filed an Answer with counterclaims to the Complaint, alleging the &#8217;495 patent is invalid and/or not infringed through the manufacture, sale, or offer for sale of the product described in product described in eVenus&#8217;s ANDA submission.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a second Notice Letter advising that eVenus submitted to the FDA an amendment to its ANDA with a Paragraph IV Certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (133 mg/10 mL) in the U.S. prior to the expiration of the &#8217;495 patent. In the Notice Letter, eVenus also advised that it submitted a Paragraph IV Certification to the FDA seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL and 133 mg/10 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,179,336 (the &#8217;336 patent). eVenus further alleges in the Notice Letter that both the &#8217;495 patent and the &#8217;366 patent are invalid and/or not infringed.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company filed a second patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (22-cv-00718) asserting that the 133 mg/10 mL ANDA product will infringe the &#8217;495 and &#8217;336 patents and that the 266 mg/20 mL ANDA product will infringe the &#8217;336 patent. This filing triggered a second automatic 30-month stay of final approval for the 133 mg/10 mL ANDA product.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These litigations are in their infancy, and the Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research Development Foundation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an agreement with the Research Development Foundation, or RDF, the Company was required to pay RDF a low single-digit royalty on the collection of revenues from certain products, for as long as certain patents assigned to the Company under the agreement remain valid. RDF has the right to terminate the agreement for an uncured material breach by the Company, in connection with its bankruptcy or insolvency or if it directly or indirectly opposes or disputes the validity of the assigned patent rights. The Company&#8217;s U.S. Patent No. 11,033,495 was issued on June 15, 2021. Thereafter, RDF asserted that the issuance of that patent extends the Company&#8217;s royalty obligations under the agreement until 2041. The Company believes that the royalty period under the agreement was set to end on December 24, 2021 with the expiration of its U.S. Patent No. 9,585,838. Because of the disagreement over the interpretation of the agreement, in December 2021, the Company filed a declaratory judgment lawsuit in the U.S. District Court for the District of Nevada (21-cv-02241). The lawsuit seeks a declaration from the court that the Company owes no royalties to RDF with respect to its EXPAREL product after December 24, 2021. During the pendency of the lawsuit, the Company will continue to pay royalties to RDF under protest, however, the Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments and Contingencies</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Trial Commitments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the U.K.&#8217;s withdrawal from the E.U., the agreed pediatric plan is applicable in the U.K.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#8220;PLAY&#8221;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and U.K. to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency, or MHRA, are still reviewing the Type II variations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hong Kong Pharma Tainuo Ltd.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Flexion Acquisition, in March 2020, Flexion entered into an exclusive license agreement with Hong Kong Tainuo Pharma Ltd., or HK Tainuo, and Jiangsu Tainuo Pharmaceutical Co. Ltd., or Jiangsu Tainuo, a subsidiary of China </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shijiazhuang Pharmaceutical Co, Ltd., for the development and commercialization of ZILRETTA in Greater China (consisting of mainland China, Hong Kong, Macau and Taiwan). Under the terms of the agreement, HK Tainuo paid Flexion an upfront payment of $10.0&#160;million during the year ended December 31, 2020 which was recorded in other liabilities as of June&#160;30, 2022 and December 31, 2021. The Company was also eligible to receive up to $32.5&#160;million in aggregate development, regulatory and commercial sales milestone payments under the exclusive license agreement. HK Tainuo was responsible for the clinical development, product registration and commercialization of ZILRETTA in Greater China. The Company was solely responsible for the manufacture and supply of ZILRETTA to HK Tainuo for all clinical and commercial activities. The terms related to product manufacturing and supply, including pricing and minimum purchase requirements agreed to in the license agreement, were to be covered by a separate supply agreement, which had not yet been finalized as of June 30, 2022. Unless terminated earlier in accordance with its terms, the license agreement was scheduled to continue in effect in perpetuity or as long as HK Tainuo or Jiangsu Tainuo continued to sell ZILRETTA in Greater China. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequently, in July 2022, the Company submitted a termination letter to HK Tainuo associated with this license agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090091482080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Report on Form&#160;10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at June&#160;30, 2022, and for the three and six-month periods ended June&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Concentration of Major Customers</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#176; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Adopted Accounting Pronouncements</a></td>
<td class="text">Recently Adopted Accounting Pronouncements<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span>which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $64.9&#160;million, reduced accumulated deficit by $47.2&#160;million, reduced additional paid-in capital by $96.5&#160;million and decreased deferred tax liabilities by $15.7&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of presentation and principles of consolidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090551104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of percentage of revenue comprised by the three largest customers</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes the percentage of revenues comprised by the Company&#8217;s three largest wholesalers in each period presented: </span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090637088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregated revenue</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;ZILRETTA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,003&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,601&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090747904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of recognized identified assets acquired and liabilities assumed</a></td>
<td class="text">The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(as previously </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">reported) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS ACQUIRED</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES ASSUMED</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(957)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,260&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)  As previously reported in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b)  Represents pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Unaudited pro forma summary of operations</a></td>
<td class="text">This pro forma information does not purport to represent what the Company&#8217;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic and diluted net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090829904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of components of inventories</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,588&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090725712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of fixed assets summarized by major category</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,473)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,279&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,401&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090091806352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of operating lease cost and other operating lease information</a></td>
<td class="text">Total operating lease costs are as follows (in thousands):<div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The weighted average remaining lease term and the weighted average discount rate are summarized as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.33 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.71 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of maturities of operating lease liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining six months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock', window );">Schedule of operating lease not yet commenced, payments due</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company has entered into one lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining six months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Operating Lease Not Yet Commenced, Payments Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090933072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of finite-lived intangible assets acquired as part of business combination</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net, consist of the in-process research and development, or IPR&amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,737)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years, 5 months</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,766)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,766)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,097)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years, 5 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,090&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,122)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090091535360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of long-term debt instruments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s outstanding debt is summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan B facility maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% Convertible senior notes due August 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375% Convertible senior notes due May 2024 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Convertible senior notes due April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755,654&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The 2022 Notes (as defined below) matured on April 1, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of composition of the Company's debt and financing obligations</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the Term Loan is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,497&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% convertible senior notes due August 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,894&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,627&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% convertible senior notes due April 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ScheduleOfInterestExpenseTableTextBlock', window );">Schedule of total interest expense recognized related to the Notes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,767)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ScheduleOfInterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of interest rate expenses related to convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ScheduleOfInterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090086655744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of carrying amount and fair value of the long-term debt</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility due December 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,562.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;0.750% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;3.375% convertible senior notes due 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was $58.30 per share at June&#160;30, 2022 compared to a conversion price of $71.78 per share. Therefore, at June&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is 5.6&#160;million shares of the Company&#8217;s common stock, which assumes no increase in the conversion rate for certain corporate events.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of investments without readily determinable fair value</a></td>
<td class="text">The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,627&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,926&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of key assumptions used in the valuation of contingent consideration</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flexion Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June&#160;30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MyoScience Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.64% to 14.37%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.69% to 13.34%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5% to 15%</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of change in contingent consideration recorded at fair value using Level 3 measurements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of short-term investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s short-term available-for-sale investments at June&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June&#160;30, 2022 Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,332&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2021 Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,651&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,831&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090829904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables illustrate the changes in the balances of the Company&#8217;s accumulated other comprehensive (loss) income for the periods presented (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.131%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.131%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090575872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of recognized stock-based compensation in consolidated statements of operations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,733&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,544&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,733&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,571&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of the company's stock option activity and restricted stock unit activity</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the six months ended June&#160;30, 2022:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,363,638&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179,790&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of share-based payment award, stock options, valuation assumptions</a></td>
<td class="text">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:80.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.15%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92 years</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090183280160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computation of basic and diluted loss per share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per common share for the three and six mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended June&#160;30, 2022 and 2021 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net income&#8212;basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Adjusted net income&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,915&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,782&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090183291504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of income before income tax, domestic and foreign</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes and income tax expense is as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,371&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090090866368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock', window );">Schedule of Acquisition-related Restructuring and Discontinuation Costs</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related (gains) charges, product discontinuation and other for the three and six months ended June&#160;30, 2022 and 2021 summarized below (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,630&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flexion contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoScience contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,757)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,034)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuance Biotech Co. Ltd. agreement dissolution costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related (gains) charges, product discontinuation and other</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,058)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,721)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090091757392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>segment </div>
<div>product</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ConcentrationRiskNumberOfProducts', window );">Concentration of products (in products) | product</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ConcentrationRiskNumberOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Number Of Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ConcentrationRiskNumberOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090081186240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details) - Concentration risk by major customer - segment<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ConcentrationRiskNumberOfCustomers', window );">Number of customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Sales Revenue, Net | Largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Sales Revenue, Net | Second largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Sales Revenue, Net | Third largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Sales Revenue, Net | Three largest customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">77.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ConcentrationRiskNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Number of Customers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ConcentrationRiskNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_LargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_LargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_SecondLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_SecondLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_ThirdLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_ThirdLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_ThreeLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_ThreeLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085260416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="num">$ (756,636)<span></span>
</td>
<td class="num">$ (709,576)<span></span>
</td>
<td class="num">$ (730,408)<span></span>
</td>
<td class="num">$ (687,168)<span></span>
</td>
<td class="num">$ (650,818)<span></span>
</td>
<td class="num">$ (619,688)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="num">(895,151)<span></span>
</td>
<td class="num">(867,890)<span></span>
</td>
<td class="num">(942,091)<span></span>
</td>
<td class="num">(911,368)<span></span>
</td>
<td class="num">(894,108)<span></span>
</td>
<td class="num">(873,201)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="nump">$ 137,956<span></span>
</td>
<td class="nump">$ 157,832<span></span>
</td>
<td class="nump">211,895<span></span>
</td>
<td class="nump">$ 224,425<span></span>
</td>
<td class="nump">$ 243,506<span></span>
</td>
<td class="nump">$ 253,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Cumulative Effect, Period of Adoption, Adjusted Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Increase (decrease) in deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Cumulative Effect, Period of Adoption, Adjusted Balance | Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Cumulative Effect, Period of Adoption, Adjusted Balance | Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (47,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090088051840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AccountsReceivablePaymentTerms', window );">Accounts receivable, payment terms</a></td>
<td class="text">0 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AccountsReceivablePaymentTerms', window );">Accounts receivable, payment terms</a></td>
<td class="text">97 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AccountsReceivablePaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AccountsReceivablePaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085658912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Schedule of Disaggregated Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 169,411<span></span>
</td>
<td class="nump">$ 135,590<span></span>
</td>
<td class="nump">$ 327,402<span></span>
</td>
<td class="nump">$ 254,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember', window );">EXPAREL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">137,007<span></span>
</td>
<td class="nump">130,058<span></span>
</td>
<td class="nump">266,212<span></span>
</td>
<td class="nump">244,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_ZILRETTAMember', window );">ZILRETTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">27,417<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">51,052<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_IoveraMember', window );">iovera&#176;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">3,201<span></span>
</td>
<td class="nump">3,813<span></span>
</td>
<td class="nump">6,227<span></span>
</td>
<td class="nump">7,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_BupivacaineLiposomeInjectableSuspensionMember', window );">Bupivacaine liposome injectable suspension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">956<span></span>
</td>
<td class="nump">992<span></span>
</td>
<td class="nump">2,512<span></span>
</td>
<td class="nump">1,784<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 168,581<span></span>
</td>
<td class="nump">$ 134,863<span></span>
</td>
<td class="nump">$ 326,003<span></span>
</td>
<td class="nump">$ 253,601<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_ZILRETTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_ZILRETTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_IoveraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_IoveraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_BupivacaineLiposomeInjectableSuspensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_BupivacaineLiposomeInjectableSuspensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087356880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION - Narrative (Details) - Flexion - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration transferred</a></td>
<td class="nump">$ 578.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt', window );">Retirement of term loan</a></td>
<td class="nump">85.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration', window );">Fair value of contingent value rights (CVRs)</a></td>
<td class="nump">45.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Additional amount payable to holders of the CVRs</a></td>
<td class="nump">$ 380.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember', window );">RSUs, In-The-Money Stock Options, and Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 448.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Liabilities Incurred, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090074543616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>ASSETS ACQUIRED</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets', window );">Total assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES ASSUMED</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses', window );">Accrued expenses</a></td>
<td class="nump">957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities', window );">Total liabilities</a></td>
<td class="nump">957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets', window );">Total identifiable net assets acquired</a></td>
<td class="num">(957)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">146,132<span></span>
</td>
<td class="nump">$ 145,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill</a></td>
<td class="nump">957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Total consideration transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember', window );">Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>ASSETS ACQUIRED</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">113,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Short-term available-for-sale investments</a></td>
<td class="nump">11,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">32,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">29,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">4,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="nump">23,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">58,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="nump">6,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets</a></td>
<td class="nump">480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="nump">61,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">820,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">820,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES ASSUMED</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">9,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued expenses</a></td>
<td class="nump">23,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Lease liabilities</a></td>
<td class="nump">6,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="nump">1,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="nump">201,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,450<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="nump">252,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,762<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets acquired</a></td>
<td class="nump">568,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,628<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total consideration transferred</a></td>
<td class="nump">$ 578,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 578,845<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085197600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION - Schedule of Pro Forma Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Pro forma basic net loss per share (in usd per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Pro forma diluted net loss per share (in usd per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember', window );">Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenues</a></td>
<td class="nump">$ 163,765<span></span>
</td>
<td class="nump">$ 307,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (3,367)<span></span>
</td>
<td class="num">$ (20,487)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Pro forma basic net loss per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Pro forma diluted net loss per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.47)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090091848576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 36,301<span></span>
</td>
<td class="nump">$ 36,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">39,407<span></span>
</td>
<td class="nump">35,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">24,880<span></span>
</td>
<td class="nump">27,031<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 100,588<span></span>
</td>
<td class="nump">$ 98,550<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085680688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FIXED ASSETS - Summary of Major Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">$ 286,752<span></span>
</td>
<td class="nump">$ 273,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(95,473)<span></span>
</td>
<td class="num">(85,240)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">191,279<span></span>
</td>
<td class="nump">188,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">116,364<span></span>
</td>
<td class="nump">117,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">60,155<span></span>
</td>
<td class="nump">59,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">13,598<span></span>
</td>
<td class="nump">13,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">2,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">$ 94,332<span></span>
</td>
<td class="nump">$ 80,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085291808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest and other (Note 6)</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">$ 2,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">191,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligation</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest and other (Note 6)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 25<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116646717&amp;loc=d3e6290-110844<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087390640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>lease </div>
<div>segment</div>
</th>
<th class="th">
<div>Jul. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_NumberOfLeases', window );">Number of embedded leases | lease</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts', window );">Number of leases not yet commenced | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">$ 72,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_NumberOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_NumberOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090074701184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Summary of operating lease cost and other operating lease information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Fixed lease costs</a></td>
<td class="nump">$ 3,542<span></span>
</td>
<td class="nump">$ 2,922<span></span>
</td>
<td class="nump">$ 7,069<span></span>
</td>
<td class="nump">$ 5,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="nump">980<span></span>
</td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total</a></td>
<td class="nump">$ 4,050<span></span>
</td>
<td class="nump">$ 3,346<span></span>
</td>
<td class="nump">8,049<span></span>
</td>
<td class="nump">6,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash Flow, Operating Activities, Lessee [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for operating lease liabilities, net of lease incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,637<span></span>
</td>
<td class="nump">7,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets recorded in exchange for lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">7 years 3 months 29 days<span></span>
</td>
<td class="text">8 years 8 months 15 days<span></span>
</td>
<td class="text">7 years 3 months 29 days<span></span>
</td>
<td class="text">8 years 8 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (in percent)</a></td>
<td class="nump">6.95%<span></span>
</td>
<td class="nump">6.89%<span></span>
</td>
<td class="nump">6.95%<span></span>
</td>
<td class="nump">6.89%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085200192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of maturities of operating lease liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022 (remaining six months)</a></td>
<td class="nump">$ 6,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">13,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">13,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">12,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">12,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">39,422<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">97,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(21,846)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 75,709<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087530048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear', window );">2022 (remaining six months)</a></td>
<td class="nump">$ 81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne', window );">2023</a></td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo', window );">2024</a></td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree', window );">2025</a></td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour', window );">2026</a></td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">443<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability', window );">Total future lease payments</a></td>
<td class="nump">$ 2,518<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087436896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill recorded in connection with the acquisition</a></td>
<td class="nump">$ 146,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">14,322<span></span>
</td>
<td class="nump">$ 1,967<span></span>
</td>
<td class="nump">28,644<span></span>
</td>
<td class="nump">$ 3,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Amortization expense, remainder of fiscal year</a></td>
<td class="nump">28,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1', window );">Amortization expense, first period</a></td>
<td class="nump">57,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2', window );">Amortization expense, second period</a></td>
<td class="nump">37,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3', window );">Amortization expense, third period</a></td>
<td class="nump">7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4', window );">Amortization expense, fourth period</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember', window );">When annual net sales collected reach $500.0 million | Skye Pharma Holding Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition', window );">Milestone payments for EXPAREL agreed in connection with acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition', window );">Annual net sales threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_SkyePharmaHoldingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_SkyePharmaHoldingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090084327472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 590,090<span></span>
</td>
<td class="nump">$ 590,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(55,766)<span></span>
</td>
<td class="num">(27,122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">534,324<span></span>
</td>
<td class="nump">562,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Value</a></td>
<td class="nump">651,090<span></span>
</td>
<td class="nump">651,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">595,324<span></span>
</td>
<td class="nump">623,968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">590,000<span></span>
</td>
<td class="nump">590,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(55,737)<span></span>
</td>
<td class="num">(27,097)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 534,263<span></span>
</td>
<td class="nump">$ 562,903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Lives</a></td>
<td class="text">10 years 5 months<span></span>
</td>
<td class="text">10 years 5 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">Acquired IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Value</a></td>
<td class="nump">$ 61,000<span></span>
</td>
<td class="nump">$ 61,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 61,000<span></span>
</td>
<td class="nump">$ 61,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090074446320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Carrying Value of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 755,654<span></span>
</td>
<td class="nump">$ 1,049,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 352,120<span></span>
</td>
<td class="nump">359,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 394,894<span></span>
</td>
<td class="nump">330,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member', window );">Convertible Senior Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member', window );">Convertible Senior Notes Due May 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 8,640<span></span>
</td>
<td class="nump">201,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 157,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090073500416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>payment </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 02, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>d </div>
<div>payment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>d </div>
<div>segment </div>
<div>payment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 07, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 06, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_SettlementPeriodConvertibleDebtConversionRequest', window );">Settlement period - convertible debt conversion request</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 706,000<span></span>
</td>
<td class="nump">$ 5,744,000<span></span>
</td>
<td class="nump">$ 1,412,000<span></span>
</td>
<td class="nump">$ 11,401,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to APIC, convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock', window );">Convertible debt, premium on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentMarketPrice', window );">Market price of principal amount of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of common stock per $1,000 of principal amount of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0139324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Debt Redemption Terms Prior to February 3, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Debt Redemption Terms on or after August 1, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice', window );">Debt instrument, percentage of principal amount for computation of redemption price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue', window );">Leverage ratio, maximum, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate', window );">Basis spread two on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate', window );">Basis spread one on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentVariableRate', window );">Variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentVariableRate', window );">Variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Minimum | Federal Reserve Bank Of NY, Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member', window );">Convertible Senior Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice', window );">Debt instrument, percentage of principal amount for computation of redemption price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member', window );">Convertible Senior Notes Due 2024 | Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 317.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of common stock per $1,000 of principal amount of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0373413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount', window );">Debt conversion, converted instrument, warrants or rights issued, per principal amount (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.3413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member', window );">Convertible Senior Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 755,654,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,049,230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 755,654,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 755,654,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 402,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt instrument, unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,718,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Debt issued in private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 390,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 402,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 394,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,627,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 394,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt instrument, unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Debt issued in private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2024 | Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,249,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Term Loan B Facility Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt instrument, unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,649,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,649,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,649,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear', window );">Number of payments in next fiscal year | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1', window );">Prepayment penalty, percent, year 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2', window );">Prepayment penalty, percent, year 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter', window );">Prepayment penalty, percent, year 3 and thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 359,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Term Loan B Facility Due 2026 | Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="nump">$ 14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Balloon payment to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Term Loan B Facility Due 2026 | Scenario, Forecast | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread One On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentBasisSpreadOneOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread Two On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentMarketPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt market price, per $1,000 principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentMarketPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty, Percent, Year 1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty, Percent, Year 2</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_SettlementPeriodConvertibleDebtConversionRequest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of trading days in a settlement period for convertible debt conversion requests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_SettlementPeriodConvertibleDebtConversionRequest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsPriorToFebruary32023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsPriorToFebruary32023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=pcrx_FederalReserveBankOfNYRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=pcrx_FederalReserveBankOfNYRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090073434464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 30, 2021</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">$ 755,654<span></span>
</td>
<td class="nump">$ 1,049,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible senior notes</a></td>
<td class="nump">$ 402,500<span></span>
</td>
<td class="nump">402,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(7,606)<span></span>
</td>
<td class="num">(7,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(64,718)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">$ 394,894<span></span>
</td>
<td class="nump">330,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible senior notes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,920)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">157,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Term Loan B Facility Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible senior notes</a></td>
<td class="nump">365,625<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(3,856)<span></span>
</td>
<td class="num">(4,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="num">(9,649)<span></span>
</td>
<td class="num">(11,060)<span></span>
</td>
<td class="num">$ (11,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">$ 352,120<span></span>
</td>
<td class="nump">$ 359,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085562080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Schedule of Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="nump">$ 8,196<span></span>
</td>
<td class="nump">$ 1,713<span></span>
</td>
<td class="nump">$ 17,381<span></span>
</td>
<td class="nump">$ 3,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">874<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">706<span></span>
</td>
<td class="nump">5,744<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">11,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest and other (Note 6)</a></td>
<td class="num">(943)<span></span>
</td>
<td class="num">(1,093)<span></span>
</td>
<td class="num">(1,767)<span></span>
</td>
<td class="num">(2,135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total</a></td>
<td class="nump">$ 8,833<span></span>
</td>
<td class="nump">$ 7,023<span></span>
</td>
<td class="nump">$ 19,079<span></span>
</td>
<td class="nump">$ 13,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average discount rate (in percent)</a></td>
<td class="nump">5.08%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
<td class="nump">5.31%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085856352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments</a></td>
<td class="nump">$ 25,627,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">5,299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">35,247,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">352,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">394,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">8,640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">366,562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">417,855,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">8,606,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments</a></td>
<td class="nump">25,627,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">5,299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">35,247,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share)</a></td>
<td class="nump">$ 58.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share)</a></td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConvertibleConversionPremiumShares', window );">Debt instrument, convertible, conversion premium (in shares)</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member', window );">Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConvertibleConversionPremiumShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Conversion Premium, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConvertibleConversionPremiumShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085672768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Investments Without Readily Determinable Fair Value Roll Forward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at December&#160;31, 2021</a></td>
<td class="nump">$ 18,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">12,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss', window );">Foreign currency adjustments</a></td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at June&#160;30, 2022</a></td>
<td class="nump">30,926<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity Investments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Investments Without Readily Determinable Fair Value Roll Forward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at December&#160;31, 2021</a></td>
<td class="nump">14,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">11,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss', window );">Foreign currency adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at June&#160;30, 2022</a></td>
<td class="nump">25,627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=pcrx_ConvertibleNotesReceivableMember', window );">Convertible Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Investments Without Readily Determinable Fair Value Roll Forward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at December&#160;31, 2021</a></td>
<td class="nump">4,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss', window );">Foreign currency adjustments</a></td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at June&#160;30, 2022</a></td>
<td class="nump">$ 5,299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=pcrx_ConvertibleNotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=pcrx_ConvertibleNotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090074822064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 19, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,351,000<span></span>
</td>
<td class="nump">$ 988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_NumberOfMajorCustomers', window );">Number of major customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Amount of allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,757,000<span></span>
</td>
<td class="num">$ (139,000)<span></span>
</td>
<td class="nump">9,034,000<span></span>
</td>
<td class="nump">$ 988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsideration', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationCurrent', window );">Contingent consideration, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition | Contingent Consideration | Measurement Input, Discount Rate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition | Contingent Consideration | Measurement Input, Expected Milestone Payment | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">$ 425,500,000<span></span>
</td>
<td class="nump">46,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="num">$ (45,200,000)<span></span>
</td>
<td class="num">(1,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition | Contingent Consideration | Measurement Input, Discount Rate | Level 3 | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition | Contingent Consideration | Measurement Input, Probability of Success of Regulatory Milestones | Level 3 | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAndMyoScienceAcquisitionMember', window );">Flexion And MyoScience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of Contingent Consideration related to the acquisition of a business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Payment Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_NumberOfMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of major customers of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_NumberOfMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAndMyoScienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAndMyoScienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090073489136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details) - Fair Value, Inputs, Level 3 - Contingent Consideration<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Myoscience Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Myoscience Acquisition | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Myoscience Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.1169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Myoscience Acquisition | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Flexion Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.1264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Flexion Acquisition | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.05<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Maximum | Myoscience Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.1334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Maximum | Flexion Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.1437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Maximum | Flexion Acquisition | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087733440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2021</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsideration', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember', window );">Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December&#160;31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments and accretion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,351)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at June&#160;30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of Contingent Consideration related to the acquisition of a business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Payment Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085547232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 195,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,098)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">194,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">30,906<span></span>
</td>
<td class="nump">3,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(239)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">30,667<span></span>
</td>
<td class="nump">3,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">138,705<span></span>
</td>
<td class="nump">57,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(796)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">137,909<span></span>
</td>
<td class="nump">57,611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds | Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">6,288<span></span>
</td>
<td class="nump">9,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">6,257<span></span>
</td>
<td class="nump">$ 10,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember', window );">U.S. Government bonds | Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">19,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">$ 19,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090074790032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="nump">$ 709,576<span></span>
</td>
<td class="nump">$ 650,818<span></span>
</td>
<td class="nump">$ 730,408<span></span>
</td>
<td class="nump">$ 619,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized loss on investments, net of tax</a></td>
<td class="num">(160)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="nump">756,636<span></span>
</td>
<td class="nump">687,168<span></span>
</td>
<td class="nump">756,636<span></span>
</td>
<td class="nump">687,168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Net Unrealized (Loss) Gain From Available For Sale Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized loss on investments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="num">(754)<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="num">(754)<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Unrealized Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive (Loss) Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="num">(527)<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized loss on investments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="num">$ (605)<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="num">$ (605)<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090084311808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 11,544<span></span>
</td>
<td class="nump">$ 10,461<span></span>
</td>
<td class="nump">$ 22,733<span></span>
</td>
<td class="nump">$ 20,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Stock-based compensation from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_Compensationexpensefromstockoptionsemployees', window );">Stock options</a></td>
<td class="nump">6,542<span></span>
</td>
<td class="nump">6,552<span></span>
</td>
<td class="nump">13,327<span></span>
</td>
<td class="nump">13,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Restricted stock units</a></td>
<td class="nump">4,717<span></span>
</td>
<td class="nump">3,646<span></span>
</td>
<td class="nump">8,830<span></span>
</td>
<td class="nump">7,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">485<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">11,544<span></span>
</td>
<td class="nump">10,461<span></span>
</td>
<td class="nump">22,733<span></span>
</td>
<td class="nump">20,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,478<span></span>
</td>
<td class="nump">1,465<span></span>
</td>
<td class="nump">2,830<span></span>
</td>
<td class="nump">2,917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,520<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">2,978<span></span>
</td>
<td class="nump">2,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 8,546<span></span>
</td>
<td class="nump">$ 7,667<span></span>
</td>
<td class="nump">$ 16,925<span></span>
</td>
<td class="nump">$ 15,219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation Expense From Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_CompensationExpenseFromEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_Compensationexpensefromstockoptionsemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation expense from stock options (employee and board of director awards)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_Compensationexpensefromstockoptionsemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087556608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning of period (in shares) | shares</a></td>
<td class="nump">6,050,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,010,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(630,413)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(54,215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares) | shares</a></td>
<td class="num">(13,054)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding end of period (in shares) | shares</a></td>
<td class="nump">6,363,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 49.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">60.22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">34.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">52.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in dollars per share) | $ / shares</a></td>
<td class="nump">85.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 52.39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of period (shares) | shares</a></td>
<td class="nump">955,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">568,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares) | shares</a></td>
<td class="num">(298,607)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(44,929)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of period (shares) | shares</a></td>
<td class="nump">1,179,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value (Per Share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 52.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">60.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">49.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">54.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 57.36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090091881536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>offeringPeriod </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease', window );">ESPP increase to shares allowed to be sold</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, ESPP (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods', window );">Number of offering periods for ESPP | offeringPeriod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod', window );">ESPP purchasing period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090074417936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Valuation Assumptions (Details) - Employee Stock Option<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="nump">2.83%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">45.15%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090086636864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income&#8212;basic</a></td>
<td class="nump">$ 19,876<span></span>
</td>
<td class="nump">$ 19,081<span></span>
</td>
<td class="nump">$ 26,704<span></span>
</td>
<td class="nump">$ 29,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther', window );">ASU 2020-06 convertible notes if-converted method adjustment</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,078<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToParentDiluted', window );">Adjusted net income&#8212;diluted</a></td>
<td class="nump">$ 20,915<span></span>
</td>
<td class="nump">$ 19,081<span></span>
</td>
<td class="nump">$ 28,782<span></span>
</td>
<td class="nump">$ 29,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">45,501<span></span>
</td>
<td class="nump">44,145<span></span>
</td>
<td class="nump">45,185<span></span>
</td>
<td class="nump">43,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect of convertible debt securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">52,478<span></span>
</td>
<td class="nump">45,592<span></span>
</td>
<td class="nump">52,262<span></span>
</td>
<td class="nump">45,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in USD per share)</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in USD per share)</a></td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect of convertible debt securities (in shares)</a></td>
<td class="nump">5,607<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,607<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">347<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic and Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToParentDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToParentDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090085682688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">1,979<span></span>
</td>
<td class="nump">2,114<span></span>
</td>
<td class="nump">3,075<span></span>
</td>
<td class="nump">1,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Weighted average number of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">1,948<span></span>
</td>
<td class="nump">2,088<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
<td class="nump">1,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeniorNotesMember', window );">Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Weighted average number of RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090091877216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income (loss) before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 23,798<span></span>
</td>
<td class="nump">$ 25,863<span></span>
</td>
<td class="nump">$ 30,380<span></span>
</td>
<td class="nump">$ 41,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(1,791)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="num">(1,079)<span></span>
</td>
<td class="num">(3,424)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">22,007<span></span>
</td>
<td class="nump">25,648<span></span>
</td>
<td class="nump">29,301<span></span>
</td>
<td class="nump">38,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 2,131<span></span>
</td>
<td class="nump">$ 6,567<span></span>
</td>
<td class="nump">$ 2,597<span></span>
</td>
<td class="nump">$ 8,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rates (in percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090087542144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Product Discontinuance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Severance-related expenses</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,065<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts', window );">Total acquisition-related charges</a></td>
<td class="nump">3,222<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8,630<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,351)<span></span>
</td>
<td class="num">(988)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther', window );">Total acquisition-related (gains) charges, product discontinuation and other</a></td>
<td class="num">(18,058)<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="num">(13,721)<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pcrx_NuanceBiotechCo.Ltd.Member', window );">Nuance Biotech Co. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Nuance Biotech Co. Ltd. agreement dissolution costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember', window );">Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="nump">12,523<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,317<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="num">(8,757)<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="num">(9,034)<span></span>
</td>
<td class="num">(988)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=pcrx_AcquisitionRelatedFeesMember', window );">Acquisition Related Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="nump">2,168<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">4,013<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 552<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition-Related Charges, Product Discontinuation, And Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquisition And Integration Related Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pcrx_NuanceBiotechCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pcrx_NuanceBiotechCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=pcrx_AcquisitionRelatedFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=pcrx_AcquisitionRelatedFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090084312176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION&#8211;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,351)<span></span>
</td>
<td class="num">$ (988)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member', window );">Nuance Biotech Co. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Estimated settlement fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="nump">$ 45,200<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="num">$ (12,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition | Legal Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,757)<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="num">$ (9,034)<span></span>
</td>
<td class="num">$ (988)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=pcrx_LegalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=pcrx_LegalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140090091132416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 20, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pcrx_FortisMember', window );">Fortis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought</a></td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pcrx_HongKongPharmaTainuoLtdMember', window );">Hong Kong Pharma Tainuo Ltd. | Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA', window );">Proceeds from development and commercialization of ZILRETTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum', window );">Maximum milestone payment to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Milestone Payments to be Received, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Development And Commercialization Of ZILRETTA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pcrx_FortisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pcrx_FortisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pcrx_HongKongPharmaTainuoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pcrx_HongKongPharmaTainuoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>pcrx-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pcrx="http://www.pacira.com/20220630"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pcrx-20220630.xsd" xlink:type="simple"/>
    <context id="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i065f6b275a044a978b8835a167a0421e_I20220801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2022-08-01</instant>
        </period>
    </context>
    <context id="ibfe1468fe7344d909a88362d4b43314a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if1e299ef910a46358668913b0b2f165d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf4570f968674f3bbe27c560bfb9be87_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7284aa2c87d44f68ba483dff38427eec_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0df55d4c445d47adb69a0c7a9cd64df5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i872e83e0083747ac98f21041708778df_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaeac445eb2804a44bf29e75079f90ec5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id57b66a9719a44e5b652fa1c6eea2346_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1899070b94594becb2264b63d5eea7dd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i53613137983c432ca979eea4cef3c97d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic98bf5546d144ab99b2b83c44eb9cc95_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia7ee03c49a9340679a4b219e33e24837_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0314b81a8a7c4118becd58eee01d8a94_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7e93fd6ed579409bb376796f42c77e60_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iccf3379ece1b49aea990c4cbfe1e487c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8d0b4678edcd488697408216205ad39b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id2c3caff01d94b05951897818e26b19d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic5453e5f10bc4d4aa7d46326ba9a6399_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7067da57a3274ecf8bb92bb5fda7ddaf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0438bbb5f15b47bd8ab7763bf832a111_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie08d96e6b19e4981b99d8b86ea0ec01d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i777b16255019457c83b5ff68beb54018_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i185060e0af3c419b9d025a6ac414a2f5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i95d1f5844c744661a795601ebc428092_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i20af892b1391416d8055702cfd957969_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3cecd213310d42d68564b49f725b9213_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i567c41f53acf4b4bae12b345b50893b0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id58a1548551d42eba0f5d2a6190bebda_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia659c853cae9490aae174ba93d4c6a36_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia4392427a33b4b249cac4e1f1e0c7826_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7562b9b9bc8848fc8b1a14abdedbaf01_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaf4fb171f06b4fec8794e510a10f6378_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9d156e98f8514a71bf2585134d6222c5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9755c2106fc64b00958c9861c96d0980_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie21f1393db9f45fa9638f6757ed692e7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icbf1abb3d2514d0f971d679c231c0a78_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic4d8d5d2b3b942849ad9361740d23cec_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id12c8e6e979d472c83e9f7f03a527326_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8e6079e472454d8fb92f206183fe3fe5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8530ce71c50341ceb2fe3a2f7c1ce761_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id6ae8fb92c414c1c9c45317f16ffd7cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c7debda168a402bbbfc0400a6f7fb72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02ecdd29c7414c46a2309f3f15aa4ef2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib06fd977f58642338910637dc9ee051e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d66fc0f21124cb982ea945c36dceeba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0c67d9e97e742bfa7decef41c722bc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71d1eeb1f3f6452887a684bfaeb06c53_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i40fceb10d076413aa7ec6129f9f379d7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i496381cd52774acb947c0ce28a210627_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic8e4e8f15d4b41d3bd530ae73c637d3a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2c30c32c194470fb58444961164cced_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dfdd1ff2fdf4d5ca8edd50b87a21dbe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67ba2e38a38f4c4c81d24bf4be710a79_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12b13809861f4e14b44f538d78e89322_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i56eabe321e00448ea73bc225c791a124_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie355b25162354a51a4bc570c648c9f9e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8a25b26562da46c48252ec4826cc94cf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic1b7745796664d7e8311edc369bcf819_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1f182ffbc7a04691b94793c0d2ea763b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6dc9a2abb73b42f889beb685eb78dd97_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id49160a04d45489ba6dde67831452514_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieec41903ab5748ad8e93035d8503fcf3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ied39c8b2a0e847a5aafe78db72f6e93b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i03aa3ab5fbee4d6896c79200467028e0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id48c04a202fa42f2867a0499bc23d873_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1a665b7edb9415ebeb211b1577d0e34_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idcb274e947a44a4e80b58a578e44dac3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3a79f2001b894c3ea7b2a9c85bc4315c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i52d4cf75231141769e7cdbeaae57f7f8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i39f4cab5dbc846cf86be5b20cc204e02_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if69a41444b6640d0b674261a2129cd82_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i80247e37f19a4037b6459ac43a27bcd0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2059729d521343c3aa297a7c8e0d5961_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i574ac6f9ebfe47ff8dc15c79df815095_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iecace58dec9b480d953f4cefa650d762_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie417a4089ec14158a8f46542e241d728_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id1a0b4f16e3040808a0a4267e092d844_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia484b08689c24460bdf7e5e604ec229e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i86ff898a5c1f4f7b89f0bc15a892e222_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ed27d17e7e04841a903c038b2cd6d5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1dcc7f6a743b4e1c826e40098ec5b555_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id39f0d77661b4d21bd5c329207058dec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5dd7ecccda904eaca960004478e3d7cf_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i137156d0fcb14f6083cfb7e0561f67e9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icf70633f4d2743c483f890199a5aad26_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0f1153b8275e426baedcb6cb32988ed3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8c7a76e695d24007a56305d765b02b64_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i74f4f821973e47688841421beb03e3aa_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i093201d8522546898104838bef2c7008_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7c42c8c170474d2a954da97bce047946_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6903f565b296494fb0447554914bdfeb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iac412655aca24aa0a92d19bfdb08ebfe_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i561be2fe92244f3c871d388185d4dbf7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0762b6431de84121b7b88717e0492b34_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib7c1bb2dd8df417db479a9448b35c207_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia8ea87effbd54309b6396f1449ed1cb1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6ccef0cf2b3a4d7aa7364dc01727ff19_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i50dda10391554e928f44961a18eb294f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i577bddc29b634b9c8f0d64449773fe54_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5e15ee9cbfaa484b99723cebd4de0305_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i19c54c90141d46f5b4ed7575ff155dfa_D20211119-20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-11-19</endDate>
        </period>
    </context>
    <context id="ia90f47b531e341d18e987adf7e3cab92_D20211119-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pcrx:RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e42aa47b25f48e0be0ab8750e25e349_I20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-19</instant>
        </period>
    </context>
    <context id="i521f1b4e7f96420b850707ae1c48fed0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6affd4b067a74053a80dafaecc998dce_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2d78b23f2b384db1952457d16ecfc25a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id3a7bcd6cd0649a3af561d8e804dfa32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f0c585d3783403c875879dfaad021a3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iee1c1e7325aa446388971997460585da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie1509ca5743b4070b16fb4bc87afe9d7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i826ff833dd74486b9ea7e8f9bff4a586_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33dfed9d67c948b4a47a8e552ba5b8b0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8b8d87ead91c4e5d9b76bca54c19862f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i15e904416e0c433ca74cb7980b2e6633_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4be0edf10e0548a6b2cff393c65da1f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i763696419f734dfaa3b176b7f09e6547_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2d0655252144469e8a6289d5d0cea2f3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if281a36c7ccc4a4aae4dad712d455bfc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8a7ee7ba6eb240858ec746652a6fdc24_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i391acdd0982f425f84071afc5d969737_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i29a197404c3243d9b8b707eb226c77fd_I20220701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-01</instant>
        </period>
    </context>
    <context id="i83f2e14bdb904ac69fc8abf1f24b5ab6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:SkyePharmaHoldingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis">pcrx:UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i65d966ca6353411282f9165d72de2694_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib460bbff86ec431dbef5039959fb47c2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iede544d07eb8434cbb48cd6e2d2f78cf_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia5ee767a49874dee966e06f8b34939c7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie5a8f5d97b3248aeb01adea4b0c7fe72_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1658c43324b5453cb15e998032d6549e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c9452190b1e4796b95b0775fa97bde7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i123f4f9994ab4fb68fe6439b61e60b8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76602afa0926462bbcd383a88f3f3ef8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibc3334cacbe145ba953c4eed59a7b31b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ea958f7cb56441bb8f52e823cc43b24_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i125dd11a1f7244a59ed136faf48d4dc0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i292cd08d718c48e594813938f2045cca_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c9dded19a964d11981b36b085b753ff_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id4d6abb8ceed479bada14abc5c7d6b1b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib7189f61d0f74daea85087e80f151740_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e4c5d796d09442cacf138a186e3cdec_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i356d1afe505c441eb90b0423c3fb17f2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i86c516f1d6f04f26b3b01ed70a06cb25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c5268d5a41d453387099bbdce493860_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib78f8ec858814f8b9f80f0d166898244_I20211230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-30</instant>
        </period>
    </context>
    <context id="ie2012b55273641219ce287b6c7a3676c_D20220630-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id396246417f747219b1efc00393a410a_D20251231-20251231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-31</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="i14cfaef699694c8aa95e5b1497db08f8_I20261207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-12-07</instant>
        </period>
    </context>
    <context id="i9713356e4b794cad87f61cdf66d71cda_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8ba15de8dac143c1b4bc141eea541035_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7f34a25fd03649ce9d8283d456471160_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9511fd772a33485880857ed5ca7d851a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4de17e595d074a81bcbe5f3e180aa7ae_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iaae7a6225dc9403087ba9ca504bd5fb5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i31ba252e9c0a48188e8038d7fcbf3bc2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idb0b227a9c66456c9e5719df73099bd6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">pcrx:FederalReserveBankOfNYRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if7caa5a1b4a74f499d82959cd49c6133_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id3d5f239abc04c23a4020b220c65ce7b_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i6590fbf0d3a9462e9127e6b54ee201c6_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="iccd912dc0b8b41f3bd7d557dac967d17_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="iba8867ac2f1d4283b42fe8008031479f_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i15c1498310e443e7af3ba4aa7ad28e3a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsPriorToFebruary32023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8fd9f584f9084e259a06bbfddce30195_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="ia62779f0fd434d20b021fcde6a57f24a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsOnOrAfterAugust12023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9395aa55649e4194b09292b57bc4118a_I20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-02</instant>
        </period>
    </context>
    <context id="i48e21d63eae54e80a8ef9375cebac9c5_I20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-02</instant>
        </period>
    </context>
    <context id="i45a17b9799754d8382dc1b30711bd51f_D20211206-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="if3c970a4569147d397783bc1f4e7311d_I20211206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-06</instant>
        </period>
    </context>
    <context id="i991d1519897b4f2ea80c13d8da3de071_I20220107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-07</instant>
        </period>
    </context>
    <context id="i015d29a64d0646edbc9915f35b26c446_D20170301-20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-01</startDate>
            <endDate>2017-03-31</endDate>
        </period>
    </context>
    <context id="ib5b5fbc6d47e4f9f9e6d40924ce413db_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="idecdb2c3fc1449cfab60ca69c9d1fe48_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i37476438df894c20a4bc4a280d425eb6_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i230c25fa74ac476dacc08c72752f5a63_D20170502-20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-02</startDate>
            <endDate>2017-05-02</endDate>
        </period>
    </context>
    <context id="if2e6ec6d226541d0822abc76ae23a4ea_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2e4721a6974c47a4b2d7646849bd93fd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2c8cd2acac994e3fb138accb3626a770_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id24058253a50408188a9e11bcb502ad1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0a50652bf64e4acb8120bf54d9198e87_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib8e4e6f04e6b4ff791a9370ec1559121_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6b8cad7de1da4c2db70aedc902c27e25_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i16c8b9c91dac49cca9cd3167f0c77333_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i87be4045b1ee4290b6f4d157746a446a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifb17c50c746a4fb99da95cf89348f9ce_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie68e64f1b5724490a26fff0a570e6bba_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i724c52c24b4d431f9f6b2362fdc0f0e1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ieede5540398c4dc58694079e2fb20f85_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4904ad55b53844fba2ec392689cda980_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if52a538e2d054df5b39586e4fac623ae_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idea088cac0574f4bb8455403924088b6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic2c7ec07806341f485488028d8ebbf96_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2055f75ada8d436fb802dc413014b5c1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib5f5585697664021b9b028fc12de735e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8ba288a5b7ff409c940d4b0449afb0cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e03211b48e14029b06e9f14140d2baa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c295ad4598945c2ba9f47a504b4472c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia819f5487dbc4bb38b0e991835be6ef0_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic59e7ba74b4b45cfab0ae29982cc8e9d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0c4255beee6d40db938f1050821cc199_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i65bfea142670495289d5c647467570b9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAndMyoScienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1587b3c1d7e7411cbd588e6bc0bfb723_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAndMyoScienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0fc8018e6ec54834baf8d0e5d5a8d0db_I20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-19</instant>
        </period>
    </context>
    <context id="i4f0c78a9972546d4a4bf2bfb19a1c536_D20211119-20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-11-19</endDate>
        </period>
    </context>
    <context id="i0d717792cb904a9c8671026179052f91_D20211119-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6168e02aa26e4349847195bf09c3eacf_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i21ca7a53ce30416b93b74cd8a9870e74_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0c49317fb1254c648300f85c536d596a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9835d59ac7914259affd398b5712be27_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4c963cd0f8b24890b29f01580d4dafa6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3e462270f4d749ada2b41a121bfaaf93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59c47ce6aa614060975818db7878464b_D20190401-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="ic35614cca1f842c6b25edec7754b753e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8b2f0c4184a8447cb9800ac82b098ef2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie60dfafd369d49e9a8915074448de244_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1f238205c3474a579a6577a0cfb931fc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib55aafc43f234774b601b8faca0c6b5d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i15a06e8c3c614623bffeb6e3b147f2bf_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i77eaafc589a34116b77b15bbc4fff3e5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2efee5eb27da4de2a1ed8e6d5e6eecd3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebe6ca8b87dc455e8cbf5d62768fb93d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iee968166c6e54c399c9428c7ce8b8057_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idc02a21d3efb40b2a085eac6cf253ef8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0a822b3a761c4bf49157f47c28748111_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i55e627016d97492ba0681471fbd8968c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6f80639d084b4aa89ec55b9178bb46a1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9a5bb2973c6b4c96abe3db554e6d078f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iee16b76f339b45f1bc4250ddc76ad052_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd89bb1f4f08443fb61357d5cf825054_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0afc326973624dedabbf6ad485dfc1e5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i710e2f14bbb34bba99311d3b4e837f2f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icf3fcd52747443ab910304b3bdf6b6e8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifd1f2abc0e78467d927adac6fa878af8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idc2e8e031b6c4f349a9a22d1b983860b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i93ff7976ca834ff8be1fb773760bf3ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43ff4e22b20243b28a23578412c3b209_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb3acbf69765400b99cbf96568b817cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7c6f1c8ace3439a97adbf4622bc27e9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iddf44d8e1eb24bb38df6f546dbde1595_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic92dd8c00b21453d812274cd1558efeb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i364140fb0ecb4c5b90678acdcbc6f1ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6fb800aa91a443a8562539853dbd945_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia1df9fb6c8864c09a8ff94e2cb57ad21_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaeada0763b1349a6a781e82453974c12_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iab2955eb68904b22a10de3106fc90299_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34fc14fcb0fe4ad4984107a1fefc0823_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie211f03ed1a748f1aa10a0c73727da12_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iedea906cd76a4d4bba0431551477a909_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i31ac85e1887749e4b9a817256cbd8b28_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i48031d7bf51f42d489a3a3a50bf8e6af_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if6cb2fdecf4b4a0a85c84a8fd76f0bbe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25d448a3f20f451b9239b04a6513c8cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08b536b7990b4e1894b876ae5ada1a24_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id1995fc5495b4921bfb8486c9d6f9f19_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if83f4b65463347e6a51d901c1e50e22e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8e1e3475775b4e76ab6efcb59dd158f6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iff0cddc2bc28438a8934112eb263d081_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2c88759301c941b096aecd8a4937c534_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i55eab178e9a043b1a145b43918fe8858_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4a8f20a978a34500a4d487f8a56ade4b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i212b2c71c3a147c7a27ebf79f5a7c12e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i20270789c96347f29c7c132e72ddd5c4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i50d1f8b7f2c346eeb7844217241e3a36_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i02b1b5de0b8e42078315f31d7aef6b00_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i03a4c08595d646a1baa2a16e237083a6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifecfe644d38148929046d13feafd4dab_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaf0d15f2737042a888b6d0615dc70cd1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic7634d27564544329107cc50cd79208f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i85df01f524b547a39620a6cd60ab5eae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5ca303801f644e169133ec4d7e0c6998_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie5b71027039a48cebc64faf0916105d2_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i39a0a2f43861465f96e848700239814f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i43454386d0e64c9aa58f37a86d3898e1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i303f42a872d84848a26c7935521e8d9d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id76d6ea4321e4124937fc7c109c12121_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i23b9728da5774e0f8865eb56c0287548_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibb138ead7c8749139ab55dab62470f1f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4cfbe4103aec4e4dbf93af04eba8abe1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0362692f03ce4f04b845f4ef84d3150e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibd17b7148b4b4336ae3a8a8ab12951b8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6a329b7adfca4c45be13dd71376e3285_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie39e757d15684b84b80beb859cc71a9a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if5e85fea4b1749a0a9ab002bc71033a2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0baf3a23aeb847d8b41472f49c4054e5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i111e70709f1a49f58e7bc236e873db49_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i80a72523d0c1401185af1aa98e145d67_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibcb41bddccc844a8b1608c8a5f1eb2f1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie519317e61de4bd4b61b769f86af2017_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7926f8178c944494b800dc70a8aee09b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6b13dbca109f40d59b428f6eb0fcce41_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia852df3ea8e7487d833721f9de1ece5b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i23cdbff094c5425f8aa1a90414d51f06_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iae72f39fcbeb458cb1ae7c42c5e4d55e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i33a60813e9f44095913e43e93a53efc0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i728ca8324e5149769ed4f7f8eb7732dc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3ec452862f584d9196d9a07fc8b8ddc6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1c65baa223334a0a825004fd918ececa_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i21203a7e95a542a1bb5a7bdfa160cd8e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i812548bedd2c4f138ae40720d5ab3452_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7d271c16dc5b4e50b5f8b6e36bc439dd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie3eff8369f3a447bb8c7f19a5bccdce2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i89ca9116e3b44efaa7a91cf17de3ff05_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1626a61d1e96472bb1b34f2c5b6812bb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i990dfdef52e040719fa28dbb661db8d9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib78e38aec2fa45a58c7a556502d296ac_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9662be69372649fdb9f55eaf2dddc1cb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i77aff11637744366ad3beae32e8eac9d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie51cc6d770c1439bbf87e1a1246d6e15_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id0e717cf4ed5406d82a7bcd4eb4a20c9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i56aff27448c64dbaacbbf8b0552a16b7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i29042b95beda4bcf93f5b0e944d9e035_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8634775cc9bc464884a372b878f6a608_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idf3a6876c8774d06bf57b261d16c5eaf_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic60ea8d3b79d48c4b025712186e3026c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibe0d71dff18d49c48f2bf3e271341ed5_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:FortisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ib0b9052c119f49399daa2d218196b388_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifec5c95984324d979dd83044fa9e7ec4_I20200320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-20</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="product">
        <measure>pcrx:product</measure>
    </unit>
    <unit id="segment">
        <measure>pcrx:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="lease">
        <measure>pcrx:lease</measure>
    </unit>
    <unit id="payment">
        <measure>pcrx:payment</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="customer">
        <measure>pcrx:customer</measure>
    </unit>
    <unit id="offeringperiod">
        <measure>pcrx:offeringPeriod</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV8zLTEtMS0xLTg2MTI3_0e0a2a94-9650-4039-829a-8af8960d490a">0001396814</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV80LTEtMS0xLTg2MTI3_c66d9871-8aa7-445a-acf4-3cdc5ebbc4d6">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV82LTEtMS0xLTg2MTI3_eaff17cf-d9f9-4c11-bebb-a1d341d02c57">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV83LTEtMS0xLTg2MTI3_309efad3-337b-4678-9bc1-f28ffb83552e">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180L2ZyYWc6ZjcyYjdhNjVhZTg3NDJlYzk2NDM4ZWZlNWQ0ZTRhZmYvdGFibGU6ZjJiNTNiYzc5MTM5NDMwMjhkOWU5MjRmY2Q5ZDI5NjkvdGFibGVyYW5nZTpmMmI1M2JjNzkxMzk0MzAyOGQ5ZTkyNGZjZDlkMjk2OV84LTEtMS0xLTg2MTI3_553a5951-91be-4530-934b-0f8c374fe1e5">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ib06fd977f58642338910637dc9ee051e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy0wLTEtMS04ODU1Mg_82e450ad-29e0-449d-a33a-5002227870d7">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006RetrospectiveMember</us-gaap:AccountingStandardsUpdateExtensibleList>
    <pcrx:AccountsReceivablePaymentTerms
      contextRef="i5dd7ecccda904eaca960004478e3d7cf_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfMjk1OA_60482776-f82e-46b2-bdd2-45bb82b080c0">P0D</pcrx:AccountsReceivablePaymentTerms>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i230c25fa74ac476dacc08c72752f5a63_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182NC9mcmFnOmQyZWY2NTljNjg4ZTRiMmY4YWJiNWI5NjY3ZjYxMDQ4L3RleHRyZWdpb246ZDJlZjY1OWM2ODhlNGIyZjhhYmI1Yjk2NjdmNjEwNDhfMjQ0_524c4740-228d-4802-a0fe-2c34b05b4e43"
      unitRef="number">0.0373413</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <pcrx:DebtInstrumentMarketPrice
      contextRef="i292cd08d718c48e594813938f2045cca_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182NC9mcmFnOmQyZWY2NTljNjg4ZTRiMmY4YWJiNWI5NjY3ZjYxMDQ4L3RleHRyZWdpb246ZDJlZjY1OWM2ODhlNGIyZjhhYmI1Yjk2NjdmNjEwNDhfMjc1_19ee4390-4eb2-476b-87d8-2f468fad0bcc"
      unitRef="number">1.038</pcrx:DebtInstrumentMarketPrice>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="if2e6ec6d226541d0822abc76ae23a4ea_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182NC9mcmFnOmQyZWY2NTljNjg4ZTRiMmY4YWJiNWI5NjY3ZjYxMDQ4L3RleHRyZWdpb246ZDJlZjY1OWM2ODhlNGIyZjhhYmI1Yjk2NjdmNjEwNDhfMzIw_f3f510c5-2e7b-40ca-9f95-aa0c19fbd4b1"
      unitRef="number">0.0139324</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDcz_b38602c7-c193-44d0-80c3-80e418688270">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6ZDRiZWJlMTg5YWVmNDk0ZmI1ODM2ZjBmNzI0NjY2ZmUvdGFibGVyYW5nZTpkNGJlYmUxODlhZWY0OTRmYjU4MzZmMGY3MjQ2NjZmZV8xLTAtMS0xLTg2MTI3_8c220ed5-a192-46cb-ad32-5e7e55d1e056">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8xMjg_21dfa1f9-2350-43fc-9018-174d92288f00">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6NWQ0NmMxOWJjY2Y4NDc5OWJkOGY5MGRlZjJkZGFlZjAvdGFibGVyYW5nZTo1ZDQ2YzE5YmNjZjg0Nzk5YmQ4ZjkwZGVmMmRkYWVmMF8wLTAtMS0xLTg2MTI3_4a29ae81-ae77-40fd-9d68-7c48acfccd73">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDgz_d4681c00-3f9d-43d6-93b6-a41bf6a9bcbb">001-35060</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc5_d942dc54-c07f-4ea6-a13b-5b4e60d12f38">PACIRA BIOSCIENCES,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6NWZmOWVkODYwZmFhNGE2YjhiYmVmYWRmOWYzMmM1NDUvdGFibGVyYW5nZTo1ZmY5ZWQ4NjBmYWE0YTZiOGJiZWZhZGY5ZjMyYzU0NV8wLTAtMS0xLTg2MTI3_6acf7e9d-ca1d-4a72-84e8-6e81802817b9">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6NWZmOWVkODYwZmFhNGE2YjhiYmVmYWRmOWYzMmM1NDUvdGFibGVyYW5nZTo1ZmY5ZWQ4NjBmYWE0YTZiOGJiZWZhZGY5ZjMyYzU0NV8wLTItMS0xLTg2MTI3_474c1f68-8cb3-4bdc-8969-7cbac9dcb363">51-0619477</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDg0_68a8676a-f232-45e2-becc-d304ad315e16">5401 West Kennedy Boulevard, Suite 890</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc0_f7f488ff-6408-43e6-8947-74c917b6a0fe">Tampa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDgw_c24cbd58-96bc-4984-aab1-3324f97503ec">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc2_fdaeb3c9-10d0-4556-97bd-73203ed4badc">33609</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc3_67fc1298-0da9-4317-a22d-309de8ef6782">813</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDgx_a1fa4d45-4e5b-4df9-a2e7-e6833bdbdb7f">553-6680</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Yzk4YjgzY2UxNjVjNDQyODkyY2EyYzU5ODc3YTFmNGQvdGFibGVyYW5nZTpjOThiODNjZTE2NWM0NDI4OTJjYTJjNTk4NzdhMWY0ZF8xLTAtMS0xLTg2MTI3_6f678c95-b6d6-497c-bb5d-eb267ba27b42">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Yzk4YjgzY2UxNjVjNDQyODkyY2EyYzU5ODc3YTFmNGQvdGFibGVyYW5nZTpjOThiODNjZTE2NWM0NDI4OTJjYTJjNTk4NzdhMWY0ZF8xLTItMS0xLTg2MTI3_ac695272-5493-4c3b-9f2f-d5446be72125">PCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Yzk4YjgzY2UxNjVjNDQyODkyY2EyYzU5ODc3YTFmNGQvdGFibGVyYW5nZTpjOThiODNjZTE2NWM0NDI4OTJjYTJjNTk4NzdhMWY0ZF8xLTQtMS0xLTg2MTI3_6694a5ae-7044-4d9b-afd2-e75bd507bd73">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDg1_426c2f4e-3a7b-4331-ba2f-bf76224c664d">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDc4_f5cf3aa9-4d89-4742-8c09-6f006f0e2c57">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Njc5ZWMzOWViMzQ5NDkyNDlkODZhMDY3NDU1MTkyMjkvdGFibGVyYW5nZTo2NzllYzM5ZWIzNDk0OTI0OWQ4NmEwNjc0NTUxOTIyOV8wLTEtMS0xLTg2MTI3_98d3814d-98d2-4a40-aea6-d0e87384d16e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Njc5ZWMzOWViMzQ5NDkyNDlkODZhMDY3NDU1MTkyMjkvdGFibGVyYW5nZTo2NzllYzM5ZWIzNDk0OTI0OWQ4NmEwNjc0NTUxOTIyOV8xLTUtMS0xLTg2MTI3_bf54ce5f-03b3-41f4-9891-a7ace7eaed3d">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGFibGU6Njc5ZWMzOWViMzQ5NDkyNDlkODZhMDY3NDU1MTkyMjkvdGFibGVyYW5nZTo2NzllYzM5ZWIzNDk0OTI0OWQ4NmEwNjc0NTUxOTIyOV8yLTUtMS0xLTg2MTI3_49729089-f1e6-4e2a-9119-6dbcc0b70b78">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8yMDgy_df2aef4f-fad7-4b94-a8b8-5f7a7b6d266e">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i065f6b275a044a978b8835a167a0421e_I20220801"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xL2ZyYWc6NGVlNjYzZjc5YzU4NGU3ZmJhMTQ2M2Y4OTdkMDEyZmEvdGV4dHJlZ2lvbjo0ZWU2NjNmNzljNTg0ZTdmYmExNDYzZjg5N2QwMTJmYV8xOTg1_15259543-28c2-4842-a899-d2e13946da34"
      unitRef="shares">45824210</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMy0xLTEtMS04NjEyNw_c5eb2787-291d-4c22-877c-076e4e168b7b"
      unitRef="usd">122061000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMy0zLTEtMS04NjEyNw_daeddc55-3dd5-4165-a93e-b0aa81d6eea9"
      unitRef="usd">585578000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNC0xLTEtMS04NjEyNw_3425b599-2d68-4e2a-9d40-e1d5ee453ca8"
      unitRef="usd">194332000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNC0zLTEtMS04NjEyNw_e62b01ff-9a9e-4aea-995d-9114efe3e8c9"
      unitRef="usd">70831000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNS0xLTEtMS04NjEyNw_8ab548d4-8fb9-42ff-a6ec-78ca86b543d2"
      unitRef="usd">91105000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNS0zLTEtMS04NjEyNw_6c33fa80-e0aa-48bd-ae32-abcab87f273d"
      unitRef="usd">96318000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNi0xLTEtMS04NjEyNw_70f14a42-238a-499e-944c-013c5533abbb"
      unitRef="usd">100588000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNi0zLTEtMS04NjEyNw_53324c14-293a-47b1-b857-97bc0be24afe"
      unitRef="usd">98550000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNy0xLTEtMS04NjEyNw_4826cb5f-b983-4fd9-b083-5c730e826efd"
      unitRef="usd">18124000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNy0zLTEtMS04NjEyNw_20388e2d-6e96-4e4c-a502-1c2c67b69e21"
      unitRef="usd">14771000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfOC0xLTEtMS04NjEyNw_224ff459-5e89-4b59-8842-04cd1896590c"
      unitRef="usd">526210000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfOC0zLTEtMS04NjEyNw_0fcd2e95-3319-440e-ab80-a9db1f25e92e"
      unitRef="usd">866048000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTAtMS0xLTEtODYxMjc_557963c9-a637-4d77-b4ff-baccb55c1659"
      unitRef="usd">191279000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTAtMy0xLTEtODYxMjc_52bcd851-4c73-4d6e-affe-12319e35f909"
      unitRef="usd">188401000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTEtMS0xLTEtODYxMjc_d596c213-8d6a-48b6-b5dd-07858e3bbbe5"
      unitRef="usd">72082000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTEtMy0xLTEtODYxMjc_9a3c0113-081c-4dcb-889e-c89fa2577a86"
      unitRef="usd">76410000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTItMS0xLTEtODYxMjc_6e8ffe54-7279-4f43-87fc-a3d541a478b3"
      unitRef="usd">146132000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTItMy0xLTEtODYxMjc_0cbf3914-0340-4d3b-8da7-2d0381156a75"
      unitRef="usd">145175000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTMtMS0xLTEtODYxMjc_881867e2-8185-458f-9ca2-9c6186aedf7f"
      unitRef="usd">595324000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTMtMy0xLTEtODYxMjc_cd0195dc-9bb5-4a49-8b21-d8e9bc67b5e6"
      unitRef="usd">623968000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTQtMS0xLTEtODYxMjc_0d319ed4-c48f-459e-9c51-d60a014b4388"
      unitRef="usd">167149000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTQtMy0xLTEtODYxMjc_4c5ab739-e942-42b1-bddf-ecf3e23d78ec"
      unitRef="usd">153364000</us-gaap:DeferredIncomeTaxAssetsNet>
    <pcrx:EquityMethodInvestmentsAndOtherAssets
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTUtMS0xLTEtODYxMjc_eb622caa-2a7f-487f-a6f6-58ecc232fcc0"
      unitRef="usd">35812000</pcrx:EquityMethodInvestmentsAndOtherAssets>
    <pcrx:EquityMethodInvestmentsAndOtherAssets
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTUtMy0xLTEtODYxMjc_dddb396d-20dc-4622-9f05-b828e87cc233"
      unitRef="usd">21987000</pcrx:EquityMethodInvestmentsAndOtherAssets>
    <us-gaap:Assets
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTYtMS0xLTEtODYxMjc_1f809f81-ae4f-495e-aa2c-a323544fe695"
      unitRef="usd">1733988000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMTYtMy0xLTEtODYxMjc_0111594e-d18d-4c76-897d-a1586b678a5a"
      unitRef="usd">2075353000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjAtMS0xLTEtODYxMjc_9d73120e-5a83-49e6-936d-7de1ba9a97e8"
      unitRef="usd">13983000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjAtMy0xLTEtODYxMjc_c1607968-fde5-4a48-9483-57128b14006c"
      unitRef="usd">10543000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjEtMS0xLTEtODYxMjc_74c08d75-e9dd-4bd1-a2f3-c176580739a3"
      unitRef="usd">77275000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjEtMy0xLTEtODYxMjc_3b403a43-6e32-469d-8620-46e4bcbf99be"
      unitRef="usd">127555000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjItMS0xLTEtODYxMjc_3cd0c9b3-c2d8-4116-94e8-6791a12994e2"
      unitRef="usd">8134000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjItMy0xLTEtODYxMjc_8328ef8b-7aaa-48a1-8610-ec3c84455c48"
      unitRef="usd">7891000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjMtMS0xLTEtODYxMjc_39cdb37a-cbbe-4716-b259-27b9f7e3cc23"
      unitRef="usd">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjMtMS0xLTEtODYxMjc_40aaad8e-7be3-4071-b5ae-4840257deeb6"
      unitRef="usd">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjMtMy0xLTEtODYxMjc_943ae2fe-967a-4f88-b17a-eaaba1f96f17"
      unitRef="usd">350466000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjMtMy0xLTEtODYxMjc_b3da91c2-0c8c-4616-93a5-17f699a62b5a"
      unitRef="usd">350466000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjUtMS0xLTEtODYxMjc_c27f8eda-dfb6-47e5-9b31-14150ffe276c"
      unitRef="usd">33776000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjUtMy0xLTEtODYxMjc_fe750462-2d05-4322-89e8-ea555a52cffb"
      unitRef="usd">24234000</us-gaap:SecuredDebtCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjYtMS0xLTEtODYxMjc_c2b46f49-9fc3-403b-a8ab-f474de7b8be6"
      unitRef="usd">11000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjYtMy0xLTEtODYxMjc_ebfc0ec6-b2a2-4e78-b89d-de9d3f12c479"
      unitRef="usd">429000</us-gaap:TaxesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjctMS0xLTEtODYxMjc_9f272e6d-bc4c-4afc-9d4d-b5f6ece4e57f"
      unitRef="usd">133179000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjctMy0xLTEtODYxMjc_aa03062f-d0df-40fb-8ba4-8af248850fb7"
      unitRef="usd">521118000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjgtMS0xLTEtODYxMjc_abbc0bc6-47c7-4480-8038-c2d74b2ebbff"
      unitRef="usd">403534000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjgtMy0xLTEtODYxMjc_4f224eea-0822-426b-9488-8d6d4c9faf6a"
      unitRef="usd">339267000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:SecuredLongTermDebt
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjktMS0xLTEtODYxMjc_f552c09a-66aa-4a66-8e38-aff9e34e5a41"
      unitRef="usd">318344000</us-gaap:SecuredLongTermDebt>
    <us-gaap:SecuredLongTermDebt
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMjktMy0xLTEtODYxMjc_cf17b822-6c1a-4929-9fe8-8f724a304369"
      unitRef="usd">335263000</us-gaap:SecuredLongTermDebt>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzAtMS0xLTEtODYxMjc_fef43669-83a3-42e5-8a4b-00ebd347c587"
      unitRef="usd">67575000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzAtMy0xLTEtODYxMjc_e0377dbd-ffd1-407c-88eb-0127ee10284c"
      unitRef="usd">71727000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <pcrx:ContingentConsiderationNoncurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzItMS0xLTEtODYxMjc_852f7a16-0ea5-4ecc-8228-c528139e5ff4"
      unitRef="usd">35247000</pcrx:ContingentConsiderationNoncurrent>
    <pcrx:ContingentConsiderationNoncurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzItMy0xLTEtODYxMjc_98333c5d-23c1-4023-9774-b56e035fb15f"
      unitRef="usd">57598000</pcrx:ContingentConsiderationNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzMtMS0xLTEtODYxMjc_ebfb48bd-4f97-4bed-99eb-4b53942ff544"
      unitRef="usd">19473000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzMtMy0xLTEtODYxMjc_e8b8e48f-a309-481a-892f-1a1080cff62e"
      unitRef="usd">19972000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzQtMS0xLTEtODYxMjc_07959387-7a6d-43fa-a2e5-bf043c6b817f"
      unitRef="usd">977352000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzQtMy0xLTEtODYxMjc_25496763-a5b3-4793-a812-6b71a1cd9e40"
      unitRef="usd">1344945000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzUtMS0xLTEtODYxMjc_3fa6965e-e253-41bc-8079-8a315154afd7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzUtMy0xLTEtODYxMjc_ae129100-795f-4bcd-8b86-6d34e1e21e1e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl8zMQ_5e73da2e-2723-4160-962d-3dd186c56e56"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl8zMQ_de7de8f1-2f94-464a-b4f6-bc1e5842e5a5"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl8zNQ_100a265a-e6fe-4f2a-b7c2-88a19691ca84"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl8zNQ_f3de7f39-b313-4e1e-aedc-8abd3b4a4480"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl81Nw_48238eaf-a3df-4c13-88ea-dfcc43f39f48"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl81Nw_78decc01-afd2-4a88-883b-0682d9218710"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl81Nw_e6a75cda-8002-4e21-9c9b-aca682a282bc"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjo5OTc2OTQyZWE0Nzc0ZDA5YTgxOGVhMjdjMjM1YjY5Yl81Nw_f1c88fa2-d074-4cca-9cd2-250ce5d4a3fd"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMS0xLTEtODYxMjc_aca2d0e6-3ecc-488e-ad3d-15efc1a53242"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzctMy0xLTEtODYxMjc_65dbb43d-bc64-4d7c-b1ff-6184b85ccb02"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV8yOA_028d7579-813a-40f3-8e40-e1444c0a9817"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV8yOA_76b4baef-7ef3-4e37-aae0-0f978f5dc5b6"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV8zMg_65e16a35-327b-4839-afd4-83055c146110"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV8zMg_f16e56eb-b1b1-490f-9b6f-37e31ff7c1a9"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV81NA_25470ab4-e0b9-4e24-b6ea-dcb599867278"
      unitRef="shares">45801578</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV81NA_7e6996e4-5cdf-488b-802b-25abf56ea7f8"
      unitRef="shares">45801578</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV82MQ_2fc204ab-4e21-4dff-ad38-520d7ef4b9bd"
      unitRef="shares">44734308</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjpmZWIzMTg2ZGFjY2U0NDc5YjQ5ZjhlNTljNTZhMDIyNV82MQ_e2bc389f-d1c7-4d51-9e06-19edf74ba262"
      unitRef="shares">44734308</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMS0xLTEtODYxMjc_e3058df4-a20e-4373-9769-4848d724eb67"
      unitRef="usd">46000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzgtMy0xLTEtODYxMjc_487dfc20-72a5-4c25-9f8a-3f6759a7fa44"
      unitRef="usd">45000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzktMS0xLTEtODYxMjc_0d5e2a70-70d2-4bcc-9a56-ae5508af144a"
      unitRef="usd">895151000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfMzktMy0xLTEtODYxMjc_c8ba0392-a559-445c-ae4a-3d35d0ec8beb"
      unitRef="usd">942091000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDAtMS0xLTEtODYxMjc_19ebe11c-9e14-455f-89d0-cdea63eeb300"
      unitRef="usd">-137956000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDAtMy0xLTEtODYxMjc_9912e4a6-db3b-470f-8fee-5b9ea170a3a3"
      unitRef="usd">-211895000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDEtMS0xLTEtODYxMjc_8f9468f5-c753-462c-9e2d-b89f9ef0291e"
      unitRef="usd">-605000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDEtMy0xLTEtODYxMjc_9c1f614a-6a59-495c-85c2-d524d11599e4"
      unitRef="usd">167000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDItMS0xLTEtODYxMjc_48e0c467-7954-45cb-94d5-5a9dd87044d6"
      unitRef="usd">756636000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDItMy0xLTEtODYxMjc_302fda93-813b-4409-bd5e-f7cd00cd1b01"
      unitRef="usd">730408000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDMtMS0xLTEtODYxMjc_da6d6bd1-5f60-4dfe-ae6f-c78fbf68af79"
      unitRef="usd">1733988000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xNi9mcmFnOjZjM2RkNjYwY2U0NDQ2NDFiZTFiZTk1MGFhOThlZGM2L3RhYmxlOmQ5MWYzZTE4ZTI4MTQwYzhhNDIxOTExYzdlNzAxNWQ5L3RhYmxlcmFuZ2U6ZDkxZjNlMThlMjgxNDBjOGE0MjE5MTFjN2U3MDE1ZDlfNDMtMy0xLTEtODYxMjc_56fcdd55-5e49-418c-87ff-67a8f3d90116"
      unitRef="usd">2075353000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf4570f968674f3bbe27c560bfb9be87_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMy0xLTEtMS04NjEyNw_e52e219b-9cab-4b25-8faa-ce85b426029f"
      unitRef="usd">168581000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7284aa2c87d44f68ba483dff38427eec_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMy0zLTEtMS04NjEyNw_12c8d27c-27ed-482a-84e2-b0f99463782f"
      unitRef="usd">134863000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0df55d4c445d47adb69a0c7a9cd64df5_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMy01LTEtMS04NjEyNw_a626d10d-3595-482f-b69d-7f15e5593157"
      unitRef="usd">326003000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i872e83e0083747ac98f21041708778df_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMy03LTEtMS04NjEyNw_70c80cc7-d0a5-4e15-80dd-594fe06ab942"
      unitRef="usd">253601000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaeac445eb2804a44bf29e75079f90ec5_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNC0xLTEtMS04NjEyNw_b1216e20-0477-4ede-9116-792270f35eff"
      unitRef="usd">830000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id57b66a9719a44e5b652fa1c6eea2346_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNC0zLTEtMS04NjEyNw_ebfdb45a-f629-4b65-afe7-28c0eeb9db1e"
      unitRef="usd">602000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1899070b94594becb2264b63d5eea7dd_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNC01LTEtMS04NjEyNw_9abc6346-2f22-4a88-97a9-4ba1dcef5171"
      unitRef="usd">1399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53613137983c432ca979eea4cef3c97d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNC03LTEtMS04NjEyNw_0db560cc-f486-4efa-b934-ebdc5d0ad2a8"
      unitRef="usd">891000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic98bf5546d144ab99b2b83c44eb9cc95_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNS0xLTEtMS04NjEyNw_463e51b7-58dd-45ee-9f97-a7ad7f782373"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7ee03c49a9340679a4b219e33e24837_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNS0zLTEtMS04NjEyNw_c2184068-3a28-44d8-b617-4a5a6e7266f8"
      unitRef="usd">125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0314b81a8a7c4118becd58eee01d8a94_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNS01LTEtMS04NjEyNw_a722f9f0-265e-49ce-8c45-78c823659a30"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e93fd6ed579409bb376796f42c77e60_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNS03LTEtMS04NjEyNw_9683ab7f-e9fb-4381-98ba-7e565f072c01"
      unitRef="usd">125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNi0xLTEtMS04NjEyNw_8b2f6fa0-48ec-4977-b37e-95ae32b9ba35"
      unitRef="usd">169411000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNi0zLTEtMS04NjEyNw_1b8ff1dd-fec0-48df-ba55-8a14a58ab0f8"
      unitRef="usd">135590000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNi01LTEtMS04NjEyNw_9f72e920-bbe8-4734-b57f-b1f90c2f2a11"
      unitRef="usd">327402000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfNi03LTEtMS04NjEyNw_dd1def58-9a9b-40ca-9159-dd437b44218c"
      unitRef="usd">254617000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOC0xLTEtMS04NjEyNw_034f8a77-62ed-4752-843e-3922c9a03300"
      unitRef="usd">50627000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOC0zLTEtMS04NjEyNw_8736a8d4-7d72-4139-a65f-a68758d1cbd2"
      unitRef="usd">35248000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOC01LTEtMS04NjEyNw_6ab9b3cd-da25-4e5a-80ff-20b55a588224"
      unitRef="usd">86701000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOC03LTEtMS04NjEyNw_3b76a3ce-2922-4ba7-bc76-174eaa27da4a"
      unitRef="usd">66597000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOS0xLTEtMS04NjEyNw_d16819e1-8e15-4702-a422-5864bbed0956"
      unitRef="usd">26282000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOS0zLTEtMS04NjEyNw_da432cc5-bde7-4472-9961-87c9705da4bd"
      unitRef="usd">12573000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOS01LTEtMS04NjEyNw_3f5bdaeb-1052-4308-ba43-9391ee9a2f55"
      unitRef="usd">47887000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfOS03LTEtMS04NjEyNw_f6eea932-071e-426b-86dd-55f26bd6dc6f"
      unitRef="usd">28453000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTAtMS0xLTEtODYxMjc_e2913f15-e099-47d3-9349-9b760a7abf53"
      unitRef="usd">65003000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTAtMy0xLTEtODYxMjc_9992bd88-f4dc-4baa-b42c-4b45c654c124"
      unitRef="usd">50813000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTAtNS0xLTEtODYxMjc_baff6aa5-cba7-48be-9679-d87bb89614a6"
      unitRef="usd">129263000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTAtNy0xLTEtODYxMjc_5ed61ded-5145-4897-8cfb-f09089c3d558"
      unitRef="usd">99335000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTEtMS0xLTEtODYxMjc_2615610e-c3e1-4194-8a0b-864630420a96"
      unitRef="usd">14322000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTEtMy0xLTEtODYxMjc_1dda6341-8341-46ab-84c7-639d1e263c7d"
      unitRef="usd">1967000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTEtNS0xLTEtODYxMjc_427e0afb-6d36-4dc9-a9b8-8ef08de62259"
      unitRef="usd">28644000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTEtNy0xLTEtODYxMjc_2f731c57-ec65-4ca3-a3f0-beb2f0ee2c91"
      unitRef="usd">3933000</us-gaap:AmortizationOfIntangibleAssets>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTItMS0xLTEtODYxMjc_86ba6025-c93b-4bfd-a372-06bb29a86bd6"
      unitRef="usd">18058000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTItMy0xLTEtODYxMjc_fd66af17-927f-4791-8000-a6d942f9559d"
      unitRef="usd">-146000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTItNS0xLTEtODYxMjc_979773a8-b3ad-48f6-90a9-cffb58bd7d0d"
      unitRef="usd">13721000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTItNy0xLTEtODYxMjc_aca04532-5287-4997-a430-ef35fe5b6308"
      unitRef="usd">-2019000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <us-gaap:CostsAndExpenses
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTMtMS0xLTEtODYxMjc_61b77207-6804-45b1-b25c-9ad9e139d3b7"
      unitRef="usd">138176000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTMtMy0xLTEtODYxMjc_40fe5132-4697-41d2-ab88-ef4898c99311"
      unitRef="usd">100747000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTMtNS0xLTEtODYxMjc_ffda57cc-4e06-42fb-ab90-224b620f6a0f"
      unitRef="usd">278774000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTMtNy0xLTEtODYxMjc_41ffb6f8-0c9e-4bca-a0a8-9d12b93f6b84"
      unitRef="usd">200337000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTQtMS0xLTEtODYxMjc_7d9baf08-b30c-43e4-a65c-feb6f3d34215"
      unitRef="usd">31235000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTQtMy0xLTEtODYxMjc_17e039cf-5f11-4366-98b0-75c2aabeb2a6"
      unitRef="usd">34843000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTQtNS0xLTEtODYxMjc_b8c0699b-d9bc-484e-b6b2-fb43204a3a71"
      unitRef="usd">48628000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTQtNy0xLTEtODYxMjc_be99974d-256b-407a-b0ba-72983ae7d665"
      unitRef="usd">54280000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTYtMS0xLTEtODYxMjc_b7503372-4a59-4c5c-8c42-f9c212297968"
      unitRef="usd">252000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTYtMy0xLTEtODYxMjc_563bd809-3148-4932-80c0-e72222bdb6a2"
      unitRef="usd">224000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTYtNS0xLTEtODYxMjc_54e1fb2e-d8fe-4e8d-9cf8-18d5fc07a468"
      unitRef="usd">523000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTYtNy0xLTEtODYxMjc_ffcecd9b-fae2-4680-b487-642b59c17c45"
      unitRef="usd">639000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTctMS0xLTEtODYxMjc_69b58715-1884-4f3a-8fdc-3470461c1327"
      unitRef="usd">8833000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTctMy0xLTEtODYxMjc_b9d0b951-d7ff-42b7-8482-1bdf0b1b31d7"
      unitRef="usd">7023000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTctNS0xLTEtODYxMjc_0cef3dee-00f2-45ff-8185-820091bf8fb1"
      unitRef="usd">19079000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTctNy0xLTEtODYxMjc_2c2a5223-bffb-4009-b976-5d8f219460df"
      unitRef="usd">13994000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTktMS0xLTEtODYxMjc_3604fe3c-bd87-42b8-ab5c-bd9d0a5f23a1"
      unitRef="usd">-647000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTktMy0xLTEtODYxMjc_d03c4eb3-4fc2-4c21-a5c3-f9f449a40efe"
      unitRef="usd">-2396000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTktNS0xLTEtODYxMjc_23e36f21-e8ba-4208-9d4c-c5c76f2fbb53"
      unitRef="usd">-771000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMTktNy0xLTEtODYxMjc_87f1d12d-f7f1-445e-acef-a5959c066ae2"
      unitRef="usd">-2554000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjAtMS0xLTEtODYxMjc_fef5e389-4617-4d92-bdae-1837783960d9"
      unitRef="usd">-9228000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjAtMy0xLTEtODYxMjc_ba35fb12-a305-47b2-9f54-a8a3915abb92"
      unitRef="usd">-9195000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjAtNS0xLTEtODYxMjc_ce2efb09-4cd6-4e0e-8f30-cca79a8e92b7"
      unitRef="usd">-19327000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjAtNy0xLTEtODYxMjc_2d3be483-e4a5-41d2-a5fe-41d69cf32f98"
      unitRef="usd">-15909000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjEtMS0xLTEtODYxMjc_191c8c42-ac57-461e-aae8-73f9a90c7f61"
      unitRef="usd">22007000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjEtMy0xLTEtODYxMjc_fa000da0-ff72-4d43-986c-dca0823af1a2"
      unitRef="usd">25648000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjEtNS0xLTEtODYxMjc_10e47049-4c89-4087-930a-6abf702c33b3"
      unitRef="usd">29301000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjEtNy0xLTEtODYxMjc_ac35f001-f590-41c4-8a6f-f2619dee9403"
      unitRef="usd">38371000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjItMS0xLTEtODYxMjc_589b3d2d-a751-4f73-9a97-f5bce6fb96fd"
      unitRef="usd">2131000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjItMy0xLTEtODYxMjc_ba7b8cd4-f83a-42e3-9a2c-7e671b852d7f"
      unitRef="usd">6567000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjItNS0xLTEtODYxMjc_36d7bafa-e02c-4a32-9cfa-6ca0ca99285a"
      unitRef="usd">2597000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjItNy0xLTEtODYxMjc_e9c339e0-c027-4455-bfe6-1ea73c364a4b"
      unitRef="usd">8921000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjMtMS0xLTEtODYxMjc_a8a6a987-f9dd-47b4-88aa-b71fe5740c77"
      unitRef="usd">19876000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjMtMy0xLTEtODYxMjc_adf26d4e-6d3f-4eca-9caf-11c19961359c"
      unitRef="usd">19081000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjMtNS0xLTEtODYxMjc_4faeef17-c885-4e17-8c1f-65f98bf6f29f"
      unitRef="usd">26704000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjMtNy0xLTEtODYxMjc_516a95a9-4bcf-4364-bdcd-fd4d28da0cf0"
      unitRef="usd">29450000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjYtMS0xLTEtODYxMjc_5227a05f-2911-4e11-9d10-5370ef6f361c"
      unitRef="usdPerShare">0.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjYtMy0xLTEtODYxMjc_5ec63f63-798f-4fe9-8a0f-4524b013119c"
      unitRef="usdPerShare">0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjYtNS0xLTEtODYxMjc_9ab683d7-92a9-4ba9-9c75-5854828df522"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjYtNy0xLTEtODYxMjc_73d96873-4c74-407c-afb9-d67240d464a4"
      unitRef="usdPerShare">0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjctMS0xLTEtODYxMjc_2653492b-c7bd-444a-b44b-4c08fde807fa"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjctMy0xLTEtODYxMjc_51d50910-014b-45fc-af71-7d3d822ebbaa"
      unitRef="usdPerShare">0.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjctNS0xLTEtODYxMjc_4d034885-adc2-42a9-80a9-cf74d7eab821"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjctNy0xLTEtODYxMjc_3e125f79-2cce-47e7-90ce-d609e70d1c8d"
      unitRef="usdPerShare">0.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjktMS0xLTEtODYxMjc_8e3913bb-8848-4d4d-8803-bd8f3575204e"
      unitRef="shares">45501000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjktMy0xLTEtODYxMjc_8367c2fd-0a88-4876-8263-d0afb87ce095"
      unitRef="shares">44145000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjktNS0xLTEtODYxMjc_6cf7260e-5412-4d1c-8216-3d0ad7285658"
      unitRef="shares">45185000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMjktNy0xLTEtODYxMjc_44c5ce6d-ca9f-4047-84df-8fb1ab982410"
      unitRef="shares">43989000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMzAtMS0xLTEtODYxMjc_18ce1a29-e1c6-4a09-ae08-34f3d440ca1a"
      unitRef="shares">52478000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMzAtMy0xLTEtODYxMjc_edc03a8b-1bd6-44b1-adcc-fbc350cad5f8"
      unitRef="shares">45592000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMzAtNS0xLTEtODYxMjc_7a08bb94-04da-4d0f-8e83-6ceeae05aaa6"
      unitRef="shares">52262000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18xOS9mcmFnOjcwOWQ0Mjc2Y2ZiMDQwMGRhNzc2M2UyM2E1NDk0ZTYzL3RhYmxlOmIwNTlhOGVlNDJlMDRmMzA4NzBlOTY1NDIwYjE0NjI5L3RhYmxlcmFuZ2U6YjA1OWE4ZWU0MmUwNGYzMDg3MGU5NjU0MjBiMTQ2MjlfMzAtNy0xLTEtODYxMjc_04156c5c-b52a-47bc-a559-b5d63a91ed2a"
      unitRef="shares">45779000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfMi0xLTEtMS04NjEyNw_a8a6a987-f9dd-47b4-88aa-b71fe5740c77"
      unitRef="usd">19876000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfMi0zLTEtMS04NjEyNw_52d64a14-a98b-46f9-95ca-e3231c348253"
      unitRef="usd">19081000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfMi01LTEtMS04NjEyNw_4faeef17-c885-4e17-8c1f-65f98bf6f29f"
      unitRef="usd">26704000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfMi03LTEtMS04NjEyNw_b96ecf49-b037-4db4-bfcd-74169a2645db"
      unitRef="usd">29450000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNC0xLTEtMS04NjEyNw_49c4bc1a-e350-46a4-a34a-9fe066e8d3fc"
      unitRef="usd">-160000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNC0zLTEtMS04NjEyNw_6904e4b1-1257-4843-9033-ebaeeed09206"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNC01LTEtMS04NjEyNw_f8d6d456-6222-4d6a-a689-591b686c233f"
      unitRef="usd">-893000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNC03LTEtMS04NjEyNw_5530133a-31f8-4490-879e-267ef97d1725"
      unitRef="usd">-138000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNS0xLTEtMS04NjEyNw_5377067b-c642-41ad-9321-a43f768fea46"
      unitRef="usd">82000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNS0zLTEtMS04NjEyNw_7cdae59a-1d7a-4075-af81-9e71841c3bb4"
      unitRef="usd">-3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNS01LTEtMS04NjEyNw_e78caa98-3b0c-4542-b880-bbc84877459a"
      unitRef="usd">121000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNS03LTEtMS04NjEyNw_ef4f4bb9-946d-4d9f-9e50-36af470ef19b"
      unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNi0xLTEtMS04NjEyNw_80061f52-bcb2-45bb-bcb4-57a42beaf104"
      unitRef="usd">-78000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNi0zLTEtMS04NjEyNw_e4d681e0-8cc6-4c38-a226-57b6f9ce2ca5"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNi01LTEtMS04NjEyNw_392e06dd-7dcc-4be0-bfe1-e857f490f1ba"
      unitRef="usd">-772000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNi03LTEtMS04NjEyNw_d488e633-651d-4ede-8ea7-ead3110c190c"
      unitRef="usd">-137000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNy0xLTEtMS04NjEyNw_d27e4a1a-8286-43c6-9d90-94bc11afc761"
      unitRef="usd">19798000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNy0zLTEtMS04NjEyNw_728905d7-b219-4da0-a020-24a8cda00e95"
      unitRef="usd">19090000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNy01LTEtMS04NjEyNw_1b06fe82-a9c4-4e52-b63e-446c97e8ce8c"
      unitRef="usd">25932000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yMi9mcmFnOmUyMTljMzhjMDdhYTQyZmRhNTRiZGNmODBjZTY4OGViL3RhYmxlOjFhODMxOTU0YmQ2ZjRkNWNhODVhNDk2YWFlMjI2YzU5L3RhYmxlcmFuZ2U6MWE4MzE5NTRiZDZmNGQ1Y2E4NWE0OTZhYWUyMjZjNTlfNy03LTEtMS04NjEyNw_7020a80a-302f-4843-808b-2b0f9df72f6d"
      unitRef="usd">29313000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="iccf3379ece1b49aea990c4cbfe1e487c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi0xLTEtMS04NjEyNw_f6ce9479-fdad-4aa0-a729-5058d66e5813"
      unitRef="shares">45064000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iccf3379ece1b49aea990c4cbfe1e487c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi0zLTEtMS04NjEyNw_373d1a29-b03e-4784-a950-e300fe36efd5"
      unitRef="usd">45000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8d0b4678edcd488697408216205ad39b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi01LTEtMS04NjEyNw_d649c14c-d81b-4e00-9b1d-e2742f516bb2"
      unitRef="usd">867890000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id2c3caff01d94b05951897818e26b19d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi03LTEtMS04NjEyNw_f72d9a5f-bf87-4714-8be1-b2852b3e55ea"
      unitRef="usd">-157832000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5453e5f10bc4d4aa7d46326ba9a6399_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi05LTEtMS04NjEyNw_699c5ad8-b58f-4043-b5fc-7004578bbc4a"
      unitRef="usd">-527000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7067da57a3274ecf8bb92bb5fda7ddaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMi0xMS0xLTEtODYxMjc_2aa39a72-0224-4cd6-b755-eace8036b64a"
      unitRef="usd">709576000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNS0xLTEtMS04NjEyNw_cd826559-27b9-493d-af25-cd80bdf70a5f"
      unitRef="shares">307000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNS0zLTEtMS04NjEyNw_ab21882e-9d0f-4a46-99c9-c3023815e500"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNS01LTEtMS04NjEyNw_cd879d84-3234-4b78-af7b-f67318e9a4a3"
      unitRef="usd">10856000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNS0xMS0xLTEtODYxMjc_02df7dd3-481a-4b2c-96d5-8c899e8bee74"
      unitRef="usd">10857000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNi0xLTEtMS04NjEyNw_3e595030-f964-4fba-8afb-df4ae14b54ab"
      unitRef="shares">292000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNi0xMS0xLTEtODYxMjc_ee67c4d9-5328-4bf2-a32f-123e4d9f0fca"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNy0xLTEtMS04NjEyNw_51514aed-fbf0-41c9-ae2c-bfd3e6c39f3e"
      unitRef="shares">37000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNy01LTEtMS04NjEyNw_e24d5d7d-da69-41de-93c8-7dc05f5829fd"
      unitRef="usd">1821000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfNy0xMS0xLTEtODYxMjc_c3ca2a65-09eb-4a81-b2bb-a795f17b2a90"
      unitRef="usd">1821000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOC01LTEtMS04NjEyNw_d271c1c6-cd66-446a-95e2-eaf44c38b510"
      unitRef="usd">11544000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOC0xMS0xLTEtODYxMjc_6500a20f-a4ef-4fa6-a6ca-e823bc9bad01"
      unitRef="usd">11544000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="iefa69580cd0b4538bb99f89eeafd8dcb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOS0xLTEtMS04NjEyNw_db5fdfb8-4c5b-4b49-b145-c88df688f44e"
      unitRef="shares">102000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ib019683fd449466eb89c9548e115dc3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOS01LTEtMS04NjEyNw_82576189-a4b1-4ad1-8d1b-0d7684755066"
      unitRef="usd">3040000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfOS0xMS0xLTEtODYxMjc_8828c8ec-6b47-4ddc-a087-35a7990abcd0"
      unitRef="usd">3040000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0438bbb5f15b47bd8ab7763bf832a111_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTItOS0xLTEtODYxMjc_17b2d6e7-d2cc-420c-8ffb-ad3a1869933a"
      unitRef="usd">-78000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTItMTEtMS0xLTg2MTI3_763a10d4-4acc-41bf-adf2-ce598d786eae"
      unitRef="usd">-78000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="ie08d96e6b19e4981b99d8b86ea0ec01d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTMtNy0xLTEtODYxMjc_3ad8d295-28e4-42a9-a94d-13258fb7bca4"
      unitRef="usd">19876000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTMtMTEtMS0xLTg2MTI3_e14bbda0-a3f6-4679-996b-2ed88dedb229"
      unitRef="usd">19876000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i777b16255019457c83b5ff68beb54018_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtMS0xLTEtODYxMjc_4dadcd18-39d8-4a66-856e-3d48ef49c29e"
      unitRef="shares">45802000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i777b16255019457c83b5ff68beb54018_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtMy0xLTEtODYxMjc_596083ec-133b-41f2-b085-a82b2568d903"
      unitRef="usd">46000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i185060e0af3c419b9d025a6ac414a2f5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtNS0xLTEtODYxMjc_fdea005a-28f8-4a2d-82c0-ef06ede1446e"
      unitRef="usd">895151000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i95d1f5844c744661a795601ebc428092_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtNy0xLTEtODYxMjc_1b55aa9a-69d0-4bdc-9558-ead24a0806c8"
      unitRef="usd">-137956000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20af892b1391416d8055702cfd957969_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtOS0xLTEtODYxMjc_f05519f5-5411-4db4-882b-27a6e6f471c7"
      unitRef="usd">-605000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFkMDIwNTcyOWUxMTQxNjU5OWIwNjNhZTQyYTZiMTU5L3RhYmxlcmFuZ2U6MWQwMjA1NzI5ZTExNDE2NTk5YjA2M2FlNDJhNmIxNTlfMTQtMTEtMS0xLTg2MTI3_3a57f87d-ffea-4953-9704-d389ea5178dd"
      unitRef="usd">756636000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i3cecd213310d42d68564b49f725b9213_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi0xLTEtMS04NjEyNw_0318a7e1-196f-4f57-bbf5-4f664d4ce953"
      unitRef="shares">43958000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3cecd213310d42d68564b49f725b9213_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi0zLTEtMS04NjEyNw_ded46d64-b423-4400-9da2-ceffbe913118"
      unitRef="usd">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i567c41f53acf4b4bae12b345b50893b0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi01LTEtMS04NjEyNw_e4e37f3d-025f-4e6f-bbfe-5012d0715497"
      unitRef="usd">894108000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id58a1548551d42eba0f5d2a6190bebda_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi03LTEtMS04NjEyNw_7ae8431f-21f9-47dd-b01e-1cd1235e92f5"
      unitRef="usd">-243506000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia659c853cae9490aae174ba93d4c6a36_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi05LTEtMS04NjEyNw_c428a63c-e364-4fee-b674-b5d296e18f55"
      unitRef="usd">172000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4392427a33b4b249cac4e1f1e0c7826_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMi0xMS0xLTEtODYxMjc_7f22c80c-81ef-477a-85af-d2ab17b64a7f"
      unitRef="usd">650818000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7562b9b9bc8848fc8b1a14abdedbaf01_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNS0xLTEtMS04NjEyNw_4e7e6eac-d2cc-41d1-8316-16e434b21157"
      unitRef="shares">162000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iaf4fb171f06b4fec8794e510a10f6378_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNS01LTEtMS04NjEyNw_c40f2dba-5c12-4e15-8598-d952ee7aaa4e"
      unitRef="usd">5225000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNS0xMS0xLTEtODYxMjc_5a34d268-e916-4a31-9b7c-4c0656817e4d"
      unitRef="usd">5225000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i7562b9b9bc8848fc8b1a14abdedbaf01_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNi0xLTEtMS04NjEyNw_93b64e39-666d-44ed-963e-9c24b58da2a9"
      unitRef="shares">286000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNi0xMS0xLTEtODYxMjc_90880d94-0d6a-4bc2-a78e-9df9c7b4ff7f"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7562b9b9bc8848fc8b1a14abdedbaf01_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNy0xLTEtMS04NjEyNw_dd7e223a-aa15-4c0a-8eaa-2bf1f277ebc2"
      unitRef="shares">31000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iaf4fb171f06b4fec8794e510a10f6378_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNy01LTEtMS04NjEyNw_4450b956-0694-4485-aa41-e9cc30ee4161"
      unitRef="usd">1574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfNy0xMS0xLTEtODYxMjc_9ba635dc-adf9-4186-bc8d-90f86b038432"
      unitRef="usd">1574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaf4fb171f06b4fec8794e510a10f6378_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfOC01LTEtMS04NjEyNw_0971e058-f26c-4111-95cb-aab38cf67031"
      unitRef="usd">10461000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfOC0xMS0xLTEtODYxMjc_a04de27e-8415-439e-9042-00f12bf15476"
      unitRef="usd">10461000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9d156e98f8514a71bf2585134d6222c5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTItOS0xLTEtODYxMjc_cd799915-ae74-4bb5-976b-346a049d62c4"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTItMTEtMS0xLTg2MTI3_2db81523-be26-4037-ad2c-b3d1b56f5be9"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i9755c2106fc64b00958c9861c96d0980_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTMtNy0xLTEtODYxMjc_3533c84c-7928-45d7-bc4e-54426f51f75b"
      unitRef="usd">19081000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTMtMTEtMS0xLTg2MTI3_3d474f03-a93a-4d1c-adfb-2572c10859d8"
      unitRef="usd">19081000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ie21f1393db9f45fa9638f6757ed692e7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtMS0xLTEtODYxMjc_6d37296a-29d5-4381-9429-874dda3c84e9"
      unitRef="shares">44437000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie21f1393db9f45fa9638f6757ed692e7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtMy0xLTEtODYxMjc_082a983a-ea4c-45b3-aced-d93d7aa7dedd"
      unitRef="usd">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icbf1abb3d2514d0f971d679c231c0a78_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtNS0xLTEtODYxMjc_60921d0e-03d4-4709-94b5-3dee3b06de8e"
      unitRef="usd">911368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic4d8d5d2b3b942849ad9361740d23cec_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtNy0xLTEtODYxMjc_bfda2118-76f3-4ac2-8761-1e464734e667"
      unitRef="usd">-224425000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id12c8e6e979d472c83e9f7f03a527326_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtOS0xLTEtODYxMjc_fd98ad9c-1a3d-48fa-b4a1-ac137b7ccb22"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjFmYzZlZWQ2YmVhNzRkNGY5MmI3N2MxMmU3MzkwYWQwL3RhYmxlcmFuZ2U6MWZjNmVlZDZiZWE3NGQ0ZjkyYjc3YzEyZTczOTBhZDBfMTQtMTEtMS0xLTg2MTI3_ab5f2d6a-a34f-4dbd-8856-11734bac9025"
      unitRef="usd">687168000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i8530ce71c50341ceb2fe3a2f7c1ce761_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi0xLTEtMS04ODU1Mg_d3355fa2-4000-4498-9116-dfdb6891ddea"
      unitRef="shares">44734000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8530ce71c50341ceb2fe3a2f7c1ce761_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi0zLTEtMS04ODU1Mg_c6a629b4-3d38-406e-b849-50e381bee639"
      unitRef="usd">45000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id6ae8fb92c414c1c9c45317f16ffd7cb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi01LTEtMS04ODU1Mg_2f6366c1-b571-48c0-b879-c120af2d9805"
      unitRef="usd">942091000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c7debda168a402bbbfc0400a6f7fb72_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi03LTEtMS04ODU1Mg_1a500099-88c5-4290-8061-60348b91ecfd"
      unitRef="usd">-211895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02ecdd29c7414c46a2309f3f15aa4ef2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi05LTEtMS04ODU1Mg_8f0a81a5-d549-4487-ba37-7a4a18e12b0d"
      unitRef="usd">167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMi0xMS0xLTEtODg1NTI_56d915d7-b774-44e1-a0a8-dc415e07ca08"
      unitRef="usd">730408000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d66fc0f21124cb982ea945c36dceeba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy01LTEtMS04ODU1Mg_f6ff9525-8e87-41d5-9add-6aeab56481ab"
      unitRef="usd">-96468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia0c67d9e97e742bfa7decef41c722bc2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy03LTEtMS04ODU1Mg_7824889b-8a74-46e0-ad9f-499a53d05b09"
      unitRef="usd">47235000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i71d1eeb1f3f6452887a684bfaeb06c53_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMy0xMS0xLTEtODg1NTI_bf14d0c8-2f26-4d48-afa8-71c620585a61"
      unitRef="usd">-49233000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNS0xLTEtMS04ODU1Mg_406059d2-ade1-4fc5-9eea-c05100e94255"
      unitRef="shares">630000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNS0zLTEtMS04ODU1Mg_7b7ebc81-2d28-4aea-a37b-2996bad8f3d5"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNS01LTEtMS04ODU1Mg_cb68c88b-65fb-4411-9127-dbf9f04e8bc4"
      unitRef="usd">21934000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNS0xMS0xLTEtODg1NTI_b1fed4bb-0aec-4ea3-9bde-7111b277b57e"
      unitRef="usd">21935000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNi0xLTEtMS04ODU1Mg_baaf37a3-a568-4f89-93fc-7aad81e22867"
      unitRef="shares">299000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNi0xMS0xLTEtODg1NTI_833555b5-02d9-4680-8963-af67d2de2ef2"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNy0xLTEtMS04ODU1Mg_40504fd4-a7f9-4de4-aaae-10e81dea1404"
      unitRef="shares">37000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNy01LTEtMS04ODU1Mg_2dee467e-de34-42a8-9536-55ff23c70ef8"
      unitRef="usd">1821000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfNy0xMS0xLTEtODg1NTI_ff053c73-ee50-481e-9227-b9919aae23d5"
      unitRef="usd">1821000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOC01LTEtMS04ODU1Mg_d9c0f7d1-e57d-4273-8e3e-7ea318b08a3c"
      unitRef="usd">22733000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOC0xMS0xLTEtODg1NTI_f43113f7-6110-46db-be35-faa9edb304b6"
      unitRef="usd">22733000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ic6e48efc63294d789b5a9a591a2f48a8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOS0xLTEtMS04ODU1Mg_6067d82a-eea5-44e4-8dc2-c657739a4246"
      unitRef="shares">102000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="icb3abbebc01f482fa1c30e7f02de8453_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOS01LTEtMS04ODU1Mg_d60f5026-cf76-4842-8040-265df90dc80d"
      unitRef="usd">3040000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfOS0xMS0xLTEtODg1NTI_ef43453b-f08f-4145-b2a9-cf765ea52322"
      unitRef="usd">3040000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i40fceb10d076413aa7ec6129f9f379d7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTItOS0xLTEtODg1NTI_3732278a-cf65-42e8-b13e-049e1e039cae"
      unitRef="usd">-772000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTItMTEtMS0xLTg4NTUy_21c4ebd9-ee59-4674-8c50-26da4eef831e"
      unitRef="usd">-772000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i496381cd52774acb947c0ce28a210627_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTMtNy0xLTEtODg1NTI_cb4bb9cf-fab1-4324-b468-698cd86053d3"
      unitRef="usd">26704000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTMtMTEtMS0xLTg4NTUy_11ebe6d0-b74f-4044-935a-da22df4dd5ed"
      unitRef="usd">26704000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i777b16255019457c83b5ff68beb54018_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtMS0xLTEtODg1NTI_8b9dee93-713b-494d-b422-4a848eb92b9f"
      unitRef="shares">45802000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i777b16255019457c83b5ff68beb54018_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtMy0xLTEtODg1NTI_1ad3abb5-73a8-4b61-b6c7-b997d7daa3e8"
      unitRef="usd">46000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i185060e0af3c419b9d025a6ac414a2f5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtNS0xLTEtODg1NTI_d57bf6e7-b4c9-469e-b941-08976eb10cec"
      unitRef="usd">895151000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i95d1f5844c744661a795601ebc428092_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtNy0xLTEtODg1NTI_27db4a01-74a7-4c46-8235-43f72145503b"
      unitRef="usd">-137956000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20af892b1391416d8055702cfd957969_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtOS0xLTEtODg1NTI_ff4a9eb3-2f89-4a7d-8607-11fde8695150"
      unitRef="usd">-605000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjZjOTNlOTE1ZDFiYjQ3ZWY4MDQ4ZGQ3YTRiMTMzZTMzL3RhYmxlcmFuZ2U6NmM5M2U5MTVkMWJiNDdlZjgwNDhkZDdhNGIxMzNlMzNfMTQtMTEtMS0xLTg4NTUy_c45155c6-0f4f-4c0d-aa80-fb4ef669add7"
      unitRef="usd">756636000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ic8e4e8f15d4b41d3bd530ae73c637d3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi0xLTEtMS04ODU1Mg_69d8ae79-b131-4b10-b558-843d941ace6a"
      unitRef="shares">43637000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic8e4e8f15d4b41d3bd530ae73c637d3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi0zLTEtMS04ODU1Mg_0d5dcbc3-ee1c-4577-8b91-a599fcb5249b"
      unitRef="usd">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia2c30c32c194470fb58444961164cced_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi01LTEtMS04ODU1Mg_af64b51d-4e3d-41a8-bba8-389098aa9cb3"
      unitRef="usd">873201000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0dfdd1ff2fdf4d5ca8edd50b87a21dbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi03LTEtMS04ODU1Mg_5bc75c5b-9420-461b-ada0-ee3a6abbf695"
      unitRef="usd">-253875000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67ba2e38a38f4c4c81d24bf4be710a79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi05LTEtMS04ODU1Mg_abaf58d6-73ba-4528-9226-db7921f1f576"
      unitRef="usd">318000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i12b13809861f4e14b44f538d78e89322_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMi0xMS0xLTEtODg1NTI_9dc0ddc2-0a70-4c89-9479-47182e50fecd"
      unitRef="usd">619688000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNS0xLTEtMS04ODU1Mg_724036cc-1833-49e1-a32a-f64a5fae5d3a"
      unitRef="shares">479000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i56eabe321e00448ea73bc225c791a124_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNS01LTEtMS04ODU1Mg_4fcc7c45-0c3d-4592-a286-6322a2625dd3"
      unitRef="usd">16022000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNS0xMS0xLTEtODg1NTI_6df2b886-46a6-4ca2-af78-0aab9391e3f3"
      unitRef="usd">16022000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNi0xLTEtMS04ODU1Mg_67cc94f0-01bb-4dae-a432-219f43a648d8"
      unitRef="shares">290000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNi0xMS0xLTEtODg1NTI_b91adbc4-8b2b-44fa-8228-85684b3c563b"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNy0xLTEtMS04ODU1Mg_c5f0c305-45df-4dd4-a414-c30b1474047d"
      unitRef="shares">31000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i56eabe321e00448ea73bc225c791a124_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNy01LTEtMS04ODU1Mg_45ced4ae-8acc-46c7-9637-838a3abbc4a8"
      unitRef="usd">1574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfNy0xMS0xLTEtODg1NTI_b839a05b-bd4e-4e89-8d21-7b212d60c484"
      unitRef="usd">1574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i56eabe321e00448ea73bc225c791a124_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfOC01LTEtMS04ODU1Mg_7a34cb78-351f-44c8-8cda-6c66efcf72d0"
      unitRef="usd">20571000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfOC0xMS0xLTEtODg1NTI_4cf76b85-6f83-494b-a800-5c485fd3680a"
      unitRef="usd">20571000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie355b25162354a51a4bc570c648c9f9e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTItOS0xLTEtODg1NTI_c7bb8083-e061-4a31-a2df-499d20b7631e"
      unitRef="usd">-137000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTItMTEtMS0xLTg4NTUy_5aad4660-52c0-4c2b-8c16-c1697d5e3961"
      unitRef="usd">-137000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i8a25b26562da46c48252ec4826cc94cf_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTMtNy0xLTEtODg1NTI_dbf02a1a-9e88-4d36-b72b-4a817948ca2e"
      unitRef="usd">29450000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTMtMTEtMS0xLTg4NTUy_e46040b6-e389-4eb8-8b19-f05534794df0"
      unitRef="usd">29450000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ie21f1393db9f45fa9638f6757ed692e7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtMS0xLTEtODg1NTI_58d13426-e68a-4f4e-b351-7fe88d7ae0b1"
      unitRef="shares">44437000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie21f1393db9f45fa9638f6757ed692e7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtMy0xLTEtODg1NTI_76f737f7-50a1-4a7d-a451-09a9cc07380d"
      unitRef="usd">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icbf1abb3d2514d0f971d679c231c0a78_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtNS0xLTEtODg1NTI_8e4dff99-3fe6-481b-9406-5d5fdbcdf111"
      unitRef="usd">911368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic4d8d5d2b3b942849ad9361740d23cec_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtNy0xLTEtODg1NTI_15aea857-297f-4591-9e15-f50328df2cdf"
      unitRef="usd">-224425000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id12c8e6e979d472c83e9f7f03a527326_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtOS0xLTEtODg1NTI_9addfb65-04ec-40af-84cc-9e148df873c7"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yNS9mcmFnOjc1MzE4YTVjNzVmNTQ2ZjE4NTgwYzQzYjhlY2Q5NzM1L3RhYmxlOjg4ZWJlYjM5MjVhZjQzM2M4YTBiYzYzNDQ2M2Y4ZDIzL3RhYmxlcmFuZ2U6ODhlYmViMzkyNWFmNDMzYzhhMGJjNjM0NDYzZjhkMjNfMTQtMTEtMS0xLTg4NTUy_8fc14e33-8414-4d1f-ace6-6308f3c70b81"
      unitRef="usd">687168000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMy0xLTEtMS04NjEyNw_4a5efab3-cf26-4a75-8539-018af30781a9"
      unitRef="usd">26704000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMy0zLTEtMS04NjEyNw_945138b6-057a-4fad-9056-4534c73eb071"
      unitRef="usd">29450000</us-gaap:NetIncomeLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNS0xLTEtMS04NjEyNw_611644e9-6d64-4442-afde-1c779bcb439b"
      unitRef="usd">2193000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNS0zLTEtMS04NjEyNw_04e45d41-4e4a-444e-b662-f10e93c33bc4"
      unitRef="usd">7613000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNi0xLTEtMS04NjEyNw_7bd1ce34-17bc-41f0-8880-304e73cf5ea4"
      unitRef="usd">40897000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNi0zLTEtMS04NjEyNw_3bfe0ddd-fb9f-4b9e-b3b9-e936cdddf4df"
      unitRef="usd">9748000</us-gaap:DepreciationDepletionAndAmortization>
    <pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNy0xLTEtMS04NjEyNw_a612bfec-8fa0-4b1f-8622-9f0c26d35685"
      unitRef="usd">2053000</pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation>
    <pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNy0zLTEtMS04NjEyNw_d7417891-838a-4364-a742-bbf8ba846447"
      unitRef="usd">1310000</pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfOC0xLTEtMS04NjEyNw_35c680e9-deb2-429b-813a-67d814859706"
      unitRef="usd">1412000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfOC0zLTEtMS04NjEyNw_dbc518c4-3186-44c6-8cd5-06e9905db18f"
      unitRef="usd">11401000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTAtMS0xLTEtODYxMjc_a4fda597-19ad-47a0-a058-7f2ff4a24f1e"
      unitRef="usd">-193000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTAtMy0xLTEtODYxMjc_040cceaf-7b76-4b30-9c6f-05aa63f19851"
      unitRef="usd">10000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ShareBasedCompensation
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTEtMS0xLTEtODYxMjc_feaf5e5c-8528-4da7-a974-6c530c047489"
      unitRef="usd">22733000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTEtMy0xLTEtODYxMjc_379cb85d-36dc-45c7-a3b2-0c6df8bfed5b"
      unitRef="usd">20571000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTItMS0xLTEtODYxMjc_f1c6654d-2032-418c-82e0-8ecdce932272"
      unitRef="usd">-22351000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTItMy0xLTEtODYxMjc_bdc8aac6-0103-4827-9765-1a7b85661bdc"
      unitRef="usd">-988000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTMtMS0xLTEtODYxMjc_d0978da9-cdf0-41fb-a8f1-d394e30db815"
      unitRef="usd">108000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTMtMy0xLTEtODYxMjc_9004d2da-3d58-4d72-9d7b-44bdca22e013"
      unitRef="usd">2601000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTUtMS0xLTEtODYxMjc_ade354fb-cf62-43f0-99ee-e165eccb18b1"
      unitRef="usd">-5213000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTUtMy0xLTEtODYxMjc_d6b6f10b-7a53-41c4-aec3-49041be47b39"
      unitRef="usd">15312000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTYtMS0xLTEtODYxMjc_c2e5df6d-2ecf-45dd-87b5-6daa79ac1c6a"
      unitRef="usd">2038000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTYtMy0xLTEtODYxMjc_71290524-e2fd-44d2-b748-369905330ef7"
      unitRef="usd">615000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTctMS0xLTEtODYxMjc_7ef916a9-ec1d-43a6-b374-d384f309ffbe"
      unitRef="usd">3233000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTctMy0xLTEtODYxMjc_ccd71e51-a253-483f-bc4b-161c3103890e"
      unitRef="usd">944000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTgtMS0xLTEtODYxMjc_ecb9d259-e24e-4db2-b076-afcfbba8b758"
      unitRef="usd">5258000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTgtMy0xLTEtODYxMjc_6051af14-c648-444d-9c55-ebb279f467c3"
      unitRef="usd">2156000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTktMS0xLTEtODYxMjc_a38de9d0-45eb-4ab8-ab06-a26588528cbe"
      unitRef="usd">-19038000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMTktMy0xLTEtODYxMjc_4cf94a46-908e-4c98-8451-a2f527d87f69"
      unitRef="usd">-18140000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:GainLossOnInvestments
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjAtMS0xLTEtODYxMjc_3191d7ef-bec2-4997-b546-8a866dbc2a7f"
      unitRef="usd">-479000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjAtMy0xLTEtODYxMjc_e5876d65-9e21-4f5d-9745-5d8b00b9bf79"
      unitRef="usd">964000</us-gaap:GainLossOnInvestments>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjEtMS0xLTEtODYxMjc_19546ebc-91f0-4dba-bc43-c0f4097f214b"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjEtMy0xLTEtODYxMjc_9310006d-7a46-465d-9d55-942cd72e8dc4"
      unitRef="usd">5662000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjItMS0xLTEtODYxMjc_cdc2755b-1910-44de-9a5c-dc3e7f47d225"
      unitRef="usd">60583000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjItMy0xLTEtODYxMjc_03868a2b-8b17-4b3a-842d-9bb7e990e2f0"
      unitRef="usd">42215000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjUtMS0xLTEtODYxMjc_27b83433-ec86-4773-99bd-4d5a5990277f"
      unitRef="usd">19403000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjUtMy0xLTEtODYxMjc_f4dc5226-a14d-4beb-a3ec-354d9c971548"
      unitRef="usd">23624000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjYtMS0xLTEtODYxMjc_696e67a4-3664-4694-bb85-ccdcafa3c550"
      unitRef="usd">187641000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjYtMy0xLTEtODYxMjc_b1e1b6ec-9482-49ef-accb-cdb8095024e1"
      unitRef="usd">318132000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjctMS0xLTEtODYxMjc_157c59c6-c535-4abb-ba9d-d59f7ad45c0c"
      unitRef="usd">62936000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjctMy0xLTEtODYxMjc_6a3a49fe-ede4-423e-b96b-19c25e931dea"
      unitRef="usd">294288000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <pcrx:PaymentOfContingentConsideration
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjgtMS0xLTEtODYxMjc_b466eaa0-f016-41aa-b010-459d735ae82b"
      unitRef="usd">32000000</pcrx:PaymentOfContingentConsideration>
    <pcrx:PaymentOfContingentConsideration
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjgtMy0xLTEtODYxMjc_fef4b1f3-2a52-44f4-a8ae-c08682db1bd3"
      unitRef="usd">0</pcrx:PaymentOfContingentConsideration>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjktMS0xLTEtODYxMjc_4606384b-970c-479a-a9c7-76ce47890363"
      unitRef="usd">12750000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMjktMy0xLTEtODYxMjc_05f0964a-a33a-4003-9c90-7a193c3cdd12"
      unitRef="usd">14220000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzAtMS0xLTEtODYxMjc_5ff93992-8930-409b-9106-ffa3548a7e87"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzAtMy0xLTEtODYxMjc_43d8bda4-6cc4-42b1-b107-9f94fbce66fd"
      unitRef="usd">9057000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzItMS0xLTEtODYxMjc_873dee1c-15cc-44ac-870f-2315731003b7"
      unitRef="usd">-188858000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzItMy0xLTEtODYxMjc_5cec3d92-fe80-4f7a-978c-fbab491b62d3"
      unitRef="usd">-52631000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzQtMS0xLTEtODYxMjc_19c90110-07ef-4e75-94b1-df640fc0346d"
      unitRef="usd">21881000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzQtMy0xLTEtODYxMjc_968c63ae-afab-4eb9-91da-5cb5df018e57"
      unitRef="usd">15997000</us-gaap:ProceedsFromStockOptionsExercised>
    <pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzUtMS0xLTEtODYxMjc_b49fc723-b87d-494e-9a79-6d8c19af5330"
      unitRef="usd">1821000</pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans>
    <pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzUtMy0xLTEtODYxMjc_721dfa21-f503-4db9-85a0-7ae450762b80"
      unitRef="usd">1574000</pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="ic1b7745796664d7e8311edc369bcf819_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzgtMS0xLTEtOTYzNTQ_b8d6a2ba-2a81-45a9-a9c8-e8925a4878dd"
      unitRef="usd">156960000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i1f182ffbc7a04691b94793c0d2ea763b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzgtMy0xLTEtOTYzNTQ_d69e425e-0664-49a3-ad2c-4b4d5192cefd"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i6dc9a2abb73b42f889beb685eb78dd97_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzgtMS0xLTEtODYxMjc_62a3f9a3-1d2d-4f17-a80c-1a1e658071eb"
      unitRef="usd">192609000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="id49160a04d45489ba6dde67831452514_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfMzgtMy0xLTEtODYxMjc_113caaa1-7db7-41cd-991f-6d207e546530"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDAtMS0xLTEtOTQ4NzA_227d1fa7-ea45-48f9-83f6-773377816ccd"
      unitRef="usd">9375000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDAtMy0xLTEtOTQ4NzA_67636c22-c2c0-48a3-8efa-7ea2dce8f455"
      unitRef="usd">0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDMtMS0xLTEtODYxMjc_180e4592-4919-4e7c-af88-250b4306a01f"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDMtMy0xLTEtODYxMjc_54f2d378-2605-4ff0-8fd7-876ebccc6164"
      unitRef="usd">1338000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDQtMS0xLTEtODYxMjc_fe9d9398-34ed-497f-8495-8b194887713d"
      unitRef="usd">-335242000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDQtMy0xLTEtODYxMjc_520f344c-c8b3-4b74-9617-409f1bdcc7e2"
      unitRef="usd">16233000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDUtMS0xLTEtODYxMjc_001268e4-cc7f-4c08-b453-d654b56f90e4"
      unitRef="usd">-463517000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDUtMy0xLTEtODYxMjc_77e74e46-d84e-47ce-8338-1737f0d953fa"
      unitRef="usd">5817000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDYtMS0xLTEtODYxMjc_f5a3a844-e42d-48fe-ab9b-26a38da818cd"
      unitRef="usd">585578000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i12b13809861f4e14b44f538d78e89322_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDYtMy0xLTEtODYxMjc_ae51b82a-904d-42a8-821c-e31b3dec1b0a"
      unitRef="usd">99957000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDctMS0xLTEtODYxMjc_2a6ccd61-b387-48c1-afec-8133bf4d3bf0"
      unitRef="usd">122061000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNDctMy0xLTEtODYxMjc_e72c14e3-db38-46c9-803c-3976d84f4fef"
      unitRef="usd">105774000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTQtMS0xLTEtODYxMjc_9ab4c46c-a6df-4ec4-b14f-a53b42a87e87"
      unitRef="usd">14686000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTQtMy0xLTEtODYxMjc_37881ead-2999-4889-944e-6960ba286ecb"
      unitRef="usd">3586000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTUtMS0xLTEtODYxMjc_0a40c887-be5a-4c03-88fb-3c399da119b8"
      unitRef="usd">4104000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTUtMy0xLTEtODYxMjc_6832917e-c98b-4421-8e44-6e2528292d3c"
      unitRef="usd">1447000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTctMS0xLTEtODYxMjc_d6a0099e-b71d-4e88-bf69-96bd0fc5ea6c"
      unitRef="usd">3040000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNTctMy0xLTEtODYxMjc_62ddbc7c-44ca-4940-83ef-6e75ef4af5c9"
      unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNjEtMS0xLTEtODYxMjc_aa1d76ba-163e-4bff-bcca-5eeabe5f9b2b"
      unitRef="usd">2454000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18yOC9mcmFnOjIwODM1NjRiNWQ0ODRjMTBhOTg5MzJlMmZiMjIwNmJhL3RhYmxlOmI3MzQwNDRlNjE3ZDQ5Nzk5ZmZiZDRiZmYyYmZmNThiL3RhYmxlcmFuZ2U6YjczNDA0NGU2MTdkNDk3OTlmZmJkNGJmZjJiZmY1OGJfNjEtMy0xLTEtODYxMjc_a0a6fc48-cfa0-46cd-bcd1-4c7d58934fcc"
      unitRef="usd">8096000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNC9mcmFnOjI4MzJmOGZiODY0MTRjMTg4YzdhMTg5OTM1ZjdiNWQwL3RleHRyZWdpb246MjgzMmY4ZmI4NjQxNGMxODhjN2ExODk5MzVmN2I1ZDBfNDQ1MQ_a1144ef6-ab07-46ea-a52e-dda258892fe9">DESCRIPTION OF BUSINESS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#x201c;Company&#x201d; or &#x201c;Pacira&#x201d;) is the industry leader in its commitment to non-opioid pain management and providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain and spasticity. The Company&#x2019;s long-acting, local analgesic, EXPAREL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(bupivacaine liposome injectable suspension), was commercially launched in the United States, or U.S., in April 2012 and approved in select European countries and the United Kingdom, or U.K. in November 2021. EXPAREL utilizes the Company&#x2019;s proprietary multivesicular liposome drug delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In November 2021, the Company acquired Flexion Therapeutics, Inc., or Flexion, and added ZILRETTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (triamcinolone acetonide extended-release injectable suspension) to its product portfolio. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of osteoarthritis, or OA, knee pain. For more information, see Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flexion Acquisition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In April 2019, the Company added iovera&#xb0;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience (the &#x201c;MyoScience Acquisition&#x201d;). The iovera&#xb0; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to only targeted nerves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from three products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as one reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Coronavirus (COVID-19) Pandemic and Global Economic Conditions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since early 2020, the Company&#x2019;s revenues have been impacted by COVID-19 pandemic-related challenges that included the significant postponement or suspension in the scheduling of elective surgical procedures due to public health guidance and government directives. While the degree of impact has diminished during the course of the pandemic due to the introduction of vaccines and therapeutics, as well as the lessening of elective surgery restrictions, certain pandemic-related operational and staffing challenges persist. It remains unclear how long it will take the elective surgery market to normalize or if restrictions on elective procedures will recur due to future COVID-19 variants or otherwise. Direct effects of the pandemic and global economic conditions may negatively impact the Company&#x2019;s business, financial condition and results of operations. Such impacts may include the effect of prolonged periods of inflation on the Company&#x2019;s customers and suppliers and longer lead-times or the inability to secure a sufficient supply of materials. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <pcrx:ConcentrationRiskNumberOfProducts
      contextRef="ieec41903ab5748ad8e93035d8503fcf3_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNC9mcmFnOjI4MzJmOGZiODY0MTRjMTg4YzdhMTg5OTM1ZjdiNWQwL3RleHRyZWdpb246MjgzMmY4ZmI4NjQxNGMxODhjN2ExODk5MzVmN2I1ZDBfMTY3Nw_22139b84-afc2-4508-a25a-df6dac985495"
      unitRef="product">3</pcrx:ConcentrationRiskNumberOfProducts>
    <us-gaap:NumberOfReportableSegments
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNC9mcmFnOjI4MzJmOGZiODY0MTRjMTg4YzdhMTg5OTM1ZjdiNWQwL3RleHRyZWdpb246MjgzMmY4ZmI4NjQxNGMxODhjN2ExODk5MzVmN2I1ZDBfMjQ3Mw_18df68f3-0387-4083-8f84-ce81151c65c0"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc3Ng_8e0ae60d-ec57-4fd5-adde-8a8445e134e4">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Annual Report on Form&#160;10-K for the year ended December 31, 2021&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements at June&#160;30, 2022, and for the three and six-month periods ended June&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#xb0; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below includes the percentage of revenues comprised by the Company&#x2019;s three largest wholesalers in each period presented: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Second largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Third largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The percentage of revenues from the Company&#x2019;s three largest wholesalers have shifted in the current year with the addition of ZILRETTA sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40), &lt;/span&gt;which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $64.9&#160;million, reduced accumulated deficit by $47.2&#160;million, reduced additional paid-in capital by $96.5&#160;million and decreased deferred tax liabilities by $15.7&#160;million.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc2Mw_605bf0e3-d6b2-4e1d-90cc-57cb47eeebc9">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Annual Report on Form&#160;10-K for the year ended December 31, 2021&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements at June&#160;30, 2022, and for the three and six-month periods ended June&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.&lt;/span&gt;&lt;/div&gt;</pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc4NA_9ae308ad-d3f0-4625-8b6c-8e04b5747376">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#xb0; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.&lt;/span&gt;&lt;/div&gt;</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc2MQ_cdd4eab3-3594-4470-b58e-1d1ae4926927">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below includes the percentage of revenues comprised by the Company&#x2019;s three largest wholesalers in each period presented: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Second largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Third largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <pcrx:ConcentrationRiskNumberOfCustomers
      contextRef="ied39c8b2a0e847a5aafe78db72f6e93b_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfMjk0MQ_50b7fb46-13eb-4206-8ba7-6c026f6efd3c"
      unitRef="segment">3</pcrx:ConcentrationRiskNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i03aa3ab5fbee4d6896c79200467028e0_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMi0xLTEtMS04NjEyNw_295e8148-3b21-4c4d-9513-73af6519aea1"
      unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id48c04a202fa42f2867a0499bc23d873_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMi0zLTEtMS04NjEyNw_194e3c13-76f4-4016-ba34-aac51cbc25a3"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia1a665b7edb9415ebeb211b1577d0e34_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMi01LTEtMS04NjEyNw_e4018dd6-7ad9-43e0-ad6f-34e4829df320"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idcb274e947a44a4e80b58a578e44dac3_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMi03LTEtMS04NjEyNw_4857b8c5-af99-477c-9a48-0dbef131fde3"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3a79f2001b894c3ea7b2a9c85bc4315c_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMy0xLTEtMS04NjEyNw_a6963a23-9f5c-4805-ae42-0c8aae83ebb6"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i52d4cf75231141769e7cdbeaae57f7f8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMy0zLTEtMS04NjEyNw_76f5e854-8d14-411a-91a7-506e3d0f8481"
      unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i39f4cab5dbc846cf86be5b20cc204e02_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMy01LTEtMS04NjEyNw_45272790-5a61-41b5-8702-0f98495b936a"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if69a41444b6640d0b674261a2129cd82_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfMy03LTEtMS04NjEyNw_d44e1457-c5ff-463a-ac05-b4efd85bdd0c"
      unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i80247e37f19a4037b6459ac43a27bcd0_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNC0xLTEtMS04NjEyNw_326ead23-10f0-45d6-83e3-032d9369fd6a"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2059729d521343c3aa297a7c8e0d5961_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNC0zLTEtMS04NjEyNw_1f05eeff-400b-416d-a674-da9e8c1e3f0b"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i574ac6f9ebfe47ff8dc15c79df815095_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNC01LTEtMS04NjEyNw_59b87cdb-49d5-4247-9133-a302bdf7b75a"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iecace58dec9b480d953f4cefa650d762_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNC03LTEtMS04NjEyNw_51343182-a9c4-415b-9801-751e88853970"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie417a4089ec14158a8f46542e241d728_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNS0xLTEtMS04NjEyNw_05f889d8-e510-4140-b6ae-532591c6c295"
      unitRef="number">0.77</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id1a0b4f16e3040808a0a4267e092d844_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNS0zLTEtMS04NjEyNw_121d8f0f-d42d-40a6-b694-3a5a12b88c76"
      unitRef="number">0.86</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia484b08689c24460bdf7e5e604ec229e_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNS01LTEtMS04NjEyNw_3a0bc81a-b262-4207-bb3e-a364e8b9ee4d"
      unitRef="number">0.76</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i86ff898a5c1f4f7b89f0bc15a892e222_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RhYmxlOjE4NGNhNzBmYjg2YzQ2ZjdhYWM1ZWYwOTZlM2Q2YmU5L3RhYmxlcmFuZ2U6MTg0Y2E3MGZiODZjNDZmN2FhYzVlZjA5NmUzZDZiZTlfNS03LTEtMS04NjEyNw_e7d8ae6a-2b15-49c5-b3b7-c1b7063b9cf2"
      unitRef="number">0.86</us-gaap:ConcentrationRiskPercentage1>
    <pcrx:ConcentrationRiskNumberOfCustomers
      contextRef="ied39c8b2a0e847a5aafe78db72f6e93b_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfMzAzOA_50b7fb46-13eb-4206-8ba7-6c026f6efd3c"
      unitRef="segment">3</pcrx:ConcentrationRiskNumberOfCustomers>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc1Ng_a08f6acc-a3f1-4b26-88e1-73bf24c2d8c7">Recently Adopted Accounting Pronouncements&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40), &lt;/span&gt;which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $64.9&#160;million, reduced accumulated deficit by $47.2&#160;million, reduced additional paid-in capital by $96.5&#160;million and decreased deferred tax liabilities by $15.7&#160;million.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i7ed27d17e7e04841a903c038b2cd6d5b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDYyNw_c7a4afe6-46b1-4382-90a0-527f1b767b35"
      unitRef="usd">64900000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquity
      contextRef="i1dcc7f6a743b4e1c826e40098ec5b555_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDY2Mg_bec835c6-472a-4bf1-b794-f4cd5d5c0a43"
      unitRef="usd">47200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id39f0d77661b4d21bd5c329207058dec_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDcwNA_d25bb6a1-e8ba-4a62-b35a-710b61012e87"
      unitRef="usd">-96500000</us-gaap:StockholdersEquity>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7ed27d17e7e04841a903c038b2cd6d5b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN18zNy9mcmFnOjdhNjA0NTAyNDNiMjRjNzBiY2Y3OTA4Njg2NGYwNTYyL3RleHRyZWdpb246N2E2MDQ1MDI0M2IyNGM3MGJjZjc5MDg2ODY0ZjA1NjJfNDc0OQ_ee565b26-8c8e-4cc7-b1b8-685cf0622700"
      unitRef="usd">-15700000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfNDYzNw_086296e8-65dc-4739-ac2a-3269d74847ec">REVENUE&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net product sales consist of (i) EXPAREL in the U.S., the European Union, or E.U., and the U.K.; (ii) ZILRETTA in the U.S.; (iii) iovera&#xb0; in the U.S., Canada and the E.U. and (iv) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use. Royalty revenues are from the Company&#x2019;s collaborative licensing agreements. The Company does not consider revenue from sources other than sales of EXPAREL and ZILRETTA to be material sources of its consolidated revenue. As such, the following disclosure only relates to revenue associated with net EXPAREL and ZILRETTA product sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Product Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. The Company primarily sells ZILRETTA to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as GPOs. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL and ZILRETTA revenue is recorded at the time the product is transferred to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, service fees, government rebates, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts, statutory requirements and other related information that may become known in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers, specialty distributors, specialty pharmacy, GPOs and doctors. Payment terms generally range from&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfMjk1OA_60482776-f82e-46b2-bdd2-45bb82b080c0"&gt;zero&lt;/span&gt; to 97 days from the date of the transaction, and accordingly, there is no significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#x2019;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#x2019;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL and ZILRETTA to its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregated net product sales in the periods presented as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;EXPAREL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;ZILRETTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;iovera&#xb0;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Bupivacaine liposome injectable suspension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <pcrx:AccountsReceivablePaymentTerms
      contextRef="i137156d0fcb14f6083cfb7e0561f67e9_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfMjk2NA_1471b95c-8ee9-40e4-8126-9e636180e8a1">P97D</pcrx:AccountsReceivablePaymentTerms>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RleHRyZWdpb246NDc5YTYwMGZkYmQyNGIwYzhmNTRmMjNlZmE1NjM3ODdfNDY0MQ_4697f357-e15b-4e53-bf7b-448e3bfa28b2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregated net product sales in the periods presented as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;EXPAREL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;ZILRETTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;iovera&#xb0;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Bupivacaine liposome injectable suspension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf70633f4d2743c483f890199a5aad26_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfMy0yLTEtMS04NjEyNw_6b56bc88-fc00-4754-ac68-c09b97419992"
      unitRef="usd">137007000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f1153b8275e426baedcb6cb32988ed3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfMy00LTEtMS04NjEyNw_d95906fb-d326-4c82-8763-6bdfe71662eb"
      unitRef="usd">130058000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c7a76e695d24007a56305d765b02b64_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfMy02LTEtMS04NjEyNw_98f15f28-de04-41a0-94c0-1f2b1e6c2637"
      unitRef="usd">266212000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74f4f821973e47688841421beb03e3aa_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfMy04LTEtMS04NjEyNw_85d4cf39-2c8c-43eb-bd13-05bbbb228e8b"
      unitRef="usd">244736000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i093201d8522546898104838bef2c7008_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNC0yLTEtMS04NjEyNw_4b69209e-76e4-41ae-a259-46764b3e27bf"
      unitRef="usd">27417000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c42c8c170474d2a954da97bce047946_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNC00LTEtMS04NjEyNw_7993b5fe-a728-4917-8c63-e57d29e94e61"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6903f565b296494fb0447554914bdfeb_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNC02LTEtMS04NjEyNw_ef8fae07-785c-4288-a7bb-ee78469277f7"
      unitRef="usd">51052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac412655aca24aa0a92d19bfdb08ebfe_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNC04LTEtMS04NjEyNw_c249d26d-dce3-4b9d-a733-23b864c19bca"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i561be2fe92244f3c871d388185d4dbf7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNS0yLTEtMS04NjEyNw_48398c62-5c11-4642-8963-6fbe4ced196e"
      unitRef="usd">3201000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0762b6431de84121b7b88717e0492b34_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNS00LTEtMS04NjEyNw_bb0fe857-1bad-4378-aeea-56493c7d33a0"
      unitRef="usd">3813000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7c1bb2dd8df417db479a9448b35c207_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNS02LTEtMS04NjEyNw_1313c2cb-d7a1-45c9-b5d6-033087fff6d8"
      unitRef="usd">6227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8ea87effbd54309b6396f1449ed1cb1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNS04LTEtMS04NjEyNw_179a3a35-227d-4f22-9bd2-9658fb51fbc2"
      unitRef="usd">7081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ccef0cf2b3a4d7aa7364dc01727ff19_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNi0yLTEtMS04NjEyNw_56982449-7423-4c9c-9ca5-c99b8ec70c9b"
      unitRef="usd">956000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50dda10391554e928f44961a18eb294f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNi00LTEtMS04NjEyNw_d76fa7a8-0b0d-4ba1-97ef-61d9b60584b5"
      unitRef="usd">992000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i577bddc29b634b9c8f0d64449773fe54_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNi02LTEtMS04NjEyNw_dd4249d1-add5-4502-a0d8-9065d551633e"
      unitRef="usd">2512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e15ee9cbfaa484b99723cebd4de0305_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNi04LTEtMS04NjEyNw_00f4abbd-e5be-44ab-a6a2-ce8c3e8ea1ad"
      unitRef="usd">1784000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf4570f968674f3bbe27c560bfb9be87_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNy0yLTEtMS04NjEyNw_319e1a58-aba1-4667-9344-ed48c5d3c005"
      unitRef="usd">168581000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7284aa2c87d44f68ba483dff38427eec_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNy00LTEtMS04NjEyNw_e6673d3b-27cb-4dd6-b5a0-905640a766e1"
      unitRef="usd">134863000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0df55d4c445d47adb69a0c7a9cd64df5_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNy02LTEtMS04NjEyNw_965f60cc-7f89-4679-b5f9-c96bfd2c223c"
      unitRef="usd">326003000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i872e83e0083747ac98f21041708778df_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180My9mcmFnOjQ3OWE2MDBmZGJkMjRiMGM4ZjU0ZjIzZWZhNTYzNzg3L3RhYmxlOjRhMTJmY2NiZTU3MDQzNzg5YWJkYjg2NjJmMjI3NDZmL3RhYmxlcmFuZ2U6NGExMmZjY2JlNTcwNDM3ODlhYmRiODY2MmYyMjc0NmZfNy04LTEtMS04NjEyNw_ee71fe1e-9824-49a7-ac5b-256a7b12d0f4"
      unitRef="usd">253601000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMzQzMg_5183852b-afa6-4e47-a459-8bbab23f09f4">FLEXION ACQUISITION&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 19, 2021, the Company acquired Flexion (the &#x201c;Flexion Acquisition&#x201d;), a biopharmaceutical company focused on the discovery, development, and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. Upon consummation of the Flexion Acquisition, Flexion became a wholly-owned subsidiary of the Company and was renamed Pacira Therapeutics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The total consideration for the Flexion Acquisition was approximately $578.8&#160;million consisting of: (i) $448.5&#160;million of cash paid to former Flexion stockholders and to settle restricted stock units and in-the-money stock options; (ii) an $85.1&#160;million cash payment to repay Flexion debt that was not assumed by the Company and (iii) $45.2&#160;million of estimated contingent consideration related to contingent value rights, or CVRs, that were issued to Flexion shareholders and certain equity award holders in conjunction with the Flexion Acquisition. The consideration is subject to adjustments based on the achievement of certain potential milestone payments. Up to an additional $380.2&#160;million in the aggregate may be payable to holders of the CVRs if each of the applicable milestones are achieved. No contingent consideration milestones were achieved in the six months ended June&#160;30, 2022. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for information regarding the methodology and key assumptions used in the fair value measurements of contingent consideration and for more information regarding the changes in fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is finalizing its valuation of liabilities and tax analyses, and anticipates finalizing the purchase price allocation as the information necessary to complete the analysis is obtained, but no later than one year after the acquisition date. The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Recognized at the Acquisition Date &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(as previously &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;reported) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Recognized at the Acquisition Date &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS ACQUIRED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term available-for-sale investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES ASSUMED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(a)  As previously reported in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(b)  Represents pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Summary of Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the unaudited pro forma summary of operations for the three and six-month periods ended June&#160;30, 2021, as if the Flexion Acquisition had occurred on January 1, 2020. This pro forma information does not purport to represent what the Company&#x2019;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma financial information was prepared using the acquisition method of accounting and was based on the historical financial information of the Company and Flexion. The summary pro forma financial information primarily reflects the following pro forma adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Recognition of the income tax benefit resulting from decreasing Flexion&#x2019;s existing valuation allowance on deferred tax assets for the three and six months ended June&#160;30, 2021;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Removal of Flexion&#x2019;s interest expense and associated deferred financing cost amortization related to the $85.1&#160;million of debt not assumed;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Adjustments to the Company&#x2019;s interest income for the cash used to acquire Flexion; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Additional cost of goods sold related to a step-up value in inventory;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Additional amortization expense from the acquired developed technology intangible assets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Additional depreciation of Flexion&#x2019;s fixed assets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Additional lease expense on Flexion&#x2019;s right-of-use, or ROU, assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, all of the above adjustments were adjusted for the applicable tax impact.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i19c54c90141d46f5b4ed7575ff155dfa_D20211119-20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfNTcz_64f0ae28-edd1-44ef-b149-dc662cd05289"
      unitRef="usd">578800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia90f47b531e341d18e987adf7e3cab92_D20211119-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfNTk1_e5df499f-7fd9-424a-b7ce-c1d043c1d4c7"
      unitRef="usd">448500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfNzE5_1b76bfe6-28fb-40fe-a4c4-2e14cbb0097f"
      unitRef="usd">85100000</pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt>
    <pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration
      contextRef="i19c54c90141d46f5b4ed7575ff155dfa_D20211119-20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfODAz_61aa4b12-c7af-4e6d-aba8-255576540908"
      unitRef="usd">45200000</pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMTEzOA_255004d6-ba42-4672-b64b-ae705308fe1c"
      unitRef="usd">380200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMzQyOQ_bf3f3eef-7642-4d5a-b30a-2c7bac78a8c1">The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Recognized at the Acquisition Date &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(as previously &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;reported) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Recognized at the Acquisition Date &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS ACQUIRED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term available-for-sale investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES ASSUMED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(a)  As previously reported in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(b)  Represents pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMi0yLTEtMS04NjEyNw_05a49719-a71f-42e4-91f6-ce18a4c727bc"
      unitRef="usd">113562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMi02LTEtMS04NjEyNw_8ecf11f2-b6ef-4138-98ed-bacb94728674"
      unitRef="usd">113562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMy0yLTEtMS04NjEyNw_34b41371-a32a-49fd-924f-688af3539847"
      unitRef="usd">11153000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMy02LTEtMS04NjEyNw_80cc8e43-eb69-4bd4-920d-6407cc572e18"
      unitRef="usd">11153000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNC0yLTEtMS04NjEyNw_fc5893e0-5e42-450f-84cf-77eb83c44a7e"
      unitRef="usd">32838000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNC02LTEtMS04NjEyNw_09bb149d-e55c-4eab-8358-7de50279afa1"
      unitRef="usd">32838000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNS0yLTEtMS04NjEyNw_111c19c7-bb3c-413c-bc6f-33df8f1b6e1f"
      unitRef="usd">29667000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNS02LTEtMS04NjEyNw_826ee909-c87a-46de-a144-109e50d7b9cf"
      unitRef="usd">29667000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNi0yLTEtMS04NjEyNw_8349f923-879c-4e07-953a-1b383dfdf6e4"
      unitRef="usd">4852000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNi02LTEtMS04NjEyNw_352613ab-7e3c-4c0d-9ab9-3bc5d0e82658"
      unitRef="usd">4852000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNy0yLTEtMS04NjEyNw_12932268-5665-4cac-abb7-ca3351529c43"
      unitRef="usd">23307000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfNy02LTEtMS04NjEyNw_5ca644fa-fd45-4d47-9f2e-0306d62fb7c0"
      unitRef="usd">23307000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfOC0yLTEtMS04NjEyNw_4da03a23-e58c-4447-bc9e-2916d96545d5"
      unitRef="usd">58015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfOC02LTEtMS04NjEyNw_e61a6d94-e2c8-4ca3-92b4-bda9f22ec6cf"
      unitRef="usd">58015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfOS0yLTEtMS04NjEyNw_b130db70-b9da-45f9-9b3b-dfca287f9fcf"
      unitRef="usd">6585000</pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfOS02LTEtMS04NjEyNw_1d8634d2-9a76-4321-a138-765a12e0566a"
      unitRef="usd">6585000</pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTAtMi0xLTEtODYxMjc_68645054-94f3-4f37-ad3b-6e056d5f1fdd"
      unitRef="usd">480000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTAtNi0xLTEtODYxMjc_0d2a5c4c-ba1d-4912-be9e-ee5918f0ef6a"
      unitRef="usd">480000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTEtMi0xLTEtODYxMjc_3ce9fc87-4a49-4ea3-977a-43ac92b524b3"
      unitRef="usd">61000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTEtNi0xLTEtODYxMjc_749342ea-f0b2-43be-97c5-e2b776f76670"
      unitRef="usd">61000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTItMi0xLTEtODYxMjc_6b3930d0-d147-4cd7-ad24-604bdec7028a"
      unitRef="usd">820979000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets
      contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTItNC0xLTEtODYxMjc_1836e049-2b8b-4868-a73d-1181f7304361"
      unitRef="usd">0</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTItNi0xLTEtODYxMjc_e90ffba2-58bf-47b2-ab1d-3510e3ff6bb5"
      unitRef="usd">820979000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTUtMi0xLTEtODYxMjc_8eb425c9-c95a-494b-809c-3d675faf9905"
      unitRef="usd">9794000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTUtNi0xLTEtODYxMjc_cb71f1b9-7ac5-46eb-be5d-e4cdd62a8262"
      unitRef="usd">9794000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTYtMi0xLTEtODYxMjc_78ba6e55-0466-438e-9b95-28ddbfb84bfd"
      unitRef="usd">22746000</pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses
      contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTYtNC0xLTEtODYxMjc_f5090c99-6fbe-4c0e-82a6-2807967de526"
      unitRef="usd">957000</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses>
    <pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTYtNi0xLTEtODYxMjc_86de65a4-97bd-485b-ac58-a5acedb3bd0b"
      unitRef="usd">23703000</pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTctMi0xLTEtODYxMjc_1d4cd047-7476-42d5-9b1b-db825972a364"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTctNi0xLTEtODYxMjc_7e532cd5-8ee3-488c-8167-7476034cdb8f"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTgtMi0xLTEtODYxMjc_06e1df4e-40da-43f0-a508-70d0f6bac613"
      unitRef="usd">6585000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTgtNi0xLTEtODYxMjc_1ea9b98d-1c7f-4d9a-9b02-8bbd2d3d8332"
      unitRef="usd">6585000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTktMi0xLTEtODYxMjc_db4d2db7-f96b-4328-83ff-4c2aee3a7233"
      unitRef="usd">1187000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMTktNi0xLTEtODYxMjc_13fe7348-a6dd-485a-a862-998f06ed1a6b"
      unitRef="usd">1187000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjAtMi0xLTEtODYxMjc_221d5004-824d-4e15-b8c2-dc6f56a5b781"
      unitRef="usd">201450000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjAtNi0xLTEtODYxMjc_56223dfb-5195-4093-869e-16c72b341200"
      unitRef="usd">201450000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjEtMi0xLTEtODYxMjc_80afcbde-8ade-4bdb-a1a9-ad2dcb574347"
      unitRef="usd">251762000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities
      contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjEtNC0xLTEtODYxMjc_89ef4c6d-bae3-4ac2-ad82-4bc4940e0b21"
      unitRef="usd">957000</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjEtNi0xLTEtODYxMjc_4f421e24-def5-491f-ba1b-0013a6f8220d"
      unitRef="usd">252719000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjItMi0xLTEtODYxMjc_0ef4a2ae-de26-4e05-be4f-96a998ac4cc5"
      unitRef="usd">569217000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets
      contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjItNC0xLTEtODYxMjc_7a46a752-7ccd-4835-a0ef-fd1ecb944eba"
      unitRef="usd">-957000</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjItNi0xLTEtODYxMjc_8b50a38e-3cfb-418f-a4b8-51e3c07eaead"
      unitRef="usd">568260000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjMtMi0xLTEtODYxMjc_6b2c9c6a-40fc-4123-81b7-2c5ae9c278b4"
      unitRef="usd">9628000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjMtNC0xLTEtODYxMjc_13983e17-cf84-4fbe-be3c-756b4ce3c3df"
      unitRef="usd">957000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjMtNi0xLTEtODYxMjc_7723f69a-f9f7-43a2-b9e0-5ce45f896c73"
      unitRef="usd">10585000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjQtMi0xLTEtODYxMjc_95d9a5cf-487b-417d-806c-d02b9d344deb"
      unitRef="usd">578845000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjQtNC0xLTEtODYxMjc_0109f0fc-e196-4def-926c-da6a7a2a4084"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i521f1b4e7f96420b850707ae1c48fed0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjRjZGY5ZTdkOGIwNzQ4ZDk4Yjk3NjNjMDI0MjZiMDNjL3RhYmxlcmFuZ2U6NGNkZjllN2Q4YjA3NDhkOThiOTc2M2MwMjQyNmIwM2NfMjQtNi0xLTEtODYxMjc_672d65e2-3a7d-45cc-a376-74e3abf8cc39"
      unitRef="usd">578845000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMzQzMA_4bb71814-59be-47bf-817c-1d26f843981d">This pro forma information does not purport to represent what the Company&#x2019;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i6affd4b067a74053a80dafaecc998dce_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMS0xLTEtMS05MTE3Ng_a9cb4e87-f418-4752-bd74-c0a99c46b05f"
      unitRef="usd">163765000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMi0yLTEtMS04NjEyNw_97e29921-d23f-4ca3-93ae-541d1c188bf5"
      unitRef="usd">307381000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i6affd4b067a74053a80dafaecc998dce_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMi0xLTEtMS05MTE3Ng_da0ed871-78f1-45da-abec-8a776fa75e94"
      unitRef="usd">-3367000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMy0yLTEtMS04NjEyNw_93097c87-8000-4612-b65d-40ce075c9966"
      unitRef="usd">-20487000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMy0xLTEtMS05MTE3Ng_abc5f608-8044-49fd-aa79-052014dae28a"
      unitRef="usdPerShare">-0.08</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfMy0xLTEtMS05MTE3Ng_d5aa51d5-bc14-4d20-b13c-81f9946852b0"
      unitRef="usdPerShare">-0.08</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfNC0yLTEtMS04NjEyNw_a4735145-e2ea-4638-850a-a277e39bc05a"
      unitRef="usdPerShare">-0.47</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RhYmxlOjk2ZmYyZTAzNjRiNjRmYWJhMmZmM2U4YTgwYzM5NzQxL3RhYmxlcmFuZ2U6OTZmZjJlMDM2NGI2NGZhYmEyZmYzZThhODBjMzk3NDFfNC0yLTEtMS04NjEyNw_db1e85a8-1622-48cf-9ec5-2214bb12e504"
      unitRef="usdPerShare">-0.47</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt
      contextRef="i7e42aa47b25f48e0be0ab8750e25e349_I20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180Ni9mcmFnOmYyOGRmODY5NGZhMDQ2NTBiOThmYTk2MWFjNmFlZDk1L3RleHRyZWdpb246ZjI4ZGY4Njk0ZmEwNDY1MGI5OGZhOTYxYWM2YWVkOTVfMjk1Mg_0e054391-1ffa-4a36-9159-a7469285bcac"
      unitRef="usd">85100000</pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RleHRyZWdpb246NTg5NDcxNWM0MjFjNDkwY2I4ZWU3YzA5YWU4Yjg1YjBfOTg_7229eea0-1324-4a09-913d-5f13bcde6acd">INVENTORIES&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of inventories, net are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RleHRyZWdpb246NTg5NDcxNWM0MjFjNDkwY2I4ZWU3YzA5YWU4Yjg1YjBfMTA0_7da2fd5a-e4c0-435a-b389-65919efb7792">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of inventories, net are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfMi0xLTEtMS04NjEyNw_1b312855-dc25-427c-99c3-8d794bfc700d"
      unitRef="usd">36301000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfMi0zLTEtMS04NjEyNw_72a1bc8a-f38e-4153-81eb-3a53573885ee"
      unitRef="usd">36337000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfMy0xLTEtMS04NjEyNw_ddbf3b0b-ce1f-47e9-a019-b175c48207cb"
      unitRef="usd">39407000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfMy0zLTEtMS04NjEyNw_122950df-198a-41c7-8254-cd0b84f6ee5f"
      unitRef="usd">35182000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfNC0xLTEtMS04NjEyNw_ad96a945-6591-4e5d-820e-6f7468407705"
      unitRef="usd">24880000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfNC0zLTEtMS04NjEyNw_03f7218f-5753-4612-b1d1-2c6f016f28f1"
      unitRef="usd">27031000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfNS0xLTEtMS04NjEyNw_e996fd91-04f6-41da-a4fb-c363e8dcd482"
      unitRef="usd">100588000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN180OS9mcmFnOjU4OTQ3MTVjNDIxYzQ5MGNiOGVlN2MwOWFlOGI4NWIwL3RhYmxlOjA3YmViZDU1M2I2YjRlYTE4YmQzNmE5OWZiYjQzY2NkL3RhYmxlcmFuZ2U6MDdiZWJkNTUzYjZiNGVhMThiZDM2YTk5ZmJiNDNjY2RfNS0zLTEtMS04NjEyNw_0d4b003d-cc8e-4637-bbc7-43eed16a0493"
      unitRef="usd">98550000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfODM5_60460d3e-9b8d-483f-acad-1ba37b96e4c0">FIXED ASSETS&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed assets, net, summarized by major category, consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended June&#160;30, 2022 and 2021, depreciation expense was $6.5 million and $2.9 million, respectively. For the three months ended June&#160;30, 2022 and 2021, there was $1.0 million and $1.1 million of capitalized interest on the construction of manufacturing sites, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June&#160;30, 2022 and 2021, depreciation expense was $12.2 million and $5.8 million, respectively. For the six months ended June&#160;30, 2022 and 2021, there was $1.8&#160;million and $2.1&#160;million of capitalized interest on the construction of manufacturing sites, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022 and December&#160;31, 2021, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $60.0 million and $65.4&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022 and December&#160;31, 2021, the Company had asset retirement obligations of $3.1&#160;million and $2.4&#160;million, respectively, included in accrued expenses and other liabilities on its condensed consolidated balance sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfODQx_73dd855e-9ad5-41dd-8da7-9e370362aeda">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed assets, net, summarized by major category, consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2d78b23f2b384db1952457d16ecfc25a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfMi0xLTEtMS04NjEyNw_62b8303a-6673-4dd3-b3ef-857b1e9f3f10"
      unitRef="usd">116364000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id3a7bcd6cd0649a3af561d8e804dfa32_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfMi0zLTEtMS04NjEyNw_a576e0aa-6ae3-4b92-a861-1aceb87e48e0"
      unitRef="usd">117264000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9f0c585d3783403c875879dfaad021a3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfMy0xLTEtMS04NjEyNw_ef36a343-c7a7-4746-b60a-87708afe4eea"
      unitRef="usd">60155000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iee1c1e7325aa446388971997460585da_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfMy0zLTEtMS04NjEyNw_a9292937-60f7-4da4-aee2-a7bac791c09c"
      unitRef="usd">59740000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie1509ca5743b4070b16fb4bc87afe9d7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNC0xLTEtMS04NjEyNw_1a0fea11-a7b9-4fa8-8f2c-f3aba769f68e"
      unitRef="usd">13598000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i826ff833dd74486b9ea7e8f9bff4a586_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNC0zLTEtMS04NjEyNw_9f76f01d-94a5-40c2-a034-e8b86f86c852"
      unitRef="usd">13197000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i33dfed9d67c948b4a47a8e552ba5b8b0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNS0xLTEtMS04NjEyNw_1c69fffa-6a73-447b-8fbd-f46be7a0bef9"
      unitRef="usd">2303000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8b8d87ead91c4e5d9b76bca54c19862f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNS0zLTEtMS04NjEyNw_88c30aee-cfe3-41da-b362-b8875c3c9600"
      unitRef="usd">2883000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i15e904416e0c433ca74cb7980b2e6633_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNi0xLTEtMS04NjEyNw_ebf5f696-5f0e-439c-9bdd-cdc77faaaab4"
      unitRef="usd">94332000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4be0edf10e0548a6b2cff393c65da1f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNi0zLTEtMS04NjEyNw_7ccf59e4-2b7a-468a-b566-a127051b54d9"
      unitRef="usd">80557000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNy0xLTEtMS04NjEyNw_dbd211d5-cfdf-40b9-8e32-7c5c2a87e2bd"
      unitRef="usd">286752000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfNy0zLTEtMS04NjEyNw_bcab4634-bfc8-4405-8c22-15fa802a0931"
      unitRef="usd">273641000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfOC0xLTEtMS04NjEyNw_10898b93-0108-4c5b-b968-412e5dda5e53"
      unitRef="usd">95473000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfOC0zLTEtMS04NjEyNw_98fbc3b2-a1aa-47f5-87e2-2087e518405d"
      unitRef="usd">85240000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfOS0xLTEtMS04NjEyNw_bb95c19d-20ef-4e6f-b676-df3d90ba723d"
      unitRef="usd">191279000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RhYmxlOjI3MjE2YTM4YjVlOTRhNmRhNDEwNTA2YTEwMjIxN2I3L3RhYmxlcmFuZ2U6MjcyMTZhMzhiNWU5NGE2ZGE0MTA1MDZhMTAyMjE3YjdfOS0zLTEtMS04NjEyNw_346aee29-b0e0-41ff-989f-a2349b3a498c"
      unitRef="usd">188401000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfMTgx_5b8f2bee-e1bd-4801-9dad-5b05041b1a53"
      unitRef="usd">6500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfMTg4_5c6d53fc-56ce-426f-8246-cc33f1c6156d"
      unitRef="usd">2900000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="i763696419f734dfaa3b176b7f09e6547_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfMjU0_fb93d3aa-eb0c-48e4-8525-3269c3ff989e"
      unitRef="usd">1000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i2d0655252144469e8a6289d5d0cea2f3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfMjYx_06c6b994-c2db-4d41-a7ec-bc0ac413e644"
      unitRef="usd">1100000</us-gaap:InterestCostsCapitalized>
    <us-gaap:Depreciation
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk0NzgwMjMyNjEzMw_be81be52-ea8a-40f8-afa7-017c3ecc87fd"
      unitRef="usd">12200000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk0NzgwMjMyNjE0MQ_f72a59bd-ca27-47cf-bdb5-596d760661fe"
      unitRef="usd">5800000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk0NzgwMjMyNjM5Mg_2d2b3398-feaa-45ae-8ea2-e39693f23efc"
      unitRef="usd">1800000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk0NzgwMjMyNjQwNw_31f457b6-40dd-4fad-8712-181f21b1a96f"
      unitRef="usd">2100000</us-gaap:InterestCostsCapitalized>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if281a36c7ccc4a4aae4dad712d455bfc_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDg4_6f250a64-c134-415d-9e5e-9546dcc3546c"
      unitRef="usd">60000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8a7ee7ba6eb240858ec746652a6fdc24_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNDk1_470b0248-565f-4bab-91c2-862297039b11"
      unitRef="usd">65400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetRetirementObligation
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNTc5_72bf0c44-ca55-4b31-aa61-b0bc2390beb7"
      unitRef="usd">3100000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181Mi9mcmFnOmZlZjRjODg5YzJiNzRjMmFhMjg1ZmIwZWY3ZDdmNGFhL3RleHRyZWdpb246ZmVmNGM4ODljMmI3NGMyYWEyODVmYjBlZjdkN2Y0YWFfNTg2_5532fafe-69d9-4d66-89e8-8233c5a09118"
      unitRef="usd">2400000</us-gaap:AssetRetirementObligation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE1Mg_038f98ac-3c5e-45cc-a58e-1fc881aa2404">LEASES&lt;div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases all of its facilities, including its EXPAREL and iovera&#xb0; manufacturing facility in San Diego, California. These leases have remaining terms up to 8.2 years, some of which provide renewal options at the then-current market value. The Company also has two embedded leases with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England for the production of EXPAREL and ZILRETTA. A portion of the associated monthly base fees has been allocated to the lease components based on a relative fair value basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. Total operating lease costs are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for operating lease liabilities, net of lease incentive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets recorded in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to net the amortization of the ROU asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. The weighted average remaining lease term and the weighted average discount rate are summarized as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.33 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.71 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the Company&#x2019;s operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining six months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the Company has entered into one lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining six months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to June 30, 2022, the Company entered into a sublease for the former Flexion research and development laboratory in Woburn, Massachusetts in July 2022 which resulted in a $0.4&#160;million ROU asset to be reclassified to a fixed asset.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i391acdd0982f425f84071afc5d969737_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE1Nw_bf21647b-8bf6-4421-9131-375a815cc007">P8Y2M12D</us-gaap:LesseeOperatingLeaseTermOfContract>
    <pcrx:NumberOfLeases
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE0OQ_0ba09a6c-5d2f-427c-acad-da54d3b7da22"
      unitRef="lease">2</pcrx:NumberOfLeases>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE0Ng_9c2758a3-012d-4c11-b42b-6564238bbda5">Total operating lease costs are as follows (in thousands):&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for operating lease liabilities, net of lease incentive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets recorded in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The weighted average remaining lease term and the weighted average discount rate are summarized as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.33 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.71 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfMy0yLTEtMS04NjEyNw_4e47f738-af2f-4478-bd32-9d2953b28c56"
      unitRef="usd">3542000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfMy00LTEtMS04NjEyNw_8406db85-f18f-496c-880e-a47a1e24f020"
      unitRef="usd">2922000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfMy02LTEtMS04NjEyNw_19b154d9-949e-4d00-95ba-ea5315ff26f2"
      unitRef="usd">7069000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfMy04LTEtMS04NjEyNw_2ef23414-535a-4038-a9b7-4f01f92538fc"
      unitRef="usd">5843000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNC0yLTEtMS04NjEyNw_974570b8-edb3-45c7-a973-7034e71cd568"
      unitRef="usd">508000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNC00LTEtMS04NjEyNw_aa24d9d9-7c6b-40b9-91e9-0bdea79941d6"
      unitRef="usd">424000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNC02LTEtMS04NjEyNw_0f41d64c-762a-4cd0-8758-81cdbfc1d7a4"
      unitRef="usd">980000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNC04LTEtMS04NjEyNw_e502d51a-b319-405c-98aa-eff291ef00f7"
      unitRef="usd">902000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNS0yLTEtMS04NjEyNw_a3d2c51b-d2e0-4a42-b04a-68c704a6335f"
      unitRef="usd">4050000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNS00LTEtMS04NjEyNw_6f0a8fd3-418f-4948-81ad-54e37c03f774"
      unitRef="usd">3346000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNS02LTEtMS04NjEyNw_49a4ad72-ee85-48f8-accb-731f86cb47b9"
      unitRef="usd">8049000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjJiNjZkYzRjYTlhZTQyZDE5NjM2ZWZlNzdlZWZkZjJhL3RhYmxlcmFuZ2U6MmI2NmRjNGNhOWFlNDJkMTk2MzZlZmU3N2VlZmRmMmFfNS04LTEtMS04NjEyNw_1984cd19-167b-432f-96d5-c9c863aa93cf"
      unitRef="usd">6745000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjZlNGU2NzAxYWJkZTQ4YTNiYzc3YWU4NzNkYWU4NTdhL3RhYmxlcmFuZ2U6NmU0ZTY3MDFhYmRlNDhhM2JjNzdhZTg3M2RhZTg1N2FfMy0yLTEtMS04NjEyNw_904df07e-7532-417d-ac30-6f88425b998b"
      unitRef="usd">6637000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjZlNGU2NzAxYWJkZTQ4YTNiYzc3YWU4NzNkYWU4NTdhL3RhYmxlcmFuZ2U6NmU0ZTY3MDFhYmRlNDhhM2JjNzdhZTg3M2RhZTg1N2FfMy00LTEtMS04NjEyNw_c1bf3976-bf58-4f94-9a05-1b6f9163f10e"
      unitRef="usd">7177000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjZlNGU2NzAxYWJkZTQ4YTNiYzc3YWU4NzNkYWU4NTdhL3RhYmxlcmFuZ2U6NmU0ZTY3MDFhYmRlNDhhM2JjNzdhZTg3M2RhZTg1N2FfNC0yLTEtMS04NjEyNw_53d26b96-5f76-4e9f-8419-da079e744065"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOjZlNGU2NzAxYWJkZTQ4YTNiYzc3YWU4NzNkYWU4NTdhL3RhYmxlcmFuZ2U6NmU0ZTY3MDFhYmRlNDhhM2JjNzdhZTg3M2RhZTg1N2FfNC00LTEtMS04NjEyNw_586c665c-c3eb-4822-af2c-76efe47377e2"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmYxZjNmMDJhYjM3NjQ0MmNhNzI4MjgzOWY1ZTRkZGQ0L3RhYmxlcmFuZ2U6ZjFmM2YwMmFiMzc2NDQyY2E3MjgyODM5ZjVlNGRkZDRfMi0yLTEtMS04NjEyNw_0d60d228-0ee6-48a3-9541-632c8a400285">P7Y3M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmYxZjNmMDJhYjM3NjQ0MmNhNzI4MjgzOWY1ZTRkZGQ0L3RhYmxlcmFuZ2U6ZjFmM2YwMmFiMzc2NDQyY2E3MjgyODM5ZjVlNGRkZDRfMi00LTEtMS04NjEyNw_2d615217-6e91-4a48-ba0e-e38ad95e333d">P8Y8M15D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmYxZjNmMDJhYjM3NjQ0MmNhNzI4MjgzOWY1ZTRkZGQ0L3RhYmxlcmFuZ2U6ZjFmM2YwMmFiMzc2NDQyY2E3MjgyODM5ZjVlNGRkZDRfMy0yLTEtMS04NjEyNw_c8c8263e-8bbf-49b2-9bf8-c12a709e5331"
      unitRef="number">0.0695</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i8e6079e472454d8fb92f206183fe3fe5_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmYxZjNmMDJhYjM3NjQ0MmNhNzI4MjgzOWY1ZTRkZGQ0L3RhYmxlcmFuZ2U6ZjFmM2YwMmFiMzc2NDQyY2E3MjgyODM5ZjVlNGRkZDRfMy00LTEtMS04NjEyNw_b152b0bb-a194-4aac-a887-87ba2dce8078"
      unitRef="number">0.0689</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE1MA_aa885630-b510-4ba9-8066-97980a0d1f71">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the Company&#x2019;s operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining six months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfMS0yLTEtMS04NjEyNw_2c4d9550-75c0-4747-a91a-15180879769f"
      unitRef="usd">6509000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfMi0yLTEtMS04NjEyNw_bed921c9-1ec7-42ed-8b2f-a10978390f3a"
      unitRef="usd">13304000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfMy0yLTEtMS04NjEyNw_6497456a-ecdd-410b-ad95-4aa2209e359f"
      unitRef="usd">13435000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfNC0yLTEtMS04NjEyNw_d33649a5-9afc-4fd6-a955-01a19e662d6e"
      unitRef="usd">12575000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfNS0yLTEtMS04NjEyNw_2c7c8596-37eb-42ab-a140-5aaa6b4c0675"
      unitRef="usd">12310000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfNi0yLTEtMS04NjEyNw_6d0d404f-f228-40e9-9618-76e525a4e1f0"
      unitRef="usd">39422000</pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfNy0yLTEtMS04NjEyNw_0da531c9-3a5f-4f60-9a8c-6e574d136a07"
      unitRef="usd">97555000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfOC0yLTEtMS04NjEyNw_c0f60cc6-3648-49bf-be43-34d3bd94c468"
      unitRef="usd">21846000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmE0YzFiZTQ5YzkxZjRhZGFiMTAxOGI2OTZjYjI0NzE4L3RhYmxlcmFuZ2U6YTRjMWJlNDljOTFmNGFkYWIxMDE4YjY5NmNiMjQ3MThfOS0yLTEtMS04NjEyNw_ba44c9a0-185b-4749-a760-ebc05ae0a0fa"
      unitRef="usd">75709000</us-gaap:OperatingLeaseLiability>
    <pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMjE1MQ_39572707-5334-4ef8-a0ae-c309ec0ac1dd">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the Company has entered into one lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining six months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMTYzNA_411805ea-207e-4015-a493-264d396b7e5f"
      unitRef="segment">1</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfMS0yLTEtMS04NjEyNw_66580feb-0802-4254-b707-4a5500c57900"
      unitRef="usd">81000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfMi0yLTEtMS04NjEyNw_f6d1cd27-0ada-4864-acc1-605985868243"
      unitRef="usd">492000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfMy0yLTEtMS04NjEyNw_3317e998-98e1-4608-b8b7-e14e9afc503b"
      unitRef="usd">494000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfNC0yLTEtMS04NjEyNw_32c5e942-6f3a-465f-bb94-fb081b541ab9"
      unitRef="usd">503000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfNS0yLTEtMS04NjEyNw_aba221e8-1ee8-45b8-9e0a-7efd16612707"
      unitRef="usd">505000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfNi0yLTEtMS04NjEyNw_f50f5d79-3c27-4b66-b21b-f8d8d931a086"
      unitRef="usd">443000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RhYmxlOmI1YTNlYTdlNjE4ODQ5ZmU4NjRiNjYyMTE4ZDcxMmUyL3RhYmxlcmFuZ2U6YjVhM2VhN2U2MTg4NDlmZTg2NGI2NjIxMThkNzEyZTJfNy0yLTEtMS04NjEyNw_d704d0e0-2a43-4999-b7cc-65913bbeb30b"
      unitRef="usd">2518000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i29a197404c3243d9b8b707eb226c77fd_I20220701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181NS9mcmFnOjk3YWI5OTM3NGNkYTQzMzU4OWQ3ZGNkMzM3MzdlNTc0L3RleHRyZWdpb246OTdhYjk5Mzc0Y2RhNDMzNTg5ZDdkY2QzMzczN2U1NzRfMzI5ODUzNDg4NjI5NQ_751e4cfd-8e10-43b0-acd2-d6cee253bfb0"
      unitRef="usd">400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTk0NQ_6e5ddccd-215b-4e4b-8afa-d45028efd32d">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#x2019;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#x201c;Skyepharma Acquisition&#x201d;), MyoScience, Inc., or MyoScience, (the &#x201c;MyoScience Acquisition&#x201d;) in April 2019 and the Flexion Acquisition in November 2021. The balances at June&#160;30, 2022 and December&#160;31, 2021 were $146.1&#160;million and $145.2&#160;million, respectively. The increase was due to measurement period adjustments associated with the Flexion Acquisition. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flexion Acquisition,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. The final Skyepharma milestone payment of $32.0&#160;million when annual net sales collected reached $500.0&#160;million was achieved in the fourth quarter of 2021 and paid during the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net, consist of the in-process research and development, or IPR&amp;amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible&lt;br/&gt;Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years, 5 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible&lt;br/&gt;Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years, 5 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense on intangible assets for the three and six months ended June&#160;30, 2022 was $14.3&#160;million and $28.6&#160;million, respectively. Amortization expense on intangible assets for the three and six months ended June 30, 2021 was &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.0&#160;million and $3.9&#160;million, respectively. The increase in amortization expense in the current year is a result of the amortization of ZILRETTA for osteoarthritis knee pain acquired as part of the Flexion Acquisition in November 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assuming no changes in the gross carrying amount of these intangible assets, the future estimated amortization expense on the finite-lived intangible assets will be $28.6&#160;million for the remaining six months of 2022, $57.3&#160;million from 2023 to 2030, $37.4&#160;million in 2031, $7.9&#160;million in 2032 and $2.2&#160;million in 2033.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its long-lived assets for impairment whenever an event or change in circumstances arise that indicate the carrying amount of an asset group is at risk of not being recoverable. A triggering event was identified for the ZILRETTA asset group due to a reduction in the near-term projected cash flows from the ZILRETTA product. The Company completed an impairment assessment through a recoverability test at June 30, 2022 by comparing the net carrying value of ZILRETTA asset group against the undiscounted net cash flows expected to be generated from ZILRETTA. It was determined that the ZILRETTA asset group was recoverable and not impaired.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjIwMg_ed2ffe1c-f792-4ff5-bc2e-771b66cd36cb"
      unitRef="usd">146100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfNDc5_4887dba2-bb7b-4558-9653-05725273fd96"
      unitRef="usd">145200000</us-gaap:Goodwill>
    <pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition
      contextRef="i83f2e14bdb904ac69fc8abf1f24b5ab6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfOTgx_7cd0e334-6a60-47f4-839f-f90b18d5c295"
      unitRef="usd">32000000</pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition>
    <pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition
      contextRef="i83f2e14bdb904ac69fc8abf1f24b5ab6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTAyNA_b5ebe8f4-b336-400b-9d86-aceae6a2c8f8"
      unitRef="usd">500000000</pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTkzNw_3053033f-ebaa-4acd-9e02-17257f6c4315">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net, consist of the in-process research and development, or IPR&amp;amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible&lt;br/&gt;Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years, 5 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible&lt;br/&gt;Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years, 5 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i65d966ca6353411282f9165d72de2694_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMS0yLTEtMS04NjEyNw_84cc2a07-373a-4f63-b6ad-420b5bdbdb5c"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i65d966ca6353411282f9165d72de2694_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMS00LTEtMS04NjEyNw_db583523-8d2f-4c6b-9942-2daa69d59d7c"
      unitRef="usd">55737000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i65d966ca6353411282f9165d72de2694_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMS02LTEtMS04NjEyNw_2c765716-18ad-47a0-acc6-24764a94e203"
      unitRef="usd">534263000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib460bbff86ec431dbef5039959fb47c2_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMS04LTEtMS04NjEyNw_46433248-9824-4b8d-b9f1-0c7140dc9e79">P10Y5M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iede544d07eb8434cbb48cd6e2d2f78cf_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMi0yLTEtMS04NjEyNw_5ed0f297-0133-483a-866d-91bfd79c349b"
      unitRef="usd">90000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iede544d07eb8434cbb48cd6e2d2f78cf_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMi00LTEtMS04NjEyNw_be7a1c50-bcac-490f-a580-dce9d5c0ec4b"
      unitRef="usd">29000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iede544d07eb8434cbb48cd6e2d2f78cf_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMi02LTEtMS04NjEyNw_4c8f9550-602c-46fe-bbf7-a04fa8520972"
      unitRef="usd">61000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia5ee767a49874dee966e06f8b34939c7_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMi04LTEtMS04NjEyNw_e84d1064-3112-4a94-a1fb-16abe096e0b9">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMy0yLTEtMS04NjEyNw_cd6a9518-e02f-4ade-8920-2c74fc2b5236"
      unitRef="usd">590090000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMy00LTEtMS04NjEyNw_a803b12c-8598-42e6-bb3e-956ef8a51780"
      unitRef="usd">55766000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMy02LTEtMS04NjEyNw_777bc90d-3ece-40f7-9ac7-3f5ee9a2755d"
      unitRef="usd">534324000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie5a8f5d97b3248aeb01adea4b0c7fe72_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNC0yLTEtMS04NjEyNw_ca471f40-e14c-47c3-8897-33ea0f03afce"
      unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie5a8f5d97b3248aeb01adea4b0c7fe72_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNC02LTEtMS04NjEyNw_aaf2f9d7-4d0c-46b5-80f3-b171b00a0b3c"
      unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNS0yLTEtMS04NjEyNw_fc6c49e2-c75f-4169-8b80-40653b7c9170"
      unitRef="usd">651090000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNS00LTEtMS04NjEyNw_ad6ab9fa-0a7a-4d96-8c3b-891fa17f956b"
      unitRef="usd">55766000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfNS02LTEtMS04NjEyNw_797d033c-6c68-4d93-9c09-3e1159c1d96b"
      unitRef="usd">595324000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1658c43324b5453cb15e998032d6549e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOC0yLTEtMS04NjEyNw_bd3fb2b8-9be8-4157-9d58-23077c4ebd4e"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1658c43324b5453cb15e998032d6549e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOC00LTEtMS04NjEyNw_3e68e8c1-1936-4ad3-86f2-4be5061bd7c1"
      unitRef="usd">27097000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1658c43324b5453cb15e998032d6549e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOC02LTEtMS04NjEyNw_ffde7e72-381b-4ce1-a5ed-39c1257b5f4a"
      unitRef="usd">562903000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i7c9452190b1e4796b95b0775fa97bde7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOC04LTEtMS04NjEyNw_455c6dfb-88f9-4712-877d-1c08a024c4da">P10Y5M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i123f4f9994ab4fb68fe6439b61e60b8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOS0yLTEtMS04NjEyNw_ba4361da-2f10-4da1-9cb3-52c976b5f32c"
      unitRef="usd">90000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i123f4f9994ab4fb68fe6439b61e60b8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOS00LTEtMS04NjEyNw_3231295a-5df3-43d6-abf5-406682d40fbc"
      unitRef="usd">25000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i123f4f9994ab4fb68fe6439b61e60b8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOS02LTEtMS04NjEyNw_497d6a24-6bb6-4e6a-999a-15456e3fc7be"
      unitRef="usd">65000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i76602afa0926462bbcd383a88f3f3ef8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfOS04LTEtMS04NjEyNw_ed3019cb-d5a3-4392-8397-650718048bff">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTAtMi0xLTEtODYxMjc_e9b5acc7-cada-49f5-bea4-d37c3267030e"
      unitRef="usd">590090000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTAtNC0xLTEtODYxMjc_1fb56cb7-1c8f-46c8-97c9-bb1ba058e786"
      unitRef="usd">27122000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTAtNi0xLTEtODYxMjc_9d61eb07-3a4b-44f2-9274-edcdd12fde25"
      unitRef="usd">562968000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibc3334cacbe145ba953c4eed59a7b31b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTEtMi0xLTEtODYxMjc_f2af82a0-345e-4d78-af09-fdcac1a60215"
      unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibc3334cacbe145ba953c4eed59a7b31b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTEtNi0xLTEtODYxMjc_2caf8fad-fff5-443f-ba1a-6f70449fe862"
      unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTItMi0xLTEtODYxMjc_9d0318fc-9123-4864-ac63-f511456acfbc"
      unitRef="usd">651090000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTItNC0xLTEtODYxMjc_dc43c015-5125-4f1e-baf0-541619949893"
      unitRef="usd">27122000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RhYmxlOjhlYzIxZTcyZDRjODQxMWE5MjFjYmE1ODk0YTNmNWUwL3RhYmxlcmFuZ2U6OGVjMjFlNzJkNGM4NDExYTkyMWNiYTU4OTRhM2Y1ZTBfMTItNi0xLTEtODYxMjc_7e36fe36-c6db-4255-a72a-4d121c8f27f6"
      unitRef="usd">623968000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjI1Mg_e7d17a13-f15d-4843-95f3-62c03495aeaa"
      unitRef="usd">14300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjI4MQ_0b038420-539d-4e0d-8138-8b5fb62bcdd4"
      unitRef="usd">28600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjIyNA_07f15077-3d0f-4b10-b06d-6835c2e84fef"
      unitRef="usd">2000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMzI5ODUzNDg4NjIzOA_4687c035-499f-47d2-a721-c4e2f6663f77"
      unitRef="usd">3900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTgzOQ_03eefa4a-cfc8-4a70-8c18-dc82b6f74f0a"
      unitRef="usd">28600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTg3Nw_9f3e6cd5-ef4c-4eda-921e-89cc673cead3"
      unitRef="usd">57300000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTkwMA_0c7ce8d7-3643-44d5-bd46-be11b3621391"
      unitRef="usd">37400000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTkxMg_52dff262-3d24-4768-90a4-6fe0549ff162"
      unitRef="usd">7900000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN181OC9mcmFnOjZkMzkwYjI5ZmYwMjQ0YzJhNjA4Y2QzNDkyNjMyNTdlL3RleHRyZWdpb246NmQzOTBiMjlmZjAyNDRjMmE2MDhjZDM0OTI2MzI1N2VfMTkyNw_25ced9d3-b19c-4a88-8705-63efa4b1390b"
      unitRef="usd">2200000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NDQ_68b4436b-52f3-4981-a689-a5a322f26c44">DEBT &lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company&#x2019;s outstanding debt is summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan B facility maturing December 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% Convertible senior notes due August 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375% Convertible senior notes due May 2024 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% Convertible senior notes due April 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The 2022 Notes (as defined below) matured on April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Term Loan B Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company entered into a term loan credit agreement (the &#x201c;Credit Agreement&#x201d;) with JP Morgan Chase Bank, N.A., as administrative agent and the initial lender. The term loan issued under the Credit Agreement (the &#x201c;Term Loan&#x201d;) was issued at a 3% discount and allows for a single-advance term loan B facility in the principal amount of $375.0&#160;million, which is secured by substantially all of the Company&#x2019;s and each subsidiary guarantor&#x2019;s assets. Subject to certain conditions, the Company may, at any time, on one or more occasion, add one or more new classes of term facilities and/or increase the principal amount of the loans of any existing class by requesting one or more incremental term facilities. The net proceeds of the Term Loan were approximately $363.8&#160;million after deducting an original issue discount of $11.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the Term Loan is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan maturing December 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan matures on December 7, 2026 and requires quarterly repayments of principal in the amount of $9.4&#160;million commencing June 30, 2022, increasing to $14.1&#160;million commencing December 31, 2025, with a remaining balloon payment of approximately $188.0&#160;million due at maturity. During 2022, the Company is required to make three quarterly payments totaling $28.1&#160;million. The Company is also required to make mandatory prepayments of principal from (i) the Company&#x2019;s excess cash flow (as defined in the Credit Agreement) existing in any fiscal year and if the Senior Secured Leverage Ratio (as defined in the Credit Agreement) for such fiscal year exceeds certain predetermined limits (ii) net proceeds (as defined in the Credit Agreement) of non-ordinary course assets sales and casualty events and (iii) debt issuance proceeds (other than permitted debt under the Credit Agreement). Prepayment penalties for the Term Loan are 2% in the first loan year plus an interest make-whole payment, 2% in the second loan year, 1% in the third loan year and nothing thereafter. Prepayment penalties generally do not apply to mandatory prepayment obligations under the Credit Agreement, such as prepayments due in connection with excess cash flow. During the three and six months ended June&#160;30, 2022, the Company made a scheduled principal payment of $9.4&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan requires the Company to, among other things, maintain (i) a first lien net leverage ratio, determined as of the last day of any fiscal quarter, of no greater than 1.75 to 1.00 and (ii) liquidity, at any time, of at least $150.0&#160;million. The Term Loan also contains customary affirmative and negative covenants, financial covenants, representations and warranties, events of default and other provisions. As of June&#160;30, 2022, the Company was in compliance with all financial covenants under the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company may elect to borrow either term benchmark borrowings or alternate base rate borrowings. Term benchmark borrowings bear interest at a variable rate per annum equal to the Adjusted Term SOFR Rate (as defined in the Credit Agreement) (subject to a 75 basis points floor) plus an applicable margin of 700 basis points. Alternate base rate borrowings bear interest at a variable rate per annum determined using a base rate (subject to a 175 basis points floor) equal to the greatest of (i) the Prime Rate (as defined in the Credit Agreement) in effect on such day, (ii) the NYFRB Rate (as defined in the Credit Agreement) plus 50 basis points or (iii) the Adjusted Term SOFR Rate (as defined in the Credit Agreement) plus 100 basis points, subject to certain exceptions, plus an applicable margin of 600 basis points. As of June&#160;30, 2022, borrowings under the Term Loan consisted entirely of term benchmark borrowings at a rate of 7.81%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes Due 2025&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company completed a private placement of $402.5&#160;million in aggregate principal amount of its 0.750% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per year, payable semiannually in arrears on February 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and August 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of each year. The 2025 Notes mature on August 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2025 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% convertible senior notes due August 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds from the issuance of the 2025 Notes were approximately $390.0&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $185.0&#160;million in aggregate principal amount of its then-outstanding 2.375% convertible senior notes due 2022 in privately-negotiated transactions for a total of $211.1&#160;million of cash (including accrued interest).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert the 2025 Notes at any time prior to February 3, 2025, only if certain circumstances are met, including if during the previous calendar quarter, the last reported sales price of the Company&#x2019;s common stock was greater than 130% of the conversion price then applicable for at least 20 out of the last 30 consecutive trading days of the quarter. During the quarter ended&#160;June&#160;30, 2022, this condition for conversion was not met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the 40 consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#x2019;s common stock or a combination of cash and shares of the Company&#x2019;s common stock, at the Company&#x2019;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $71.78 per share of the Company&#x2019;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately 32.5% to the closing sale price of $54.17 per share of the Company&#x2019;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the 2025 Notes had a market price o&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $1,038&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; pe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$402.5&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#x2019;s option).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; scheduled trading day immediately before the maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for (i) each of at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) 100% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#x201c;make-whole fundamental change&#x201d; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the 2025 Notes are currently classified on the Company&#x2019;s condensed consolidated balance sheet at June&#160;30, 2022 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#x2019;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes Due 2024 Assumed from the Flexion Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Flexion Acquisition, on May 2, 2017, Flexion issued an aggregate of $201.3&#160;million principal amount of 3.375% convertible senior notes due 2024 (the &#x201c;Flexion 2024 Notes&#x201d;), pursuant to the indenture, dated as of May 2, 2017 (the &#x201c;Original Flexion Indenture&#x201d;), between Flexion and Wells Fargo Bank, N.A., as trustee (the &#x201c;Flexion Trustee&#x201d;), as supplemented by the First Supplemental Indenture, dated as of November 19, 2021, between Flexion and the Flexion Trustee (the &#x201c;First Supplemental Flexion Indenture&#x201d; and, together with the Original Flexion Indenture, the &#x201c;Flexion Indenture&#x201d;). The Flexion 2024 Notes have a maturity date of May 1, 2024, are unsecured, and accrue interest at a rate of 3.375% per annum, payable semi-annually on May 1 and November 1 of each year. Upon the Flexion Acquisition, the principal was assumed and recorded at fair value by the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion of the Flexion 2024 Notes, at the election of each holder thereof, each Flexion 2024 Note was convertible into cash, shares of Flexion&#x2019;s common stock, or a combination thereof, at Flexion&#x2019;s election, at a conversion rate of approximately 37.3413 shares of Flexion common stock per $1,000 principal amount of the Flexion 2024 Notes, which corresponded to an initial conversion price of approximately $26.78 per share of Flexion&#x2019;s common stock. As a result of the Flexion Acquisition, and in connection with the Notice (as defined below), holders of the Flexion 2024 Notes became entitled to certain Flexion Acquisition-related conversion and repurchase rights, as discussed below. In addition, as a result of the Flexion Acquisition and as discussed in more detail below, any future conversion rights are subject to the occurrence of any future events giving rise to such conversion rights under the Flexion Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 6, 2021, as a result of the Flexion Acquisition and in accordance with the Flexion Indenture, Flexion provided a Fundamental Change Company Notice and Offer to Purchase (the &#x201c;Notice&#x201d;) to the holders of the Flexion 2024 Notes and offered to repurchase for cash all of the outstanding Flexion 2024 Notes, at a repurchase price in cash equal to 100% of the principal amount of the Flexion 2024 Notes being repurchased, plus accrued and unpaid interest thereon to, but excluding, January 7, 2022, subject to the terms and conditions set forth therein. The offer to purchase expired at 5:00 p.m., New York City time, on January 6, 2022, as scheduled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any holder that did not exercise its repurchase right in accordance with the terms of the Notice retained the conversion rights associated with such holder&#x2019;s Flexion 2024 Notes under the Flexion Indenture. For conversion of Flexion 2024 Notes in connection with the Fundamental Change and the Make-Whole Fundamental Change (each as defined in the Flexion Indenture) resulting from the Flexion Acquisition, each $1,000 principal amount of the Flexion 2024 Notes was convertible into (i) $317.40 in cash and (ii) 37.3413 CVRs, based on the conversion rate of 37.3413, prior to 5:00 p.m., New York City time, on January 7, 2022. Alternatively, holders could retain their Flexion 2024 Notes and such Flexion 2024 Notes would remain outstanding subject to their existing terms, including with respect to a holder&#x2019;s right to receive interest payments on the Flexion 2024 Notes and exercise any future conversion rights that may arise under the Flexion Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 7, 2022, following the expiration of the offer to purchase, the Company accepted the $192.6&#160;million aggregate principal amount of Flexion 2024 Notes that were validly tendered (and not validly withdrawn). No Flexion 2024 Notes were converted in connection with the Notice. At June&#160;30, 2022, the remaining principal outstanding is $8.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes Due 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2017, the Company completed a private placement of $345.0 million in aggregate principal amount of 2.375% convertible senior notes due 2022, or 2022 Notes. The 2022 Notes accrued interest at a fixed rate of 2.375% per year, payable semiannually in arrears on April&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and October&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of each year. In July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $185.0&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $211.1&#160;million in cash (including accrued interest).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2022 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% convertible senior notes due April 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, the 2022 Notes matured and the Company settled the remaining outstanding principal balance of $160.0&#160;million and a conversion premium of $4.8&#160;million through a cash payment of $156.9&#160;million and the issuance of 101,521 shares of the Company&#x2019;s common stock, which increased additional paid-in capital by $3.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest and other (Note 6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate on total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Upon the adoption of ASU 2020-06 effective January 1, 2022, the Company eliminated the convertible debt discounts associated with the 2022 Notes and the 2025 Notes that were originally recorded as offsets to the embedded conversion features recognized in equity. Effective January 1, 2022, the Company will not record interest expense on the previously recorded discounts on convertible debt. The deferred financing costs previously allocated to the conversion features have since been re-allocated to the outstanding debt, slightly increasing the future annual amortization of deferred financing costs. For additional information regarding the adoption of ASU 2020-06, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NDk_388ab25e-bf27-4606-bf81-dbc821d9b6db">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company&#x2019;s outstanding debt is summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan B facility maturing December 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% Convertible senior notes due August 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375% Convertible senior notes due May 2024 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% Convertible senior notes due April 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The 2022 Notes (as defined below) matured on April 1, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMi0xLTEtMS04NjEyNw_9759b411-6fa8-465d-94f3-6edf04bf282f"
      unitRef="usd">352120000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMi0zLTEtMS04NjEyNw_d7950c04-300a-49e3-b71c-387f8b096317"
      unitRef="usd">359497000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i292cd08d718c48e594813938f2045cca_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMy0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOmM0N2VjMWRhMDlkMjQ3OTNhMjZkNWFlNGNkY2ZiZGU0XzQ_08083722-b88d-4d55-9843-1e806a021a79"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMy0xLTEtMS04NjEyNw_dfb583b4-5e95-4050-8d5b-b178a0f2643b"
      unitRef="usd">394894000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfMy0zLTEtMS04NjEyNw_4b34b8cd-d944-4a4a-975f-abed19f09229"
      unitRef="usd">330627000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8c9dded19a964d11981b36b085b753ff_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNC0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOmViYWMyYWRiMDdhYzQ2NmE5OTdmNzBhODAzZmUzZjIwXzQ_30d44774-68d6-4b77-aca4-65bea7f0f307"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id4d6abb8ceed479bada14abc5c7d6b1b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNC0xLTEtMS04NjEyNw_7c7d3c9f-7622-4439-bddb-9c92af0615ae"
      unitRef="usd">8640000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib7189f61d0f74daea85087e80f151740_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNC0zLTEtMS04NjEyNw_246dea42-f4ad-485a-a8eb-1185ff9e3b33"
      unitRef="usd">201249000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1e4c5d796d09442cacf138a186e3cdec_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNS0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOjg5Yzg4MGJjMTk5YjRjNzhhMGFjMjAyN2U4YjdiMDc0XzQ_dc1c42b4-f9d4-41eb-beec-1b9c9548d7e8"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNS0xLTEtMS04NjEyNw_ae3c1bea-c9f5-4153-8dd8-b2e2e2750823"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNS0zLTEtMS04NjEyNw_356281fc-903b-42b8-803a-9b6e803c3780"
      unitRef="usd">157857000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i356d1afe505c441eb90b0423c3fb17f2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNi0xLTEtMS04NjEyNw_e33fefd1-321d-4810-aa44-66aaa65a68c6"
      unitRef="usd">755654000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i86c516f1d6f04f26b3b01ed70a06cb25_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjk4M2U0YWIyZDNmZTQ1YzY4NWExN2YwMzk5Y2M4ZTdhL3RhYmxlcmFuZ2U6OTgzZTRhYjJkM2ZlNDVjNjg1YTE3ZjAzOTljYzhlN2FfNi0zLTEtMS04NjEyNw_7daed849-133f-4879-acce-ac4e2b822214"
      unitRef="usd">1049230000</us-gaap:LongTermDebt>
    <pcrx:DebtInstrumentDiscountRate
      contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDU5_19ee2992-6d52-4bfe-ad01-4d0f7ebf339a"
      unitRef="number">0.03</pcrx:DebtInstrumentDiscountRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNTUx_3c04caae-ed0e-44ef-902f-95de375580b6"
      unitRef="usd">375000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i7c5268d5a41d453387099bbdce493860_D20211201-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfOTYz_563ae9dc-677f-4580-b708-c37dee421bd5"
      unitRef="usd">363800000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ib78f8ec858814f8b9f80f0d166898244_I20211230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTAxMg_24fdda1e-b2da-4eb1-86ed-0cd5b170c85a"
      unitRef="usd">11200000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NTg_4b10bcd4-eb44-48bd-8c47-545eaf7ae072">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the Term Loan is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan maturing December 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2025 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% convertible senior notes due August 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2022 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% convertible senior notes due April 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfMi0xLTEtMS04NjEyNw_3e8738f8-eec2-4fc3-8ade-bee3f0489ec7"
      unitRef="usd">365625000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfMi0zLTEtMS04NjEyNw_b5fea520-9651-4df3-8923-8b540e23acd8"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfMy0xLTEtMS04NjEyNw_6cd76f18-72f9-4280-861a-0c6e240fcb69"
      unitRef="usd">3856000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfMy0zLTEtMS04NjEyNw_fe690a8e-8b71-41a5-ad83-afb84ee82539"
      unitRef="usd">4443000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfNC0xLTEtMS04NjEyNw_7282685b-1c40-4bdf-be49-ced549b507e5"
      unitRef="usd">9649000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfNC0zLTEtMS04NjEyNw_b609224d-eb0b-4cc1-8b0d-123af1f28fd3"
      unitRef="usd">11060000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfNS0xLTEtMS04NjEyNw_1dc13d67-d6bd-4439-bf2a-8fa4613a40c8"
      unitRef="usd">352120000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i125dd11a1f7244a59ed136faf48d4dc0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjBkN2VlY2NiMjhiNzQzMzM4NjdhM2YxZDIxZDVkMzQxL3RhYmxlcmFuZ2U6MGQ3ZWVjY2IyOGI3NDMzMzg2N2EzZjFkMjFkNWQzNDFfNS0zLTEtMS04NjEyNw_4fbc16ec-9902-4f3c-8860-6871a96af52b"
      unitRef="usd">359497000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="ie2012b55273641219ce287b6c7a3676c_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTE5Nw_9bd729ac-bc34-482f-bd1e-cf9984698549"
      unitRef="usd">9400000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="id396246417f747219b1efc00393a410a_D20251231-20251231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI0MA_4cac023d-8b22-4563-8b82-2e310d1431e1"
      unitRef="usd">14100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
      contextRef="i14cfaef699694c8aa95e5b1497db08f8_I20261207"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTMyMw_80431d53-9f56-4135-828f-c4ad2f26a267"
      unitRef="usd">188000000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <pcrx:DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NDc_d23c0392-8133-4dfa-b0e5-0242db0ecd9f"
      unitRef="payment">3</pcrx:DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i9713356e4b794cad87f61cdf66d71cda_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQyNw_5b6d2e29-f807-4443-a0ab-f50b76bb7242"
      unitRef="usd">28100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <pcrx:DebtInstrumentPrepaymentPenaltyPercentYear1
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTk4Nw_f0bd64ce-3d85-4233-bed3-d465eca7ae26"
      unitRef="number">0.02</pcrx:DebtInstrumentPrepaymentPenaltyPercentYear1>
    <pcrx:DebtInstrumentPrepaymentPenaltyPercentYear2
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMjA1MA_00f47175-6373-4ee2-adc6-83fe342edf3a"
      unitRef="number">0.02</pcrx:DebtInstrumentPrepaymentPenaltyPercentYear2>
    <pcrx:DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter
      contextRef="i4ea958f7cb56441bb8f52e823cc43b24_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMjA3OA_fc1c589a-47fc-437f-bbe6-9742e4f4209d"
      unitRef="number">0.01</pcrx:DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i8ba15de8dac143c1b4bc141eea541035_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzI5ODUzNDg5ODkxNw_7ca5cb1a-1032-454e-b449-faaffeccc2a6"
      unitRef="usd">9400000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i7f34a25fd03649ce9d8283d456471160_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzI5ODUzNDg5ODkxNw_f286d363-1699-4a5b-a27d-86cdbcbfd56b"
      unitRef="usd">9400000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <pcrx:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i9511fd772a33485880857ed5ca7d851a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMjQ2OQ_ba4ba165-862f-4cd2-b19b-c6cb15eea883"
      unitRef="number">1.75</pcrx:DebtInstrumentCovenantLeverageRatioMaximum>
    <pcrx:DebtInstrumentCovenantLeverageRatioMaximumValue
      contextRef="i9511fd772a33485880857ed5ca7d851a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMjUyMw_f12f5d74-2790-4ecb-b64e-13ec42e89ce0"
      unitRef="usd">150000000</pcrx:DebtInstrumentCovenantLeverageRatioMaximumValue>
    <pcrx:DebtInstrumentVariableRate
      contextRef="i4de17e595d074a81bcbe5f3e180aa7ae_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzA0OQ_083744c5-03ce-4770-9c25-f28946f76668"
      unitRef="number">0.0075</pcrx:DebtInstrumentVariableRate>
    <pcrx:DebtInstrumentBasisSpreadTwoOnVariableRate
      contextRef="iaae7a6225dc9403087ba9ca504bd5fb5_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzEwMQ_c6ac0bc8-062f-4458-a35e-a9abe8da8c78"
      unitRef="number">0.0700</pcrx:DebtInstrumentBasisSpreadTwoOnVariableRate>
    <pcrx:DebtInstrumentVariableRate
      contextRef="i31ba252e9c0a48188e8038d7fcbf3bc2_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzIzNQ_79c6e4f1-7fd6-4376-91d7-ee008c97c930"
      unitRef="number">0.0175</pcrx:DebtInstrumentVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="idb0b227a9c66456c9e5719df73099bd6_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzQyNA_0f59e1c1-49c2-44d4-8aa5-f5b2d144bce2"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pcrx:DebtInstrumentBasisSpreadOneOnVariableRate
      contextRef="iaae7a6225dc9403087ba9ca504bd5fb5_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzUxOQ_1c5b8244-4dff-4bad-845d-67dd43aa1fe1"
      unitRef="number">0.0100</pcrx:DebtInstrumentBasisSpreadOneOnVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if7caa5a1b4a74f499d82959cd49c6133_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzU5Ng_d83b267b-d0af-45c7-82df-38a0ea202fec"
      unitRef="number">0.0600</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i9511fd772a33485880857ed5ca7d851a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzcxNQ_8e584e10-e762-4d4e-b5d7-b6549c405e7a"
      unitRef="number">0.0781</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id3d5f239abc04c23a4020b220c65ce7b_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzgxMg_7a0f7267-ab1e-4ca7-b90c-b24ca520abb9"
      unitRef="usd">402500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id3d5f239abc04c23a4020b220c65ce7b_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzg1Mg_8f3239fc-2129-4e03-82a8-8747d3bad586"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id3d5f239abc04c23a4020b220c65ce7b_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDAzNw_0d675d7f-0a31-4d94-8a29-af422fdeb4e0"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMi0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOmI1NmFlNGY5ZDRlNTQ0YjU5OTRhNDExOGJjZWNjZTQ1XzQ_8af9fe3e-3d07-48d3-8f2f-35ec085409bc"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMi0xLTEtMS04NjEyNw_3ea6cb25-c508-4e27-8364-73f556c074d9"
      unitRef="usd">402500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMi0zLTEtMS04NjEyNw_652737d2-298a-4cb5-bc4d-d187c5350c81"
      unitRef="usd">402500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMy0xLTEtMS04NjEyNw_a98aaa6b-b6bf-4df8-87c4-61085c5b27c2"
      unitRef="usd">7606000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfMy0zLTEtMS04NjEyNw_149bb35d-02b6-42f4-8065-b478b336ab98"
      unitRef="usd">7155000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfNC0xLTEtMS04NjEyNw_5d9e876a-e100-4c77-951f-977914fa1187"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfNC0zLTEtMS04NjEyNw_b0619132-6c49-4f1f-bed7-869778837c1c"
      unitRef="usd">64718000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfNS0xLTEtMS04NjEyNw_7636ccef-c056-445a-8ae2-026190ed037d"
      unitRef="usd">394894000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i499d8cf29f8a4f2c9548fc82a6bce487_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjE1ZmMyODc5MDIyMDQxMGNiZmY1MGVmODk3NWVlNzkwL3RhYmxlcmFuZ2U6MTVmYzI4NzkwMjIwNDEwY2JmZjUwZWY4OTc1ZWU3OTBfNS0zLTEtMS04NjEyNw_10ec0389-2d62-4f52-b6f0-d3447b670d13"
      unitRef="usd">330627000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i6590fbf0d3a9462e9127e6b54ee201c6_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDMxNg_79972d23-0b1d-47b0-be00-796413bbf958"
      unitRef="usd">390000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="iccd912dc0b8b41f3bd7d557dac967d17_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDQ4NA_b87e5702-d57b-4212-ad2c-766827ffa8b4"
      unitRef="usd">185000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iccd912dc0b8b41f3bd7d557dac967d17_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDU0MQ_516aaca9-4f47-4034-b39a-bb564dc91212"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="iba8867ac2f1d4283b42fe8008031479f_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDYzMA_c8cc69c1-83ee-4635-a161-b212bac12404"
      unitRef="usd">211100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i15c1498310e443e7af3ba4aa7ad28e3a_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDkxMg_fe7d0016-c159-441e-91be-f5b2613a6a60"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i15c1498310e443e7af3ba4aa7ad28e3a_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDk2OA_4bfad832-8cc5-42a1-a7c4-ef3be804749b"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i15c1498310e443e7af3ba4aa7ad28e3a_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNDk4Nw_bb8ed561-fe75-4db3-98c0-5f3730a477b1"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <pcrx:SettlementPeriodConvertibleDebtConversionRequest
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNTQ3Nw_d4354c0d-8c54-4f7c-b711-f658b2663345">P40D</pcrx:SettlementPeriodConvertibleDebtConversionRequest>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i8fd9f584f9084e259a06bbfddce30195_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNTk0Ng_97c67561-b3c0-4257-821a-e97d0bb1181c"
      unitRef="usdPerShare">71.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock
      contextRef="i8fd9f584f9084e259a06bbfddce30195_I20200731"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNjIwMg_92d91af5-9662-4a0c-8014-c608234ba6d0"
      unitRef="number">0.325</pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock>
    <us-gaap:SharePrice
      contextRef="i8fd9f584f9084e259a06bbfddce30195_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNjIzNA_02216669-d4d8-492b-9e27-1bda6fbe774f"
      unitRef="usdPerShare">54.17</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ia62779f0fd434d20b021fcde6a57f24a_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNjg3MA_8e1dfae1-b216-4bc3-ab47-7193e129c450"
      unitRef="usd">402500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNzQ0Mg_316f8f70-c656-4ddc-9e2a-2d59b3184437"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNzUwOQ_e56af9eb-f0a3-4cc4-86a5-d857219a679a"
      unitRef="segment">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNzU2NQ_1f891dcc-5a0b-466e-b01e-791d9c4846c5"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice
      contextRef="i42b5b9370909456096ce4ed2becc1923_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfNzg0NQ_e7426b1f-1ab5-447c-940c-777f2b16fd10"
      unitRef="number">1</pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9395aa55649e4194b09292b57bc4118a_I20170502"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfOTEyOQ_d8106333-36ed-4f00-89cd-d2a17bb5cee4"
      unitRef="usd">201300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9395aa55649e4194b09292b57bc4118a_I20170502"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfOTE1Mg_b424f91d-a778-47cb-9f42-25e425ec34d8"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9395aa55649e4194b09292b57bc4118a_I20170502"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfOTcyMQ_ec310eb6-f685-41f6-896d-0d4829fadbbd"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i48e21d63eae54e80a8ef9375cebac9c5_I20170502"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTAzMDU_122ec762-60cd-4ac2-a1e0-112f8830c083"
      unitRef="usdPerShare">26.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice
      contextRef="i45a17b9799754d8382dc1b30711bd51f_D20211206-20220106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTExNzQ_b6d5942e-e17c-4841-a769-e55147c347a5"
      unitRef="number">1</pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="if3c970a4569147d397783bc1f4e7311d_I20211206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTE5NjM_0cf40794-4893-484f-903a-850c236a4d6c"
      unitRef="usdPerShare">317.40</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount
      contextRef="if3c970a4569147d397783bc1f4e7311d_I20211206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTE5ODM_4ad548cc-0a28-417d-98bd-a9ad9bbc3136"
      unitRef="shares">37.3413</pcrx:DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i991d1519897b4f2ea80c13d8da3de071_I20220107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI1MTU_67594dee-7958-4bf3-8e95-f4a4a72c8452"
      unitRef="usd">192600000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:LongTermDebt
      contextRef="id4d6abb8ceed479bada14abc5c7d6b1b_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI3Mzc_061cce1c-ea8d-4c09-ac9a-4812f5e9ad5c"
      unitRef="usd">8600000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i015d29a64d0646edbc9915f35b26c446_D20170301-20170331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI4MzU_f9e47d71-9ae3-4029-8d67-b2bdb92c78be"
      unitRef="usd">345000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib5b5fbc6d47e4f9f9e6d40924ce413db_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI4NzE_242199c9-468d-42cb-a286-15d318e6e75f"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib5b5fbc6d47e4f9f9e6d40924ce413db_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTI5NzU_e27b18c0-a7d4-4774-bce6-14bac6b0f4dd"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="iccd912dc0b8b41f3bd7d557dac967d17_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTMxODk_d5b9e5c3-55f1-4f09-8420-51512088974e"
      unitRef="usd">185000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:RepaymentsOfDebt
      contextRef="iba8867ac2f1d4283b42fe8008031479f_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTMyOTQ_e8284e9c-f75c-461c-84cd-24895adea058"
      unitRef="usd">211100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMi0wLTEtMS04NjEyNy90ZXh0cmVnaW9uOjk2OTExZDUwMzU1MDQ2ZTViMTM5YWY4NjA2MWQxZDZlXzQ_3be6f422-c2f3-43df-b57a-a6986f8ff47c"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMi0xLTEtMS04NjEyNw_d8541d89-3898-478b-95dc-d0f31f6ff2e0"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMi0zLTEtMS04NjEyNw_6ba2227d-88d3-4e08-b353-24cc175bd3bd"
      unitRef="usd">160000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMy0xLTEtMS04NjEyNw_d5e8d298-659e-4fa0-a8e8-4876d917052a"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfMy0zLTEtMS04NjEyNw_4a326d56-bb5d-4551-8724-e5df4e870f13"
      unitRef="usd">223000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfNC0xLTEtMS04NjEyNw_381dc0c2-b6f4-4391-9e0b-63caa439d3e9"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfNC0zLTEtMS04NjEyNw_fd74c709-2fd9-4b3a-bf94-cdd336743c09"
      unitRef="usd">1920000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="ic4d33b17a5274f13a184a1ac6ec91b38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfNS0xLTEtMS04NjEyNw_62f41748-cf1a-461f-b9bc-1db5dd36b96f"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if76738e63d8a4e2ca86812f5bc97e3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjc0NWYxYTliYTg0OTRmOGVhZTJlZGUwNzZkMDFiODk4L3RhYmxlcmFuZ2U6NzQ1ZjFhOWJhODQ5NGY4ZWFlMmVkZTA3NmQwMWI4OThfNS0zLTEtMS04NjEyNw_e1d47c9b-64e8-4abb-b5f7-87ce15d82da6"
      unitRef="usd">157857000</us-gaap:LongTermDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="idecdb2c3fc1449cfab60ca69c9d1fe48_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTM1Mzg_b3d508b3-bd28-4012-a152-22a6a06555a6"
      unitRef="usd">160000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="idecdb2c3fc1449cfab60ca69c9d1fe48_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTM1Njk_cd25b35c-4c65-427f-8e3d-8692cc6b22e9"
      unitRef="usd">-4800000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:RepaymentsOfDebt
      contextRef="idecdb2c3fc1449cfab60ca69c9d1fe48_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTM1OTg_22fa83f5-1b34-4904-9aed-d01e247ba085"
      unitRef="usd">156900000</us-gaap:RepaymentsOfDebt>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i37476438df894c20a4bc4a280d425eb6_D20220401-20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTM2MjE_ec934203-fdaa-4930-b528-e8b2c513962b"
      unitRef="shares">101521</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i37476438df894c20a4bc4a280d425eb6_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMzI5ODUzNDg5ODY3Nw_a6287182-b963-4d23-aa22-f0a5d468c1ba"
      unitRef="usd">3000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <pcrx:ScheduleOfInterestExpenseTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RleHRyZWdpb246NmE2NTYyNTUzYmJjNGViZGFmMGI2YjI4YzdmNmNhMDBfMTQ1NTM_99e113c2-3b1d-4035-a29f-035c9247bb50">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest and other (Note 6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate on total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pcrx:ScheduleOfInterestExpenseTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMi0xLTEtMS04NjEyNw_8db87a00-ef9c-4a9a-853c-73fdc4e114ca"
      unitRef="usd">8196000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMi0zLTEtMS04NjEyNw_94584ae9-328f-4bfa-ab4b-29d4ed8c9cd9"
      unitRef="usd">1713000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMi01LTEtMS04NjEyNw_632c66a5-6ecb-4e2d-9158-630875a1b6c6"
      unitRef="usd">17381000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMi03LTEtMS04NjEyNw_3eac5ca4-9846-4710-9b84-437f00b46e79"
      unitRef="usd">3418000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMy0xLTEtMS04NjEyNw_c48c67c2-4578-4b84-9178-b45a450c438d"
      unitRef="usd">874000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMy0zLTEtMS04NjEyNw_045a0f16-9971-44fd-a441-dd23c17dfaa8"
      unitRef="usd">659000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMy01LTEtMS04NjEyNw_d24ceda7-cd5d-4a6a-8327-d5bac237e504"
      unitRef="usd">2053000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfMy03LTEtMS04NjEyNw_fbfc63cd-649e-42b5-b7fa-754126c89aeb"
      unitRef="usd">1310000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNC0xLTEtMS04NjEyNw_093a81c0-7f33-434a-ae56-3a660d9a446c"
      unitRef="usd">706000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNC0zLTEtMS04NjEyNw_76f08d47-2924-4c5c-b2f3-dd52c88422ef"
      unitRef="usd">5744000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNC01LTEtMS04NjEyNw_0fe67130-45b8-4c3f-a318-be9bdde233bf"
      unitRef="usd">1412000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNC03LTEtMS04NjEyNw_01b6e3ef-54b4-4191-ab35-0dae64b9370f"
      unitRef="usd">11401000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestCostsCapitalized
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNS0xLTEtMS04NjEyNw_25bef7c4-1fd6-469d-bfa7-ffc1f982c0de"
      unitRef="usd">943000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNS0zLTEtMS04NjEyNw_77f2ce50-c0a2-4e51-a509-960fbb97b040"
      unitRef="usd">1093000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNS01LTEtMS04NjEyNw_d9b4b20d-e412-4d50-8b60-36306ced48f4"
      unitRef="usd">1767000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNS03LTEtMS04NjEyNw_25337d2f-6653-4e06-ad2f-f0e598f55a7d"
      unitRef="usd">2135000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestExpenseDebt
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNi0xLTEtMS04NjEyNw_57ec4993-5ada-45f1-b74b-d61c7b65766e"
      unitRef="usd">8833000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNi0zLTEtMS04NjEyNw_563dae65-17ca-426a-b1b4-c8202d584f13"
      unitRef="usd">7023000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNi01LTEtMS04NjEyNw_c32bfd94-bd1d-40a3-955c-463383f593e1"
      unitRef="usd">19079000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfNi03LTEtMS04NjEyNw_91158b52-d149-4aa4-a601-a91877afc505"
      unitRef="usd">13994000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfOC0xLTEtMS04NjEyNw_ee03ed62-9f0e-42b4-bf9f-28217d588395"
      unitRef="number">0.0508</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfOC0zLTEtMS04NjEyNw_314dc274-c2f4-41ce-935c-fa7034da6447"
      unitRef="number">0.0670</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfOC01LTEtMS04NjEyNw_e64d4c45-28bb-4dbf-815d-5d98efb44a8a"
      unitRef="number">0.0531</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182MS9mcmFnOjZhNjU2MjU1M2JiYzRlYmRhZjBiNmIyOGM3ZjZjYTAwL3RhYmxlOjNiZDY5ZjM5MWRkMzQ4ZGZiZDVhY2YwYWQxMWFkMmUzL3RhYmxlcmFuZ2U6M2JkNjlmMzkxZGQzNDhkZmJkNWFjZjBhZDExYWQyZTNfOC03LTEtMS04NjEyNw_5536f1cf-1ddd-4f5f-9faf-a3e8ec925ce4"
      unitRef="number">0.0670</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE5MA_743896e6-1393-416b-b07b-16daf913c0a1">FINANCIAL INSTRUMENTS&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#x2019;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#x2019;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amounts of equity investments and convertible notes receivable without readily determinable fair values have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Acquisition-related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Liabilities Measured at Amortized Cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan facility due December 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,562.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;0.750% convertible senior notes due 2025 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;3.375% convertible senior notes due 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The closing price of the Company&#x2019;s common stock as reported on the Nasdaq Global Select Market was $58.30 per share at June&#160;30, 2022 compared to a conversion price of $71.78 per share. Therefore, at June&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is 5.6&#160;million shares of the Company&#x2019;s common stock, which assumes no increase in the conversion rate for certain corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity and Convertible Note Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds strategic investments in clinical and preclinical stage privately-held biotechnology companies in the form of equity and convertible note investments. The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Convertible Notes Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-Related Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has recognized contingent consideration related to the Flexion Acquisition and the MyoScience Acquisition in the amount of $35.2&#160;million and $57.6&#160;million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. The Company&#x2019;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rates used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Company completed the Flexion Acquisition, which provided for contingent consideration related to CVRs that were issued to Flexion shareholders and certain equity award holders which could aggregate up to a total of $425.5&#160;million if certain regulatory and commercial milestones are met. The Company&#x2019;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2030, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $45.2&#160;million, which represented the Company&#x2019;s potential achievement of meeting the regulatory and commercial milestones. For the period from the date of the Flexion Acquisition through December 31, 2021, the Company recorded an additional $1.2&#160;million liability. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recorded gains of $12.5&#160;million and $13.3&#160;million, respectively, primarily due to adjustments to near-term forecasts for the earnout period of the contingent consideration. These adjustments were recorded as acquisition-related gains in the condensed consolidated statements of operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; At June&#160;30, 2022, the weighted average discount rate was 13.5% and the weighted average probability of success for regulatory milestones was 11.1%. As of June&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the Flexion Acquisition was recognized in the amount of $33.1&#160;million and $46.4&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $100.0 million upon the achievement of certain regulatory and commercial milestones. The Company&#x2019;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As of June&#160;30, 2022, the maximum potential remaining milestone payments to be paid are $43.0&#160;million. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized contingent consideration gains of $8.8&#160;million and $9.0&#160;million during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively, due to the reduced probability of meeting the contingent consideration milestones by December 31, 2023, the expiration date for achieving the milestones. The Company recognized a $0.1&#160;million contingent consideration charge and a $1.0&#160;million gain during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended June 30,&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, the weighted average discount rate was 12.5% and the probability of success for the regulatory milestone that has not yet been met was reduced to zero. As of June&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $2.1&#160;million and $11.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the key assumptions used in the valuation of the Company&#x2019;s contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Flexion Ranges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Utilized as of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;MyoScience Ranges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Utilized as of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.64% to 14.37%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.69% to 13.34%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probabilities of payment for regulatory milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5% to 15%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected years of payment for regulatory and commercial milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 to 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the Company&#x2019;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Fair value adjustments and accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available-for-Sale Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate and government bonds with maturities greater than three months, but less than one year. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#x2019;s short-term investments are reported in other comprehensive income (loss). At June&#160;30, 2022 and December&#160;31, 2021, all of the Company&#x2019;s short-term investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term investments had an &#x201c;A&#x201d; or better rating by Standard&#160;&amp;amp; Poor&#x2019;s.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the Company&#x2019;s short-term available-for-sale investments at June&#160;30, 2022 and December&#160;31, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June&#160;30, 2022 Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;U.S. Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021 Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, there were no investments available for sale that were materially less than their amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elects to recognize its interest receivable separate from its available-for-sale investments. At June&#160;30, 2022 and December&#160;31, 2021, the interest receivable recognized in prepaid expenses and other current assets was $0.2&#160;million and $0.1&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term available-for-sale investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;As of June&#160;30, 2022, three wholesalers each accounted for over 10% of the Company&#x2019;s accounts receivable, at 34%, 17% and 17%. At December&#160;31, 2021, four wholesalers each accounted for over 10% of the Company&#x2019;s accounts receivable, at 30%, 20%, 17% and 11%. For additional information regarding the Company&#x2019;s wholesalers, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. EXPAREL and ZILRETTA revenues are primarily derived from major wholesalers and specialty distributors that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the Company&#x2019;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of June&#160;30, 2022 and December&#160;31, 2021, the Company did not deem any allowances for credit losses on its accounts receivable necessary.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE5MQ_0fdb7988-587e-4455-98f5-f48493ee0834">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Acquisition-related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Liabilities Measured at Amortized Cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan facility due December 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,562.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;0.750% convertible senior notes due 2025 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;3.375% convertible senior notes due 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The closing price of the Company&#x2019;s common stock as reported on the Nasdaq Global Select Market was $58.30 per share at June&#160;30, 2022 compared to a conversion price of $71.78 per share. Therefore, at June&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is 5.6&#160;million shares of the Company&#x2019;s common stock, which assumes no increase in the conversion rate for certain corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i2e4721a6974c47a4b2d7646849bd93fd_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNC0yLTEtMS04NjEyNw_b0501368-a884-44c3-b8c7-b1bea5297833"
      unitRef="usd">25627000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i2c8cd2acac994e3fb138accb3626a770_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNC00LTEtMS04NjEyNw_68a7260d-a43e-4be2-b1ca-dfd943066a8b"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="id24058253a50408188a9e11bcb502ad1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNC02LTEtMS04NjEyNw_cf121e72-17eb-4f99-9840-d368558dad74"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i0a50652bf64e4acb8120bf54d9198e87_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNC04LTEtMS04NjEyNw_e72ba06d-b9c2-4e71-929b-c06fb38b9465"
      unitRef="usd">25627000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i2e4721a6974c47a4b2d7646849bd93fd_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNS0yLTEtMS04NjEyNw_73e6d357-46d5-4ad3-b9d2-b7825604bdbd"
      unitRef="usd">5299000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i2c8cd2acac994e3fb138accb3626a770_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNS00LTEtMS04NjEyNw_53a63687-ca56-471b-abcf-d66517ca8bb4"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="id24058253a50408188a9e11bcb502ad1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNS02LTEtMS04NjEyNw_5cb6d0b9-a2a2-4422-abf5-3bfb0cf66dca"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i0a50652bf64e4acb8120bf54d9198e87_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNS04LTEtMS04NjEyNw_3020c442-6a52-4be2-a111-4e4aefa432c8"
      unitRef="usd">5299000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2e4721a6974c47a4b2d7646849bd93fd_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNy0yLTEtMS04NjEyNw_cbddc29d-5e8a-4a91-8aae-8a8bfa32a140"
      unitRef="usd">35247000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2c8cd2acac994e3fb138accb3626a770_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNy00LTEtMS04NjEyNw_a67e5289-a884-42be-a662-aa765771da32"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id24058253a50408188a9e11bcb502ad1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNy02LTEtMS04NjEyNw_d103e3d2-ca47-42bb-bb65-1f7f903768e7"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0a50652bf64e4acb8120bf54d9198e87_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfNy04LTEtMS04NjEyNw_2611fe26-f46e-488c-a62d-b213eb741543"
      unitRef="usd">35247000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib8e4e6f04e6b4ff791a9370ec1559121_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTAtMi0xLTEtODYxMjc_24b7ef9b-5887-466b-8117-e748de552cf4"
      unitRef="usd">352120000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6b8cad7de1da4c2db70aedc902c27e25_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTAtNC0xLTEtODYxMjc_0a84f055-2991-4c90-9eb6-d0c52c087dcb"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i16c8b9c91dac49cca9cd3167f0c77333_I20220630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTAtNi0xLTEtODYxMjc_30bef4da-a48a-4537-8ecf-45b3e6145a90"
      unitRef="usd">366562500</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i87be4045b1ee4290b6f4d157746a446a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTAtOC0xLTEtODYxMjc_83197300-2b2e-4757-9f54-46989d3867e6"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjplZjc4N2VmMzU0MTg0ODM0YjI4ZDI0NWUwOTY5Zjg3Yl83_a0fc1891-adf4-4462-850b-c01dccdce592"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ifb17c50c746a4fb99da95cf89348f9ce_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtMi0xLTEtODYxMjc_394262a1-5948-4cf9-ae1a-a8617cc37d02"
      unitRef="usd">394894000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie68e64f1b5724490a26fff0a570e6bba_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtNC0xLTEtODYxMjc_2211d889-ef7b-4e7b-89f5-ed86e16885e6"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i724c52c24b4d431f9f6b2362fdc0f0e1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtNi0xLTEtODYxMjc_760fc1f9-6631-4059-ab40-e0f8ad433352"
      unitRef="usd">417855000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ieede5540398c4dc58694079e2fb20f85_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTEtOC0xLTEtODYxMjc_0d4f7a6a-2bd4-4552-a6a7-2ec0dcded990"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4904ad55b53844fba2ec392689cda980_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItMC0xLTEtODYxMjcvdGV4dHJlZ2lvbjoyYzFmNzAyMDhlOGI0ZGU4OGI1MzY2MzJhYzkzZTMzYl83_e5c62a3d-acba-4867-b3c5-e425e0d17363"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if52a538e2d054df5b39586e4fac623ae_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItMi0xLTEtODYxMjc_60ea7bc0-57d2-4948-8e60-58e74361e2c7"
      unitRef="usd">8640000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idea088cac0574f4bb8455403924088b6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItNC0xLTEtODYxMjc_bf6e361e-5eb3-4477-ba78-cf9f39bef113"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic2c7ec07806341f485488028d8ebbf96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItNi0xLTEtODYxMjc_68f8a204-ba3b-4059-b42d-4841ba83357f"
      unitRef="usd">8606000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2055f75ada8d436fb802dc413014b5c1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiNzkzYjJiZWI0NzQyYTQ5ZTM5YTZiYzkwMjdlMzZhL3RhYmxlcmFuZ2U6ZGI3OTNiMmJlYjQ3NDJhNDllMzlhNmJjOTAyN2UzNmFfMTItOC0xLTEtODYxMjc_aebf8413-b394-424d-8334-769a41e48bf7"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SharePrice
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzI5ODUzNDg5NDE3OQ_83ea961e-c13f-473a-94e2-ea603ca6617f"
      unitRef="usdPerShare">58.30</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i292cd08d718c48e594813938f2045cca_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzI5ODUzNDg5NDE4OA_51ab3fe4-fbd3-49bc-8e88-787bf8fb366c"
      unitRef="usdPerShare">71.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentConvertibleConversionPremiumShares
      contextRef="ib5f5585697664021b9b028fc12de735e_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzI5ODUzNDg5NDMxMw_68b0375f-8759-4ec2-adfc-ec45caa795de"
      unitRef="shares">5600000</pcrx:DebtInstrumentConvertibleConversionPremiumShares>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE3Mw_84863492-b87e-4899-8b41-39fb2e674da3">The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Convertible Notes Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i8ba288a5b7ff409c940d4b0449afb0cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMS0xLTEtMS04NjEyNw_bcc106da-3b2b-49a9-8db3-c1972807e393"
      unitRef="usd">14127000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i8e03211b48e14029b06e9f14140d2baa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMS0zLTEtMS04NjEyNw_d0f59ed2-bb62-4e1c-a808-658dda96729a"
      unitRef="usd">4132000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMS01LTEtMS04NjEyNw_e05ea6e5-6928-4a70-8613-2600b56a3b4c"
      unitRef="usd">18259000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i6c295ad4598945c2ba9f47a504b4472c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMi0xLTEtMS04NjEyNw_7f77b269-959f-4708-99bc-3df18cfcc76d"
      unitRef="usd">11500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ia819f5487dbc4bb38b0e991835be6ef0_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMi0zLTEtMS04NjEyNw_1df5f88e-b73e-4918-8c77-d95b952e6155"
      unitRef="usd">1250000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMi01LTEtMS04NjEyNw_f2520559-5b8e-4541-b607-5f31b74c4415"
      unitRef="usd">12750000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="i6c295ad4598945c2ba9f47a504b4472c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMy0xLTEtMS04NjEyNw_71010232-2c51-4925-a5a3-0ad398982be7"
      unitRef="usd">0</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="ia819f5487dbc4bb38b0e991835be6ef0_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMy0zLTEtMS04NjEyNw_d59f7693-064c-4d18-9cd5-c6cd748fc64b"
      unitRef="usd">-83000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfMy01LTEtMS04NjEyNw_e85db494-b7e4-4c61-8bd1-d1c10f2cda08"
      unitRef="usd">-83000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ic59e7ba74b4b45cfab0ae29982cc8e9d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfNC0xLTEtMS04NjEyNw_8b34dde1-e465-4573-899d-9b860f74da5b"
      unitRef="usd">25627000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i0c4255beee6d40db938f1050821cc199_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfNC0zLTEtMS04NjEyNw_03262d62-d789-472a-bbb7-e60d15f905e3"
      unitRef="usd">5299000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjJjNmVhYzIxNDE5MTQ1YjdhMWY4MTZjZmYwZGExZmJlL3RhYmxlcmFuZ2U6MmM2ZWFjMjE0MTkxNDViN2ExZjgxNmNmZjBkYTFmYmVfNC01LTEtMS04NjEyNw_98002036-8320-4785-9a6b-0dd6df4bd95d"
      unitRef="usd">30926000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i65bfea142670495289d5c647467570b9_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzA1Nw_553da366-94b6-4ab4-af31-a3406220bf8f"
      unitRef="usd">35200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1587b3c1d7e7411cbd588e6bc0bfb723_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzA2NA_547aa9ed-6918-4337-a837-2c237534c50c"
      unitRef="usd">57600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0fc8018e6ec54834baf8d0e5d5a8d0db_I20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDM5ODA0NjUyNDE5OQ_5e9dab1f-42e8-4b37-a4e5-7521734ddc11"
      unitRef="usd">425500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <pcrx:ContingentConsiderationPaymentTerm
      contextRef="i4f0c78a9972546d4a4bf2bfb19a1c536_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDM5ODA0NjUyNDYyNA_0cb50947-8813-4679-ba6f-90250cfac2fc">P60D</pcrx:ContingentConsiderationPaymentTerm>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4f0c78a9972546d4a4bf2bfb19a1c536_D20211119-20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDEyNw_e85316bb-0554-4f8b-bc2b-9acc07e078cc"
      unitRef="usd">45200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0d717792cb904a9c8671026179052f91_D20211119-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDM1Mg_607c3a74-d134-472c-a61e-991a283a150e"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6168e02aa26e4349847195bf09c3eacf_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzI5ODUzNDg5NDg1NQ_7c1f9b0e-1e78-455c-8c03-c42a2c6aa9e9"
      unitRef="usd">-12500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i21ca7a53ce30416b93b74cd8a9870e74_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDUwMg_888aabca-5795-49af-a3f0-aac8a1e31b45"
      unitRef="usd">-13300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i0c49317fb1254c648300f85c536d596a_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDc0Mg_193c0b71-93e9-4d32-9e55-fd38f5d9d82a"
      unitRef="number">0.135</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i9835d59ac7914259affd398b5712be27_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDgyMw_e75b90e2-b146-442d-9cbb-8f495dad5525"
      unitRef="number">0.111</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4c963cd0f8b24890b29f01580d4dafa6_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDk0OA_d5ec9855-8fb6-4896-a36a-6e7e09270c29"
      unitRef="usd">33100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3e462270f4d749ada2b41a121bfaaf93_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNDk1NQ_2ec934e5-2397-4b8c-923e-0cef04663715"
      unitRef="usd">46400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <pcrx:ContingentConsideration
      contextRef="i59c47ce6aa614060975818db7878464b_D20190401-20190430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTE2OQ_7632f391-0852-4cfe-ac9d-87acb556df34"
      unitRef="usd">100000000</pcrx:ContingentConsideration>
    <pcrx:ContingentConsiderationPaymentTerm
      contextRef="i59c47ce6aa614060975818db7878464b_D20190401-20190430"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTM4Nw_c4960dcd-2ba1-4b37-8704-eaf9dcc975a2">P60D</pcrx:ContingentConsiderationPaymentTerm>
    <pcrx:ContingentConsiderationCurrent
      contextRef="ic35614cca1f842c6b25edec7754b753e_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTUyMA_801f4245-bade-40d5-b926-88eafec97e6a"
      unitRef="usd">43000000</pcrx:ContingentConsiderationCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8b2f0c4184a8447cb9800ac82b098ef2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzg0ODI5MDcwNjg1NQ_5a7dd1df-55b2-468f-9252-ccaa23ed56e7"
      unitRef="usd">-8800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ie60dfafd369d49e9a8915074448de244_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzg0ODI5MDcwNjg2OQ_5077d286-f5c1-4268-aefe-eda06d4083d7"
      unitRef="usd">-9000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1f238205c3474a579a6577a0cfb931fc_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzg0ODI5MDcwNzM2Mw_b46c23de-4d4a-45cd-a9d1-780d9084bcb9"
      unitRef="usd">100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib55aafc43f234774b601b8faca0c6b5d_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfMzg0ODI5MDcwNzM3Nw_d787ba3c-47ad-4a77-8da1-c06e8eb2d409"
      unitRef="usd">-1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i15a06e8c3c614623bffeb6e3b147f2bf_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTY5Ng_12d62eab-4fd0-4466-a99e-51784f546729"
      unitRef="number">0.125</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i77eaafc589a34116b77b15bbc4fff3e5_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTc4OQ_dc246fa9-5b93-4061-88b0-a9f9f3c75986"
      unitRef="number">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic35614cca1f842c6b25edec7754b753e_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTkyMw_9a115be6-4f4c-4957-9beb-61b335b95b96"
      unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2efee5eb27da4de2a1ed8e6d5e6eecd3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNTkzMA_59cabb01-8aca-490a-996f-9ec01e8f07f7"
      unitRef="usd">11200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE5OA_f4f711dc-1398-4ce5-89a0-e278dc7c84f4">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the key assumptions used in the valuation of the Company&#x2019;s contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Flexion Ranges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Utilized as of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;MyoScience Ranges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Utilized as of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.64% to 14.37%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.69% to 13.34%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probabilities of payment for regulatory milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5% to 15%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected years of payment for regulatory and commercial milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 to 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="iebe6ca8b87dc455e8cbf5d62768fb93d_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMS0yLTEtMS04NjEyNy90ZXh0cmVnaW9uOmNkY2U0YTEwNWRlNTRmYmY4NDk0M2FkNjQ1ZjVjMGJmXzQ_ff25539e-9b92-4842-a8f0-79875a957dfe"
      unitRef="number">0.1264</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="iee968166c6e54c399c9428c7ce8b8057_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMS0yLTEtMS04NjEyNy90ZXh0cmVnaW9uOmNkY2U0YTEwNWRlNTRmYmY4NDk0M2FkNjQ1ZjVjMGJmXzEw_5e97acca-b9ed-47f2-85f5-6e5cb5f2c0a1"
      unitRef="number">0.1437</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="idc02a21d3efb40b2a085eac6cf253ef8_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMS00LTEtMS04NjEyNy90ZXh0cmVnaW9uOjFkMTQ3ZjE3NmFkYTQ2ZTU5NDVjMmFhMTYxMmMzMjM0XzQ_12e5cb34-2e4e-4f94-ad64-d0b65288b16c"
      unitRef="number">0.1169</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i0a822b3a761c4bf49157f47c28748111_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMS00LTEtMS04NjEyNy90ZXh0cmVnaW9uOjFkMTQ3ZjE3NmFkYTQ2ZTU5NDVjMmFhMTYxMmMzMjM0XzEw_f8c04ddc-6aff-4f98-a476-6f7e2c1fee08"
      unitRef="number">0.1334</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i55e627016d97492ba0681471fbd8968c_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMi0yLTEtMS04NjEyNy90ZXh0cmVnaW9uOjMwNmFlNzg0NjQwYzQzMTZhN2VlOTJkNDM2NjRiYzVmXzQ_44159c69-6228-4ecb-8c58-6ac03f8a050f"
      unitRef="number">0.05</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i6f80639d084b4aa89ec55b9178bb46a1_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMi0yLTEtMS04NjEyNy90ZXh0cmVnaW9uOjMwNmFlNzg0NjQwYzQzMTZhN2VlOTJkNDM2NjRiYzVmXzEw_c2998d16-77e3-4cf3-a0fd-3c222e2aca66"
      unitRef="number">0.15</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i9a5bb2973c6b4c96abe3db554e6d078f_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjY4YTBkMTczMTM3NTRjODJhYjBlYWE4MmI4M2FmZDBkL3RhYmxlcmFuZ2U6NjhhMGQxNzMxMzc1NGM4MmFiMGVhYTgyYjgzYWZkMGRfMi00LTEtMS04NjEyNy90ZXh0cmVnaW9uOmJkMzMxYzNhNjQ2OTQxYjM5ZGMxYTk1M2VhMjM3N2U5XzQ_d1d84001-28eb-44e0-a655-cb39b66ffcb6"
      unitRef="number">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE4Mw_ddb86435-9eff-4c00-a814-8271d3133e34">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the Company&#x2019;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Fair value adjustments and accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iee16b76f339b45f1bc4250ddc76ad052_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjAyZDljOWE4ODljNDQ4Yjg5ZTFhZTZiMjg2NDNiMjAzL3RhYmxlcmFuZ2U6MDJkOWM5YTg4OWM0NDhiODllMWFlNmIyODY0M2IyMDNfMS0yLTEtMS04NjEyNw_0d4f6f03-6a23-4074-a546-28709cd6e845"
      unitRef="usd">57598000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="idd89bb1f4f08443fb61357d5cf825054_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjAyZDljOWE4ODljNDQ4Yjg5ZTFhZTZiMjg2NDNiMjAzL3RhYmxlcmFuZ2U6MDJkOWM5YTg4OWM0NDhiODllMWFlNmIyODY0M2IyMDNfMy0yLTEtMS04NjEyNw_1c28b134-549d-49eb-8bc2-f080e782c924"
      unitRef="usd">22351000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0afc326973624dedabbf6ad485dfc1e5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjAyZDljOWE4ODljNDQ4Yjg5ZTFhZTZiMjg2NDNiMjAzL3RhYmxlcmFuZ2U6MDJkOWM5YTg4OWM0NDhiODllMWFlNmIyODY0M2IyMDNfNi0yLTEtMS04NjEyNw_57c88513-f62d-4fd4-b09d-b4fc595bdd11"
      unitRef="usd">35247000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTE3MQ_54e4792d-7858-4c97-b1df-9e5f82071c76">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the Company&#x2019;s short-term available-for-sale investments at June&#160;30, 2022 and December&#160;31, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June&#160;30, 2022 Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;U.S. Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021 Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i710e2f14bbb34bba99311d3b4e837f2f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMi0yLTEtMS04NjEyNw_50f7ba4c-9e88-4286-ad19-39dcc2b5eec7"
      unitRef="usd">30906000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i710e2f14bbb34bba99311d3b4e837f2f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMi00LTEtMS04NjEyNw_fc578883-ab80-4532-b09c-9ab19886e9de"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i710e2f14bbb34bba99311d3b4e837f2f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMi02LTEtMS04NjEyNw_c239b135-da2e-4d63-8519-191b88dc877b"
      unitRef="usd">239000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i710e2f14bbb34bba99311d3b4e837f2f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMi04LTEtMS04NjEyNw_4fc53981-bcde-4387-b699-026d38b60d6d"
      unitRef="usd">30667000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icf3fcd52747443ab910304b3bdf6b6e8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMy0yLTEtMS04NjEyNw_fbb0d939-ebfb-48b1-94c6-3bfd1bc4b9cc"
      unitRef="usd">138705000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icf3fcd52747443ab910304b3bdf6b6e8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMy00LTEtMS04NjEyNw_f68cf23b-b03b-4983-8358-2b8c72f2cd96"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icf3fcd52747443ab910304b3bdf6b6e8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMy02LTEtMS04NjEyNw_3a3ad7b4-b433-48e0-9dab-521c93ecb5a3"
      unitRef="usd">796000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf3fcd52747443ab910304b3bdf6b6e8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMy04LTEtMS04NjEyNw_08705f89-ff64-4b3d-a7a6-1e8022be1a4b"
      unitRef="usd">137909000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifd1f2abc0e78467d927adac6fa878af8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNC0yLTEtMS04NjEyNw_1cd2d700-10a1-4ed0-8f2c-9a78f5320982"
      unitRef="usd">6288000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifd1f2abc0e78467d927adac6fa878af8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNC00LTEtMS04NjEyNw_530eff9a-c979-4666-ad87-483504ddbd74"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifd1f2abc0e78467d927adac6fa878af8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNC02LTEtMS04NjEyNw_7ce8aa90-9735-4564-ba82-f992e44a1c0a"
      unitRef="usd">31000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd1f2abc0e78467d927adac6fa878af8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNC04LTEtMS04NjEyNw_94f64b02-6066-4007-9d5c-4073f2f6648b"
      unitRef="usd">6257000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idc2e8e031b6c4f349a9a22d1b983860b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNS0yLTEtMS04NjEyNw_b2c22152-2360-4c30-a788-8df8f7b9f41d"
      unitRef="usd">19531000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idc2e8e031b6c4f349a9a22d1b983860b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNS00LTEtMS04NjEyNw_dc3e8a04-b561-4ada-a612-6cf86e8cd804"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idc2e8e031b6c4f349a9a22d1b983860b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNS02LTEtMS04NjEyNw_3a26f712-ae83-45ea-8b1a-90ec7f3b3d88"
      unitRef="usd">32000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idc2e8e031b6c4f349a9a22d1b983860b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfNS04LTEtMS04NjEyNw_6b10abfa-c8bb-487e-8d22-0bfa05ee2e1f"
      unitRef="usd">19499000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMTItMi0xLTEtODYxMjc_d61cfb41-fd30-4d70-ae57-9aaac23d1d44"
      unitRef="usd">195430000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMTItNC0xLTEtODYxMjc_eb97dfb5-308e-4ff1-a393-b91b60987526"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMTItNi0xLTEtODYxMjc_c7fb54b0-c465-4fa9-8775-0a05553084b7"
      unitRef="usd">1098000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOmRiMjcyMDgxMGQ2MzRhNGQ5ZWQzYmE4Zjk3ZDU2YjJmL3RhYmxlcmFuZ2U6ZGIyNzIwODEwZDYzNGE0ZDllZDNiYThmOTdkNTZiMmZfMTItOC0xLTEtODYxMjc_01bedff7-27ea-464d-af26-a7f49e0d70b7"
      unitRef="usd">194332000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i93ff7976ca834ff8be1fb773760bf3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMi0yLTEtMS04NjEyNw_a5d2417e-e6a2-4d2e-9209-34c5cb8bd05b"
      unitRef="usd">3182000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i93ff7976ca834ff8be1fb773760bf3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMi00LTEtMS04NjEyNw_1c7d53e5-4b7b-4cc4-a28e-87591efdcd2a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i93ff7976ca834ff8be1fb773760bf3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMi02LTEtMS04NjEyNw_ead44572-10ad-49a0-85e6-03cb4f5f1b00"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i93ff7976ca834ff8be1fb773760bf3ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMi04LTEtMS04NjEyNw_8107347e-e2db-448e-ada6-d4cba7d9bc1d"
      unitRef="usd">3182000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i43ff4e22b20243b28a23578412c3b209_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMy0yLTEtMS04NjEyNw_62d7e651-f7ab-4f12-a483-4b0528ed9548"
      unitRef="usd">57533000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i43ff4e22b20243b28a23578412c3b209_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMy00LTEtMS04NjEyNw_531921db-14e9-4cf1-abcc-3b4c6af55623"
      unitRef="usd">80000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i43ff4e22b20243b28a23578412c3b209_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMy02LTEtMS04NjEyNw_26249285-8e8c-41ca-bae3-38dba56c56bf"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i43ff4e22b20243b28a23578412c3b209_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfMy04LTEtMS04NjEyNw_16b4ddfa-d886-4ff3-9903-4f30696b160b"
      unitRef="usd">57611000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idb3acbf69765400b99cbf96568b817cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNC0yLTEtMS04NjEyNw_aa0c496c-c834-413f-afe2-ee01cf25622e"
      unitRef="usd">9936000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idb3acbf69765400b99cbf96568b817cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNC00LTEtMS04NjEyNw_ab8ab4ef-7d9b-43b7-8df5-fc75dd528319"
      unitRef="usd">102000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idb3acbf69765400b99cbf96568b817cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNC02LTEtMS04NjEyNw_9e7b04a7-a70e-49db-9b7a-43d939efa322"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idb3acbf69765400b99cbf96568b817cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNC04LTEtMS04NjEyNw_29d84e05-c4ae-4e52-abe8-bd55c94f8e11"
      unitRef="usd">10038000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNi0yLTEtMS04NjEyNw_7507a1a2-93ac-4dd8-8aa0-7f8c31dcd87d"
      unitRef="usd">70651000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNi00LTEtMS04NjEyNw_a221f14c-3b42-4c62-80cb-6e2b395bc069"
      unitRef="usd">182000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNi02LTEtMS04NjEyNw_7cba5dd3-ce10-4e7b-9a78-143f9c525491"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4dbf2b62de404b8fa8423e1fb8f1bd7f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RhYmxlOjE3NDg0MTM3OTJmYjQ4ZTJhMTc2MzUwOGQ3MWQxNWJhL3RhYmxlcmFuZ2U6MTc0ODQxMzc5MmZiNDhlMmExNzYzNTA4ZDcxZDE1YmFfNi04LTEtMS04NjEyNw_08a39282-aff6-434d-9e95-24dc722ce1c8"
      unitRef="usd">70831000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InterestReceivable
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNzgyNA_86c5a689-e238-4206-a496-49ddd410395d"
      unitRef="usd">200000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfNzgzMQ_92d3ea2f-b47c-4053-aeea-2e3ec9cba831"
      unitRef="usd">100000</us-gaap:InterestReceivable>
    <pcrx:NumberOfMajorCustomers
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODIzMA_d2740865-5028-48bb-a904-a5077d0b59ab"
      unitRef="customer">3</pcrx:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id7c6f1c8ace3439a97adbf4622bc27e9_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODMxNA_de86d933-7d46-4bf8-941f-1549f10dd1da"
      unitRef="number">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iddf44d8e1eb24bb38df6f546dbde1595_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODMxOA_973aa968-ab0c-4766-ad70-35d7e03bdc33"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic92dd8c00b21453d812274cd1558efeb_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODMyNQ_9272d75b-67f6-47d0-8788-0d747231fd6a"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <pcrx:NumberOfMajorCustomers
      contextRef="ib06fd977f58642338910637dc9ee051e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODMzNg_200033d4-ed1b-4530-a05a-39356f180bc0"
      unitRef="segment">4</pcrx:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i364140fb0ecb4c5b90678acdcbc6f1ab_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODQyMA_5cf19d59-702d-4f7d-8dce-ea1c3ac3c118"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if6fb800aa91a443a8562539853dbd945_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODQyNA_21163b6c-08bf-421d-a4aa-134e8118c086"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia1df9fb6c8864c09a8ff94e2cb57ad21_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODQyOA_cef5c5a0-b974-4a1f-abab-a747bcd4365f"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iaeada0763b1349a6a781e82453974c12_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfODQzNQ_eae037d6-4aa8-4b5d-8690-7363ff4da51b"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTA4OA_a24a966c-e331-416e-a7eb-d6c291610a72"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN182Ny9mcmFnOjVkNjQ4MWY2NzAxODRkNzM5NjY5NzY2NTc2OTBlNWUyL3RleHRyZWdpb246NWQ2NDgxZjY3MDE4NGQ3Mzk2Njk3NjY1NzY5MGU1ZTJfOTA4OA_bfded682-dbc9-4a7c-985a-52f350a7ffa7"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RleHRyZWdpb246YjVmMTM2MzEzMjc5NGU4ZGFjZWVlNWQ0ZDEzZWM4ZDFfMjUx_d7c36333-9607-44ca-a704-bfe428b78a00">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive (Loss) Income &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables illustrate the changes in the balances of the Company&#x2019;s accumulated other comprehensive (loss) income for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Unrealized (Loss) Gain From Available&lt;br/&gt;For Sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on investments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Unrealized (Loss) Gain From Available&lt;br/&gt;For Sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on investments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RleHRyZWdpb246YjVmMTM2MzEzMjc5NGU4ZGFjZWVlNWQ0ZDEzZWM4ZDFfMjQx_d4fa53f8-2c48-44e0-9c9f-6c65a95495c7">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables illustrate the changes in the balances of the Company&#x2019;s accumulated other comprehensive (loss) income for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Unrealized (Loss) Gain From Available&lt;br/&gt;For Sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on investments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Unrealized (Loss) Gain From Available&lt;br/&gt;For Sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on investments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="iab2955eb68904b22a10de3106fc90299_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMS0yLTEtMS04NjEyNw_f4ba0ebf-c63b-442a-8b15-62ef997c7624"
      unitRef="usd">139000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i34fc14fcb0fe4ad4984107a1fefc0823_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMS00LTEtMS04NjEyNw_e7f547e8-9d91-453c-a413-6feea4236637"
      unitRef="usd">28000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02ecdd29c7414c46a2309f3f15aa4ef2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMS02LTEtMS04NjEyNw_f5f6d6c5-7931-4c3e-bb30-2e34fdea8025"
      unitRef="usd">167000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ie211f03ed1a748f1aa10a0c73727da12_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMi0yLTEtMS04NjEyNw_9cb3e2a1-97d7-405b-8ea5-9a1c96957991"
      unitRef="usd">-893000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i40fceb10d076413aa7ec6129f9f379d7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMi02LTEtMS04NjEyNw_e5224ae6-199a-4d0d-94e2-fd2aeaea8de8"
      unitRef="usd">-893000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iedea906cd76a4d4bba0431551477a909_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMy00LTEtMS04NjEyNw_2211cddf-c0ac-4c6c-8fc9-a5c2f6399cb3"
      unitRef="usd">121000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i40fceb10d076413aa7ec6129f9f379d7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfMy02LTEtMS04NjEyNw_12294013-d2a9-4ee5-882a-af676767686f"
      unitRef="usd">121000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i31ac85e1887749e4b9a817256cbd8b28_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfNS0yLTEtMS04NjEyNw_3e702020-c358-4f6a-94c3-826567e36736"
      unitRef="usd">-754000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i48031d7bf51f42d489a3a3a50bf8e6af_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfNS00LTEtMS04NjEyNw_3a042285-f45b-4be1-a080-96cdbd01d655"
      unitRef="usd">149000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20af892b1391416d8055702cfd957969_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOmJlMzA2NjEzOTkwNTQ1MzdhYzU4YWY2NzFhZDg2OTRiL3RhYmxlcmFuZ2U6YmUzMDY2MTM5OTA1NDUzN2FjNThhZjY3MWFkODY5NGJfNS02LTEtMS04NjEyNw_d1951c5c-70ec-4db0-9ae7-177ddbcbe7e0"
      unitRef="usd">-605000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if6cb2fdecf4b4a0a85c84a8fd76f0bbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMS0yLTEtMS04NjEyNw_812acb80-b8fd-4a24-96e6-0d4414611b71"
      unitRef="usd">319000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25d448a3f20f451b9239b04a6513c8cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMS00LTEtMS04NjEyNw_2b29ee60-9898-49bb-9b32-ef4ae4ba6b2a"
      unitRef="usd">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67ba2e38a38f4c4c81d24bf4be710a79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMS02LTEtMS04NjEyNw_db43c7ae-d896-44c2-a03a-dc0faf2d8be6"
      unitRef="usd">318000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i08b536b7990b4e1894b876ae5ada1a24_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMi0yLTEtMS04NjEyNw_ccd7b083-6797-4e19-bc32-5eca6bfb1e71"
      unitRef="usd">-138000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ie355b25162354a51a4bc570c648c9f9e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMi02LTEtMS04NjEyNw_7d85c157-d8c1-475e-8df5-4bd61131413c"
      unitRef="usd">-138000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id1995fc5495b4921bfb8486c9d6f9f19_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMy00LTEtMS04NjEyNw_066edac6-eb5e-486a-a017-f8b402f0076b"
      unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie355b25162354a51a4bc570c648c9f9e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfMy02LTEtMS04NjEyNw_b128d24b-4207-48b3-b373-300b2405cae7"
      unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="if83f4b65463347e6a51d901c1e50e22e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfNS0yLTEtMS04NjEyNw_0ef36e63-4a35-48ad-9f71-f00fe0f56de7"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e1e3475775b4e76ab6efcb59dd158f6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfNS00LTEtMS04NjEyNw_158b0eb3-7a72-4297-9b24-e2bb3d3cbc1d"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id12c8e6e979d472c83e9f7f03a527326_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183MC9mcmFnOmI1ZjEzNjMxMzI3OTRlOGRhY2VlZTVkNGQxM2VjOGQxL3RhYmxlOjY1MGVmYmRiNTVkMDQ4YThiNzBhMWJiNGVhNTE4ZTM2L3RhYmxlcmFuZ2U6NjUwZWZiZGI1NWQwNDhhOGI3MGExYmI0ZWE1MThlMzZfNS02LTEtMS04NjEyNw_29694036-3a65-4edf-a549-774b38b5ba9f"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTA5NA_fbe37845-5a60-42cb-b7e8-f3005c27a5e8">STOCK PLANS&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables contain information about the Company&#x2019;s stock option and restricted stock unit, or RSU, activity for the six months ended June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Exercise Price (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,050,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(630,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,363,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Grant Date Fair Value (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of stock options granted during the six months ended June&#160;30, 2022 wa&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$25.69&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;per share. The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Black-Scholes Weighted Average Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.83%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company&#x2019;s stockholders approved the Amended and Restated 2014 Employee Stock Purchase Plan, or ESPP. The ESPP was amended to increase the number of shares of common stock that may be sold under the ESPP by an additional 500,000 shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ESPP features two six-month offering periods per year, running from January 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at 85% of the closing fair market value of the Company&#x2019;s common stock on either the offering date or the purchase date, whichever is less. During the six months ended June&#160;30, 2022, 36,729 shares were purchased and issued through the ESPP.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTEwOA_97c0e02b-b52a-42be-964a-574081dd2fa9">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iff0cddc2bc28438a8934112eb263d081_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMi0yLTEtMS04NjEyNw_656bcc24-1413-4e3a-9437-828ab417cc78"
      unitRef="usd">1478000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2c88759301c941b096aecd8a4937c534_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMi00LTEtMS04NjEyNw_aadb02c7-7ab9-4506-922a-86fea0bae3f4"
      unitRef="usd">1465000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i55eab178e9a043b1a145b43918fe8858_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMi02LTEtMS04NjEyNw_a8b3884c-0523-492e-96f6-be95d8888f7f"
      unitRef="usd">2830000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4a8f20a978a34500a4d487f8a56ade4b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMi04LTEtMS04NjEyNw_8b3baafe-ccdd-4d7b-8ec6-36af60d6223c"
      unitRef="usd">2917000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i212b2c71c3a147c7a27ebf79f5a7c12e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMy0yLTEtMS04NjEyNw_0d969976-13d1-4af8-b1b5-09b85481f27f"
      unitRef="usd">1520000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i20270789c96347f29c7c132e72ddd5c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMy00LTEtMS04NjEyNw_5f9621fd-185f-46ce-bdcc-3cedc3c116e7"
      unitRef="usd">1329000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i50d1f8b7f2c346eeb7844217241e3a36_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMy02LTEtMS04NjEyNw_809517a8-79e5-4a87-b5e7-2cf5cdf0b12d"
      unitRef="usd">2978000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i02b1b5de0b8e42078315f31d7aef6b00_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMy04LTEtMS04NjEyNw_0ac62f3e-b5a5-4136-929f-d86441b87254"
      unitRef="usd">2435000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i03a4c08595d646a1baa2a16e237083a6_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNC0yLTEtMS04NjEyNw_b36f2021-2245-4da3-be13-7cad24255bf7"
      unitRef="usd">8546000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifecfe644d38148929046d13feafd4dab_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNC00LTEtMS04NjEyNw_72ea6c99-74ce-4e7d-b45d-9910bb6955f0"
      unitRef="usd">7667000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf0d15f2737042a888b6d0615dc70cd1_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNC02LTEtMS04NjEyNw_0bdefb71-ef38-4cfe-9d25-ea6ad25abe5d"
      unitRef="usd">16925000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic7634d27564544329107cc50cd79208f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNC04LTEtMS04NjEyNw_b080699e-5685-428d-a800-090a4f0aee8b"
      unitRef="usd">15219000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNS0yLTEtMS04NjEyNw_667bd6b2-4c21-45cc-a4dc-5f44e6d412c5"
      unitRef="usd">11544000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNS00LTEtMS04NjEyNw_fc661b6f-da80-4413-9b9a-860620d13c17"
      unitRef="usd">10461000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNS02LTEtMS04NjEyNw_c338e7d4-9ac3-434b-9575-4528a914cb24"
      unitRef="usd">22733000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfNS04LTEtMS04NjEyNw_c899d48b-564e-439a-8b45-c921a703d9ee"
      unitRef="usd">20571000</us-gaap:AllocatedShareBasedCompensationExpense>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOC0yLTEtMS04NjEyNw_ac1ee2fb-218c-41af-bbe4-5ca58c88c9d2"
      unitRef="usd">6542000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOC00LTEtMS04NjEyNw_4d9b1848-b998-456a-825c-f59b1809f9c9"
      unitRef="usd">6552000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOC02LTEtMS04NjEyNw_c7698bb6-71a7-41fc-a0cd-203adf49b3a7"
      unitRef="usd">13327000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOC04LTEtMS04NjEyNw_9f5478b8-4cf9-456b-ad0b-494abf5dfebc"
      unitRef="usd">13048000</pcrx:Compensationexpensefromstockoptionsemployees>
    <us-gaap:RestrictedStockExpense
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOS0yLTEtMS04NjEyNw_07521642-9f55-4744-88e9-32fc577a0919"
      unitRef="usd">4717000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOS00LTEtMS04NjEyNw_00a41fd1-578c-4205-a681-097a96ac4753"
      unitRef="usd">3646000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOS02LTEtMS04NjEyNw_1e998cf4-6c8b-42a9-9b20-427cda385a0f"
      unitRef="usd">8830000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfOS04LTEtMS04NjEyNw_7f69aa3b-8663-4537-a424-da042c61559b"
      unitRef="usd">7038000</us-gaap:RestrictedStockExpense>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTAtMi0xLTEtODYxMjc_6eed832a-fa94-46bb-9ece-da77e99f89bb"
      unitRef="usd">285000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTAtNC0xLTEtODYxMjc_463281e3-4e09-40ad-a1d3-95e1197887ee"
      unitRef="usd">263000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTAtNi0xLTEtODYxMjc_f89f6e0a-b934-4c75-ab95-e9a2b3990a6d"
      unitRef="usd">576000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTAtOC0xLTEtODYxMjc_b03a65ce-ba89-462d-85f8-38d9aeeda059"
      unitRef="usd">485000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <us-gaap:ShareBasedCompensation
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTEtMi0xLTEtODYxMjc_147e82e7-c2a4-4f6b-a7d7-f75a79796d4d"
      unitRef="usd">11544000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTEtNC0xLTEtODYxMjc_01717bda-4297-4c41-8fd2-a5e5679f3e5a"
      unitRef="usd">10461000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTEtNi0xLTEtODYxMjc_d659994d-b1e1-4276-8689-3d0d232f3e3c"
      unitRef="usd">22733000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjc2MThjZTIwYjkyOTRmNWFiNjlhODk2NDJlNzhmNTg1L3RhYmxlcmFuZ2U6NzYxOGNlMjBiOTI5NGY1YWI2OWE4OTY0MmU3OGY1ODVfMTEtOC0xLTEtODYxMjc_29607823-c001-4f58-adf9-947f5f480c85"
      unitRef="usd">20571000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTExMA_c51a7fce-e2b3-4ebc-9a67-8eede5a554a2">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables contain information about the Company&#x2019;s stock option and restricted stock unit, or RSU, activity for the six months ended June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Exercise Price (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,050,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(630,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,363,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Grant Date Fair Value (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMS0yLTEtMS04NjEyNw_1a3f57ee-0b53-4cc7-8b08-e919b0363aea"
      unitRef="shares">6050540</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if1e299ef910a46358668913b0b2f165d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMS00LTEtMS04NjEyNw_1315471a-7995-4095-b29f-bfc27231111c"
      unitRef="usdPerShare">49.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMi0yLTEtMS04NjEyNw_3c4baf99-3a47-4869-a753-b1ad9e003dfa"
      unitRef="shares">1010780</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMi00LTEtMS04NjEyNw_519ccc63-d001-4a37-a321-fffc4aca9664"
      unitRef="usdPerShare">60.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMy0yLTEtMS04NjEyNw_c053f6e5-0e28-42bd-a5b6-6ce3d37e39d5"
      unitRef="shares">630413</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfMy00LTEtMS04NjEyNw_a02f7152-c0d0-48c3-9b4f-527e7bd4bf9b"
      unitRef="usdPerShare">34.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNC0yLTEtMS04NjEyNw_3d9a9e65-72be-432c-88bb-fb23eed45f19"
      unitRef="shares">54215</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNC00LTEtMS04NjEyNw_fd1f87f3-cd46-4ae1-a352-3a07ef68e777"
      unitRef="usdPerShare">52.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNS0yLTEtMS04NjEyNw_0be765fa-9a60-4dd3-8852-57e4c93b9143"
      unitRef="shares">13054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNS00LTEtMS04NjEyNw_43df9c7a-76a0-487d-b515-bd92a4e1db75"
      unitRef="usdPerShare">85.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNi0yLTEtMS04NjEyNw_a023638e-9544-4b1f-b10c-e91e2b0f0a55"
      unitRef="shares">6363638</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ibfe1468fe7344d909a88362d4b43314a_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjUwNmQyMDU4MzNmZjRiZjJiMWVhNTI3MWRlNTg0NDBiL3RhYmxlcmFuZ2U6NTA2ZDIwNTgzM2ZmNGJmMmIxZWE1MjcxZGU1ODQ0MGJfNi00LTEtMS04NjEyNw_cea9bd27-db65-458e-adc8-13ccd8ec8ac3"
      unitRef="usdPerShare">52.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i85df01f524b547a39620a6cd60ab5eae_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMS0yLTEtMS04NjEyNw_78311ff9-5d3f-4b31-96da-ad5510511ed9"
      unitRef="shares">955277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i85df01f524b547a39620a6cd60ab5eae_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMS00LTEtMS04NjEyNw_4822b989-d6ee-439b-bf80-55a678bd97c8"
      unitRef="usdPerShare">52.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMi0yLTEtMS04NjEyNw_2533e5e1-6f2e-42c9-a726-1e5d9e8adf39"
      unitRef="shares">568049</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMi00LTEtMS04NjEyNw_a2ea4fcd-8f0a-46c6-b52a-d10e1b75fe09"
      unitRef="usdPerShare">60.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMy0yLTEtMS04NjEyNw_35fef379-0f0b-4f65-9f96-a1298ed45c37"
      unitRef="shares">298607</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfMy00LTEtMS04NjEyNw_bf5e28c1-e615-46c4-a05e-2d101d503255"
      unitRef="usdPerShare">49.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfNC0yLTEtMS04NjEyNw_3dbcc440-d6de-404b-9df9-9e6abecbfff3"
      unitRef="shares">44929</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfNC00LTEtMS04NjEyNw_75a18a57-130c-41df-9390-7617e85f647f"
      unitRef="usdPerShare">54.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5ca303801f644e169133ec4d7e0c6998_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfNS0yLTEtMS04NjEyNw_afc9012d-616f-42ed-9c32-21020ded655d"
      unitRef="shares">1179790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5ca303801f644e169133ec4d7e0c6998_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjE2OTA3ZWY2ODVkNjRjOGZiMDEyNTI5NTBlYThjNWQ5L3RhYmxlcmFuZ2U6MTY5MDdlZjY4NWQ2NGM4ZmIwMTI1Mjk1MGVhOGM1ZDlfNS00LTEtMS04NjEyNw_d87f94b8-b879-459c-8f4b-0f11a5ac2fd9"
      unitRef="usdPerShare">57.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfNDE1_ffa9e01d-4c8e-4ca1-ad23-89f450a6b0cf"
      unitRef="usdPerShare">25.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTEwMQ_efc03388-aba4-4cc6-ba38-b1457c9be635">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Black-Scholes Weighted Average Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.83%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjRlNzZjZDc1ZTVlZTQ3OTk5ZmM1MTlhMmFlMjZmOWU3L3RhYmxlcmFuZ2U6NGU3NmNkNzVlNWVlNDc5OTlmYzUxOWEyYWUyNmY5ZTdfMS0yLTEtMS04NjEyNw_19b97ba4-274e-40c0-80f3-695c1974f692"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjRlNzZjZDc1ZTVlZTQ3OTk5ZmM1MTlhMmFlMjZmOWU3L3RhYmxlcmFuZ2U6NGU3NmNkNzVlNWVlNDc5OTlmYzUxOWEyYWUyNmY5ZTdfMi0yLTEtMS04NjEyNw_c1ab9baf-92e9-4b2d-a7cb-c3b311b38cf5"
      unitRef="number">0.0283</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjRlNzZjZDc1ZTVlZTQ3OTk5ZmM1MTlhMmFlMjZmOWU3L3RhYmxlcmFuZ2U6NGU3NmNkNzVlNWVlNDc5OTlmYzUxOWEyYWUyNmY5ZTdfMy0yLTEtMS04NjEyNw_6a09f7cd-d09c-4308-af96-17715339ba6d"
      unitRef="number">0.4515</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RhYmxlOjRlNzZjZDc1ZTVlZTQ3OTk5ZmM1MTlhMmFlMjZmOWU3L3RhYmxlcmFuZ2U6NGU3NmNkNzVlNWVlNDc5OTlmYzUxOWEyYWUyNmY5ZTdfNC0yLTEtMS04NjEyNw_dd5ab241-859f-4a3a-b3df-dcee39f9e62c">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <pcrx:EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease
      contextRef="ie5b71027039a48cebc64faf0916105d2_D20220601-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTA5OTUxMTYzMDQ5OQ_0ec80bf9-eacd-414a-855a-82b2976fa881"
      unitRef="shares">500000</pcrx:EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease>
    <pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods
      contextRef="i39a0a2f43861465f96e848700239814f_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfNjc5_1a241adb-7ee6-43a9-8f64-7668066eaa44"
      unitRef="offeringperiod">2</pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods>
    <pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod
      contextRef="i39a0a2f43861465f96e848700239814f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTA5OA_559ccce6-8107-44a2-bff0-d160e53d6521">P6M</pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfODcw_53ff5688-33cc-4910-8570-7704985a46fb"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183My9mcmFnOjJmYzI1ZDc0NzA2NTQ4NWM4ODE1MTU4NjdkYzdhMzZmL3RleHRyZWdpb246MmZjMjVkNzQ3MDY1NDg1Yzg4MTUxNTg2N2RjN2EzNmZfMTAzNg_7afcdfa8-c9a5-4937-9444-c202252c4b01"
      unitRef="shares">36729</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RleHRyZWdpb246MWViOWVmMjdhZDJmNGQ5MmE0YmJjOGIwY2EzODMyNmVfMjE4NA_dd8fe6dc-9949-43f1-b605-5da6cdffae1b">NET INCOME (LOSS) PER SHARE&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2020-06 was adopted on January 1, 2022 and requires the Company to use the if-converted method to calculate the number of potentially dilutive shares for convertible debt. Under the if-converted method, adjustments are made to the diluted net income (loss) per common share calculation as if the Company had converted the convertible debt on the first day of each period presented. Adjustments to the numerator are made to add back the interest expense associated with the convertible debt on a post-tax basis. Adjustments to the denominator reflect the number of shares assumed to be convertible at the beginning of the period. For additional information regarding ASU 2020-06, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Prior to January 1, 2022, the Company used the treasury stock method to calculate dilutive shares on its convertible debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs and the purchase of shares from the ESPP (using the treasury stock method), if applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per common share for the three and six mon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ths ended June&#160;30, 2022 and 2021 (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net income&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 convertible notes if-converted method adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Adjusted net income&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computation of diluted securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 convertible notes if-converted method adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of conversion premium on the 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RleHRyZWdpb246MWViOWVmMjdhZDJmNGQ5MmE0YmJjOGIwY2EzODMyNmVfMjE3Mw_30f389d4-e9fe-43b3-944f-b889d63a6bf9">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per common share for the three and six mon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ths ended June&#160;30, 2022 and 2021 (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net income&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 convertible notes if-converted method adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Adjusted net income&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computation of diluted securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 convertible notes if-converted method adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of conversion premium on the 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMy0xLTEtMS04NjEyNw_a8a6a987-f9dd-47b4-88aa-b71fe5740c77"
      unitRef="usd">19876000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMy0zLTEtMS04NjEyNw_b96f8954-4e13-4041-a2d8-2caa3909d3ff"
      unitRef="usd">19081000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMy01LTEtMS04NjEyNw_4faeef17-c885-4e17-8c1f-65f98bf6f29f"
      unitRef="usd">26704000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMy03LTEtMS04NjEyNw_0865c80d-ed85-4e1f-8353-903d21380f3c"
      unitRef="usd">29450000</us-gaap:NetIncomeLoss>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNC0xLTEtMS05MTQ3MA_3ed9c6db-549d-45df-8402-5dc1d9ecb2f3"
      unitRef="usd">1039000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNC0zLTEtMS05MTQ3MA_7d24b80b-c7aa-47ca-91b3-3da2bdb6cad6"
      unitRef="usd">0</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNC01LTEtMS04NjEyNw_27ea9404-1b3e-4b10-9dec-08e093cd4a91"
      unitRef="usd">2078000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNC03LTEtMS04NjEyNw_146974e6-c243-47db-af58-3b1cacf8151f"
      unitRef="usd">0</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNi0xLTEtMS04NjEyNw_cd92a547-987d-4fcd-b4ea-5ee99c94e2ab"
      unitRef="usd">20915000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNi0zLTEtMS04NjEyNw_f8ea6dbf-19a4-42cc-9331-5b04a14aed00"
      unitRef="usd">19081000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNi01LTEtMS04NjEyNw_ddbc615b-b675-4564-871e-2959b4bb2f1e"
      unitRef="usd">28782000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfNi03LTEtMS04NjEyNw_c75322bb-841e-48d2-9ecd-25d980ae5ef0"
      unitRef="usd">29450000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTMtMS0xLTEtODYxMjc_f0944291-da58-4494-aa6c-a31bafdc80a8"
      unitRef="shares">45501000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTMtMy0xLTEtODYxMjc_48455602-aeed-4e5f-8d01-389ba7f63e7b"
      unitRef="shares">44145000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTMtNS0xLTEtODYxMjc_af84c92f-c9ee-4c92-ac9b-69d5b4488714"
      unitRef="shares">45185000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTMtNy0xLTEtODYxMjc_eda1be55-7704-4038-a30c-986d19354794"
      unitRef="shares">43989000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i43454386d0e64c9aa58f37a86d3898e1_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTUtMS0xLTEtODk5ODg_fd2aa14d-f3a7-40b0-947d-91082637d6b2"
      unitRef="shares">5607000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i303f42a872d84848a26c7935521e8d9d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTUtMy0xLTEtODk5ODg_b761f32d-0a42-4a6b-b51e-17896b024d87"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="id76d6ea4321e4124937fc7c109c12121_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTUtNS0xLTEtODYxMjc_fbb0ebf4-0e7c-4b1c-be51-44d1c86e5dee"
      unitRef="shares">5607000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i23b9728da5774e0f8865eb56c0287548_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTUtNy0xLTEtODYxMjc_0489e453-1a42-4c58-a96d-2111364cde6c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibb138ead7c8749139ab55dab62470f1f_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTYtMS0xLTEtODYxMjc_90a76ff0-6fb4-422b-b296-5514397b84c7"
      unitRef="shares">1016000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4cfbe4103aec4e4dbf93af04eba8abe1_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTYtMy0xLTEtODYxMjc_23442147-223a-46cd-9ddc-edcd88c45070"
      unitRef="shares">1062000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTYtNS0xLTEtODYxMjc_cadaa73c-65e1-4d0a-9cf2-d362d419b43d"
      unitRef="shares">1106000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0362692f03ce4f04b845f4ef84d3150e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTYtNy0xLTEtODYxMjc_09ca4bba-1bef-4bc1-b289-be94520c53b4"
      unitRef="shares">1284000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibd17b7148b4b4336ae3a8a8ab12951b8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTctMS0xLTEtODYxMjc_cdac0686-f7a9-43ca-98aa-8a60aabb8858"
      unitRef="shares">347000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6a329b7adfca4c45be13dd71376e3285_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTctMy0xLTEtODYxMjc_c820fc7c-0076-4095-b859-ae4ebd5b6596"
      unitRef="shares">381000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3a7f29d1a6e5480db676bd3362066db5_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTctNS0xLTEtODYxMjc_b69d8ac6-8fd2-4324-a8f2-768d6121eed7"
      unitRef="shares">360000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie39e757d15684b84b80beb859cc71a9a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTctNy0xLTEtODYxMjc_06eb6224-10d3-4a96-abc3-914312ade8f6"
      unitRef="shares">426000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTgtMS0xLTEtODYxMjc_a1fbaaa3-4f25-41b0-b737-821bba9a621c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTgtMy0xLTEtODYxMjc_fcf1a713-9d35-47b3-b993-a4cae7542f27"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTgtNS0xLTEtODYxMjc_a4212176-8bb1-4695-871b-565f1691fcd4"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTgtNy0xLTEtODYxMjc_95c02e04-6212-4b61-9235-cb47ae501c6b"
      unitRef="shares">76000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if5e85fea4b1749a0a9ab002bc71033a2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTktMS0xLTEtODYxMjc_70bcf796-8cba-4847-b105-60223679cd26"
      unitRef="shares">7000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0baf3a23aeb847d8b41472f49c4054e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTktMy0xLTEtODYxMjc_b95ef1bf-6833-43a5-aff7-35559310404b"
      unitRef="shares">4000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i39a0a2f43861465f96e848700239814f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTktNS0xLTEtODYxMjc_82b64da5-d1ac-47b9-8ae1-e6b95bb3018f"
      unitRef="shares">4000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i111e70709f1a49f58e7bc236e873db49_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMTktNy0xLTEtODYxMjc_f15463f3-b884-4e18-8c03-bdb138a6b99a"
      unitRef="shares">4000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjEtMS0xLTEtODYxMjc_3fc27253-be4e-44e7-a2ac-191abdffb1d9"
      unitRef="shares">52478000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjEtMy0xLTEtODYxMjc_c99ef07d-7cbf-4b98-9940-ff73c13e3859"
      unitRef="shares">45592000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjEtNS0xLTEtODYxMjc_a2824037-9be0-4b99-ac1d-1b8d78fa425b"
      unitRef="shares">52262000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjEtNy0xLTEtODYxMjc_14a02358-0041-484c-872e-c47226d9a4b2"
      unitRef="shares">45779000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjMtMS0xLTEtODYxMjc_ebdac077-cf17-4761-bc72-34f5d4ea7e31"
      unitRef="usdPerShare">0.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjMtMy0xLTEtODYxMjc_b47163d0-41db-4f91-8b6e-ae57b26907b3"
      unitRef="usdPerShare">0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjMtNS0xLTEtODYxMjc_e2bd38cb-5437-4b75-9e16-4e8318105553"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjMtNy0xLTEtODYxMjc_94a81177-29f0-42fe-be1d-f909fe6e017e"
      unitRef="usdPerShare">0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjQtMS0xLTEtODYxMjc_02239255-d586-423a-a4c3-c13e15c05569"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjQtMy0xLTEtODYxMjc_9c4e63fb-b470-4544-8260-3b78f2a00a7e"
      unitRef="usdPerShare">0.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjQtNS0xLTEtODYxMjc_4e8bdeea-6056-4a10-bec2-c77951f76c82"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjYyOTYyYTIyMTNiYzQyZTBhZjg1MjhhZmEwNWI3YzFiL3RhYmxlcmFuZ2U6NjI5NjJhMjIxM2JjNDJlMGFmODUyOGFmYTA1YjdjMWJfMjQtNy0xLTEtODYxMjc_61539f24-dc28-4f9c-9618-cf54fe4e1852"
      unitRef="usdPerShare">0.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RleHRyZWdpb246MWViOWVmMjdhZDJmNGQ5MmE0YmJjOGIwY2EzODMyNmVfMjE4OQ_1c1a2753-da83-47a5-906b-fdadc2573d8c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i80a72523d0c1401185af1aa98e145d67_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMi0xLTEtMS04NjEyNw_af5ffb71-8936-46f4-ad00-21fc417a7479"
      unitRef="shares">1948000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibcb41bddccc844a8b1608c8a5f1eb2f1_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMi0zLTEtMS04NjEyNw_7d7f567e-efc6-4048-90cc-9da17c8eba26"
      unitRef="shares">2088000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie519317e61de4bd4b61b769f86af2017_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMi01LTEtMS04NjEyNw_790338ef-f734-4b69-9903-dff5a9bf118f"
      unitRef="shares">1855000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7926f8178c944494b800dc70a8aee09b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMi03LTEtMS04NjEyNw_c64404a6-46fc-4b39-b6d3-1e245214b65a"
      unitRef="shares">1489000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6b13dbca109f40d59b428f6eb0fcce41_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMy0xLTEtMS05MDA0NQ_1bc72056-1191-4c4b-b820-c8bd8e3b5d7f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia852df3ea8e7487d833721f9de1ece5b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMy0zLTEtMS05MDA0NQ_e0947592-a0ca-47aa-b68b-8ae343c9c8f3"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i23cdbff094c5425f8aa1a90414d51f06_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMy01LTEtMS04NjEyNw_46198a96-b356-4541-b810-8691f72de868"
      unitRef="shares">1196000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iae72f39fcbeb458cb1ae7c42c5e4d55e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfMy03LTEtMS04NjEyNw_8e191f81-2418-444e-90b2-326b1d0a53ea"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i33a60813e9f44095913e43e93a53efc0_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNC0xLTEtMS04NjEyNw_367b7d3b-e2f1-4661-8b29-ab6a5a5ef264"
      unitRef="shares">31000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i728ca8324e5149769ed4f7f8eb7732dc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNC0zLTEtMS04NjEyNw_d2ff4956-2529-4444-b40c-8c4ee34800fd"
      unitRef="shares">26000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3ec452862f584d9196d9a07fc8b8ddc6_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNC01LTEtMS04NjEyNw_d6be8685-b35a-474f-9467-f83b73f346dc"
      unitRef="shares">24000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1c65baa223334a0a825004fd918ececa_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNC03LTEtMS04NjEyNw_bbdaa1ce-ada4-4d73-aeb6-ee8bcff57b19"
      unitRef="shares">14000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNi0xLTEtMS04NjEyNw_ac840ad5-fa5b-4012-9f47-94d2daf4c288"
      unitRef="shares">1979000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNi0zLTEtMS04NjEyNw_c6721fb5-fe11-4ef2-b883-c95e24a20e77"
      unitRef="shares">2114000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNi01LTEtMS04NjEyNw_6fd07376-eeb4-4d9f-b5f1-37057185acbd"
      unitRef="shares">3075000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183Ni9mcmFnOjFlYjllZjI3YWQyZjRkOTJhNGJiYzhiMGNhMzgzMjZlL3RhYmxlOjFmZTNhMjcxNzY3ZTQ4MDhhMjMwZWQ4MWFhOTlhMTFjL3RhYmxlcmFuZ2U6MWZlM2EyNzE3NjdlNDgwOGEyMzBlZDgxYWE5OWExMWNfNi03LTEtMS04NjEyNw_2b3ad6c3-2c70-43d5-8f21-5b92595bfb3f"
      unitRef="shares">1503000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RleHRyZWdpb246OWY4NDMyMDU0MzZlNGNjZGJmNTMxN2ZlZTJkYzRlYzhfMzg1_f4735025-3626-4ef5-8284-b2ec021dd9ba">INCOME TAXES&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes and income tax expense is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s income tax expense represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items. The Company&#x2019;s effective tax rates for the three and six months ended June&#160;30, 2022 include benefits related to stock-based compensation, a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration, partially offset by non-deductible executive compensation costs and a valuation allowance against non-U.S. results. The Company&#x2019;s effective tax rates for the three and six months ended June&#160;30, 2021 include benefits related to stock-based compensation offset by non-deductible executive compensation costs and valuation allowances recorded against deductible capital losses and non-U.S. results.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RleHRyZWdpb246OWY4NDMyMDU0MzZlNGNjZGJmNTMxN2ZlZTJkYzRlYzhfMzg0_ae9c4f4f-1733-4caa-9fb6-a9e3f82fc6f9">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes and income tax expense is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfMy0xLTEtMS04NjEyNw_0140f2bf-55e3-4070-8499-d55d1ed12029"
      unitRef="usd">23798000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfMy0zLTEtMS04NjEyNw_fb82df71-3026-4082-b1a6-72da8c554f9c"
      unitRef="usd">25863000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfMy01LTEtMS04NjEyNw_eaa2a069-37cd-4015-bd66-8e3c35eae849"
      unitRef="usd">30380000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfMy03LTEtMS04NjEyNw_72ca15af-d5dc-49ce-a2aa-fbd25459cc92"
      unitRef="usd">41795000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNC0xLTEtMS04NjEyNw_7f029c16-d7bf-404b-90c8-628c42c3844d"
      unitRef="usd">-1791000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNC0zLTEtMS04NjEyNw_a4b8a69b-2bc7-467e-a98e-8e10548ac9a1"
      unitRef="usd">-215000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNC01LTEtMS04NjEyNw_fb6a7864-96b1-41f8-9279-837bab576bcd"
      unitRef="usd">-1079000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNC03LTEtMS04NjEyNw_dd43fb55-addd-4938-bb95-06c6f5bfe31d"
      unitRef="usd">-3424000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNS0xLTEtMS04NjEyNw_36c2edc7-7c86-44b5-855e-4c4d02b3fda6"
      unitRef="usd">22007000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNS0zLTEtMS04NjEyNw_50045157-5a38-45b7-8460-f06326f380a0"
      unitRef="usd">25648000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNS01LTEtMS04NjEyNw_65ae801d-9220-43de-87db-675b2891b2cc"
      unitRef="usd">29301000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNS03LTEtMS04NjEyNw_e2545c4c-c953-4254-9604-6a9ee0ee0f75"
      unitRef="usd">38371000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNy0xLTEtMS05ODI1Ng_a3114b85-aefe-42bf-a6c8-d92c3fbce8fd"
      unitRef="usd">2131000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNy0zLTEtMS05ODI1Ng_b2ce288f-cdcc-42ea-947f-483f76ab2892"
      unitRef="usd">6567000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNy01LTEtMS05ODI1Ng_6428e838-f0b1-4974-9088-03343dfde94a"
      unitRef="usd">2597000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfNy03LTEtMS05ODI1Ng_fa7bd7a4-5a2b-46dd-8a0a-be263d2d3d6d"
      unitRef="usd">8921000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfOC0xLTEtMS05ODI1Ng_8e8e364b-5be9-43b3-85f4-22aa93fed8fd"
      unitRef="number">0.10</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfOC0zLTEtMS05ODI1Ng_50288be2-a4a7-43d3-899c-8aa4edcb9e19"
      unitRef="number">0.26</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfOC01LTEtMS05ODI1Ng_47985ca7-b279-4e0b-9d0d-7899e4dc100d"
      unitRef="number">0.09</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN183OS9mcmFnOjlmODQzMjA1NDM2ZTRjY2RiZjUzMTdmZWUyZGM0ZWM4L3RhYmxlOjYzYzI1YWM3MTU5MzQzYmRhOGQ1NDhkNDIyYWE2YjlkL3RhYmxlcmFuZ2U6NjNjMjVhYzcxNTkzNDNiZGE4ZDU0OGQ0MjJhYTZiOWRfOC03LTEtMS05ODI1Ng_34ea2b58-5595-424f-8d5a-506749076e3b"
      unitRef="number">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMjIwOQ_b5cfc934-403f-4a38-8651-82256c036220">ACQUISITION&#x2013;RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition-related (gains) charges, product discontinuation and other for the three and six months ended June&#160;30, 2022 and 2021 summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquisition-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Flexion contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MyoScience contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,757)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nuance Biotech Co. Ltd. agreement dissolution costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquisition-related (gains) charges, product discontinuation and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flexion Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized acquisition-related costs of $3.2&#160;million and $8.6&#160;million during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022, respectively&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, primarily for severance, legal fees, third-party services and other one-time charges related to the Flexion Acquisition. See Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flexion Acquisition&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 19, 2021, as part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $45.2&#160;million, which represents the Company&#x2019;s potential achievement of meeting regulatory and sales-based milestones. During the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recorded $12.5&#160;million and $13.3&#160;million gains, respectively, due to a decrease to the fair value of its contingent consideration, which was included in acquisition-related (gains) charges in the condensed consolidated statements of operations. See Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MyoScience Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $8.8&#160;million and $9.0&#160;million contingent consideration gains during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized a $0.1&#160;million contingent consideration charge and a $1.0&#160;million gain during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended June 30,&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nuance Biotech Co. Ltd.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#x2019;s intellectual property against the risk of a generic product. Dissolution costs of $3.0&#160;million were included in other operating expenses in the condensed consolidated statements of operations for the six months ended June 30,&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock>
    <pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMjIxMA_9465bdb0-e924-4227-a5ae-4f6a684896c7">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition-related (gains) charges, product discontinuation and other for the three and six months ended June&#160;30, 2022 and 2021 summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquisition-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Flexion contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MyoScience contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,757)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nuance Biotech Co. Ltd. agreement dissolution costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquisition-related (gains) charges, product discontinuation and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMi0xLTEtMS05MDE4OQ_49fb2b07-ad7b-47a9-a776-2740f40c607b"
      unitRef="usd">950000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMi0zLTEtMS05MDE4OQ_3057c3e9-600a-4b38-9e81-9c015942608c"
      unitRef="usd">0</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMi0xLTEtMS04NjEyNw_3a67fff6-bb60-4adf-a363-eb7418c38ba5"
      unitRef="usd">4065000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMi0zLTEtMS04NjEyNw_735adb8a-7585-4489-919b-326314a91135"
      unitRef="usd">0</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i21203a7e95a542a1bb5a7bdfa160cd8e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMy0xLTEtMS05MDE4OQ_646f3154-492c-4ced-ad8c-a058912c56d8"
      unitRef="usd">2168000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i812548bedd2c4f138ae40720d5ab3452_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMy0zLTEtMS05MDE4OQ_ec38f537-e02a-404d-9e64-33026a537ce2"
      unitRef="usd">7000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i7d271c16dc5b4e50b5f8b6e36bc439dd_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMy0xLTEtMS04NjEyNw_a3bd348d-1448-48f7-bafa-80938a9a8e3f"
      unitRef="usd">4013000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie3eff8369f3a447bb8c7f19a5bccdce2_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfMy0zLTEtMS04NjEyNw_f6e54f97-08dd-4359-b0af-c53c906f6f7d"
      unitRef="usd">7000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i89ca9116e3b44efaa7a91cf17de3ff05_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNC0xLTEtMS05MDE4OQ_1be889ce-7c95-4847-ae54-a74e4894728f"
      unitRef="usd">104000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i1626a61d1e96472bb1b34f2c5b6812bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNC0zLTEtMS05MDE4OQ_cd2bd191-9e8e-46b1-8c7e-074d11a75930"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i990dfdef52e040719fa28dbb661db8d9_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNC0xLTEtMS04NjEyNw_0051ad8d-e925-4c64-99e8-85b453ff3864"
      unitRef="usd">552000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ib78e38aec2fa45a58c7a556502d296ac_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNC0zLTEtMS04NjEyNw_75493b69-6d6b-401e-83f5-bd5e34bd6936"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNS0xLTEtMS05MDE4OQ_e656b7de-f4eb-490c-8953-33068d79835d"
      unitRef="usd">3222000</pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts>
    <pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNS0zLTEtMS05MDE4OQ_75a8974d-e44e-4107-8b3c-e02d31be951c"
      unitRef="usd">7000</pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts>
    <pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNS0xLTEtMS04NjEyNw_665b9264-10df-41c8-a8db-65bd03f89449"
      unitRef="usd">8630000</pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts>
    <pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNS0zLTEtMS04NjEyNw_e006d765-3897-4d3a-a377-e7adf4dc8640"
      unitRef="usd">7000</pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i9662be69372649fdb9f55eaf2dddc1cb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNi0xLTEtMS05MDE4OQ_66cd1232-bbf2-453c-8fa7-a94fbadcde2c"
      unitRef="usd">12523000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6affd4b067a74053a80dafaecc998dce_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNi0zLTEtMS05MDE4OQ_e506d6ac-8a46-4979-b1b0-beea6541b5eb"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i77aff11637744366ad3beae32e8eac9d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNi0xLTEtMS04NjEyNw_e66f950c-c8e4-4dab-aefc-46b50e34745b"
      unitRef="usd">13317000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8bf765eaf4e641e6a679a2bf0b36d68f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNi0zLTEtMS04NjEyNw_d1995979-f361-4fd3-be01-69bc40d7fcde"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8b2f0c4184a8447cb9800ac82b098ef2_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNy0xLTEtMS05MDE4OQ_790e2b98-9060-4c35-9a90-15eb94bace7e"
      unitRef="usd">-8757000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1f238205c3474a579a6577a0cfb931fc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNy0zLTEtMS05MDE4OQ_852849dd-fb14-49e3-b31b-ebaf17c19646"
      unitRef="usd">139000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ie60dfafd369d49e9a8915074448de244_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNy0xLTEtMS04NjEyNw_d230f9cd-8873-4a08-ac65-6dba24617b6d"
      unitRef="usd">-9034000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib55aafc43f234774b601b8faca0c6b5d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfNy0zLTEtMS04NjEyNw_0b93fdfa-536e-4621-94c9-fdc44e73281f"
      unitRef="usd">-988000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainLossOnContractTermination
      contextRef="ie51cc6d770c1439bbf87e1a1246d6e15_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOC0xLTEtMS05MDE4OQ_3c1c4562-208b-4b8d-a702-4c124cbaaf83"
      unitRef="usd">0</us-gaap:GainLossOnContractTermination>
    <us-gaap:GainLossOnContractTermination
      contextRef="id0e717cf4ed5406d82a7bcd4eb4a20c9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOC0zLTEtMS05MDE4OQ_3835dbd6-e351-48c2-851f-67a3199a3e19"
      unitRef="usd">0</us-gaap:GainLossOnContractTermination>
    <us-gaap:GainLossOnContractTermination
      contextRef="i56aff27448c64dbaacbbf8b0552a16b7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOC0xLTEtMS04NjEyNw_a7d0dde4-b112-4e63-a90f-b6ec5dacfbb7"
      unitRef="usd">0</us-gaap:GainLossOnContractTermination>
    <us-gaap:GainLossOnContractTermination
      contextRef="i29042b95beda4bcf93f5b0e944d9e035_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOC0zLTEtMS04NjEyNw_35887102-ff70-4e49-a06e-98167f9ae936"
      unitRef="usd">-3000000</us-gaap:GainLossOnContractTermination>
    <pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther
      contextRef="i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOS0xLTEtMS05MDE4OQ_b9447810-c88f-45a0-bb42-049c8af4516e"
      unitRef="usd">-18058000</pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther>
    <pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther
      contextRef="if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOS0zLTEtMS05MDE4OQ_320a339f-0db4-4cb9-a73a-3d07b5420062"
      unitRef="usd">146000</pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther>
    <pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOS0xLTEtMS04NjEyNw_f86318d2-ed7a-4a00-805e-09bf24a05319"
      unitRef="usd">-13721000</pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther>
    <pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther
      contextRef="ie4f121bb2fc242f89586df94466423ff_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RhYmxlOjJlM2ZmMmU3NGI0ZjRlNjhhNWJjYWVhYTNiOGFmODZiL3RhYmxlcmFuZ2U6MmUzZmYyZTc0YjRmNGU2OGE1YmNhZWFhM2I4YWY4NmJfOS0zLTEtMS04NjEyNw_e721f862-0e1a-4f5d-b28c-3b64cdf23140"
      unitRef="usd">2019000</pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i8634775cc9bc464884a372b878f6a608_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDY5OTUyOQ_195a3e14-ec8f-4edd-bb65-5d6de94a885d"
      unitRef="usd">3200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="idf3a6876c8774d06bf57b261d16c5eaf_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMjgz_c94f8305-6ad0-4a11-bac0-7ce63271cf41"
      unitRef="usd">8600000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4f0c78a9972546d4a4bf2bfb19a1c536_D20211119-20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfNjQ0_cbacadff-8327-4afb-a3ec-b11c21b015ca"
      unitRef="usd">45200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6168e02aa26e4349847195bf09c3eacf_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDY5OTY1Mg_5ee5aa26-b9c4-445f-8784-3a94ac297905"
      unitRef="usd">-12500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i21ca7a53ce30416b93b74cd8a9870e74_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfODA4_af7e2e94-4d01-4edf-b796-598d1467711c"
      unitRef="usd">-13300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8b2f0c4184a8447cb9800ac82b098ef2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDcwMDI3Mw_a799548e-9d71-41ee-ac79-bf1da25218ce"
      unitRef="usd">-8800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ie60dfafd369d49e9a8915074448de244_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDcwMDMwNg_a32a2fc2-6e9b-4a39-aec5-e00334595937"
      unitRef="usd">-9000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1f238205c3474a579a6577a0cfb931fc_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDcwMDA4Nw_6af9ae75-d056-49b0-867f-814aba266fae"
      unitRef="usd">100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib55aafc43f234774b601b8faca0c6b5d_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMzg0ODI5MDcwMDExNA_5c1a8668-1ca3-4264-9ba4-aed4e2436e44"
      unitRef="usd">-1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:LitigationSettlementExpense
      contextRef="ic60ea8d3b79d48c4b025712186e3026c_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184Mi9mcmFnOjVjNWEzMzUzYjkzNTRmMzE4YThhNzY3NTJlMjU4MDU0L3RleHRyZWdpb246NWM1YTMzNTNiOTM1NGYzMThhOGE3Njc1MmUyNTgwNTRfMjA2OA_b31e450b-c991-4c87-8d24-38faeafaebc4"
      unitRef="usd">3000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184OC9mcmFnOjNmYTNiOWExYmY1ODRiMTM5ZjlhZWFkOGM5MDliN2UxL3RleHRyZWdpb246M2ZhM2I5YTFiZjU4NGIxMzlmOWFlYWQ4YzkwOWI3ZTFfNzMxNQ_9b6f760a-d8f5-4d67-adf0-b85fa47b142b">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MyoScience Milestone Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#x201c;Pacira CryoTech&#x201d;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#x201c;Fortis&#x201d;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#x201c;Merger Agreement&#x201d;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $30.0&#160;million, plus attorneys&#x2019; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;eVenus Pharmaceutical Laboratories Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the Company received a Notice Letter advising that eVenus Pharmaceutical Laboratories, Inc., or eVenus, of Princeton, New Jersey, submitted to the FDA an Abbreviated New Drug Application (ANDA) with a Paragraph IV certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,033,495 (the &#x2019;495 patent).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Company filed a patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (21-cv-19829) asserting infringement of the &#x2019;495 patent. This triggered an automatic 30-month stay of final approval of the eVenus ANDA. On January 6, 2022, eVenus filed an Answer with counterclaims to the Complaint, alleging the &#x2019;495 patent is invalid and/or not infringed through the manufacture, sale, or offer for sale of the product described in product described in eVenus&#x2019;s ANDA submission.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company received a second Notice Letter advising that eVenus submitted to the FDA an amendment to its ANDA with a Paragraph IV Certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (133 mg/10 mL) in the U.S. prior to the expiration of the &#x2019;495 patent. In the Notice Letter, eVenus also advised that it submitted a Paragraph IV Certification to the FDA seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL and 133 mg/10 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,179,336 (the &#x2019;336 patent). eVenus further alleges in the Notice Letter that both the &#x2019;495 patent and the &#x2019;366 patent are invalid and/or not infringed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, the Company filed a second patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (22-cv-00718) asserting that the 133 mg/10 mL ANDA product will infringe the &#x2019;495 and &#x2019;336 patents and that the 266 mg/20 mL ANDA product will infringe the &#x2019;336 patent. This filing triggered a second automatic 30-month stay of final approval for the 133 mg/10 mL ANDA product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These litigations are in their infancy, and the Company is unable to predict the outcome of this action at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research Development Foundation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to an agreement with the Research Development Foundation, or RDF, the Company was required to pay RDF a low single-digit royalty on the collection of revenues from certain products, for as long as certain patents assigned to the Company under the agreement remain valid. RDF has the right to terminate the agreement for an uncured material breach by the Company, in connection with its bankruptcy or insolvency or if it directly or indirectly opposes or disputes the validity of the assigned patent rights. The Company&#x2019;s U.S. Patent No. 11,033,495 was issued on June 15, 2021. Thereafter, RDF asserted that the issuance of that patent extends the Company&#x2019;s royalty obligations under the agreement until 2041. The Company believes that the royalty period under the agreement was set to end on December 24, 2021 with the expiration of its U.S. Patent No. 9,585,838. Because of the disagreement over the interpretation of the agreement, in December 2021, the Company filed a declaratory judgment lawsuit in the U.S. District Court for the District of Nevada (21-cv-02241). The lawsuit seeks a declaration from the court that the Company owes no royalties to RDF with respect to its EXPAREL product after December 24, 2021. During the pendency of the lawsuit, the Company will continue to pay royalties to RDF under protest, however, the Company is unable to predict the outcome of this action at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pediatric Trial Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the U.K.&#x2019;s withdrawal from the E.U., the agreed pediatric plan is applicable in the U.K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#x201c;PLAY&#x201d;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and U.K. to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency, or MHRA, are still reviewing the Type II variations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hong Kong Pharma Tainuo Ltd.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Flexion Acquisition, in March 2020, Flexion entered into an exclusive license agreement with Hong Kong Tainuo Pharma Ltd., or HK Tainuo, and Jiangsu Tainuo Pharmaceutical Co. Ltd., or Jiangsu Tainuo, a subsidiary of China &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shijiazhuang Pharmaceutical Co, Ltd., for the development and commercialization of ZILRETTA in Greater China (consisting of mainland China, Hong Kong, Macau and Taiwan). Under the terms of the agreement, HK Tainuo paid Flexion an upfront payment of $10.0&#160;million during the year ended December 31, 2020 which was recorded in other liabilities as of June&#160;30, 2022 and December 31, 2021. The Company was also eligible to receive up to $32.5&#160;million in aggregate development, regulatory and commercial sales milestone payments under the exclusive license agreement. HK Tainuo was responsible for the clinical development, product registration and commercialization of ZILRETTA in Greater China. The Company was solely responsible for the manufacture and supply of ZILRETTA to HK Tainuo for all clinical and commercial activities. The terms related to product manufacturing and supply, including pricing and minimum purchase requirements agreed to in the license agreement, were to be covered by a separate supply agreement, which had not yet been finalized as of June 30, 2022. Unless terminated earlier in accordance with its terms, the license agreement was scheduled to continue in effect in perpetuity or as long as HK Tainuo or Jiangsu Tainuo continued to sell ZILRETTA in Greater China. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequently, in July 2022, the Company submitted a termination letter to HK Tainuo associated with this license agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ibe0d71dff18d49c48f2bf3e271341ed5_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184OC9mcmFnOjNmYTNiOWExYmY1ODRiMTM5ZjlhZWFkOGM5MDliN2UxL3RleHRyZWdpb246M2ZhM2I5YTFiZjU4NGIxMzlmOWFlYWQ4YzkwOWI3ZTFfMTczNw_8bdea37f-e9db-408e-a2bb-d2f6a599a4de"
      unitRef="usd">30000000</us-gaap:LossContingencyDamagesSoughtValue>
    <pcrx:ProceedsFromDevelopmentAndCommercializationOfZILRETTA
      contextRef="ib0b9052c119f49399daa2d218196b388_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184OC9mcmFnOjNmYTNiOWExYmY1ODRiMTM5ZjlhZWFkOGM5MDliN2UxL3RleHRyZWdpb246M2ZhM2I5YTFiZjU4NGIxMzlmOWFlYWQ4YzkwOWI3ZTFfMzI5ODUzNDg5MjMyMw_b3151e9a-418d-4672-87ed-a1a4c46347ca"
      unitRef="usd">10000000</pcrx:ProceedsFromDevelopmentAndCommercializationOfZILRETTA>
    <pcrx:CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum
      contextRef="ifec5c95984324d979dd83044fa9e7ec4_I20200320"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjNzEyZjdiZTIxZTQ5NWViN2FmNjczMjdjYmQ3ZTA3L3NlYzo1YzcxMmY3YmUyMWU0OTVlYjdhZjY3MzI3Y2JkN2UwN184OC9mcmFnOjNmYTNiOWExYmY1ODRiMTM5ZjlhZWFkOGM5MDliN2UxL3RleHRyZWdpb246M2ZhM2I5YTFiZjU4NGIxMzlmOWFlYWQ4YzkwOWI3ZTFfMzI5ODUzNDg5MjM1Mg_a96e9ddc-5d10-48ec-84a5-719f12c5b8c3"
      unitRef="usd">32500000</pcrx:CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>89
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M6A&F.)2: JF?)1YA2C63TO&S)+6J,S5P??S$?F[,*S/W2. 1H]]()..!U;-
MA.<HI_*6K2YP:<C3?"&CPGR#51';]2T0YD*RI 0K!0E)BU_T6"9B#>!T7@"X
M)<#=%] N 6UCM%!F;(V11$&?LQ7@.EJQZ8')C4$K-R35CW$FN=HE"B>#T<WU
M>'(]FXR!&LUNKB['PSLU.1M>#:]'$S"[F$SN9N!HBCA.98PE"1%]#SZ M\ &
M(E:KHF]+I4.SV6%YYEEQIOO"F9_RM 7:\!BXT'4;X*/M\#$.%=PQ<*<.MY7[
M*@5NE0+7\+5?X)M))+&J3 G8')R3%*4A011,F2"FTKX/[X7DJMY^-%DMN#O-
MW/H2GHH,A7A@J5LF,%]B*WCWQNG"CTW&_Q-9+0WM*@WM;>S!5-T?S#F.@"JZ
M\.$89(B#):(Y!D<D!1&C%'$!,LR+!_^^*1O%$;XY0O^#+ /8@E ]I>6ZS5U1
M-?V=2G_G,/U%>0*4RYAQ\EMM:!_%:J/X@M];D^5!\]F0OSNN9L"K#'BO,D"$
MR'>+]YZ)VI2]+:(FN%L)[KY*L'I;"(G2B*2+7:J[.U5OBZBI]BO5_E;5(Y8D
MZE;_0Y'[>Q7YKJB:^%XEOG> ^(,KO/<LF6Y9NIMIWR>RYN"D<G!RN(/]2OSD
MF::.UX..Y_<VQ#<$=OQVIPU[S=H=^/=M"0]7?T"]E_1[>&B*;#9AK[W]=>OU
M&?$%206@>*Z@L.4K#EYT,\5$LLPT!/=,JO;"#&/5 6*N ]3^G#'Y--$]1M53
M!G\ 4$L#!!0    ( -9] U5"QY)8Z <   $L   8    >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&ULM5IK4^,X%OTKJNS45G=5T[$DRP\64@6QIX:M:>@"9N>S
M243B&L=B; 6Z]]>/_"".I6LUS&J_D#@<'>M<74GGVCI[$=4?]99SB;[MBK(^
MGVVE?#J=S^O5EN^R^K-XXJ7ZSZ.H=IE4E]5F7C]5/%NWC7;%G'A>,-]E>3E;
MG+6_?:T69V(OB[SD7RM4[W>[K/I^R0OQ<C[#L]<?;O/-5C8_S!=G3]F&WW'Y
MV]/72EW-#RSK?,?+.A<EJOCC^>P"GZ:4-0U:Q']R_E(??4>-E <A_F@NKM;G
M,Z_I$2_X2C84F?IXYDM>% V3ZL>?/>GL<,^FX?'W5_:?6_%*S$-6\Z4H?L_7
M<GL^BV9HS1^S?2%OQ<LOO!?4=G EBKK]BUYZK#=#JWTMQ:YOK'JPR\ON,_O6
M!^*H@>*!&Y"^ =$;^!,-:-^ OO4.?M_ ?^L=6-^@E3[OM+>!2S*9+<XJ\8*J
M!JW8FB]M]-O6*EYYV23*G:S4?W/53BZ6-]=)>GV7)DA]N[OY]2JYN%<7=_?J
MXTMZ?7^';GY&-U_3VXO[*P5 )^BWNP1]^.DCJK=9Q6N4E^A^*_9U5J[K3^BG
MT?797*HN-C>:K_KN7';=(1/=H>B+*.6V1FFYYFN@?6)O'UC:SU5H#O$AK_&Y
M)%;"?^_+SXAZGQ#Q" 'ZLWQ[<PS)^=_NGO[MNX^"00_)0EL^.L%WRY]YN>?U
M*32P75,?;MJL=Z?U4[;BYS.UH-6\>N:SQ3__@0/O7U!479(E+LE21V2C^/N'
M^/LV]L6]D%F!2K5]/%5BO5])5&<%!Z=91Q2T1,UF\;S 0>QCE07/QW$&8)2Q
MV!O#$A-&2>A[9 Q+31AA?H## VRDFAU4,VO6W3SQ*I-YN4'\F]H?ZXG\8R[S
MSR59XI(L=40V&HG@,!*!-?^6HI9(/**-$.L:U:* 5NC+CH,=90'S A)JF6>B
M*"-^I"6>B8J"T-.R.#510<#BB;0+#V)#J]A;%;ZL6FV1VLF4]7A6GNI).20)
M20Z-#I" 1-KT6)HH3%A(-<DFR@^C2 M?"MPQ\AF%)4<'R9%5\IWR:VJ>?4(;
M7JHY5[32L[6R'7DMFSGXS"'UD1E^YGF:KJ6)8EZ$=?4F"I.8!!HL-6%Q3"F#
MY<<'^;%5_L5.5#+_;]8Z6)7FV>K/?5[QM?(T,BLW^4/!45;77((K;FSVW*=$
MSP$ %0?:X"8FB$2![VLQ,%%4Q0 . ?8&/^C9@]"(KO,F!B<5+S*I]'_8J(JC
M_HA6RO)MN+)YK]O/.J]7RF_EY;X+6I,O0FYY!3H_S^CP"8X\ILWY)8##?J"%
M""2C(=&7!@!'/!Q/1.G(->,W[,3"V)E W=C40R,<!KIN .=YH:]G!X C812&
M>GY .#4MZ<2ZB,D@GEC%7Y4KL>/HL1*[UQ"($I9.S!S%Y&B>]LH!F!_Y^MH
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M\1 L8(:O!-F."Z5>,@"+8C(AF0S6DMBMY36WK=-]X]&SB#@R7!((4X6$)A6
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MD] $5\,4+D*$*P \7S$F]Q.U07NUFOP 4$L#!!0    ( -9] U4OSDJ?RPX
M '"P   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULQ9UK<]O&&87_"D;-
MM,E,9.$.(I4TXY# [J;QI9:=3J?3#S"Y$E&3  . 5O+O"X",H 5>+@GKR/EB
MDQ+V.0OR8'$Y^ZXN[_/B4[F4LC)^6Z^R\NIL656;'RXNROE2KI/R1;Z16?V;
MV[Q8)U7]MKB[*#>%3!9MH_7JPC9-_V*=I-G9]67[L[?%]66^K59I)M\61KE=
MKY/B]Q_E*K^_.K/._OC!N_1N634_N+B^W"1W\D96'S9OB_K=Q0-ED:YE5J9Y
M9A3R]NKLI?6#\(.F0;O%+ZF\+Q^]-II=^9CGGYHW8G%U9C8]DBLYKQI$4O_W
M64[E:M60ZG[\NH>>/6@V#1^__H,>MSM?[\S'I)33?/6O=%$MK\XF9\9"WB;;
M5?4NO^=ROT->PYOGJ[+]U[C?;VN>&?-M6>7K?>.Z!^LTV_V?_+;_(!XU\,(#
M#>Q] [O?X)""LV_@]!I8SH$&[KZ!VVM@!P<:>/L&7J]!<*B!OV_@]Q4.[4.P
M;Q#T%0XUF.P;3'H-7/] @W#?(&SML/O^VB]_EE3)]661WQM%LW5-:UZT#FI;
MU]]YFC5FOZF*^K=IW:ZZGKYY/8M>WT0SHWYU\^9G,7OYOGYS\[[^[U7T^OV-
M\2:NW[V9_H._^7D6O;OYFQ']\X-X_V_CW/AP,S.^_>8[XQLCS8SWRWQ;)MFB
MO+RHZGXU](OYO@\_[OI@'^C#^[Q*5D2SJ;[9=+O>KI+F6#&BV]OZX/G>>"N+
M-%\8^:WQ<I%OFJ/I^_K5_^J/L3X^*T)B=D0B7Z_S[*]_L7SS[S=5/O]$("(]
MXN5BD38=25;&VR1=G(O,F":;E-[C^$M9!N+#8$?4Y_.=B%P8,WF;SE,*PD=#
M('T7I\OFU5(6QCQ?UV>'93-LU[K?KO*R_*[V<?UCJ>(OZB/JX;"R'PXKN]5S
M#^C]*._2+$NSNWHD7B79O%:HCY%RF12REDFJ>M_G+PS'^MZP3=ND#ADMOSD%
M_E!NDKF\.JOWHI3%9WEVO?,I=2 A8;,=S&MAS;GT\[7K^$Y@FO5^?'Y\8"!5
M8R2,(6$<"1,@F&):Y\&TCMZT>ZO6]OSXX-_Z$-SL#L937+L3\!]YP[="?S)1
MG3'5]F.L'X>:KMMSXG"32>#8IJ5N%B.[Q8::Y[;G3 )/%>5(43$4=:SNPU=<
MX3ZXPFT;.0=<(;)Y?15=UB-8_>VWKYIQTFA/A\M\M9!%65\3_+I-J]\I1[C(
M<0P)FR%A$1(6(V$,">-(F #!%%=[#Z[VM&-=])LLYFGMZGI\*QLK&[O+C/+Q
MB9KRLQ8[UL](V,P;GI>#<'A61FK&2!A#PC@2)D PQ:G^@U/]+W,JY4Y_X(&Z
M%[;=._UJ!<?:#@F+3NI_C)1D2!A'P@0(IK@N>'!=H'7=+[)L[I5J<%6D\^;E
MSGO;+*V.CI%:]-@Q$@F;!0-_V<T0V1\CD9HQ$L:0,(Z$"1!,<>ODP:V3+W<K
MY=#)P <]"TRU@F-MAX1%2%B,A#$DC"-A @13S!D^F#/4FG/W$''OR+0LM[4]
MMUE]WV3(]6:5_R[E_G>;;3%?-G=:F_H^_-@8J]4<.\8B8;-P<&PYUG"(14K&
M2!A#PC@2)D PQ<66V24%YC/XF(P#S.%EGA?T'MI,]=T9ZTHH+3II#V*H)H/2
M.)0F4#35FH]"+$MKS?9AU'D3>B[:!_LR*Y/F'HDTGS6\!C2]P.J[3ZLXVGU(
M6G3:+L1040:E<2A-H&BJ_;JPQ]*G/6^(1&D7)>V#)=*'PQSEW'*"O@VAT0V4
M%D%I,93&H#0.I8ECW[SJPBZ]L?3QS6M9D0'FWFX.<>OK>OW;'KW&:+\A:1&4
M%D-I[+2/ET-%!8JF&JX+ABSM$_KK*%MH$NZ?MMD+PS';K- B'0F-AJ"TV9ZF
M/$QW72KDANK&4!J#TCB4)E TU;M=_&/I\Y]'6;?,%FK*?=RYPZC%GP26WX^Y
M]7T8[4GO>-!-]"RT+*??LQC:,T:HGMNVZ]K]K!LJ*PA9:V(=.(UV<8NESUN>
M/G5'+S!Z8(.F-=8P83DP>P>J&T-I#$KC4)I T53[=KF-I0]N )-XK&%*0L[B
MT?=DM#.#$X:W8<_(B3S0GC%"E9[* Y45A.S!R3Q6EY18^JA$?]'VV!OTJ0_Y
M6'X*I<VL8:KCNH'C$F,;-$.!TAB4QJ$T@:*IWNV"%$N?I.@NVHX[-QR,+X%C
MNN9@5!MN=^Z&MN.HV\V([5RO[[-A%A*ZMAD.QBM",_3=_F4;(WCGMF5-PL%(
M1'0NL)W>9H+@6?Z!!Q%V%Q38NZ>]SS1CT$8^F9Y":3,H+8+28BB-06D<2A,H
MFNKO+FVP]6G#.SE?)669WJ;S-F5H!J)J*0W96KI]#IQG,JN:G\_S[+,LJO3C
M2AJES-*\,+*\DJ51Y<8J33ZFJ[1*Z[?;35/YM:]U:.L>YO-\FU7-N?JF2K)%
M4BQ*X\-FD52RO7 [-WWCV]=Y\XY\O'QD'T[!OY-5D9<;V=:C&?]Y)=<?9?%?
M\B"#AB506@2EQ5 :@](XE"90-/4@ZS(5^XD5-*^20G_"UPN,/H]@:VBH(IK0
MFQ!%--@J&FP9#;:.!EM(\QR5-'87QMA/K:4Y[E^BF,8S)U;_@E7?D]'./*&<
MQAZ&'9/0M?J7TC&T9XQ0/;==QS/]WL4O5%80LE9@'[A&[K(3VWW6:V1H=@*E
MS:"T"$J+H30&I7$H3:!HJK^[?,5^IOH:/7>TLZ$)C$T$#KY-G+.A-390&H/2
M.)0F4#35LUWR8P,K;>QAD.+9_<!KJE<<[3]HK<U)>Q!#-1F4QJ$T@:*I[NN"
M&_L9*V[T[-&C)C38L8FBFXE/C)K0JALHC4%I'$H3*)KJVRY0LL&U-_;QXAN]
MY&@#0LMOH+082F-0&H?2!(JFVK3+CNP_HPI'+SIZW(76X=BG%>) 16,HC4%I
M'$H3*)JZ5$L7LCE?JQK'.:D:1]^=L=Z$TJ*3]B"&:C(HC4-I D53K=GE8PZN
M&L<9EK)8INOWJW'TBJ/=!PV83MN%&"K*H#0.I0D43;5?EQPYSU"-XPP#F;#O
M06@"!*5%4%H,I3$HC4-I0ONUJ_Y[M(K:4^IP'").",W)8,##+I$&K<.!TF(H
MC9WV\7*HJ$#15,-U69*C?9;_U#H</7WL/0R4-MO33JC#@>K&4!J#TCB4)E T
MU;M=3N0\8QV.<V(=CKX/HSUY0AT.T3.R#@?:,T:HTG4X4%E!R!ZLPW&Z-,8!
MUN'0]H#6X4!I,X>HPZ'GJD-U8RB-06D<2A,HFFK?+LYQD'4XM'^'%3'DC'5B
M.W+&.K'=8,:Z,PQKR!GKE"8U8YW@T3/6J<X1,]8)WL$9ZTZ783B3YYR-XT"+
M8J"T&90606DQE,:@- ZE"11-]7<7?CCZ\..+9^,XPPS!KX<@R^D/0=#D@E8E
M3HW0Z )*8U :A]($BJ:N)]Y%%ZX^NA@USV;/>GQ>L*VP?UZ8ZB7'&I 0[9T
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M=WCC]^.=IRJ1ZZ)R(8UM$ R3#E*'$&8!=D/%@6&VP OVFU0*?7B$4N8C K@
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M':]PA]>K%GAHT 00;03^H];.AX#,2P'2E'F,9NLKJ]=K\ 'I=YUD,5XJ$,7
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M0EDFN%&TQ$3\\XH#&[^'E@59+)*T!1=I;R"%\ M M2V8YV?.H-99Y[L((^S
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M4="C.*J[R0ULXK&X_Y[4C>P :T$#=TTG!OY24*0O/O]4U'X9G]4J5-,W&9T
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M#:XO.(W6>)92V]JS<B5=956X@RSSDHS$DQ#DAISN11C)6N(TN]7VEN X39C
M9980$6F:#E'4$E&;!3,M%SJ#O54=\_(1?V7VY)0+F5X"8J*1KM4.)[J^K"P0
M.#P@.< 0&67^@-\Q01=YH1(4?,J;''-YB4RO@D/P?0"*?V9!KJI2I/W*(_P%
MA2EE13@F^>N3DE;(9=A3H0[6&3(%99!]B7QM-HR2W0Q9C*M0'6QH!3*-UHVP
M=#"_7!.>"PH!B'*;9CHFKKD4BA,77=S6:NGW8D86(T<QE8.ZW>&IN,I-10YR
MJQ*S*O3W[=$NIG=\%(J&. \:IU$2D$HAI4H/\>)0?-IZF[A15ANT5YV4\7IQ
M^%>NNKJ[>W]_%_J4V_?OQ%M*XYSPZ(&R'13 C _$:#2.IK,83]1XC.*SSM[=
M&A#[,& NY(/4&5FH#^/T'8[#8QY4 W TBD;3<<NB7EXE2<!LX5"XDPP\CJ/Y
M>-Y2ULMK\"J\L>3;\4DTFQVW%/7RAFH/BJ%ZQ$SEZA PU+DTQIM$\VG<'@NK
M#_J1]!0(XG$T'G88A^4[M526;,[Q%"BG\V@XFK:4]9*GKKY9]I$R&LI9-)UO
M"</J.J7<O=0LKRX\ E_38X-S/HR&P^$6:;V^+OKH&2CRJ(@C>))@M$Y#)UY?
MW]R^DGEY]NY0S$8[;.KE/3<K]54'8AX/HY/CDQWS-GL?KZ_>7']$'_O^CESF
MZR>X2FNRIE <B)/H^&2RPR#L@-12A6TM$L?1\60F3J;'I-OCX7BK6_B]*BK*
MXSN8Z^5'10';S6_[U/J%C=VE@I?-M_8,JX^F6 67Y?8D'HZBR71[8[,.:NHR
MBZ>CZ!A.S_"G$&5T4E/IKCWW98OI["2*1\?B-<X>8C6/XME0_,V8=(-R#'7-
MXCGSA;PDR?V>AA)S4^%J;1T(](O1?#+=T7JS1_GB:F\N:<I875#XZ/&9$U=%
M4>'"6R:CSH.&<H#I_Z/M8SE9AQK\#L'*\\QX%.:9 ><?G":W9-^PJM]-C:T'
M;+LOCM5G;2#045F/\-)2;Y-17[ZD(;(F1+)G3]CI"^MAD-J>0E;H=ZA?MX9E
MD.(N?!"A(U_*6I=N?V59FTTH=57+!_'&K;5L/JP0'[/ETXY#:ZL4!R,ZECYW
M+*+D-+VO<8':)+=2+]6HM43J2I**C8WUKQ+VP>5!WT.JC-IUP'5K<VI4Z+51
MZ-B<H2T/IL'\4]>$YRZ H9Q< &151I.<J3*TNO)!H2E4Q9\&*[D7>H8W-!\Z
MP-*8!JE*/[ 9&8^KD,EV;T8G2D[#8PHIF4?:RE?D.:'\[53:"-2)*CV]#&V\
MD*$<H@;?LW&Z7U'$'?K*G8T0<746XK(W0X::48"A!D3C^4A\AA]BK*67KU$9
M9HAD/$&ZR1R/-ZTQT+[K)"1FG54D0-&<W*+#R>%@.#\,#Q,PN'_!\99M4]NU
M\B8T"P@4$-,'F-4/_4CH:WE\#CF;B)K!=F?&@#-1::5)?_]M>Z;CVA-"D]8$
MQ_]#C98+=)HSTI*^'89XVT;BED%G(#H-'T-F9TUKT\6D"_2?BFOS0A5JJ7WM
M2<1N:0VE^<0B:]"Z!MTZ/59ARM[VT=1$;@!="1Y@?RS]>T/^Y2%E=-9!GQM<
M1,B? T$3H&@P;S)EZ-:=,U AN4,+I-8K("?TG01.CDSY_8<YF #N3NJXE.M=
M9PK?(NNVDO7IY_FA15@KO%$#=XP\(M'$&0I>(U[W@G8.9=Q LS*4'!UFS"YP
M)%JORGY5UBVX+KB-I-;O:2^['0TTVF.[M_%@5=LCT24J61=AVONA]=I[0TK)
MD^Q0J_&Y[9:=%O*,#;>'2:A;#3ZJL,^XV$[OR)\K;K]\C6JN [1^[2@?D8NV
M\_?"((]V/QZ$,9HWZM3Y;$XG5]:P;>('^[Z;'G4^=^?*KOBCOA.<0,*7[W:W
M_=W@*GPNWY*''QT^2;O2*)*96N+H<' \[04QFX4W)7\\7QCO3<Z/:R71\1 !
MWB\-1OMZ01>TOZ9<_@]02P,$%     @ UGT#5=O/,!F4 @  >@4  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&ULA51=3]LP%/TK5]DT;5(@7_T(75N)
M#M"8!$.%P<.T!S>Y;2P<.[,="O]^UTG(.JET+\FU?<_QN;;/G6Z5?C0%HH7G
M4D@S\PIKJTD0F*S DIEC5:&DE;72);,TU)O 5!I9WH!*$<1A. I*QJ4WGS9S
M-WH^5;457.*-!E.7)=,O"Q1J._,B[W5BR3>%=1/!?%JQ#=ZB_5'=:!H%/4O.
M2Y2&*PD:US/O-)HL!BZ_2;CGN#4[,;A*5DH]NL%E/O-")P@%9M8Q,/H]X1<4
MPA&1C-\=I]=OZ8"[\2O[15,[U;)B!K\H\<!S6\R\U(,<UZP6=JFV7[&K9^CX
M,B5,\X5MFYO$'F2UL:KLP*2@Y++]L^?N''8 :?@&(.X <:.[W:A1><8LFT^U
MVH)VV<3F@J;4!DWBN'27<FLUK7+"V?GE]?WY]=WWY>7Y[32P1.BF@ZP#+UIP
M_ 9X!%=*VL+ N<PQ_Q<?D)!>3?RJ9A$?)/Q6RV-(0A_B,(X/\"5]=4G#E[Q5
MG7Q":95^@3-N,J%,K1%^GJZ,U?0<?NVKN"4<["=T%IF8BF4X\\@#!O43>O,/
M[Z)1^/F W$$O=W"(_7^7<1"\7]H.(]P5")DJ*R7I3 RH-?#N>#@:'R1U $;'
MPPRLE2"S&OC()=A"U8;)W'R: %T/-M=SAAF6*]201.U=N4\$2[:EMVE1<R8,
MO(=DY"=AU 7)&![(H$=<'E5:96@,)"?^(!Q#,O2C-(8++CD]Y!PV2N4&XH&?
MIB'$8S],(KA3E@EBBL+0'Z8I12>I/QR&L._8@QT_E*@WC>L-%5]+VUJCG^T;
MRVGKI[_I;5>Z8GK#I0&!:X*&Q^.A![IU>CNPJFK<M5*6O-J$!35'U"Z!UM=*
MV=>!VZ!OM_,_4$L#!!0    ( -9] U5C&),Y@P0  -D*   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;+5666_C-A#^*P,U*!) D'7:<FH;<([%;M&@
MP69[ $4?:(FRV*5(+4G%27]]AY3LV-DX&[3HB\1CYIM[.+.-5)]U3:F!AX8+
M/?=J8]KST4@7-6V(#F1+!=Y44C7$X%:M1[I5E)2.J>&C. S'HX8PX2UF[NQ6
M+6:R,YP)>JM =TU#U.,%Y7(S]R)O>_"1K6MC#T:+64O6](Z:7]I;A;O1#J5D
M#16:20&*5G-O&9U?I);>$?S*Z$;OK<%:LI+RL]U\*.=>:!6BG!;&(A#\W=-+
MRKD%0C6^#)C>3J1EW%]OT=\YV]&6%='T4O+?6&GJN9=[4-**=-Q\E)OW=+ G
MLWB%Y-I]8=/3IBBQZ+21S<",^X:)_D\>!C_L,>3A$89X8(B=WKT@I^45,60Q
M4W(#RE(CFETX4QTW*L>$#<J=47C+D,\LWGWX_?H*EG=WUY_N9B.#B/9\5 S<
M%SUW?(1[##=2F%K#M2AI><@_0DUVZL1;=2[B5P%_[$0 2>A#',;Q*WC)SKS$
MX25'\&X5IJ\RCS[<<B(,$%'"]9>.M9A7!OY8KK11F!A_OF1ZCYR^C&R+Y5RW
MI*!S#ZM!4W5/O<7WWT7C\(=7]$YW>J>OH7\S+&_GAG?L@99 M*9&^R"H\8<*
M9'_C^>H1L^DOJ: @AJZE0D\5$DM.&Y 5F)I")3E6+A-K.&4"3V2GT8OZ[!PP
M6-0%ZXH6M%E1!4G41\Y^(K@A18V:J4?G=KIS^PE$T=A/QJE;3?P85S]1+*U:
M\A)8TRIY3RVEAG'H1UD&V=2?I"%<RJ;M#,IYPK+(6E9F0Q2%*/&S:6Y_T70"
M/U<5*U#_3@EF.KP^U"+VDS#!;YXG""PP$;J^4:"5J,$:@ZIAFOI)$D,>^EDV
M@4_2$ YQ/O8G&=HX2?QQ&J'J6I]C>RFZIN/HQ1*[ J9$P8B#.YUF?CI)SN T
MS_PX#<^^CHCUPS3RX\G4KO+<3\,(L.DX_YM:40I-7V?4UMF3XYVOK5G6W_ZA
M7/J C5M3V! -)^,@P^[!N6N$2'\2!]/M@8_-5;?4M4?^&/P;P4BN!DE1$!Y*
MBH)H=X I59"6H1==\C&!P:0VU8236.R' 6D;(KH*R[-3-OTT,U0?4U:SA__J
MHR@.XD/5LR#_EI/>+/? 1?GS8/R?+EJ:%Y1Z7K)60Y?=U5?)R43!NY)JX"_7
MJ(4[5 ,O"UL]3\7&9>$J VOKNK,]&5AO#VED)URO.1F'SU-GG 7IL0 LM65Z
MFV$HQ[8.(AZA)H-Q"&>8<B: 7'&V=AGA0$^2O7@, 3JBA[_UCC,->X#J<#FD
M5>\::2,/G)$5X\PP/+4]!OV&H2PM6>F"*CDKG8M6!%\J[%ON3?>Q_6)OEMKZ
M66MI$Q=I-LS4U@#;VM#?+C#8!^USI#&.UF*F0"JV9@)C:B4QES%=.^019A5.
M$V2;1@4^DCC!]4A L/GUP0U>>LM&>^-&0]7:#576'HQD/WGL3G=SV[(?5Y[(
M^Z'OABA4T:96A:QA,,D\4/T@U6^,;-WPLI(&1R&WK''VI,H2X'TEI=ENK(#=
M-+OX!U!+ P04    " #6?0-5.Z <8M &  #D#P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6RU5VUOVS@2_BL#;V_1 EY;EB6_I$D -TVQNVAP0=S=
MW@ON RW3-E%)U))4;.^OOV=(RY'3Q+=?[D,B6N+,///,&WFYU>:;W4CI:%?D
MI;WJ;)RK+OI]FVUD(6Q/5[+$EY4VA7#X:=9]6QDIEEZHR/MQ%(WZA5!EY_K2
MO[LWUY>Z=KDJY;TA6Q>%,/L/,M?;J\Z@T[QX4.N-XQ?]Z\M*K.5<NM^J>X-?
M_:.6I2ID:94NR<C556<VN/B0\'Z_X7<EM[:U)O9DH?4W_O'+\JH3,2"9R\RQ
M!H''H[R1><Z* ../@\[.T20+MM>-]D_>=_BR$%;>Z/RK6KK-56?2H:5<B3IW
M#WK[LSSXD[*^3.?6_Z=MV#O YJRV3A<'82 H5!F>8G?@H24PB5X1B \"L<<=
M#'F4'X43UY=&;\GP;FCCA7?52P.<*CDH<V?P54'.77^^G<UOYY=]!UW\II\=
MY#X$N?@5N1'=Z=)M+-V62[D\E>\#PQ%(W #Y$)]5^&M=]F@8=2F.XOB,ON'1
ML:'7-WS-,8E86?KW;&&=0>S_\Y*/047RL@JNAPM;B4Q>=9#P5II'V;G^\8?!
M*'I_!F!R!)B<TWZ&^;\B1U\VDFYT48ER3WGP5>0YZ14I9VDE,I4KIZ3MDBJS
MO%ZJ<NV_W/[C?O9P^YE$N22E'Z41\&@\>H^D*FN(N=KPUH."/:1I+DKZJ.1:
M=^E&Y J=H%2BQPBL;&QOQ*-$D7(;8'$G36&IKLAIFO1BVDMA ,7J0C+$[49E
M&ZJ,?E1+%BOE5@![Q84*/QPY>(>_\J>L-OCL@,Y\0XMZ%'DM>R?.B]QJF+?D
MMIIDL9!+)&0#:ZO<AG>;0M,GA3(Q-,\4%*J5RNA^(U#8-$=D58;=\,Q;KJU'
MB:4RYWC9JG*IRRYJ8)TSGXT\'%O6H>M 39OQ?_WR^>'VRY=9CV94:=-L82%A
MK<Z4< !?<&GE>]]N:"4]O9864I8<8YWY36"6Q;RCE($,7<(OZX66Q T/Q.:"
MFQY0PQ'/'7]6-C"(SF[P'5XU2JQ[(N$IA0X9U-AB/TI=_O3<,L);(ZI BG<%
M \"4(,X()TM19D%2.P["8<<3 KG#F+&<KB+7^.T#)W<RJYTV^P.T1K\J;6V.
M&F$E)VD=6"$G=I*]T\[GTTO^ 17K6&DPN;7T%H%T&UU;J++O+D",D?*DN=%<
M[4Y?H%=)WZN."VY:_&_06GU2NR81#Z;?T+";)C&><7<:\W/<C493/-/N)!G2
M[\(HL<CEB5 :32B)$YI.(II&\<&W-Y1THS3R*H?)",])-TI8U:@[3E*:UU65
M2TQ/WIP)NZ$5W 5S88Z'D9HWB?2,*3!LSW'T.B%/WM^PS4JH4!7/0Y'#SV.#
M*E'8*(+P!;G&Y8FD95=&P[%G:3 >T\/??^,BD>#$R$P;-@Q@<I=M1+F6WD[0
MH1>Y6HO03-[0CS],XD'\OK5JMP^N+']&"$PP%E^-!5?GGZ)=H4< /NWXC9&M
M.G^JQL:[/3H!_%$58@"D(?5;KI/GE0,-%DLN6ZRLSM72!\:G-(>0M1]C:'O?
MX2]@M39,![@Y0S5W5O1RU(HJO(6ELIFN8<!P\>!K:,S* 4B=+VFA#4\UWTQP
MTN!\,9@ ?T+4]Q'B 7)@HMWZ?2RD@*IG: +VK3\K08G@^;-N2P?,7D=#\G>[
MGZ%&/8<CI<?UE+87+Z7EU[]D>MP;#L/,PO0:#P[+[V1/@8QZTY3^AL=DBL>=
MX(GA63_DQB%B/@G'[_]'H,XWJ7\"#\W6:R/7;/D.#A1U0?=B7_@9\!&-WOO\
M]LD]BZ+U@\6^\Z651E/>,Z0!.DB4\#KA=3),>9W2(.ZF8[\>\7HXB/PDE6(%
MCF@X[29QTXU6-9QMLK]J4$S'W31-Z;.TB(4JJMKYBH4T,I#>Q@,TO=&[5YIU
MFPUT@+0[!MZ9)_,DK-TVMZ&:O05O"9VM/(XML!6JJ=2N&6F(Y0(YS%P_5\.[
M]MP-Q#?,W4JC\*UME3J&/""[?8^^XJ!R.HMA)N/.YN=HFYMV9]HJG-<6_^<X
M3P8AR,DT#A%.IDD(;QH-0VS3*&T'-L$@.A=5'E[I8(()L[#RCYH)!<]G8G(2
M#X%:702-QX,&)A+L?LKE+HPE"Z]YT*/^E_(1]\;*ARU'J) B?!P 35_UHC8X
M>]VA(Z/1X,CFG&^HO]8X.7E20C.#/MS0PJP0]";J);A'Y3F;>FKH0+;@7I#E
M^(VS81@&@E9^AOL]O9?._/W6S0M.K/W]D@] Z KA$G9\>[S"SL+-[6E[N/_>
M";/&P09TKR :]<9IATRX4X8?3E?^'K?0#K="O]S@&BX-;\#WE=:N^<$&CA?[
MZ_\"4$L#!!0    ( -9] U7KRE3!J0<  $$3   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;+U8:V_CMA+]*P,W6"2 8\MR["2;!^ \NDV1W09)NEO<
MB_N!EFB;74G4DE0<]]??,Z2L*!LGZ&W1^R612,[PS,R9AW6\U.:K74CIZ#'/
M"GO263A7ON_W;;*0N; ]7<H".S-M<N'P:N9]6QHI4B^49_TXBL;]7*BB<WKL
MUV[,Z;&N7*8*>6/(5GDNS.I,9GIYTAETU@NW:KYPO- _/2[%7-Y)]VMY8_#6
M;[2D*I>%5;H@(V<GG<G@_=D>G_<'/BNYM*UG8DNF6G_EEZOTI!,Q()G)Q+$&
M@7\/\EQF&2L"C&^USDYS)0NVG]?:?_2VPY:IL/)<9U]4ZA8GG8,.I7(FJLS=
MZN5/LK9GQ/H2G5G_EY;A[&C8H:2R3N>U,!#DJ@C_Q6/MAY; 0?2*0%P+Q!YW
MN,BCO!!.G!X;O23#IZ&-'[RI7AK@5,%!N7,&NPIR[O3#+[]<?+FZOJ;)IPNZ
M^G0_^?3AZNSZDB9W=Y?W=\=]ASOX9#^I]9T%??$K^L;T41=N8>FR2&7Z7+X/
M; W > WP+'Y3X<]5T:-AU*4XBN,W] T;@X=>W_ U@[5.ERK+2!0I715.%',U
MS21-K)7.TH6R2:9M923]>S*USH V_]GDAG#+WN9;.)7>VU(D\J2#7+'2/,C.
MZ;L?!N/HZ T;]AH;]M[2_A>"]G?T4>.R^X6D<YV7HEB]^^$@'NP?69JO-V$F
M,L'2S.B<'$Z*Y%NEK/+)IV=T(Q)E!-TL!)(ID953B<AL%S%(>K3M-J@^%YE"
MV2F4(!0A(YPJYJ@>4ZM2A0*R$ZZZ^[J202G]I+,49X+.+FGC-TN_V:7M EX6
M+06,ZC.J0P58'XRN2BJS9(=401^%219@7+0?D#&D.#IZTD:3)^/\YN!HITL?
M5_HN4;)(9 M">[&M[&E]DS)&,2F-RH!B<.C)RK(_9O*1_=F2X).?](/,I])P
MD@QZ/DY3D0GHMB0<(8=DDT->UX5,@L!PX%<'M)2@_-9@;]P;H,YDF2^9.(FE
M42]>+W4YS*7TI31;A9M4D: =6$E+82FM)#E-.1:00ZC>CA ZI5,2Z>\H9[P"
M3-;J1 DG4Y0[MWC-M![=20GCG*2][J8#70(_*->&480.Y<48UN9@D4Z2RAA<
M_"S,78*OH0K0&8N1$ CP+:\9F6B34H+2!GZQ47@$BSPIV5&.9D(9>A 9[*]0
M^@R2YYP.HM'N,.J!#"Q0U)VH,7DSQ"ZUDH'$W$B@!8A$&H<NRZ&0Z L(:2E6
M 2)[X4*6^JPJU8-(< J;1J=5XI!A"%!6<6+0Y6\WD]O+Z^"@F2I$UL;P0C$G
MR-8P[D4-(Y8+R;0H*D@6&!FL@ ALR[C+ B:(@+$!K!E%45L,S,"&D@_!\6S@
M3%<&?OA6">/@+ESE><B<*X5*P23#D/U19:S[[F3<VU"]6RO"KW0993=$RWI[
MG&?L+KR#Y+!,9^E9P/>FP)?IDDWWJ7MU<_M.Y.711;>]S=&0R:+0F9ZOGLK=
MIM1\58HW0G>'049FGD9VH<I6_=Q<(+RH .'#&*7^@&+!#,@P7UG:3O$@#(E<
M5\P,[VQ=64C9G???50(4/<MEUI@5N_JS9^\$"9)7F4_.EC^_^/E&IKN3![!^
M+NE7*V=51M>H!&B;+XU46-ZBT6'4C:((3]NC47=_N+_#B\.];CP>TB"B%;R/
M*(V0Q'YL.-_LE,.(MN/#'1H/&B&ZUPXL!(N5D[N9"M3:%/\ @E4PA/%XQP,8
MQGO!KUP,FDCC!H_7-Z'X:/T:[GI%_1:-1P-_P=;3%6SZR%_RLM;^?_T>[P-;
M\/LX[AY&_[/?1_#[Z&_Y'1 &<;P3 (P/_@F_KZ_ 8CP,EZ O./5'J-#R$3]C
MT*-\O_Q.FR^?G'%N@5KK$\RJQ[5G) ^RWR4.US,TQM[P>:N,#WKCUSKE/X9F
M$-"TJ[0',^P=_JFNC0HA-F&KR[3OEF@%''M2*./UH+>NI<]DL?:OJ^O;R_O[
MB3=#6R<UJO;"H'99^EI([BU\XYH @%[BP%K;GYMO4.VKG#.G0%=<P'W2KN'.
M?6HEZ]0*9;#6[HUZP23?8"K'$S^ZG\I] F[TB*X;UYO,)S\,3^5S-C1!Q5 !
M^_T@^Q34NJ-UT3;W6YSRG0 ;0^[^<<3QWAKN]_:: [ 9RZ@J6_M/P:Y7XYJ2
M3[-;O3'LM>=X 'K@7[JD #W3Q;RVJ\5%A8/*^'F VS\J#MH+O/+@)P131X"U
M8\!'#;.N'CR-LLQB#$>J2#'M.QD8]3(X4.<OY/!A#%=^:H7X5]XLM(,_68#'
M,*Z"\#9(0,ZH^5SZ*2& X43 4(8A;:9@P]KG#27;=]2#*M.9QZ3:/WR\ --W
M,6CD/$+]'N::1-@%S7R';?ISH[:>M)[[-<'_3'HN%6T7,@9K_2/20E?SA<=0
M&Z8RY5:HY9A57LSMTZ!4-&,1U\#&F6'T;"=@VUHQ!^NL\V(83_$CEUT/<$%'
M8QQ3W1L,UX##&'5YQ&5?LM5KU1B]@K-3R7["M)F&.+_J;3[<BI[G)L<U.$:F
MO4V_BONMSQIH37/_\8:G34 /7SB:U>;[T"1\%GDZ'CXN8=*?PP&4R1E$H][^
MJ -^^0\VX<7ITG\DF6J'/N@?%U)@CN<#V)]I_ JI7_B"YJO9Z7\!4$L#!!0
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MP_V%$?+AC6GDO4L? N\JKPOCH3X<U;?CIT;9^4$BE.3TF)P!^Q"%+"5QBH[
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M]>Z(7)MK"'((?@ >NEYJM!$"P-#T'0_O]+$$$H"!VX>V-[Q>XT4<J_>C^=Q
M0P3V OM.7M^MOVA<VA?Y[7'[.>0SRW'.4A#S)9*ZW=&@ [G]Q& W6F;FM7XA
MM9:)6:XX#I8Y'<#G2XGF*#<DH/[.<_$?4$L#!!0    ( -9] U7>V8%5$@0
M (<)   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;+56;6_C-@S^*X1O
M.[2 F_@EK[TT0-\.=P.Z%9?>-F#8!\6F$Z^RY)/D)OGW(^4D2]&T&S;LBTU)
M?,B'E$AILM+FT2X1':PKJ>Q%L'2N/N]V;;;$2MB.KE'12J%-)1P-S:)K:X,B
M]Z!*=I,H&G0K4:I@.O%S]V8ZT8V3I<)[ [:I*F$V5RCUZB*(@]W$EW*Q=#S1
MG4YJL< 9NJ_UO:%1=V\E+RM4MM0*#!87P65\?M5C?:_P<XDK>R #1S+7^I$'
MG_.+(&)"*#%S;$'0[PFO44HV1#2^;6T&>Y<,/)1WUC_ZV"F6N;!XK>4O9>Z6
M%\$H@!P+T4CW1:\^X3:>/MO+M+3^"ZM6-TT#R!KK=+4%$X.J5.U?K+=Y. ",
MHE< R1:0>-ZM(\_R1C@QG1B] L/:9(T%'ZI'$[E2\:;,G*'5DG!N^OG'ZY_N
M;N'A\M?;V:3KR"+/=[,M^JI%)Z^@!W"GE5M:N%4YYL_Q76*RIY/LZ%PE;QK\
MH5$=2*,0DBA)WK"7[L-+O;WTM?!4IBN$![&&F])F4MO&(/QV.;?.T('X_5C(
MK<7><8M<).>V%AE>!%0%%LT3!M/W[^)!].$-OKT]W]Y;UO]V._XY&K:ASY$J
M%Z%L1TZLT8)0^<$$X)I*W)(.K5@HM*1*M7"2DR ,B$HWRED"@%OJQA+8GI[#
MP](@/MM^F)7KYQ.\B?R)#Z0MK1/:"GMZC-TYW)!L79G!=Y"DX7 \8J$?C@8I
M"70XTE%$0B^FI3Y0;5+E*3CA87P*)TG</^51-!S3/PU[2>\4'K03<N?F6$K(
M0Q)&T;!U->AYG^,PC6+V.0K3X9[Z8<I(*8Q3UAF$_8%'A_TQ_T?AF**]+0KT
M?<>CC' (<03?0S*@SYB%E#X/2X1K7=5";=Z_&R7Q\(,]MC\&_8GCS7"$X!Q1
M6Z(\"Z4:"@]?.A-U+4O2<-I#-BC,F=-G.:_ENS13AR?E4BW(@Z5N1L<@_X-:
M#^$H49"A<=3=(:<",NA:ZZ7#RG:.,G])PWH[3,#Y4\/GS])AJ=K#@OZP4.GC
MOO0Y?-GDO%<*BY(H&90^5HJ$FF+V>,:]. =*$B='<(L/04!1&NO@6R.,0P.S
MQPW62T'=FWJGI&@U^:C%AFX5YUD00)0&GH1L<!NU7V.^'R6N^>+(B"4EAZ=)
MM&7NL\7N:O)2"BDWH(O"T@TZWX#2ZHS":2@#<TF;M,:L\<DX9$H#Z^R6 3MO
M9P57GE 945E0QBD0MO:U,^OL=N9_RWC\KS+^'^(^$C6[S+1A:KOX#RQFHBZY
MB+EQ;'O8B^P<Z\#=@\NQ0K/P3P!+3*BKM??D?G;_RKAL+]>_U-LGRITP"Z(%
M$@N"1IUA/P#37OOMP.G:7[5S[>CB]N*27DIH6('6"ZW=;L .]F^OZ9]02P,$
M%     @ UGT#58@25WB,!@  #1(  !D   !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&ULW5AM;]LV$/XK!R\H$D"5]6(G3O,"."]M/;1)%B?;@&$?&.EL$Y5$
ME:3BI+]^=Y0L.ZF=O@#;AWU(1%'DW7-W#^^./IPK_<G,$"T\Y%EACCHS:\LW
MW:Y)9I@+XZL2"_HR43H7EE[UM&M*C2)UF_*L&P7!;C<7LN@<'[JY*WU\J"J;
MR0*O-)@JSX5^/,%,S8\Z86<Q<2VG,\L3W>/#4DQQC/:VO-+TUFVEI#+'PDA5
M@,;)46<8OCGI\7JWX'>)<[,R!K;D3JE/_#)*CSH! \(,$\L2!#WN\12SC 41
MC,^-S$ZKDC>NCA?2WSK;R98[8?!497_(U,Z..H,.I#@156:OU?P]-O;T65ZB
M,N/^P[Q9&W0@J8Q5>;.9$.2RJ)_BH?'#]VR(F@V1PUTK<BC/A!7'AUK-0?-J
MDL8#9ZK;3>!DP4$96TU?)>VSQ\/3WVY'X]'-Z/+BU2^#* P/KL\_#&_.SV#[
MW7!T,=Z!T_?#ZW?G8P^NKB_/;D]OX&PT/KV\N!E=W YY&PPOSN#RYOWY]6'7
M$B*6VTT:[2>U]FB#]EWXJ H[,W!>I)@^W=\E2UISHH4Y)]&+ G^M"A_BP(,H
MB*(7Y,6M>V(G+]X@[U)/12&_"&:0!Z>J,"J3J:@)5:1PI=%@8>L)-8&WLA!%
M(D4&8YI$8J\U\-?PSEA-_/M[G8=J +WU /A,OC&E2/"H4[(N?8^=XU>_A+O!
MP0OF]5KS>B])_]>C_]]IAV'RN9)&<B!>:\S(^2EL3RDKF1U(9D)/T7A0:I56
MB854FH2()XMJ&4IE9ZB!TAS0@/XTHILW\@'RFJ7(+ 7B&+8<<TMH$#9I37ZA
M%7><ZV!;%B1&58:6F)TW<.-$KA(>QB3[R803Z<0M1V.\1TVLPM8N?*"<;-#
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MDN8%]'VBZ"0U+ZR@_07H^!]02P,$%     @ UGT#5>PG$ .R#@  9"@  !D
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MZ6RV=ART6.2PST*!UW2JD#DT =VIR02P*$!M7<< >RLI(*!=!V##HPFL@NC
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M7#&DU*2MYC'D:*T(10P?9XO'PV=/#YX]0CYT9 "N]SJ<1 S;$H_B@1S:ZBD
M(()0C6X(&LO0$#R>4Y\AG)>K@,(EP7J%"@Q@D*A&R<@G^N)#*=[!K(34)Z&=
MZ*4%#<R- LRQ^W3#W26CD7+Q@(&X0-$7 F '_Q3"J#5EH8EPO@]54:679,^I
MMJ/DM.%N2/Q.%HK#Q*!&LZQD>I1D2A5N6Z["0CL?!N$B9T$+(; <N2R[SQFB
M^PONTPE\5"JH_+XF_K\4MQ*VSMG>>$Y.QLSLBM+3ORI*AX>'%*7#;XK2+[CJ
M1=B]IJ#&N63A3- 66SUT!:VB'I2_H\6_"+!X[Q_2S0X$&SYYUCL\/%E#,/K>
M(%B*/Z )ERD44J&$VM)G4-W8Q.IE.^"(\>XY)R?-+U8]&(MLP#=J;!D< C+L
M0M(8!_]'0#T@0!T,G@R?=@&UJ5"Z=@LAEH!AB?*GX7A3@<3HEG5<5&@DO>8C
M7T>ZI17!''ID=EM,3RK]>F1/*OJBJ%Q(H0@L.A5.< #:IRVQBC9PU6L<YL\I
MNC[B4&E1ZIZA:BQ,Q6[Q!CDD#Q%R4UM7RX" A(A-M=X4Y+]#@7/"Q[,WZ[ZY
MY#X3;9I-DY 5+:(NV"P% 72A'N=Z"O>T9B4+=*:FC.5LD4:C$ QE%9P6L<>%
M;:K-HTYI"H##<51A"%Y<NR#Y"G+*M&QQ/['75O*MP*%N%QR/?6:6IDBTQM((
ME4F@4X7=O=K8RER4H(K66>7M6",V1.-5]_#>KE:,QQVR_&SKRF<K4BE"EH94
M9?Q&4R>10YT9C7GX]_9;51D''>%IKEU5>Q7X9E&HZ8\IHM%&A J6:[W$;]+R
M X4?V1;)N@8AL/^N1HLT/.;29<BT(/2$,PT;G.% =4*6MM+ (W"%AY$;=1\[
MDQW<-#XR+IKHV65#E$:Z "='P]_KFA+%"I8R^4YB)*=3;'AJCDRW+CD*\K91
MLIYTR)R;&GS6.WYZW'MZ^+0O7JM,UJZIG6"T]E1N0EE/5.8AWOU:FI=MRZT?
M+)12=M@YBMD817T]Z"]D+E,%C81T-'P4%)T(4CG@.J=R,<"SVM"I6M^:('%J
MEHKFC=$D.LPDR7<V!T:DU50=))AG5]LV#,0)-0?7IC!?"*2@P\CL!F)1OLAX
M[%ZK!%E;+ 4_P>&(,1"8@?<%N?J?!]@?N.1X^#[@!C0E647<,<YT5]^%PJQ'
M<"B[L]&VLDI9J\<(U\)T1P9P[GR=KYH]!*K-J8A8'0;;V+]44%Q$2ID#'\EA
MY-:9Q$U)5PYB7)CL<W*]EBA"C41<#UR*012AI8^^C-;#=M)MPWM+QI-&7$2"
MX!TAFO)8O1+'-%-E)8261.8T4^Z+6SW7<-LB8/1Y;4VU<;' X9>W81_6 /NO
MR,PTK18CLM**T^+Y%>Q %NY8[*([Z1<W!25=T@T<A:5QVH>9;*S%N7 65TW9
M/%HKM->&#%>C45,6G_<_(080.SIFJT_]]_T&3XG_W,HEJ3)%)^WHM1C3U6E%
M7)+#AM/(M1OD>+_9L0V?;0Y 2Q0+&1$T-+1=J#3$9S$IJ /TTXHPJ#%H*125
M7>3Z3DX4@#JX8S-LOQS](XUWF0Q\B@>HLD"EKB7GV)DN<DN70-38.GU/7CU\
M$F)X:DB9F;2Y1BBXK(;=R610&/*9JVF^I\/PC2YUMEAG'R(QQ])IUSADV\B&
M_L;54!GC-;C;-1IB/W'7%+!=,";![U:5$A<72.-PZ>"Y7>/2$E8_Y:?[*I6-
M*> *B:3'J,GW4TI0P@FE$<<N*V2%RHY'[U 1$^2A?W"_6*,9WH9LDH*:08W
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MT'N'L6'C9Y%X W?"IXB9\9@,X1(-B)YC ;SGWR_-#1MHOTV=_1=02P,$%
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M2PFD0<#WI1"Z!HR YMOKXE]02P,$%     @ UGT#5:^C:4*@ @  D04  !D
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M-U>66K@Q"YJ9J%T G2^4LAO'7;"=PN._4$L#!!0    ( -9] U4<(MW[+0,
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MU3CU0 _#;]A8U?8#9ZTLC:]>K.A_@=H9T'FIE'W=N "'/]#B.U!+ P04
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M. !4GSU1.FBQ@ EA0%4Z^6MNIOP'^Y:K">Q^YPH:N^+Z"25["?F]..U'/EO
MF&;.*:5>Y2_ML.#D'ZL0RO4Q755M]=H;!?U1NL;HD_JHCTH+[PU>PP>O84@7
M/E'/PDW7QW$S#HR*EBRJ8G.=*"2&[)Q3.%;YE,TYUD^$*)W1&PLXAUX[5TC#
MXGZ"2ICGA."4-1^QK,>6<YG-B8NJ DM*A4S-T,<8P63Y^D1("J(RS3($!%H;
MS&EXA4;!*TCMOHN%6Y=5ANQ* %]S\9-6NUAQ^O89>@>&E*!-ZA8* AZ\*)P
M&WM(A8EE_1V5(FXK1?SA2M%EH:4D5K6,FC:9(_\$%0=D,@7ZFL*W%8J=&VXO
M?/<;1:"KA_,M[/X+/1Q#4QR#!96>UK22@4RH_ZD0 G"RU 3I,3F#],ICBQP3
M9&DGH2:DBX.M0S.;<W">BQ,P'A@P0R9!W$@$$M<;6KZN0@VM7W9$NH1=A^7M
MFK#OE07X.<]!E"X76ZJ+ I<_ 8@B&(+MB&MQCT(:2+TP'K.;2D-7 \0@\&+?
M9P&&<0T]T![%$KI,!"-*D2BS%>/3OZH7I5KN2:.#^M+189,/.F7II;A@;@PB
MWA&%21N%R8>C\$FLZH1;4-@;5AEXL\DV\G5=>JBQ>:<L;8O)W=MOAI]U+D&B
MY]64\A23']9I.Z-LU_.(NH &LJ6!VSKH'BS*'A5$[@)PTQ57*W6724%N^H@X
MM:RN\]..=X*PGPP_$?T$0]2P3XB:?C*N!U#4,'6C437:0@V\!5]1O#ART^*Q
M H$IO2)"17BK$D)QO1XWWZW_"_4&ZJP$U[L0*&N)<(5V_4$'$)J/"#+T4:;P
M$NV(LE$;9:./=\4NNYECZ7>ZFRZ5=)BFZK2.$2LZ7>6VP-NIT?MDN%;O[T34
MWU>9:N.N;GJ]T<7&1K^@JGCDQ>.T;H@;?NZPCN/J#'740>VC.8CB8"?U-)WD
MCAA(VQA(/QP#9HZ>J?[HZ9#Y-B_NQ/Q(2:O_7R!%S5:'=C3ASQSE!0QTB%PY
M--Q1T;J,O#$.&?.M"UX[<G/-9EU"D?RFE3'-M?,5X[Y2#B<\>T)(&?J:J2FA
MIOZ-[G4/?HS&!_54DM '2IO6"TX]8A"EWLB/US5G-$X.,#H"TACB+[W21$%E
MEGAAFJYE(\0'AN(1>^C?]=DW=(RZ=(Q2BP=C+XZ"CCP:+8P-4:?JVHIJ.8Z]
M8;39@^\'GC].#]SLT(M05=^:\O]@+"](P_>^D=S<&V-1 D412WW7,N(M"8(W
M-AI[XRAA@1^V>('O^5':'GD$5\2N=7#[UU\B&$QAJFVY-.C\$X(^C^[/%]$-
MJD?]>Z@=;7^NG=7_E-;B]9\Y?&L\2E3*7,RPE+[ >DS7?[OJ%ZL6[@_31%FK
M"O<X1X\G- E@?J;0)#4OM$'[R_'T?U!+ P04    " #6?0-51BH@KV #   W
M"   &0   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6S-5FUOVS80_BL'=>AL
MH(A>_!(WL0W83KIF:YLT=C8,PS[0TMGB0I$N2=G)?OV.E*VJ@..BW_;!$H^\
M>^ZY$^_.PYW2CR9'M/!4"&E&06[MYB(,39ICP<R9VJ"DDY72!;,DZG5H-AI9
MYHT*$291U \+QF4P'OJ].ST>JM(*+O%.@RF+@NGG*0JU&P5Q<-BXY^O<NHUP
M/-RP-<[1/FSN-$EAC9+Q J7A2H+&U2B8Q!?3KM/W"K]SW)G&&EPD2Z4>G7"3
MC8+($4*!J74(C%Y;G*$0#HAH?-EC!K5+9]A<']#?^=@IEB4S.%/B#Y[9?!0,
M LAPQ4IA[]7N/>[CZ3F\5 GCG["K='NDG);&JF)O3 P*+JLW>]KGH6$PB%XP
M2/8&B>==.?(LKYAEXZ%6.]!.F]#<PH?JK8D<E^ZCS*VF4TYV=CQ?W,Y^>W_[
MX>KZ?OXS7']^N%G\":T%6PHT[6%HR853#-,]W+2"2UZ Z\-')6UNX%IFF'UK
M'Q*UFE]RX#=-3@+^6LHSZ$1O((F2Y 1>IXZWX_$Z+\5K5?J8*Y&A-A3OEY+;
M9_BD+,)?DZ6QFF[)W\?"KE"[QU%=Y5R8#4MQ%%!I&-1;#,:O7\7]Z/($YV[-
MN7L*?3RG2LQ*@:!6=(O3LB@%LYB!LCEJ2%5!/G-7)UL$+DE&: EECG^_DZZ.
M![+($59*4/URN0;K[P9P(4J7+\H<T8 T9W+MMJ47ETPPF9),E)T\(Y),/K]^
M-4CB\TOSW3 J_H=HJ/=XE UJKC(#GIITMBWO3Y6&R<RT+^ 3M;$'2=U)\'_=
M\0</\PLU)WBG50&3+>/"!=#4HO*FXI4P*[5&F3[#0C-IB)QK&Y,&TUO/=/8M
MT\K%3<5T6L4-S,(5IE@L2;\3^]L;PT\0=][2,QFX9?_<LRV_\G Q [GD<HO&
M4N>SY@U(TG%)9$_0&KSMM,'G,+G<2P?NZ8&[;7!GV3_E'J@VBXF(^S684HUA
M76-$K77>Z[8=Q:YCV^I'O?;_.;$1D>S$GFK<]NO!#V<V[@P:F?72CV<67LRJ
M__8#]SPH5_*QYA VFGF!>NU'EJ'Z**6M^GJ]6T_%234,OJI7(_4CTVLN#0A<
MD6ET=MX+0%=CJA*LVOC1L%26!HU?YC3943L%.E\IZHQ[P3FH_RN,_P-02P,$
M%     @ UGT#5?3DJ1M[!0  V P  !D   !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&ULC5=M<]HX$/XK._2N#3,N^-V0)LPD:7JO33,A:3_<W =A"]#$MEQ)
MAG"__G9EXT!+F'Q!LKW[Z-G5/BMQMI;J42\Y-_!4Y*4^[RV-J4Z'0YTN><'T
M0%:\Q"]SJ0IF\%$MAKI2G&76J<B'ONO&PX*)LC<YL^]NU>1,UB87);]5H.NB
M8&ISR7.Y/N]YO>V+.[%8&GHQG)Q5;,&GW#Q4MPJ?AAU*)@I>:B%+4'Q^WKOP
M3B]CLK<&7P5?ZYTY4"0S*1_IX8_LO.<2(9[SU! "PV'%KWB>$Q#2^-YB]KHE
MR7%WOD7_9&/'6&9,\RN9?Q.969[W1CW(^)S5N;F3Z]]Y&T]$>*G,M?V%=6OK
M]B"MM9%%ZXP,"E$V(WMJ\_ :![]U\"WO9B'+\B,S;'*FY!H462,:36RHUAO)
MB9(V96H4?A7H9R;3^R]7?\'MWQ<W4SBY9[.<Z_[9T" R?1^F+<IE@^*_@!+#
M9UF:I8;K,N/9OO\0&76T_"VM2_\HX)]U.8# =<!W??\(7M"%&5B\X*4PC4P?
MES+/N-+OX/I[+<P&;J3A\,_%3!N%Q?'OH; ;U/ P*@GF5%<LY><]5(3F:L5[
MD[=OO-C]<(1SV'$.CZ%/IBC K,XYR#F6?RH7I?B/9Z IE/=4B1FDLD!U:F8+
M7)3X7&J9BXP9:X@#ZL=H0D 9*VNG#\5YE,GA..^7'*YP?59N7D6//]&<$TV#
MKDA'R$R#!2R)+],PESEV"0TGUDC6FI69[I_"_5)QOE=C,!5/^R^H4NC'VYE=
M26TH^(6DI3 U&?P"GA,FHV:,(QQ]9Q2X=AQ["=PA':;2)>#2*.\5MJV*DHCF
MD>_B;^"/R10A?"<,(IAB1Q'EPH$%+S'%N75D&6I54&%1TX&1$X4Q)$X<)^#%
MSMB/P(L<WQO#O33H@F00/@QIXB(MC^CX3A($-'&=*/%@^E)BYTH6I\UGW&6[
MQ>@5(Y[?C!&-7H#,DV;BAB.*TRB1FNV605T*K)3023 )@1,CWY%-3.*XP0BN
MBRJ7&]R$QKBJ,45(!:J<E>"/(O#C *(DAA#GKP_JB$RB3B;1JV5"A94V-?E.
MMU2;E#3MGU1/VZ,.!=^9'!+(40XO"Z0I:"P/,+:WDD(-'I6H@N9 M=1F>%I:
M[JV>WKX9^5[RX<<(7B+N@%1P-WUPGH-$< NH425%HQ)N58*-E7>-=5LU7]JJ
MN:F+&5>4R.V;;_940[^+%=;V@L/U$U>IP(V_11H<3F[1?KIDBO?A2VVPY909
M1<L,?.0IMW"!YS1JC!TWPFT/26SA>!#X\)MB5OJ>XV*))",78G> XMVNDL%)
MC&1#+^A#$ [P.Q[%<R[(YR0*44%1'R)_$'KH4@E%KZF^H[ /HVB 9?X#J;WP
MD5 08ZEC>2-&,-[51).8!ZN)Y[0TSS\EQ88!>/YR^,2$@J\LK_=S\U"N$)N:
MW*'$C"-L!@F)$WF@?K9IB>(1:G5,24%U?6T03OSQR(G=I$\YQ :VDY$PQ-8R
MQHR$ R_>6W,_;L_QDK&3C%U4[""(CZDP[E08OUJ%FF)N.U7%-K9[LC53F;-7
MT-J!%2:JU8#&:V'UXOET?'&K-$H\X7%[W.TM!(LVH6NN.&!21&%/R%I;9:+W
M9<ZPN6(0DD3:"NZ972$S3C<SL[36SZI>;TN!M:6P$\?I#Z@_E<U%9_OS:;:_
M85C<W)9EAO+.4,FP$1P/LQN)5G="/[Z?TP$I,$CJ$*"H%+&4@E^?75<RQV!R
MZ@YA-/"BG4_H531WA"9=X6#LPP:/07VH,H8[M\V"JX6]4U-GJTO37#R[M]VU
M_:*YK3Z;-W?^STPM!"Z8\SFZNH,$VZQJ[M'-@Y&5O;O.I,&;L)TN\:\'5V2
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MYD,[5S0;]EX*46.CA6Q X>IL<!Y-+Q*K[Q3^%+C6.S+82)92?K*3M\79(+2
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MH.[UH&>!:-I:XRB^,:UDQ14U)F-F]"= H0-H/>5<'1R=H/VW1/\!4$L#!!0
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MI9L=I0F@]VM!O3T\F +U_PK#?P%02P,$%     @ UGT#53\^9;2. @  N08
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M-!#/5X3PPXWLH#K-&7X#4$L#!!0    ( -9] U71(HA,DP4  (8K   9
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;,6:_6^C-AC'_Q4K.VUW4GO!O(9;
M&BD77I;IVHN:=M,T[0<7G(8=X!R8]D[:'S]#* G$1<GV5/VE,>3Y?FS,UX_I
M$\:/+/N2KRGEZ%L2I_G%8,WYYL-PF =KFI#\/=O05'RS8EE"N#C,[H?Y)J,D
MK$1)/%05Q1PF)$H'DW%U;I%-QJS@<93218;R(DE(]OTCC=GCQ0 /GDY<1_=K
M7IX83L8;<D^7E-]N%IDX&C:4,$IHFD<L11E=70RF^(./[5)01?P6T<=\KXW*
M2[EC[$MY, \O!DHY(AK3@)<((CX>Z(S&<4D2X_A:0P=-GZ5PO_U$]ZJ+%Q=S
M1W(Z8_'O4<C7%X/1 (5T18J87[/'7VA]04;)"UB<5W_18QVK#%!0Y)PEM5B,
M((G2[2?Y5D_$G@#KSPC46J >*]!J@7:L0*\%^K$"HQ88QPK,6F >*[!J@57=
MK.WL5K?&(9Q,QAE[1%D9+6AEH[J_E5K<D2@MK;CDF?@V$CH^6=Y>7DZO_T"?
M/;2<^U=S;SZ;7MV@Z6SV^?;J9G[EH\7G3_/9W%VB<W0EG#4- E:D/$KOT2)C
MJ6@'5%B3Y^BM0SF)XOR=B+Q=.NCMFW?H#8I2=+-F14[2,!\/N1ARV?$PJ(?W
M<3L\]9GA_5JD[Y&FG"%5456)?-8OOR29D.-GY4Z_W*%!(\<2N7O\X&5R[_C!
MR^3^\8-7VO*A,$GC%+5QBEKQM&=XU_2!I@4]0_,TXA&)T72SB:. 5!EE0;.(
MA6A6)$5,RN2"W-5*9!MTDQ&1MJJ8/S\)(IISFN1_R9RP[5Z7=U^FY _YA@3T
M8B!R;DZS!SJ8_/@#-I6?9;Z A#F0,!<2YD'"?"!8RUU:XRZMCSY9<A9\6;,X
MI%G^$Z)?BXA_1X3S++HK.+F+*>(,;4@F,HW,.UNX6<'+W?=A<FX9IJF9X^'#
MOBUD<8IM6)TX1Q:G*;HR:L>YDCAS9&&S$^?)X@QEA#MQOBP.V^9H%]>:7;V9
M7;UW=J=A6*U!L6H7) K/YRF:D4W$22R;S%[6J0L1$N9 PEQ(F <)\X%@+:L8
MC56,UTWS!J2[(&$.),R%A'F0,!\(UG*7V;C+?,DTOX4;^^EQ9!O8P)TT+XLS
MK9&M=-*\),[65<7N\%Q9',;:09J7CD_'W6W#E\59FJI@>9JWFMFU^M-\$&Q7
M)@V10U=1$$EGL1=RZ@J$A#F0,!<2YD'"?"!8RR.CQB.CU\WO(TAW0<(<2)@+
M"?,@83X0K.4NNW&7_9+YW3YX_,6:91O=IWA)F&&--+63W>V#+*MB+/:+3G(_
MI*FJKJN=,$\2IFN&TAF;+PDSM)%ER#,[5G9U&J5W9@_6Y-G3:F4K- W9IER<
M9Z+U=Y&7^?\CB4D:4&G)I;>G4Y<H*,T!I;F@- ^4YD/1VG[:J_OAU]T'ZOZA
M7 9)<T!I+BC- Z7Y4+2VRW8U0]Q;-)I\8NG].:=9@D)Z)TWY_8"3;0):]ZMI
M^SN(J=M*Y[\(%[13#Y3F0]':]W]7U</]9;UY&F24Y!2]#>FV]:[\12"D*YIE
M8I>*TH EXJ& ?*/R7P=Z\2>[ Y+FU#2C_1ARZ [(3CU0F@]%:[MC5Y7$_67)
M__A,@_Y!IQ4T^X=QLHM 2YJ@-!>4YH'2?"A:VVR[NB9^Y<(F!JUL@M(<4)H+
M2O- :3X4K>VR77T3OVB!LY]^LH<@:0X^K%K:IG&XWT%VZH'2?"A:VQR[\BSN
MK\_^C_WNN,IN?_\GVP>TM@M*<T%I'BC-AZ*U7;8K\.)7KO!BT!(O*,T!I;F@
M- ^4YD/1VB[;%7KQBU9Z^^DG>PB2YN##&NZY;JF'.QUDKQXHS8>B;=TQW'O!
ML'Q#]9)D]U&:HYBN!%YY;XF'@FS[TN?V@+--]<[A'>.<)55S38GP2AD@OE\Q
MQI\.RM<8FU=O)_\"4$L#!!0    ( -9] U424,,%9@(  #L'   9    >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;+65VX[:,!"&7\5*I:J5MB2$XU*(! M5
MMRHKQ&JW%U4O3#(DUOJ0V@Z'MZ_MA)1*D(M*W"0^S/S^QF./QWLAWU0&H-&!
M4:XF7J9U/O)]%6? L&J)'+B9V0K)L#9=F?HJEX 3Y\2H'P9!WV>8<"\:N[&5
MC,:BT)1P6$FD"L:P/,Z BOW$:WNG@35),VT'_&B<XQ2>0;_D*VEZ?JV2$ 9<
M$<&1A.W$F[9'LZ&U=P:O!/;JK(UL)!LAWFSG,9EX@04""K&V"MC\=O  E%HA
M@_&[TO3J):WC>?ND_L7%;F+98 4/@OX@B<XFWM!#"6QQ0?5:[+]"%4_/ZL6"
M*O=%^]*V<^^AN%!:L,K9$##"RS\^5/MPYF!T+CN$E4/HN,N%'.4<:QR-I=@C
M::V-FFVX4)VW@2/<)N592S-+C)^.UHO7Q=/+ GU"3UA*;+<(?9B#QH2JCV-?
MFR6LH1]7<K-2+KPBUT=+P76FT((GD/SK[QNTFB\\\<W"1L%O!6^A3G"'PB ,
M&_0Z=;P=I]>]HK<DG+""78JLT=%>CI'*<0P3SYQ^!7('7O3^7;L??&[ ZM98
M7:?>N8(U)PJGJ804N[,JMF@-.^ %H)_?C2EZU,#4KTO4W1M0]VKJ7N-F3N-8
M%%PK<SMC(#N\H7"'<GPTEU8C#9*I2\3-F@%*\%$UP/5KN'YSIO'A6J8;'?]S
MSP8UUN!&F1[<@'I84P]OD.EFS?O!U53[9P6-@4Q=V5;(,92UK1ZM7X9I61#_
MFI?/RA++E'"%*&R-:] :F.,GRU)==K3(77G<"&V*K6MFYG4#:0W,_%8(?>K8
M!>KW,OH#4$L#!!0    ( -9] U4VRYY1D@0  )<<   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0S+GAM;+69;8^C-A#'OXI%3]6=U"[8/&:;1-HL5-UJ[[3*
M[EZK5GWA#4Y"#S#%)KE^^S,/(0$<M&F];Q(@__F9F;$G#)[N:?Z%;0GAX&L2
MIVRF;3G/KG6=K;8DP>R*9B05OZQIGF N3O.-SK*<X+ R2F(=&8:C)SA*M?FT
MNO:0SZ>TX'&4DH<<L"))</[O@L1T/].@=KBPC#9;7E[0Y],,;\@CX<_90R[.
M])821@E)6413D)/U3+N!UP&<E :5XG-$]NSD&)2NO%#ZI3RY"V>:4=X1B<F*
MEP@LOG;DEL1Q21+W\4\#U=HQ2\/3XP/]Y\IYX<P+9N26QK]%(=_.-$\#(5GC
M(N9+NO^%- [9)6]%8U9]@GVM=2<:6!6,TZ0Q%G>01&G]C;\V@3@Q$!RY 6H,
M4-_ .F-@-@;F:T>P&@/KM2/8C4'ENE[[7@7.QQS/ISG=@[Q4"UIY4$6_LA;Q
MBM)RHCSR7/P:"3L^7P:?@T_/ ?@1/(HY&!8Q 70-_(CAS28G&\Q)")9D1]*"
M@/<^X3B*V0>A?G[TP?MW'\ [$*7@:4L+AM.0374N[JDDZZMF_$4]/CHSO@D^
MTI1O&0C2D(02>W_<WAFQUT4LVH"@0T 6:!3X:Y%> =/X 2 #(<G]W+[>',K<
M^7^C!_]Y]$XPS'9VF!7//,,[F0?EJA8SXS 7_KP74G#'2<+^DF6]YEIR;EG]
MKEF&5V2FB?+&2+XCVOS[[Z!C_"0+N4J8KQ(6*()UDF.UR;'&Z/,GRG$,4O%G
MDN4T+%8<,!P3Z1JL04X%*O\Z=G/H3"PHILCN-,X2F6G;$Z,K\X<R$[F6@;JR
M8"A#MN5 MY5UO+9;K^U1KX/?'VZ6P;W,RU'#2^><2IBO$A8H@G6B[[31=]ZH
M(#@JDZ,2YJN$!8I@G>2X;7)<506A!MF=E>X:AMLK"#*98=A>KR ,9<AQ$.P7
M!(G,LES3D1<$K_7:&_7ZC[O[9?#T="-S<]3RTDFG$N:KA 6*8)WP3]KP3]ZH
M(DQ4)D<ES%<)"Q3!.LF!QO'QWE!5$QI29WVZ%NS7!(FL_X @D=C0L/OU8)34
M]?>DG8&C_D9T1W(L N@ZLFPLQLTOG75*:;Y26J"*UDT$.B8"O5%=:,"J4J22
MYBNE!:IHW10=FSLXVIY<5!O,P5(UD='O'V0J#YK]ZC!4.0BY_>(P5+F&!\_4
MAV//!,>;ID6113N\PN44C*.,,IH0$*5_DQ7'+S$!K&!9_1I,&H91^,534R7-
M5TH+5-&Z:3HV>=!^J^JAM M42O.5T@)5M&Z*CIT@'.UE+JH>SF M3VRG7SPD
MH@GJUXZA"-F#1D.B@JYGG:D=Q_8**NNOQDD7ST*5-%\I+5!%Z^;DV/Q![ZT*
MA=+F4"G-5TH+5-&Z*3HVB'"TQ;EHV4PD+RH]VQL\:$ATIN4Y@T>-H<Y$CF&8
M_8(QU"';=(S^XX9^LM&2D'Q3[7 QL*)%RNNWZNW5=A?MIMH[ZEU?P.M;*+GN
ME[MNU<;.$5]OV7W$^29*&8C)6@QE7+FBNN7U+EA]PFE6;?.\4,YI4AUN"0Y)
M7@K$[VM*^>&D'*#=BYQ_ U!+ P04    " #6?0-5OHYQBG@#  !A"P  &0
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M3Y_0HFQ3RXGB<]OIW7*E^T8[S'1K#\($Z/M3SM7#Q&Q0_UF(_P)02P,$%
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ML$ DY:]DW*?U"KQ\\0J\ "0''W>TY"C?\+DI)"4%;,9-]V_K[NT3W?]1YM?
ML:Z ;=FV)GTYGK["L4R'53H<IIMR(-K1L-O1L"L\YSM&0R>FSI[IL]6*N^$%
MBO'"D$N*8[;'1O3K+]"S?M-)FPAL(-1IA3ICZ-$]DR\")KY>@2)%N;@"<OH
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MP$*3%9(#.X"V?/V;Z1IO^_*BDLQ32>:K) L4D37R.:KS.1IBE\^')-T07&P
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M(6A27$: 0V"Y@;R_I7+7K :Y@[IYOOP!4$L#!!0    ( -9] U7>//(2F ,
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M'*]'Q6?XZD^ SYBM2<GE+EC)I:R+4-8S5LW5U8V@&STX+JF08ZB^S "GP)2
M?+^B5.QOU +-OQO3_P!02P,$%     @ UGT#57(JL7[5 @  _ <  !D   !X
M;"]W;W)K<VAE971S+W-H965T-3(N>&ULC95K;YLP%(;_BL6JJ976 N:69 E2
M;],V=5+5M-N':1^<< A6#6:V2=I_/QLHRQ0GV1?P[;S/>PP^GFZX>)8%@$(O
M):ODS"F4JB>N*Y<%E$1>\!HJ/9-S41*ENV+EREH R=J@DKG8\V*W)+1RTFD[
M=B_2*6\4HQ7<"R2;LB3B]0H8W\P<WWD;>*"K0ID!-YW69 5S4$_UO= ]=U#)
M: F5I+Q" O*9<^E/KOPVH%WQG<)&;K61267!^;/I?,EFCF<< 8.E,A)$O]9P
M#8P9)>WC=R_J#$P3N-U^4__4)J^361 )UYS]H)DJ9L[(01GDI&'J@6\^0Y]0
M9/26G,GVB3;]6L]!RT8J7O;!VD%)J^Y-7OJ-V K >$\ [@-PZ[L#M2YOB"+I
M5/ -$F:U5C.--M4V6INCE?DJ<R7T+-5Q*KV[O9S?SM$YFNOOG34,$,^UOFH$
M512DZ>D_0!!%JQ5BH/-'C)(%9=WTZ0TH0ID\0R>(5NBQX(TD52:GKM+F#,)=
M]D:N.B-XCY&O376! N\#PA[&Z&E^@TY/SOZ5<75N0X)X2!"WNL&^!(UGB7Y>
M+J02^A_X9;/6281V"7,P)K(F2Y@Y^L^7(-;@I._?^;'W\8#!8# 8'%)/VWQ/
M!9@C9#99TA=4\DH5\LQFM1.+6S%SY-9I''GCJ;NV6 @'"^$Q"X&-U45%6RP_
M"+S0#HL&6'0,%MI@D046!I$=%@^P^!@LLL'B71B.DCVP9( EQV"Q#9988('O
MV6&C 38Z"'LL0%?A7(&P(4<[R& <8FQ'C@?D^#"2*\)0WNCB 'TMJ,FK+M'*
M>M['.Q[&213MV6/?^UNPO(,N[D#*":)EW2C(=-'1.P!260N.M^/@'/NC,-YC
M8:MF^O^Q$0?JHM6-OW-RDRC9.;KN5BTW]^(W(E:TDIJ1ZSCO(M'IB.ZJZ3J*
MUVUY7W"E+XNV6>CK&819H.=SSM5;Q]P8PX6?_@%02P,$%     @ UGT#53AF
M!N*F @  ]P8  !D   !X;"]W;W)K<VAE971S+W-H965T-3,N>&ULA95K;YLP
M%(;_BL6J*9&V0@CDTB5(O6S:IDVJFG;[,.V# X=@U=C,-DG[[W<,%&6KDWP!
MW\[[O ?CX\5.JD== !CR5'*AEUYA3'7A^SHMH*3Z7%8@<":7JJ0&NVKCZTH!
MS9J@DOMA$$S\DC+A)8MF[%8E"UD;S@3<*J+KLJ3J^0JXW"V]D?<R<,<VA;$#
M?K*HZ 968!ZJ6X4]OU?)6 E",RF(@GSI78XNKN9V?;/@!X.=WFL3F\E:RD?;
M^9(MO< : @ZIL0H47UNX!LZM$-KXTVEZ/=(&[K=?U#\UN6,N:ZKA6O*?+#/%
MTIMY)(.<UMS<R=UGZ/*)K5XJN6Z>9->M#3R2UMK(L@M&!R43[9L^==]A+R ,
M#P2$74#8^&Y!C<L;:FBR4')'E%V-:K;1I-I$HSDF[*:LC,)9AG$F^?;Q<O5Q
M1=ZO<+>SF@.1.<J;6C'#0-L>[K^BAHD-X8#I$\[HFO%V>M ."6G(,_Y J2QQ
MOU+(AF1P X8RKH?DC#!![@M9:RHRO? -NK9L/^T<7K4.PP,.O];BG(R#=R0,
MPI \K&[(X&SXKXR/2?>9AWWF8:,[/I2YM:[)K\NU-@I_CM\N:ZU$Y):P!^9"
M5S2%I8<G0H/:@I>\?3.:!!^.&!SW!L?'U),FWX$">[3LY]?LB912F$(/759;
ML4DC9H_B-IF-%O[682#J#42G#(Q=I#8JWB-%\]"-BGM4? H5N5"Q Q6Y49,>
M-3F%BEVHR2M4'(S=J&F/FIY"35RHJ0,5NU&S'C4[BKHO &MR;D"Y@+/7GS$Z
MD-N\!\Z/ Z6AG.0UE@KH*D-%G_'X&^<9G[_Z.\-X-/O/@K]7Q^R5\)VJ#1,:
MY7,,"\ZGF(%JRVS;,;)J2MM:&BR43;/ FPF478#SN93FI6.K97_7)7\!4$L#
M!!0    ( -9] U4:,2R2[P0  !<>   9    >&PO=V]R:W-H965T<R]S:&5E
M=#4T+GAM;*U9[4[C.!1]%2N+5C/2+,U'FU*VK53(Q[ "!E%FV;\F<1N+Q.[8
M+H71/OS:20A-&[(IXS]MXOB<8_O<V,[U>$/9(T\0$N Y2PF?&(D0J]->CT<)
MRB _IBM$Y),%91D4\I8M>WS%$(QS4);V;--T>QG$Q)B.\[(;-AW3M4@Q03<,
M\'660?9RAE*ZF1B6\5IPBY>)4 6]Z7@%EVB.Q/?5#9-WO8HEQADB'%,"&%I,
MC)EU&EI]!<AK_(W1AF]= ]65!TH?U<U%/#%,U2*4HD@H"BC_GM Y2E/%)-OQ
MHR0U*DT%W+Y^90_RSLO./$".SFEZCV.13(P3 \1H =>IN*6;KZCLT$#Q133E
M^2_8E'5- T1K+FA6@F4+,DR*?_A<#L060/(T ^P28.\"^N\ G!+@=%7HEX!^
M5X5!"1AT!;@EP.T*&): 86Y6,;JY-1X4<#IF= .8JBW9U$7N;XZ6CF"B0G$N
MF'R*)4Y,PV_?O/N+RTLPN_; Q?7=[#J\.+OTP6P^]^_FX ]P#1F#*ES )P\)
MB%/^699^GWO@T]%G< 0P 7<)77-(8C[N"=DD1=R+2OFS0MY^1]X!5Y2(A .?
MQ"ANP'OM>+<%WY-#48V'_3H>9W8KX5]K<@P<\PNP3=MN:,]Y=[C5U)U?4_=_
M33UHAU]!)N'6N^IA.]Q#406W6JQPJM!T<C[GO="D--[@-&V*J@+9;T:JZ?N4
MKV"$)H:<GSEB3\B8_OZ;Y9I_-EFJD\S32>;K) MTDH6:R&J!T:\"H]_&7@6&
M7 HCRN1[KR:AB!)2+F\;+!(@$B37N1]KS+$J; JB0L7-5=22_32U^J[ER-!_
MV@Z/UL8<&A[=-'V=FH%.LK"I P-K.*@Z4+-T4%DZ:+5TEE$F\$^8^T<7A7,L
M=U9 LL0/J723<R0:UYB">U!KDV/O^CC8;_G('=8K>?M4]HG;[^_8LT_EC!RG
M7BEH[?&APZZ)K&:.6YGC=C<'/<M=,$=?Y,NG=KHQ8LJO!>813,$+@JS)(+=I
M5$USQZ#65ASZHG62]'5*!CK)0DUD-<.'E>'##QB^P(P+L$(,TZ:=VMEP;\0'
M0V?/Y%;E0TWN).GKE QTDH6:R&HFGU0FGWS 9"Z75!*WN'RR-^3.L+_G<JOT
MH2YWDO1U2@8ZR4)-9#671Y7+HP^X+!+,VDP>[8WX<+3G<:OPH1YW4?1U*@8Z
MR4)-9#6++?/M&][\R'Q-UTQNA-]WN63=WL;8]I[-[=J'^MQ)T]>J&6AE"W6Q
MU;W>RM=8K5[?)X@ 2,A:;K<($H##%''Y]9.JY)[<,#,$HP0<#4SSV 29_$I2
M,?$OF#^^('"30)9!\)6F,29+<$&BX\:X:&W!H5_76MD\K6R^5K9 *UNHBZT>
M9_9;G-D?SKZ44%T!HI/-T\KF:V4+M+*%NMCJ ?*6G;-:<SS3*RPG'D$) BOX
MDB$BN%QQ&/#_N9G=^I< +AEJSLS\3U:F7?;@X-*:W-/*YFME"TJV6E)"KJP[
M2VNH2[0>-6^I.ZL]=S?;7;E$(F42N2(UQH+.U-6Y5C9/*YNOE2VP]K-T<D/0
M$ R:5(M@Z&T=0V6(+?,31K4W61-1I/VKTNH4<Y:?W>V4GUFGYU9#N6>=^L49
MY1M]<61Z!=D2$PY2M)!2YO%0?DFPXA2RN!%TE1^"/5 A:)9?)@C&B*D*\OF"
M4O%ZHP2JL^#I?U!+ P04    " #6?0-5!=.@BH<$  "\%0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970U-2YX;6R]6%USVC@4_2L:;Z?3SI38EK&!%)@AD*;L
MT#03DN9A9Q\46X"GMD4E&9K]]2M_8&,L1-CUY 7\<>_1N5?2O<?J;PG]R588
M<_ [#"(VT%:<KR]UG;DK'")V0=8X$F\6A(:(BUNZU-F:8N2E3F&@0\-P]!#Y
MD3;LI\_NZ+!/8A[X$;ZC@,5AB.C+%0[(=J"9VN[!O;]<\>2!/NROT1+/,7]<
MWU%QIQ<HGA_BB/DD A0O!MK(O!S#=N*06OSP\9;M78,DE&="?B8W4V^@&0DC
M'&"7)Q!(_&WP& =!@B1X_,I!M6+,Q''_>H?^)0U>!/.,&!Z3X,GW^&J@=37@
MX06* WY/ME]Q'I"=X+DD8.DOV.:VA@;<F'$2YLZ"0>A'V3_ZG2=BS\'L'G&
MN0-\K8.5.UAIH!FS-*P)XFC8IV0+:&(MT)*+-#>IMXC&CY)IG',JWOK"CP]O
MOG^?/$UG,S"ZG8#I[</H]F9Z-;L&H_G\^F$.6F :<10M_>< @Q%CF#/P88(Y
M\@/V4;Q]G$_ AW<?P3O@1^!A16*&(H_U=2ZH)0/H;D[C*J,!C]!PP#<2\14#
MUY&'/8G_6.UO0@6 +G)2) ;N$G,%E8A_QM$%L(Q/ !H0R@BIW2?8%>YFZFXJ
MZ%C%/%DIGG4$;^3^BGV*/?#%CWR.6S.Q^#W)Y/PU$XY@RG'(_I9-0S9*6SY*
M4C,NV1JY>*")HL PW6!M^/X/TS$^RU+0$%@E(>TB(6T5^O"&$L; &%'ZXD=+
M\ ,%,98%G*$X*4I2TS9#NV<8/:.O;_9#.6E6(6D7)&TER9'KQF$<("[F:A02
MROU_4%*]9$0S)'N/0<NV.XYS0%1B!CMFLD1E1)V"J*,D6EM(G\ MYC*:3FU\
MVVI;L'U 4V+FP)[3E=/L%#0[C4QZIS:Z8YOU23]I5B'9+4AV&\IEMYZDGEW/
M9=W,@=;17/8*FCTES0G>B":^%BN38W<5D8 L?2PMW4J<<VM&0V"5D$VC[';&
MFY31?)B&<M(46C4I>Q+ ;&17Y3#V09$T#K?5:;LJ45@2A8V5TQSJL)Y:G4.R
M$CO8,7J=(V3+AFTJV]\992 '<JHU%3K6(56)G2BJAG6$:ME*374O?4K%+O9:
MHPVF0KR#1X87<0"2W2$7<VH\TP O&%$&;!"FJDRZZ/\71C72LA^;ZH8\3A4U
MIN(+)$B7#EOY:WF(2J"S=WA#:-6PR^YN.F]3]I0JXNRD-(1634JI)<QFQ$0.
ML[_M:DI";5,E6.H(4RTDSBIW=9'0@KU#EC(C^PC-4D>8:B%Q1J'KU;+DF(<<
M)39'*,*R[4-E!SV_P)W VQ4GZ7?A?W&MQE5V;JCNW,6^GM[=OT?A^O-$&HP2
MY-Q=VQ1:->12 T#X)J4,*J7&V4EI"*V:E%)K0+76>&TI@W4%X9AU 7?2K$JS
MU!E0W=-?7RE@_7M<2O246494WSL?$\U_F1X;,N"2..+945GQM#B:'*4'<GII
MGIUK?D-TZ4<,!'@A7(V+CBBF-#LJS&XX6:>G;<^$"Z617JXP\C!-#,3[!2%\
M=Y,,4!S8#O\%4$L#!!0    ( -9] U6:\%5V/04  #LK   9    >&PO=V]R
M:W-H965T<R]S:&5E=#4V+GAM;+6:;V^K-A3&OXK%KJ96VBW8_$G2)9'6P-4Z
MM5-UV]Z]F/;"39P$7<"9<9I;:1]^AE"($^J&]O1-"XG/S^8Y<#A/8+CAXGN^
M9$RB'VF2Y2-K*>7JW+;SZ9*E-#_C*Y:I;^9<I%2J7;&P\Y5@=%8&I8E-'">P
M4QIGUGA8?G8CQD.^EDF<L1N!\G6:4O%TP1*^&5G8>O[@:[Q8RN(#>SQ<T06[
M9?)^=2/4GEU39G'*LCSF&1)L/K)^P^<1Z14!Y8AO,=OD.]NH.)0'SK\7.Y>S
MD>44*V()F\H"0=6_1S9A25*0U#K^K:!6/6<1N+O]3/]2'KPZF >:LPE/_HIG
M<CFR^A::L3E=)_(KW_S.J@/R"]Z4)WGY%VVV8P/?0M-U+GE:!:L5I'&V_4]_
M5$+L!&#OA0!2!9!C ]PJP#TVP*L"O&,#_"J@/'1[>^RE<"&5=#P4?(-$,5K1
MBHU2_3):Z15GQ8ER*X7Z-E9Q<AQ&%W?H,YI0(9[B;(&^T63-$)^CD#U(=!(R
M2>,D/U5#[F]#=/+I%'U"<8;NEGR=TVR6#VVI5E&P[&DUX\5V1O+"C'^LLS/D
M.K\@XA#2$CXQAX=LJL)Q&8Y;PL/79D_J<*<E/#*'7U/Q'(Y[>KBME*_E)[7\
MI.1Y+_#NLYQ-UX+-2KW;Q#3&%V7D/%_1*1M9JD[D3#PR:_SS3SAP?FV3%A(6
M0L(B()B6!+=.@EO2W1=/*76J7V:Y%&M5 B7Z^TH-0)>2I?D_;2EQ(5,""0LA
M81$03$N)5Z?$,UX75SQ;?)9,I*KHMU\7V_B@C"_NAH_CGN\'OC>T'W?E/1R&
M'6] 7$<?%QJ7TU4Y()BFG%\KYQN5NRM$N^(T0Q?H"YW&22R?4*AJNBIX ?H/
MW;Y2;XSTKB<W)"R$A$5 ,"U%09VB +3>!) I@82%D+ ("*:EI%>GI/?.>M,[
M*"2N3S#9JR.3[3!?&S;P!KV]<F-<35?A@&":</U:N+Y1N G/'IF0\4/"5&G)
M8B[0GURR_+GD^&U:&I%=3VA(6 @)BX!@6EX&=5X&H#5F )D22%@("8N 8%I*
ML--X+<=XL=Q**M6M-\Y4I6&Y1$+MHA.:(XI63$Q5GDY;_=26BLE.57'.'*?G
M[Q4?\_1=A0>E15 T7?H=FXO?5Z=4:_2Z&3-/TO4R :6%H+0(BJ:GJ['%F("6
M+PQJDT%I(2@M@J+IB6FL,C;:OB,:I0J@=4H#KS_8=V;5.*U5<IV [+=*Y@5U
MEN\C7"UN;"TV^]JWW@&\8^\ D#XV/';:"&I:7=7&\F*SYS46]VOZ5!1XKU57
M4+<+2@M!:1$43<]0XW@QK.7%H)X7E!:"TB(HFIZ8QO=BL_%]:T':4K&K5P;7
M/:Q(D%8W!*5%4#1=^\8ZXW=XY^>R=5Q?"NJH06DA*"V"HNDI:UPUAK75&-17
M@])"4%H$1=,?HS76FIBM]>M]:078[4O[@;?_^UTU:K<K)0XFWF"O*S4OI_/3
MKX\PQZ0QQ^1]YKCM,>V%F=GYR22H%P:E15 T/3L[CXAAO3"!?60,^\P8]J'Q
M1WAATGAA8O;";^R=*NI^[T0.>R?S_)VU!S724#1=^\9($[.1?K5D'=4WF2?I
M?*F FF]06@1%T]/5.'3BP]8P4&,.2@M!:1$434],8\R)T5\>TS<%!WW30=-T
M. 3[O;Z__U.>>2V=E?L(YTP:YTP^Q#F3=N?<5OU!G?/1\T;'C-QJ9N^\=UB\
M5GI-Q2+.<I2PN8ITSGKJW!;;-S6W.Y*ORE<1'[B4/"TWEXS.F"@&J._G7-7P
M:J=XN[%^7W;\/U!+ P04    " #6?0-5W&=+N[LA  #*; ( &0   'AL+W=O
M<FMS:&5E=',O<VAE970U-RYX;6RUW6MSVFB:QO&OHLIV;:6K/#'B3#:=JB0Z
MGZ7TS-2^5$"VV0;D$2*'J?[P*W&P$(@'D?Y/OYCQ 7XW1O85\4@7>O<MS?Y8
M/R5)+GU?+E;KWUX]Y?GSV_O[]?0I6<;K-^ESLBJ^\Y!FRS@O/LT>[]?/61+/
MMG=:+NZ[G<[P?AG/5Z_>O]M^+<C>OTLW^6*^2H),6F^6RSC[\3%9I-]^>R6_
M.GPAFC\^Y>47[M^_>XX?D\])_O?G("L^NW]19O-ELEK/TY64)0^_O?H@OXUD
MN5_>8WN3?\R3;^NCCZ7R9_F2IG^4GYBSWUYURH>4+))I7AIQ\7]?DT_)8E%2
MQ0/YUUY]]3*TO./QQP==V_[TQ4_S)5XGG]+%/^>S_.FW5^-7TBQYB#>+/$J_
M&<G^)QJ4WC1=K+?_*WW;W[;S2IINUGFZW-^Y> 3+^6KW__'W_3-Q=(=N]\(=
MNOL[=$_NT)<OW*&WOT/O=,+DPAWZ^SOT3^[0N_20!OL[#$[N4#P7S7<8[N\P
M;/M#C_9W&)T^I-Z%.XSW=QBWG3#9WV%R<H?!Q0W7.6RY3ML9\LO&/MW:@_&E
MNQPVMWRZO2]/.6QP^6R+7[S+89/+I]O\\ET.&UT^W>J7[W+8['+K[2X?-KQ\
MMN4OWN6PZ>7MMK_?_2EN_XZ5.(_?O\O2;U)6WK[PR@^V8;"]?_'G.U^5P?4Y
MSXKOSHO[Y>\5]>/OTM\D+\ZRN$P0Z;62Y/%\L?[UW7U>^.6M[J=[2]M9W0N6
M++GI*G]:2^IJELP:[F^)[]^[=G]'?/_AM?M[5QY_5P#<%T_LR[/;/3R['[M"
M44FF;Z2>?"=U.]V!]/?/BO3ZEZ8G]I.8L3:K@NELF>Z!D9[C'\6_(+GTBW0O
MK9_B+%DWR(I8_O"<O9$Z\HE\45/%FAO_D#K=$I-'+YCPX6E7?O"X^,$[P]W#
M:[B[WO[IEP5/OW'MZ5^\,)UV/Y=Y[8G*#F+U3#7]P?S,[\6LX3?C\B.UVX\0
M/87.SSW2=?*X?:2W/&*7><1>^]^=KH#Q6S"=T989"IB@S1_"Z.JC"=O\4->?
MFZC-#S7<,U>V62TX>R__+/6V$WJB?Y8^>(JDF=X'[Y/IZ9+_T3'U#[^;OO>Y
MX1%_W'G]9J_<_7^[?HZGR6^OBOW[=9)]35Z]_^__DH>=_VF*8Q)32$PE,8W$
M=!(S2,PD,8O$;!)S2,PE,8_$?!(+2"PDL0C":NG;?TG?ODA__SG)\T6R^X<Y
MR>;IK'B%,$U77Y,LGW]9)-(L^9+OO[!?P/C7)EGG3;$L''1K+).80F(JB6DD
MII.806(FB5DD9I.8(_Y3ZW>D6?RC<3>7?!0>B?DD%I!82&(1A-4B>/ 2P0/A
M[\6G1;J>KQZE=5SD[7,VGR;2Z_E*FJ6+19RMRUC>[6S_*OTI?B7Z43CGU@3>
M8>,M5JZ)?WT_&+_IO;O_>IRLY$25Q#02TTG,(#&3Q*PVF]PF)SIM)KKD1(_$
M?!(+2"PDL0C":NDX?$G'H3 =/RS38E?TW_'VT%?ZL-LAG<W7TW13[+.^+B8N
MYYMET\K&1R%\:QR2F$)B*HEI)*:3F$%B)HE9.VQX%&*CSK#3Z9P$Y_G-!J-^
M_^QVSOGMY+[</;N=VW [N=^1SV[HD3^L3V(!B84D%D%8+?)&+Y$W$N\0ILME
MNMIQG_-T^D=3N F)6\.-Q!024TE,(S&=Q P2,TG,(C&;Q!P2<TG,(S&?Q (2
M"TDL@K!:X(Y? G<,'X(:D^E+8@J)J22FD9A.8@:)F21FD9A-8@Z)N23FD9A/
M8@&)A20605@M?2<OZ3NYLKO[<G2I>'U_?/!IG4PWV3R?)^OMBNANX;-<!KV\
M!"H<=6LPDYBRPP;'+]<Z\J KUU^LJ>1,C<1T$C-(S"0QJVD[G;_ZMLF93KN9
M+CG3(S&?Q (2"TDL@K!:3,J=EYPLS\06+87._F^SSLMC]6LI3Z4/@?GI[NQ@
M?5,HBMU;4Q'5E+UVO(S5ZVS_.PE&=*R&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ
M!:@6HEI$:?7(/:I,R"WV37?I^CE9S=-,\M*\V!]5-LGV3/_&N!6:-\<MJ2FH
MIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):1&GU3.Y6F=R%5VOW(!7(
MI*:@FHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:75 [DJ<,G"AL+[
MSWF<)S-IOLJ3@L^EK/A4>AVOI;@\>76:K/+&T[/$ZLVIO-/D[M%"0N=-IS,:
MG)RRBHY544U#-1W5#%0S4<UJN_%M=*S3=JR+CO50S4>U -5"5(LHK1Z35=.J
M?/,)04R:JWD^CQ?';:K=V?[I@[3:+BH4"9H6WR[/_I+6Y8E?/UL$$#^2FZ-U
MIQV?I3V2WXS&I\%*#E5134,U'=6,=D^OB0ZUV@VUT:%.NZ$N.M1#-1_5 E0+
M42VBM'I:5J4H^4HKZN2XUET1EMM3_:4B'(\SLC'_T"84JBFHIJ*:AFHZJAE[
M[61GJ]<=G.8D6HE"-1O5'%1S4<U#-1_5 E0+42VBM'KJ5F4K6=RVXKJHXD$W
M1S!:OT(U%=4T5--1S=AKM;IF_XT\.DU@M%V%:C:J.:CFHIJ':CZJ!:@6HEI$
M:?4$KKI?LKC\Y<;9'TE>K0P4'ZRF\^=X(<7+;>7UL%K0&+IH*VROR?VCOW?Y
M3:=W]L(?;7RAFH9J.JH9J&:BFM5RV]OH5*?E5!>=ZJ&:CVH!JH6H%E%:/2FK
MTI8L;"4TK:=NCSQM2P1':ZCE3NLO\EVGT[F4I][%/$5[7JBFH)J*:AJJZ:AF
MH)J):A:JV:CF[#7YN*70>=.1>Y->MW^:SVBA"]5\5 M0+42UB-+J^5S5NN0V
MO2[!N;/2GY)2OIM+E,R2Y?/V#5Y^3[+E6@JR\L9Y*FG)EVP39S^DWO8-:'N-
M&8U6OE!-0345U314TU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)*JU_5H"J=
M=7<-"^YLVR[:-D,U!=545--034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(LH
MK1[(526M*ZZD_?Y4J$_I8G8XN39^3 XK'=M%XSR;/SXF66,TH\TT5%-0344U
M#=5T5#-0S40U:Z]-:LNYIV\HBXYT4,U%-0_5?%0+4"U$M8C2ZHG;K1)7V)\X
M2MP\BV?EZ1'E^[A+?TI-%Q[[*,9NSEBT;(9J*JIIJ*:CFH%J)JI9>^UX6;9[
M^F8UZ$0'U5Q4\U#-1[4 U4)4BRBM'K%5A:PKKI!5$3M-5^7;?FTO4-DJ;M$6
M&:HIJ*:BFH9J.JH9J&:BFK77CN.V=Q:W:,L,U5Q4\U#-1[4 U4)4BRBM'K=5
M%:WX\#]S:*Y\D\9,BA_R)),^;!XWZUR2+Q^;$S^,F\.9U!144U%-0S4=U0Q4
M,U'-0C4;U1Q4<U'-0S4?U0)4"U$MHK1ZC%<=N>Z /C:'%N-034$U%=4T5--1
MS4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B2JL'<E6?ZXKK<W_IV!Q:F$,U!=54
M5--034<U ]5,5+-0S48U9Z\)CQNZZ$@/U7Q4"U M1+6(TNJ)6]7ENN*ZW,5C
M<^ODL7RG],:D15MRJ*:@FHIJ&JKIJ&:@FHEJ%JK9J.;L-='10Q>=Z*&:CVH!
MJH6H%E%:/6BKMEU7W+;["T?HT!(=JBFHIJ*:AFHZJAFH9J*:A6HVJCE[373T
MT$4G>JCFHUJ :B&J1916C]NJ/-<5E^>V1]_FJW6>;<K=V+OC!86F%O-#FI6M
MY^=-_G*E]*PZ=K==?&C,9K0\AVH*JJFHIJ&:CFH&JIFH9J&:C6K.7JLM.IQ&
M,]J(0S4?U0)4"U$MHK1:-/>J1EQ/?!FV:R=/=)N"5FS>&K2HIJ":BFH:JNFH
M9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1I=4SN2K%]63X3(@>6H5#-0755%33
M4$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+**T>R-TJD,6=N9^\)I!8O3F5
M=YK<.WI)UWG3Z?;.+@J$SE5134,U'=4,5#-1S6J]]6UTKM-ZKHO.]5#-1[4
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M3?/#)^6 ;VGVQ_;'?/__4$L#!!0    ( -9] U5Z@]K<0P8  "8W   9
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M?H%.3Z#Y4E[(YI<<6FR$'M-:*EYVQC@N\ZK]9X]='(X,D,=LX'8&[M# ?\;
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M/.B;EJ\KRY?E(EX'/C/7W&1J2^C[6] ["H#4W/ZR_!40J. 'I2\H-=>VY:_
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M_/.!QTLNBPO,YW>YF3+UBZ*"S=/$COX'4$L#!!0    ( -9] U5C4(@=GP,
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M92?@]Y5$J1<#ZZ"\O8W^!5!+ P04    " #6?0-574OZ<5P*  !Y?@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6R]G6]OZC@6QK^*Q:Y&=Z7;0OX
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MK?Z2EVK=7H=,EUF>S*O@H@7S,%[_#WY6.V(KP+;?";"K /O0 *<*< X-<*L
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MZN63# H5ERL4GS\D2?[VIDRP>=K\^']02P,$%     @ UGT#5;NKGDK@ P
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M2(^"TX'B47+\^LR5XD%RN02J(S$+]/R<<_4V,">Z^8'\^#]02P,$%     @
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M@*S1>&@6^;:8G,/E=[DB?^0-1:P1?6A6_79%8-FC,.? !IUR4#%TXP'6IB]
M<V.X(T(J8=&OMUJ#W>=4"G!Q-[\?6&H9[9VK-DW_@-&1"Z,2M)?0V(+.)6QZ
M"S0WE_M\JV*JXJE>?:\>'M-?8+?!Q+Z/PK#_?:.FOR!C-VCD[QB*O:TVA1]$
MCC>0=:CI&<C<,QZJ"!T' ;MK !1'@3,4BZ85(',K:"G;42"H"^)Y,1J*1B/]
MR"S][8QY)19'<;G=Q2L,XS >6+RB1OJ1=]IBI,P>H+[]"/B *0</."T(N)BI
MBIR7.M;+9^PO9]8C:KH$,G>)']9C(9)3E'CO[I421P,+8]1T#63N&G5EGLH3
M]*Y(@H$O!M2T!F1N#8<B/94G[/*HE5LP%*!&^I'YVZ%5KJ<B13TK$&\$@P&D
M1NO1\5K_JG)/18R[616.W->$=FOS)2-\56XQ";!@12ZK?9CZ:KV-=55MWC2/
M5WM@GS!7Q2! 2I9JJ#,*55[S:ENI.I%L4V[E/#(I658>K@E."-</J/M+QN3A
M1#NH-_>F_P)02P,$%     @ UGT#57=4-\6  P  C P  !D   !X;"]W;W)K
M<VAE971S+W-H965T-CDN>&ULK5=MCYLX$/XK%E>=6JD-+]F09"]!VJ0]7:_M
M'FJN[6<')@&ML3G;)*W4'W]C0UBV1ZAR2CX0;#S/S#-O#(NCD \J ]#D:\&X
M6CJ9UN6MZZHD@X*JD2B!XY.=D 75N)1[5Y42:&J%"N8&GA>Z!<VY$RWL7BRC
MA:@TRSG$DJBJ**C\M@(FCDO'=TX;'_-]ILV&&RU*NH<-Z$]E+''EMBAI7@!7
MN>!$PF[IW/FW:]\*V!.?<SBJSCTQ5+9"/)C%VW3I>,8B8)!H T'Q[P!K8,P@
MH1W_-*!.J],(=N]/Z+];\DAF2Q6L!?N2ISI;.C.'I+"C%=,?Q?$/: A-#%XB
MF+)7<JS/AE.'))72HFB$T8(BY_4__=HXHB,0^&<$@D8@^$'@YIR&<2,PMD1K
MRRRMUU33:"'%D4AS&M',C?6-E48V.3=AW&B)3W.4T]'F[[_6[TC\_NY^0UZ1
M>RHE-7XESU^#ICE3+Q:N1C7FL)LTD*L:,C@#Z9,/@NM,D3<\A;1'?CTL'P[(
MNTBOY1B<.*Z"0< _*SXB8^\E";P@("JC$E2?69>@B-T.9,[W,5Y%2IX1MP'N
MQ7]B]K@-S=@J')\+C1;) WG+$^ V)#&CO,_N50USTP]C^L"M*FD"2P<+78$\
M@!/]^HL?>K_U.>%*8$\8W[2,;X;0HR^VZ" E]  2FPC9T5R2 V45)F3.22H8
MHU*1$F3MYA?D>\?U?;X95'BI;VJPF04S_?$0!9-1.%^XAQ[2DY;T9)#TFTT<
MDYPGV(05$"U.>409MECT!>YL@2C!^DII56-/.B9-//-K;:HM'S3A?T8U; F&
M@P3C2B:9X5;*/ &L')*(HL 6KDR"OR36 <\I,C:!-=G>VW0&E5P:R1ILWG&;
M-YI-^@,Y;7E.!WFN.ZQ(KE2%P:NPA4D"1<G$-X#F6=DZ!"O:)G8=\E[:@SHO
MI3W]3[:,PVEP)H%G+>_93Q.XS_)!J4LMOQ+8$X+SEN#\.HUX?DW&5P)[PMCW
M'L<";S"H]U6QQ<S%8CV]Z4QQXJM.$9P=ZYK]_L-;L'=4&%1SJ4\:M&X"!_W)
MZW<&(/_G_;<IR4>:O5P&@2[F,FQ62 H[!?5%T^W,>P7(O1V#%;;5BNMZ]&MW
MVU'[S@Z8[N/Q>D[_0.4^YXHPV*&H-YJB;V4]^M8++4H[/6Z%QEG4WF;XN0#2
M',#G.R'T:6$4M!\@T;]02P,$%     @ UGT#59$2'^>J @  EP8  !D   !X
M;"]W;W)K<VAE971S+W-H965T-S N>&ULC95M;],P$,>_RBE(:).@>>C3&&FD
M=@PQ8*Q:8;SVDDMCU;&#[;3KM\=VTE"DK.J;Q';N_O[=V7>)=T)N5(&HX:5D
M7,V\0NOJVO=56F!)U$!4R,V77,B2:#.5:U]5$DGFG$KF1T$P\4M"N9?$;FTI
MDUC4FE&.2PFJ+DLB]PMD8C?S0N^P\$C7A;8+?A)79(TKU+^JI30SOU/):(E<
M4<%!8C[SYN'U8FKMG<$3Q9TZ&H.-Y%F(C9W<93,OL$#(,-56@9C7%F^0,2MD
M,/ZTFEZWI74\'A_4/[O832S/1.&-8+]IIHN9=^5!ACFIF7X4NR_8QC.V>JE@
MRCUAU]H&'J2UTJ)LG0U!27GS)B]M'HX<HM$K#E'K$#GN9B-'^8EHDL12[$!:
M:Z-F!RY4YVW@*+>'LM+2?*7&3R>KGP\WWV#Y??YC!>]A9<X\JQF"R.&)L)JX
MS,V5.;+*#A5<?$)-*%.7QOJVK)C8(\)*BW0##\XD]K7!LN)^VB(L&H3H%80)
MW NN"P6W/,/L?W_?A-/%%!UB6D0G!;_6? ##X!U$012=T!MV.1HZO>%K.7+A
MW?$4N;U"L&2$J[XX&YE1OXPMKVM5D11GGJD?A7*+7O+V33@)/IZ ''60HU/J
MR>U+92XZ9I#1+<V09["GR#*X( H(5"@M_64?=:/[P>G:&MXF0>QO>U#&'<KX
M),HC51O(I;D8E&LTH6J01.,9*(UN&!VS#(+H:M@/-.F )N?E9BN8N=*,ZOT9
M,),^F-$X'/?#3#N8Z7DP)C6E+31Q*"W*88]$JEZ:TZ*CQA/"$,JFF$+(R+[O
M7OE'S:)$N78M44$J:JZ;OM&M=EUWWC2;?^9-R[XG<DT-.</<N :#J3D_V;3!
M9J)%Y5K/L]"FD;EA8?X<**V!^9X+H0\3NT'W+TK^ E!+ P04    " #6?0-5
MFW)X/S,&  !5)0  &0   'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6RU6FUS
MFS@0_BL:M]-)9IJ 9(QQZG@F,;II;ZZM)VZNGPG(,5= /I"3]M^?!!B,D.6X
MIWQ)C/SL(^V+5KM8TV>:_RC6A##P,TVRXGJP9FQS95E%N"9I4%S2#<GX-RN:
MIP'CC_FC56QR$D2E4)I8R+9=*PWB;#";EF.+?#:E6Y;$&5GDH-BF:9#_NB4)
M?;X>P,%NX"Y^7#,Q8,VFF^"1+ F[WRQR_F0U+%&<DJR(:09RLKH>W, KC%PA
M4"+^CLESL?<9"%4>*/TA'CY%UP-;K(@D)&2"(N#_GLB<)(E@XNOXMR8=-',*
MP?W/._8_2N6Y,@]!0>8T^1Y';'T]\ 8@(JM@F[ [^OR1U J-!%](DZ+\"YYK
MK#T X;9@-*V%^0K2.*O^!S]K0^P)<!ZU *H%D"S@'! 8U@+#E\[@U +.2V<8
MU0*EZE:E>VDX/V#!;)K39Y +-&<3'TKKE]+<7G$F F7)<OYMS.78[ O^!CY]
MF7_]C,'97U^7RW.PP'=@^?'F#H,+L.1Q&6T3 N@*S&FZV;*@="]_Q(LE./,)
M"^*D..?0^Z4/SMZ>@[?  L4ZR$D!X@S<9S$KWN\-?%O3;1%D$1]\VWF>6HRK
M(Q9EA?72;ZNEHP-+'X+/-&/K N L(I%"WM?+NQIYBYNQL27:V?(6:0G_W&:7
M8&B_!\A&2+&>^<O%H4J=_S<[_NW9.\88-H$U+/F&AP)KFY(\8#2_4GFVDG74
MLB(Y7A6;("37 Y[]"I(_D<'LW1OHVA]49C5)YILDPX;(.@YP&@<X.O;9%W[*
MQ%E(4_+NC8<@^L#S:1RJG%'QN"6/.%B>9G#BC=VI];1O917*]F 7Y?=1R!W;
M3A>%%:B),[(;5$?A4:/P2*OPS?)>!*]]8;L@I-D3R5G\P'-71IG(/:N+>I!$
M("5L32,01/_P#,N//:8R2S7;:%]A>SB1K-('V9)%^@ADCSW)(#J:CC'<QABN
MWABE:ES53 Z#*$ZV3)DO;]V^6^P)'$DJ]U&J0%!P>6,/27HK4(<#8=SH/M:F
M'I]DE!^5!Y//V&3R,4GFFR3#AL@Z+O :%WC:\/M>%F@\_ *^XWC!R3=DFO+"
MH2X$>,5:,'[JQ]DC+QW*Q 3.XMW7YRJG>;T=XHQ&MA1U<P7*@8X4P;Z*"WH2
M"BM0PXDW4<?FI#',1!N;4A55;T90D'";QRPFA3)B)R8CUB29;Y(,&R+K. ;:
M;25L:V/6%[[@70L@JQ5O8X1[]H^1B#RP/3\=B]=Z,LW),#\.\8]#L *R=W9W
M;;'7%<#3]F^V31](+FRBW,*[.#YF%-A;ZP@Y\FDX5\#X9I\@V3@J-N3*9XR2
M;3P^L)$A:FV$]!5N<[*"#3=-J;9R]]8\AK:O43;?*!LVQ=;U2-MR0&U!/;LM
M#Y*LZY?]DZ>,3]&I-@Y3AVDUC;>_ZRX=1XY2)6HH!ZD*-9K(,:I"N>,#(=JV
M %#? _CUMC1@$D>EK&P1):BW;56HD7SZ*E&N<\ B;8\ CS0)84BW&1-9:RG2
M5Y!'!;C?1 $CN^9!J;Z6]>0M;)+--\J&3;%U_=.V+=!]A?H(:INAD]UCDLTW
MRH9-L77=TW964-LUF*Z1QOT#W+7'<E;IHWIETDN(L):H:Y"VSX'Z1@>GFX3^
M(H1G$QK^ %\W(G*5NFIY3@Y1DVR^439LBJWKD;;!@J_184&C+991-M\H&S;%
MUGU%WG99Z.0NJZI#Q,\]D2A--B0K*O<%>1YDCT2\H#N:2U"_#8(VE%]B*E%R
MQ^"K4-"6N+ *A;P#%0IJ6R^D;[WN2,'R.!0Q6^64\C<4<':WO#^@N9;OU- U
MRN8;9<.FV+J>:1L^I&_X?B^S(*/=GU$VWR@;-L76=4_;_2%]]_=JF678V^=#
M1RY25*#>.W$5R)7?YRA #CKP0@>UG2#2=X)XN5@HE=.*G1R=)ME\HVS8%%O7
M 6WCB4:OD3R,]IU&V7RC;-@46]<];=^)]+^7O5KR</MO9^74T8<X<N(X"L%:
M2&44:^^:2$KRQ_)^3@'*%R+5#_O-:','Z*:\^2*-W\*K.52,^_ *5S=\6OKJ
MPM'G('^,LP(D9,6GLB_'?)UY=8>G>F!T4UY2>:",T;3\N"9!1'(!X-^O*&6[
M!S%!<Y-J]A]02P,$%     @ UGT#56Y_%%#+ P  T1,  !D   !X;"]W;W)K
M<VAE971S+W-H965T-S(N>&ULK9AM<Z,V$,>_BH;.W-S-M.'13ZGM&<?0NW0N
MN8S)]5[+(-N:@.1*PKY^^TI L,$*35*],2#O_R?MKK0@38^4/?$=0@+\S#/"
M9]9.B/VU;?-DAW+(K^@>$?G/AK(<"OG(MC;?,P334I1GMN<X0SN'F%CS:=GV
MP.936H@,$_3  "_R'+)_;E!&CS/+M9X;5GB[$ZK!GD_W<(MB)+[O'YA\LAM*
MBG-$.*8$,+2960OW.G)])2@M_L+HR,_N@7)E3>F3>KA-9Y:C1H0RE B%@/)R
M0$N498HDQ_%W#;6:/I7P_/Z9_D?IO'1F#3E:TNP'3L5N9HTMD*(-+#*QHL<O
MJ'9HH'@)S7CY"XZUK6.!I.""YK58CB#'I+K"GW4@S@22HQ=XM<#K"H(7!'XM
M\%_;0U +@M?V,*@%I>MVY7L9N! *.)\R>@1,64N:NBFC7ZIEO#!1$R463/Z+
MI4[,[Z-'<'N__'87@8]?O\7Q)_ 0K4#\9;&*P&\@EO,R+3($Z 8LB, IS@J5
M6!"CI&!88,3!QQ )B#/^2=KS'62RJ;Y@ AYWM."0I'QJ"SE:U:>=U".[J4;F
MO3 R']Q1(G8<1"1%J48?]NN'/7I;1JD)E?<<JANO%_AG0:Z [_P*/,?S-.-9
MOE[NZMSY?[U'[^Z]%0R_F3=^R?-?X$6+U?WM_>?X-%UT&:X8@9ZA:N UW\,$
MS2Q9Y#AB!V3-/_SB#IW?=>$U"0M-PB)#L%8B@B8101]]_D@%S'2QKV2#4J9>
M%X>Y.QE-IO;A/*:71I[K!FVC\-+(=T:#ME&DZ6[@^(U1R[=!X]N@U[<?99E'
M*8 'Q.1K"Y B7R.FJI$LC,D3H'OUMM$6EU[R6Z>>25AH$A89@K72,VS2,S10
M X8F$V$2%IJ$189@K42,FD2,WE<#1IH:$(P[->#2R'/&':-00QH/NC5 8Q2,
M)_H:,&Y\&_?ZMJ1$+GZ!U_(KA"."*0.$"J1=\[VDMTXUD[#0)"PR!&NE8]*D
M8V)@S4],)L(D+#0)BPS!6HEPG=.7N_.^55_KSM>ATUGS_VT2:DQ<=S+L+/E>
M4-NQLRV)^][7_BK^KM]*]!+?.N.,TD*CM,@4K9T;[Y0;S\#ZKR&FTF&2%AJE
M1:9H[72<=F%N[]ZBIP;XEQ_M;K<(7-IXPVX5T-@$W1IP:7.VAZ@\L\^.*'+$
MMN79$ <)+8BH=IU-:W/^M"A/73KM-^[UTM6TA^J\JCP2.>&KPZX[R+:8<)"A
MC>S*N1K)@;+J_*AZ$'1?'I"LJ1 T+V]W"*:(*0/Y_X;*#X[Z0770G.+-_P50
M2P,$%     @ UGT#51H<'+QU P  J@L  !D   !X;"]W;W)K<VAE971S+W-H
M965T-S,N>&ULK5;;;N,V$/T50ET4"; ;W2]V;0&)I<6F:-I@G6W[RDAC6UA)
M=$DZ3O^^0TI1;9DQ@C8O-DF=<X9GAA)GMF?\N]@ 2/+<U*V86QLIMU/;%L4&
M&BJNV!9:?+)BO*$2IWQMBRT'6FI24]N>XT1V0ZO62F=Z[9ZG,[:3==7"/2=B
MUS24_WT#-=O/+==Z6?A:K3=2+=CI;$O7L 3Y;7O/<68/*F750"LJUA(.J[EU
M[4[S1.$UX/<*]N)@3)231\:^J\EM.;<<M2&HH9!*@>+?$RR@KI40;N.O7M,:
M0BKBX?A%_;/VCEX>J8 %J_^H2KF96XE%2EC172V_LOT7Z/V$2J]@M="_9-]C
M'8L4.R%9TY-Q!TW5=O_TN<_# 0%US 2O)WAC0O *P>\)_ELC!#TA>&N$L"=H
MZW;G72<NHY*F,\[VA"LTJJF!SKYF8[ZJ5IV3I>3XM$*>3&]_7?QVEY.'ZS_S
M)?E$EG@.RUT-A*W(9RB!T_HC64HJ@="V)+^P0BVH(98)B]"2V[9@#9 '^@R"
M7&0@:56+2Y3ZMLS(Q8=+\H%4+7G8L)U FIC9$G>M8MM%O\.;;H?>*SOTR1UK
MY4:0O"VA-/"S\_SH#-_&; TI\UY2=N.=%?QYUUX1W_E(/,?S#/M9O)WNFNS\
MO^CY?XY^E Q_.#^^UO-?.S]=^2]J)K#JCX!?+L""ZT6ISL345/%.,S!KJD_C
M5&QI 7,+OWT"^!-8Z8\_N)'SDRG=[RF6O:=8_DYB1X4)AL($Y]33#"L@9%68
MTM\Q(\U4%\E3ZOGQ))G93X=Y-:#")/*/4=DIRG?\Q#E&Y:>HP(TGX8 ZLA@.
M%L.S%OM/D,EA1PP/XGW">.[(H0'EN>'(H$G*B2<C@P:4'WB!V6 T&(S.&NQ?
M+L-;9?(<G6S!PVXA'GDVH,(H&-4^,Z FOC/*7WZ*\A,_=LVFX\%T_!;3:)/
M,[9# DQFX]/#Z?KC^IZ"HC :)20S*(63$2@_!243[Q6CR6 T.6LT7ZU MTG:
M*\<[%B]0O"NWP MHY:7)=J<X.=B'<S5V;<)XT<BU">2,#[51R1^YM@^:CP;X
M6G=]@A1LU\KN'AE6A\;R6O=3H_4;=[IP#>L9-J)=W_BO?-?%WE&^KEI!:EAA
M*.<JQJ/(N\ZPFTBVU:W/(Y/82.GA!IMIX J SU>,R9>)"C"TY^D_4$L#!!0
M   ( -9] U7>F739< 4  ' @   9    >&PO=V]R:W-H965T<R]S:&5E=#<T
M+GAM;+6:;7.;.!" _XK&[732F20@8?R2.IYQ#&E\D[>SG;L/-_>!@&(S!>0B
M.4G__4E P("BQCGE2\S+[B/MKEAII8R>2/J#KC%FX#F.$GK:63.V.3$,ZJ]Q
M[-%CLL$)?_- TMAC_#9=&7238B_(E.+(0*;9,V(O3#KC4?;L-AV/R)9%88)O
M4T"W<>REO\YP1)Y..[#S\F >KM9,/##&HXVWP@O,[C:W*;\S2DH0QCBA(4E
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M:8Y6FJN+5H]354I"91VT^_%4^V:O5B/#]MX"[#7W,B12S7TSB4C7A%8S7ZA
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M3+>W)+T@4_(\&K#D$VW3NJJ"O#7C-$S%H@>A'^V^W9=T( X$6NV,0$\%^K'
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MB2LL("N(W^>4\M<3V4"VOZ;['U!+ P04    " #6?0-5*Y:/$6L#  !!#0
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MI2R84;(SP$1,7W2:HHHX2_AWYJ*:7,*?X]O[T6)Q70:YLK'70K[XSP+1>K%
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M".Q&',$<@ <,B2+S'-Q['@7KYU2P^9?"Z ]02P,$%     @ UGT#59>*NQS
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M0.]A'KH3Q,0$9)UDENW0Z$IFMS !6=0C'Q13V8Z$"<BB'OE@SZ8:34Q %K&
MVB<M6[*[A6[N(O8/G+54LV=4%<OO$!.3D/41Z_WO8:IMCDG(^KBE_S:I0TQ,
M0A;UY-N[T:RK)"@A&Y.032PA;-9:8D-,3$(VL8103.79M#$)V<024B;7U58?
M\Q6<U[(Q"=G$$L*GV:&$;$Q"-K&$<$QE5RPF(9M\AS&R-409!=F8A>S&0MWF
MR^75Y8JOTYRO OD3I3R_3++E3+#ZI=GII!EFO=MIO<NRH3P7YGZ1K(Y_0CC^
M@>+J/U!+ P04    " #7?0-5<WQX+%$"  #[+   &@   'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QSS=I+;J- %(7AK5@L(+CNJY)6G%%/,HVR >24'XIM
M$-!*LONVG(%]4 ]Z$G%&J$!<_@F?$/#X4@[-N&]/PV[?#8O/X^$TK*K=.':_
MZGI8[\JQ&>[:KIS.1S9M?VS&\[+?UEVS?F^VI9;E,NK^=D;U]'@[<_'ZU97_
MF=AN-OMU^=VN_QS+:?S'X/JC[=^'72ECM7AM^FT95U7]>;CN'NK+)MV=)U>+
MY[=5U3^_I:J>.T@@2.8/4@C2^8,,@FS^((<@GS\H("CF#\H0E.</NH>@^_F#
M'B#H8?Z@M$09EP1)$ZP)M$[(=2+P.B'8B4#LA&0G K,3HIT(U$[(=B)P.R'<
MB4#NA'0G KL3XIT(]!;46PCT%M1;"/26R<,V@=Z">@N!WH)Z"X'>@GH+@=Z"
M>@N!WH)Z"X'>@GH+@=Z">@N!WHIZ*X'>BGHK@=Z*>BN!WCIY64*@MZ+>2J"W
MHMY*H+>BWDJ@MZ+>2J"WHMY*H+>BWDJ@MZ'>1J"WH=Y&H+>AWD:@MZ'>1J"W
M35YV$^AMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z&VHMQ'H[:BW$^CMJ+<3Z.VHMQ/H
M[:BW$^CMJ+<3Z.V3CY4$>COJ[01Z.^KM!'H[ZNT$>COJ[01Z!^H=!'H'ZAT$
M>@?J'01Z!^H=!'H'ZAT$>@?J'01ZQ^1G$P*] _4. KT#]0X"O0/U#@*],^J=
M"?3.J'<FT#NCWIE [XQZ9P*],^J="?3.J'<FT#NCWODG]1[&KT,9KCW?:[S^
M3U(]GL\MU\M?EM\[)_?X!>?ZMF)X^@M02P,$%     @ UWT#5<X5S%\/ @
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M\=.S[&T[O.2SZ2^^ZS]02P$"% ,4    " #6?0-5!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -9]
M U7%;>1![P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( -9] U697)PC$ 8  )PG   3              "
M <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ UGT#55#G/$[F
M!0  YAX  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( -9] U740:1@* <  %L>   8              "
M@2H.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #6?0-5
MJ^-B%PX#  !?"@  &               @(&(%0  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ UGT#54+'DECH!P   2P  !@
M     ("!S!@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M -9] U7I+/9^M0,  &8-   8              " @>H@  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " #6?0-5+\Y*G\L.  !PL   &
M            @('5)   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ UGT#52.*%YOR"   92H  !@              ("!UC,  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( -9] U41C@&OEPD  ) 5
M   8              " @?X\  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " #6?0-5]"$.;.<'  !M$P  &               @('+1@
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ UGT#5=2XJ,MT
M"0  DA<  !D              ("!Z$X  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " #6?0-5($CT/&@*  !9&0  &0
M@(&36   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( -9]
M U7;SS 9E (  'H%   9              " @3)C  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ UGT#56,8DSF#!   V0H  !D
M         ("!_64  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    " #6?0-5.Z <8M &  #D#P  &0              @(&W:@  >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( -9] U7KRE3!J0<  $$3
M   9              " @;YQ  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ UGT#56],?M<4%@  #$8  !D              ("!GGD
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #6?0-5IE2K
M-,D1  !--0  &0              @('ICP  >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( -9] U4JF#UQ5P,  %((   9
M  " @>FA  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
MUGT#53SO]FMR!@  90X  !D              ("!=Z4  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " #6?0-5YM)[SH8&  #S$0  &0
M            @($@K   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( -9] U7>V8%5$@0  (<)   9              " @=VR  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ UGT#58@25WB,!@
M#1(  !D              ("!)K<  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " #6?0-5["<0 [(.  !D*   &0              @('I
MO0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( -9] U7L
M3;'D=0<  *<2   9              " @=+,  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ UGT#52\Y3P#/ @  -08  !D
M     ("!?M0  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -9] U6+=OL\EP0  +(+   9              "
M@4SG  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ UGT#
M5<%V&OZ^ P  '@D  !D              ("!&NP  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " #6?0-5U'LM^2(%  #?#0  &0
M        @($/\   >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( -9] U7PBJ=&EP<  'X4   9              " @6CU  !X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ UGT#548J(*]@ P  -P@
M !D              ("!-OT  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " #6?0-5].2I&WL%  #8#   &0              @('-  $
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( -9] U4V;0/0
MU00  '4,   9              " @7\& 0!X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ UGT#5?ANM,[L @  9P8  !D
M ("!BPL! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #6
M?0-5O=D.V\$#   W"   &0              @(&N#@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( -9] U4_/F6TC@(  +D&   9
M          " @:82 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#
M%     @ UGT#5?:[)0HT!   V1D  !D              ("!:Q4! 'AL+W=O
M<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " #6?0-5T2*(3),%  "&
M*P  &0              @('6&0$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM
M;%!+ 0(4 Q0    ( -9] U424,,%9@(  #L'   9              " @: ?
M 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ UGT#53;+
MGE&2!   EQP  !D              ("!/2(! 'AL+W=O<FMS:&5E=',O<VAE
M970T,RYX;6Q02P$"% ,4    " #6?0-5OHYQBG@#  !A"P  &0
M    @($&)P$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M -9] U6^XV4><P8  & F   9              " @;4J 0!X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ UGT#51_=(:T\ P  . P  !D
M             ("!7S$! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    " #6?0-5_+N0-X\"  ##!@  &0              @('2- $ >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( -9] U594';I @0
M 'L3   9              " @9@W 0!X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ UGT#5;KJY_ I!   2!<  !D              ("!
MT3L! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #6?0-5
MWCSR$I@#  !W$   &0              @($Q0 $ >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( -9] U4\K#/_,P0  .D0   9
M      " @0!$ 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ UGT#57(JL7[5 @  _ <  !D              ("!:D@! 'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " #6?0-5.&8&XJ8"  #W!@
M&0              @(%V2P$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+
M 0(4 Q0    ( -9] U4:,2R2[P0  !<>   9              " @5-. 0!X
M;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ UGT#5073H(J'
M!   O!4  !D              ("!>5,! 'AL+W=O<FMS:&5E=',O<VAE970U
M-2YX;6Q02P$"% ,4    " #6?0-5FO!5=CT%   [*P  &0
M@($W6 $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( -9]
M U7<9TN[NR$  ,IL @ 9              " @:M= 0!X;"]W;W)K<VAE971S
M+W-H965T-3<N>&UL4$L! A0#%     @ UGT#57J#VMQ#!@  )C<  !D
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M=#8R+GAM;%!+ 0(4 Q0    ( -9] U6[JYY*X ,  )P7   9
M  " @3BA 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @
MUGT#57SRQ541!   3Q0  !D              ("!3Z4! 'AL+W=O<FMS:&5E
M=',O<VAE970V-"YX;6Q02P$"% ,4    " #6?0-53L)'@"L%   ['P  &0
M            @(&7J0$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4
M Q0    ( -9] U6VX<T6.04  *@?   9              " @?FN 0!X;"]W
M;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ UGT#51+L'PJS!
MI1D  !D              ("!:;0! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX
M;6Q02P$"% ,4    " #6?0-5:O[@,J $  #H$P  &0              @(%3
MN0$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( -9] U5W
M5#?%@ ,  (P,   9              " @2J^ 0!X;"]W;W)K<VAE971S+W-H
M965T-CDN>&UL4$L! A0#%     @ UGT#59$2'^>J @  EP8  !D
M     ("!X<$! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -9] U7JBEZ@] 0  &LC   9              "
M@8'8 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ UGT#
M52N6CQ%K P  00T  !D              ("!K-T! 'AL+W=O<FMS:&5E=',O
M<VAE970W-BYX;6Q02P$"% ,4    " #6?0-5K3J336\#  !?&   #0
M        @ %.X0$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -9] U67BKL<
MP    !,"   +              "  >CD 0!?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( -9] U4:Q^'5KP4  ,0Q   /              "  ='E 0!X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " #7?0-5<WQX+%$"  #[+   &@
M    @ &MZP$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" #7?0-5SA7,7P\"  #J*P  $P              @ $V[@$ 6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     5 !4  ,7  !V\ $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>334</ContextCount>
  <ElementCount>383</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>95</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - FLEXION ACQUISITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITION</Role>
      <ShortName>FLEXION ACQUISITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - FIXED ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETS</Role>
      <ShortName>FIXED ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2134109 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2140110 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2148111 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2151112 - Disclosure - STOCK PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANS</Role>
      <ShortName>STOCK PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2157113 - Disclosure - NET INCOME (LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHARE</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2161114 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2164115 - Disclosure - ACQUISITION???RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER</Role>
      <ShortName>ACQUISITION???RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2168116 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/REVENUE</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - FLEXION ACQUISITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITIONTables</Role>
      <ShortName>FLEXION ACQUISITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FLEXIONACQUISITION</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INVENTORIES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2321305 - Disclosure - FIXED ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETSTables</Role>
      <ShortName>FIXED ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FIXEDASSETS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/LEASES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2335308 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/DEBT</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2341309 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2349310 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2352311 - Disclosure - STOCK PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSTables</Role>
      <ShortName>STOCK PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKPLANS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2358312 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARE</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2362313 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INCOMETAXES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2365314 - Disclosure - ACQUISITION???RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables</Role>
      <ShortName>ACQUISITION???RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/DESCRIPTIONOFBUSINESS</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - REVENUE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUENarrativeDetails</Role>
      <ShortName>REVENUE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - REVENUE - Schedule of Disaggregated Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails</Role>
      <ShortName>REVENUE - Schedule of Disaggregated Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - FLEXION ACQUISITION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails</Role>
      <ShortName>FLEXION ACQUISITION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails</Role>
      <ShortName>FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails</Role>
      <ShortName>FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INVENTORIESTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - FIXED ASSETS - Summary of Major Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails</Role>
      <ShortName>FIXED ASSETS - Summary of Major Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - FIXED ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETSNarrativeDetails</Role>
      <ShortName>FIXED ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails</Role>
      <ShortName>LEASES - Summary of operating lease cost and other operating lease information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails</Role>
      <ShortName>LEASES - Schedule of maturities of operating lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails</Role>
      <ShortName>LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2436418 - Disclosure - DEBT - Carrying Value of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTCarryingValueofDebtDetails</Role>
      <ShortName>DEBT - Carrying Value of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - DEBT - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTScheduleofDebtDetails</Role>
      <ShortName>DEBT - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - DEBT - Schedule of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails</Role>
      <ShortName>DEBT - Schedule of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2443423 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2444424 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - STOCKHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2453429 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2454430 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - STOCK PLANS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSNarrativeDetails</Role>
      <ShortName>STOCK PLANS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2456432 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2459433 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2460434 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463435 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2466436 - Disclosure - ACQUISITION???RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Product Discontinuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails</Role>
      <ShortName>ACQUISITION???RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Product Discontinuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2467437 - Disclosure - ACQUISITION???RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails</Role>
      <ShortName>ACQUISITION???RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="pcrx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2469438 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="pcrx-20220630.htm">pcrx-20220630.htm</File>
    <File>pcrx-20220630.xsd</File>
    <File>pcrx-20220630_cal.xml</File>
    <File>pcrx-20220630_def.xml</File>
    <File>pcrx-20220630_lab.xml</File>
    <File>pcrx-20220630_pre.xml</File>
    <File>pcrx-6302022xex311.htm</File>
    <File>pcrx-6302022xex312.htm</File>
    <File>pcrx-6302022xex321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pcrx-20220630_g1.jpg</File>
    <File>pcrx-20220630_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1025">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pcrx-20220630.htm": {
   "axisCustom": 2,
   "axisStandard": 31,
   "contextCount": 334,
   "dts": {
    "calculationLink": {
     "local": [
      "pcrx-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pcrx-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pcrx-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pcrx-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pcrx-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pcrx-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 642,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://www.pacira.com/20220630": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 10
   },
   "keyCustom": 67,
   "keyStandard": 316,
   "memberCustom": 38,
   "memberStandard": 52,
   "nsprefix": "pcrx",
   "nsuri": "http://www.pacira.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.pacira.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - REVENUE",
     "role": "http://www.pacira.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - FLEXION ACQUISITION",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITION",
     "shortName": "FLEXION ACQUISITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - INVENTORIES",
     "role": "http://www.pacira.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - FIXED ASSETS",
     "role": "http://www.pacira.com/role/FIXEDASSETS",
     "shortName": "FIXED ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - LEASES",
     "role": "http://www.pacira.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134109 - Disclosure - DEBT",
     "role": "http://www.pacira.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140110 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148111 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151112 - Disclosure - STOCK PLANS",
     "role": "http://www.pacira.com/role/STOCKPLANS",
     "shortName": "STOCK PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157113 - Disclosure - NET INCOME (LOSS) PER SHARE",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHARE",
     "shortName": "NET INCOME (LOSS) PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2161114 - Disclosure - INCOME TAXES",
     "role": "http://www.pacira.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164115 - Disclosure - ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER",
     "role": "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER",
     "shortName": "ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2168116 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - REVENUE (Tables)",
     "role": "http://www.pacira.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - FLEXION ACQUISITION (Tables)",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITIONTables",
     "shortName": "FLEXION ACQUISITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.pacira.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321305 - Disclosure - FIXED ASSETS (Tables)",
     "role": "http://www.pacira.com/role/FIXEDASSETSTables",
     "shortName": "FIXED ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - LEASES (Tables)",
     "role": "http://www.pacira.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335308 - Disclosure - DEBT (Tables)",
     "role": "http://www.pacira.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341309 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349310 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352311 - Disclosure - STOCK PLANS (Tables)",
     "role": "http://www.pacira.com/role/STOCKPLANSTables",
     "shortName": "STOCK PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358312 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables",
     "shortName": "NET INCOME (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2362313 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.pacira.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365314 - Disclosure - ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables)",
     "role": "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables",
     "shortName": "ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)",
     "role": "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
     "shortName": "DESCRIPTION OF BUSINESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ied39c8b2a0e847a5aafe78db72f6e93b_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:ConcentrationRiskNumberOfCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ied39c8b2a0e847a5aafe78db72f6e93b_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:ConcentrationRiskNumberOfCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i7ed27d17e7e04841a903c038b2cd6d5b_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i137156d0fcb14f6083cfb7e0561f67e9_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:AccountsReceivablePaymentTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - REVENUE - Narrative (Details)",
     "role": "http://www.pacira.com/role/REVENUENarrativeDetails",
     "shortName": "REVENUE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i137156d0fcb14f6083cfb7e0561f67e9_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:AccountsReceivablePaymentTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - REVENUE - Schedule of Disaggregated Revenue (Details)",
     "role": "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails",
     "shortName": "REVENUE - Schedule of Disaggregated Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "icf70633f4d2743c483f890199a5aad26_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i19c54c90141d46f5b4ed7575ff155dfa_D20211119-20211119",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - FLEXION ACQUISITION - Narrative (Details)",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
     "shortName": "FLEXION ACQUISITION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i19c54c90141d46f5b4ed7575ff155dfa_D20211119-20211119",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
     "shortName": "FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i8ff32cab5cf2450193a2f0b2ae4657cb_D20211119-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails",
     "shortName": "FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "if4f19ce4f1c44aa2a1a359acbc6ce6c4_D20210401-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - INVENTORIES (Details)",
     "role": "http://www.pacira.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - FIXED ASSETS - Summary of Major Categories (Details)",
     "role": "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails",
     "shortName": "FIXED ASSETS - Summary of Major Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - FIXED ASSETS - Narrative (Details)",
     "role": "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
     "shortName": "FIXED ASSETS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:NumberOfLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - LEASES - Narrative (Details)",
     "role": "http://www.pacira.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:NumberOfLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)",
     "role": "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails",
     "shortName": "LEASES - Summary of operating lease cost and other operating lease information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)",
     "role": "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails",
     "shortName": "LEASES - Schedule of maturities of operating lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)",
     "role": "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails",
     "shortName": "LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i83f2e14bdb904ac69fc8abf1f24b5ab6_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i356d1afe505c441eb90b0423c3fb17f2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - DEBT - Carrying Value of Debt (Details)",
     "role": "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
     "shortName": "DEBT - Carrying Value of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:SettlementPeriodConvertibleDebtConversionRequest",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - DEBT - Narrative (Details)",
     "role": "http://www.pacira.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:SettlementPeriodConvertibleDebtConversionRequest",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i292cd08d718c48e594813938f2045cca_I20220630",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - DEBT - Schedule of Debt (Details)",
     "role": "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
     "shortName": "DEBT - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i7a89013bf3a64b9bb64b17ee4b05bc88_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - DEBT - Schedule of Interest Expense (Details)",
     "role": "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails",
     "shortName": "DEBT - Schedule of Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ic8e4e8f15d4b41d3bd530ae73c637d3a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "iee3dac9327834a67bda1e2785f19bd23_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i2e4721a6974c47a4b2d7646849bd93fd_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i2e4721a6974c47a4b2d7646849bd93fd_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "if1e299ef910a46358668913b0b2f165d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443423 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "if1e299ef910a46358668913b0b2f165d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444424 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "pcrx:NumberOfMajorCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "customer",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i15a06e8c3c614623bffeb6e3b147f2bf_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "idc02a21d3efb40b2a085eac6cf253ef8_I20220630",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i59c47ce6aa614060975818db7878464b_D20190401-20190430",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:ContingentConsideration",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "iee16b76f339b45f1bc4250ddc76ad052_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibfe1468fe7344d909a88362d4b43314a_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i7067da57a3274ecf8bb92bb5fda7ddaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - STOCKHOLDERS' EQUITY (Details)",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "iab2955eb68904b22a10de3106fc90299_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453429 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails",
     "shortName": "STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "if1e299ef910a46358668913b0b2f165d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454430 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
     "shortName": "STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "if1e299ef910a46358668913b0b2f165d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - STOCK PLANS - Narrative (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
     "shortName": "STOCK PLANS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456432 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails",
     "shortName": "STOCK PLANS - Schedule of Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ic81f6fe7f20c42f1b4de4a1b31d5c81d_D20220101-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459433 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
     "shortName": "NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460434 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
     "shortName": "NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463435 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)",
     "role": "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466436 - Disclosure - ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Product Discontinuance (Details)",
     "role": "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails",
     "shortName": "ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Product Discontinuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i96d5ac6c780a4e15977a76b8c05fb8f8_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467437 - Disclosure - ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Narrative (Details)",
     "role": "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
     "shortName": "ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ic60ea8d3b79d48c4b025712186e3026c_D20210101-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibe0d71dff18d49c48f2bf3e271341ed5_D20201001-20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469438 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "ibe0d71dff18d49c48f2bf3e271341ed5_D20201001-20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://www.pacira.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220630.htm",
      "contextRef": "i1ca0dfdd5ff14c5c974a5296974495da_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 95,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pcrx_AccountsReceivablePaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Payment Terms",
        "label": "Accounts Receivable, Payment Terms",
        "terseLabel": "Accounts receivable, payment terms"
       }
      }
     },
     "localname": "AccountsReceivablePaymentTerms",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-Related Charges, Product Discontinuation, And Other",
        "label": "Acquisition-Related Charges, Product Discontinuation, And Other",
        "totalLabel": "Total acquisition-related (gains) charges, product discontinuation and other"
       }
      }
     },
     "localname": "AcquisitionRelatedChargesProductDiscontinuationAndOther",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AcquisitionRelatedFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Related Fees",
        "label": "Acquisition Related Fees [Member]",
        "terseLabel": "Acquisition Related Fees"
       }
      }
     },
     "localname": "AcquisitionRelatedFeesMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net",
        "label": "Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net",
        "negatedLabel": "Acquisition-related (gains) charges, product discontinuation and other"
       }
      }
     },
     "localname": "AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.",
        "label": "Agreed Milestone Payments for Sale of Product in Connection with Acquisition",
        "terseLabel": "Milestone payments for EXPAREL agreed in connection with acquisition"
       }
      }
     },
     "localname": "AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.",
        "label": "Amortization of Other Assets and Unfavorable Lease Obligation",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfOtherAssetsAndUnfavorableLeaseObligation",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.",
        "label": "Annual Net Sales Threshold for Determining Milestone Payments for Product in Connection with Acquisition",
        "terseLabel": "Annual net sales threshold"
       }
      }
     },
     "localname": "AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of presentation and principles of consolidation.",
        "label": "Basis of Presentation and Principles of Consolidation [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_BupivacaineLiposomeInjectableSuspensionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bupivacaine Liposome Injectable Suspension",
        "label": "Bupivacaine Liposome Injectable Suspension [Member]",
        "terseLabel": "Bupivacaine liposome injectable suspension"
       }
      }
     },
     "localname": "BupivacaineLiposomeInjectableSuspensionMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails": {
       "order": 2.0,
       "parentTag": "pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Acquisition And Integration Related Costs",
        "label": "Business Combination, Acquisition And Integration Related Costs",
        "terseLabel": "Total acquisition-related charges"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionAndIntegrationRelatedCosts",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration",
        "terseLabel": "Fair value of contingent value rights (CVRs)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Liabilities Incurred, Debt",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred, Debt",
        "terseLabel": "Retirement of term loan"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "terseLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets",
        "totalLabel": "Total identifiable net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]",
        "label": "COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]",
        "terseLabel": "Schedule of Acquisition-related Restructuring and Discontinuation Costs"
       }
      }
     },
     "localname": "COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Milestone Payments to be Received, Maximum",
        "label": "Collaborative Arrangement, Milestone Payments to be Received, Maximum",
        "terseLabel": "Maximum milestone payment to be received"
       }
      }
     },
     "localname": "CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_CollaborativeLicensingAndMilestoneRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Licensing and Milestone Revenue",
        "label": "Collaborative Licensing and Milestone Revenue [Member]",
        "terseLabel": "Collaborative licensing and milestone revenue"
       }
      }
     },
     "localname": "CollaborativeLicensingAndMilestoneRevenueMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_CompensationExpenseFromEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Expense From Employee Stock Purchase Plan",
        "label": "Compensation Expense From Employee Stock Purchase Plan",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "CompensationExpenseFromEmployeeStockPurchasePlan",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_Compensationexpensefromstockoptionsemployees": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation expense from stock options (employee and board of director awards)",
        "label": "Compensation expense from stock options, employees",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "Compensationexpensefromstockoptionsemployees",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConcentrationRiskNumberOfCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number of Customers",
        "label": "Concentration Risk, Number of Customers",
        "terseLabel": "Number of customers"
       }
      }
     },
     "localname": "ConcentrationRiskNumberOfCustomers",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_ConcentrationRiskNumberOfProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number Of Products",
        "label": "Concentration Risk, Number Of Products",
        "terseLabel": "Concentration of products (in products)"
       }
      }
     },
     "localname": "ConcentrationRiskNumberOfProducts",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_ContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum amount of Contingent Consideration related to the acquisition of a business.",
        "label": "Contingent Consideration",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsideration",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Current",
        "label": "Contingent Consideration, Current",
        "verboseLabel": "Contingent consideration, current"
       }
      }
     },
     "localname": "ContingentConsiderationCurrent",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ContingentConsiderationNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Noncurrent",
        "label": "Contingent Consideration, Noncurrent",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationNoncurrent",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationPaymentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Payment Term",
        "label": "Contingent Consideration, Payment Term",
        "terseLabel": "Payment term"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentTerm",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_ConvertibleNotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Receivable",
        "label": "Convertible Notes Receivable [Member]",
        "terseLabel": "Convertible Notes Receivable"
       }
      }
     },
     "localname": "ConvertibleNotesReceivableMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2022 [Member]",
        "label": "Convertible Senior Notes Due 2022 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2022"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2022Member",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2024",
        "label": "Convertible Senior Notes Due 2024 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2024"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2024Member",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2025",
        "label": "Convertible Senior Notes Due 2025 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2025"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2025Member",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDueMay2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due May 2024",
        "label": "Convertible Senior Notes Due May 2024 [Member]",
        "terseLabel": "Convertible Senior Notes Due May 2024"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDueMay2024Member",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtConversionAndRedemptionTermsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information regarding the conversion and redemption terms of the debt instruments.",
        "label": "Debt Conversion and Redemption Terms [Axis]",
        "terseLabel": "Debt Conversion and Redemption Terms [Axis]"
       }
      }
     },
     "localname": "DebtConversionAndRedemptionTermsAxis",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_DebtConversionAndRedemptionTermsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the conversion and redemption terms of the debt instruments.",
        "label": "Debt Conversion and Redemption Terms [Domain]",
        "terseLabel": "Debt Conversion and Redemption Terms [Domain]"
       }
      }
     },
     "localname": "DebtConversionAndRedemptionTermsDomain",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount",
        "label": "Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount",
        "terseLabel": "Debt conversion, converted instrument, warrants or rights issued, per principal amount (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pcrx_DebtInstrumentBasisSpreadOneOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread One On Variable Rate",
        "label": "Debt Instrument, Basis Spread One On Variable Rate",
        "terseLabel": "Basis spread one on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOneOnVariableRate",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread Two On Variable Rate",
        "label": "Debt Instrument, Basis Spread Two On Variable Rate",
        "terseLabel": "Basis spread two on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadTwoOnVariableRate",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.",
        "label": "Debt Instrument, Conversion Obligation Premium on Common Stock",
        "terseLabel": "Convertible debt, premium on common stock"
       }
      }
     },
     "localname": "DebtInstrumentConversionObligationPremiumOnCommonStock",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentConvertibleConversionPremiumShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Conversion Premium, Shares",
        "label": "Debt Instrument, Convertible, Conversion Premium, Shares",
        "terseLabel": "Debt instrument, convertible, conversion premium (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPremiumShares",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pcrx_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Leverage ratio, maximum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum, Value",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum, Value",
        "terseLabel": "Leverage ratio, maximum, value"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximumValue",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_DebtInstrumentDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Discount Rate",
        "label": "Debt Instrument, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DebtInstrumentDiscountRate",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentMarketPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt market price, per $1,000 principal amount.",
        "label": "Debt Instrument, Market Price",
        "terseLabel": "Market price of principal amount of notes"
       }
      }
     },
     "localname": "DebtInstrumentMarketPrice",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.",
        "label": "Debt Instrument, Percentage of Principal Amount for Computation of Redemption Price",
        "terseLabel": "Debt instrument, percentage of principal amount for computation of redemption price"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year",
        "label": "Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year",
        "terseLabel": "Number of payments in next fiscal year"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty, Percent, Year 1",
        "label": "Debt Instrument, Prepayment Penalty, Percent, Year 1",
        "terseLabel": "Prepayment penalty, percent, year 1"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyPercentYear1",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty, Percent, Year 2",
        "label": "Debt Instrument, Prepayment Penalty, Percent, Year 2",
        "terseLabel": "Prepayment penalty, percent, year 2"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyPercentYear2",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter",
        "label": "Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter",
        "terseLabel": "Prepayment penalty, percent, year 3 and thereafter"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Rate",
        "label": "Debt Instrument, Variable Rate",
        "terseLabel": "Variable rate"
       }
      }
     },
     "localname": "DebtInstrumentVariableRate",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption Terms on or after August 1, 2023",
        "label": "Debt Redemption Terms on or after August 1, 2023 [Member]",
        "terseLabel": "Debt Redemption Terms on or after August 1, 2023"
       }
      }
     },
     "localname": "DebtRedemptionTermsOnOrAfterAugust12023Member",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtRedemptionTermsPriorToFebruary32023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption Terms Prior to February 3, 2023",
        "label": "Debt Redemption Terms Prior to February 3, 2023 [Member]",
        "terseLabel": "Debt Redemption Terms Prior to February 3, 2023"
       }
      }
     },
     "localname": "DebtRedemptionTermsPriorToFebruary32023Member",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EXPAREL/bupivacaine liposome injectable suspension [Member]",
        "label": "EXPAREL/bupivacaine liposome injectable suspension [Member]",
        "terseLabel": "EXPAREL"
       }
      }
     },
     "localname": "EXPARELbupivacaineliposomeinjectablesuspensionMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted EPS",
        "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase",
        "label": "Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase",
        "terseLabel": "ESPP increase to shares allowed to be sold"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pcrx_EquityMethodInvestmentsAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments and Other Assets",
        "label": "Equity Method Investments and Other Assets",
        "terseLabel": "Investments and other assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndOtherAssets",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)",
        "terseLabel": "Foreign currency adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FederalReserveBankOfNYRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Reserve Bank Of NY, Rate",
        "label": "Federal Reserve Bank Of NY, Rate [Member]",
        "terseLabel": "Federal Reserve Bank Of NY, Rate"
       }
      }
     },
     "localname": "FederalReserveBankOfNYRateMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1",
        "terseLabel": "Amortization expense, first period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2",
        "terseLabel": "Amortization expense, second period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3",
        "terseLabel": "Amortization expense, third period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4",
        "terseLabel": "Amortization expense, fourth period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FlexionAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Flexion Acquisition",
        "label": "Flexion Acquisition [Member]",
        "terseLabel": "Flexion Acquisition"
       }
      }
     },
     "localname": "FlexionAcquisitionMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FlexionAndMyoScienceAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Flexion And MyoScience Acquisition",
        "label": "Flexion And MyoScience Acquisition [Member]",
        "terseLabel": "Flexion And MyoScience Acquisition"
       }
      }
     },
     "localname": "FlexionAndMyoScienceAcquisitionMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FlexionTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Flexion Therapeutics, Inc.",
        "label": "Flexion Therapeutics, Inc. [Member]",
        "terseLabel": "Flexion"
       }
      }
     },
     "localname": "FlexionTherapeuticsIncMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails",
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FortisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fortis",
        "label": "Fortis [Member]",
        "terseLabel": "Fortis"
       }
      }
     },
     "localname": "FortisMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_HongKongPharmaTainuoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hong Kong Pharma Tainuo Ltd.",
        "label": "Hong Kong Pharma Tainuo Ltd. [Member]",
        "terseLabel": "Hong Kong Pharma Tainuo Ltd."
       }
      }
     },
     "localname": "HongKongPharmaTainuoLtdMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_IoveraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "iovera\u00b0 [Member]",
        "label": "iovera\u00b0 [Member]",
        "terseLabel": "iovera\u00b0"
       }
      }
     },
     "localname": "IoveraMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_LargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the largest customer of the entity.",
        "label": "Largest Customer [Member]",
        "terseLabel": "Largest wholesaler"
       }
      }
     },
     "localname": "LargestCustomerMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_LegalFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Fees",
        "label": "Legal Fees [Member]",
        "terseLabel": "Legal Fees"
       }
      }
     },
     "localname": "LegalFeesMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiability",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 5.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 6.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 2.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 4.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 3.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 1.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year",
        "terseLabel": "2022 (remaining six months)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts",
        "terseLabel": "Number of leases not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_MajorCustomerFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major Customer Four",
        "label": "Major Customer Four [Member]",
        "terseLabel": "Major customer four"
       }
      }
     },
     "localname": "MajorCustomerFourMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer One [Member]",
        "terseLabel": "Major customer one"
       }
      }
     },
     "localname": "MajorCustomerOneMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer Three [Member]",
        "terseLabel": "Major customer three"
       }
      }
     },
     "localname": "MajorCustomerThreeMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer Two [Member]",
        "terseLabel": "Major customer two"
       }
      }
     },
     "localname": "MajorCustomerTwoMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MeasurementInputExpectedMilestonePaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Expected Milestone Payment [Member]",
        "label": "Measurement Input, Expected Milestone Payment [Member]",
        "terseLabel": "Measurement Input, Expected Milestone Payment"
       }
      }
     },
     "localname": "MeasurementInputExpectedMilestonePaymentMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Probability Of Success Of Regulatory Milestones",
        "label": "Measurement Input, Probability Of Success Of Regulatory Milestones [Member]",
        "terseLabel": "Measurement Input, Probability of Success of Regulatory Milestones"
       }
      }
     },
     "localname": "MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to milestone payments for products by the stage at which they are payable, in connection with the acquisition.",
        "label": "Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]",
        "terseLabel": "Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]"
       }
      }
     },
     "localname": "MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_MyoscienceAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Myoscience Acquisition [Member]",
        "label": "Myoscience Acquisition [Member]",
        "terseLabel": "Myoscience Acquisition"
       }
      }
     },
     "localname": "MyoscienceAcquisitionMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_NuanceBiotechCo.Ltd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nuance Biotech Co. Ltd. [Member]",
        "label": "Nuance Biotech Co. Ltd. [Member]",
        "terseLabel": "Nuance Biotech Co. Ltd."
       }
      }
     },
     "localname": "NuanceBiotechCo.Ltd.Member",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_NumberOfLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Leases",
        "label": "Number Of Leases",
        "terseLabel": "Number of embedded leases"
       }
      }
     },
     "localname": "NumberOfLeases",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_NumberOfMajorCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of major customers of the reporting entity.",
        "label": "Number of Major Customers",
        "terseLabel": "Number of major customers"
       }
      }
     },
     "localname": "NumberOfMajorCustomers",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents earnout and milestone payment made which is associated with the acquisition of business.",
        "label": "Payment of Contingent Consideration",
        "negatedTerseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Development And Commercialization Of ZILRETTA",
        "label": "Proceeds From Development And Commercialization Of ZILRETTA",
        "terseLabel": "Proceeds from development and commercialization of ZILRETTA"
       }
      }
     },
     "localname": "ProceedsFromDevelopmentAndCommercializationOfZILRETTA",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from shares issued under Employee Stock Purchase Plans.",
        "label": "Proceeds From Shares Issued Under Employee Stock Purchase Plans",
        "terseLabel": "Proceeds from shares issued under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, Money Stock Options, And Common Stock",
        "label": "Restricted Stock Units, Money Stock Options, And Common Stock [Member]",
        "terseLabel": "RSUs, In-The-Money Stock Options, and Common Stock"
       }
      }
     },
     "localname": "RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ScheduleOfInterestExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of interest rate expenses related to convertible notes.",
        "label": "Schedule of Interest Expense [Table Text Block]",
        "terseLabel": "Schedule of total interest expense recognized related to the Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseTableTextBlock",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Operating Lease Not Yet Commenced, Payments Due",
        "label": "Schedule of Operating Lease Not Yet Commenced, Payments Due [Table Text Block]",
        "terseLabel": "Schedule of operating lease not yet commenced, payments due"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_SecondLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the second largest customer of the entity.",
        "label": "Second Largest Customer [Member]",
        "terseLabel": "Second largest wholesaler"
       }
      }
     },
     "localname": "SecondLargestCustomerMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_SettlementPeriodConvertibleDebtConversionRequest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of trading days in a settlement period for convertible debt conversion requests.",
        "label": "Settlement Period - Convertible Debt Conversion Request",
        "terseLabel": "Settlement period - convertible debt conversion request"
       }
      }
     },
     "localname": "SettlementPeriodConvertibleDebtConversionRequest",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods",
        "terseLabel": "Number of offering periods for ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period",
        "terseLabel": "ESPP purchasing period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_SkyePharmaHoldingIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to SkyePharma Holding, Inc.",
        "label": "Skye Pharma Holding Inc. [Member]",
        "terseLabel": "Skye Pharma Holding Inc."
       }
      }
     },
     "localname": "SkyePharmaHoldingIncMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stages at which milestone payments for products are payable, in connection with the acquisition.",
        "label": "Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]",
        "terseLabel": "Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]"
       }
      }
     },
     "localname": "StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_TermLoanBFacilityDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Facility Due 2026",
        "label": "Term Loan B Facility Due 2026 [Member]",
        "terseLabel": "Term Loan B Facility Due 2026"
       }
      }
     },
     "localname": "TermLoanBFacilityDue2026Member",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ThirdLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the third largest customer of the entity.",
        "label": "Third Largest Customer [Member]",
        "terseLabel": "Third largest wholesaler"
       }
      }
     },
     "localname": "ThirdLargestCustomerMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ThreeLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest Customers",
        "label": "Three Largest Customers [Member]",
        "terseLabel": "Three largest customers"
       }
      }
     },
     "localname": "ThreeLargestCustomersMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the stage for milestone payments when the annual net sales reach 500.0 million dollars.",
        "label": "Upon Annual Net Sales Reaching Dollar 500.0 Million Threshold [Member]",
        "terseLabel": "When annual net sales collected reach $500.0 million"
       }
      }
     },
     "localname": "UponAnnualNetSalesReachingDollar500.0MillionThresholdMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ZILRETTAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZILRETTA",
        "label": "ZILRETTA [Member]",
        "terseLabel": "ZILRETTA"
       }
      }
     },
     "localname": "ZILRETTAMember",
     "nsuri": "http://www.pacira.com/20220630",
     "presentation": [
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r53",
      "r55",
      "r121",
      "r122",
      "r312",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails",
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r2",
      "r128",
      "r136",
      "r223",
      "r442",
      "r443",
      "r444",
      "r459",
      "r460",
      "r515",
      "r520",
      "r521",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjusted Balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r128",
      "r136",
      "r142",
      "r223",
      "r442",
      "r443",
      "r444",
      "r459",
      "r460",
      "r515",
      "r518",
      "r520",
      "r521",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r128",
      "r136",
      "r142",
      "r223",
      "r442",
      "r443",
      "r444",
      "r459",
      "r460",
      "r515",
      "r518",
      "r520",
      "r521",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r128",
      "r136",
      "r142",
      "r223",
      "r442",
      "r443",
      "r444",
      "r459",
      "r460",
      "r515",
      "r518",
      "r520",
      "r521",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r194",
      "r378",
      "r382",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Major Customers [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r286",
      "r288",
      "r289",
      "r290",
      "r311",
      "r347",
      "r400",
      "r403",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r628",
      "r674",
      "r678",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails",
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r286",
      "r288",
      "r289",
      "r290",
      "r311",
      "r347",
      "r400",
      "r403",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r628",
      "r674",
      "r678",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r194",
      "r378",
      "r382",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Name of Major Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r191",
      "r288",
      "r289",
      "r378",
      "r380",
      "r630",
      "r673",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r191",
      "r288",
      "r289",
      "r378",
      "r380",
      "r630",
      "r673",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r272",
      "r286",
      "r288",
      "r289",
      "r290",
      "r311",
      "r347",
      "r390",
      "r400",
      "r403",
      "r435",
      "r436",
      "r437",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r628",
      "r674",
      "r678",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails",
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r272",
      "r286",
      "r288",
      "r289",
      "r290",
      "r311",
      "r347",
      "r390",
      "r400",
      "r403",
      "r435",
      "r436",
      "r437",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r628",
      "r674",
      "r678",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails",
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r54",
      "r55",
      "r121",
      "r122",
      "r312",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails",
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r137",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r137",
      "r142",
      "r284",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r192",
      "r193",
      "r378",
      "r381",
      "r676",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r192",
      "r193",
      "r378",
      "r381",
      "r676",
      "r707",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r137",
      "r142",
      "r284",
      "r401",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r604",
      "r606",
      "r609",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r129",
      "r130",
      "r131",
      "r132",
      "r199",
      "r200",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r442",
      "r443",
      "r444",
      "r459",
      "r460",
      "r486",
      "r487",
      "r488",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r559",
      "r560",
      "r568",
      "r569",
      "r570",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2)"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r41",
      "r595"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r195",
      "r196"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r14",
      "r266"
     ],
     "calculation": {
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r58",
      "r59",
      "r60",
      "r64",
      "r71",
      "r72",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Net Unrealized (Loss) Gain From Available For Sale Investments"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r62",
      "r63",
      "r64",
      "r663",
      "r686",
      "r690"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r71",
      "r72",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r61",
      "r64",
      "r71",
      "r72",
      "r73",
      "r125",
      "r126",
      "r127",
      "r505",
      "r592",
      "r681",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive (loss) income",
        "verboseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r57",
      "r64",
      "r71",
      "r72",
      "r73",
      "r505",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Unrealized Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-Average Useful Lives"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r25",
      "r595"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r442",
      "r443",
      "r444",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r129",
      "r130",
      "r131",
      "r132",
      "r142",
      "r199",
      "r200",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r442",
      "r443",
      "r444",
      "r457",
      "r458",
      "r459",
      "r460",
      "r486",
      "r487",
      "r488",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r559",
      "r560",
      "r568",
      "r569",
      "r570",
      "r571",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r632",
      "r633",
      "r634",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Adjustments to APIC, convertible debt"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r406",
      "r446",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r31",
      "r197",
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Amount of allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r86",
      "r103",
      "r331",
      "r563"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount",
        "verboseLabel": "Amortization of debt discount (premium)"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r79",
      "r103",
      "r331",
      "r565"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r103",
      "r253",
      "r260"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r209",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetRetirementObligation": {
     "auth_ref": [
      "r270",
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligation",
        "terseLabel": "Asset retirement obligation"
       }
      }
     },
     "localname": "AssetRetirementObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r17",
      "r116",
      "r180",
      "r183",
      "r189",
      "r219",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r502",
      "r506",
      "r541",
      "r593",
      "r595",
      "r638",
      "r660"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r40",
      "r116",
      "r219",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r502",
      "r506",
      "r541",
      "r593",
      "r595"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r203",
      "r232"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r201",
      "r204",
      "r232",
      "r644"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value (Level 2)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r409",
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r399",
      "r402",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r399",
      "r402",
      "r476",
      "r477",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Acquisition, Integration, Restructuring and Other Related Costs [Text Block]",
        "terseLabel": "ACQUISITION\u2013RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER"
       }
      }
     },
     "localname": "BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHER"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Pro forma basic net loss per share (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Pro forma diluted net loss per share (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Unaudited pro forma summary of operations"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r474",
      "r475"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r474",
      "r475"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r473"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition-related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r490",
      "r491",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r102",
      "r497"
     ],
     "calculation": {
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails": {
       "order": 1.0,
       "parentTag": "pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther",
       "weight": -1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Changes in contingent consideration",
        "terseLabel": "Changes in contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Additional amount payable to holders of the CVRs"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r489",
      "r492",
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Acquisition-related contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Measurement input, contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r483",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "FLEXION ACQUISITION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Severance-related expenses"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r481"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "negatedTotalLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "ASSETS ACQUIRED"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease obligation assumed in business combination.",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities",
        "terseLabel": "Short-term available-for-sale investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "In-process research and development (IPR&amp;D)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Identifiable intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "LIABILITIES ASSUMED"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total identifiable net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Fixed assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Fixed assets included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r12",
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r99",
      "r105",
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r99",
      "r550"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Cash Flow, Operating Activities, Lessee [Abstract]"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r113",
      "r116",
      "r145",
      "r149",
      "r152",
      "r154",
      "r156",
      "r164",
      "r165",
      "r166",
      "r219",
      "r296",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r345",
      "r346",
      "r350",
      "r354",
      "r361",
      "r541",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r50",
      "r645",
      "r667"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r291",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r125",
      "r126",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r595"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, par value $0.001; 250,000,000 shares authorized; 45,801,578 and 44,734,308 shares issued and outstanding at June\u00a030, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock": {
     "auth_ref": [
      "r388",
      "r389",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]",
        "terseLabel": "STOCK PLANS"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r67",
      "r69",
      "r70",
      "r77",
      "r648",
      "r669"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r170",
      "r171",
      "r194",
      "r538",
      "r539",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r170",
      "r171",
      "r194",
      "r538",
      "r539",
      "r691",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r170",
      "r171",
      "r194",
      "r538",
      "r539",
      "r691",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]",
        "verboseLabel": "Concentration of Major Customers"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r170",
      "r171",
      "r194",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)",
        "verboseLabel": "Percentage of revenue from customers to total revenue"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r167",
      "r170",
      "r171",
      "r172",
      "r538",
      "r540",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r170",
      "r171",
      "r194",
      "r538",
      "r539",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible Debt, Current",
        "terseLabel": "Convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r81",
      "r116",
      "r219",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r541"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r168",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "verboseLabel": "Concentration risk by major customer"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r107",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Issuance of common stock from conversion of 2022 convertible senior notes"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r325",
      "r332",
      "r333",
      "r335",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r115",
      "r123",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r340",
      "r341",
      "r342",
      "r343",
      "r566",
      "r639",
      "r640",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r20",
      "r336",
      "r640",
      "r657"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r310",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price of notes into common stock (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r47",
      "r310",
      "r362",
      "r363",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate of common stock per $1,000 of principal amount of Notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r308",
      "r340",
      "r341",
      "r564",
      "r566",
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r323",
      "r340",
      "r341",
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r46",
      "r328",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Weighted average discount rate (in percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r46",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "verboseLabel": "DEBT AND FINANCING OBLIGATIONS"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r48",
      "r115",
      "r123",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r340",
      "r341",
      "r342",
      "r343",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment, principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.",
        "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid",
        "terseLabel": "Balloon payment to be paid"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r48",
      "r115",
      "r123",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r334",
      "r340",
      "r341",
      "r342",
      "r343",
      "r362",
      "r364",
      "r365",
      "r366",
      "r563",
      "r564",
      "r566",
      "r567",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r321",
      "r563",
      "r567"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discount on debt",
        "terseLabel": "Debt instrument, unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r321",
      "r565"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r117",
      "r456",
      "r463",
      "r464",
      "r465"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r449",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedLabel": "Increase (decrease) in deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r103",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r103",
      "r178"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation of fixed assets and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technologies"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities",
        "terseLabel": "ASU 2020-06 convertible notes if-converted method adjustment"
       }
      }
     },
     "localname": "DilutiveSecuritiesEffectOnBasicEarningsPerShareOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/REVENUENarrativeDetails",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/REVENUENarrativeDetails",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregated revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r78",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r143",
      "r145",
      "r154",
      "r155",
      "r156",
      "r160",
      "r161",
      "r521",
      "r522",
      "r649",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income per common share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r78",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r145",
      "r154",
      "r155",
      "r156",
      "r160",
      "r161",
      "r521",
      "r522",
      "r649",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income per common share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rates (in percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Weighted average number of stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r71",
      "r72",
      "r73",
      "r125",
      "r126",
      "r127",
      "r130",
      "r139",
      "r141",
      "r163",
      "r223",
      "r361",
      "r367",
      "r442",
      "r443",
      "r444",
      "r459",
      "r460",
      "r520",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r592",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r215",
      "r658",
      "r704",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Investments"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r323",
      "r340",
      "r341",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt, amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of key assumptions used in the valuation of contingent consideration"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Investments Without Readily Determinable Fair Value Roll Forward [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r528",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r528",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of investments without readily determinable fair value"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r524",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r323",
      "r340",
      "r341",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r525",
      "r601",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r323",
      "r340",
      "r341",
      "r524",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r323",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r323",
      "r391",
      "r392",
      "r397",
      "r398",
      "r525",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r323",
      "r340",
      "r341",
      "r391",
      "r392",
      "r397",
      "r398",
      "r525",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r323",
      "r340",
      "r341",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r525",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of carrying amount and fair value of the long-term debt"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r528",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r528",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of change in contingent consideration recorded at fair value using Level 3 measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r530"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Balance at June\u00a030, 2022",
        "periodStartLabel": "Balance at December\u00a031, 2021"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Fair value adjustments and accretion"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance at June\u00a030, 2022",
        "periodStartLabel": "Balance at December\u00a031, 2021"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r323",
      "r340",
      "r341",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r601",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r209",
      "r210",
      "r216",
      "r217",
      "r218",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r334",
      "r359",
      "r510",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial Liabilities:"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r16",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Amortization expense, remainder of fiscal year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r254",
      "r256",
      "r259",
      "r262",
      "r631",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r259",
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r254",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r259",
      "r631"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Office furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnContractTermination": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails": {
       "order": 3.0,
       "parentTag": "pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.",
        "label": "Gain (Loss) on Contract Termination",
        "negatedTerseLabel": "Nuance Biotech Co. Ltd. agreement dissolution costs"
       }
      }
     },
     "localname": "GainLossOnContractTermination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r84",
      "r103",
      "r202"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss (gain) on disposal of fixed assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r15",
      "r239",
      "r240",
      "r247",
      "r251",
      "r595",
      "r637"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill recorded in connection with the acquisition"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r246",
      "r472"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "Acquired IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r118",
      "r466"
     ],
     "calculation": {
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r75",
      "r180",
      "r182",
      "r185",
      "r188",
      "r190",
      "r636",
      "r646",
      "r651",
      "r671"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r118",
      "r466"
     ],
     "calculation": {
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income (loss) before income taxes:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r268",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r453",
      "r454",
      "r455",
      "r461",
      "r467",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r140",
      "r141",
      "r179",
      "r451",
      "r462",
      "r468",
      "r672"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r150",
      "r151",
      "r156"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Dilutive effect of convertible debt securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r156",
      "r408"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of share based compensation arrangements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Value",
        "verboseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r252",
      "r257"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "negatedTerseLabel": "Capitalized interest and other (Note 6)",
        "terseLabel": "Capitalized interest and other (Note 6)"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails",
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r74",
      "r177",
      "r561",
      "r565",
      "r650"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r86",
      "r329",
      "r339",
      "r342",
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r88",
      "r330",
      "r342",
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r97",
      "r100",
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r32",
      "r237"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r38",
      "r595"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r34",
      "r237"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r33",
      "r237"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r83",
      "r176"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r583",
      "r585"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease, Cost [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of operating lease cost and other operating lease information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of maturities of operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022 (remaining six months)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r116",
      "r184",
      "r219",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r503",
      "r506",
      "r507",
      "r541",
      "r593",
      "r594"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r116",
      "r219",
      "r541",
      "r595",
      "r641",
      "r665"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r45",
      "r116",
      "r219",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r503",
      "r506",
      "r507",
      "r541",
      "r593",
      "r594",
      "r595"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Estimated settlement fees"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r20",
      "r322",
      "r337",
      "r340",
      "r341",
      "r640",
      "r662"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt, net of debt discount and deferred financing costs"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r48",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average interest rate, at point in time"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r283",
      "r285",
      "r286",
      "r287",
      "r288",
      "r292",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r283",
      "r285",
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss contingency, damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r167",
      "r170",
      "r171",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Major Customers"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r99",
      "r101",
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r65",
      "r68",
      "r73",
      "r76",
      "r104",
      "r116",
      "r129",
      "r134",
      "r135",
      "r136",
      "r137",
      "r140",
      "r141",
      "r153",
      "r180",
      "r182",
      "r185",
      "r188",
      "r190",
      "r219",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r522",
      "r541",
      "r647",
      "r668"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income\u2014basic"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToParentDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.",
        "label": "Net Income (Loss) Attributable to Parent, Diluted",
        "totalLabel": "Adjusted net income\u2014diluted"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToParentDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r136",
      "r142",
      "r160",
      "r199",
      "r200",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r442",
      "r443",
      "r444",
      "r457",
      "r458",
      "r459",
      "r460",
      "r486",
      "r487",
      "r488",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r559",
      "r560",
      "r568",
      "r569",
      "r570",
      "r571",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r632",
      "r633",
      "r634",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other (expense) income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesReceivableFairValueDisclosure": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.",
        "label": "Notes Receivable, Fair Value Disclosure",
        "terseLabel": "Convertible notes receivable"
       }
      }
     },
     "localname": "NotesReceivableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r180",
      "r182",
      "r185",
      "r188",
      "r190"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r577",
      "r585"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Fixed lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r573"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r573"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r573"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r574",
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for operating lease liabilities, net of lease incentive"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r572"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r582",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (in percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r581",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r500",
      "r501",
      "r504"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r66",
      "r69",
      "r500",
      "r501",
      "r504"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r58",
      "r62"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net unrealized (loss) gain on investments, net of tax",
        "verboseLabel": "Net unrealized loss on investments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Loss on investment"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r273",
      "r274",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Restructuring"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of contingent consideration to MyoScience, Inc. securityholders"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "negatedTerseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r90",
      "r494"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLongtermInvestments": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.",
        "label": "Payments to Acquire Long-Term Investments",
        "negatedTerseLabel": "Purchases of equity and debt investments"
       }
      }
     },
     "localname": "PaymentsToAcquireLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedLabel": "Purchases of available-for-sale investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22",
      "r595"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at June\u00a030, 2022 and December\u00a031, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Debt issued in private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r94",
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from lines of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfLongtermInvestments": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.",
        "label": "Proceeds from Sale of Long-Term Investments",
        "terseLabel": "Sale of equity investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-Term Investments",
        "terseLabel": "Sales of available-for-sale investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r93",
      "r441"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercises of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "netLabel": "Net product sales:",
        "terseLabel": "Net product sales",
        "verboseLabel": "Total net product sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r269",
      "r710",
      "r711",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "FIXED ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r13",
      "r265"
     ],
     "calculation": {
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant, and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "FIXED ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r267",
      "r595",
      "r655",
      "r666"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Fixed assets, net",
        "totalLabel": "Fixed assets, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of fixed assets summarized by major category"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables, Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial Assets:"
       }
      }
     },
     "localname": "ReceivablesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedTerseLabel": "Repayment of convertible senior notes"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedTerseLabel": "Repayment of Term loan B facility maturing December 2026"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r448",
      "r629",
      "r724"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.",
        "label": "Restricted Stock or Unit Expense",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)",
        "verboseLabel": "Weighted average number of RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r273",
      "r274",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r367",
      "r595",
      "r664",
      "r685",
      "r690"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r125",
      "r126",
      "r127",
      "r130",
      "r139",
      "r141",
      "r223",
      "r442",
      "r443",
      "r444",
      "r459",
      "r460",
      "r520",
      "r681",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r174",
      "r175",
      "r181",
      "r186",
      "r187",
      "r191",
      "r192",
      "r194",
      "r377",
      "r378",
      "r630"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total net product sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r580",
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "ROU assets recorded in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalty revenue"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r170",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r64",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of short-term investments"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r207",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r476",
      "r477",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r48",
      "r123",
      "r340",
      "r342",
      "r362",
      "r364",
      "r365",
      "r366",
      "r563",
      "r564",
      "r567",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of long-term debt instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of composition of the Company's debt and financing obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computation of basic and diluted loss per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r145",
      "r149",
      "r154",
      "r156",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r439",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of recognized stock-based compensation in consolidated statements of operations"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of finite-lived intangible assets acquired as part of business combination"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of income before income tax, domestic and foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r11",
      "r35",
      "r36",
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of components of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of recognized identified assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r405",
      "r407",
      "r409",
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r412",
      "r427",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of the company's stock option activity and restricted stock unit activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of share-based payment award, stock options, valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r167",
      "r170",
      "r171",
      "r172",
      "r538",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of percentage of revenue comprised by the three largest customers"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtCurrent": {
     "auth_ref": [
      "r18",
      "r639",
      "r661"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt, Current",
        "terseLabel": "Current portion of long-term debt, net"
       }
      }
     },
     "localname": "SecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredLongTermDebt": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.",
        "label": "Secured Long-Term Debt, Noncurrent",
        "terseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "SecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Stock-based compensation from:"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r421",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of period (shares)",
        "periodStartLabel": "Unvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r421",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of period (usd per share)",
        "periodStartLabel": "Unvested at beginning of period (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value (Per Share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (shares)",
        "terseLabel": "Vested restricted stock units (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "negatedTerseLabel": "Vested restricted stock units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Stock Incentive Plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding end of period (in shares)",
        "periodStartLabel": "Outstanding beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "periodStartLabel": "Outstanding beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r409",
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "verboseLabel": "Closing sale price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term of options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock, ESPP (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r39",
      "r642",
      "r643",
      "r659"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term available-for-sale investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r703",
      "r704",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "terseLabel": "Short-term:"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r111",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r113",
      "r116",
      "r145",
      "r149",
      "r152",
      "r154",
      "r156",
      "r164",
      "r165",
      "r166",
      "r219",
      "r296",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r345",
      "r346",
      "r350",
      "r354",
      "r361",
      "r541",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r52",
      "r71",
      "r72",
      "r73",
      "r125",
      "r126",
      "r127",
      "r130",
      "r139",
      "r141",
      "r163",
      "r223",
      "r361",
      "r367",
      "r442",
      "r443",
      "r444",
      "r459",
      "r460",
      "r520",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r592",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "verboseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r163",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r51",
      "r326",
      "r361",
      "r362",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible securities (in shares)",
        "verboseLabel": "Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r22",
      "r23",
      "r361",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r361",
      "r367",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r52",
      "r361",
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r22",
      "r23",
      "r361",
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r52",
      "r361",
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r28",
      "r29",
      "r116",
      "r198",
      "r219",
      "r541",
      "r595"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedLabel": "Stockholders' equity attributable to parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r346",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r367",
      "r368",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r558",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r558",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r558",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r209",
      "r210",
      "r216",
      "r217",
      "r218",
      "r334",
      "r359",
      "r510",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r129",
      "r130",
      "r131",
      "r132",
      "r142",
      "r199",
      "r200",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r442",
      "r443",
      "r444",
      "r457",
      "r458",
      "r459",
      "r460",
      "r486",
      "r487",
      "r488",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r559",
      "r560",
      "r568",
      "r569",
      "r570",
      "r571",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r632",
      "r633",
      "r634",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r273",
      "r274",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDGAINSCHARGESPRODUCTDISCONTINUATIONANDOTHERProductDiscontinuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryBondSecuritiesMember": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities greater than ten and as long as thirty years, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Bond Securities [Member]",
        "terseLabel": "U.S. Government bonds"
       }
      }
     },
     "localname": "USTreasuryBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r578",
      "r585"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Computation of diluted securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r144",
      "r156"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r143",
      "r156"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=116646717&loc=d3e6290-110844"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "https://asc.fasb.org/topic&trid=2127225"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r725": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r726": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r727": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r728": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r729": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r730": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r731": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r732": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r733": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r734": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r735": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r736": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r737": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0001396814-22-000050-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001396814-22-000050-xbrl.zip
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MU8)1WCNT'EA^B UY,GHI-W,*7+($GDJR6@7(SH=H,* )D@- \.@;4)9AGJ+
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MO&"$#!I5$5$A@34NQ:MV^DY0ND6+,ST^:K&4#%%8APZ$T>A%QH*44@@^)VI
M)#E?TCW[^-''XJPA+$ 6)%FT+J"*K W:9NN;M)78?$)Z]X&%RLY'I6LRST..
M,A@V<BY+2ZDD97#^70\'C/R^X[,773;P3"+KI/+C>HVOK9G:P'3(N _//F_8
M$$>4-=:B5S9E82&@QF*LS)Z\ (X M9K?50D-@6IZD_]#$<EXDW7="E?4(6'C
M:UT<Q,RW0;U@6O6<<$2'@VY>[QT/!^\FH>#MKO69GE81LVQ)3K.M0P"KO0].
MAN# BHH@+IA6W3U4T],JJE6E$IK)FCZ.D**T)4)D[<)"(;L%T:J+S==ZQR=C
M&GYLP:UW!F7\'H>WNP1SBH&3JBO"M<[9 7@; Z$C7T(L!=!XNR":-5NXIJ==
M#%2A'+)U*8"/@.#0DS$JHHD^-B )\5V&\.G)L-\9GPR)&S[MG-9/37%9/OKL
M'6$.,@&9'**SD>TB)!F\565!%&MF2$UQ%;JA(  XFA()M$[H($47O(B*K-6+
MQ@.?#";[B*8:3:_W^=0#AJHI6@61!.4B!0D#'FU4J10==++, F6!!=.J&6 U
M/;UR5MM@08;B= U^44?)-M 5$<@::,*4V[D&;?;SD%06EKF'4;6:O0W$"JE\
MR":+1*A*$Q9^-@?AF223B_(2M4TNI<1D$Y$@8W9293 FEC2_OK%.4_DXY/V,
M&"(\/NPD['Y:=K]V4D&?UB#VG$?X4V2V'"&2BV@I*A#>>$H.K#4*;<E)S;$/
M7LK$K<6E06+*602O"BA3/ @GL22.>VQP>HZS/G=9CF-:ZOAQJ]UN%9FO;S ^
M.71Y_HUWVE4!97 @(&D%FH-6'YUPK.B*?8 K^0)')^9.MS].<SJ)(_KW"9^T
M]H[_^E+-KC6X;93=9S[[9XRN+HKJ.M'(L2HF&TKR&(LL"J+!:"^ T?-G="?2
MN-'ITF@\Z-,+/)O8M:>#X<4DTO4^TZD^3<C4F\[X\+/!WL=G;*U9,\=OV$H?
M[A[2V<JP7J%.)?TLK_?J>-!?Z?=/L+M)XXMBCY-QJ8/50;>+0R/$?<%/T)V,
M%C-5JT;V;N:N[;P]HQ>'..SAO_B>_$1W,*5&3\>DVVJ[;4*KC09VYVS9@^0?
MG<JD;(#Y->D?<U(=-G/TO/..\GJ?N^&@4^5F-*+QZ/'9>>W,.A7RJGE8I7?4
M9:^==RD=]@?=P<'9=N?@L#'L+-8JQ;$4;ZEN7YHC%2-T"":4""XU:;>\><=O
M]LL)*),!R-5#>]"08@2?LB6557$^E075T<N2MMO4G=33'1UVCINBGV@X>+(.
M(7@'F8AM+ E;?-00=$A-6!#;!.SF0#<-^L(^U$6FTAXI"HF9$*)(KI!3"ZJ;
MDWQ88D*T32/"83KDL/?")C=H&A<3'5\'@RJ[!J-3K(-$P0NMLC40:'YS'$UQ
MGK<SY) "&"6#B)+ !1N#B<(Y4VJ1I$SNVMS7)7ZSF!4[K=4RC%Z!$D( C%"B
M]84LZ!"M)*; O@&3PN;9@=[2D* 5"@N*H"Q8%6/*VFOTONBBZ>/6] NKG[,@
M/S/1S9BTYG@$4R0))F)@'PI$V01D/B3G>%^&QI*?Z6DI$./EBTO16  9(_-8
M15[IQ)0HJ@9D?E8ICM<G8[23:7Z?;8Q"P][S ?8?/\74Z?(CKYX0OXR=5C;P
M^:!_,.9[U ?X2NJ9TLF0<CW8%!ZL3,Y2HBQ. :"IE7^T+5C YUI.9O[U^!<7
MA>E9!154RL)G)SDR\F0">(9+^Z($F)0:L CI3T7AR:#_CH;C:N%WJ-\9##<'
M8QJ=RX-IB*8ZK'7U=2P:+<00(_\M'1%$86+R_A>%9TKJ^JH_:ISMAA"R3T6%
MXA&*2L& +\DKM#$1>-=@V_U+2<3T3+A/(6?VX &#!7;KP<NH;13>1&=T:<!P
MP?=+Q :>\4M!0W26295%)MR)8R5P(6)&"1B322[;>!$WS35"T].:I5!\K*$J
M?2A69E$<9"3T1GA'7A1II(,&D/"E4$Q_U0I!,MD%FT4 4 E3D=JC])9TNMS^
M;JXMQ0]Y=]40G4V0=5WO@$8Y8&08&$")R5(*['07E8Y_"Y[&D:_I241QUFE/
M5F>FX\0*ZQDQ53@X"XYT;,!PQ5(BICQIVM@LL9 1)@%(BD%$ 4HG7=ARE ;,
M$)@73*:XN,$F(VV1V1;!0;.-.@I)V0D4-D4UQUL2SQLFTQS5-\KZ;+#6535:
M>R="B#$G@J"]%1?%W50#1@U_Q6ST]2IWZNY'(YTOGI(WGN$L/H;"L9/(TM8-
MT!1\6K$TMX;V5Y2;+VS)5"H)L950T3 KU[;N)1,2*>^B30ZU=39=3+]DGSOW
MTR]_19FX/JWS<Z]_-],Z,P.I@&7'%0>.!2A**DD('33[)W%>Y-M4']2^_+ 4
MH*^MO]Q)U$?N]D_K[BY_>3H84L+1U%)!\R*OYJI#^RMY-=.;)0>I(!4;@@V0
M/&(P9**$X.K&=>4\$6&9/+FEF/ZR8OJ9J[43@N9^S-5^7)AZ?+[,[^M+4R\.
M7E[CQHM3@Y.:8V:"Z%B4,7M7K$RY6)L=_XO7EDXL3>_BR/2-;SC[Y;\_OO)D
M6B;?1Y0FD\^8).@D:_E%"9((#3,4;1JTQ&C)<6>R$7S1@,J4+#A(X@@I9*^\
MSF L."DO$B[-J-RT%*!9%(8*1LJ2G5.H-=2TB_#&438)7?9&-GFNX _*S;SD
MMR&3=&2"R<(!>AE3)%,T22\0'5(#?,/7*K9T^C>HV#+_1N,U<[!:W&*;]>ZK
M!F/K'0W[=477TTX?^ZG3/ZA-=P9E^/'(>C_3Z<Y[/*Y'%M$[(9)#JY3)*8#0
MPKN(M>*T@)A-B4MZLQ2TZ0B:EI%9D**0!(*7ON[BH'UV)<6B8R-*:?R2MO(Q
MCFA193)'$95R;/"L93Z> ADG0RY.US'1;)<R.5\R>;Y3$64:8K<N"AR^H\?8
M?[M5-O<6542+2X@&901T4":K$%0P(64.):W4N@$B.H>"]$L8-\T$3NF ,0E(
M2B,(5<V=2-8D<N>SWX5P#<SK_E(K5D0M>SBE(G1!E%A$UAC ,A63RI&-!J@.
MY*=S=R=J/<KV4C3F5C2N6!9QM2;F7UF6:W+T$Y8EI<RBDY.(/H)D]IY=-L9E
M3,&Z+-V"6I:%FWP[/<L2T7OK,*DB,RBO(ZC"\9W@$$^""V71+<MBB,;L+8LT
M24+P6@H"T.20C4LME.\P*T\:&S!6,I&5BL^YO-0?5_IYFX.6WF37]TIV1Y^)
M56UZ[>@+[J_A[N IQ>$)#L\TOZJ^]6CNCI?MSV18Y>.,BOS%7(J3\?#AZN5I
M-YY$X4L.Q7@H07@@90(*&V/).9$6,I@%]82W6\9A>FX)K7+L?43)H"%S]".4
M+"F31>.*@NMS7.;1G"P)[QR$TJ"BB4$[$40 8T6PB8"RBI22#&HADC"W*D=3
M<(I;_:WA2F$A7#DY.!F-Y0V<8B-E+>A@$(VQ$ AD@"B""BQ_+B:0\KP0HW3"
M"+50(@;S9ZJ^><M,G8?/Z0"[:Q, /L]1=^ETLC\"#?&83L:=-+KEO0HDDW73
M%FH:LQH\*9FM)B0#',6AI\+&SR2*'.$GLY3 7TL<#$H7@PO!&<A>>Y63C%HX
M*6,VLGQ<,&C;%U[0_E)R\;->YGP1G[VAEY&?-?V9826=@A/(9"9(<%D'Y[R.
M218@#E9DOES$]XMAV2@=ORXY/Z'C(<@LC0P^N A%$7J1I,X^H\[$FGXQQ5 V
M<%U+PTC'STG$N8'XP?4F5R1"2)-50 M96+"48V(9,46;J&P"F(P5,0G0DY"G
M?EBP%,?B970K)= W"V?.FTYGM;B)IL1D,SB"$DH@_L@A#7 $S18F7I#)I?C,
MH_A<Y9-3V@HM4\I1)5V2! BI8+0BH0TI9%D(_/4</\SO]HB_L&C\1/[^\Z8_
M,Z'4@;.@?2X^0%),9F,"5%YD4(:B;9 <?5Q+6+>T'9\]&?2.!WW^>GW#@T&O
M-^COC ?I[2("JK1(RA1T@(FAS9B2\,DI9U0Q:/4%Y3!"M9<)B/D,3J[SC<]3
M$-_@&Y\W_:D]ULD2TPVEK &9A5<*8W(6J<Z HU]^R*>1.7%%M3@(<P0';!G8
MT*O,IM]Z"#$'_7$CY3G&\BEVAJ^Q>T*/SS;.!Y?K!1[CJ'/=QN-P>%87B-#Q
M8#BFO-(;G/3''T]?[8Q2=U#/O^TX<DI+Y%3R*2M,R/$C4*W%IST;]JBMLNB<
M:!1T'S_^BZ]8=Z0Y>U[WH[F*X,=&Z_WCD_%HTD).B_/=6([61N-.C]5MJWP\
MI;E"E!4(XY71=5V:J(N',)"LRRV9 V"6OX8032UP^#6%2+#P6*-BL4#,,*.7
M2L1B( <9/%WLX- 4(;H#W.Y4MF]A*/]VJL=[ JK53,E&*,4%B75>""5I3)"J
M69;H;IC(S_/=!:XN<2M":J-/F%TFF1&2RM$)I)R"4$DYNBB[.]=".C-1^(7)
MWB^K+M(F'T,*K"T)0DH84M;2NB*2<UKKI;HL:>U273[->7>10(")D@A4$-$6
MR-(X!Q:!_RS5Y5>5T&7$\!5UJ;M/),.NI*I'B2%D#"85'S3X$A+-O[HT,&)8
M_$41MR*K9#U9*#*:ND%Q$*AL*46@X0C7QM@ TSY7_'VVXME(9]-$K6%=289#
M:XB00<L2BHU*6U5R$D50LW)"LZ?Q2ZWY);2&*),Q('3P"7(RW@80+I J48GB
MFYRD6@KJG2R_^A6C"29E@-F8:+0'#B=04=)!61\2QQ6^ </IRXGZ4XXOC4(6
M!E)9&,C%1!W8EA(43%9I7,:7=TU%EK+Z%U._47B?, E3BQG&Z.&< BC@WZ-M
ME*S./KZ<4PJPU)HI[WZMDJ,DG&?% %G &_!>*)\]Q5C"+Z(UBSY,M-2:*4\\
M%<849S"CSZ!MB:PR.8'40D(TJ5E9F:6@+N/+NYG?9HHQWMC@K 6A9 R1/4U)
M4F5RVC1A1Y/9IF>^5H\=3V]0C_T')&#V"S-\1.4]FNA* 1'J%B(9H@ (6*)(
M:?XW>+_8D0.[UT7EHW&=+,F;#()WQAT:W:HB3V^;=T]"<\]'\"19D5F-+84B
M@;]D%1$;C,QU)9ZH[S8EZKRK5=X; I!-*C [ 1-\ ),8DU# 33;> 7 J-<C2
MSH$.S=X4HI>A<&3F<DP0H_914 C2:Q/)4A&+@.>=:][L84TFD(OH6"LCJVG!
M*)!4"%ZEY"DT8>GA[+7S=M;S)%"&E8LF%45R#-H7*8SP2M:JG*'!R,S2PTUQ
M&8*)A5""LDY ,,J';)(%!]89)V(# 'I\,NKT:31:2:PBHTZM1?KEHOJ5?MXX
M&^RD#O43?=:R(2A)XUW4269'#J1,,1OOR<8D8HE.Z?DGBO.+TO38HBC)"^EK
M;0/F&!HB%I\%F6R0_STOH\0H21F:C=+= </_#],8D*^K1#R&X)0!=D0(L2C6
M'!E0)J/M175,!J:]1.B[Z-XUC/Z*[EUK^A-T3V0GG0LJQ3K1(B1OG13*2A>$
M427(ZW VWBS.*9QJ.M7GK+2>A$)4ED!#\.!D8%HB0M*$J31@/Y$YA7,F.Z$S
MLT>'1M?=-4!:IOS10<IL?KT33%\:%&//'YQW'UMS!!>T=.PLV7=R9."UJ#,_
MJ]O,)C1A)=DW([AQIW_ /_*G4:=N6WH#*&]\\\\&!2<C35\.AUUO40<#ZY2I
M&VQY.2M!_N9]OS+ \H;J#MJ45SA>QH-E78L?4,7@-<<2 9,+'+#SAU*R#CX:
M)U4DU8#B*'^N#1-!O'[XQ7 0,4X6>6Z5G9.46(2WRC8=G'1Q/!B>;72Z-!H/
M^M],AS7#5BRU=!&T%%*P.F5VDE&!#R*J4(0TM>1IQH(-F DV>]IS*\!H JN4
M$P6R@X 9502)4LE8$$M8F"1:X_)F)B1PB2RBE2"L",YXZ7-TWGFP$"<U9<-%
M %@_-%5U-LX&HSM(;EXI\!IN' .>-YW.@)PV#&5**(L'E6Q4AC(EYPQ$9W0#
MUCO,!9"W4QHDJL)!G?2 'ECO8O!"8/(JBN"IJ(5)M\Q VV:3<2$K<D&.!6S(
M$"B@#]((!P ^DX+%R;C,"-&[3[K(HK17PB0-#M"X@-8XAR*5&+0LY_..Y*6.
MRB6BWX.HO+F.RJDA&HUADIE ,[+@'$0K9/0%$X-JH\D7B,HEHC^&Z$UU='J(
M2H/"DD\Z,=6Q2L=2*%K248*KHXOSSW&6B=$[24PT2[%NI_J*HVK]C ^H04H;
MG8O2Q)B@E**I 74D9JHK<R6EWYG#73L]IC2F_#%7^P+/ZL&ETGQ+:105(D-1
MN8S 1!XE94\V&[)$*3<^7W7WV$PO9461;$(?O<L)C&$:$(O)5CGK*T6?XQG'
M7UO[U.G?8.U3,TSE?-"*NQ[)^17'68BJ3EB;+!E(.M2%;<HGEXC54I@&C(8N
M%66A%>6'3/%M+4.]G5(Q22A4,FLJ$414*+PA3#859?@W/[\JN/2"R^!Z4>($
M@5ZIJ-%9F2 6"-*X BXI[\!+V80B&DM=67!=67Q?R$$@AW]"VAP<!!515"UQ
MLL3L66'2_&KA@OO"7YIBWFW2;EYTT99:ABUDX2$"H@^4C(E!.A\C6%QZQ*7&
MS(G&++Y?#&AB5,'I9&.=&HN1=([& -DLG)_C8=(%]XM+;?L5@T6B.OIJB]8A
M@BDRU@(=(N?D+&9AU/P/*GTFM\\[%ZM#GG1Q-/IIU9F7P:7,$4.,LD!A @.Z
M1"NU<;EN2,58F2;-YYLKL&8_KT]@25I9]H960::,,1;6._ FER0;,0]BG@"]
MG;DJ4I J$F*,FO_"$+2464<@KUU1<TQ8;EQ,:F4THO%C3&\IW[BBU(WOOMY_
MQSZYWO0KVQ0>#H;CNH'CIT9-J625BBXI&^7 L4U&CB:%%A!US,5&2W,\UG%C
ML7@RZ/5H6%N\0.Z9I4#\]9X>61:%,0FJJY1<#LIAQF0+>N=QG@>_;@F8:0KB
M\'C 3H,>#_HWMU#S(A@Y*:J5766T"8J&@ &5RC(&K[T5<2D8/RP8KW9VAY-0
M\*R1DA%T*2ZX.G-,0RD^DBS1.>U8*HJ.3:[W^^M1B^G%>QSB%2"E8JW!KZ/R
MJ#C>\R!5XF\B+(!8_ K48HH)@*@Q<63(IL* $#&$5/>0,=9'+UT3*K;/K0>9
M!;68HJ7(M7"A59F 8P_/5!.4KD[$%QFS*[^<8,P0F)-^YQR5=#(:#]BZ?>SR
MWGFV^CP9<GGT\BJ7!R^_U\M\W0@XCB5D\IA(@V82R>%%++6$14S*46A0%O#)
MH)_XC/,TT'9G]/;QV9?H/[GHJ"\:3\LV?.4I'E,_'?9P^/8:B4F3^3TWK^;\
MS6<X'[<[&@POW_+S?-F5 UO]A2S1GG,!R)XD136IO)^++;48:\PD33 -D.:;
M8[C[?G"+0KM8JM-(:4Y!Y>P34S,EP>CLI5*UR*4TQE.AN%C2?#BDJ<US7,KS
M/,JSMG7/H1(%I0C)Q""L8^*14ZP<!..UZ@3S3# 77L :Q36^JS+#M I*E\E&
MD@(Q2*QC-=Y8973P;*AC#F :(,U+KC&/MGDFTHPREU"B3=Y;2"*@+R4 J10-
M1X1*+I8T+[G&PLLS84;AK(ZRCHU9=%Z25TRC U-HJ19*GI\.3J:6[%Z*\UR*
M<U3!&(K6!P%1*90BDY;"EA2$"@T8O-D9\ZO7<\[WF'LRZ!T/^C7W^@6<)[U:
M>)OR)HU?]8>$W<X'RI^2M<^PTW\^&,UQSO9JT ,E2?X312' 7#<>D<*A+%22
M\$W85.O[D=L=8G_4G>CN2CXZ.<>M(7@1@U&$IBS1@>>PE%4-17+:U0HY4C4@
MZ=(@E9M]4H(R81 V96<1<IV**4!+8R0XQP>:-  RMXHZ>Y2UQ.0-2>^=@T 0
M.<"13AF;8O91-6 :70.4^78V.O!"R^QB,;* RE"+^_'_C(C%D\4&3)2>6[6\
MG0FKK%*J9$JEKHH5Z$VJ-< +V]<B8CPORBX6B^_,4M/$U)B/,AG HRY*%# R
M!J5#%(#62)U\RHN(W-UKVO3P$CX:;:,+041@UQ8@>B8Q9)!Y*BIH4+'G!JC<
M[$M!9QF"*<E ,!%"W5 F>O VA6Q+*#(L--ZS8*HS0;EXS9[3&K!:@V.&8V0.
M0M9U>X*4.O>?"P;N;#,]4]ORA"0Q9,8YUD]B2QPME11-R%D:7^PB(C>+3,_4
MF&H1*>=4)SIZT!Y]J%7#%45E=19>-FB+FO5^&O3H(WS/!PD_51/XE%,?C;?*
M#G9O8R+R[/>G48F#>Q,TV\H ,HK 5*AN" Q!NV0T-&@WDSF#<R9;F1A#&*7S
M%&I"+DJ4P&95!^D+>6]\@_)R<P;G3!)P-06@! ;' 288(6JNU;OBT5C,!-?G
M?BWAG&^6JJ2**CF9-.NE2PZ5HUA<* 9=8A^Z:+YSFT942Q:M<)?5DD2#XPE-
M.CWFJ]W!7,T9>%.AG' ^U&UFZTY#(3&N6I%3.6>3%LZ;SA+@V?A7D67QD:%-
M&BQ1=!Y 2:> HQC4=M'\ZXPU> 95@%24T602T1,HUF4M3:E#*4C%1B$6S>/.
M6(/OW@<+C9"$-\%D6^N-1D2%TI+23GB-=M%\\ YUNYW^P3/JTQ"[#/-*[G7Z
MG=%DEM@[ND!Z(6/;0JF0!<B:.]X'%038+'4A+'6_][AHWG@^H)Z)7\;"CMD4
MY5B+0:'W/MHLK#0Y.9&R7#2_/!]0SV9]GV-NG94S%@R 5D$*EY)AE%U0PI=%
M\]#S ?5,?'4MO2AD,0JB 8<,@!)H4[8"HR&D^9\%NO(>A_G+F>#,NL;#3JV2
MNS,>I+>O^IWQ:'OG54,F>VJLH6V66'?W\B)'ZVS,6C,ZUN;8A/7B\X+/[,VI
M2:B%]JQFS)1(VB"UI@39D4@VA ;,\9LUAK=3TM(S((58T40"562$3,#1"H>B
MAH_EYNO86N^X.S@CFJ"S=;RH987)1"=K6E '!)\H)@N%Z6J05@J3+V?&VSL$
M\@?ZS=[]W..  E4![>L6[J8$2QZ\$T+IP.]5%DP!%D3T/Q9>&I3"#?L'Y\V_
M7G[ILLV+29O+*]ZX"!-H#@!8/++@(#\%1..+=L@_:!\\-6DFPJ=9(*.G@^$F
MO;]8GU<[9SCH\\<TB1"^G%)RT8ICB'YF*1N].LZ,5ITQ*>PBYG28JY0:X#N5
MV1R 1V63"]H8)<GGD!N4TVDDZ#/)[F1GLR7D8%\22%7GII0ZLB9"DDJJ)F5W
M&@GZ3(B3TC$XY3,:YX!$\=X:BL8FH;SCN+-!>9Y&@CZ3C$^,4GO"[))WP*%H
MP&A,QF@5.%%D:9)/GZ.PY^[]-*02V58+C92 :FW4H#GJ 8KH,9)LDI^>%R!G
MXGN%MLH&581.!*56M@53@(J'K*41U"0S/$= SL"T9NFBD^ C1-#:(FE6159&
MJ8*1T3??M,XL:WOWYM6B5B$ZS"4A)#!L477.3FIG22MOFF]>9P/F3$PLZ4#.
MN"R-]=6^1B\B16]"2DYBP.:;V)F!.8.5:(:\*1RL1LD,%@7C%X50D:$46J-J
MOIF]X[SEW1M7$;$P4DQ=61E=9H<IP:D"(8$P0 M@7.\2PIF85"DE.>%$*!(A
M%./)Q:2T)>]TCM"D5;_S >$,)G\(=,HHG462K&K2&ZQUI6IF'TRVKDF&E*^0
M.]V3.E_GT[XF:Z>I>Y(I/QT.>G71Z,EX,OMGJZSAL-_I'XQ>T'#G$(?T^.SK
M%YAU&#,3XQP3F^.8<TK) Z"/T@J?/)I2MR\HC4HL+*98S(9#&QFT=&1E71>7
M(5H9G0W%6RQ*2->D(8+%%(N9#"*XH&SQTOD4 *#6>A&B3@E&CT0B-&D!Y8**
MQ4RXA8V2:6!"R0011#8A@O+%4A0E)8)&31VX"['8H7YG,-P<C!=SH0AZHW+1
MA!PF@.>(3VNG9 F9)"4R35HHLF#B,!,NH73*L101(!E0IGA$B4& A&QD$4U:
MY+E@XC 3#H'D5-&AI$@1C$]1\B\)5#+$ F$:-0*V6.(P$^Z@-7+$*34Q=0 1
M3."/P-\T&EVKDR^YPSSD_F?"(YSR=?MP!1R-0N#PDS(45SS5C<153DL>,0^B
M,1-.4=?4&.6M*L9##C+8'%"XDGST.:<EIY@+T9@)OY#)FEJ%0&FM)[6?E1$"
M"@N)Y^@C-6KX=W%%8U8%HX1&1\$@1R(H8S3H8BXHK4C9-ZE@U 2UDS0^J2L^
M:IVOE7ZNQ4>&[^BS#9I6TK]/.J/.9/\BFM3*?$J+F7/P4AGPD7)6"8K4'@F$
M4R(;C)I=18.XPAQ#.Q-?[[)R,DF;4RUI:T0TQ4=+VL8$.N0FK=V<8VAGLYJ3
M0[SBM0U%(X"+T2=79$ 34\J)KF^0MX2V.;[6AX1!2M;3"$ %T?'75*3+I$L1
M9I%\[67#K?$A#:^T7D17*ZVR:&66%"PX%:-D#UL46V?N>/ZZ2*YV9LC.Q-.&
M('+)5(PBAL_)4%#Y'*-EM#FN;M(V9/.+[$P<;72>*B=.JB!P],-^%HVQ1JBL
M@L6T2(YVECI[]WXV6*LBV:"=LA!*CJ'4JN6EELA-,L4&^=G')Z-.GT:CSTC2
M9]3I:9=.^9==!A6/Z63<2:/U?EI$!^L<EL+423L'H*W%K",A:46>,(4F!3SS
M">DLRM;(E&QVKLZ^U2'&XAU)E KJ4GS9!#9<=P)_4A=0T_"8N^QL$WN?1S:;
M)]A/]+@S&%,Z?#*X_WR<[R^B<F9!3KI4@+(!8;-7Z&+*0!%0B10:P'[G#\G9
M%!^W;&85FUB?+.2(F*I:1F%,K6 <FS#'=?Z0G$UMBR! Q6 B98282M#%1$$!
M( <2VC2 W<X?DK/)&M6-'IQ)*<0$%KP'9&(;O?/%UGDB#?"3WT5]/COX#3AO
M?-^_K(([N?=S.L#NH@X$Y:+1>F=3W60["QN+<5'5=)5--2YJ@%5?2M!,O4FR
M@M!SS.5"9FX 42CCI)+>DA;*-BE74M<Y;I65X1#[!Q,L?T&7$DED)S-'U#[7
M-<>^J%@T*2<U2";Q$S@9S7,X^</\E;_^!CEX.AB..[>MBJ(MQ0VQFS3]5!K[
M9[ 3,0BCDI2A0- A9$25615EL%'[<SH@+E5Q+K<%S]0Y-Y=KD^?YV>S'S\K*
MOP;]@__A/R\.<=C#7>ST3P:L^;<N/#=6_&M;D__<?B4F!1,\:,6! %OS[+4
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MPJAA4O!80]&Y3WS7-7/&M3\]UYG,Q45[>.%3)U/==24:2P>CC= I?FGVAKY
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MR+>*#O\:1;S8I8_7_N0[UW,<!6Y$?;KJ.H)]Q?/D*"$?&3P.IM/EGN(F6[I
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M^']I3H*)-?X8VR(RUNYWELBD575=\=9N(JS28W"\?WH5[_%OCQ4B 3'@H5*
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M<N?O1]2;*;$[3QS$@TMNKA\S+J3P8N*X22A7=LQ6R'%',XX*CHP0& K ):2
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M"!4R00:3TE!5 XK9[4!&\%H@> $[]XS@Q2%XNL:OQ9%O,0$FA!1P!14P2G#
MG P8*<HC.Y=ELI2:=9<_"X)_LI=W[<%E1U^G^_0_!GW^Y/>?W*@HA3)@K5%T
M_7## A26[!Z9*J#V-;"VK(76Z_:^#[#]2OF9U1_!ZA]G/".$0QH\L<"X5 0-
M&PFT8>F?<<>E6<!$1UW&[R@-DBL?K@5RJZ]C_%#D9K%6(:RGQ)J#Q%)O"*!1
M:P-J,0*:60*""G&WK"GTP:?:AD3-5OW*P%X+8%?@+\E+\C*P.^TJP<03'K=4
MP$NCXY(,4Z$.:D&TH8@_#\8PLK4C1"Y&O*;(K;X:<5Z2GP'64TNR% $YA!T(
M\06@E'F@K0]Q759,6<BY]BG6L,'8/.Z3^H5"U'IS7T&EX3*?;1) \70WP9K6
M&*N'#R$SWN(9[WQWQK<0?&">2 4H1P)0IS P3GN )!%"QJT'=&IK1S7P'5GZ
MCW88UR9!/U<<K+E?(K/!<MA@.H0CVB\8A($FD $J# 8J, JTU$0AIHU1.+$!
M4K.UNS(;;#@;+,Z9D=E@*6PP[>2P'OM@8,J1=#Q5)O9 !@*!M5HH+;W"96,"
MU2!XGJ.'3 =K20>+\Y!D.E@.'4P'ESAB/)4$^,CKDRX%+.5X(<>5#00')2,=
ML(:"%82'U:^0S^K6)C8^XL)/2C@40WWUQ%9+N2;9 E),;DJ1O>SW+O9Z9:.Y
M.'['7RM)_UX:;_RY5C+=P=6PKZ,)VEW=OSX<^HM!),1TE_U>IU-2XDUN7&;#
MJMCP8,9Q@A2R9=D(;9E(WA,/M/82"!*45M"*P%%*2V] .'>Y]ES?<!VY9 '9
M+IE+5H-+II-P=9R43D,00BI+XR@!2G(+7-Q12TQT0&6)"];@--=*S5RRG,2;
MS"4KP2733AL$?4J834Z;=*H#I0"*0 VX-D% ; DQ)'*):A X&YR2N21SR2)2
M@#*7K :7S'3?)BS :.? % 0TZE0@-0\@8(Z4\UY1&+F$R :Y(]"MIERR8<5#
M;CP^N7S(<_EV(I]-W-._^ZX/[<Q9%7+6X8Q?ADEEB,,.:,$0H$'$O916(E*8
MB;OJ8!0/+H7P(3)/;&[.8:XQD!?D6,E 7BR09V)11.1>1T&0)(78^P1D;('P
M7" C&78B;.WP!N,5'#YG(-<1R OR:F0@+Q3(TQX)PITP.FC@880OU02GBJ :
M\&A=JY7"DNDRJ%YE(*\ID!?D4LA 7BR0IU9DKRPARD-@(18I.X8!$SP'R&M!
M+.%44Y,J]"E<$VF]"2$>37]?;X[%NCAK-Q#_L[CGKS<1/Z>+(\Z^W$QO$>Q[
M-./8T%)SK:0 03F78O,ID%)K8 0*G@D*K1A'XTHQ6R^@IL[8B@YV,M-EIENT
M#R@SW>*8;OK8R07,'?6 .Q( ]5;'#:,. "&+E.(H&M*.ZU#*E3EVRDR7F6Y%
M0G\RTRV,Z:9=8S3H.&V1 %9*%IDNOI(6!<!94-($'K *6SN8-P2LJKU59KK,
M='5Z\.?T(F:F6QS337?Q0W'SRK0"U-BHZ0BGP#CK0'#48>DTM &688F4K5HK
M^)L;N9G6K.2QYVVZ3.(CN=[(=/S,$\_S#?DN5_XN-\LG7ESZB,\SW?<OGM02
M_></7[\5=8X.\ \-H,Y#ML9#ED=L62.6J_?]K@=MFPKRW>;K^.(B[@1*VI[G
MV'C==GYW/6*]>?5'F[O7OG^2+%SM$26>WN,=Z'XWCM;@YNO*&?=U.P?S=NX!
MV[G3V2AKC(6.%@%8(90<5P@HAR!@1$ ?>" <V:T=N$WG=EO5+ZXK4]":4]"<
M9X>9@A9#0=,>)6\Y"9P H60 -'@%I(;Q%</40$004F,*FKO3?*:@3$%+IJ Y
M#_4R!2V$@J:/[Y0V7!(G@,*E9SO^H:Q@@$E&)98N1)F4*(C-UD/+%)0IJ-X4
M-.=I6Z:@Q5#0E H2Q"DN!0'4"@HH%!;H8!1P7& *'4U!^8F"[DB2>SX*VH0S
MB!_[O?;;G='0NTH\7P]MN%.[(7ITS,-Z$^ZB/5^3.9<I]U&4:V=\7Y@S0A4V
MP KC *54 T.IB0P,97!>0A%TN?&L*I!AA:*R,@G5Z=EJZ/O*)/1$$IJ)IW(,
M*@0!1(EZ6$BZ3R @''$28V^,'I,0SB2426C%2&C1WJ],0D\CH9GP=0<)39'K
MVJ4.QLD)%K6K C8(ZH371F)4^K]FNP5E$LHD5&\26K3_*Y/0$TEH2@D1CS +
M0@$<IR6@P@N@8'SE.%1>0(>L=*4'K*H,FAI5H:PUG_Q5_L.[0L>[TA_\=]ZM
M0=$;#0=#W2T?YTEQA#\?DOKQT!QADQ6&C><A6Z]K9']Z>9@T3T^C%2S =:^F
M&1/LHDN_W-#[[IC=FZ,+X_O'H=0V@^-OY#XYY\O)=55)H(\S'FGIB4+$&" E
ME:E_B(NO( '&R4"88-&L?FN'L@:KK.9_C79B&>:+K'N28?Y\,)_:Z4C"A<7!
M :AEA+D4'$C,"7!01PH7UD/%(LQI ]$U=+ADF"^RZ$>&^;/!?-JKRFT0F$,/
M&$6I&QBR$>:( Q)Q[@26C#-9KN9(9IBO-\PKKWB18?Y\,)]:S6GB;<_CG-8J
M  JI )*Z &0P2!LE,44PPIPTE)P[?#A[+JN/W=NP3CKU]#9,;#'#7YFZ*J.N
M+[NSO8^E]4AC!3RR'% -%= >2D!H((Y2:..N<VN'X085<_<KK5_F0P;Z,_@;
M,M"7 O3IBO_.0J*E <BX"'1J4 KUL" 82UB$>=Q_CK<B3,T=9Y:!7FN@+\OC
MD(&^#*!/^QR$AM(810&D3@/J8-R'>$E )'$?EW:FM>;EBHYY!OIZ WU9/H<,
M]*4 ?6I%AQ0Q'ND;&(9UZB)A@69,Q7\Z3K1"WF%=KNA"U"EIN?0Z_'.H3<?'
MOUW[T\Z_XA\W7WWK6M:GSM#+!QJ^(U3E&6^SO.*+]C!^FWW C9]X7VAK>Q?Q
M;JZCK8IN;QB_;]A+U.!2@ZU$DMVRA*I.(5VAW=5=V]:=>._Q!Q?Q<0;;]S[X
MY+LHWA8LWN%E;]!.\^E%WW?TL/W)__:Y[89G-VQUZQ?'D^ %_/8KVL2;B+QQ
M[Z\L?)#5-GO09'BM;;NOB]_;O1/;]EWK!XWBL&NWB^)_B^(-+I)**EY&JBL0
M!&_*G[Y.47+L^V&\_6=ZS)+UF!4(!V$\1CZJ+V^$#EP0+*QQPD/Q=ZH[,/FE
MLZ\%:B_CY8'I>_T1Z!!'YH7N?-;7@ZU_?C> %^TNF#+8]%C?.Z(A+ Q=8\*(
MRT!OW#/^120:WT^?BO>D:W,OQ5D_K:+_^+F)Q-9.*_%9T0O%7EJ (X3^]4^]
M<Y?YGY7KQ-W3>W?O\.UN\?OA\<G>X4%S[^"D,::_P^;>_4Q0E[O?.V[N'S1/
M#O:+^.KD^-7A_FXK_N.D%?\Z.FBV3HKCE_&MH]=O#_X=/W?XYT$1G^OXZ*!X
M]*/M_,OT_[E3^Q'YY;!;#,]ZHW@--_BU_K?[KJM'KAW7HL?=:RDAOBTO9?GD
M>,\=?3GP+VY>_.;:@\N.OG[1[I;?7/[2;Q>Z_R%RXV1-2KPX)5G*[QN__8TR
MM^&8-B=')I-OGKR]7;XU):3&[U&V+;&Z]VVXC>Y][T>716B;HZ==]L?O,7+_
ME^:;K>/-8OJ@R_[DP.^G>VHU\]$[-LUC?"YGUZQ^1C E8%MQ(??%4?S<V: X
MB.N[*WG\/Z.N+PAL/" >?5U'YJ1]]<!Q>>#4>=XCX0<]\\.3$![1=*+>9D[[
MDZH>^"$9#^LT<*@*>EC3L<F3JI))M0DY/[FW=>X.EGM;/_Q4XOJH/3F52)]M
M=<Z/OIR='^V[L]/6F^OW%V_/FJVW[?=_-"^.]W\_?]\ZI<=__-G^>BIQ_O+L
M>/_HZKCU#L9[P._/WWYL_M6,/_OSK+G_$9_^];)S='Z(3[^\FSF5./KK@!Y]
M.6#E]???7S3_>(-.\0%M_G40[_?]V>E?\7[.WY\W6YUPU!Z?2!R=0-H\/[AN
M?LZMK7,;Q$QTN;7U^A'=ERFB8]AQJA$%D>T,H#PHH)C5P!-,D"548D9R9^M,
M=)GH<F?KE2(Z-$5TN;%U)KI,=+FQ]=H1'9DB.J.XMX$J8" 1@+JX=37!.B H
MXDIC3IDS*]K7>JU3_(Z'9^-Z^Y=]?^:[@_8G7_S2B6CY=>)QG*LFV;TFJDT=
MJ16^PY_X[E>A\6L>SN?MH_N#?&A$QC&/=2:O="XRZO9]O)4OWMWPU@?=[A91
M:+2[G_Q@6(;D-LH&([U0#/75AE5'^V6Y1P>#^,#QU;00*Y>9O=NKS%B7O?MJ
MO7_W.FEH_XC&2V+MN'OB[:C?'K;]8+??'L2W]N,_NQ]>QV'HN6CYX]#25UFV
M/4*V-?=F3ARHLM18E#QO# +*-06:4 U4\)!S+QT)=FLG$LV,9OOUL7*M1EO/
M-8?\<_K0,]#K ?1ICSM7D/J4MXPPB_LS20E0D!#@C?;>.Z@BFT>@KV&7C#4'
M^V/6]PH<R7E]KS7LI_W/03KN*.. 8YQJJ'$--)<*,(4,E]QB0L+6CE2SO:'S
M^KX6D*_ I9HA7VO(3WMB&2,0$:(!04&"2.P02*$\P%SXH(1# K.XTI/9BD3/
M OF*G*QCY.)M7'>?Q<M>/_ZS6T0D]'W77A?#?KQ:I\R?++0['TU<%KFLVM("
M'.]CLHFI]B:6:B5#C6]OM^M:W\RV^]5J-QSVNM<OWQ@.^VTS*M/F6KW7.EYF
MF.GM,?1V,N.Q8$0(R(4!-BY@@"+M@"(8 4U)$%P&KVG<R,A<G675&. QJJ8"
MM\4C54WF@AIPP;130UBG?;0[0$[HU/2= 1TD LH+)"FRQ!BZM3//WB:S0'UU
M0.5A<1G[-<;^M&?#"VFU5A(0 RV@+(H!(R4$QEA)I1 T\D)R:,X=/YPIH+X4
M4'G 6*: &E/ M*?#1QE(C5% 4>X =2K$E9]!0+@.5$ ?-:*)%% C MBT (U6
M;Z@[1>]G,6;SA&3,%R9</_:K=[Q&\N-F9JN8V683026$' 46)8TU.(H;8](K
M"IC0%!NO0]S;;NW<453^T2[<5<D6V&1*J&,\1R:"A1#!M(?#4\<E\A!(FSI,
M6"*!QIA'(C \1$-CJ]G63E5]<3(9U)\,ZAWOD6EA(;0P[?P@"GO(G0,B=:&@
M)A*$"1X!+YD(5,& C([Z0,R>@F2!L.&<L/R D,P)"^&$:6^(HU)Z3@C@##E
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MHP!5Q $=, /QY]"X(*!F86N'P%EQGAL%K2B4[RB#L"0<_ZD[(Y]A7 &,IX^
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M3,NJ "]UNU]NVK_?GX?VE7?@B^_WLGY]I'Z=WII[SX6E3@%&L(Q;\X"!)C@
MA(F//PXP6/V5%VHD8C<M-&9<3&RR(6^7GJVB+)Q;^(O+3N_:^_%[9:&HRU'?
MGD7\%9<=W<VQ,[6)G3F8F*K\T.N)D5Y'&PTRCSV&QV:;#3+$4-QQ.Q!,@( B
MJX#VV (3'/'<$A6(W]JYHZ]L/D6H-YSS8<]*F*FN$1+W,FX^\*F0C:>C)#RF
MCCGA@(NK:V1CYX$B5@+ATK:#2:R"V]I!#8ES+-2J(3T3<C93-M-:>'+RNOG<
MNYAI;TPJ&($U9P J;P#5,E4;, 9HH5A PF"M8/T6SDV+DRA! 8P>=Q_[Y@3=
ML!")?%B0S93-M X[Z%UW/AH,RT.95N];>X;4F>&P.^G)4'HPS?2YSUO_WU%[
MT![Z$]__U+9^+"'>>MO[T"VO<L?I318-3Q<-QWNS9=FP0!99#JSC//6NUD Q
MCX'7@5)+I&$H:0;48+2J^KF9%3)Y9S-E,ZV:F9YSMYW7V!5:8V<VYIQ!J#$,
M($Z& &C0'&AN-? 2$V.5T0ZB&BZRFQ8ED;Q995>-7D@[\V\1$Z/+^#("/-[L
M("$_OE_V8AW_:-@NFWSZ;KO7G[08_Z49_RK43.VS3?5'UB!Z8N^K^8[#WC>[
MG7@;/SIL^QQ$\2B6FZU"XE*=L[BZ 6J9 =10!0RB#%@I7>!2QOV$3VE:<R<S
MY&.&E="GV4QU8=]GCJ)X /-F\5D9+4\[>"1F@B.IHO8T"%#M$) .&0"=X)(*
MQB#G6SND$8V=B7G%$)^).9LIFVD=_#MY_:S+^CGCO)$22RN]!=Q0 :AS%F@H
M!2!,"Z6@-G'_6K\%-%?_W?!/Y@FPX9_<M+BJ,B&TC*CJ^S/?';0_^:+3&]PX
M8Q%ZFC=V=<^K\K%B-E,V4S93-E,V4]W,])CV8)"FLT'# F)Q!V:<U$8(3DR0
M!&N$T ,VV_?T"2LEP]YMQ7#8C0+"OXJRH>F'QZ&EKU[W^F6)BN&PWS:CH8X[
M[U;OM>[[[C!OK1_3=Z=U.#R>VEJGG 3'O0 .6PLHAA;($ S0CF@DN5*$I+X[
M<OZF8AG9=41V!6ZTC.Q:(/MH?.@4T?T!QW^3OR-!:P0=!50G:",3(JH#!M8S
M)9V0W&M?'VAO6J13A$#1+@&Q81%*^2@FFRF;*9MIH\STF"Y24#K%?>HP[ZF2
MR"CEI$FK-?06(O?H@\VXTGQ37OF@LCK-=32\*61ULYLBVDF'%0-8^JB[L%9
M*^H (IC)8(2Q.M7)5PTY?Q/3C.%,M=E,]8HAR52[,*J=V=ZFZOS&:0@T"1Q0
M+A10BAN O9/2>6<P5C7DVHK.A&NRMQ5W0O!WW2F3>/2P^,^HZPL"&V6VSCRG
MOY-FW>/G>D'BZ+O>*&7]W#S.PYO=KSB/W9G)(X0PB&/&(%*4"2N)82%P:;QA
MD;_DI._]PZI##XY'P\%0=].091:KCL7>#*<CVZC3SCHD 8DB'U#-.9",>T <
ME3Y09;'R6SN4->3\23N5 ^F9O?C/S!BU\RC^S_/-A$?,@%I1Z:PDK(Q'4S3Q
M6:\3QV\P+IR?N?*Q7#FUN6:*0TF\C;MI8@!% 0,#)0-:8H,9ETY!$KER;K&7
M>3+S9.;)G_ DD@QRZ*$.Q%*DC'(0,\UU_ ?5.+!Y>#(+SNI(M#DE.(/S&D*F
M 98A"4[L@,06 A\@]R[NJ2F/@E,JUD!L[A*5F4DSDVXFDSXJ!(<Y%)BDU(J(
M/HY2K5@.D3>68@D5OI]*[XF\R9RZ8$Z=$J;(,*:UTH#'51!0XRQ0C$G@M<-4
M0PFYE5L[B(A&-.S\T3:93C.=9CJ]ETYQU*1288.(0A1Q)R%C F(;G&)"<54)
MG6;&?!1C3D<=AV@3I (#C"($J#,4R+B+!UAH[GF@ EFQM<,ARVR9V3*SY0*K
M$(6XY>,R>$'H_\_>FW:UD6SIPG\E%WT_5*VEH&(>7/WR+@Q4-=4%V(8ZY]I?
M:L4(Z1(2K<$V7OWC[XY,B4$"&XP  =%]"H,RE4/LV$\\>XB]>3#86*V9I($[
MSAA8\L6,7PX G8M^,RM4TBJ@E*)%W B&C,(<!:9-M((H'<+*FA*R(]GS\8@V
MP?-?FGT"#ZY:-*M6=39FH?ZT]I_-C_:#W+;SBH/-LYZ-;#L^\+!=>S*,KZ:_
M_#K=/%[WFELV7_KUV X.Z]YTN',^^\S8-&/7'O[U<QU&1UG_5W&+ 9,4@\F=
M)X=7FT,S\FZ/,;T*2_*UA_$JN?;8MRXK5P6F/W35;Q\3[/I[OH1GU:N:_^CS
ME&>]_GL$+FO$$WE8&%AQLZM.LHZF)TPPC;8,\VJ"^MWT03-WZA6TT4=@&X.'
MH4?Z1LE);2/F=@5L:,NU64FW& LX==#_/)O,]*3&Y;RD>;.6Y;KF:+O7_#ZI
M;EX&JATH[\?'XZX=Q=",SF9,M:]'971F1Z=JZ\%<V@-:_9138W^NMK^]]>UV
M8_:M4Z]&/B+N@GP7K/A;,-[EEEN;^'<#@=SHE5_4T*T?@[&T*/U?ME.?A 0.
M^K/+TPM+L]ZQ W]4,=+D69,%Y%F_T#1JYJ,/E#"6-\[3(+60N8Q^4E0X Y\W
M_C""X7A)HYYWAQV___JA^^'?;^G[XW\=[7Y]]\_N[^_%SO$VVZ4[\ Q_P?W^
M^?S^WV\_S[O#/GS</?Y7]\/FA_K#O[?8[N]O\8>/_YR^_^C9^_R^!_[KWL'K
MHP^;K]-./=?W #.BK8H$$2-S<Q>AD'-)P&]2\L!]-")G!K*.$?/5#N[D"WLN
M48.7'A1X23[_A6'<LXV+/A2.?9WMWQ(#ET%RY#AEB(.DD0DV5VQ)R45#&"$:
M<&Q1#:H*AA4,6Z87OP6&":D\)TDPZQ. E[.14,>X< )KPQR^"X85HK8P@)OM
MA!)Y9"JQ@# 50-0BL#4@:A$)3&C B@AN5,X^YAV""U,K*/<<4>XVN6Q!: M*
MH84@0-6BLSB)0*TD!KOH@KT>YDIJ\&/@'9O!.V6CYHPD1$DRB*L0D,,D(N(#
MH4Q$0Y-86:-@F0J\N,S@ G7+I?$O%NIN@716"N.U8-Y&PPVV0.@4T#K# O?2
M,EF,TH?",#&#87D7BI7,H\C ,N4I1N2D AL55B(C(]%) (81M>#Z! 7$EDN7
M"XC= ,0X,Y1391D#FY1RXZWGD202L5>:W@G$"DM;7/A@M@J+2I1ZG4N?D]P<
M7BF+M+ ) =5V1#G)K4HK:U+@CB9/QBPMW:=>^)EE KSP,U]:2?6M+W'@ZV&L
M^@EN#4MHU3_)"'U]5M,+JX!Y=>4X(:DS\/]>:ZZ3UXY8PJW+)11MPFUO%S(M
M@DE^N)%JFQ+1'-QKQ3*55R@$YA8$9EK1XX*)QJ.*,EH_:>)"<H-Q1B0B,G(&
M1)00H<!$DW<VT4HQVP=6Y5)S^$F(Z38V8N()C J2L'0\1:^5X5$0; E.DBF]
M*+AM^E9?@[;%EEP8%,]&.#W'B<+"B80G%.6BTF!*&HV"$31&9:WEP,]$A]+Y
MO>U%RY=;RPL8%S$5,3W"F@E+)C$^PD_/N;74$LN$L=YYZ:/TO*R93VK-G/._
M"LMXH%*C:,!JX9819)P"2\9C*:0F*O*P?(OF2^ON_J\XS)OZP(@?#6J??VV=
M+%EQ?\S%\G1;;#ZVBR7?Y;4%8,J;*V-O:)LVFH.![1W&X]@;O3X]/^6-/<T?
MK7^V@]!&D[9[(,)Q_G#8;-$\.+*]">*U0M[NM8!8D.TVR#:_,<4P)WED!DDI
M ^(\!F0DB\AXRIW0 98RL[)&]:(JM"Q1>/R9 T!I<E[$5,14Q%3$5,2T;&)Z
M5,OZ@9AIL^/_-UL/&IO]LGF>ZB] M+[&0;_PUUORUUG+W&"M<3 <X2 MXLY3
M9)4& AN2\<KQE')FU 07EHC$OK34A[:HU<0@KQO'%JA]B(,J'I]T^Z<QML>:
M@D4GXX$_ OVK3KJV5W(CEB8W8FLBJN:D-Q,AO0$9#0N.W0;'3N?L\!!4I)19
M9"T1V:UHD8[6(NH2252I","VLL;NW/"D!!&>!",M8EH6U'WD_(AK$;?$>Q:(
MQK,Y$IP+[(R0"$M@EISG'GZ6$Q2-]PS'R(DD*VND(]2=*UT432^ 7,14Q/1$
MQ;2L.1)EW7P0*V;.&^.L9")X9$,N)T"T1&"9!F1PTM)AICFCR[=POK0\B48I
MD,L.3GC?<R?H"TN1*,&"(J8BIN=@0:^'C^/AJ G*'/3/VP3D#@';O4EO@,:#
MZ6;C/N_B_XSK83V*^W'PJ?:QI1#OHN\?]IJK7!&]*:3AQTG#WL:<L8V-(A$+
MC1*5>6\8(<@([\#B=DS[)!5FV=C&'2X7U>^YH$(![R*F(J:G)J;'M+;+&ON$
MUM@YP]QB'B)5$6F>XXO,1+#).448)Y)CC((KN82+;*D0\L+/+!/@A9]9)L +
M/_.E)<JU+>G\I99T==.+KOIIMS^*%2%S97>?>9"IQ *+F(J8BIB*F(J8EDU,
MMW#)F$"$C$8G+0BWBKA$!?S*>)"44B]N[9)IJ,*EYK5MT]K<P'8WCO;2@?WR
MIC]H]K>,1H/:C4?6=>-!_XT=Q-ZH.%5N4Y7W8'NT-^-4\4$98XA -BJ.N',"
M&24=8EQ:S V(U?.5-;-$F0Y%IY?=S5IT^F%U>J<-1H)>'U+XF_U-@]-$4(9<
MI!)QS!2R@7KD6"!.R"1<-,NEU"\M?0G48&(1EX2E$J4K8BIB*F)ZOF*ZC8&E
MA/"99"4ON</8".V-EL0;&;#1^-9D#%::<_95 M2+XUT[H^D>V*DMQ01C7G./
ME*$:<1$4<IY')#BG0+I(4L*MK!'3P7J9 M1%APO4/ALQ/:;=6Z#VWJ!VSL1E
M@2N>,$/6,(MX(,U^'8>H4-03K(4)>@FQ=D&1X"6Q;=65*OC:=FW/Q\J.JC_&
MO5@QW*FR MTEXCMIY-6^URL&HQ_Z8]>-9\V\[M8(\ GAV)4E5"(EB3##@C.)
MBV2-9#I))50,TM"H)CWQ;E98:K@W'@U'MI>'K*#8XE#L[6@VHU$&IJB1%E$3
M<D:C)LAP:I!6/ 2;N63VTW'>X4PMR%FW.$5Z9/_](R/&TGD4;]XZ=/$#]$2A
M=)X2+@Q'2X/D.V/EC'&--;5& ]>+%BQL+AQ0/Q\#"B M9:T*,82,E04G"TX6
MG+QGG/0N$>L<"U00'G RB@2IC*>,>&R5O@M.%L*Y.!#=G26<V% 2<$08[&?$
M%39 .)U +,3(')8AZKBR9@CI,'GG'LP%20N2ODPD_>DV4,J##B)0QQS8?IH;
M"XQ&$L5QH,Q'?SV4#N$]X;>"J0^,J3/$U*5@*2$:*9D8XM93L-\E021RR17C
M44JULD8I6/%7=%::VP=1X+3 :8'3'R6F@5"OHXQ&F< 5_,ZB22IA9@55C,IB
MP#\83LYF&J=@-*QM'A'+ N(Z6>2X)6#%$Z:<\M[17%?M[N&: I0%* M0?@<H
M 22Q,A$PD@M@H,D9FBB61+,4X7^B6/#+@:)S@6_K1**Y3XAE/"$>7$!:"XD(
M :X)*F P%2MK4JL.>48F?!,W_Z79)@#_AOK3VG\V/]KWR/TVSMYI>G#Z5A=N
MY"-HP.#^E+.YXJM<1:;VWU97VM2PC+&R/F^3MKU3&*&JUQ_!_4;]K*HA]MK:
MEKUF-&UN!9KJGNWYVG;AV>&#II#-ZJU?_#OC-7E$3E=5SJ(_Z0^; C>O!K%K
M1_6G^.OG.HR.IHASX8N3Z8'/OV(=//MX=/U7[ETV9E5\#SD;4;RQOA[8ZG7=
MW_=U[/DX[%3;/;]:5?];56]ISE^@U6^ :Q7!Z&WSZ1M[&"MU>1@O_CP:3-_B
M!,Y$;A#M/\@F>,E7MOO9G@Y7?KDT%L=U#\V,_>RP73LX*=W/J@)CTRHJP'=_
MT%1">M5TO,EGP3/9I7F6ZFB0U[7_J(57A";E(@4#W(CHE$T2J+_R+JB(U=]@
MC!]D'*GZJ=K(2V(O-]:U:U=)\H)X)BB&,AUZI6C6C,DG@S87AEZF3>U\;C^I
MLS:/7C'9\+H'SLEIY_?ZQO:[]>KU]M[^QO;6[L;6?J=="K9W-VZ/( _]]!M[
MNYM;N_M;FQ7\MK_WY_;F^@'\L7\ _^QL[1[L5WN_P5][&__]7WM_;FZ]VV^2
M-=6OU=;;O[8/WB_]^_VV]ZXZ^*^M:G_[_U8[>[L'_[5?;<$;;U9__+6[-<V?
MHM7Z[N;E1*H%(?ZR#,-/V[UJ=-0?PS7"\.?E?]R_>G8<:EB8YY\5:%6#,6=+
M8\./X,FZ]F087TU_^75:+:;N-==OOO3KL1T<PF(P64_S0C##C9H1: ^?KQ&K
MN%TG)MF%DSM/#J\VAV;X7GN,Z55!S+6'\2JY]MBW+BM7!:8_=-5O'Q/L^GN^
MA&?5JYK_Z/.49[W^>P0N:\03>5@86'&SJTX2CF?(/6T]3%<[J)8CU_A&J<97
MF[-G[V1N\DX3HO8@;Z5O]%9MG\GVW1K_RK4O."^T:[=[P*F#_N?9A.LG-2[G
M%5L;/I/+MJ+M7O/[I'AK&:AVH+P?'X^[V6?0C,YF3+6O1V5T9D>G:BO57:I5
M4?V4M^_\7&U_>WO^[<9LN<;IA\'UZM6$B!>QFEP(X=S"W;G<NM!N^%C4*]]
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M9TCT*:RL@00[VMQE4UB!N@)U2PAUMT Z3*,/@1JO,J'CTE*&36*)"&MY3-]
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M7D<9C3*!*_B=19-4PLP*JAB5Q8!_,)R<S3:&A2TD)P7"/'K$L4U(<^\S6'*
M2:V85RMK1"^J5G0!R@*4!2BOS3.*$BL3 2.Y  ::G*&)8DDT6(;P/U$L^.5
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M?!+1 LIQW-'FSD5O2OF]Y=7L>Z N1;,?5+-G^0MS*>(0 DK.),2=R>6LG$%
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M\PEN#4\31Q:4_'C<S0*#F33NVL'Y&(3!^!"TH0O'X*Q1]$<]D,DA_'ID1Q5
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M.K_3&,A.GAS?]2[?KRMVQW[L#S:FP8;6O?7BG5Q\=_UO8R/#V@846,JE$*A
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MZ+,-AFL5>LJHA>+6RV2B2Y&KE'3P1'AE0M+Y\+VHG;1?J$+33IHP3N>@$N*
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M$GO3ZYZ,@UB?B\'A>,-I0>+PN'4)\>_9SN<,U7^>[+_]ZQ@@OFB];?']HT\
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MK%'3E%(MD!=?(T =AGTVR[3DG+4&ZJ< ZIEP*Y4Q&FR0U\HB+D-$EG"."#;
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M4Y%73([YR6AU$6%/N[P/S*W/V;=47NX,_GR9NSY?^2LK:Z/#69.K7I2QPL;
M?FNXV(FI&(S2=?."I5XW]XGUO6A+(1R)Q65F,?RK7U[XU;9'J;8V+S8(1\SB
M%V)UD+:\_:C&^XU)](V3*@_OMNSY/QYPV&(T!YRNJIR&>]JM-.95+[;+W.2K
M[-O_7+GVQ5'N+K[ZBG7];C98MWYE)K]Q[IF,]SP2\\[ZHF<;?Q;=C[Z(,/W]
M9F.KXU<;C?]K--[3\J#+Y7&?]^5OW]F#V"!\:F8G_CSL7:5U'D3D0 J.D4WP
MEJ]L^\R>]U?^?5U?05FG)G]ZWFZ=G92>3A'*10(I[E;G.%Z!28N]?!6,R2[,
M6!J@#T#3_J,07A&:E(N41&Y$=,HFJ1A5W@45L?JBP)R4B>J@PJ\SPP,4_:]_
MV[6;5O+&3/A HC44_&"J*&<4.V*)41H3):630JPL, PO(^B>= $?\VI-XV>1
M(2/V!^,3:R4< DYVP;9FGG")GR.#"TCKNW"Y/>D"N;JHEK3$M8RQW1)7__7T
M17'$7:7:;RNH,'':=ZOJ81KNWZ]4+J>O\.-GCHZ.2>O@"XY8<&8((BF!/VB9
M1(8(@ZSBTE MG+=^94V+U=N2DT#(VR.#GUN^ER=U;'76^H\EX5[+I_0313S'
MBCE]+.M2^4<4;$R,O.T? NFO-'K4$6>,''\TZA5[LA4+)>DK*]S!JH"Z''3S
MB4Z@@&$29#-EB*=H>%JRWLR@X7]?85:[O?-:H7["\ERS?F/+6;HJETYRKS2>
M7V.[>YH7+?K##HS\()_Y'MC.09'94^6/+,N*/0?W<V(-0SZVFEG.R#)-,Z.R
MV-)XB3(MJI?I5RQ35?]@K&.Y8L34.I6Q/M1-" Q6LP$6[,/.I^9HW6;K1=Q<
M#^&/A8G2;74:=O3RS1S)& =)K.M^C9-!JZJH1/6+T3'F\KK34UCWTC?+$8\"
M#+X?W*M01,EL[_3\N%FY<S:??.IF#E.64[>]L[O9$..274];JV!K;&XWBKYO
M=_O#7ER4P@0['T=.PM$GOK/[GK5VX7D;6]_V+MZ+UMOM8N?M/^UMVCK;^?RF
MO?-VBV]_WCJ;=A*V=P_$]H;_MOVYA5M'X$QL')_M47 </G]B>Q?K8N_S)[YW
M=$#VCOY,.[L'7Q2E)D:+ =PH!P\!&_ 06$ B$>9\B-+ZF:H$EB=,I7/,*O#_
M@K0"KB->XH0)B<%/5R78VOYG<WMWY\/6YL?;#MU_KY#.74];>V*)^>@/8QBV
MXTZZE)W7V?WL#,I(RDN5GM;N.OZB@J4I"(LB]QAQ!C\YI@V2PA 3DU/*T&EQ
M6 8PSUL7N=9CMU,B-D#YF*87.3I:MAW-(-X?[5#TK]>=^/U>&Q,5X"Y-W0A%
M5]53E&(@JY+<KQ3# M2-@,'2^PWHA=:-&-= >,&U(2:+GSVD"L1SG8]L6%^P
M.+S(8B ?[%DCU[SK%;8]OUH@^(6?BY]Y_\7.17S ;I)+D7"I4U2YHK[!QFK-
M) W<<<8(M_>M*GM)T4$ 6V/YVXZ#G?1A5'MQ.8XU_2";'R67K<,S_BGV-SZ1
M%MVB>T<?VGN[FQS&<[%]LBEV/N\7>T?O+_;H]O%T<EEK ][G,XQC]]/%WM%^
ML?WVG\/6[B'<JT7W=H_%_LE?Q?;&]M$>_3!Y$'.<7$8<(U0+@8*G G&J/#+&
M,Z2#,MPE#P@95M:8;#+\Y.?AIY5EP=.H:]![<:"72"X?$9,AV'+)A)92&\(<
M=C01*<)H"YTR4H/> H'>Q13H*6J)\]JBE'L6<R)RF\_H$+.""<6T%C%6H,?F
MU2OPR4'O)=0!^=SM':.B@TY[71]GRX'X^S1!O.]!^Z7&J;F3LSSS6SG1/\][
M#51/ U3G,^PL!)>R=4$^DH2XB@993 QR1 G/-<7*.P JT^3XT4"U>,4R:GU^
M,MY1Z_-/T>=IXD$H-0*'A(@!]L&)5TA3P9$/V&F>9(RYZB(33:+I NGS2XA_
MO2DZ1?\PABH/[(>HQ8OHKSQW:C&>^-PGJ(:BIX&B<4NVR9.GP4AKN"AW?A&/
M(@ 4X8AD4K"\P"<4%BMKE#>UQ@O4>;GNE[[HU*+6YY^BS]/4 K.D*-$)"278
MJ#X5"011+Q,F,E&=".BS:F(VKT!N';:XGS96LWO;GV45_KFV6,/?Z[+VW(/3
M\Y^@9P/U<Z=N2].]<2DP_>,,1XO&R!2 GF'P#<%=S%52>7+(,\FB#CYP35?6
M0 Z:0L_6-'J"YHT/4IP%+[5:0V@-H;^>+=<0.E\(G:'%N8HX9B#;/F_U2::0
M<UXASF(,1%K,#5M9,[HIQ*/=W(5!T.L%=RX/HEQ+XW_$P11!%_M@BOPY!U/>
M]7*WT,'YN[;M#-8[8?-_A\5I/C"T< =52.OR-/M^>__HP]'.QH'8NP#%N?AP
MU#IY<]@Z.B#[)UMG^Y_WV/Y&.-E^^^9PYC3[R3_P^Q;?V6C#=[88_'R^]WGS
M?&?CGY.]HS_AO@&>MX?W/K]).QLM\45B+G%@$1FG ^*:)62]#8@XRY0S,I]
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M^X/7W?Z@_]J>%@, ]XL8:AFZ48:./N$OR1D6F+4H.NP!+B)'6E"!&)7&LY3
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M#_J=.!4LJT^:)N@+IHG#=0+F#\:)*Z($DDR!&A$C139XB31+D7$:0V+V2IH
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M.C&+^F&LW''BNGQ"#8%WE%'%$S$^PD_/N;74$LN$L=X!+$;I>=47=PR!I(;
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M6\IY?"_GT>IG$017E*I )7U;(/@JK:$[; >0@5D,1Q#OI?3K1Y#B,&;01.(
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M:,YR 82TCABM930A9NU,4T+_J#&QQL0GB(FWR<I_:%#,'HT)4*S![S;@1Z?
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M*N^"BEA]46SIZDSA_$IS[8U^5?I8W6&ZV=K:&*T7H:=:;KX=SK.7,/:&=NP
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MHU(*H("N\%EEH!7OT6R\1P?M0?$=O42V5"]]?4]A2[.'R$OZLKFHI$@V)W*
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MO.3))FR()%@$.H8[>7UFRH$?_'AU.C7US)Q.3)Z7X:A5]EH7E,?AVM'A7G\
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MQ6"=.HRI\XI@QBPM\0Z+CEO?IMP/"CN?E %2XIU%7'.%',$"25A )I7Q@4K
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M(Q,L45Y'9W.#![J,=0&, AA3E7P$,8RH*$F(W(7<U\@I:9*6-E%,U*W+?!7
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MOPI^/1'\FGFH7\&OQ<"OR0 _1;TEPB8P&(-'W.247&HM2BY0P87QWM"E54[
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M<,47I#+:/4_JDE3Z_HQ<+UCHOF::/<.V>^ 8U^8,R '\73AH+[8*.G7P4;>
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MLQG'DA.4)3+1K20IS,1Y]O@*YW$.UDE8K!]P)2RG&&ULV!OPRFE"DQ!1O;S
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M/43'&MZI*8!,^4**2MYLGEX+PUD*FHT4?XM&=J"-OG:GX6XS2#FT'8FVKUV
M>N=5"W/Y%;4^SQ(0'PO.LJH+^A4'U26IF=8!U#TV3X\UB@?DVGQ":A@,HQ,@
M739C^/B,S3GHDU 9]\?08OYDAH4:,WX%LQTA;\Z(RQJ[2(N".P;;R,"UP0^D
M#B4[9\PN&Q9-0VE?I>4$MG,Z![.,^M+'98$F0R7+I,70JY40T4=+PM4=[,'
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MHUK''B^B0&Z>G*Z-II-'NWI/MZ=FUMO-O=B@O8-@.3JM?W@57_:^\_3IZ?H
M7GGDZ#W=GIK9:*RAH>=X@_90Y+P8"GJM],?B 47/UXNM:VJ6"'IO1Z"<2\*V
M6:NM@?F\=?KDQ=.Q@B_JR47O5Z 2V,)J-[;+%CD)8AZLZTOV*GD5IWMYX907
MSNKQBWIM#7],>>,<QHUC-<QV=?VX5GGEY/C*J5D+++F"(O@N0.E(T7@]'Z&=
M$#T34:-@V? 9>]U?!,N[ %O6J#5_H:'JS5^2"2#.AS.3BJ-CB*R)D)O%E'NT
M0QV>ZGW]M*%A01'>K.O#KGPQ8#)])])0K8[P"ZAWU*J?[_#!K_ @_6Y]_I"%
M[((5)("NA.L$BW7"=(6/$F1O%J.48+3N0T+;\P=&7]Q+_.08(;S&/GQ#(G?9
M8>CW' *>(D@P"==&YP4%AN='&F)5' 2X@JFP@Q1NUY\0O%6G1\/CC[<14)5P
MM[Y/$-3*-/S Z-Q^)U)6CZM-')"IBN0G'#<[XIU!S"N80ZT"%/TE,Q58C@/C
M\(SP[3R"'S"'("I?"+\JU#'&OZU5$-C)0 &!ZP6678XEQTMA(#*8K9JLACR:
MU(.]THFC$5='!S*-VW@, H)P@V]!L#D#$'*P0=I>? /IWG. ,KM$ MP$"%"B
M928@BT])1II&;D1C&E-4!P<8$IB0CDV*7"21XFS@0D32@Q]=/PR1@0GES68,
M*YB^^#-&;&@'C@(#6ZMA%: 10M'!@EEB93"Y:Y5F]J^KRS\CA?+,R-O5\9+R
M<4@D>-:=_=.XF,G'+,Q=NP%\%@$>TLHC6/F"Z^\5(+1*@*Q" 0Z5<RWG6J2Y
M[@ @ZZ"1@TJ4J]>C;8ER5:)<'0 +ERA7.T*Y*J%\]@/*IXBD+G&L\K8C)?,7
MF/D/IQBC.^>P*M&L7FO]^0Y\UTRK;NTWWD?)RH?!RDVST3S=;U9>9XS<@U:N
M7#\W"W!2RH52+JQUQ37:>RX72E8^#%9NF>W:GFMK6[GB"GC+G5H'"^-U,1AP
MT@L9I &V33\P)"^KNN:A7KS7ZY[;72RU1%W:0(-IENQ1))?V@;+INNBB)9<>
M$G>L#2M<LL<K1+V+5_XR$H:84Q!#[@)N5;D:I?U+TK3[!<4F7.&R]&6J]*56
MW^QM<_4T\U$8>& "SU!:/@XOPL@94^:^[7G837U^<H8]F;@.-WO'KV#N.^SB
M,2;\&WT8'X;H:<W18?C8A>'M_A]Q2#4!L)0>'![;\:AT)1 1C^Y$8APNI\E&
M!%?9^,:]\,3 @7E0/W2>?ACYO1_']S:7+8R1(I1M;1JV,7"",#+^C.T +#?C
M]L=4?!O9P=@V_NZ[R.K<9YR*5/##"7UH&D>>_PC?#N/[T.D[LH#CG]B:/K"-
M7^'H3(R)V_M@8D$14,KWA#&QIY3ZCRN"]]I.8#S8;BPDQ>@S7/NE*WYRDWJJ
M_Z D;M^#U\@^\J96)N3YWC$0).YQ@8WX*7HQD5-?IL'M[OF]^$I9.(3IZ#86
M&-E#V".@ H[VO7);47NYW3VR-MJC%RQVP5+QE3TT[OO)HK41>_8$BQ*HBD/P
M&',DF2\]</I_??=\5W.KVGZWPY*+94%O$H5?G3]CX.*(R_S.)!5N1.C' ="L
M<-46MPZ5S7$!A>"*,*I7PU*P1V&,;&":OGCPD??&P"^J9JUGAR/<:5XWLB7,
M)1[8/2YM(SD+8K W(D+!",+U)\FA#H7KTE-P9N&LNGSB^F/'<\((SRZ\U<:3
MY$2.R# _'J79T8"IQR+ FBI5Z0>3O/C7M\[-Q5<4\4E%'"W)[L$68M7A_W2_
MWES<W74,65B(W\+AE53IX(.AHVARY3^DQ8GT7@?^$MAP<D^;GV<'^6WJW_8<
M*DJ<&8<K]FI5JUTQ_@NF$U#)%# (["XL;2*(+51I5+HVD* ]('6H+8YFH99!
MH]%^<8D9K! W2EX[(!:UUU#Y(Q=K^3TA^B"F G^<J<5:6HV([^126"RU-&F&
MOL=2R<0!44C0,*'<'=>U[WVYJZ[3 _F#MR!^EHK\ /;4BT7%Z- "%^D)Q(YX
M#<,6]N)QS#S1!_G8<XCN[ZUZ*RU,-9E':0KX U:6@9RCBYUX<.0'T3%5K]H/
MMN.B4G8,TOJ8*) 6H'')6=UJ5DZ2FE?\_J,?_,!U*%%(3[7KZ016K1[+CS3X
M+T%:$&Q?-+*C])S3Z7R&1AYL#E(%U@ZW%APYH#?J/W!F>WA.:#2-YFXB23UD
M0%4="Z^%?7[T8[=/PR#[8>6M9'WB.R5T@.*RFA*V 8;&[R +XX!PKIQ0%&\+
M0%K]1F(3"W)-6LZ9'_B>_> $<6ATG+X)UPUHFP,BV 4<4W\,VN4MW/ !4O/H
M#"3#[0>0.A&53(=@BJD2:]=^1 F$*K"/JJZ4IV?7_^R>'UMM$&!  1B-M1D:
M",<QL10.Z^R(^M$(R(W[A9I"F-%=Q\(.XX"O@Z1N.]UH?/0^AL,O2&E8NC>2
M(">URBD6QTU\%IZ?Z!H (9+6Q&$=C/9%65%73;]BWX>^&T?+OS(7DMAZ,ATR
MTPH;_\WN.: 0?W'4O1&R/FT8_\\P?J^QZG[IP\FQJL>_TU^_V4-AG)QDZ:C_
M=Y3D5T_@T>-[V) ?Q_8 5OG)=A_M:?CN8_90P(F8(?XLW9929S!XM5/!I[./
MZBC=9)_ VA8!/@5SLG,S%P,T_,%?W_W'\QKN*=C4)-E @IW!"U&"_N='^V^+
M=G)W&O!B/@4M9(3*#BMB Q$$?/>)\<3UIR ?P'@+X,I'$PAYV"9;2 )#H 0
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M=U1F@JR@3;Z)0,P]4RX@5RFW]TUNUQ*Y72OE]K;D]GSE?"FJ2U%=BNI25+]
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M413$,G&KRK& P%8F(O&P+<TD$;$J'A0]AD-_R.>7 J#Q)@=EE0/^W2;N&KO
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MN>X1QXF?./H[ 8?[--S#Z>/T7<3QB(]PC;[GSID7,QJO@)\&+/.!_3NB/'H
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M1\ 9H4MJ'?(F4)\C!?H[FC_1^VQXE;,3O!<GP%-6?9#T#BX6V=B^P2)X!=?
MCARDY'JE5Q9TW]7\\3<(.J"OENC#3_\"4$L#!!0    ( -=] U6S[>]'XB@
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MI$*Z9(DO:13G@3J64\[51TT^2,@R(')O#$3K2Z1>E[-;VK5,.&KORZ/S=]3
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M?L/;IR;(>KJ+YB.>O@\TLXI&*8@+2A"IK2'.8T0<O,?_LV;9URYI[F0A?:J
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M /_UXL/;GUX-T_D9#B8_O1QAF&#^Z<_^Y--/?V0<__.G,AJ>_?3'</3/_I<
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M3J;VWHMOEW_R/GRK'QU4,<WD=C@83T;3 J_CZ9V/CY_"8#[$OY/'BOEP,)-
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MMOD5_XMW_Z#9UAKI(J7M LC[\U'Z%,9X2>E+(H][2@5E5.1@6!&U8K4#7U!
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M11: 7 2REB)9[\(@)$6F?!8IH6R=&+$$RE,P(5M*NX,SQD6PZK<C_-Y/;@6
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MN *<]X30JJCD02M+)EAMU>62)1G%Q%,0L3B_^S5K"=CGPJP6NEK LHV#N]-
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M3[5Z2CU-6+BQLO60!:^-0Q!1"E \N5K#B(/F6G!I;60W#WCNV%>:0'K<7'E
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MGIDVMQ1=P]RHNT3]-C];7'9\$4%PRQ%J:A9AC+P$SS2'4"JERGE;!B9:WK_
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M>U][8&-F^$$ IV?!ZXT+]3]/5I_O,+/\GIOE][Q?%?2N/^N8,^YB=(;,+J]
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MT)O2V9>:&83Y'XOYDKS4!8;3RD!-R/D%RWR!'\-?QUZE%,@@H*N'(2BE',1
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MOGAUM%HM3N+9JIIN'^?OPH*VQAM<O2T?PU\WVRK9%+@W(9-5IPKMOL(@1*_
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M)V[I&N@"# P,P$/H!Z#/ ?=U IR? ("1$2 - , Q@(E!'C@";7%#4\OX!,
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MEB2IO^[NUCL=QL#DSWO(S%>JL2:UCUE<<*/D5Y"SBA="S@GJP<+&-F3@DG2
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M62Y@[E>S[HT+Z!%/!HCW%V=7+$6>LU1&GPR^33AUY'B"D>[DZ*FU=K^Y SJ
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M+W=8?)##&\$(H470M#?_"MJOH/&[[=K6V&!N:__3K#:>R4DK]!B!E68+SC;
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M&H@W@6M_R8FAN)%>_%^^B<<(*4>2]$0GY93I? $UVBJ;EO(=E-RC0LC98E5
MAE-.J<ZG/">I4\$K4;0J2J[%NBW$I>I&_L.EJO^+2X&SPU 4!5()5VD="Q#U
MN>*ZYX&1A'Y[?!_5D\U[EK84\\DMQ/T$>(OZ^#]\2L3B'Y_R_Y]\Z@T=F*U9
M@N%O>4*,BB7V/XRJ6&8!2Y)]U3F!F4VA X*98X;5"/+JX3AHM>,-'@C<I0,B
MX&Z>]RPX<X$.1*,<M^>1 YT4H68?J#',C,'7@S"0)5>%:(%KAYS0FC"3T]@B
M2?K'G*4#65H:WUD(9=^4R2R0-OR93P=BX(7$]SJTI1V]E12.-I;7 :?WT4N=
M-$X *CPXUP1+YZG@!R3?SVXD.UQLKXLYWR!MJW5_2(Q'BEQ=7G85'J&JA>QF
MOT8'KH]$$\3G.B()8+-ZYRN*4?[DFBULK-2^_/=%#XMG_I=KVRYL:D:=#@\[
M=EJ(4A"YTUWWY()Y1-ES W_DWWKX8,6"]WHP/C5POL9L&K2&=>#T!]7+*V0N
M_#P]&XX<A%%.*-)85S'5G:U[)-?Y#0-K7,W+2WJI/AK9C03-,.!H!V*F-O'5
M&]^'YM??UR)^<I%DH/QI_VN"KJC!8:=28JEV<],99SD-F>*?&,*.Q[%I3QF&
MQ$KM.C-"?'/NBT^MB=FH$\$/"/S-R.A#6%SCN:('3DT2^,5)VW';:R@G>],_
MSQP>I3H\-$M]IW\Z"5GQ9,*#7[/G=V%54>.YB8.#9ZY[>E/SERLKV!6\4,YT
M !E-33!&JH MLO#9W"S1?U^^H?6--DD/CV*-".;))CWMA])JESY/;_RT9TJ[
M?(O!:7SI1;>!?7"()#(,]ZWJZ9[#C?+*G/7!@T47TWS5.RY]1WF,'_Q]I,,;
M2Q#'\:7@T^<VZW ?4!L7E> <XXC"57ZY_8=A I,&PG@S2='57'[)[AHAHP;Q
M;48:9PFU"M7O,$L'7AQ>PO9YU;33)+AK\$<&)Z:JN?Q.=G>##8S^O/XT#CUJ
M$KR<(C??'S^9__G\B$@ \KK_@\L1"A6V^DU%0X''!)Y=_JGINIU"?$^:PWE.
M88EM!,FX_*K:!@)+^Z6GLMD/(WN3E?WNNU\Z-6;_6"KRZR#R-V;=DJP,1:-L
M?[UP%AE1[_]FD&1Z*V84=[^#;W6EXEQO,SAL, .UY-"Q59%K:<9))CUVA-\D
MC!I*Q=;IL+>'&BL7P1ML@MT!X],_K?X30U;!K\UA[8D1A_ ?:.89)_6]]_[U
M[MONSS04Q'X5%)5G71?E\#"^!NL?HX@XDL\%5,R.%N)WD+]K7"8Y4YB:!"M&
MV9&-R0,_]_G*]&?**GY]0B 4Q<, 2CMZ+9QX0'T#"=(I.Z(V8:S-E;0QZ7EB
MI5SV@U+;8D438L:J+RO7K?OE/-/7N8$,VBW*]8\S) O;IJ$]&<N2*@X5G*%U
M<:"%V^M;<6:#D4_,F;A798@S0"^M[,5A99.T!Y:X-H)2M8V&^;<%H)TCB(@
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M#WDZQC0SUGWO[1_=*V5"QE9B598+7K?KK MT65O&;G\M6+DT'YUT+UJZGZX
M_XUB@!%(OY.L9A?X,I4%)V3HRBGT'5UJ:SVK@5JZU! QLQ/K(VWX)M_,CJ&1
M"BNI6RD9V:7!NCP)B\"H3""Y!&=D'])Z]"=AR9B#S%L]]J;AUXZL)T!,**G3
ML/J\",/8>,K-)6L;M+O=\]U.JNK.GI3YQX+.TE7@?6!FT.(W8+4"[=L>B&US
M9)[<9Y 39]YB1GZ;IJRJMR@J7M5ZM5+O\=*7J',9=4 PHH6]\1HM@P!>DO@
M4S\&7,:^AZL0XR;0#(-HP\.09B_JH0".Q?BEA3ZO+]NKE<(<04XF'^"_&$$I
M N$$FMDB-8,N[BU<?89H]5A6\WS#4TE(R_MQP>*ZJN$?E0@^AXH;+"(J@6)6
MM8@6,3AW(-*$W$*Y!WN,;+$9;#T&1&)Y&N^ZAN+ +)O5"\X-4?>9\@:RQ'\<
M Q+\ZP,L)5]/W?_Z0P\4E&%(?EE3_UBI>*;1U55(I+AXHJ2AUZVJ;N_*&J7
MLRJB9'W/1GSX('B;I#.7'2V].(C2N7:R\]]>P""T K3JSQ867SHTKHAQF!RQ
MYQ^A^B9GQHE>5"[4O3$E+%G2"I_AZY>_R5M='_FARD 6DCFU'+VAFU+XR/.G
M]']Z'"/>B9N*I-3@J=%F:?I<_C'@^Y*_,S;F7P(]*0P+8L2)8\!):OXCHL6:
M+GV7R#H O 13IWTIV9N3;J,+-(-5C1O&T<^#\ILSF0_%WYPG2K[NK<IBNHZ]
M4[0(_!"<6<Y _\V,]^/)E*6)/-S"12B*J5GC]S-0E+(VGPGR";+E")/B)I86
MZ,1^#'!+4O&7^Y;QSQDH>>&[4<AXG/R2FHW03N"<O*JP2\,VQM71:^<'S')T
M8I.TB^G!$IXE3"';&&!LIR4$/&V.DPO/(0.7K%IH>@.T4B6H2UF"P^AJ;?3\
M4@_^.FM%9Z^(NN,SJ=MA3)? L$"C]M?DMM9ZMY)7Q=5'>;E6B<R4%K$[RSKD
MZUA-Q"O$M&<7G4U\44AQ$?)34NON$I EL,:B"ME)5T_6KQ_=BV,SJLF02))<
MJ8U7E!UM?,&K?$8HERNL Z%757+[ I=1=24F[CFF\L/SB%O#E^Y8 /\[C;YM
M<>U]CA$/XN77*L3EA :7G<+)S[E'T$I=I[K4*_?0[5\6WE1AZ 'E3LU0AKJ:
M83>(!UU LH15.Y8=IFQ;T&A>8*U;,3)]_^I17(7=@P/+X;*U-V4R!37D@U=T
MJ2.S6I-I$"E\&.&Z$XYT4"">38CRVHOAQT7CWGC<MM=;XDEL/?PNV>(EJU@7
M=0X@S&FXJZ L9=X^6F#@:V"@U%"UIR\G;!;WK(<5K^P"8S"=,S1R'464/KS6
M%@QZ"V-;1#!3[Q.D9(8#K2P(>QJ(J$9-;P&G>YE.+&*NW7,RK]J3ZZ*<H/AH
M*I;VHUD+IG9RO)<^M, $)OF-[B=P,?QO0+R,<JAMY\0\L'%4EJJ:TU([U^;G
MZ\VM>Q#WUO'PW46KL!GP_NFFJYOOWF>I^^IVJRRK!NF#-36UQT?@#<VQ?CI6
M_)K?C[0GJ>=&CYZ#!1 M8+H8^8MI)?D^P:@U>/4@?*=9.[#\C9"Y=7DHTE_C
MP4.QIG^"9%<7ER?!///8CD22/8Q!EL\ZT[[ O(CZ+0R03!>CRI=%VI!C"*#V
MX<"<Q\.KR;T"^S\$/8M3&[2B+L:OB$H>?O:.,)*"\I\SF_,(32D^M-UPE78X
M"E#\65M(]*'Z-U517P7SM9WPOLCM8P!A%%>EPS4*YX1I)>O%\X3I-@V5[$ :
M *?JW?/TDJS4^ .<YO?QZ?XHKUQW@HU-&T]323&4_=:#+#,QTW +IO\  ("&
M56?].2H?<E'T]UW(DD%CZ.*.H)*C">Z"44M]SDM"_[Q(^<_A\E\B0HM7?>-3
M22HQA5WH%R3D4''WA96;&C+#GU8L7-F9I!V+'/^=_Z7UU(W;>\A]F1O3]!6-
M]O^R,,Y\/?.ZQJ2)PX&L52>"\-HPDC%/]ZGVLTRP=-,5Q)A#3W,?.H%!-)N"
MSYX43BTF8WEEE!H$YPR/<$KE/)C<"UHCSI:5$N>_)?_'HG858'+7*K'!3<W_
M&) )/#(39J+]09&1?Q(*88!;B]I<]$:18\ PU&8_>5'9A: 275Q<7*UP^HKC
MNU6TJ<WXG\$EB$R-EB"=]:,BP]SFR R.[22'/@;D)EEU ,L@7?*_F9<7@2TE
MYVQ&Z"RSL,>A;+IE37S"[ ;RN>-]%W-V/I<\WHCK]%D=L)7P5T?78!>_U[L.
M8$XV*,AS$(B7=U" WV*<C:1CF*)84H/-P].%L0Q(=;KY.2T6NU@,8M:Y0/^%
M9:5*+%T +9W%1L'D<;+2AF-.)H!-GR"K)S:ZW(5"CM?*-A<4)+1#)L=6O0MD
MJDWS^;MW:9$0POZ!_>1L,-E"(OREE/%N*-(SXPUD/9S[]PW;J,NZ U/<"K]:
M6DCY5CW"ZL0$*A])FA%W%I&92L;W^.5D;"V'PML?SM@\'$"[-]W=-ER!5+\$
M,NRGP]B<%$K.6SH&3*EV62&YML#L2_1A@G".?SLVJO&FZ"6/"!'FM,DH((!=
MTN)<KW\1EN PQ\K@CRC"(Y"@C7LUWW3J\DL-Z9*FC(;91S@_6\M7UT]WL;(L
M^I<,DJ6 V_U+G()D2.O"E6;^Z<\ZMV <31X!]Z-EBK9(#YPH!C[?DFHN>K$"
M) )Z5 YCH9L*OOE:]9F7BRJ^KD&H%88HZ;T ]T/-/>V7MV/+AG.T\VY"IZ95
MX!G 9.S]3\> =R'##*H49DQ5L7A26!,\!. X1WTL#\5+D8\!]//:>7;K6(+1
M,0#0YI>[\,('\Q<C6=;X(2=]"FC5^,:2_12EN'$YL3_TK8-#X,ZG2<0"DIXR
M\ A>FXY:0GPV:0_>QX8W:B,*[7EM[57FC0JB8S]&Y7UA6K\ 8V),=CXM74N3
M\AJF]H642>[_M@'7(DZVX_7^+3^LGA0QHLBS;+RV-SK;E)%[FTG N==M]_1?
MS;<2WCX+WVRJD5ZE[E:6JJ;%$S6)2EQZP1H*4FW$,]'4>5H"UAU+]I4(\^-\
MBQ6N0G&[.YPC-!<$R8?!1:S7#P32$@LWD@=VB\TQ]9IM/@G2KJP?59W_*QSQ
M<V58B>S+0/!2C1!?^_*.K_CX5N\;#+1;T4Y>,4]MA/RW>J[$$SDPJ4,CNQ.X
M?C+<T<X^%'V.K-E*YZF=3%<=RQW>JY6QH>6PB]X^-&SHB7!D@P@FE/BEKH K
M(O%=A!W2=/D$NOGJ E2C&9G5>*OWA_T+9+H?ICM%7=C(3I<?*<B!SUGM6=MA
M/\('74GWRS+MNIB.M)VG^#4W7/5S5NL9ET=HMV*OZ?!2+6G)=$'X/!#S"E2E
MF]]FS9!#6"8=1!5K%A3(+3K_[B#3]HK8[[Q?O\ZX[$;30M!]P*E!4C<!M VF
M0.GCKZD/1AI=F0)SNJ!!>=WN.$'\/>E/9A=BM\1,%3IWX,&QDW4?;ZHY<7/G
M'EHF^B.[A#)0@\8)]^4:XAXD!\MF9&YUT_7G%RH>5Q*P[2C &VV3Q?Z:"#S\
MZJ8PK-YF72/X][-RKE_)W.&FIU'J+G/_PIYQ[3@D.H10;M-'''AH!70!%%>@
MCK:;MK!FG4SU9K!N)U+UTULCIYN)5] #"C\=O\:N7 WF"0S\T6V9E.X^M[Z/
M4,U;"+VT-FYLG(_(/ 8H:,5+_T/066A+P#!0)7[A YT#/NYP@3"?2&P#$SFR
MO L#$SJG90)X'70,2OFS:\/H+B^H3:6%HFX6Y\1@VXOP4GL[-B-W<5?_9V-U
MYQL^,;CH+,5J#8&/.RG_H'W%0E%3-1TH#KE&U65Y_D"*S:B<;-7@:3NRJ*F]
MC]#=Q#1F^R'N\)%[^?W6'+/>22HHB"BITCSKBJ%I<MRLDC=F>P>#"7C</?6R
MQ+=!?BTI59EW%#,]YP79F#\&!(/N:6GC*$"6%[P:CY$0C_R-=-=&_[2T:F(4
MKCI"^7QB=CR/Q1T !P!@T4-<($MTM8'Y8$*TJ&9>,K@KV4 UI@K$,6WS\NXJ
ME]9E*?9[ RSLSO;E:6?"S$42^T-X FNC)"U2N.N*I[&A 8=?>41[59*;&PY8
M);/+122S&Q$D21KZI(C0%^>0OVS,=W=<"<'95CJ_?F3?L9V()8U9#ER'_JJ^
M?,98)!$@H?ZAJ>C9\->"^H*0\@JO"1)EF[Z4JJY65X+<#&% >NO+/(2FH6-
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M! 6(1$@H3IR@/$G)0$7%(,#.S"[P/UP('P#Z$\<[R#1)2<X#Q^A)2.E)"*T
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MB/GVN\"[O?Q;;(,R!]H<RK(2#4KR!='9I95FT3EC"LV,='SMHATL]^"F5<J
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M/T-'30!ZV[()P)07#&L(V?S=SQX?(<1+ $BS",!TP4P4'^;].N27V/\58HN
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M"#C"RKTR,-0FX Q=@\7XF>1%6?1\5JH2[@!GP6$)NL,,4D L@>0<'"UWF'X
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M<DI?CC[RKV23(<KRL'O:7Y)7P6A",6'[;6:BSN6>D6%\X 6(O>7!ZG/+!B%
M>\\;)/5)]:CYJO(O^-_ _I U#@)P>1+7 %L3:,B&?2H )]2B"H+1V57=BR4
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MNL0E_ @8?D'I89-6\$HS6,]G8I]I2D#?ZK,'')9C+HB%><@AFN_0I02+;2$
M,+('*BD.>S=E:>O6AA#;VW0X+$-P[3 ^!#QX$6$UI+?R5I,]MCC@8VNPA>6C
M@<%Y6-QUXD"/7'"@8/4#[G)\+[BG,ZJA&U-9A]<&\"%3Q+'5C]2TOQ4C5_M
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M)ORC !B>3!4ON8T"IU0?[HZI70^F(  G5:*)Z6IBNCCK*-_.WP==E,V#31G
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M?T,Q-@I(^#<HG?C1*LZ+K)R?0OKO=\]C:5*E5]L]TV8Q(9(7\PJ^+:*:+N9
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M_]GH0N5TUN1Z+T&96[!@H\FBM;TW>ND::+61SC6Z_1C+.[J]6[X9$F+LW>K
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M#&[3X/./'$J4?MS=RXL ?J@02N!%)7#SZ]_J.@5X$1/QT/=_;G;R(DC$$20
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M7&"XF^N$YZ>&>^EGHEU8K[N "8I8<@^3,8DTX=OREDW8/MP<NCQD=^@"!,A
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M(G ;$\^>0+X#;<MX68=C _Y7%KW0/[+^*L-#P/XHVR:Z +%[64A$Q.04Y\$
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M4O]52^?5XC01K-R>0$=0ZRL'Q%FX^S#7[N/#6O:T^K) W,+WC6%@0,B@!FO
M4OR'#W?I&GN>:%\N:=#7&0N7N_&%3-!7<EK-?82CF2"#M!HOR;9VT:(8^L.C
M)LDO3@Y4GZS>;<_S3B[+DI\$_FQW$?-_81<\W#C*^0M6)I7;-Z3?U\2I53GT
M;/^&I.G-5-/KN]W4@".3*V/">-M\\:F^X7;WNW@_[6L=(=%A27QUWJZ38>.+
MY+6PP/+>9[J!A:NN*Y4J!](.!+'[]U)"M634JV:I4DF><<!].T\I>@\S,VY/
MBU?]E,FEO+T53VP2<V3UD/^JD2U>GYWZ2]<JF>%5UP+N&1OVZACDC#+WO0Q_
MTF7GKR?*Q+*R1'/!H(FTTFUQS0P#"Y6Q-O%\B=8RW1/DM_8R/^K[0B;7,'28
M#%3_LP\VM&LW!+H]1F&EW8-3\84FD;HQ+(R\>9&^=^<J\5I:A,%X33)V<8U,
MP5T+;Z\+;/6;"(:LR!#0KMP6B7\=!>YQGHR.O#IQ=8W$<%A@4_><XT7]4,6@
M"?'I1Q4WN D_]<M2=3PMZB?*U'<I4DFC@KN:4"\^94WW6CG9,45-$\0Q*)5_
M*ZR-E.?G?W S])+W&^'53 L%<97)^H-GGUH#]9=,\30?][#\PJ=?N_2,@Z:M
MPUTVTXZ.LNPG2RPSF$.@H-1M382+X9#!J(5PN9] K6VA@7*AKW.#=@YE<?L\
M9?)FXVHT"\5D6!N52#?(I0/T3E7O +W:-A@4/RO&6A]&MTM?7E3"^R;[IU'&
MW6[Q2KQ..0H'%=3]N*R2.[<5F-V\+:_KNG%?8S-[35,Y(BS,!II;_)I*HL/!
ML-F12/\E,^SGZ<<W](]O6VP4M+[CWB+&[Z$G5+.]HM#!*?E@, NQ:R,YOM1F
M9.=T%)AR)R TK'N.MYN9SF$2C%<LXR#:%;AM+?XHI]\XOS==P;+,J[?S"Y.K
M$&_+_EN5ET)WZ8R+,Z$;DG<1Y3^ZM[G?)NR\#?U^M[(R:N'Q^T6[ER.!>JCH
M3G/\%\&=<1VUY#1<E86"F==>ZLN7=MDZ5-GUDW1]ER5U,28P6LA&")R+:54G
MSO2]DFD'@2/U='L(@LFDO\FH^VZ&JER)^7]X\"[-9]PBFBXPOH[4'SVW@YT3
MC"2^^U106FY/G/ZA0$(JE2SQK7/$$;3"?"R?Q.:N[];(F(4!0\4>[G!](FX_
M@8G&-'V>C,3Y#,MDN[B>#8=?<W8&'[WIT:_J^1L91%^*ZO2N%C;!><@VZYQW
ML!69.:XV"B-.(21:6$1O R+(\I5GIR%GLMG[QQ)BOH\9Y.;)B%QAV#MQ@5;+
M97C@JN"5GN<[XC7\V2XS)XW& TL.>JC*$0RT")VVL-E69BF$/.:7(^AZI6NX
MU9SA-TE[,Y)71-QN,]I@T6O.AF3#@,77L&%H2$F-4$[1ASEW*GY"GN *,WZ.
MQ&5MI#<-6JZ=)LF"IC*$>/2YE!NE7(3;H5$!'L8<_[NX%#3/(A9V_=>Y^_[3
M^NK$E1F/$,N83\%NGU+OR;#<4J=;.A0I"NCROG0F4!26Y?J&:!<\B2_0T>ES
M/W50H+64H(3UFZU#G^LVLN&6#>':[9X,L?72W,&7%>_#$@@(PWWD"7?":]:?
MHQ@_8"069MG1ODJ*E1]OTNXZFA!6:OA&6(#VN2S;2YI:)"3$P:.G5A]/B\=V
M0A$)#.,BSH_/G_WJ*FG9U/?^"@QAFADHD#S@S;I-U_NE4F!!E[H,VY\4;_7'
M6UC?3R,(,YTYYKGPQ$4=*88*.V/=)ZU.%/H<4FKZ1?HL8A/V=EL3)<*6L^#I
M3R(-LN-LBW;9XFOZ^-M3ZE'/R6@1TE#(#7%&ITQS(0:&$+5X:],1R:'103[5
MFK@\VZYB/=10K9CE9N&C!:'VI&T)%WW==>Q;/3/B&S?L9NGMMO61\+VVE@G-
MZ881_^!/RE:\*0_$UZECNJ2CNIC'4-LZ1XVT0^\J\K<-)GZR'J5^M3;A[OH)
M ET9LA5UOO1>T@OQJ]!^MXTR$1N1KL"0<?_ L)U_$Q7!NR.B%3:&-^G;3[<J
M,&XARBG)C#X4\"\RO2'Y.4S\QL]NUDY$:7!R3+]P_VO];QCN/3WWR$:E2U,O
M:&UI9XT@.]:3IUK=>SNQC2Q6GCJ+ZN:>OI#XJ>RLJ>WM4>JL1QU;3A+2;=[7
MT#[&:?VB;5D;]V9&5UDF.X>^\1'F"..G="5:^Z5M:FEC:4?*E0C6O=\.7D]:
M%QC+I/E0"EJ^3OI"^;O(*E6O!U>V7[DNY7!OPT?C,QUIUHVZ1P4_'9+]6<CJ
M7:GHD-9)>[.M.K(YB?[PM Z*8:L:NNZ=&Z?O?SZ&2#V^BN+!*A0!KI1!UTGP
MOH3B,T0YS)^!$24;G?-"8%90X)5?RQM7D4!NVTMS=A'&R(9--825@)>@!XDL
MCRAR7E"!8:$N8/B&W/Q+R@L0"889FC,YJ[L6R7(T_]3,(5(P_*J:K3*]?)_;
MYG,S$DE?FX7B<)TOX66KUU]G=8DC4=]5Y)]T7BHE%+Y\<'@I#>4.=8<'"Y!P
MCTHUCK(AN&X:]HY(]I.D?63DQQ_>?Y22+;!AMT;SEN$>7#]XU#I37/)I]*Y-
MPA7AR608T2KU0MDA[)*KI?[(E?2\=54]_3E\)A?]L3EKT/LI8H=$ C>5T8J7
MC:#)<I=H_/M?CUZQ32G*D;$5Z[W%^R5<]'VSU9MQ;_5C18\C]91$9Y"M#D]Y
MW*NXU^<[0\H2WX17:NMLKID[)Q+7<M(XPL:'2LVJ[/45V%CV%>BP^GE%27,0
M$O.CXTCHA,Z3N)+R.XSUSCRTQ!0];QZ?OHGOOULW8 7XH+X3VD&%F;7ZKTP9
M]+ >WNLN)1/Y Z2/-I,/] .KV18SDQ%-C&.38Z>V"D5],")S%P:ZD,>Q7<X)
M-R_?/= S^J \T[>3<9S;%>!8,6J,I!R^CDX]$U5JJ(Y 4'=Y5_?RBK/I)TX<
M/($;#)9;2?$Y7MJ,T\DRX:K;.3'>G,QT/FTOAK3/XO_@L';CNLYWR*H@,-2S
MU]^RKP0N3).IM6D(8@%Y@=[QS <CX]H2-2;"_#"Q[Z?6>Y8G>E9X]T>I.A_Y
M=A694_NA-!;G4PHC3@''/SVJFDNGM5]Z$,.Q0'(+ZU:15)-^2]Z,V_2RMTFG
M+4A8S_AK2[$""AOM5N1*JX(H[Z[?S/WHK>?Q8:<]N"OJ\1J)]H#GY:_0'\:P
M^]'$[ADJ72N2"T^ZR=_Z]4VM5I,WKX#/$@H:F5PW-@9=E"_')=Q:%#%Z[W,2
MO,3Y3L!*NLUN4TOT+7SBGCJSY3=+]FRF<*FPP$GTN;MVE:ZYCE5*L4N>KBY!
M?3U(^?Z16/-ZBS"]V+4>FP#OVQZ[%94A>)\K%X0$?UZ :KXT9?(*VS#H3Z-A
M'8(3*2%,$2]K$?$6-SIKKGVU6Z%S-P+<UTM?D=OO"B3I7%5_G7AV,YS<CW7H
M7"=B#?IU]P-D3F"#8WZ;R\FR07'+IVB7>3_[TW22O1%)-1O(5A1/DWG/V9?R
MXZGH^L8[!F5PZW[=ZP8I-N9LX\W-QWUFVBDBWL*N7F]B]#(S?#Y4.B^SBF.I
M!/K&)KE]%BQU&[RI>72.T+1*%D-GSGO*1#W)%.MPXT[+0<?=RZX>"O55=8CR
MX0\+DRXQ]^JBA(CIEC!3MT>%<PH]2>;SZ>4-)]9Y,ULK#ZU^/H&K9,QY7XKO
M=-U;;$ZLA*SZ8-_4;ZH-O1X2OSW??^-5KZV ")N?CG-".'GZC51'D!6([-GA
MYAFMUXM62[$US*1;W+N@*'[)],1TA_DO]P[D*Q#<7$+C$_SE?&ZA@A0$I%(]
M<RE9\0RPA=@ZI"2+<I9REF2AE=6[K.L\5==-1*XI OT5BY&[^[6^X?D13BRU
M!64MO#MR@ZA$[B@FOKVZK_6[\@MAX4V#+P5H0]G1<4:M$L4 *3^OGP6$61J^
MP4'UK%^_W%AG'%^K9&WW9W76J\HULE?&;P#9,[#N^37"YYR;$,][O? [W%CV
MY5]EO!ZI63\NZSJ&5M*$N)9UW=RH7&/Q54!\#/;-3MG\TJ07!9FC6(O2[>!*
MUY7W^?J6[QN#GWPGY&%Z.AKV? _#+Y>A$^(4XPOIZZT.3RX%=[I1Q&1E%JY5
MT22[OXNC"4C4/=.LD EL=4"\9L;'!!^1<*U&RY5YM&;-%PY\U_@@M$W=0L?@
MQ2&XV(REK6FTK"G/"?TYF43<HG"L8G>J-9&781'X55/VDL][PDQ><3.IP5\_
M^@-JOYQ/_PBI$S3]>%7^IB">'K=[Z2)D7N=@6L^@ZKU9@RDT16ZJ=Z1D\+WR
M,)X^=.^.O[-LT[CJ O\S+.J@/[<?(JVC+7K_BXO Y[+)!Q[X258%&G*(5$+&
M5F')S\T+A9Q6XNH+TU[B<LS5I=$F]??5/H O^Z-\U_ P;@6J^1N\&.&:<(X$
M'8IA[Y]QU*P?A?L)$7>]78N?#F/8TBSO&$*''7_%6ONU\=\^G)"%T92=1V23
M\)R!7[5S!DXN;9_ SKT.D/%]VBI[V$]I:#-UK_M:) *^E,H0VTB[LY\,V,5P
M2_PVUT:DHZ62QP,KDI)HY0CLJ^\G&U[[9 S-7AYUAE?-G7GUI"V-<N+XXI=/
MQF+5)UF6O,E/Z@4RE*!0*]9XOE=TDPNR5R#I^'"D3Z)I@C+XNQ'3G[UBO$-J
MB<^N@!'0SJ3G5VBDGT%)^$)_[S9[?B41FDT#337^N]TL*QZZ$F_A_WNGF3DU
M=1:-6Q:-\9^]:_'$X F[+ 159Q:-ASK)WPUM\9TTK[,37P/\?+DK\2./^1.A
MPXC'W;V"R= *:2JH?PK4__V??_&=B6%YTJH5?)\J_FP:(_J[G<P\[7[.1(9%
M6)Y_X.2NAFF&38-J8@;_(Z5L&BN5UO_Q2]H<2"RMI\#TTF;*O8!P!N1@EZ&<
M'29@P?)AA?$S\:%[#BK:9H9[XQ4K>Y_EV@UF37C@X*YPH0O0"_2FOA.Y=O\+
MO2'[TF6% [$@&7*-6TS_#DL?XO^S14R%@")N09_Q#-9&XQ]3+SMJ"[983:N4
M5/,J"QY.>R^^J^7JI$RHF+V)I:J.,_S04YAV 0HRUN-)-&YV7=%DSWM!ZD)L
MG'Q3E9Y9??!PF_MHQ4IK"#]-VIBEUN2;/IC_:X^L(;=T^07(399?1()CR#R5
M3#A..JJ5BT<;L7VH>^;JE,"SRUSK)].V^\1?,TCS!=ZJ]<!4RD/]=[WY%A,I
M539FXH*4[A2]I1YK$Z/;MR2I[K-<:Y$5,?:)[GIB.9!7E)FM:W%JT@F',299
MV?J+W+:C)IRR9\?O!U/653;L%<P\U!U[4QFJ"RUZMQ!$\XIY@L#O_J=OVG=-
M5,R*!6KFZO2EG^\IH8,[HBY V]I1;<1KQ@=4=>1]=BTG;K\*K\.(VLM>"G[-
MMQ!-=O<@K/1?3[L6?H6BKUWMYQ6[ZI2,PY5:&M#^,'9\Q*G_JKY>98T+I] ]
MW>5JA$R]8.A@Y6-)G5+J[KX5.GLWZCBY$<G>+/3W=JCV*/_4QF@^X?AVHL:7
MI.OEWS[<IGO;>(6H15CXUT3?$%C7B\H@1#L&.^G&NI3RFI!TZ2TQ7A<=3!2T
M+/[HZRQ4DFN(N<Y?2]>0.+,@>IN5X(,FJY!C/[W$95,2#C7!@P<EM1>@3]/6
M&FY<V.R?ZBN.9U^\K6/6?ZD04F3H*<U_,6OGM1!UPNRZ>=M8F9:71YE\H0==
MK9'2,&&7Z].P)WMAJ=LYH3E3-^>EK(P8/7_H"G,.;;:^ZS^9DKQ(A^H7USHG
MQVM=/QK8J*V,<7-R6H NETS;EAI >VSH:_@BI6]>LMFL(M)E2S:^_\U1_Y%J
M*2J9@0,NE\!989FP>'8C:$))O*?\ZG>'BHSQ@V22U-"4M(8GP:#]7EI5D[V(
M8,?J7TF;22&]3TXY8/?',\*=G1_X.U$]9\CL7OR4B- >=4QX5YZ4>ZBKRR'!
M330?IUBJ&UN;S*Y-NDV;9VS>Z>Q;'659-.BH:'5M8H%6+@:YL*(8RQ\I#Z6U
MPP?9I<1D/F8PG)]F5/-50'O1]\$=(TSL[*TUYVVF/GP#Z49\MN>#6PS5(SQW
M*5RK+6JM?IV:;%=$45;Y!;VSOAP9_C++Y4:-N"-;\&Y.*AG/R+W1"K++KHDM
ML/(*17+*GFQ%M[>#^O)2ZO<^CQ7,&=%WR-I/)=LU1@CZ+)Z;GJE\JXOM5_^
M;^-@:<G:V4838SYN3/SCAS5!*(-;=U%G,.B +VW#[%E)39)RBF #ZHT%S'2\
M9GO>=&/N+8]2%\)%?*46\FT:UCHE!#.+VPJ0WJ\_#S"] $'$7!S[1+HRG<#_
M_WS-^6HPGZ(,Z/X#P40G<E!O5EC !#SQT7,B3-FV7*Q7WO/!1&X" ]6CC/VD
M88UQAO*W[H.V3/NZPVIN)!L//2-T^"7,ZZ@)(V?2HK=V-RHDY7+2;0_)=UJ7
M8660O"&OA'/M@WRQ -Q-QB]W7ML7CQN.P$25OREL-'W1G9*06Y5=!@AT/[F_
MPXVC<932'H"B-]68?I!N?QK1%VYZQX2G5.%\&=/+-F:"W?<V+;;&1=B&_3B?
M/QG\V;J5?G055@]/R,#VQYWUG,#W\L]&S]H.TO\$XSKPUCVZ )4M WQFF =-
MXV4P-\@C+$5F ZP>(JJT"8A K!C7/8*5W?^#@/R]X%#^:;C+LZJPPG,<L"HG
M=KV,=]T!OA!Q )F7=\R] #4PKL!:*\0[L*=81[<07+CN:J1^@N$XH,L= OB/
M?FQ',EW'Z9A^M%95/'S6L"^"#]+8]$72C? 1/VF$W3GZ O0(2PX?&V6<Q<G4
M97@#\X*)B@_CY#ETBR2$G8<XG*.;?F/B(+,A.(R!Q7_'!)T'_,7,;G$4[W8
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M9+CE?04=?P'Z,1,'% 7PYEATA.^EBRL#9>YN^)>G#E"R* >4R$SVX43+87#
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M/'">XUX&SZ99, A!C#MD).OEE([HM@B;3W!@/T!Z]JVFPIG3!;\EE<@S <?
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M,^<E>#(&GM&.$21#97]77@P%&O[0?WZK-!>W#J$R(XMXJ2=#]:/^>9Z$ H4
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M)]0O1-%<8662)@7Q<+/B#_034<S^BO/^^=N7S>'?NCIWC]!)"P.1-[=VMTR
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MXD[3 ONOQC]<1'HC*W;UJ_)?K'A*U79SZ%O]:\#>&%D:S23_-3 5]Z<X7NE
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M,D<\+N75,_;1"%F!:#:QU0;1<3)E\CKS50U?,8-=W*S>O6P83O$5FJMT,WG
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MB$!E@5;)"-N1R"N[S.EF%S3!!\VT$0KG'P)S2 +*%'YS2^5#]N5+[OQ@&'I
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M5WFF)P[E.M160V]!RJR*OO*.O3Q]?2S0,3E;F^*\2TET,?"*+"P5HB<M[UC
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M"^]30V*FE39L_!U !XG;,I=*@VV91,,?!95KX'OCX?=G('MFYPHJOQG3OU"
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M1N3T^,X:9+X:L3^4AM)O1N_'8% "YY+?C$8$9H<>KG,?[YE[]8%77'P&Q_J
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MYJ=0H23DDP:SQ\%IH%.\G1@T]X'J<>@_@-T2T(!CY7E#V\FZ>(/Q?\$=A^$
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MN6< ^D 7^K? ,,B<3.1>AM87+&#Z%-KI5W9\: BFD40]QH,+L8XKT\&((XN
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M2N]([P140.D=13J$*B"]&Z1*$^D0I"-(DQY*0O+M!+V?YWG/^W[7N<[?<WY
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M"[8J<:/Q@]8P2VK3F$[2.?/A[K6IG7'BW<L/#\ML!=)6 Q&*^HKG66_!<H$
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M[O[G?B9XZ'LBYE,>U?)[KV58&;Z84N4>H*%:7B\KF7U[U\_-<BJO;<FF(C!
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M4#F&@4*^?1M7K5(R(+-V<%C\]O5YQ&T>%170G(M"D6< PZ @V6R-R2^$?_\
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MJH_%?#]+5*C!P"&G+Z4H,I)TEH910?X%+FU@N#0^':$&/FLAIZ)TH>^0QB&
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MF;Z>"'E7!D1!P2;YT(&#\27<EG'.4U$,M!3.BOL)MNI%3?7^/L6&/51(L/I
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M)9?]R"R?XC@ KS#4YCD*<PYJN@C!J:"N*#(.A,6ME;BC$F>\ 'RK?%RJ^P'
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MGL17!,@_TCB9YOD)M3(5#6"[P;YIE(^^I?T/4K >+OG_7ZQ%S !.'C_P'-N
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M)LKS8 4.0EKC7W/>A'LQ0;LY00(AV>/IO&2J)&2OH2J\4D-B?N-_!6AY\G>
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MZB1S<:BPBX8Q*==UOS!'3\#RL.0>J XA&^\^=N9MJ:L=E'Z7JSWY*GJ/A,(
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M9&8RYCK5P? $\MP"25\#;0UJ#8%R'(<+>,WV2"-=KDTMKX#F :K;Z^"#\;^
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ME:^N*P$I ]@V_Y+J$_[12>BSJ4&JE^^J8BZN@)3O:A#LW"J+6$H<QEL-T5?
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MVBFS @RC:\Z&=V0T@T5+;&/9=> KKI 5_-P6L?'MFP<7F[ (_C1M@+;G_OK
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M7//T VRH#C-(EN?"E^4O9Y?M&GT.)86$O9!=4\I:LJ9C).B+^V_Q_?MER+!
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M!_Z]<"P ($30VB%OB5O)Q&WW*::8<<E\P1"8]4I&WW@A7SC'@=*V@\O!<\*
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M?ML%>-J2_MXS/DP#QK@-XE2$G0?_.8<)E:J$GABM4.E"07FW7>RW].05M_>
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M:',EZ3:"^!XXVVB]IIC6!-T#].F@7Q0D4/_J?F]82QB3O0AM@C4U$IX[!_?
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M @6SCQ]*% RL?X_JKZ1?RM0#1 6 $\@.E$I;9]$]1>; =J4N7)<+.0$):]_
MP;=Z :*W.^V9H[.3@M*D([\N_ISN>3BE'46DTQ::9^<(=Z$S*)1OJB;'!G6B
MR3JS 4,B:E@T$##2U]TB;L5G7Y[*P=ONNS .T5;G):%DY-\=J[]SN^&[L5N]
MP15]VW^E/7\WFMD\K'=6?B('W!I-O$?HM)&N[4_0X!!==J,6_70/; L#'GM$
M.R)T1\X&Y$>/_ <4 S,4OND/=FPZ>&%YXAKV%WG+C1KQ-?C\R)6)FW\1>,C9
M= 3.])49'A_S$]H//9<%WQQ@6_*>MQ",&37 >C9E*1IOMB,59>@SO(ZT#7C&
MNBX"@BI [VITXBG<BO$4'^RUTQ5NTHV?9.%R_..9B213+F&V'^532=H\0F!9
M,3_4!6 JP+0HP 14Y&6>6B!\3WN:G?:?V++3%0AW !V'_/% @"F/T#]>&2GP
M[_B.BJP<$X*EY!.F+)0"3%M^9<10%9FGD@"_:JCX/P'"'8N"?P#L5CJ*$V!@
M6>XI"AP!^R?Z$:H%<JO!U&=_D 0$XE550P&5O]!E!<)E,12F7+B_DH@PNB+A
MJ"(AH#JF.H(42(@)TS\!<0$0?_L-Y.7F9:'D$<9G^Y%4$[K"/&0BQ$0!^%7$
MLOT(5<<P=0 5N H7Q%"4OZX$\3Q+!?)![ $D7M459@&<'1NO##SU4L4TF #
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MQ#V 'O3A'A K <%NTI>ON'&O46#]S$6>*DG &/3]419HA'D1=NN%XF,C03_
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MO/8@4FZ<BDD96]@!E:+,$DTI\S0T?CJ^*BYLMA+@,FRL"[SBF\#Q<9:_XGP
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M#P8V..-!GA6K;K+1XE[<'V6A0S\:+(WD=2R:AH,G]]\G93SAM&[5[]7VT7Z
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MT1G<!"T2OXABJZ6(;RZVS+.0>)&/-'Z>4$[+6P!%[FMCZHF^WRHF[0TL@NB
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MS,&$Y! W3FHB7#ZV!.-6.8;7X;9KJ%7 N\_/%N9-?O3MN?L(![/@N(NA%'"
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MNC3MNO$@^SXB0B!!L]_(U&#)4(D&E-R1L&=MQ5/XD4Q?I\V.VG"13:;%5HR
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MXBVSV[\"6M[]X;X%!T^P#[$:=S_0(C+9=^V2< 796X0>B\OI>H'>+.Z16HZ
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M*?/YA('2UJO;4[&)EK1Z;6FZ?>8C"IT<7\J[:%CV'AU3M/3L]U\!&J/YF<B
MX%VA&@D:O,@ISRCFMXHJ*VI]Q^V0PSX(\7V<%K !R6X!Z(/#$BD1*M@*?_?D
M <4?99,?)@!.Y"TZ-5R8ON7JCX4?'A(+43]1.AJ>XFN]A]H89:?D'T%T07(=
MS$9_/E6/*$UY@ZZ )@.2,AL"RP-=CN#Z"3,[+F47B\NDH+6BMSCSE;%-S,B-
MX!GDQ-<K8%%POV>#R0I-N?%63:3[D+^B7$ ZV=%S@Y.F47%__/P*>#M2X*&S
M%%26(SA!:F-9;F']Q9^_QD)L_;'5N\657@Q_]<01'YFN^;#!\X<UX71.T"<
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M6V?JR$2V+10Y!X):6R^050O.Y1FY"6R+?!*A2<N&#*FLE*X-.6P]:1K0&LL
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MW-<@2%RAHP:_BSD^"2EN_%,T$JSI[H>.PW$ST09R?'=UW6%]&D74F;KYB,@
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MK?G/U>9_& R\LJ]XKRV37#E^$N/?N)7AG^NFE4K<SO!-O*$;#QQS?^^0W@]
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M1L0/UD:75LD*\.Z$(.C7NOO3GB@7[2"*?^!K606OL9P8,E1Q28MQNO)H=4Z
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MAJ^61S(#YU1V"2S*FW#;G3JBEP;#Y5SJ"/&8=+[_D7LK#N(--K8&%Z8255\
M:SRGSS_<?)0TF#MTJ):V!ED2P19!7PML=_KH"LK*>(@+<S\/OKSVU<\A(LS
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MT=<I<Z=2'F89S>)_,;_ QAFND?Y<6/.B%&_1OUNB_R^7J7)>E*@]L)/P27D
M"JY#)B^>!_:7@T?^FL0T90 F1@Z5%R56A0$(6@/5\<J\6O:5XP ZRC:EA@&X
M9Y.<P5Q>E(3Z>)):V,!%'K!K$_C*&L#6)WTRGTE" !0*N"H4.0SXK':5_HZ]
M^&3VS  (+*$<-C C 9#X5V-+P3_O8\F?S%+VL9-A>. !R$VH(GU@.FF?)51$
MZ ;G[\4"K,4I.O!&B"<X/ZDRR0$@YGA"QN$1F9$A^\-_LF_MV6G[MM*HV48"
MY*8K&P1\VB)AJS.IHFPC 4C<^N7=SX3%1SM3>X%N +AA=\LXW-Y8:.3=UNPJ
M8=%['XE(B&Q$M[X_B##HXI\%4-$M8!<.WW6,B(MLCE39"VFYP]FT7S^UN[E=
M"$R"I+Y!G3$;205" ),S;&^9,'H.\7!EY_0 D_B_[W_MR_=M]#=02P,$%
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MQ)^5JZ_VC"_@KP^M%I4H+3E_,K"S//*^YKS(ECE=KW3/\T/+EURYU%H7_[S
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M*Y,,28@#$X\)&'@L)L)54V84O;TO8FK4M_,:]DIX.P!D'QZ;6)J;(3)GTLX
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M=G 8F>R?CLB9VC*P5A.H!1JF"T!K3<VV-L=@U=M\6 !K8"[?P$FIJ J>7YW
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M/YA&?DQ1 &/"Y6+O408Q(AR& 4TB1E5XN%;DV\ZXDUNDE6J&AR2[4'6OIF<
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M(GK<4.L>H.Q%5/<9XYR<YNUKZ.*1_R@_2J-^GW$<QI&#'<BEWR+IS$T@%D+
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M 1,G#-2>AT,L$%.!""AP$>&!TZ^JV/FZ36UUVRRT55L'6O-4'N;*P"HCL[@
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MH;0]]C&!R!(%:8D<E8=,0-@E(Z-G+>605&6^9SX2L2-W1C F1'*0[R7R)QQ
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MQ$!+^-HBQ3.U&9=![4"W1[>6ANUYEE@=6,Z(ES 4,@$#/Y$42UT,,<<(^K'
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M=R-L2<N;Q56V6'"JOH5_2\NGC?W*S G=($A"#_J8$HC<P(=)$" 8^]A+Y :
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MZ%?5.RAB:@M"HR3X_B0EJI)>1H?C!T'4N:8X%YJA]XD-*NMNH.;<?1@<DXN
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MSN#6 E-G_G'"R!,/V<D<E8^<8'C)2VXW^ZC5?*KPVYQ&>5R@1$+&I%[G1:J
MA"<84DPS3EA$DLCIC,U.[-0<GFV9Q,=-F<1M!>9K*BZ?1-V.COQC&9B/7,I/
MAJJT? FF(&663PI]Q1K+EX X7V#YXMW7!5PV44-?))?EL_$#NI@U)+C$,L50
M*9E!A$@":1IC&!<1%X(@% NK$I!6TJ;&0?UXMC:0;:?QL-C XR"?YQ[OT 6F
MG'.H71E:>1R^87&55\/X"D&5UB_AX'C*LZC8!E,>?\BK1%*>M>=4&.7YFX8Y
M?Q]H634E;WH'[;]):G(%Q9TYI'^J-*%_>T/KLOY]N6*F9(41?KM\?%J;,WQ-
M]HNR>=?>_-R&D[Q=T+I^MS*MZ^<IU2."<@45S4R)>ZP7MH5DD"0%ERP1(DUS
M%[\QN,93HWMC<%=#BOWLA>PT*H,_6J4=#P_"#[N=XSJIP0P\ 5TYCL[>[FC8
M>G*4P^L[JH\]&OPOW?/Q! _P[(]$@ND9KBZ%;"MSW%=T6;?9J3WU;Y=&:2G,
MRF->8!ZG62)AFIL)Q72,HGF&H,RH0K)(I:#VOO_U^DQMNO@BUV6U+62^-MM[
MBQ4]'<<99(PLE@[C(A^8VX]'XN[9 WH&S4#/)+"Q:0:,5>,.E,,B9=P!&VD9
M,\; N:UZ_,%\=EWD0<QX*R=_F.RMK3P^]HH,-CT12V%"&.2R;L3>5%KNMX;"
MW_S<7=)ML-W\22OQ_C^?])R\VX2KFSB(^^]T>?=H'E'_JA]ANK.TNW-SS@A/
M6*H@Q6D!D<E3)AP1R 7/*2E2111Q:IDRDN)3FUP;[:0 OS3Y=;:% T<?;KO%
MUQ0',? \W=@#&X- WVC0L]JLSOK7=9:#QO09:(WO'5[47;#96ML/.@!FH(7
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M!8US@606716L/A#]\0/5*Q-E_0NM 1V8?'\69[LEEB_T D_!A^'IVU1ZK6G
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M['K7-'U'5\NN %;=W= OA]74P?I+D "(ZT?*(3SB"F&O%3QQ/3YG0BL\/'S
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M%EX^R^:83IH6*I_D^D[=TQ_;+?!=E?K[55NC?HY$5*1$*9@GF5D,JEA[HT+
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M]JG*$Z$B_2_;UIHG9$QMRMRH";9Z=OO]]OTT3Z%Y?O[RA%'@F<0='J?^F1<
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MR*DQ1[]3JO#1*?4(RG;LX1>[P"1RV$'UER,]9STZ,_;H!&JM>D3@J[99/0W
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MJ1X$S,'6]+"G#".X7LQNNU>QWN8TB3B3B,4Q3"/*(2HB!7&!4B@UC>4Y%ZS
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M:93G!<R%Z9N0(P)IG L8QWF>*(JER)SXS%[TU!CM6%-E;M\R>0#V=EP5!M'
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MYLI-;26?&]]80&Q'-WZ!ZYEM*F&OP$'KB#68-^? =.8:>WP\48W%@(,RC3T
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MIE!]&"+($")0(D$)I22(DM"I ,'Q<<:V).R'VDS+8CS3[8PY5A0X@:X=3WO
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M4B:9"C*>!0C&IKTL2K,$8A4G4 19AKB(22I4]TC+UK%':LL]Z =]HX5IFZV
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M)4R8"..("R)(RAPCC"\5:6S4\S&?KLIS?:F4Y.675!CY 2NC0'@S6J3A9BG
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MB@>Y*+TZ95Z)%!.2!2P-DDRS8"0AHI1#(DD*999@P:0@S"TNZ,0X8S-L:['
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MW\:3CW\))V<X<I$I[ZIOQ06M)4<"<RCK$6$QS);B&#YV^KH-=M8BK <L[02
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M=SI/7.L4G*/@3@ 7M=VE41Z<]A$\K9C(M.#&MDXP;$KCL&.8&F]N>U70=P3
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M\6Q1[X%_F*Y&4ER%<.BY#L&!-)5MDB5X)%&RX,FM]IJL>.OA"(U([^02X@&
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M"R2"96F1&3"ZSC;+@H(1BDG .&ELE"FJTOKVSW;W>_8YF7A_*K]MP7:2_]8
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M<#T:UC:"UZG>X/4.67$67>L$[7=^B6<C!&QZB6<3=70 K_OODF2M>28' ;+
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M>A31!*XLY,AHF6B129J"&%9<)YLCRN9=BG<F>MCBS>'<KL-JNP-XOYI./G[
MV6F=1CHRG"ME+2W-5-N5A)#!244N1TJ,HIEBBVN]G5Y__O>92MM2]=-&>N@
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M6I@?M5"N\)QEZ\/=IZGJU\IL@H\''9DVVN@@,+_DZ*_3V=^/:Y27*.Z[R9+
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M18<L0I!2 W=<T.]LR4D-<P$?_$9_Z#A D\OV8NW [#R2UWSY\_?PW\O5JY-
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M4L.[WV]4//@;QLU].VJBJHO4'+#B-,4 1M;US 9*RHX)I6)4K:L$[Z?D\+J
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MT%TO(GJ[7I^&1<(/I?([LX)[8S0#5C(%KD%*<((XV69OC:?++[=>9_\P-<-
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M]K=3LK5?SIZJMDFZ];7L;KD606]W8<PW<US/>)8!Z\)'S@3YDG7:5.3D6L;
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M>K0*E.YNT_V5T5'!MBKHS_:KJ")JZ;(#;ZP#$;@F^^UU,8,&I3RO@NV=E/5
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M "47!\HZBL=C(O$8EX24+@?5>L+\L]OQN9.VA^_XW$7T'8+HOK62/(EL@X#
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ME:^/5Y?I*PFP%GV>H[3"<5M?2&,"91VK$]L]%.]XS%X;(W^9+M[IFT<N73B
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M\B+[O.E"(3EF <;J1#$UN13+I16DQ1PLUZ*8?FJ0=^/QQ;SZ'\7Q'!* +^&
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M>+H^%F@_3.W?R?R?&^^-K-5&L?8_*,60 @*TP SW(0>,F%J_-NU/];C>;?<
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M(KAOK*8^ ?CPL7[%F0LQ\N@"6%-7I"CMR:";!,(C%I>T3;IU#FUSZL8-!L<
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M*G"?\-.C07=0[S1I(@08W#3A KO4^L<XK%+6#WEA]F]"Z7<,;-F33^BZR-$
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M^=\'I[!QGWA%LTYF!JLF?(Q<6]C=378I[IV7D\M/?U7:7=J^^A]02P,$%
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M@AUGZ<&%ENUCJDC4ZIPL,W>6S>;N?5_(V';MZ <:=D;#WBVXLSB0%GN+=H*
MA)B]68B@]WXC^P,!SP8!!Q_\;P.X^&LP.%S'0<N)PR=JXT?7B'/M[U$/_*^&
M$UB[6+PD6R<^V\LF/$3&+>WV)MMT^-9;RM6GOS/M;F]?_ ]02P,$%     @
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M+3(P,C(P-C,P7V1E9BYX;6Q02P$"% ,4    " #7?0-5UX\3H0QI  "4;
M%               @ %$E@, <&-R>"TR,#(R,#8S,%]G,2YJ<&=02P$"% ,4
M    " #7?0-5N!H0YDNH @!U* , %               @ &"_P, <&-R>"TR
M,#(R,#8S,%]G,BYJ<&=02P$"% ,4    " #7?0-5I8+JGR Y 0!:_ P %0
M            @ '_IP8 <&-R>"TR,#(R,#8S,%]L86(N>&UL4$L! A0#%
M  @ UWT#54)!(/IIQ   5 0) !4              ( !4N$' '!C<G@M,C R
M,C V,S!?<')E+GAM;%!+ 0(4 Q0    ( -=] U6XCJ#X/@@   \N   6
M          "  >ZE" !P8W)X+38S,#(P,C)X97@S,3$N:'1M4$L! A0#%
M  @ UWT#5=2D3_HY"   &"X  !8              ( !8*X( '!C<G@M-C,P
M,C R,GAE>#,Q,BYH=&U02P$"% ,4    " #7?0-5A_LWCC<%  #Q'P  %@
M            @ '-M@@ <&-R>"TV,S R,#(R>&5X,S(Q+FAT;5!+!08
.."P + -H"   XO @    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
